{
    "56bc751eac7ad10019000013": [
        {
            "text": "zex disease is one of the",
            "probability": 0.0681088506928361,
            "start_logit": 1.1946604251861572,
            "end_logit": 0.6699693202972412
        },
        {
            "text": "is characterized by psoriasiform changes on the digits, and in some patients spread to the ears, nose and in later stages to the limbs",
            "probability": 0.06697294732828897,
            "start_logit": 1.0659804344177246,
            "end_logit": 0.781830906867981
        },
        {
            "text": "psoriasiform changes on the digits, and in some patients spread to the ears, nose and in later stages to the limbs",
            "probability": 0.06517306985208161,
            "start_logit": 1.0387380123138428,
            "end_logit": 0.781830906867981
        },
        {
            "text": "Bazex and report three cases which illustrate both the typical and some of the",
            "probability": 0.05553582884866459,
            "start_logit": 1.1006436347961426,
            "end_logit": 0.5599073171615601
        },
        {
            "text": "Bazex and report three cases which illustrate both the typical and some of the less common changes that are seen in the",
            "probability": 0.054470849621280806,
            "start_logit": 1.1006436347961426,
            "end_logit": 0.5405446290969849
        },
        {
            "text": "Bazex and report three cases which illustrate both the",
            "probability": 0.05260869299875097,
            "start_logit": 1.1006436347961426,
            "end_logit": 0.5057603120803833
        },
        {
            "text": "zex disease is one of the rarer cutaneous paraneoplastic syndromes.",
            "probability": 0.0519619215920475,
            "start_logit": 1.1946604251861572,
            "end_logit": 0.399373322725296
        },
        {
            "text": "Bazex and report three",
            "probability": 0.05029024297548014,
            "start_logit": 1.1006436347961426,
            "end_logit": 0.4606900215148926
        },
        {
            "text": "zex disease is one of the rarer cutaneous paraneoplastic syndromes. It is characterized by ps",
            "probability": 0.04856690368850253,
            "start_logit": 1.1946604251861572,
            "end_logit": 0.33180445432662964
        },
        {
            "text": "zex and report three cases which illustrate both the typical and some of the",
            "probability": 0.04807488332717282,
            "start_logit": 0.9563751220703125,
            "end_logit": 0.5599073171615601
        },
        {
            "text": "zex and report three cases which illustrate both the typical and some of the less common changes that are seen in the",
            "probability": 0.047152978438675434,
            "start_logit": 0.9563751220703125,
            "end_logit": 0.5405446290969849
        },
        {
            "text": "Bazex and report three cases which illustrate",
            "probability": 0.04655909787124535,
            "start_logit": 1.1006436347961426,
            "end_logit": 0.3836013674736023
        },
        {
            "text": "zex and report three cases which illustrate both the",
            "probability": 0.04554099273105244,
            "start_logit": 0.9563751220703125,
            "end_logit": 0.5057603120803833
        },
        {
            "text": "Bazex and report three cases",
            "probability": 0.044353326273887266,
            "start_logit": 1.1006436347961426,
            "end_logit": 0.33506664633750916
        },
        {
            "text": "Bazex and report three cases which illustrate both the typical and some of the less common changes that",
            "probability": 0.044095115394710706,
            "start_logit": 1.1006436347961426,
            "end_logit": 0.3292279541492462
        },
        {
            "text": "zex and report three",
            "probability": 0.043534014233038966,
            "start_logit": 0.9563751220703125,
            "end_logit": 0.4606900215148926
        },
        {
            "text": "is characterized by ps",
            "probability": 0.04270270700353599,
            "start_logit": 1.0659804344177246,
            "end_logit": 0.33180445432662964
        },
        {
            "text": "is characterized by psoriasiform changes on the digits, and in some patients spread to the ears, nose",
            "probability": 0.04193473778403277,
            "start_logit": 1.0659804344177246,
            "end_logit": 0.31365668773651123
        },
        {
            "text": "ps",
            "probability": 0.0415550848131612,
            "start_logit": 1.0387380123138428,
            "end_logit": 0.33180445432662964
        },
        {
            "text": "psoriasiform changes on the digits, and in some patients spread to the ears, nose",
            "probability": 0.04080775453155374,
            "start_logit": 1.0387380123138428,
            "end_logit": 0.31365668773651123
        }
    ],
    "56c1f01def6e394741000045": [
        {
            "text": "survival primary end point was",
            "probability": 0.1155340076384991,
            "start_logit": 1.0201139450073242,
            "end_logit": 0.9551544785499573
        },
        {
            "text": "of orteronel with docetaxel. Recently, the ELM-PC5 Phase III clinical trial in patients with advanced-",
            "probability": 0.09923231982903433,
            "start_logit": 0.8099961876869202,
            "end_logit": 1.0131710767745972
        },
        {
            "text": "levels, a marker of prostate cancer tumor burden, and more complete suppression of androgen synthesis than conventional androgen deprivation the",
            "probability": 0.09463711180906961,
            "start_logit": 1.124162197113037,
            "end_logit": 0.6515910029411316
        },
        {
            "text": "of orteronel with docetaxel. Recently, the ELM-PC5 Phase III clinical trial in patients",
            "probability": 0.09137507379963522,
            "start_logit": 0.8099961876869202,
            "end_logit": 0.9306800365447998
        },
        {
            "text": "levels, a marker of prostate cancer tumor burden, and more complete suppression of and",
            "probability": 0.0864438376842973,
            "start_logit": 1.124162197113037,
            "end_logit": 0.561036229133606
        },
        {
            "text": "onel (also known as TAK-700) is a novel horm",
            "probability": 0.08004441199438068,
            "start_logit": 0.8745791912078857,
            "end_logit": 0.7337059378623962
        },
        {
            "text": "cal studies demonstrate that orteronel treatment suppresses androgen levels",
            "probability": 0.07878107422806492,
            "start_logit": 1.0363893508911133,
            "end_logit": 0.5559869408607483
        },
        {
            "text": "currently in testing for the treatment of prostate cancer. Orteronel inhibits the 17,20 lyase activity of the enzyme CYP",
            "probability": 0.07428755954825289,
            "start_logit": 0.9856385588645935,
            "end_logit": 0.5480084419250488
        },
        {
            "text": "currently in testing for the",
            "probability": 0.07260735940769077,
            "start_logit": 0.9856385588645935,
            "end_logit": 0.5251312255859375
        },
        {
            "text": "prostate cancer. Orteronel inhibits the 17,20 lyase activity of the enzyme CYP",
            "probability": 0.07188025607489529,
            "start_logit": 0.952696681022644,
            "end_logit": 0.5480084419250488
        },
        {
            "text": "of orteronel",
            "probability": 0.07020170613955352,
            "start_logit": 0.8099961876869202,
            "end_logit": 0.6670799255371094
        },
        {
            "text": "onel (also known as TAK-700) is a novel hormonal therapy that is currently in testing for the",
            "probability": 0.06497528184662656,
            "start_logit": 0.8745791912078857,
            "end_logit": 0.5251312255859375
        }
    ],
    "56af9f130a360a5e45000015": [
        {
            "text": "channels with P2X and NMDA receptor channels",
            "probability": 0.08672186036354819,
            "start_logit": 1.0323309898376465,
            "end_logit": 1.0182583332061768
        },
        {
            "text": "channels with P2X and NMDA receptor channels. This article is part of a Special Issue entitled: Gap Junction Proteins edited by Jean Claude",
            "probability": 0.07311061812778034,
            "start_logit": 1.0323309898376465,
            "end_logit": 0.847525954246521
        },
        {
            "text": "Gap Junction Proteins edited by Jean Claude",
            "probability": 0.06754166947804116,
            "start_logit": 0.9531021118164062,
            "end_logit": 0.847525954246521
        },
        {
            "text": "D-aspartate (NMDA) receptor channels. Activation of these receptor channels by their end",
            "probability": 0.06540155699781368,
            "start_logit": 0.920992374420166,
            "end_logit": 0.8474370241165161
        },
        {
            "text": "leotidase-dependent dephosphorylation of ATP. Here we summarize the current knowledge and h",
            "probability": 0.060693589356052124,
            "start_logit": 1.0105562210083008,
            "end_logit": 0.6831651926040649
        },
        {
            "text": "D-aspartate (NMDA) receptor channels. Activation of these receptor channels by their endogen",
            "probability": 0.06035463864357838,
            "start_logit": 0.920992374420166,
            "end_logit": 0.7671287655830383
        },
        {
            "text": "channels. The",
            "probability": 0.05901987218184824,
            "start_logit": 0.9054279327392578,
            "end_logit": 0.7603296041488647
        },
        {
            "text": "osphorylation of ATP. Here we summarize the current knowledge and h",
            "probability": 0.058250558000135524,
            "start_logit": 0.96947181224823,
            "end_logit": 0.6831651926040649
        },
        {
            "text": "leotidase-dependent dephosphorylation of ATP.",
            "probability": 0.054999035893161706,
            "start_logit": 1.0105562210083008,
            "end_logit": 0.584642767906189
        },
        {
            "text": "leotidase-dependent dephosphorylation of ATP. Here we sum",
            "probability": 0.05461103969755927,
            "start_logit": 1.0105562210083008,
            "end_logit": 0.5775631666183472
        },
        {
            "text": "D-",
            "probability": 0.05342832963402151,
            "start_logit": 0.920992374420166,
            "end_logit": 0.645232081413269
        },
        {
            "text": "osphorylation of ATP.",
            "probability": 0.05278522104619421,
            "start_logit": 0.96947181224823,
            "end_logit": 0.584642767906189
        },
        {
            "text": "osphorylation of ATP. Here we sum",
            "probability": 0.05241284242869004,
            "start_logit": 0.96947181224823,
            "end_logit": 0.5775631666183472
        },
        {
            "text": "membrane spanning molecules that have homology to the",
            "probability": 0.05093706992540981,
            "start_logit": 0.956653892993927,
            "end_logit": 0.561820387840271
        },
        {
            "text": "membrane spanning molecules that have homology to the inverteb",
            "probability": 0.0509233759827222,
            "start_logit": 0.956653892993927,
            "end_logit": 0.5615515112876892
        },
        {
            "text": "channels. The best-characterized member of these proteins, Pannexin1 (Panx1) was suggested to be functionally associated with pu",
            "probability": 0.04944908713191919,
            "start_logit": 0.9054279327392578,
            "end_logit": 0.5833989977836609
        },
        {
            "text": "channels. The best-",
            "probability": 0.04935963511152443,
            "start_logit": 0.9054279327392578,
            "end_logit": 0.5815883874893188
        }
    ],
    "52bf1b0a03868f1b06000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52bf19c503868f1b06000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5505edac8e1671127b000005": [
        {
            "text": "LIC enantioseparations carried out on polysaccharide-",
            "probability": 0.09393351178842028,
            "start_logit": 1.1042327880859375,
            "end_logit": 0.72959965467453
        },
        {
            "text": "comprehensive overview and insight into the experimental conditions needed to operate under HILIC mode.",
            "probability": 0.09356518047823129,
            "start_logit": 0.9764688014984131,
            "end_logit": 0.8534347414970398
        },
        {
            "text": "comprehensive overview and insight into the experimental conditions needed to operate under HILIC mode. Finally, to stimulate and facilitate the application",
            "probability": 0.08034113676679232,
            "start_logit": 0.9764688014984131,
            "end_logit": 0.7010582089424133
        },
        {
            "text": "LIC enantioseparations carried out on polysaccharide-based chiral stationary phases",
            "probability": 0.07632983806206316,
            "start_logit": 1.1042327880859375,
            "end_logit": 0.5220763683319092
        },
        {
            "text": "), which is a popular and largely applied technique",
            "probability": 0.07083029874631708,
            "start_logit": 0.999424934387207,
            "end_logit": 0.5521071553230286
        },
        {
            "text": "LIC enantioseparations carried out",
            "probability": 0.07068527187703698,
            "start_logit": 1.1042327880859375,
            "end_logit": 0.44524967670440674
        },
        {
            "text": "LIC enantioseparations carried out on",
            "probability": 0.07052452235860208,
            "start_logit": 1.1042327880859375,
            "end_logit": 0.44297292828559875
        },
        {
            "text": "), which is a popular and largely applied technique to analyze polar compounds such as pharmaceuticals, meta",
            "probability": 0.06840561938647777,
            "start_logit": 0.999424934387207,
            "end_logit": 0.5172752737998962
        },
        {
            "text": "LIC enantioseparations carried out on polysaccharide-based chiral stationary",
            "probability": 0.06706719871214593,
            "start_logit": 1.1042327880859375,
            "end_logit": 0.3927075266838074
        },
        {
            "text": "comprehensive overview and insight into the experimental conditions needed to operate under HILIC mode. Finally, to stimulate and facilitate the",
            "probability": 0.06373254558369075,
            "start_logit": 0.9764688014984131,
            "end_logit": 0.4694717824459076
        },
        {
            "text": "comprehensive overview and insight into",
            "probability": 0.06209913040818769,
            "start_logit": 0.9764688014984131,
            "end_logit": 0.44350841641426086
        },
        {
            "text": "analyze polar compounds such as pharmaceuticals, meta",
            "probability": 0.06195062501045624,
            "start_logit": 0.9003076553344727,
            "end_logit": 0.5172752737998962
        },
        {
            "text": "interaction liquid chromatography (HILIC), which is a popular and largely applied technique",
            "probability": 0.0613170705641718,
            "start_logit": 0.8551963567733765,
            "end_logit": 0.5521071553230286
        },
        {
            "text": "interaction liquid chromatography (HILIC), which is a popular and largely applied technique to analyze polar compounds such as pharmaceuticals, meta",
            "probability": 0.05921805025740671,
            "start_logit": 0.8551963567733765,
            "end_logit": 0.5172752737998962
        }
    ],
    "5518e7da622b194345000004": [
        {
            "text": "terminal kinase (JNK) subfamilies of MAP kinases use a second specificity deter",
            "probability": 0.08773335524967432,
            "start_logit": 1.2394883632659912,
            "end_logit": 0.7187128067016602
        },
        {
            "text": "kinase (JNK) subfamilies of MAP kinases use a second specificity deter",
            "probability": 0.07173353749919278,
            "start_logit": 1.038144588470459,
            "end_logit": 0.7187128067016602
        },
        {
            "text": "kinases, the",
            "probability": 0.06939236434935693,
            "start_logit": 0.8967907428741455,
            "end_logit": 0.8268851041793823
        },
        {
            "text": "38 subtypes requires the presence of a kinase docking domain (D-domain). Furthermore, the D-",
            "probability": 0.06879277734815789,
            "start_logit": 0.8029310703277588,
            "end_logit": 0.9120666980743408
        },
        {
            "text": "kinases use a second specificity deter",
            "probability": 0.06643083014057145,
            "start_logit": 0.9613474607467651,
            "end_logit": 0.7187128067016602
        },
        {
            "text": "38",
            "probability": 0.06593539057762456,
            "start_logit": 0.9505529403686523,
            "end_logit": 0.7220214009284973
        },
        {
            "text": ". In this study, we demonstrate that among the different MAP kinases, the",
            "probability": 0.06287805728966,
            "start_logit": 0.7982111573219299,
            "end_logit": 0.8268851041793823
        },
        {
            "text": "important facet of three different sub",
            "probability": 0.06284707416674594,
            "start_logit": 0.8987650871276855,
            "end_logit": 0.725838303565979
        },
        {
            "text": "or motifs poses a problem in maintaining substrate specificity and hence the correct biological response",
            "probability": 0.05338301150852925,
            "start_logit": 0.8419166803359985,
            "end_logit": 0.6194748878479004
        },
        {
            "text": "and reciprocal effects are observed upon the",
            "probability": 0.0529026575070199,
            "start_logit": 0.8593900203704834,
            "end_logit": 0.5929625630378723
        },
        {
            "text": "sufficient to confer p38 responsiveness on different transcription factors, and reciprocal effects are observed upon the",
            "probability": 0.05054405898945012,
            "start_logit": 0.8137818574905396,
            "end_logit": 0.5929625630378723
        },
        {
            "text": "and reciprocal effects are observed upon the introduction of alternative D-domains into",
            "probability": 0.05008085594070055,
            "start_logit": 0.8593900203704834,
            "end_logit": 0.5381478071212769
        },
        {
            "text": "sufficient to confer p38 responsive",
            "probability": 0.048645645672181305,
            "start_logit": 0.8137818574905396,
            "end_logit": 0.5546794533729553
        },
        {
            "text": "is an important event in the conversion of extracellular",
            "probability": 0.04824888902382626,
            "start_logit": 0.8360297679901123,
            "end_logit": 0.5242420434951782
        },
        {
            "text": "sufficient to confer p38 responsiveness on different transcription factors, and reciprocal effects are observed upon the introduction of alternative D-domains into",
            "probability": 0.047848063900627937,
            "start_logit": 0.8137818574905396,
            "end_logit": 0.5381478071212769
        },
        {
            "text": ". In this study, we demonstrate that among",
            "probability": 0.0469963718878934,
            "start_logit": 0.7982111573219299,
            "end_logit": 0.5357582569122314
        },
        {
            "text": ". In this study, we demonstrate that among the different MAP",
            "probability": 0.04560705894878763,
            "start_logit": 0.7982111573219299,
            "end_logit": 0.5057503581047058
        }
    ],
    "552fac4fbc4f83e828000006": [
        {
            "text": "Ewing's sarcoma and to determine specific biomarker candidates for the prediction",
            "probability": 0.0662998334584122,
            "start_logit": 1.209080696105957,
            "end_logit": 0.721031904220581
        },
        {
            "text": "behavior in tumor cells. In addition, proteomic approaches have been",
            "probability": 0.06306970107358036,
            "start_logit": 0.927480161190033,
            "end_logit": 0.952685534954071
        },
        {
            "text": "is an extremely rare mesenchymal malignancy of the bone, which predominantly occurs in children",
            "probability": 0.05915454628817416,
            "start_logit": 1.0388954877853394,
            "end_logit": 0.7771831750869751
        },
        {
            "text": "bone, which predominantly occurs in children",
            "probability": 0.058153940716026954,
            "start_logit": 1.0218356847763062,
            "end_logit": 0.7771831750869751
        },
        {
            "text": "Ewing's sarcoma is an extremely rare mesenchymal malignancy of the bone, which predominantly occurs in children",
            "probability": 0.0572895490025318,
            "start_logit": 1.0068602561950684,
            "end_logit": 0.7771831750869751
        },
        {
            "text": "er candidates for the prediction",
            "probability": 0.05371711200089285,
            "start_logit": 0.9986249208450317,
            "end_logit": 0.721031904220581
        },
        {
            "text": "s sarcoma and to determine specific biomarker candidates for the prediction",
            "probability": 0.05371125624731219,
            "start_logit": 0.9985159039497375,
            "end_logit": 0.721031904220581
        },
        {
            "text": "I-1 turnover has been proposed. Furthermore, proteomics has revealed the",
            "probability": 0.05311265011180062,
            "start_logit": 0.9289756417274475,
            "end_logit": 0.7793647050857544
        },
        {
            "text": "senchymal malignancy of the bone, which predominantly occurs in children",
            "probability": 0.05293082634104006,
            "start_logit": 0.9277279376983643,
            "end_logit": 0.7771831750869751
        },
        {
            "text": "behavior in tumor cells. In addition, proteomic approaches have been used to assess the",
            "probability": 0.05120077044627224,
            "start_logit": 0.927480161190033,
            "end_logit": 0.7441996335983276
        },
        {
            "text": "behavior in tumor cells. In addition, proteomic approaches",
            "probability": 0.04981981204073389,
            "start_logit": 0.927480161190033,
            "end_logit": 0.7168577909469604
        },
        {
            "text": "understand the",
            "probability": 0.04685757853894742,
            "start_logit": 0.93215012550354,
            "end_logit": 0.6508878469467163
        },
        {
            "text": "and tissue biobanks and databases are required to make effective use of the limited clinical materials and promote research into Ewing's sar",
            "probability": 0.04507854689479723,
            "start_logit": 0.8949465751647949,
            "end_logit": 0.6493850946426392
        },
        {
            "text": "I-1 turnover has been proposed. Furthermore, proteomics has revealed the regulation of IL-6 secretion by EWS-",
            "probability": 0.0445244267586367,
            "start_logit": 0.9289756417274475,
            "end_logit": 0.60298752784729
        },
        {
            "text": "understand the biology of Ewing's sarcoma and develop clinical applications. Fundamental",
            "probability": 0.042758158658970626,
            "start_logit": 0.93215012550354,
            "end_logit": 0.5593351125717163
        },
        {
            "text": "behavior in tumor cells. In addition, proteomic approaches have been used to assess the effects of unique genes and drugs on",
            "probability": 0.041791565997341865,
            "start_logit": 0.927480161190033,
            "end_logit": 0.5411396026611328
        },
        {
            "text": "I-1 turnover has been proposed. Furthermore, proteomics has revealed the regulation of IL-",
            "probability": 0.04150523031666495,
            "start_logit": 0.9289756417274475,
            "end_logit": 0.5327690243721008
        },
        {
            "text": "I-1 turnover has",
            "probability": 0.040225570384710016,
            "start_logit": 0.9289756417274475,
            "end_logit": 0.5014524459838867
        },
        {
            "text": "and tissue biobanks and databases are required to make effective use of the",
            "probability": 0.04011133952169328,
            "start_logit": 0.8949465751647949,
            "end_logit": 0.5326377153396606
        },
        {
            "text": "family, such as E",
            "probability": 0.0386875852014605,
            "start_logit": 0.8661634922027588,
            "end_logit": 0.5252804756164551
        }
    ],
    "54cf7051f693c3b16b000013": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54e0d1491388e8454a000014": [
        {
            "text": "cardiovascular risk, including patients with diabetes mellitus. Data from two large clinical trials have indisput",
            "probability": 0.06669538829216674,
            "start_logit": 0.8693723678588867,
            "end_logit": 1.1437437534332275
        },
        {
            "text": "ab in preventive major",
            "probability": 0.06493501710948804,
            "start_logit": 1.0913466215133667,
            "end_logit": 0.8950207233428955
        },
        {
            "text": "glutaryl coenzyme A reductase enzyme, statins, are powerful choles",
            "probability": 0.05623613239471236,
            "start_logit": 1.068026065826416,
            "end_logit": 0.7745137214660645
        },
        {
            "text": "ab in preventive major adverse cardiovascular events in high risk, secondary-prevention",
            "probability": 0.05471772577392484,
            "start_logit": 1.0913466215133667,
            "end_logit": 0.7238214015960693
        },
        {
            "text": "olocumab in preventive major",
            "probability": 0.054521492500235885,
            "start_logit": 0.9165545701980591,
            "end_logit": 0.8950207233428955
        },
        {
            "text": "PCSK9 monoclonal antibodies is considered a promising non-stat",
            "probability": 0.05259615455360815,
            "start_logit": 0.854516863822937,
            "end_logit": 0.9211064577102661
        },
        {
            "text": "(38.7\u2009mg/dL) reduction in LDL cholesterolaemia corresponds to a 21% lowering in the",
            "probability": 0.049994027214429124,
            "start_logit": 0.8973833918571472,
            "end_logit": 0.8275004625320435
        },
        {
            "text": "ab in preventive major adverse cardiovascular events in high risk, secondary-prevention patients with clinical manifestation of atherosclerotic cardiovascular diseases.",
            "probability": 0.04974610739286014,
            "start_logit": 1.0913466215133667,
            "end_logit": 0.6285659074783325
        },
        {
            "text": "glutaryl coenzyme A reductase enzyme, statins, are powerful cholesterol-lowering medications and have provided",
            "probability": 0.04941792638180486,
            "start_logit": 1.068026065826416,
            "end_logit": 0.6452674865722656
        },
        {
            "text": "PCSK9 monoclonal antibodies is considered a promising non-statin therapeutic option for the management of lip",
            "probability": 0.04880028358944853,
            "start_logit": 0.854516863822937,
            "end_logit": 0.8461995720863342
        },
        {
            "text": "lowering in the",
            "probability": 0.0474247956315582,
            "start_logit": 0.8446250557899475,
            "end_logit": 0.8275004625320435
        },
        {
            "text": "glutaryl coenzyme A reductase enzyme, stat",
            "probability": 0.046360434321303115,
            "start_logit": 1.068026065826416,
            "end_logit": 0.5814006328582764
        },
        {
            "text": "glutaryl coenzyme A reductase enzyme, statins, are powerful",
            "probability": 0.046359290330369105,
            "start_logit": 1.068026065826416,
            "end_logit": 0.5813759565353394
        },
        {
            "text": "olocumab in preventive major adverse cardiovascular events in high risk, secondary-prevention",
            "probability": 0.04594273179882014,
            "start_logit": 0.9165545701980591,
            "end_logit": 0.7238214015960693
        },
        {
            "text": "(38.7\u2009mg/dL) reduction in LDL cholesterolaemia corresponds to a 21% lowering in the risk of major vascular",
            "probability": 0.04559984737234125,
            "start_logit": 0.8973833918571472,
            "end_logit": 0.7355012893676758
        },
        {
            "text": "rotic cardiovascular diseases.",
            "probability": 0.045230037892650246,
            "start_logit": 0.9961758255958557,
            "end_logit": 0.6285659074783325
        },
        {
            "text": "methylglutaryl coenzyme A reductase enzyme, statins, are powerful choles",
            "probability": 0.04490864796305369,
            "start_logit": 0.8430969715118408,
            "end_logit": 0.7745137214660645
        },
        {
            "text": "(LDL-C) is one of the major modifiable cardiovascular risk factors, indeed, every 1.0\u2009mmol/L (38.7\u2009mg/dL)",
            "probability": 0.04395335243633289,
            "start_logit": 0.9317074418067932,
            "end_logit": 0.6644017696380615
        },
        {
            "text": "PCSK9 monoclonal antibodies is considered a promising non-",
            "probability": 0.043304170973277205,
            "start_logit": 0.854516863822937,
            "end_logit": 0.7267124056816101
        },
        {
            "text": "lowering in the risk of major vascular",
            "probability": 0.04325643607761563,
            "start_logit": 0.8446250557899475,
            "end_logit": 0.7355012893676758
        }
    ],
    "51404dd723fec90375000002": [
        {
            "text": "is the most",
            "probability": 0.0991914866088853,
            "start_logit": 1.156606674194336,
            "end_logit": 0.6284303665161133
        },
        {
            "text": "is the most common form of human genetic mental retardation. Several",
            "probability": 0.08469588939389563,
            "start_logit": 1.156606674194336,
            "end_logit": 0.4704452455043793
        },
        {
            "text": "is the most common form of human genetic",
            "probability": 0.08269610893066323,
            "start_logit": 1.156606674194336,
            "end_logit": 0.44655072689056396
        },
        {
            "text": "is the most common form of human genetic mental retardation.",
            "probability": 0.07578491864746126,
            "start_logit": 1.156606674194336,
            "end_logit": 0.35927748680114746
        },
        {
            "text": "is the",
            "probability": 0.07474691852759692,
            "start_logit": 1.156606674194336,
            "end_logit": 0.3454861640930176
        },
        {
            "text": "tardation. Several",
            "probability": 0.0663698617405873,
            "start_logit": 0.9127826690673828,
            "end_logit": 0.4704452455043793
        },
        {
            "text": "substrate for DNA (cytosine-5)-methyltra",
            "probability": 0.06286667902405105,
            "start_logit": 0.8644834756851196,
            "end_logit": 0.46451765298843384
        },
        {
            "text": "substrate for DNA (cytosine-",
            "probability": 0.06016955610405172,
            "start_logit": 0.8644834756851196,
            "end_logit": 0.4206678867340088
        },
        {
            "text": "tardation.",
            "probability": 0.05938699751131228,
            "start_logit": 0.9127826690673828,
            "end_logit": 0.35927748680114746
        },
        {
            "text": "substrate for DNA (cytosine-5)-methyl",
            "probability": 0.05694677347188564,
            "start_logit": 0.8644834756851196,
            "end_logit": 0.36561840772628784
        },
        {
            "text": "nsfera",
            "probability": 0.05689898832043615,
            "start_logit": 0.8837572336196899,
            "end_logit": 0.3455051779747009
        },
        {
            "text": "substrate for DNA (cytosine-5)-",
            "probability": 0.05655437339832727,
            "start_logit": 0.8644834756851196,
            "end_logit": 0.3587039113044739
        },
        {
            "text": "substrate for DNA (cytosine-5)-methyltransfera",
            "probability": 0.05581283177536433,
            "start_logit": 0.8644834756851196,
            "end_logit": 0.3455051779747009
        },
        {
            "text": "substrate for DNA (cytosine-5)",
            "probability": 0.05430284105223508,
            "start_logit": 0.8644834756851196,
            "end_logit": 0.3180779218673706
        },
        {
            "text": "tardation. Several polymorphisms in genes coding folic acid cycle enzymes have been associated to the risk of bearing a DS child; however, the",
            "probability": 0.053575775493246665,
            "start_logit": 0.9127826690673828,
            "end_logit": 0.2562991976737976
        }
    ],
    "56d0451c3975bb303a00000e": [
        {
            "text": "gulation of the Hedgehog (Hh) pathway modulates various aspects of hematologic and solid tumors, but its",
            "probability": 0.06921081381062141,
            "start_logit": 1.2110917568206787,
            "end_logit": 0.8201417326927185
        },
        {
            "text": "plasia (LRH). Sonidegib significantly suppressed proliferation in NKTCL cells and the effect was dose-",
            "probability": 0.06663963146751964,
            "start_logit": 1.0613350868225098,
            "end_logit": 0.9320407509803772
        },
        {
            "text": "plasia (L",
            "probability": 0.0634593938423508,
            "start_logit": 1.0613350868225098,
            "end_logit": 0.8831415176391602
        },
        {
            "text": "TCL cells and the effect was dose-",
            "probability": 0.05498710414939908,
            "start_logit": 0.8691343069076538,
            "end_logit": 0.9320407509803772
        },
        {
            "text": ". RESULTS Both Smo and Gli1 expression were higher in NKTCL tissue than in Lymphoid Reactive Hyperplasia (L",
            "probability": 0.05483827859048458,
            "start_logit": 0.9153233170509338,
            "end_logit": 0.8831415176391602
        },
        {
            "text": "ymphoid Reactive Hyperplasia (LRH). Sonidegib significantly suppressed proliferation in NKTCL cells and the effect was dose-",
            "probability": 0.053444659067038186,
            "start_logit": 0.840682327747345,
            "end_logit": 0.9320407509803772
        },
        {
            "text": "of hematologic and solid tumors, but its",
            "probability": 0.0525456258378693,
            "start_logit": 0.9356164932250977,
            "end_logit": 0.8201417326927185
        },
        {
            "text": "ymphoid Reactive Hyperplasia (L",
            "probability": 0.050894124019254215,
            "start_logit": 0.840682327747345,
            "end_logit": 0.8831415176391602
        },
        {
            "text": "modulates various aspects of hematologic and solid tumors, but its",
            "probability": 0.05008051689930973,
            "start_logit": 0.8875666856765747,
            "end_logit": 0.8201417326927185
        },
        {
            "text": "of hematologic and solid tumors, but its effects in human Natural killer/T-",
            "probability": 0.04918141814020422,
            "start_logit": 0.9356164932250977,
            "end_logit": 0.7539757490158081
        },
        {
            "text": "time-",
            "probability": 0.04831505728591459,
            "start_logit": 0.8551007509231567,
            "end_logit": 0.8167188763618469
        },
        {
            "text": "modulates various aspects of hematologic and solid tumors, but its effects in human Natural killer/T-",
            "probability": 0.046874136581839414,
            "start_logit": 0.8875666856765747,
            "end_logit": 0.7539757490158081
        },
        {
            "text": ". The cell apoptosis",
            "probability": 0.046438240795742144,
            "start_logit": 0.8242092728614807,
            "end_logit": 0.8079903721809387
        },
        {
            "text": "lioma-associated onco",
            "probability": 0.04423735771478478,
            "start_logit": 0.9305130243301392,
            "end_logit": 0.653132975101471
        },
        {
            "text": "lioma-",
            "probability": 0.043346440843692984,
            "start_logit": 0.9305130243301392,
            "end_logit": 0.6327879428863525
        },
        {
            "text": ". The cell apoptosis was examined by flow cytometry, CCK-",
            "probability": 0.04331886141495227,
            "start_logit": 0.8242092728614807,
            "end_logit": 0.7384552359580994
        },
        {
            "text": ". RESULTS Both Smo and Gli1 expression",
            "probability": 0.04113497601646605,
            "start_logit": 0.9153233170509338,
            "end_logit": 0.5956118106842041
        },
        {
            "text": "TCL cells and the effect was dose-dependent. Further analysis revealed that sonidegib treatment elevated the",
            "probability": 0.04093599221407235,
            "start_logit": 0.8691343069076538,
            "end_logit": 0.636951744556427
        },
        {
            "text": ". The cell apoptosis was examined by flow cytometry, CCK-8",
            "probability": 0.040724494408897124,
            "start_logit": 0.8242092728614807,
            "end_logit": 0.6766968369483948
        },
        {
            "text": "ma-associated onco",
            "probability": 0.03939287689958724,
            "start_logit": 0.8145284056663513,
            "end_logit": 0.653132975101471
        }
    ],
    "54ede8c594afd61504000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "551c23bc6b348bb82c00000b": [
        {
            "text": "recent findings on the role of germline mutations associated with familial pituitary adenomas in patients with sporadic clinical presentation.",
            "probability": 0.06072580385318107,
            "start_logit": 0.9525169134140015,
            "end_logit": 1.046764612197876
        },
        {
            "text": "associated with familial pituitary adenomas in patients with sporadic clinical presentation.",
            "probability": 0.059010693131715454,
            "start_logit": 0.923866868019104,
            "end_logit": 1.046764612197876
        },
        {
            "text": "AIP gene,",
            "probability": 0.05711803596662893,
            "start_logit": 0.994057297706604,
            "end_logit": 0.9439754486083984
        },
        {
            "text": "Hx) or X-linked dominant (GPR101) inheritance are causative of fa",
            "probability": 0.05686716277884362,
            "start_logit": 0.9624741673469543,
            "end_logit": 0.9711567163467407
        },
        {
            "text": "tumors can present in a fa",
            "probability": 0.05630244644712032,
            "start_logit": 0.893351137638092,
            "end_logit": 1.0302996635437012
        },
        {
            "text": "most pituitary adenomas occur sporadically, these common tumors can present in a fa",
            "probability": 0.05415766001443798,
            "start_logit": 0.8545125722885132,
            "end_logit": 1.0302996635437012
        },
        {
            "text": "ary adenomas (simplex cases). Areas covered: We",
            "probability": 0.05122419582370257,
            "start_logit": 0.8409339189529419,
            "end_logit": 0.9881908893585205
        },
        {
            "text": "inheritance are causative of fa",
            "probability": 0.05078464260374717,
            "start_logit": 0.849350094795227,
            "end_logit": 0.9711567163467407
        },
        {
            "text": "AIP gene, while most cases",
            "probability": 0.04957612220680674,
            "start_logit": 0.994057297706604,
            "end_logit": 0.8023648262023926
        },
        {
            "text": "uitary adenomas (simplex cases). Areas covered: We",
            "probability": 0.04933393559763681,
            "start_logit": 0.80333411693573,
            "end_logit": 0.9881908893585205
        },
        {
            "text": "ph adenomas are the most common pituitary adenomas associated with germline predisposing mutations. Genetic screening",
            "probability": 0.048200417985701564,
            "start_logit": 0.958891749382019,
            "end_logit": 0.8093887567520142
        },
        {
            "text": "pituitary adenomas (age at diagnosis/onset \u226430\u00a0years) and up",
            "probability": 0.0480436170002018,
            "start_logit": 1.0750503540039062,
            "end_logit": 0.6899717450141907
        },
        {
            "text": "recent findings on",
            "probability": 0.04648287759717059,
            "start_logit": 0.9525169134140015,
            "end_logit": 0.7794799208641052
        },
        {
            "text": "uitary adenomas (age",
            "probability": 0.04534674675169073,
            "start_logit": 1.0750503540039062,
            "end_logit": 0.6322008967399597
        },
        {
            "text": "recent findings on the role of germline mutations associated with familial pit",
            "probability": 0.04516516981489707,
            "start_logit": 0.9525169134140015,
            "end_logit": 0.7507221102714539
        },
        {
            "text": ". Genetic screening",
            "probability": 0.04512854581833007,
            "start_logit": 0.8930390477180481,
            "end_logit": 0.8093887567520142
        },
        {
            "text": "tumors can present in a fami",
            "probability": 0.0447133439652448,
            "start_logit": 0.893351137638092,
            "end_logit": 0.7998336553573608
        },
        {
            "text": "Hx) or X-linked dominant (GPR101) inheritance are causative of fami",
            "probability": 0.04408435812991192,
            "start_logit": 0.9624741673469543,
            "end_logit": 0.7165436744689941
        },
        {
            "text": "associated with familial pit",
            "probability": 0.04388954624021981,
            "start_logit": 0.923866868019104,
            "end_logit": 0.7507221102714539
        },
        {
            "text": "tumors can present in a familial setting in approximately 5% of cases. Germline mutations in several genes with autosomal dominant",
            "probability": 0.04384467827281111,
            "start_logit": 0.893351137638092,
            "end_logit": 0.7802150249481201
        }
    ],
    "56c1f02cef6e39474100004c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "550af222c2af5d5b7000000b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56c1f03bef6e394741000053": [
        {
            "text": "rea, hypothyroidism, and pulmonary disease with variable presentation. Surf",
            "probability": 0.27133940757857805,
            "start_logit": 0.9857725501060486,
            "end_logit": 0.3763750195503235
        },
        {
            "text": "rea, hypothyroidism, and pulmonary disease with variable presentation. Surfactant protein C (SFTPC)",
            "probability": 0.2603069446602243,
            "start_logit": 0.9857725501060486,
            "end_logit": 0.3348660469055176
        },
        {
            "text": "rea, hypothyr",
            "probability": 0.2470741594471345,
            "start_logit": 0.9857725501060486,
            "end_logit": 0.282693088054657
        },
        {
            "text": "rea, hypothyroidism, and pulmonary disease with variable presentation. Surfactant protein C",
            "probability": 0.22127948831406327,
            "start_logit": 0.9857725501060486,
            "end_logit": 0.1724311113357544
        }
    ],
    "532498959b2d7acc7e000017": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5509f433c2af5d5b70000008": [
        {
            "text": "SP-",
            "probability": 0.09619361692265442,
            "start_logit": 1.0614852905273438,
            "end_logit": 0.6744052171707153
        },
        {
            "text": "unique feature of FASP is the possibility to cleave proteins in a consecutive",
            "probability": 0.09533850326086171,
            "start_logit": 0.8577817678451538,
            "end_logit": 0.8691794872283936
        },
        {
            "text": ". Its popularity reflects the key features of the method: its applica",
            "probability": 0.09358833653695921,
            "start_logit": 0.8759059906005859,
            "end_logit": 0.8325272798538208
        },
        {
            "text": ". Its popularity reflects the key features of the method: its applicability",
            "probability": 0.08049302277093483,
            "start_logit": 0.8759059906005859,
            "end_logit": 0.6817920207977295
        },
        {
            "text": "unique feature of FASP is the",
            "probability": 0.07879742541627907,
            "start_logit": 0.8577817678451538,
            "end_logit": 0.6786260604858398
        },
        {
            "text": ". Its popularity reflects the key",
            "probability": 0.074844614445023,
            "start_logit": 0.8759059906005859,
            "end_logit": 0.6090356707572937
        },
        {
            "text": "unique feature of FASP is the possibility to clea",
            "probability": 0.07029469277399758,
            "start_logit": 0.8577817678451538,
            "end_logit": 0.5644420385360718
        },
        {
            "text": "preparation methods, FASP allows digestion of proteins with a variety of enzymes and a straightforward monitoring of protein-",
            "probability": 0.07010174546745172,
            "start_logit": 0.845550537109375,
            "end_logit": 0.5739246606826782
        },
        {
            "text": ". Its popularity reflects the",
            "probability": 0.0698100755710794,
            "start_logit": 0.8759059906005859,
            "end_logit": 0.5393998622894287
        },
        {
            "text": ". Its popularity reflects the key features of the method: its applicability to a variety of sample types and the high quality of the released peptide",
            "probability": 0.06923023930527696,
            "start_logit": 0.8759059906005859,
            "end_logit": 0.5310592651367188
        },
        {
            "text": "preparation methods, FASP allows digestion of proteins with",
            "probability": 0.06919565184311288,
            "start_logit": 0.845550537109375,
            "end_logit": 0.5609149932861328
        },
        {
            "text": "variety of sample types and the high quality of the released peptide",
            "probability": 0.06657356257989223,
            "start_logit": 0.8367757797241211,
            "end_logit": 0.5310592651367188
        },
        {
            "text": "preparation methods, FA",
            "probability": 0.06553851310647715,
            "start_logit": 0.845550537109375,
            "end_logit": 0.5066149234771729
        }
    ],
    "533f9df0c45e133714000016": [
        {
            "text": "back injuries did not",
            "probability": 0.08240241689339883,
            "start_logit": 0.9435818195343018,
            "end_logit": 0.9119653105735779
        },
        {
            "text": "measured at baseline, 6 and 12 months. Results Use of necessary AD (primary outcome), low-back pain, and back injuries did not",
            "probability": 0.0812714151811307,
            "start_logit": 0.9297614097595215,
            "end_logit": 0.9119653105735779
        },
        {
            "text": "Objectives This randomized controlled trial (RCT) evaluated the effect of a participatory organizational intervention for improved use of assist",
            "probability": 0.07320702468466493,
            "start_logit": 1.090354561805725,
            "end_logit": 0.6468691825866699
        },
        {
            "text": "improved use of assist",
            "probability": 0.06707954432203089,
            "start_logit": 1.0029423236846924,
            "end_logit": 0.6468691825866699
        },
        {
            "text": "measured at baseline, 6 and 12 months. Results",
            "probability": 0.0619975308269484,
            "start_logit": 0.9297614097595215,
            "end_logit": 0.6412655115127563
        },
        {
            "text": "randomized controlled trial (RCT) evaluated the effect of a participatory organizational intervention for improved use of assist",
            "probability": 0.061384531199446,
            "start_logit": 0.9142210483551025,
            "end_logit": 0.6468691825866699
        },
        {
            "text": "injuries during patient transfer, and communication and guidance in the use of AD were measured at baseline, 6 and 12 months. Results",
            "probability": 0.06101483656710168,
            "start_logit": 0.9137839078903198,
            "end_logit": 0.6412655115127563
        },
        {
            "text": "organizational intervention for improved use of assist",
            "probability": 0.05946832669662465,
            "start_logit": 0.8825070261955261,
            "end_logit": 0.6468691825866699
        },
        {
            "text": "back injuries did not change in the intervention compared with control group at 12-month follow-up. However, general use of AD measured with accele",
            "probability": 0.05876123953033598,
            "start_logit": 0.9435818195343018,
            "end_logit": 0.5738329887390137
        },
        {
            "text": "health and safety staff, and 2-",
            "probability": 0.058358642777201625,
            "start_logit": 0.8500638008117676,
            "end_logit": 0.66047602891922
        },
        {
            "text": "back injuries did not change in the",
            "probability": 0.057633439683399665,
            "start_logit": 0.9435818195343018,
            "end_logit": 0.5544534921646118
        },
        {
            "text": "trial (RCT) evaluated the effect of a participatory organizational intervention for improved use of assist",
            "probability": 0.057605349860838664,
            "start_logit": 0.8506786227226257,
            "end_logit": 0.6468691825866699
        },
        {
            "text": "health and safety staff, and 2-5 healthcare workers from each department. Based on",
            "probability": 0.05721715197845532,
            "start_logit": 0.8500638008117676,
            "end_logit": 0.6407222747802734
        },
        {
            "text": "and guidance improved significantly in the intervention versus control group. Conclusion The intervention",
            "probability": 0.057045314522297455,
            "start_logit": 0.910362720489502,
            "end_logit": 0.5774155855178833
        },
        {
            "text": "group at 12-month follow-up. However, general use of AD measured with accele",
            "probability": 0.054522532950607966,
            "start_logit": 0.8687134385108948,
            "end_logit": 0.5738329887390137
        },
        {
            "text": "devices (AD) in patient transfer. Methods We randomly allocated 27 departments from five hospitals in Denmark to a participatory intervention",
            "probability": 0.05103070232551735,
            "start_logit": 0.8430931568145752,
            "end_logit": 0.5332666635513306
        }
    ],
    "531a34d5b166e2b806000036": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56cdf40d5795f9a73e00003d": [
        {
            "text": "be controlled by TFEB. Sixteen of these genes were screened for transactivation in response",
            "probability": 0.1126573420472286,
            "start_logit": 1.1238104104995728,
            "end_logit": 0.7022538781166077
        },
        {
            "text": "importantly, not all lysosomal genes. Here, we sought to better understand the",
            "probability": 0.10157970273535723,
            "start_logit": 1.004138708114624,
            "end_logit": 0.7184184789657593
        },
        {
            "text": "importantly, not all lysosomal genes. Here, we sought to better understand the regulation of lysosomal genes whose",
            "probability": 0.09428706509844152,
            "start_logit": 1.004138708114624,
            "end_logit": 0.6439187526702881
        },
        {
            "text": "be controlled by TFEB. Sixteen of these genes were screened for transactivation",
            "probability": 0.08514370686322893,
            "start_logit": 1.1238104104995728,
            "end_logit": 0.42224353551864624
        },
        {
            "text": "be controlled by TFEB.",
            "probability": 0.08142263828798404,
            "start_logit": 1.1238104104995728,
            "end_logit": 0.37755638360977173
        },
        {
            "text": "importantly, not all lysosomal genes. Here",
            "probability": 0.07870953861803734,
            "start_logit": 1.004138708114624,
            "end_logit": 0.46333909034729004
        },
        {
            "text": "importantly, not all",
            "probability": 0.07858794569893945,
            "start_logit": 1.004138708114624,
            "end_logit": 0.46179306507110596
        },
        {
            "text": "importantly, not all lysosomal genes. Here, we",
            "probability": 0.07712296138774857,
            "start_logit": 1.004138708114624,
            "end_logit": 0.442975789308548
        },
        {
            "text": "importantly, not all lysosomal genes. Here, we sought to better understand the regulation of lysosomal genes whose expression does not",
            "probability": 0.07709055784709665,
            "start_logit": 1.004138708114624,
            "end_logit": 0.4425555467605591
        },
        {
            "text": "be controlled by TFEB. Sixteen of these",
            "probability": 0.07592234114552958,
            "start_logit": 1.1238104104995728,
            "end_logit": 0.3076140284538269
        },
        {
            "text": "importantly, not all lysosomal genes. Here, we sought to better understand the regulation of lysosomal genes whose expression does",
            "probability": 0.06984244974119135,
            "start_logit": 1.004138708114624,
            "end_logit": 0.34381672739982605
        },
        {
            "text": "importantly, not all lysosomal genes.",
            "probability": 0.0676337505292168,
            "start_logit": 1.004138708114624,
            "end_logit": 0.311681866645813
        }
    ],
    "553653a5bc4f83e828000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56c3323a50c68dd416000009": [
        {
            "text": "levels of interface pressure during the usage of the products",
            "probability": 0.12086605845975423,
            "start_logit": 0.8777868747711182,
            "end_logit": 0.933765172958374
        },
        {
            "text": "medical compression products produce different levels of interface pressure during the usage of the products",
            "probability": 0.11667585161958352,
            "start_logit": 0.8425034880638123,
            "end_logit": 0.933765172958374
        },
        {
            "text": "levels of interface pressure during the usage of the products. However, limited studies have explored the",
            "probability": 0.07712806389762619,
            "start_logit": 0.8777868747711182,
            "end_logit": 0.4845494031906128
        },
        {
            "text": "medical compression products produce different levels of interface pressure during the usage of the products. However, limited studies have explored the",
            "probability": 0.07445417393189549,
            "start_logit": 0.8425034880638123,
            "end_logit": 0.4845494031906128
        },
        {
            "text": ". However, limited studies have explored the",
            "probability": 0.07176886380355683,
            "start_logit": 0.8057703971862793,
            "end_logit": 0.4845494031906128
        },
        {
            "text": "levels of interface pressure during the usage of the products.",
            "probability": 0.06989409527368891,
            "start_logit": 0.8777868747711182,
            "end_logit": 0.3860633671283722
        },
        {
            "text": "levels of interface pressure during the usage of the",
            "probability": 0.06981309455164099,
            "start_logit": 0.8777868747711182,
            "end_logit": 0.38490378856658936
        },
        {
            "text": "levels of interface pressure during the usage of the products. However,",
            "probability": 0.06889122036483947,
            "start_logit": 0.8777868747711182,
            "end_logit": 0.37161093950271606
        },
        {
            "text": "medical compression products produce different levels of interface pressure during the usage of the products.",
            "probability": 0.06747099386841826,
            "start_logit": 0.8425034880638123,
            "end_logit": 0.3860633671283722
        },
        {
            "text": "medical compression products produce different levels of interface pressure during the usage of the",
            "probability": 0.06739280129436416,
            "start_logit": 0.8425034880638123,
            "end_logit": 0.38490378856658936
        },
        {
            "text": "medical compression products produce different levels of interface pressure during the usage of the products. However,",
            "probability": 0.0665028868121525,
            "start_logit": 0.8425034880638123,
            "end_logit": 0.37161093950271606
        },
        {
            "text": ".",
            "probability": 0.0650375434164709,
            "start_logit": 0.8057703971862793,
            "end_logit": 0.3860633671283722
        },
        {
            "text": ". However,",
            "probability": 0.06410435270600845,
            "start_logit": 0.8057703971862793,
            "end_logit": 0.37161093950271606
        }
    ],
    "52f223e02059c6d71c00000e": [
        {
            "text": "is unknown. Here",
            "probability": 1.0,
            "start_logit": 0.9963375926017761,
            "end_logit": 0.31689584255218506
        }
    ],
    "5343caffaeec6fbd07000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56a39d60496b62f23f000006": [
        {
            "text": "hyl package is implemented in R and available via Bioconductor. Its",
            "probability": 0.08641884384342326,
            "start_logit": 1.0462098121643066,
            "end_logit": 0.8840681314468384
        },
        {
            "text": "package makes it easy to perform quality assessment of large-",
            "probability": 0.08186173183296405,
            "start_logit": 1.249638557434082,
            "end_logit": 0.6264652609825134
        },
        {
            "text": "package makes it easy to perform quality assessment of large-scale methyl",
            "probability": 0.07674339158303466,
            "start_logit": 1.249638557434082,
            "end_logit": 0.5619009137153625
        },
        {
            "text": "hyl",
            "probability": 0.0756624612451938,
            "start_logit": 1.2233681678771973,
            "end_logit": 0.5739861726760864
        },
        {
            "text": "package makes it easy to perform quality assessment of large-scale methylation datasets, such as epigenome-",
            "probability": 0.07034642824544173,
            "start_logit": 1.249638557434082,
            "end_logit": 0.4748656451702118
        },
        {
            "text": "package makes it easy",
            "probability": 0.06826476879750736,
            "start_logit": 1.249638557434082,
            "end_logit": 0.44482743740081787
        },
        {
            "text": "package makes it easy to perform quality assessment of large-scale methylation datasets, such as",
            "probability": 0.062157468706856234,
            "start_logit": 1.249638557434082,
            "end_logit": 0.35110461711883545
        },
        {
            "text": "hyl package is implemented in R and",
            "probability": 0.060672783477659635,
            "start_logit": 1.0462098121643066,
            "end_logit": 0.5303575992584229
        },
        {
            "text": "hyl package is implemented in R and available via Bioconductor. Its development repository is at https://github.",
            "probability": 0.05829416098725179,
            "start_logit": 1.0462098121643066,
            "end_logit": 0.49036431312561035
        },
        {
            "text": "package for interactive quality control of DNA methylation data from Illumina 450k arrays. The package summarizes 450k",
            "probability": 0.055293489674362435,
            "start_logit": 0.9997298717498779,
            "end_logit": 0.48399749398231506
        },
        {
            "text": "hyl package is implemented in R and available via Bioconductor.",
            "probability": 0.054268960233522456,
            "start_logit": 1.0462098121643066,
            "end_logit": 0.4188148081302643
        },
        {
            "text": "package for interactive quality control of DNA methylation data from Illumina 450k arrays",
            "probability": 0.054201008176617126,
            "start_logit": 0.9997298717498779,
            "end_logit": 0.4640418291091919
        },
        {
            "text": "Reactive plots allow fast and intuitive quality control assessment of the samples. In addition, exploration of the phenotypic associations is possible through coloring and principal",
            "probability": 0.05141774332321911,
            "start_logit": 0.9016396403312683,
            "end_logit": 0.509415864944458
        },
        {
            "text": "package for interactive quality control of DNA methyl",
            "probability": 0.05128758349873994,
            "start_logit": 0.9997298717498779,
            "end_logit": 0.4087910056114197
        },
        {
            "text": "present shinyMethyl, a Bioconductor package for interactive quality control of DNA methylation data from Illumina 450k arrays",
            "probability": 0.0478403507889031,
            "start_logit": 0.8748998045921326,
            "end_logit": 0.4640418291091919
        },
        {
            "text": "present shinyMethyl, a Bioconductor package for interactive quality control of DNA methyl",
            "probability": 0.04526882558530326,
            "start_logit": 0.8748998045921326,
            "end_logit": 0.4087910056114197
        }
    ],
    "5150b807d24251bc05000072": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56c1d857ef6e394741000033": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5319ac99b166e2b806000034": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54f89e1a06d9727f76000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "51739df58ed59a060a00001c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56e857ae42442bac75000004": [
        {
            "text": "molecules. Although plant MMPs",
            "probability": 0.08394084417949856,
            "start_logit": 0.9632118940353394,
            "end_logit": 0.8096939325332642
        },
        {
            "text": ") includes",
            "probability": 0.07545634146871492,
            "start_logit": 0.9685282111167908,
            "end_logit": 0.6978195309638977
        },
        {
            "text": ". Although plant MMPs",
            "probability": 0.0749349692243008,
            "start_logit": 0.8497202396392822,
            "end_logit": 0.8096939325332642
        },
        {
            "text": "molecules. Although plant MMPs have been identified, little is known about their activity and function. Plant",
            "probability": 0.07436640686820112,
            "start_logit": 0.9632118940353394,
            "end_logit": 0.6885859370231628
        },
        {
            "text": "MMPs) are known modifiers of the EC",
            "probability": 0.0711485061271426,
            "start_logit": 0.854232907295227,
            "end_logit": 0.7533299326896667
        },
        {
            "text": "molecules. Although plant MMPs have been identified, little is known about their activity and function. Plant MMPs show structural",
            "probability": 0.06923905299516751,
            "start_logit": 0.9632118940353394,
            "end_logit": 0.6171466708183289
        },
        {
            "text": ". Although plant MMPs have been identified, little is known about their activity and function. Plant",
            "probability": 0.06638775752688376,
            "start_logit": 0.8497202396392822,
            "end_logit": 0.6885859370231628
        },
        {
            "text": "of MMP proteins",
            "probability": 0.0655902728957523,
            "start_logit": 0.8475695848464966,
            "end_logit": 0.6786513328552246
        },
        {
            "text": ") includes a variety of proteins with critical roles in the regulation of plant growth, development, and responses to pests and pathogens. Several",
            "probability": 0.06390911611008597,
            "start_logit": 0.9685282111167908,
            "end_logit": 0.5317273139953613
        },
        {
            "text": ". Although plant MMPs have been identified, little is known about their activity and function. Plant MMPs show structural",
            "probability": 0.061810509008197644,
            "start_logit": 0.8497202396392822,
            "end_logit": 0.6171466708183289
        },
        {
            "text": "critical roles in the regulation of plant growth, development, and responses to pests and pathogens. Several",
            "probability": 0.06062471956993365,
            "start_logit": 0.9157689213752747,
            "end_logit": 0.5317273139953613
        },
        {
            "text": "of MMP proteins, their activity",
            "probability": 0.0599592125022847,
            "start_logit": 0.8475695848464966,
            "end_logit": 0.5888884663581848
        },
        {
            "text": "of MMP proteins, their activity and their substrates during plant growth and development are still required. This review describes plant MMP",
            "probability": 0.05954941953387669,
            "start_logit": 0.8475695848464966,
            "end_logit": 0.5820304751396179
        },
        {
            "text": "critical roles in the regulation of plant growth, development, and responses to pests and pathogens. Several studies have shown that various EC",
            "probability": 0.05776592275289965,
            "start_logit": 0.9157689213752747,
            "end_logit": 0.4834236204624176
        },
        {
            "text": "of MMP proteins, their activity and their substrates during plant growth and development are still required. This review describes plant MMP work to date, as",
            "probability": 0.055316949237060244,
            "start_logit": 0.8475695848464966,
            "end_logit": 0.5083032846450806
        }
    ],
    "535d2cf09a4572de6f000004": [
        {
            "text": "tu.edu",
            "probability": 0.2773996185615888,
            "start_logit": 0.885062575340271,
            "end_logit": 0.67564457654953
        },
        {
            "text": "tu.edu.cn/hu",
            "probability": 0.25915283573696657,
            "start_logit": 0.885062575340271,
            "end_logit": 0.6076034307479858
        },
        {
            "text": "tu.edu.cn/hupan/ and",
            "probability": 0.23396244618303702,
            "start_logit": 0.885062575340271,
            "end_logit": 0.5053460597991943
        },
        {
            "text": "tu.edu.cn/hupan/ and https://github.",
            "probability": 0.2294850995184076,
            "start_logit": 0.885062575340271,
            "end_logit": 0.48602354526519775
        }
    ],
    "55475dc2f35db75526000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52fe52702059c6d71c000078": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5717d64f29809bbe7a000001": [
        {
            "text": "is composed of scaffold proteins that form ring-like structures and locally specify the protein-",
            "probability": 0.07371380497337507,
            "start_logit": 1.1210055351257324,
            "end_logit": 0.9490901231765747
        },
        {
            "text": "is composed of scaffold proteins that form ring-",
            "probability": 0.06086886864353679,
            "start_logit": 1.1210055351257324,
            "end_logit": 0.7576218843460083
        },
        {
            "text": "flC/K) superfamily is composed of scaffold proteins that form ring-like structures and locally specify the protein-",
            "probability": 0.0588710005747403,
            "start_logit": 0.896164059638977,
            "end_logit": 0.9490901231765747
        },
        {
            "text": "Moreover, SLP2 inhibits the stress-",
            "probability": 0.058806288374670376,
            "start_logit": 1.0866634845733643,
            "end_logit": 0.757490873336792
        },
        {
            "text": "we report that SLP2 anchors a large protease complex composed of the rhomboid",
            "probability": 0.058182614854138136,
            "start_logit": 1.0267722606658936,
            "end_logit": 0.8067198991775513
        },
        {
            "text": "we report that SLP2 anchors a large protease complex composed of the rhomboid protease PARL and the i-",
            "probability": 0.053533459379486135,
            "start_logit": 1.0267722606658936,
            "end_logit": 0.7234401702880859
        },
        {
            "text": "is composed of scaffold proteins that form ring-like",
            "probability": 0.05266061260108889,
            "start_logit": 1.1210055351257324,
            "end_logit": 0.6127678155899048
        },
        {
            "text": "i-AAA protease YME1L, which we term the SPY complex (for SLP2-PAR",
            "probability": 0.04983978098738039,
            "start_logit": 0.8782321810722351,
            "end_logit": 0.8004868626594543
        },
        {
            "text": "flC/K) superfamily is composed of scaffold proteins that form ring-",
            "probability": 0.04861248448905534,
            "start_logit": 0.896164059638977,
            "end_logit": 0.7576218843460083
        },
        {
            "text": "A1-mediated processing of the dynamin-like GTPase OP",
            "probability": 0.048326992206208626,
            "start_logit": 0.8956561088562012,
            "end_logit": 0.7522397041320801
        },
        {
            "text": ") is a member of this superfamily that localizes to the mitochondrial inner membrane (IM) where it acts as a membrane organizer.",
            "probability": 0.047334091485382805,
            "start_logit": 0.9474664926528931,
            "end_logit": 0.6796698570251465
        },
        {
            "text": "i-",
            "probability": 0.04614399289943071,
            "start_logit": 0.8782321810722351,
            "end_logit": 0.7234401702880859
        },
        {
            "text": "i-AAA protease YME1L, which we term the SPY complex (for SLP2-",
            "probability": 0.045700447661868655,
            "start_logit": 0.8782321810722351,
            "end_logit": 0.713781476020813
        },
        {
            "text": "i-AAA protease YME1L, which we term the SPY complex (for SLP",
            "probability": 0.04524725288103684,
            "start_logit": 0.8782321810722351,
            "end_logit": 0.7038153409957886
        },
        {
            "text": "i-AAA protease YME1L, which we term the SPY complex",
            "probability": 0.043324415258890255,
            "start_logit": 0.8782321810722351,
            "end_logit": 0.6603897213935852
        },
        {
            "text": "i-AAA protease YME1L, which we term the SPY complex (for SL",
            "probability": 0.04304095905878711,
            "start_logit": 0.8782321810722351,
            "end_logit": 0.653825581073761
        },
        {
            "text": "flC/K) superfamily is composed of scaffold proteins that form ring-like",
            "probability": 0.04205701979194597,
            "start_logit": 0.896164059638977,
            "end_logit": 0.6127678155899048
        },
        {
            "text": "A1-mediated processing of the dynamin-",
            "probability": 0.04159405020297218,
            "start_logit": 0.8956561088562012,
            "end_logit": 0.6022065877914429
        },
        {
            "text": "i-AAA protease YME1L, which we term the SPY complex (for SLP2-PARL-",
            "probability": 0.04142026296944024,
            "start_logit": 0.8782321810722351,
            "end_logit": 0.6154435873031616
        },
        {
            "text": "PGAM5 in depolarized mitochondria. SLP2 restricts OMA1-mediated processing of the dynamin-",
            "probability": 0.04072160070656515,
            "start_logit": 0.8744576573371887,
            "end_logit": 0.6022065877914429
        }
    ],
    "56c8f4615795f9a73e00001a": [
        {
            "text": "coverage of 194 individuals, combined 10\u00d7 and 20\u00d7 coverage of 135",
            "probability": 0.0721164861891974,
            "start_logit": 0.9502086639404297,
            "end_logit": 1.179006576538086
        },
        {
            "text": "variants. The DNA samples were obtained from four different origins",
            "probability": 0.06455403820931495,
            "start_logit": 1.0840725898742676,
            "end_logit": 0.9343626499176025
        },
        {
            "text": "KNIH) has been sequencing complete genomes of 1722 Korean individuals. As a result, more than 32 million variant sites have been",
            "probability": 0.06138280312666706,
            "start_logit": 1.2270958423614502,
            "end_logit": 0.7409664392471313
        },
        {
            "text": "KNIH) has been",
            "probability": 0.05972163524815312,
            "start_logit": 1.2270958423614502,
            "end_logit": 0.7135310769081116
        },
        {
            "text": "cleotide and short insertion/deletion variants. The DNA samples were obtained from four different origins",
            "probability": 0.05855555056778765,
            "start_logit": 0.9865458011627197,
            "end_logit": 0.9343626499176025
        },
        {
            "text": "KNIH) has been sequencing complete genomes of 1722",
            "probability": 0.055567827078249685,
            "start_logit": 1.2270958423614502,
            "end_logit": 0.6414411067962646
        },
        {
            "text": ".go.kr/coda/KRGDB/index.jsp.",
            "probability": 0.04965541913328581,
            "start_logit": 1.0832937955856323,
            "end_logit": 0.6727463006973267
        },
        {
            "text": ".kr",
            "probability": 0.04942757351703097,
            "start_logit": 0.8910720348358154,
            "end_logit": 0.8603689670562744
        },
        {
            "text": "variants. The DNA samples were obtained",
            "probability": 0.04911089529876627,
            "start_logit": 1.0840725898742676,
            "end_logit": 0.6609408855438232
        },
        {
            "text": "contains both single nucleotide and short insertion/deletion variants. The DNA samples were obtained from four different origins",
            "probability": 0.04714805966735182,
            "start_logit": 0.7698627710342407,
            "end_logit": 0.9343626499176025
        },
        {
            "text": ". The association results are displayed on our browser. The KRGDB uses the MySQL database and Apache-Tomcat web",
            "probability": 0.045600491125214075,
            "start_logit": 1.0679035186767578,
            "end_logit": 0.6029475331306458
        },
        {
            "text": "30\u00d7230 individuals and three major common diseases",
            "probability": 0.04466891364483568,
            "start_logit": 0.9118883609771729,
            "end_logit": 0.7383220195770264
        },
        {
            "text": "cleotide and short insertion/deletion variants. The DNA samples were obtained",
            "probability": 0.04454741473758455,
            "start_logit": 0.9865458011627197,
            "end_logit": 0.6609408855438232
        },
        {
            "text": "coda.nih.go.kr",
            "probability": 0.043638742222473756,
            "start_logit": 0.766508936882019,
            "end_logit": 0.8603689670562744
        },
        {
            "text": "of Health (KNIH) has been sequencing complete genomes of 1722 Korean individuals. As a result, more than 32 million variant sites have been",
            "probability": 0.04353012421373321,
            "start_logit": 0.8834193348884583,
            "end_logit": 0.7409664392471313
        },
        {
            "text": "information on the Korean genomic variant frequency, frequency",
            "probability": 0.04330198184235261,
            "start_logit": 0.9145232439041138,
            "end_logit": 0.7046077251434326
        },
        {
            "text": "contains both single",
            "probability": 0.04300483356222064,
            "start_logit": 0.7698627710342407,
            "end_logit": 0.8423823118209839
        },
        {
            "text": "of Health (KNIH) has been",
            "probability": 0.042352093227719774,
            "start_logit": 0.8834193348884583,
            "end_logit": 0.7135310769081116
        },
        {
            "text": "-",
            "probability": 0.04106327907355148,
            "start_logit": 0.8266234397888184,
            "end_logit": 0.739423394203186
        },
        {
            "text": "variant functional annotation (such as regulatory elements in ENCODE regions and coding variant functions) of the variant sites. Additionally, we performed the",
            "probability": 0.041051838314509426,
            "start_logit": 0.7995958924293518,
            "end_logit": 0.7661722898483276
        }
    ],
    "552421082c8b63434a000005": [
        {
            "text": "dysfunction unexpectedly and profoundly sensitizes cells to the inhibition",
            "probability": 0.21433325173502857,
            "start_logit": 1.0114606618881226,
            "end_logit": 1.043965220451355
        },
        {
            "text": "cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may",
            "probability": 0.1700522218838184,
            "start_logit": 0.9512348175048828,
            "end_logit": 0.8727645874023438
        },
        {
            "text": "cooperate to repair damage, and suggest that the targeted inhibition",
            "probability": 0.15812138476310766,
            "start_logit": 0.9512348175048828,
            "end_logit": 0.8000220060348511
        },
        {
            "text": "cooperate to repair damage, and suggest that the",
            "probability": 0.11780154011560118,
            "start_logit": 0.9512348175048828,
            "end_logit": 0.505660355091095
        },
        {
            "text": "of",
            "probability": 0.11722607633410141,
            "start_logit": 1.040149211883545,
            "end_logit": 0.4118489623069763
        },
        {
            "text": "cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may allow the",
            "probability": 0.1152125870651633,
            "start_logit": 0.9512348175048828,
            "end_logit": 0.48343801498413086
        },
        {
            "text": "cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may allow the design of",
            "probability": 0.10725293810317932,
            "start_logit": 0.9512348175048828,
            "end_logit": 0.4118489623069763
        }
    ],
    "5710a592cf1c32585100002a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "532366f09b2d7acc7e000015": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55000cc4e9bde69634000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54ede28094afd61504000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56ecfd572ac5ed1459000002": [
        {
            "text": "% and 82.6% of patients on the 5/14 and 2/7 schedules",
            "probability": 0.07427029641502379,
            "start_logit": 1.3084009885787964,
            "end_logit": 0.8817797899246216
        },
        {
            "text": "); RP2D was 300 mg (2/7 schedule). In phases 1b and 2, ORR across",
            "probability": 0.06417896703205948,
            "start_logit": 1.0147216320037842,
            "end_logit": 1.0294235944747925
        },
        {
            "text": "). In phases 1b and 2, ORR across",
            "probability": 0.059702679057201495,
            "start_logit": 0.9424229860305786,
            "end_logit": 1.0294235944747925
        },
        {
            "text": "MM). Our phase 1b/2 study examined",
            "probability": 0.0574922145074032,
            "start_logit": 1.1394422054290771,
            "end_logit": 0.7946770191192627
        },
        {
            "text": "is an oral proteasome inhibitor with activity in multiple myeloma (MM). Our phase 1b/2 study examined",
            "probability": 0.056722368382986305,
            "start_logit": 1.1259613037109375,
            "end_logit": 0.7946770191192627
        },
        {
            "text": "2, ORR across",
            "probability": 0.05307976412274926,
            "start_logit": 0.8248418569564819,
            "end_logit": 1.0294235944747925
        },
        {
            "text": "MM). Our phase 1b/2 study examined the",
            "probability": 0.051403596538253285,
            "start_logit": 1.1394422054290771,
            "end_logit": 0.6827356219291687
        },
        {
            "text": "); RP2D was 300 mg (2/7 schedule). In phases 1b",
            "probability": 0.05136585710785838,
            "start_logit": 1.0147216320037842,
            "end_logit": 0.8067217469215393
        },
        {
            "text": "is an oral proteasome inhibitor with activity in multiple myeloma (MM). Our phase 1b/2 study examined the",
            "probability": 0.050715279695440284,
            "start_logit": 1.1259613037109375,
            "end_logit": 0.6827356219291687
        },
        {
            "text": "P2D was 300 mg (2/7 schedule). In phases 1b and 2, ORR across",
            "probability": 0.05042947800066541,
            "start_logit": 0.7736219763755798,
            "end_logit": 1.0294235944747925
        },
        {
            "text": "). In phases 1b",
            "probability": 0.04778324462400019,
            "start_logit": 0.9424229860305786,
            "end_logit": 0.8067217469215393
        },
        {
            "text": "% for bortezomib-refractory patients (n = 28). All",
            "probability": 0.04488547788536337,
            "start_logit": 1.020960807800293,
            "end_logit": 0.6656231880187988
        },
        {
            "text": "% for bortezomib-refractory patients (n = 28). All patients",
            "probability": 0.044542898185895186,
            "start_logit": 1.020960807800293,
            "end_logit": 0.6579616069793701
        },
        {
            "text": "); RP2D was 300 mg",
            "probability": 0.04454209373918147,
            "start_logit": 1.0147216320037842,
            "end_logit": 0.664182722568512
        },
        {
            "text": "). In phases 1b and 2, ORR across dosing cohorts (210-",
            "probability": 0.043590375880899965,
            "start_logit": 0.9424229860305786,
            "end_logit": 0.7148830890655518
        },
        {
            "text": ") and safety/tolerability of the RP2D. Between July 2,",
            "probability": 0.04206041264316779,
            "start_logit": 0.836480975151062,
            "end_logit": 0.7850956916809082
        },
        {
            "text": "). In phases 1b and 2, ORR across dosing cohorts (210-330 mg) for the",
            "probability": 0.041630915870536224,
            "start_logit": 0.9424229860305786,
            "end_logit": 0.6688897609710693
        },
        {
            "text": "overall and 46.4",
            "probability": 0.0408142656828888,
            "start_logit": 0.84366774559021,
            "end_logit": 0.7478336095809937
        },
        {
            "text": "safety/tolerability of the RP2D. Between July 2,",
            "probability": 0.04042840837967644,
            "start_logit": 0.7969067096710205,
            "end_logit": 0.7850956916809082
        },
        {
            "text": "P2D was 300 mg (2/7 schedule). In phases 1b",
            "probability": 0.04036140624874971,
            "start_logit": 0.7736219763755798,
            "end_logit": 0.8067217469215393
        }
    ],
    "5709ee36cf1c32585100001e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54d649843706e89528000009": [
        {
            "text": "These results point towards encouraging prospects for chemically modifying approved drugs that not only exhibit superior effects compared to those of the original",
            "probability": 0.08962707756604195,
            "start_logit": 0.9739720821380615,
            "end_logit": 1.2199763059616089
        },
        {
            "text": "only exhibit superior effects compared to those of the original",
            "probability": 0.08566886837103291,
            "start_logit": 0.9288040995597839,
            "end_logit": 1.2199763059616089
        },
        {
            "text": "development of a small molecule targeting PARP1 based on the hydrophobic tagging",
            "probability": 0.0687104821586795,
            "start_logit": 1.1864681243896484,
            "end_logit": 0.7417245507240295
        },
        {
            "text": ") has an aggressive phenotype and poor prognosis",
            "probability": 0.068534533252927,
            "start_logit": 0.959664523601532,
            "end_logit": 0.965964138507843
        },
        {
            "text": "These results point towards encouraging",
            "probability": 0.059726124316076455,
            "start_logit": 0.9739720821380615,
            "end_logit": 0.8140883445739746
        },
        {
            "text": "development of a small molecule targeting PARP1 based on",
            "probability": 0.05833845293575487,
            "start_logit": 1.1864681243896484,
            "end_logit": 0.5780842304229736
        },
        {
            "text": "development of a small molecule targeting PARP1 based on the hydrophobic tagging (HyT) method. Targeted protein",
            "probability": 0.05763728631613313,
            "start_logit": 1.1864681243896484,
            "end_logit": 0.5659924745559692
        },
        {
            "text": "stress-related unfolded protein response (UPR), autophagy, and apoptosis. These results point towards encouraging",
            "probability": 0.05514701003903161,
            "start_logit": 0.8942050933837891,
            "end_logit": 0.8140883445739746
        },
        {
            "text": "of a small molecule targeting PARP1 based on the hydrophobic tagging",
            "probability": 0.05325386227909542,
            "start_logit": 0.9316366910934448,
            "end_logit": 0.7417245507240295
        },
        {
            "text": ") has an aggressive phenotype and poor",
            "probability": 0.048438739744130245,
            "start_logit": 0.959664523601532,
            "end_logit": 0.6189262866973877
        },
        {
            "text": "stress-",
            "probability": 0.047783546877496544,
            "start_logit": 0.8942050933837891,
            "end_logit": 0.6707671880722046
        },
        {
            "text": "of a small molecule targeting PARP1 based on",
            "probability": 0.045215050755159567,
            "start_logit": 0.9316366910934448,
            "end_logit": 0.5780842304229736
        },
        {
            "text": "These results point towards encouraging prospects for chemically modifying approved drugs that not only exhibit superior effects compared",
            "probability": 0.04482036386522146,
            "start_logit": 0.9739720821380615,
            "end_logit": 0.5269814133644104
        },
        {
            "text": "of a small molecule targeting PARP1 based on the hydrophobic tagging (HyT) method. Targeted protein",
            "probability": 0.044671613576101464,
            "start_logit": 0.9316366910934448,
            "end_logit": 0.5659924745559692
        },
        {
            "text": ") has an aggressive phenotype and poor prognosis due to the lack of specific targeted treatments",
            "probability": 0.04393285941716639,
            "start_logit": 0.959664523601532,
            "end_logit": 0.5212889313697815
        },
        {
            "text": "stress-related unfolded",
            "probability": 0.04320212483029183,
            "start_logit": 0.8942050933837891,
            "end_logit": 0.5699754953384399
        },
        {
            "text": "only exhibit superior effects compared",
            "probability": 0.04284095785095923,
            "start_logit": 0.9288040995597839,
            "end_logit": 0.5269814133644104
        },
        {
            "text": "only exhibit superior effects compared to those of the original drugs by triggering novel mechanisms but also provide great feasibility in the translation",
            "probability": 0.04245104584870031,
            "start_logit": 0.9288040995597839,
            "end_logit": 0.5178383588790894
        }
    ],
    "5335c7f2d6d3ac6a34000051": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5545186cbf90a13052000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5357a6d0f1005d6b58000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56ed03862ac5ed1459000004": [
        {
            "text": "regulate important biological processes and are a potential therapeutic target in many types of cancer. MLN4924, a small molecule of NEDD8-",
            "probability": 0.07456408824431981,
            "start_logit": 1.4092168807983398,
            "end_logit": 0.6828405857086182
        },
        {
            "text": "decreasing CD31 expression in xenograft tumor. In conclusion, MLN4924 inhibited viability, migration, and VEGF-",
            "probability": 0.06277131840232567,
            "start_logit": 0.8308309316635132,
            "end_logit": 1.0890657901763916
        },
        {
            "text": "xenograft tumor. In conclusion, MLN4924 inhibited viability, migration, and VEGF-",
            "probability": 0.06030052550186093,
            "start_logit": 0.7906734943389893,
            "end_logit": 1.0890657901763916
        },
        {
            "text": "N4924 on angiogenesis in human umbilical vascular endothelial cells (HUVE",
            "probability": 0.05857085986378548,
            "start_logit": 1.1621589660644531,
            "end_logit": 0.6884768009185791
        },
        {
            "text": "N4924 on angiogenesis in human umbilical vascular end",
            "probability": 0.057352088469143914,
            "start_logit": 1.1621589660644531,
            "end_logit": 0.6674487590789795
        },
        {
            "text": "N4924 on angio",
            "probability": 0.0569843294790721,
            "start_logit": 1.1621589660644531,
            "end_logit": 0.6610158085823059
        },
        {
            "text": "of cancer cells.",
            "probability": 0.054779854301228385,
            "start_logit": 0.7702934741973877,
            "end_logit": 1.013427495956421
        },
        {
            "text": "neddylation inhibition. MLN4924 inhibited VEGF-activated cell",
            "probability": 0.053232976405713714,
            "start_logit": 0.8012793660163879,
            "end_logit": 0.9537971615791321
        },
        {
            "text": "decreasing CD31 expression in xenograft tumor",
            "probability": 0.048726849019617303,
            "start_logit": 0.8308309316635132,
            "end_logit": 0.8357977271080017
        },
        {
            "text": "xenograft tumor",
            "probability": 0.046808871897517756,
            "start_logit": 0.7906734943389893,
            "end_logit": 0.8357977271080017
        },
        {
            "text": "manner. MLN4924 inhibits proliferation and interferes with the cell",
            "probability": 0.04422010130365523,
            "start_logit": 0.8308576345443726,
            "end_logit": 0.7387202978134155
        },
        {
            "text": "pho-histone H3. Vascular",
            "probability": 0.04415862628988205,
            "start_logit": 0.7770916223526001,
            "end_logit": 0.7910951375961304
        },
        {
            "text": "neddylation inhibition. MLN4924 inhibited VEGF-activated cell migration, capillary tube formation and VEGF-",
            "probability": 0.0434687347745702,
            "start_logit": 0.8012793660163879,
            "end_logit": 0.7511610388755798
        },
        {
            "text": "H3. Vascular",
            "probability": 0.04335543843665776,
            "start_logit": 0.7587354779243469,
            "end_logit": 0.7910951375961304
        },
        {
            "text": "neddylation inhibition. MLN4924 inhibited VEGF-",
            "probability": 0.04274085640941482,
            "start_logit": 0.8012793660163879,
            "end_logit": 0.7342743873596191
        },
        {
            "text": "umbilical vascular endothelial cells (HUVE",
            "probability": 0.04255699610077386,
            "start_logit": 0.8427659273147583,
            "end_logit": 0.6884768009185791
        },
        {
            "text": "findings provide evidence to develop therapeutic strategy for cancer treatment through anti-",
            "probability": 0.04225072907081308,
            "start_logit": 0.795781135559082,
            "end_logit": 0.7282389402389526
        },
        {
            "text": "umbilical vascular end",
            "probability": 0.041671449096510646,
            "start_logit": 0.8427659273147583,
            "end_logit": 0.6674487590789795
        },
        {
            "text": "xenograft tumor. In conclusion, MLN4924 inhibited viability, migration, and VEGF-promoted angio",
            "probability": 0.041411075728821946,
            "start_logit": 0.7906734943389893,
            "end_logit": 0.7132733464241028
        },
        {
            "text": "4924 on angiogenesis in human umbilical vascular endothelial cells (HUVE",
            "probability": 0.04007423120431536,
            "start_logit": 0.7826551795005798,
            "end_logit": 0.6884768009185791
        }
    ],
    "54f9cb34dd3fc62544000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "535d3c069a4572de6f000006": [
        {
            "text": "sequencing technologies have engendered a clear understanding of all human genes. Overlapping genes are usually observed in compact genomes, such as those of bacteria",
            "probability": 0.06969703942815689,
            "start_logit": 0.9671955108642578,
            "end_logit": 0.7411097884178162
        },
        {
            "text": "We found that the",
            "probability": 0.06965794627807637,
            "start_logit": 0.8270151615142822,
            "end_logit": 0.880729079246521
        },
        {
            "text": "We found that the divergent overlapping gene subtype had a stronger expression association than did the sub",
            "probability": 0.06873776435929924,
            "start_logit": 0.8270151615142822,
            "end_logit": 0.8674310445785522
        },
        {
            "text": "sequencing technologies have engendered a clear understanding of all human genes.",
            "probability": 0.06528121817090066,
            "start_logit": 0.9671955108642578,
            "end_logit": 0.6756563186645508
        },
        {
            "text": "completion of human genome sequences and the",
            "probability": 0.0632225042774242,
            "start_logit": 0.934654712677002,
            "end_logit": 0.6761530637741089
        },
        {
            "text": "completion of human genome sequences and the advancement of next-generation sequencing technologies have engendered a clear understanding of all human genes.",
            "probability": 0.06319110660657572,
            "start_logit": 0.934654712677002,
            "end_logit": 0.6756563186645508
        },
        {
            "text": "We found that the divergent overlapping gene sub",
            "probability": 0.06010931449301232,
            "start_logit": 0.8270151615142822,
            "end_logit": 0.7332971096038818
        },
        {
            "text": "completion of human genome sequences and the advancement of next-",
            "probability": 0.05839856104933799,
            "start_logit": 0.934654712677002,
            "end_logit": 0.5967839956283569
        },
        {
            "text": "human protein-coding genes. We analysed 19,200 well-",
            "probability": 0.0571983704279031,
            "start_logit": 0.788923442363739,
            "end_logit": 0.7217494249343872
        },
        {
            "text": "however, a few overlapping gene pairs displayed distinctive tissue expression association patterns. In summary,",
            "probability": 0.05512975997992956,
            "start_logit": 0.8391203880310059,
            "end_logit": 0.6347167491912842
        },
        {
            "text": "We found that the divergent overlapping gene subtype had a stronger expression association than did the subtypes of 5'-",
            "probability": 0.05491037807168302,
            "start_logit": 0.8270151615142822,
            "end_logit": 0.6428346633911133
        },
        {
            "text": "human protein-coding genes. We analysed 19,200",
            "probability": 0.05397879282456133,
            "start_logit": 0.788923442363739,
            "end_logit": 0.6638152599334717
        },
        {
            "text": "tandem overlapping and 3'-tandem overlapping genes. The majority of paired overlapping genes exhibited comparable coincidental tissue expression profiles",
            "probability": 0.053469561909019414,
            "start_logit": 0.7590676546096802,
            "end_logit": 0.6841923594474792
        },
        {
            "text": "human genome sequences and the",
            "probability": 0.05285050346853742,
            "start_logit": 0.7554616332054138,
            "end_logit": 0.6761530637741089
        },
        {
            "text": "human genome sequences and the advancement of next-generation sequencing technologies have engendered a clear understanding of all human genes.",
            "probability": 0.052824256758903766,
            "start_logit": 0.7554616332054138,
            "end_logit": 0.6756563186645508
        },
        {
            "text": "however, a few overlapping gene pairs displayed distinctive",
            "probability": 0.052524967141955196,
            "start_logit": 0.8391203880310059,
            "end_logit": 0.5863156914710999
        },
        {
            "text": "human genome sequences and the advancement of next-",
            "probability": 0.04881795475472388,
            "start_logit": 0.7554616332054138,
            "end_logit": 0.5967839956283569
        }
    ],
    "515df063298dcd4e51000029": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54d73e223706e89528000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "515db083298dcd4e51000012": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55058af6f73303d458000004": [
        {
            "text": "lines significantly inhibited cell proliferation, foci formation, colony formation in soft agar and tumor formation in nude mice, suggesting the strong tumor-",
            "probability": 0.07694019414737212,
            "start_logit": 1.030965805053711,
            "end_logit": 1.0795615911483765
        },
        {
            "text": "lines.",
            "probability": 0.06451075184116688,
            "start_logit": 1.0443755388259888,
            "end_logit": 0.8899553418159485
        },
        {
            "text": "further inhibited the G(1)/S transition of HCC cell lines.",
            "probability": 0.06133258370275364,
            "start_logit": 0.9938548803329468,
            "end_logit": 0.8899553418159485
        },
        {
            "text": "lines. Conversely, knock down of SCYL1BP1 restored the expression of Pirh2 and",
            "probability": 0.0538073507444591,
            "start_logit": 1.0443755388259888,
            "end_logit": 0.708533525466919
        },
        {
            "text": ")/S transition of HCC cell lines.",
            "probability": 0.05009139759698815,
            "start_logit": 0.7913929224014282,
            "end_logit": 0.8899553418159485
        },
        {
            "text": "promote the ubiquitin-",
            "probability": 0.04999403079881218,
            "start_logit": 0.7946402430534363,
            "end_logit": 0.8847623467445374
        },
        {
            "text": "esis still remains poorly understood. In this study, we find a Pirh2-",
            "probability": 0.04994384210973506,
            "start_logit": 0.9468092918395996,
            "end_logit": 0.7315889000892639
        },
        {
            "text": "promote the ubiquitin-dependent degradation of Pirh2.",
            "probability": 0.049766669274470245,
            "start_logit": 0.7946402430534363,
            "end_logit": 0.8802042007446289
        },
        {
            "text": "), that can promote the ubiquitin-",
            "probability": 0.04961385388984914,
            "start_logit": 0.7870067358016968,
            "end_logit": 0.8847623467445374
        },
        {
            "text": "), that can promote the ubiquitin-dependent degradation of Pirh2.",
            "probability": 0.04938822132394805,
            "start_logit": 0.7870067358016968,
            "end_logit": 0.8802042007446289
        },
        {
            "text": "lines significantly inhibited cell proliferation,",
            "probability": 0.047734206780473847,
            "start_logit": 1.030965805053711,
            "end_logit": 0.6021814346313477
        },
        {
            "text": "Pirh2 and",
            "probability": 0.0477162798204977,
            "start_logit": 0.9242380857467651,
            "end_logit": 0.708533525466919
        },
        {
            "text": "compared to their",
            "probability": 0.047564365018337884,
            "start_logit": 0.849130392074585,
            "end_logit": 0.7804524302482605
        },
        {
            "text": "esis still remains poorly understood. In this study, we find a Pirh2-binding protein,",
            "probability": 0.04603317203191484,
            "start_logit": 0.9468092918395996,
            "end_logit": 0.6500519514083862
        },
        {
            "text": "esis still remains poorly understood. In this study, we",
            "probability": 0.044105626177316,
            "start_logit": 0.9468092918395996,
            "end_logit": 0.6072770357131958
        },
        {
            "text": "2 domain containing E",
            "probability": 0.04298208874189489,
            "start_logit": 0.7693665623664856,
            "end_logit": 0.758915901184082
        },
        {
            "text": "still remains poorly understood. In this study, we find a Pirh2-",
            "probability": 0.04285091598882666,
            "start_logit": 0.7936370968818665,
            "end_logit": 0.7315889000892639
        },
        {
            "text": "esis still remains poorly understood.",
            "probability": 0.04204634683680825,
            "start_logit": 0.9468092918395996,
            "end_logit": 0.5594621896743774
        },
        {
            "text": "munohistochemical stain",
            "probability": 0.041797697228752394,
            "start_logit": 0.9543969631195068,
            "end_logit": 0.5459432601928711
        },
        {
            "text": ")/S transition of HCC cell lines. Conversely, knock down of SCYL1BP1 restored the expression of Pirh2 and",
            "probability": 0.04178040594562298,
            "start_logit": 0.7913929224014282,
            "end_logit": 0.708533525466919
        }
    ],
    "535d35779a4572de6f000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56b7083376d8bf8d13000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55376663bc4f83e82800000a": [
        {
            "text": "miR34a levels in patients with localized tumors. The three patients with the highest fold-increase in the miR levels did not show evidence of meta",
            "probability": 0.0802046961119152,
            "start_logit": 0.8883468508720398,
            "end_logit": 1.1854679584503174
        },
        {
            "text": "tumors. The three patients with the highest fold-increase in the miR levels did not show evidence of meta",
            "probability": 0.07984570647980467,
            "start_logit": 0.8838608860969543,
            "end_logit": 1.1854679584503174
        },
        {
            "text": "levels did not show evidence of meta",
            "probability": 0.07631766243262432,
            "start_logit": 0.8386691808700562,
            "end_logit": 1.1854679584503174
        },
        {
            "text": "miR34a levels in patients with localized tumors.",
            "probability": 0.06273992812065453,
            "start_logit": 0.8883468508720398,
            "end_logit": 0.9398839473724365
        },
        {
            "text": "tumors.",
            "probability": 0.06245910935558811,
            "start_logit": 0.8838608860969543,
            "end_logit": 0.9398839473724365
        },
        {
            "text": "limited. The aim of the",
            "probability": 0.055096284570515054,
            "start_logit": 0.912869930267334,
            "end_logit": 0.7854450941085815
        },
        {
            "text": "be extended to a larger cohort of patients, these findings imply that detection of the miR34a",
            "probability": 0.04933692198570251,
            "start_logit": 0.8383146524429321,
            "end_logit": 0.7495908141136169
        },
        {
            "text": "plasma of mice and 31 patients",
            "probability": 0.047485096380037034,
            "start_logit": 0.9051628708839417,
            "end_logit": 0.6444857716560364
        },
        {
            "text": "of mice and 31 patients",
            "probability": 0.04687917487049726,
            "start_logit": 0.8923205137252808,
            "end_logit": 0.6444857716560364
        },
        {
            "text": "levels did not show evidence of metastasis. Although this analysis should be extended to a larger cohort of patients, these",
            "probability": 0.04501026490471357,
            "start_logit": 0.8386691808700562,
            "end_logit": 0.6574541330337524
        },
        {
            "text": "be extended to a larger cohort of patients, these",
            "probability": 0.044994310314637444,
            "start_logit": 0.8383146524429321,
            "end_logit": 0.6574541330337524
        },
        {
            "text": "limited. The",
            "probability": 0.04480769161162377,
            "start_logit": 0.912869930267334,
            "end_logit": 0.5787426233291626
        },
        {
            "text": "miR34a levels in patients with localized tumors. The three patients with the highest fold-increase in the miR levels did",
            "probability": 0.04472342609958811,
            "start_logit": 0.8883468508720398,
            "end_logit": 0.6013833284378052
        },
        {
            "text": "tumors. The three patients with the highest fold-increase in the miR levels did",
            "probability": 0.04452324771776606,
            "start_logit": 0.8838608860969543,
            "end_logit": 0.6013833284378052
        },
        {
            "text": "tumors. The three patients with the highest fold-increase in the miR levels did not show evidence of metastasis",
            "probability": 0.04432170918062756,
            "start_logit": 0.8838608860969543,
            "end_logit": 0.5968464612960815
        },
        {
            "text": "levels in the",
            "probability": 0.044317004420649043,
            "start_logit": 0.8915733098983765,
            "end_logit": 0.5890278816223145
        },
        {
            "text": "levels did",
            "probability": 0.04255595372041717,
            "start_logit": 0.8386691808700562,
            "end_logit": 0.6013833284378052
        },
        {
            "text": "levels did not show evidence of metastasis",
            "probability": 0.04236332031879037,
            "start_logit": 0.8386691808700562,
            "end_logit": 0.5968464612960815
        },
        {
            "text": "be extended to a larger cohort of patients, these findings imply that detection of the miR34a levels in the",
            "probability": 0.04201849140384804,
            "start_logit": 0.8383146524429321,
            "end_logit": 0.5890278816223145
        }
    ],
    "52f11b922059c6d71c000004": [
        {
            "text": "is a pivotal regulator of the mechanistic target of rapamycin signaling pathway that controls cell",
            "probability": 0.11906156476118158,
            "start_logit": 0.9675626754760742,
            "end_logit": 0.5153210759162903
        },
        {
            "text": "is a pivotal regulator of the mechan",
            "probability": 0.1091606395750816,
            "start_logit": 0.9675626754760742,
            "end_logit": 0.4285009205341339
        },
        {
            "text": "is a pivotal regulator of the mechanistic target",
            "probability": 0.1090641878427954,
            "start_logit": 0.9675626754760742,
            "end_logit": 0.4276169538497925
        },
        {
            "text": "is a pivotal regulator of the mechanistic target of rapamycin signaling pathway that controls cell survival, proliferation, growth, and",
            "probability": 0.10871402366948943,
            "start_logit": 0.9675626754760742,
            "end_logit": 0.4244011640548706
        },
        {
            "text": "is a pivotal",
            "probability": 0.10276048950446087,
            "start_logit": 0.9675626754760742,
            "end_logit": 0.36808130145072937
        },
        {
            "text": "is a pivotal regulator of the",
            "probability": 0.09918030146314684,
            "start_logit": 0.9675626754760742,
            "end_logit": 0.3326197862625122
        },
        {
            "text": "is a pivotal regulator of the mechanistic target of rapamycin",
            "probability": 0.09207969753984606,
            "start_logit": 0.9675626754760742,
            "end_logit": 0.25833484530448914
        },
        {
            "text": "is a pivotal regulator",
            "probability": 0.09003105353750064,
            "start_logit": 0.9675626754760742,
            "end_logit": 0.2358350157737732
        },
        {
            "text": "is a pivotal regulator of the mechanistic target of",
            "probability": 0.08796512762271393,
            "start_logit": 0.9675626754760742,
            "end_logit": 0.2126208245754242
        },
        {
            "text": "is a pivotal regulator of the mechanistic target of rapamycin signaling pathway that controls cell survival, proliferation, growth, and migration.",
            "probability": 0.08198291448378373,
            "start_logit": 0.9675626754760742,
            "end_logit": 0.14219123125076294
        }
    ],
    "536787467d100faa09000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56c077e9ef6e394741000021": [
        {
            "text": "including seven cases that were only highly positive for SLAMF7, and five",
            "probability": 0.0715532540444356,
            "start_logit": 1.116745114326477,
            "end_logit": 1.0019477605819702
        },
        {
            "text": "either only CD48 or only SLAMF7, including seven cases that were only highly positive for SLAMF7, and five",
            "probability": 0.06543334800780386,
            "start_logit": 1.0273351669311523,
            "end_logit": 1.0019477605819702
        },
        {
            "text": "only highly positive for SLAMF7, and five",
            "probability": 0.06052570484260272,
            "start_logit": 0.9493712782859802,
            "end_logit": 1.0019477605819702
        },
        {
            "text": "7, including seven cases that were only highly positive for SLAMF7, and five",
            "probability": 0.05792974011777046,
            "start_logit": 0.905534029006958,
            "end_logit": 1.0019477605819702
        },
        {
            "text": "48; however,",
            "probability": 0.055640499089839625,
            "start_logit": 1.1236987113952637,
            "end_logit": 0.7434635162353516
        },
        {
            "text": "including seven cases that were only highly positive for SLAMF7, and five that were only highly positive for CD48. Our study demonstrates that the",
            "probability": 0.05563224841835477,
            "start_logit": 1.116745114326477,
            "end_logit": 0.750268816947937
        },
        {
            "text": "48; however, several samples showed expression of either only CD48 or only SLAMF7, including seven cases",
            "probability": 0.055268912130573965,
            "start_logit": 1.1236987113952637,
            "end_logit": 0.7367627620697021
        },
        {
            "text": "including seven cases",
            "probability": 0.05488592748881683,
            "start_logit": 1.116745114326477,
            "end_logit": 0.7367627620697021
        },
        {
            "text": "48; however, several samples",
            "probability": 0.05291236026091127,
            "start_logit": 1.1236987113952637,
            "end_logit": 0.6931891441345215
        },
        {
            "text": "and anti-",
            "probability": 0.05157685726142587,
            "start_logit": 0.8590804934501648,
            "end_logit": 0.9322434663772583
        },
        {
            "text": "either only CD48 or only SLAMF7, including seven cases",
            "probability": 0.05019156769413375,
            "start_logit": 1.0273351669311523,
            "end_logit": 0.7367627620697021
        },
        {
            "text": "MM cells, such as anti-SLAMF7 and anti-",
            "probability": 0.04994853294140049,
            "start_logit": 0.8270005583763123,
            "end_logit": 0.9322434663772583
        },
        {
            "text": "only highly positive for SLAMF7, and five that were only highly positive for CD48. Our study demonstrates that the",
            "probability": 0.047058391577951504,
            "start_logit": 0.9493712782859802,
            "end_logit": 0.750268816947937
        },
        {
            "text": "7, including seven cases",
            "probability": 0.04443581997787857,
            "start_logit": 0.905534029006958,
            "end_logit": 0.7367627620697021
        },
        {
            "text": "only highly positive for SLAMF7, and five that were only highly positive for CD48. Our study demonstrates that the immune receptor CD48 is",
            "probability": 0.044374745974709424,
            "start_logit": 0.9493712782859802,
            "end_logit": 0.6915501356124878
        },
        {
            "text": "38 antibodies, represent an attractive therapeutic modality for the eradication of multiple myeloma (MM) cells",
            "probability": 0.037901885486546785,
            "start_logit": 0.8865401148796082,
            "end_logit": 0.5967116355895996
        },
        {
            "text": "and anti-CD38 antibodies, represent an attractive therapeutic modality for the eradication of multiple myeloma (MM) cells",
            "probability": 0.03687527375168369,
            "start_logit": 0.8590804934501648,
            "end_logit": 0.5967116355895996
        },
        {
            "text": "38 antibodies, represent an attractive therapeutic modality for the eradication of multiple myeloma (MM) cells. However, further exploration of target",
            "probability": 0.036585010823600946,
            "start_logit": 0.8865401148796082,
            "end_logit": 0.5613493919372559
        },
        {
            "text": "MM cells, such as anti-",
            "probability": 0.035702743476574116,
            "start_logit": 0.8270005583763123,
            "end_logit": 0.5964778661727905
        },
        {
            "text": "38",
            "probability": 0.035567176632985795,
            "start_logit": 0.8865401148796082,
            "end_logit": 0.5331339836120605
        }
    ],
    "571f609c0fd6f91b6800000c": [
        {
            "text": "is (Tay-",
            "probability": 0.23647788607446377,
            "start_logit": 0.9695536494255066,
            "end_logit": 1.0626697540283203
        },
        {
            "text": "for prognosis and clinical care planning for patients with a gangliosidosis condition. Previously",
            "probability": 0.18956113262484833,
            "start_logit": 0.9966287612915039,
            "end_logit": 0.8144515156745911
        },
        {
            "text": "for prognosis",
            "probability": 0.1475313538735929,
            "start_logit": 0.9966287612915039,
            "end_logit": 0.563780665397644
        },
        {
            "text": "for prognosis and clinical care planning for patients with a gangliosidosis condition. Previously, we have developed a method to establish the",
            "probability": 0.1446534109514546,
            "start_logit": 0.9966287612915039,
            "end_logit": 0.5440805554389954
        },
        {
            "text": ".Tyr192His and p.Ph",
            "probability": 0.1413988009732786,
            "start_logit": 0.8840118646621704,
            "end_logit": 0.633941113948822
        },
        {
            "text": "for prognosis and clinical care planning for patients with a gangliosidosis condition. Previously, we have developed",
            "probability": 0.1403774155023619,
            "start_logit": 0.9966287612915039,
            "end_logit": 0.5140745639801025
        }
    ],
    "55032e65e9bde69634000034": [
        {
            "text": "first described in 1933 as a clinical condition characterized by hemiatrophy, hyperpneumatization of paranasal sinuses",
            "probability": 0.26027861312688805,
            "start_logit": 0.8842500448226929,
            "end_logit": 0.6404200196266174
        },
        {
            "text": "first described in 1933 as a clinical condition characterized by hem",
            "probability": 0.22311643663490532,
            "start_logit": 0.8842500448226929,
            "end_logit": 0.48636114597320557
        },
        {
            "text": "first described in 1933 as",
            "probability": 0.19219392082542883,
            "start_logit": 0.8842500448226929,
            "end_logit": 0.3371722400188446
        },
        {
            "text": "first described in 1933 as a clinical condition characterized",
            "probability": 0.16911399824513842,
            "start_logit": 0.8842500448226929,
            "end_logit": 0.2092404067516327
        },
        {
            "text": "first described in 1933 as a clinical condition",
            "probability": 0.15529703116763938,
            "start_logit": 0.8842500448226929,
            "end_logit": 0.12400698661804199
        }
    ],
    "5717d86029809bbe7a000003": [
        {
            "text": "egalovirus (CMV), desmin (Des), or a native tafazzin promoter (Taz)-",
            "probability": 0.09698040889272863,
            "start_logit": 0.9247109889984131,
            "end_logit": 0.6545907258987427
        },
        {
            "text": "egalovirus (CMV), desmin (Des), or a native tafazzi",
            "probability": 0.09190361940329314,
            "start_logit": 0.9247109889984131,
            "end_logit": 0.6008221507072449
        },
        {
            "text": "heart and skeletal muscle and has no curative treatment. It is caused by recessive mutations in the X-linked gene TAZ, which en",
            "probability": 0.08870684898362005,
            "start_logit": 0.9150025844573975,
            "end_logit": 0.5751272439956665
        },
        {
            "text": "egalovirus (CMV",
            "probability": 0.08673282479673089,
            "start_logit": 0.9247109889984131,
            "end_logit": 0.5429141521453857
        },
        {
            "text": "heart and skeletal muscle and has no curative treatment. It is caused by recessive mutations in the X-",
            "probability": 0.0837107107514939,
            "start_logit": 0.9150025844573975,
            "end_logit": 0.5171570777893066
        },
        {
            "text": "is a rare mitochondrial disease that affects heart and skeletal muscle and has no curative treatment. It is caused by recessive mutations in the X-",
            "probability": 0.08200184616602181,
            "start_logit": 0.8943774104118347,
            "end_logit": 0.5171570777893066
        },
        {
            "text": "heart and skeletal",
            "probability": 0.06973943019758981,
            "start_logit": 0.9150025844573975,
            "end_logit": 0.3345560133457184
        },
        {
            "text": "is a rare mitochondrial disease that affects heart and skeletal",
            "probability": 0.06831577435467799,
            "start_logit": 0.8943774104118347,
            "end_logit": 0.3345560133457184
        },
        {
            "text": "egalovirus (CMV), desmin (Des),",
            "probability": 0.06771423411221777,
            "start_logit": 0.9247109889984131,
            "end_logit": 0.2953781485557556
        },
        {
            "text": "heart and skeletal muscle and has",
            "probability": 0.06660917758168829,
            "start_logit": 0.9150025844573975,
            "end_logit": 0.28863251209259033
        },
        {
            "text": "is a",
            "probability": 0.0666068868062359,
            "start_logit": 0.8943774104118347,
            "end_logit": 0.3092232942581177
        },
        {
            "text": "egalovirus (CMV), desmin (Des), or a",
            "probability": 0.06572881545729388,
            "start_logit": 0.9247109889984131,
            "end_logit": 0.265619158744812
        },
        {
            "text": "is a rare mitochondrial disease that affects heart and skeletal muscle and has",
            "probability": 0.06524942249640803,
            "start_logit": 0.8943774104118347,
            "end_logit": 0.28863251209259033
        }
    ],
    "53319916d6d3ac6a3400003f": [
        {
            "text": "challenge with B16 cells, but not with irrelevant tumors. Finally, we extended",
            "probability": 0.0706128068668258,
            "start_logit": 1.1769993305206299,
            "end_logit": 0.9147411584854126
        },
        {
            "text": "purified from B16 melanoma cells can protect mice from a challenge with B16 cells, but not with irrelevant tumors. Finally, we extended",
            "probability": 0.06628350539210835,
            "start_logit": 1.1137288808822632,
            "end_logit": 0.9147411584854126
        },
        {
            "text": ". Finally, we extended these findings to cancer patients by demonstrating the presence of T-cell responses specific for mutated mitochondrial",
            "probability": 0.06627746883728057,
            "start_logit": 1.0059921741485596,
            "end_logit": 1.0223867893218994
        },
        {
            "text": ". Finally, we extended",
            "probability": 0.059513571087963846,
            "start_logit": 1.0059921741485596,
            "end_logit": 0.9147411584854126
        },
        {
            "text": "T-cell responses specific for mutated mitochondrial",
            "probability": 0.059114906277823606,
            "start_logit": 0.8916252851486206,
            "end_logit": 1.0223867893218994
        },
        {
            "text": "for mutated mitochondrial",
            "probability": 0.05721150974809204,
            "start_logit": 0.8588972687721252,
            "end_logit": 1.0223867893218994
        },
        {
            "text": "of T-cell responses specific for mutated mitochondrial",
            "probability": 0.05658281011357684,
            "start_logit": 0.8478474020957947,
            "end_logit": 1.0223867893218994
        },
        {
            "text": "tumors expressing mitochondrial-localized NY-ES",
            "probability": 0.05297464635991694,
            "start_logit": 1.1129908561706543,
            "end_logit": 0.6913515329360962
        },
        {
            "text": "T-cell responses specific for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing epitopes derived from mitochondrial-",
            "probability": 0.049422143585548056,
            "start_logit": 0.8916252851486206,
            "end_logit": 0.8433022499084473
        },
        {
            "text": "for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing epitopes derived from mitochondrial-",
            "probability": 0.04783083705195524,
            "start_logit": 0.8588972687721252,
            "end_logit": 0.8433022499084473
        },
        {
            "text": "of T-cell responses specific for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing epitopes derived from mitochondrial-",
            "probability": 0.0473052220156535,
            "start_logit": 0.8478474020957947,
            "end_logit": 0.8433022499084473
        },
        {
            "text": ". Consistent with these findings, we showed that injection of mitochond",
            "probability": 0.0461072383490568,
            "start_logit": 0.962411642074585,
            "end_logit": 0.7030872702598572
        },
        {
            "text": ". Consistent with these findings, we showed that injection of mitochondria",
            "probability": 0.044841721673198845,
            "start_logit": 0.962411642074585,
            "end_logit": 0.6752563118934631
        },
        {
            "text": "mutated cancer proteins elicit strong antitumor T-cell responses that correlate with clinical efficacy in a proportion of patients",
            "probability": 0.04468213962322868,
            "start_logit": 0.8826145529747009,
            "end_logit": 0.7514882683753967
        },
        {
            "text": "T-cell responses that correlate with clinical efficacy in a proportion of patients",
            "probability": 0.044456565287984307,
            "start_logit": 0.8775533437728882,
            "end_logit": 0.7514882683753967
        },
        {
            "text": "T-cell responses specific for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing",
            "probability": 0.03850543559890277,
            "start_logit": 0.8916252851486206,
            "end_logit": 0.5937030911445618
        },
        {
            "text": "for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing",
            "probability": 0.037265627957995644,
            "start_logit": 0.8588972687721252,
            "end_logit": 0.5937030911445618
        },
        {
            "text": "mutated cancer proteins elicit strong antitumor T-",
            "probability": 0.03717169408201559,
            "start_logit": 0.8826145529747009,
            "end_logit": 0.5674619674682617
        },
        {
            "text": "T-",
            "probability": 0.03698403565175324,
            "start_logit": 0.8775533437728882,
            "end_logit": 0.5674619674682617
        },
        {
            "text": "of T-cell responses specific for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing",
            "probability": 0.03685611443911927,
            "start_logit": 0.8478474020957947,
            "end_logit": 0.5937030911445618
        }
    ],
    "514a0f4ad24251bc05000053": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "51651e24298dcd4e51000054": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52b2e498f828ad283c000010": [
        {
            "text": ". This report emphasizes the benefit",
            "probability": 0.06502224049888364,
            "start_logit": 1.1055792570114136,
            "end_logit": 0.9071679711341858
        },
        {
            "text": "H) and hypochondroplasia (HCH) are genetic bone disorders known to be caused by gain-of-",
            "probability": 0.06489967317432735,
            "start_logit": 1.2579741477966309,
            "end_logit": 0.7528862953186035
        },
        {
            "text": ") in the tyrosine kinase 1 (TK1) region",
            "probability": 0.06269963202577222,
            "start_logit": 1.015725016593933,
            "end_logit": 0.9606484174728394
        },
        {
            "text": ".",
            "probability": 0.056987274555245826,
            "start_logit": 1.0393061637878418,
            "end_logit": 0.8415396809577942
        },
        {
            "text": "did not demonstrate acanthosis nigricans (AN). This mutation",
            "probability": 0.05257688966512544,
            "start_logit": 1.0320358276367188,
            "end_logit": 0.7682586908340454
        },
        {
            "text": "ia (HCH) are genetic bone disorders known to be caused by gain-of-",
            "probability": 0.05152872160035731,
            "start_logit": 1.0272709131240845,
            "end_logit": 0.7528862953186035
        },
        {
            "text": "Ig-III domain of the",
            "probability": 0.05115535755263841,
            "start_logit": 1.1127712726593018,
            "end_logit": 0.6601138114929199
        },
        {
            "text": ") are genetic bone disorders known to be caused by gain-of-",
            "probability": 0.05017485865199733,
            "start_logit": 1.000645637512207,
            "end_logit": 0.7528862953186035
        },
        {
            "text": "additional hot-spot has been identified. We report an 8-month-old infant, with the heterozygous mutation, c.",
            "probability": 0.05010202034729856,
            "start_logit": 0.9105395078659058,
            "end_logit": 0.8415396809577942
        },
        {
            "text": "did not demonstrate acanthosis nigricans (AN). This mutation has been reported in two different patients",
            "probability": 0.04930283918455309,
            "start_logit": 1.0320358276367188,
            "end_logit": 0.7039636969566345
        },
        {
            "text": "H\". He did not demonstrate acanthosis nigricans (AN). This mutation",
            "probability": 0.04821351925960854,
            "start_logit": 0.9453986287117004,
            "end_logit": 0.7682586908340454
        },
        {
            "text": "TM) domain of the receptor and individuals with HCH show the common mutation (p.Asn540Lys) in the",
            "probability": 0.046503477567105996,
            "start_logit": 1.1194722652435303,
            "end_logit": 0.5580726861953735
        },
        {
            "text": "Ig-III domain of the FGFR3 region near other mutations associated with ACH. Among the two the 8-",
            "probability": 0.046123931388663664,
            "start_logit": 1.1127712726593018,
            "end_logit": 0.556578516960144
        },
        {
            "text": "H\". He did not demonstrate acanthosis nigricans (AN). This mutation has been reported in two different patients",
            "probability": 0.04521118312090936,
            "start_logit": 0.9453986287117004,
            "end_logit": 0.7039636969566345
        },
        {
            "text": "did not",
            "probability": 0.04420549933288988,
            "start_logit": 1.0320358276367188,
            "end_logit": 0.5948312282562256
        },
        {
            "text": "be caused by gain-of-",
            "probability": 0.0436227560406863,
            "start_logit": 0.8607105016708374,
            "end_logit": 0.7528862953186035
        },
        {
            "text": "additional hot-spot has been identified. We report an 8-month-old infant, with the heterozy",
            "probability": 0.04307467540720186,
            "start_logit": 0.9105395078659058,
            "end_logit": 0.6904135942459106
        },
        {
            "text": "did not demonstrate acanthosis nigricans (AN). This mutation has been reported in two different patients and it is located in the",
            "probability": 0.042870662616401316,
            "start_logit": 1.0320358276367188,
            "end_logit": 0.5641697645187378
        },
        {
            "text": ") are genetic bone disorders known to be caused by gain-of-function mutations in the fibroblast growth factor receptor 3 (FGF",
            "probability": 0.04287061917648285,
            "start_logit": 1.000645637512207,
            "end_logit": 0.5955589413642883
        },
        {
            "text": ".1043C > G, leading to an amino acid change from serine at 348 to cysteine (p",
            "probability": 0.04285416883385083,
            "start_logit": 1.0393061637878418,
            "end_logit": 0.5565146207809448
        }
    ],
    "5147c088d24251bc05000026": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5719f5c67de986d80d00000d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "517901bc8ed59a060a00003b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54e0e902ae9738404b000001": [
        {
            "text": "member of the formin family of actin regulatory proteins, are among",
            "probability": 0.21404356421789425,
            "start_logit": 1.0671547651290894,
            "end_logit": 0.7272074818611145
        },
        {
            "text": "member of the",
            "probability": 0.1786977243756893,
            "start_logit": 1.0671547651290894,
            "end_logit": 0.5467236042022705
        },
        {
            "text": "member of the formin family of actin regulatory proteins, are among the most common causes of autosom",
            "probability": 0.16397700097992127,
            "start_logit": 1.0671547651290894,
            "end_logit": 0.4607540965080261
        },
        {
            "text": "member of the formin family of actin regulatory proteins, are among the most common causes of autosomal dominant FSGS. INF",
            "probability": 0.15596714932871816,
            "start_logit": 1.0671547651290894,
            "end_logit": 0.4106733202934265
        },
        {
            "text": "terminal diaphanous inhibitory domain (DID) and its C-",
            "probability": 0.14694638462100493,
            "start_logit": 0.9188336730003357,
            "end_logit": 0.4994167983531952
        },
        {
            "text": "terminal diaphanous inhibitory domain (DID) and its",
            "probability": 0.14036817647677202,
            "start_logit": 0.9188336730003357,
            "end_logit": 0.45361781120300293
        }
    ],
    "554356d0ed966d112c000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "532206819b2d7acc7e00000f": [
        {
            "text": "ated peptides. Protocols for the of high pH SCXtip preparation and methyl",
            "probability": 0.08294592031327049,
            "start_logit": 0.9539812207221985,
            "end_logit": 0.8841503858566284
        },
        {
            "text": "-based methods, however, can enrich methylated peptides in a global manner. Here we",
            "probability": 0.0787333648098238,
            "start_logit": 0.9346932768821716,
            "end_logit": 0.851316511631012
        },
        {
            "text": "methylated peptides in a global manner. Here we",
            "probability": 0.07483752583794896,
            "start_logit": 0.8839457035064697,
            "end_logit": 0.851316511631012
        },
        {
            "text": "allows",
            "probability": 0.0691875888903743,
            "start_logit": 1.016653299331665,
            "end_logit": 0.640110969543457
        },
        {
            "text": "-based methods, however, can enrich methylated peptides in a global manner. Here we present a chromatography-",
            "probability": 0.06433306110291107,
            "start_logit": 0.9346932768821716,
            "end_logit": 0.6493231654167175
        },
        {
            "text": "-based methods, however, can enrich methylated",
            "probability": 0.06163612531897533,
            "start_logit": 0.9346932768821716,
            "end_logit": 0.6064976453781128
        },
        {
            "text": "methylated peptides in a global manner. Here we present a chromatography-",
            "probability": 0.06114976965804379,
            "start_logit": 0.8839457035064697,
            "end_logit": 0.6493231654167175
        },
        {
            "text": "-based methods, however,",
            "probability": 0.060424659925033763,
            "start_logit": 0.9346932768821716,
            "end_logit": 0.5866467952728271
        },
        {
            "text": "methylated",
            "probability": 0.0585862820959271,
            "start_logit": 0.8839457035064697,
            "end_logit": 0.6064976453781128
        },
        {
            "text": "-based methods, however, can en",
            "probability": 0.0579142622046332,
            "start_logit": 0.9346932768821716,
            "end_logit": 0.5442131757736206
        },
        {
            "text": "allows the simultaneous analysis of both lysine and arginine methylation and improved performance for methyl-",
            "probability": 0.05761638637861749,
            "start_logit": 1.016653299331665,
            "end_logit": 0.45709648728370667
        },
        {
            "text": "regulation of gene transcription, RNA processing, DNA damage repair, and signal transduction. Proteome level analysis of protein",
            "probability": 0.05648066550719351,
            "start_logit": 0.9980970621109009,
            "end_logit": 0.45574408769607544
        },
        {
            "text": "ated peptides. Protocols for the of high pH SCXtip preparation and methyl-peptide purification are described in detail.",
            "probability": 0.05543105629368012,
            "start_logit": 0.9539812207221985,
            "end_logit": 0.4811015725135803
        },
        {
            "text": "ated peptides. Protocols for the of high pH SCXtip preparation and methyl-",
            "probability": 0.05485680713061083,
            "start_logit": 0.9539812207221985,
            "end_logit": 0.4706878364086151
        },
        {
            "text": "ated peptides. Protocols for the of high pH SCXt",
            "probability": 0.05297954395149198,
            "start_logit": 0.9539812207221985,
            "end_logit": 0.43586742877960205
        },
        {
            "text": "ated peptides. Protocols",
            "probability": 0.052886980581464196,
            "start_logit": 0.9539812207221985,
            "end_logit": 0.43411874771118164
        }
    ],
    "54d8fd334b1fd0d33c000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52f89fc62059c6d71c000050": [
        {
            "text": "gulation of FGF9 or the downregulation of miR-372-",
            "probability": 0.08468607318776161,
            "start_logit": 1.3695478439331055,
            "end_logit": 1.1289328336715698
        },
        {
            "text": "colony formation assays were conducted to investigate the effects of ectopic miR-",
            "probability": 0.06512191286161668,
            "start_logit": 1.1090039014816284,
            "end_logit": 1.126786708831787
        },
        {
            "text": "lines, whereas FGF9 mRNA was found underexpressed in LSCC tissues. MiR-372-3p directly bound to wild-",
            "probability": 0.05922080926570411,
            "start_logit": 1.0539281368255615,
            "end_logit": 1.0868743658065796
        },
        {
            "text": "mRNA was found underexpressed in LSCC tissues. MiR-372-3p directly bound to wild-",
            "probability": 0.057813022320554026,
            "start_logit": 1.0298691987991333,
            "end_logit": 1.0868743658065796
        },
        {
            "text": "gulation of miR-372-",
            "probability": 0.05637161215766471,
            "start_logit": 0.9625623822212219,
            "end_logit": 1.1289328336715698
        },
        {
            "text": "colony formation assays were conducted to investigate the effects of ec",
            "probability": 0.0530921265507495,
            "start_logit": 1.1090039014816284,
            "end_logit": 0.9225542545318604
        },
        {
            "text": "p and FGF9 expression on cell cycle distribution and apoptosis. Transwell assay was also conducted to see the",
            "probability": 0.05281198391802471,
            "start_logit": 0.8863784074783325,
            "end_logit": 1.1398892402648926
        },
        {
            "text": "lines, whereas FGF9 mRNA was found underexpressed in LSCC tissues. MiR-",
            "probability": 0.05116419778232914,
            "start_logit": 1.0539281368255615,
            "end_logit": 0.9406414031982422
        },
        {
            "text": "topic miR-",
            "probability": 0.05058827910641925,
            "start_logit": 0.8564627170562744,
            "end_logit": 1.126786708831787
        },
        {
            "text": "mRNA was found underexpressed in LSCC tissues. MiR-",
            "probability": 0.04994793122687103,
            "start_logit": 1.0298691987991333,
            "end_logit": 0.9406414031982422
        },
        {
            "text": "p in lung squamous cell",
            "probability": 0.04328287355343027,
            "start_logit": 0.9138752222061157,
            "end_logit": 0.9134113192558289
        },
        {
            "text": "GF9 mRNA expression in tissues and cells. Western blot was used to determine FGF9 expression in tissues and NCI-",
            "probability": 0.04323028927071876,
            "start_logit": 0.8506999015808105,
            "end_logit": 0.9753710031509399
        },
        {
            "text": "squamous cell",
            "probability": 0.04288942777809029,
            "start_logit": 0.9047435522079468,
            "end_logit": 0.9134113192558289
        },
        {
            "text": "lines, whereas FGF9 mRNA was found underexpressed in LSCC tissues. MiR-372-",
            "probability": 0.042720157723139425,
            "start_logit": 1.0539281368255615,
            "end_logit": 0.7602722644805908
        },
        {
            "text": "GF9 can be directly targeted by miR-372-3p. MTT, colony formation assays were conducted to investigate the effects of ec",
            "probability": 0.042557285540297134,
            "start_logit": 0.8878263235092163,
            "end_logit": 0.9225542545318604
        },
        {
            "text": "mRNA was found underexpressed in LSCC tissues. MiR-372-",
            "probability": 0.0417046214431883,
            "start_logit": 1.0298691987991333,
            "end_logit": 0.7602722644805908
        },
        {
            "text": "analyze the influence of miR-372-",
            "probability": 0.04147185288067339,
            "start_logit": 0.931435227394104,
            "end_logit": 0.8531092405319214
        },
        {
            "text": "of miR-372-3p in lung squamous cell",
            "probability": 0.04141193989976699,
            "start_logit": 0.8696874380111694,
            "end_logit": 0.9134113192558289
        },
        {
            "text": "of miR-372-",
            "probability": 0.0406725945719231,
            "start_logit": 0.8696874380111694,
            "end_logit": 0.8953965902328491
        },
        {
            "text": "of miR-",
            "probability": 0.03924100896107772,
            "start_logit": 0.8696874380111694,
            "end_logit": 0.8595644235610962
        }
    ],
    "52f350042059c6d71c000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54f60ae05f206a0c06000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5324a8ac9b2d7acc7e000018": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "571e172bbb137a4b0c000002": [
        {
            "text": "flozin and canagliflozin) among patients with type 2 DM and HF, based on",
            "probability": 0.1129099500878383,
            "start_logit": 1.3903589248657227,
            "end_logit": 0.6921985745429993
        },
        {
            "text": "flozin and canagliflozin) among patients with type 2 DM and H",
            "probability": 0.09302897170814754,
            "start_logit": 1.3903589248657227,
            "end_logit": 0.4985189437866211
        },
        {
            "text": "flozin and canaglifloz",
            "probability": 0.09188866896325462,
            "start_logit": 1.3903589248657227,
            "end_logit": 0.4861856997013092
        },
        {
            "text": "flozin and canagliflozin) among patients with type 2",
            "probability": 0.08770218166443075,
            "start_logit": 1.3903589248657227,
            "end_logit": 0.43955475091934204
        },
        {
            "text": "flozin and canagliflozin) among patients with type 2 D",
            "probability": 0.08461836515854004,
            "start_logit": 1.3903589248657227,
            "end_logit": 0.40375930070877075
        },
        {
            "text": "cardiovascular death and heart failure (HF) hospitalization in patients with type 2 diabetes mellitus (D",
            "probability": 0.06724400002786339,
            "start_logit": 0.9834704399108887,
            "end_logit": 0.5808242559432983
        },
        {
            "text": ") labelling criteria, remains unknown.",
            "probability": 0.06412545321453825,
            "start_logit": 0.9555466175079346,
            "end_logit": 0.5612616539001465
        },
        {
            "text": "heart failure (HF) hospitalization in patients with type 2 diabetes mellitus (D",
            "probability": 0.06408700984133057,
            "start_logit": 0.9353843331336975,
            "end_logit": 0.5808242559432983
        },
        {
            "text": "failure (HF) hospitalization in patients with type 2 diabetes mellitus (D",
            "probability": 0.061935471161264626,
            "start_logit": 0.9012356996536255,
            "end_logit": 0.5808242559432983
        },
        {
            "text": "cardiovascular death and heart failure (H",
            "probability": 0.05940732925630845,
            "start_logit": 0.9834704399108887,
            "end_logit": 0.4569140672683716
        },
        {
            "text": "heart failure (H",
            "probability": 0.05661825728865963,
            "start_logit": 0.9353843331336975,
            "end_logit": 0.4569140672683716
        },
        {
            "text": "failure (H",
            "probability": 0.054717460686414095,
            "start_logit": 0.9012356996536255,
            "end_logit": 0.4569140672683716
        },
        {
            "text": ") labelling criteria",
            "probability": 0.05151996437070912,
            "start_logit": 0.9555466175079346,
            "end_logit": 0.34238967299461365
        },
        {
            "text": ") label",
            "probability": 0.05019691657070057,
            "start_logit": 0.9555466175079346,
            "end_logit": 0.31637388467788696
        }
    ],
    "56b330bb39c782df06000001": [
        {
            "text": "community-developed open-",
            "probability": 0.07376839215877273,
            "start_logit": 0.9988179802894592,
            "end_logit": 0.8278354406356812
        },
        {
            "text": "community-developed open-source software distributed as R packages. Featuring state-of-the-",
            "probability": 0.0735970141931359,
            "start_logit": 0.9988179802894592,
            "end_logit": 0.8255095481872559
        },
        {
            "text": "standardized data infrastructure and interactive data visualization tools, we present an overview and online book (https:",
            "probability": 0.07237091774773918,
            "start_logit": 1.0435198545455933,
            "end_logit": 0.7640077471733093
        },
        {
            "text": "community-developed open-source software distributed as R packages. Featuring state-of-the",
            "probability": 0.06414057569836899,
            "start_logit": 0.9988179802894592,
            "end_logit": 0.6879822611808777
        },
        {
            "text": "community-developed open-source software distributed as R packages. Featuring state-of-",
            "probability": 0.061790578017399234,
            "start_logit": 0.9988179802894592,
            "end_logit": 0.65065598487854
        },
        {
            "text": "community-developed open-source software distributed as R packages. Featuring state-of-the-art computational",
            "probability": 0.05927493222851573,
            "start_logit": 0.9988179802894592,
            "end_logit": 0.609091579914093
        },
        {
            "text": "standardized data infrastructure and interactive data visualization tools, we",
            "probability": 0.05919193871279672,
            "start_logit": 1.0435198545455933,
            "end_logit": 0.5629885792732239
        },
        {
            "text": "community-developed open",
            "probability": 0.05745532311903699,
            "start_logit": 0.9988179802894592,
            "end_logit": 0.5779127478599548
        },
        {
            "text": "community-developed open-source software distributed as R packages. Featuring state-",
            "probability": 0.053205601362934715,
            "start_logit": 0.9988179802894592,
            "end_logit": 0.5010687708854675
        },
        {
            "text": "community-developed open-source software distributed as R packages.",
            "probability": 0.05280978361518797,
            "start_logit": 0.9988179802894592,
            "end_logit": 0.49360156059265137
        },
        {
            "text": "community-developed",
            "probability": 0.05125128519827505,
            "start_logit": 0.9988179802894592,
            "end_logit": 0.4636457860469818
        },
        {
            "text": "standardized data infrastructure and interactive data visualization tools",
            "probability": 0.047543533510229656,
            "start_logit": 1.0435198545455933,
            "end_logit": 0.3438490033149719
        },
        {
            "text": "genome-wide features in individual cells",
            "probability": 0.046699203559537904,
            "start_logit": 0.9285877346992493,
            "end_logit": 0.4408624470233917
        },
        {
            "text": "genome-",
            "probability": 0.04629679444863651,
            "start_logit": 0.9285877346992493,
            "end_logit": 0.4322080612182617
        },
        {
            "text": "genome-wide features in individual cells. However, single",
            "probability": 0.046230274767833424,
            "start_logit": 0.9285877346992493,
            "end_logit": 0.43077021837234497
        },
        {
            "text": "features in individual cells",
            "probability": 0.04564719238926297,
            "start_logit": 0.9058027267456055,
            "end_logit": 0.4408624470233917
        },
        {
            "text": "features in individual cells. However, single",
            "probability": 0.04518882733932141,
            "start_logit": 0.9058027267456055,
            "end_logit": 0.43077021837234497
        },
        {
            "text": "features in individual cells. However, single-cell data present unique challenges that require the development of specialized methods and software infrastructure to successfully derive biological insights.",
            "probability": 0.04353783193301501,
            "start_logit": 0.9058027267456055,
            "end_logit": 0.3935506045818329
        }
    ],
    "57090c33cf1c325851000013": [
        {
            "text": "involving both environmental and genetic factors. Recent efforts have implicated the correlation of genomic imprinting and brain development in autism,",
            "probability": 0.07446563108108788,
            "start_logit": 1.045470952987671,
            "end_logit": 0.5718407034873962
        },
        {
            "text": "involving both environmental and genetic",
            "probability": 0.07240961717964264,
            "start_logit": 1.045470952987671,
            "end_logit": 0.5438421368598938
        },
        {
            "text": "implicated the correlation of genomic imprinting and brain development in autism,",
            "probability": 0.07135974822404872,
            "start_logit": 1.0028672218322754,
            "end_logit": 0.5718407034873962
        },
        {
            "text": "involving both environmental and genetic factors. Recent efforts have implicated the correlation",
            "probability": 0.06775277389932284,
            "start_logit": 1.045470952987671,
            "end_logit": 0.47736841440200806
        },
        {
            "text": "implicated the correlation",
            "probability": 0.06492687722839273,
            "start_logit": 1.0028672218322754,
            "end_logit": 0.47736841440200806
        },
        {
            "text": "development in autism,",
            "probability": 0.06490882645185847,
            "start_logit": 0.90811687707901,
            "end_logit": 0.5718407034873962
        },
        {
            "text": "of genomic imprinting and brain development in autism,",
            "probability": 0.06377333123087706,
            "start_logit": 0.8904683589935303,
            "end_logit": 0.5718407034873962
        },
        {
            "text": "involving both environmental and genetic factors. Recent efforts have implicated the",
            "probability": 0.06018399633777207,
            "start_logit": 1.045470952987671,
            "end_logit": 0.3589094877243042
        },
        {
            "text": "implicated the",
            "probability": 0.05767378538837388,
            "start_logit": 1.0028672218322754,
            "end_logit": 0.3589094877243042
        },
        {
            "text": "involving both environmental and genetic factors. Recent efforts have implicated the correlation of genomic imprinting and brain development in autism",
            "probability": 0.05617751340396987,
            "start_logit": 1.045470952987671,
            "end_logit": 0.29001957178115845
        },
        {
            "text": "implicated the correlation of genomic imprinting and brain development in autism",
            "probability": 0.05383440862798967,
            "start_logit": 1.0028672218322754,
            "end_logit": 0.29001957178115845
        },
        {
            "text": "development in autism, however the pathogenesis of autism is not completely clear. Here, we used bioinformatic tools",
            "probability": 0.05336510271890315,
            "start_logit": 0.90811687707901,
            "end_logit": 0.3760141134262085
        },
        {
            "text": "implicated the correlation of genomic imprinting and brain development in autism, however the pathogenesis of autism is not",
            "probability": 0.050686720171450386,
            "start_logit": 1.0028672218322754,
            "end_logit": 0.229770690202713
        },
        {
            "text": "development in autism",
            "probability": 0.04896777768611859,
            "start_logit": 0.90811687707901,
            "end_logit": 0.29001957178115845
        },
        {
            "text": "of genomic imprinting and brain development in autism",
            "probability": 0.04811115031224506,
            "start_logit": 0.8904683589935303,
            "end_logit": 0.29001957178115845
        },
        {
            "text": "development in autism, however the pathogenesis of autism is not",
            "probability": 0.046104640289549526,
            "start_logit": 0.90811687707901,
            "end_logit": 0.229770690202713
        },
        {
            "text": "of genomic imprinting and brain development in autism, however the pathogenesis of autism is not",
            "probability": 0.045298099768397465,
            "start_logit": 0.8904683589935303,
            "end_logit": 0.229770690202713
        }
    ],
    "5157539ed24251bc0500008a": [
        {
            "text": "information of these genes is limited. Here, we therefore identified and characterized 32 DD",
            "probability": 0.07829118714438175,
            "start_logit": 1.2169934511184692,
            "end_logit": 0.7047318816184998
        },
        {
            "text": "subfamilies,",
            "probability": 0.07665164330743315,
            "start_logit": 1.0683033466339111,
            "end_logit": 0.8322579860687256
        },
        {
            "text": "information of these genes is limited",
            "probability": 0.06912698671837221,
            "start_logit": 1.2169934511184692,
            "end_logit": 0.5802420377731323
        },
        {
            "text": ". Overview of the gene structure and domain composition showed that the gene size varies significantly",
            "probability": 0.06853101208822333,
            "start_logit": 0.8420426249504089,
            "end_logit": 0.9465340375900269
        },
        {
            "text": "be classified into 30 subfamilies,",
            "probability": 0.06789189380223373,
            "start_logit": 0.9469489455223083,
            "end_logit": 0.8322579860687256
        },
        {
            "text": "of the gene structure and domain composition showed that the gene size varies significantly",
            "probability": 0.06675205275315406,
            "start_logit": 0.8157413005828857,
            "end_logit": 0.9465340375900269
        },
        {
            "text": "of these genes is limited. Here, we therefore identified and characterized 32 DD",
            "probability": 0.058349344672097965,
            "start_logit": 0.923006534576416,
            "end_logit": 0.7047318816184998
        },
        {
            "text": "sub",
            "probability": 0.05696151690599842,
            "start_logit": 1.0683033466339111,
            "end_logit": 0.5353628396987915
        },
        {
            "text": "of normal digestive",
            "probability": 0.055388792486035676,
            "start_logit": 0.9899134635925293,
            "end_logit": 0.5857540965080261
        },
        {
            "text": "time PCR revealed that these genes are expressed in all stages and tissues examined, overall with higher expression level at second and third-",
            "probability": 0.05524113514030255,
            "start_logit": 0.8444337844848633,
            "end_logit": 0.7285643815994263
        },
        {
            "text": ". Overview of the gene structure and domain composition showed that the",
            "probability": 0.053872751526291854,
            "start_logit": 0.8420426249504089,
            "end_logit": 0.7058724761009216
        },
        {
            "text": "of the gene structure and domain composition showed that the",
            "probability": 0.05247429801870045,
            "start_logit": 0.8157413005828857,
            "end_logit": 0.7058724761009216
        },
        {
            "text": "of these genes is limited",
            "probability": 0.05151939217290675,
            "start_logit": 0.923006534576416,
            "end_logit": 0.5802420377731323
        },
        {
            "text": "be classified into 30 sub",
            "probability": 0.05045195497095324,
            "start_logit": 0.9469489455223083,
            "end_logit": 0.5353628396987915
        },
        {
            "text": "and in the reproductive organs. RNA interference (RNAi) analyses showed that seven genes cause lethal phenotype when silenced, of which",
            "probability": 0.04717520047783611,
            "start_logit": 0.7800235152244568,
            "end_logit": 0.6351351141929626
        },
        {
            "text": "ecum, indicating that these genes are essential for the survival and maintenance of normal digestive",
            "probability": 0.046125933291099194,
            "start_logit": 0.8069115281105042,
            "end_logit": 0.5857540965080261
        },
        {
            "text": "and in the reproductive organs. RNA interference (RNA",
            "probability": 0.045194904523979534,
            "start_logit": 0.7800235152244568,
            "end_logit": 0.5922511219978333
        }
    ],
    "530cf4e0c8a0b4a00c000006": [
        {
            "text": "death in young",
            "probability": 0.26170539216192185,
            "start_logit": 0.9811201095581055,
            "end_logit": 0.511755645275116
        },
        {
            "text": "death in young athletes during sports",
            "probability": 0.22150711421334837,
            "start_logit": 0.9811201095581055,
            "end_logit": 0.34499093890190125
        },
        {
            "text": "death in young athletes during sports.",
            "probability": 0.17664152044614784,
            "start_logit": 0.9811201095581055,
            "end_logit": 0.11865860223770142
        },
        {
            "text": "death in young athletes",
            "probability": 0.1752784579648458,
            "start_logit": 0.9811201095581055,
            "end_logit": 0.11091212928295135
        },
        {
            "text": "death",
            "probability": 0.1648675152137363,
            "start_logit": 0.9811201095581055,
            "end_logit": 0.04967844486236572
        }
    ],
    "530cf4e0c8a0b4a00c000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "530a34eb970c65fa6b000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "572096c90fd6f91b6800000e": [
        {
            "text": "osphorylation site by proline-",
            "probability": 0.07291735121165704,
            "start_logit": 1.0772711038589478,
            "end_logit": 0.8040227890014648
        },
        {
            "text": "Two types of Pro22 mutations have been previously reported: Pro22",
            "probability": 0.06137538636635748,
            "start_logit": 1.036179780960083,
            "end_logit": 0.672796368598938
        },
        {
            "text": "CMT1 family. An investigation to identify the",
            "probability": 0.05991277785510696,
            "start_logit": 1.0089073181152344,
            "end_logit": 0.67594975233078
        },
        {
            "text": "Two types of Pro22 mutations have been previously reported: Pro22Ser in CMT2E with giant axons,",
            "probability": 0.05902287628565103,
            "start_logit": 1.036179780960083,
            "end_logit": 0.6337125897407532
        },
        {
            "text": "CMT1F neuropathies. Two types of Pro22 mutations have been previously reported: Pro22",
            "probability": 0.05568386735363126,
            "start_logit": 0.9388613700866699,
            "end_logit": 0.672796368598938
        },
        {
            "text": "Two types of Pro22 mutations have",
            "probability": 0.054548571360502174,
            "start_logit": 1.036179780960083,
            "end_logit": 0.5548790097236633
        },
        {
            "text": "giant axons,",
            "probability": 0.05082525215482061,
            "start_logit": 0.8866479992866516,
            "end_logit": 0.6337125897407532
        },
        {
            "text": "CMT1 family. An investigation to identify the clinical and pathological characteristics of the",
            "probability": 0.04974602309495365,
            "start_logit": 1.0089073181152344,
            "end_logit": 0.4899904727935791
        },
        {
            "text": "CMT1F neuropathies. Two types of Pro22 mutations have",
            "probability": 0.049490122861911054,
            "start_logit": 0.9388613700866699,
            "end_logit": 0.5548790097236633
        },
        {
            "text": "osphorylation site",
            "probability": 0.049308766397543606,
            "start_logit": 1.0772711038589478,
            "end_logit": 0.41279804706573486
        },
        {
            "text": "Two types of Pro22 mutations have been previously reported: Pro22Ser in CMT2E with giant axons, and Pro22",
            "probability": 0.04904697451234838,
            "start_logit": 1.036179780960083,
            "end_logit": 0.4485659897327423
        },
        {
            "text": "CMT1F neuropathies.",
            "probability": 0.0478711261185697,
            "start_logit": 0.9388613700866699,
            "end_logit": 0.5216184258460999
        },
        {
            "text": "Two types of Pro22 mutations have been",
            "probability": 0.046384609994945036,
            "start_logit": 1.036179780960083,
            "end_logit": 0.3927552103996277
        },
        {
            "text": "CMT1F. In this study",
            "probability": 0.045043824333764367,
            "start_logit": 0.9322746396064758,
            "end_logit": 0.4673285186290741
        },
        {
            "text": "CMT1 family. An investigation to identify the clinical and",
            "probability": 0.04389735029230764,
            "start_logit": 1.0089073181152344,
            "end_logit": 0.3649139106273651
        },
        {
            "text": "giant axons, and Pro22Thr in CMT1F. In this study",
            "probability": 0.04303480683891206,
            "start_logit": 0.8866479992866516,
            "end_logit": 0.4673285186290741
        },
        {
            "text": "giant axons, and Pro22",
            "probability": 0.04223489270425801,
            "start_logit": 0.8866479992866516,
            "end_logit": 0.4485659897327423
        },
        {
            "text": "CMT1F neuropathies. Two types of Pro22 mutations have been",
            "probability": 0.04208322950165939,
            "start_logit": 0.9388613700866699,
            "end_logit": 0.3927552103996277
        },
        {
            "text": "CMT1F.",
            "probability": 0.039670781519958696,
            "start_logit": 0.9322746396064758,
            "end_logit": 0.3403075635433197
        },
        {
            "text": "giant axons, and Pro22Thr in CMT1F.",
            "probability": 0.03790140924114179,
            "start_logit": 0.8866479992866516,
            "end_logit": 0.3403075635433197
        }
    ],
    "5173bdb38ed59a060a000020": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52efbfccc8da898910000018": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "530cefaaad0bf1360c000012": [
        {
            "text": "(interquartile range) ferritin was not different between the restless legs syndrome (55 [29.5-103.5]\u00a0\u00b5g\u00a0L",
            "probability": 0.06661142137821369,
            "start_logit": 1.0558435916900635,
            "end_logit": 0.8449804782867432
        },
        {
            "text": "confounders. The prevalence of restless legs syndrome at age 22\u00a0years was 3.0% (n\u00a0=\u00a033,",
            "probability": 0.06365542891542107,
            "start_logit": 1.0514031648635864,
            "end_logit": 0.8040294647216797
        },
        {
            "text": "[29.5-103.5]\u00a0\u00b5g\u00a0L",
            "probability": 0.06063453222237837,
            "start_logit": 0.9618321061134338,
            "end_logit": 0.8449804782867432
        },
        {
            "text": "community. Participants in the Western Australian Pregnancy Cohort (Raine) Study answered",
            "probability": 0.06030996517225151,
            "start_logit": 1.0261365175247192,
            "end_logit": 0.7753088474273682
        },
        {
            "text": "restless legs syndrome at age 22\u00a0years was 3.0% (n\u00a0=\u00a033,",
            "probability": 0.058492461054907886,
            "start_logit": 0.9668164253234863,
            "end_logit": 0.8040294647216797
        },
        {
            "text": "syndrome at age 22\u00a0years was 3.0% (n\u00a0=\u00a033,",
            "probability": 0.05338105384666784,
            "start_logit": 0.875374436378479,
            "end_logit": 0.8040294647216797
        },
        {
            "text": "community. Participants in the Western Australian Pregnancy Cohort",
            "probability": 0.04991402150984884,
            "start_logit": 1.0261365175247192,
            "end_logit": 0.586113452911377
        },
        {
            "text": "quartile range) ferritin was not",
            "probability": 0.04809160854911638,
            "start_logit": 1.0558435916900635,
            "end_logit": 0.5192121267318726
        },
        {
            "text": "confounders. The prevalence of restless legs syndrome at age",
            "probability": 0.04786708098495674,
            "start_logit": 1.0514031648635864,
            "end_logit": 0.5189728736877441
        },
        {
            "text": "investigating this",
            "probability": 0.047855458865248876,
            "start_logit": 1.0210672616958618,
            "end_logit": 0.5490659475326538
        },
        {
            "text": "con",
            "probability": 0.047646535266244544,
            "start_logit": 1.0514031648635864,
            "end_logit": 0.5143547654151917
        },
        {
            "text": "investigating this relationship have had inconsistent results and there are no studies in young adults. Therefore, we investigated",
            "probability": 0.04748643827284186,
            "start_logit": 1.0210672616958618,
            "end_logit": 0.5413249135017395
        },
        {
            "text": "RLS Study Group criteria were met (urge to move, dysaesthesia, relief by movement",
            "probability": 0.04657951839790149,
            "start_logit": 0.8849889039993286,
            "end_logit": 0.6581200361251831
        },
        {
            "text": "RLS Study Group criteria were met (urge to move, dysaesthesia,",
            "probability": 0.04550158442167166,
            "start_logit": 0.8849889039993286,
            "end_logit": 0.6347062587738037
        },
        {
            "text": "restless legs syndrome at age",
            "probability": 0.043984675274828175,
            "start_logit": 0.9668164253234863,
            "end_logit": 0.5189728736877441
        },
        {
            "text": "at age 22\u00a0years (n\u00a0=\u00a0865), the median (interquartile range) ferritin was not",
            "probability": 0.04367162168648726,
            "start_logit": 0.9594343900680542,
            "end_logit": 0.5192121267318726
        },
        {
            "text": "community. Participants in the",
            "probability": 0.04292667563239367,
            "start_logit": 1.0261365175247192,
            "end_logit": 0.4353049397468567
        },
        {
            "text": "at age 22\u00a0years (n\u00a0=\u00a0865), the",
            "probability": 0.042579889094012176,
            "start_logit": 0.9594343900680542,
            "end_logit": 0.49389567971229553
        },
        {
            "text": "results and there are no studies in young adults. Therefore, we investigated",
            "probability": 0.04179333169824057,
            "start_logit": 0.893359899520874,
            "end_logit": 0.5413249135017395
        },
        {
            "text": "of iron stores (ferritin and transferrin saturation) at ages 17 and 22\u00a0years.",
            "probability": 0.041016697756367265,
            "start_logit": 0.9441781044006348,
            "end_logit": 0.4717491567134857
        }
    ],
    "53398855d6d3ac6a3400005b": [
        {
            "text": "of disciplines due to its importance in a multitude of biological processes and disease states. Epigenetic functions result partly from modification of the",
            "probability": 0.11013366539447245,
            "start_logit": 0.884903609752655,
            "end_logit": 0.752266526222229
        },
        {
            "text": "of disciplines due to its",
            "probability": 0.10631196986164451,
            "start_logit": 0.884903609752655,
            "end_logit": 0.7169496417045593
        },
        {
            "text": "igenetics is currently the focus of intense research interest across a broad range of disciplines due to its",
            "probability": 0.10222864373454862,
            "start_logit": 0.845737636089325,
            "end_logit": 0.7169496417045593
        },
        {
            "text": "biology approaches that have furthered our study of bromodomains, enabled",
            "probability": 0.09753549174665548,
            "start_logit": 0.8915932178497314,
            "end_logit": 0.6240984797477722
        },
        {
            "text": "igenetics is currently the focus of intense research interest across a broad range",
            "probability": 0.094408461984431,
            "start_logit": 0.845737636089325,
            "end_logit": 0.6373684406280518
        },
        {
            "text": "biology approaches",
            "probability": 0.09004007517722436,
            "start_logit": 0.8915932178497314,
            "end_logit": 0.5441370010375977
        },
        {
            "text": "of disciplines due to its importance in a multitude of biological processes and disease states. Epigenetic functions result partly",
            "probability": 0.08406023424143425,
            "start_logit": 0.884903609752655,
            "end_logit": 0.4821053743362427
        },
        {
            "text": "biology approaches that have furthered our study of bromodomains, enabled the development of bromodomain ligands, and played",
            "probability": 0.08370485724624545,
            "start_logit": 0.8915932178497314,
            "end_logit": 0.47117915749549866
        },
        {
            "text": "of disciplines due to its importance in a multitude of biological",
            "probability": 0.07882536746487737,
            "start_logit": 0.884903609752655,
            "end_logit": 0.41780662536621094
        },
        {
            "text": "igenetics is currently the",
            "probability": 0.07695346156828735,
            "start_logit": 0.845737636089325,
            "end_logit": 0.4329385757446289
        },
        {
            "text": "igenetics is currently the focus of intense research interest across a broad range of disciplines due to its importance in a multitude of biological",
            "probability": 0.07579777158017922,
            "start_logit": 0.845737636089325,
            "end_logit": 0.41780662536621094
        }
    ],
    "56d1da3b67f0cb3d66000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "530cefaaad0bf1360c00000d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56f6d11c09dd18d46b00000f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "550c4011a103b78016000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56bc9268ac7ad1001900001b": [
        {
            "text": "p19 subunit of IL-23 in order to prevent the activation of IL-23",
            "probability": 0.07792918788494457,
            "start_logit": 1.146425724029541,
            "end_logit": 1.0279741287231445
        },
        {
            "text": "p19 subunit of IL-23",
            "probability": 0.072913081989901,
            "start_logit": 1.146425724029541,
            "end_logit": 0.9614416360855103
        },
        {
            "text": "bimekizumab, netakimab and M1095. The novel class of IL-23",
            "probability": 0.059943267225786495,
            "start_logit": 0.8855460286140442,
            "end_logit": 1.026451826095581
        },
        {
            "text": "p40 subunit shared by both IL-",
            "probability": 0.05255272254235283,
            "start_logit": 1.0188086032867432,
            "end_logit": 0.7616075873374939
        },
        {
            "text": "p19 subunit of IL-",
            "probability": 0.05077509058248608,
            "start_logit": 1.146425724029541,
            "end_logit": 0.5995794534683228
        },
        {
            "text": "kumab, risankizumab and tildrakizumab, bind the p19 subunit of IL-23",
            "probability": 0.050546523897856854,
            "start_logit": 0.7800518274307251,
            "end_logit": 0.9614416360855103
        },
        {
            "text": "p40 subunit shared by both IL-23",
            "probability": 0.05039578335270801,
            "start_logit": 1.0188086032867432,
            "end_logit": 0.7196981906890869
        },
        {
            "text": "-12/23, IL-17 and IL-",
            "probability": 0.04921410501767069,
            "start_logit": 0.931598961353302,
            "end_logit": 0.7831805944442749
        },
        {
            "text": "-12/23, IL-17 and IL-23 inhibitors. TNF-",
            "probability": 0.04821262418159035,
            "start_logit": 0.931598961353302,
            "end_logit": 0.7626212239265442
        },
        {
            "text": "tekinumab as the latter antibody inhibits the p40 subunit shared by both IL-",
            "probability": 0.04744280892285538,
            "start_logit": 0.9165166616439819,
            "end_logit": 0.7616075873374939
        },
        {
            "text": "shared by both IL-",
            "probability": 0.04744229426390422,
            "start_logit": 0.9165058135986328,
            "end_logit": 0.7616075873374939
        },
        {
            "text": "\u03b1 interleukin (IL)-12/23, IL-17 and IL-",
            "probability": 0.04655712533502146,
            "start_logit": 0.8760987520217896,
            "end_logit": 0.7831805944442749
        },
        {
            "text": "\u03b1 interleukin (IL)-12/23, IL-17 and IL-23 inhibitors. TNF-",
            "probability": 0.04560971262093729,
            "start_logit": 0.8760987520217896,
            "end_logit": 0.7626212239265442
        },
        {
            "text": "tekinumab as the latter antibody inhibits the p40 subunit shared by both IL-23",
            "probability": 0.04549559764850003,
            "start_logit": 0.9165166616439819,
            "end_logit": 0.7196981906890869
        },
        {
            "text": "shared by both IL-23",
            "probability": 0.04549510411287051,
            "start_logit": 0.9165058135986328,
            "end_logit": 0.7196981906890869
        },
        {
            "text": "p40 subunit shared by both IL-23 and IL-12. The availability of biosimi",
            "probability": 0.04395408142329802,
            "start_logit": 1.0188086032867432,
            "end_logit": 0.58293616771698
        },
        {
            "text": "tekinumab as the latter antibody",
            "probability": 0.04252596607387399,
            "start_logit": 0.9165166616439819,
            "end_logit": 0.6521974802017212
        },
        {
            "text": "dis",
            "probability": 0.041682430460769984,
            "start_logit": 0.8796308040618896,
            "end_logit": 0.6690481901168823
        },
        {
            "text": "-12/23, IL-17 and IL-23",
            "probability": 0.04158126173705662,
            "start_logit": 0.931598961353302,
            "end_logit": 0.6146499514579773
        },
        {
            "text": "ctorial aetiology and a strong genetic predis",
            "probability": 0.039731230725615685,
            "start_logit": 0.831688642501831,
            "end_logit": 0.6690481901168823
        }
    ],
    "54ff5197e9bde69634000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5343fc1aaeec6fbd07000003": [
        {
            "text": "is an autosomal dominant disorder with a mutation",
            "probability": 0.1296596062606982,
            "start_logit": 0.9700864553451538,
            "end_logit": 0.4636135697364807
        },
        {
            "text": "is an autosomal dominant disorder with a mutation in one copy of the",
            "probability": 0.12224638923349922,
            "start_logit": 0.9700864553451538,
            "end_logit": 0.4047395586967468
        },
        {
            "text": "is an autosomal dominant",
            "probability": 0.11421201643365675,
            "start_logit": 0.9700864553451538,
            "end_logit": 0.33675748109817505
        },
        {
            "text": "is an autosomal dominant disorder",
            "probability": 0.1141718792673032,
            "start_logit": 0.9700864553451538,
            "end_logit": 0.33640599250793457
        },
        {
            "text": "is an autosomal dominant disorder with a mutation in one copy of the neurofibro",
            "probability": 0.1095526674036559,
            "start_logit": 0.9700864553451538,
            "end_logit": 0.2951063811779022
        },
        {
            "text": "is an autosomal dominant disorder with a mutation in one copy of the neurofi",
            "probability": 0.10946997525089854,
            "start_logit": 0.9700864553451538,
            "end_logit": 0.2943512797355652
        },
        {
            "text": "is an auto",
            "probability": 0.10686264806790641,
            "start_logit": 0.9700864553451538,
            "end_logit": 0.2702453136444092
        },
        {
            "text": "is an autosomal dominant disorder with a",
            "probability": 0.09864177731360717,
            "start_logit": 0.9700864553451538,
            "end_logit": 0.19019584357738495
        },
        {
            "text": "is an autosom",
            "probability": 0.09518304076877471,
            "start_logit": 0.9700864553451538,
            "end_logit": 0.1545027494430542
        }
    ],
    "516be1d6298dcd4e5100006a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56d860ad51531f7e33000002": [
        {
            "text": "I-II of the dorsal horn, a major relay site in the processing of painful stimuli. Spinal cords of KO mice also exhibited changes in astroglia",
            "probability": 0.07088625253494255,
            "start_logit": 1.1336443424224854,
            "end_logit": 0.9191732406616211
        },
        {
            "text": "I-II of the dorsal horn, a major",
            "probability": 0.0696912995279119,
            "start_logit": 1.1336443424224854,
            "end_logit": 0.9021722078323364
        },
        {
            "text": "of painful stimuli. Spinal cords of KO mice also exhibited changes in astroglia",
            "probability": 0.06581954911239457,
            "start_logit": 1.0594847202301025,
            "end_logit": 0.9191732406616211
        },
        {
            "text": "not WT mice. This cellular storage phenotype was most abundant in neurons of lamina I-II of the dorsal horn, a major",
            "probability": 0.05310816246879694,
            "start_logit": 0.8618994951248169,
            "end_logit": 0.9021722078323364
        },
        {
            "text": "Sensory dysfunction in intellectual",
            "probability": 0.052603786846382006,
            "start_logit": 0.9969558119773865,
            "end_logit": 0.7575733661651611
        },
        {
            "text": "I-",
            "probability": 0.05163735803529295,
            "start_logit": 1.1336443424224854,
            "end_logit": 0.6023421287536621
        },
        {
            "text": "ina I-II of the dorsal horn, a major",
            "probability": 0.05059525281095707,
            "start_logit": 0.8134266138076782,
            "end_logit": 0.9021722078323364
        },
        {
            "text": "CNS, specifically the brain. In addition, parental reports of sensory",
            "probability": 0.04843012373604061,
            "start_logit": 0.8497508764266968,
            "end_logit": 0.8221122026443481
        },
        {
            "text": "Sensory dysfunction in intellectually disabled individuals is challenging to assess and may impair",
            "probability": 0.04784223567223334,
            "start_logit": 0.9969558119773865,
            "end_logit": 0.6626940965652466
        },
        {
            "text": "ohistochemical and ultrastructural analysis of the spinal cord and peripheral",
            "probability": 0.047569670224772605,
            "start_logit": 0.9270007014274597,
            "end_logit": 0.7269357442855835
        },
        {
            "text": "neurogenetic disorder presenting early in life",
            "probability": 0.04725499680354117,
            "start_logit": 0.9892410039901733,
            "end_logit": 0.6580584645271301
        },
        {
            "text": "istochemical and ultrastructural analysis of the spinal cord and peripheral",
            "probability": 0.04657230753556177,
            "start_logit": 0.9058114290237427,
            "end_logit": 0.7269357442855835
        },
        {
            "text": "neurogenetic disorder presenting early in life with a broad range of neurological symptoms, including severe intellectual",
            "probability": 0.045632127494465484,
            "start_logit": 0.9892410039901733,
            "end_logit": 0.6231120824813843
        },
        {
            "text": "We",
            "probability": 0.04512413794665682,
            "start_logit": 0.8045748472213745,
            "end_logit": 0.7965835332870483
        },
        {
            "text": "neuropathogen",
            "probability": 0.044560843042208115,
            "start_logit": 0.8436061143875122,
            "end_logit": 0.7449904680252075
        },
        {
            "text": ") is a recently described rare neurogenetic disorder presenting early in life",
            "probability": 0.043960964694911495,
            "start_logit": 0.9169846773147583,
            "end_logit": 0.6580584645271301
        },
        {
            "text": "regulation of early endosomal pH. Here we review what is currently known about the neuropathogen",
            "probability": 0.04284676111478452,
            "start_logit": 0.8043806552886963,
            "end_logit": 0.7449904680252075
        },
        {
            "text": ") is a recently described rare neurogenetic disorder presenting early in life with a broad range of neurological symptoms, including severe intellectual",
            "probability": 0.04245122169995724,
            "start_logit": 0.9169846773147583,
            "end_logit": 0.6231120824813843
        },
        {
            "text": "neuropathogenesis of CS,",
            "probability": 0.041765437362148265,
            "start_logit": 0.8436061143875122,
            "end_logit": 0.6802040934562683
        },
        {
            "text": "CNS, specifically the brain. In addition,",
            "probability": 0.041647511336040395,
            "start_logit": 0.8497508764266968,
            "end_logit": 0.6712318062782288
        }
    ],
    "52bf1cad03868f1b0600000a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "552faababc4f83e828000005": [
        {
            "text": "cation-negative tumors represent a minor portion of small",
            "probability": 0.15647943164353437,
            "start_logit": 1.0595861673355103,
            "end_logit": 0.5695781111717224
        },
        {
            "text": "cation-negative tumors represent",
            "probability": 0.14270014973298922,
            "start_logit": 1.0595861673355103,
            "end_logit": 0.4773991107940674
        },
        {
            "text": "cation-negative tumors represent a minor portion of small round cell tumors consistent with Ewing sarcoma morphology. The",
            "probability": 0.1356438889984269,
            "start_logit": 1.0595861673355103,
            "end_logit": 0.42668652534484863
        },
        {
            "text": "cation-negative",
            "probability": 0.12542602976868217,
            "start_logit": 1.0595861673355103,
            "end_logit": 0.3483697175979614
        },
        {
            "text": "cation-negative tumors represent a minor portion of small round cell tumors consistent with Ewing sarcoma morphology. The purpose of this study was to differentiate E",
            "probability": 0.11606624668235618,
            "start_logit": 1.0595861673355103,
            "end_logit": 0.2708146572113037
        },
        {
            "text": "cation-negative tumors represent a minor portion of small round cell tumors consistent with Ewing sarcoma morphology. The purpose of this study",
            "probability": 0.11113005346570777,
            "start_logit": 1.0595861673355103,
            "end_logit": 0.22735470533370972
        },
        {
            "text": "cation-negative tumors represent a minor portion of small round",
            "probability": 0.10919750119781703,
            "start_logit": 1.0595861673355103,
            "end_logit": 0.2098117172718048
        },
        {
            "text": "PET-",
            "probability": 0.10335669851048646,
            "start_logit": 0.9946718215942383,
            "end_logit": 0.21975398063659668
        }
    ],
    "53189656b166e2b80600001c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54d6562c3706e8952800000b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "515ddda6298dcd4e5100001f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56bc7d71ac7ad10019000018": [
        {
            "text": "of new drugs used to treat patients with multidrug-",
            "probability": 0.16062834480789082,
            "start_logit": 0.8979641199111938,
            "end_logit": 0.7053506970405579
        },
        {
            "text": "of new drugs used to treat patients with multidrug-resistant tuberculosis (MDR-TB) since",
            "probability": 0.1523584638161201,
            "start_logit": 0.8979641199111938,
            "end_logit": 0.6524934768676758
        },
        {
            "text": "of new drugs used to treat patients with multidrug",
            "probability": 0.12525088555515443,
            "start_logit": 0.8979641199111938,
            "end_logit": 0.45657622814178467
        },
        {
            "text": "of new drugs used to treat patients with multidrug-resistant tuberculosis (MDR-",
            "probability": 0.12327660917160052,
            "start_logit": 0.8979641199111938,
            "end_logit": 0.4406881034374237
        },
        {
            "text": "of new",
            "probability": 0.1114413999864303,
            "start_logit": 0.8979641199111938,
            "end_logit": 0.3397563099861145
        },
        {
            "text": "of new drugs used to treat patients with",
            "probability": 0.11063497895885656,
            "start_logit": 0.8979641199111938,
            "end_logit": 0.33249372243881226
        },
        {
            "text": "of new drugs used to treat patients with multidrug-resistant tuberculosis",
            "probability": 0.11045560630006898,
            "start_logit": 0.8979641199111938,
            "end_logit": 0.3308711051940918
        },
        {
            "text": "of new drugs used to treat patients with multidrug-resistant tuberculosis (MDR-TB) since September 2016. Therefore, this",
            "probability": 0.1059537114038784,
            "start_logit": 0.8979641199111938,
            "end_logit": 0.28925973176956177
        }
    ],
    "52b2e1d8f828ad283c00000c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55411d9f379ddf3f47000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54d907c84b1fd0d33c000008": [
        {
            "text": ".g., sialic acid-binding immunoglobulin-like lectin 8 antibodies, the",
            "probability": 0.07216978997576336,
            "start_logit": 1.007529854774475,
            "end_logit": 1.1282376050949097
        },
        {
            "text": "is associated with es",
            "probability": 0.06178868543209263,
            "start_logit": 0.986345648765564,
            "end_logit": 0.9941205382347107
        },
        {
            "text": "ymphopoietin antibodies, antibodies targeting the \u03b14\u03b27 integ",
            "probability": 0.0579332760053008,
            "start_logit": 1.0971214771270752,
            "end_logit": 0.818916380405426
        },
        {
            "text": "suboptimal for long-term management. Persistent, uncontrolled esophageal inflammation is associated with es",
            "probability": 0.05612353274438573,
            "start_logit": 0.8901805877685547,
            "end_logit": 0.9941205382347107
        },
        {
            "text": "oietin antibodies, antibodies targeting the \u03b14\u03b27 integ",
            "probability": 0.05456086062686525,
            "start_logit": 1.0371463298797607,
            "end_logit": 0.818916380405426
        },
        {
            "text": "flix",
            "probability": 0.052226942885151575,
            "start_logit": 1.1433875560760498,
            "end_logit": 0.6689568758010864
        },
        {
            "text": "fliximab) that have been evaluated as treatments for EoE are summarized. Finally, several",
            "probability": 0.050550704742859755,
            "start_logit": 1.1433875560760498,
            "end_logit": 0.6363352537155151
        },
        {
            "text": "), a chronic allergic disorder of the esophagus, is characterized by symptoms of esophageal dysfunction and e",
            "probability": 0.05006670818741114,
            "start_logit": 1.0362451076507568,
            "end_logit": 0.7338570952415466
        },
        {
            "text": "ymphopoietin antibodies, antibodies targeting the \u03b14\u03b27 integrin, anti-",
            "probability": 0.04952754192836464,
            "start_logit": 1.0971214771270752,
            "end_logit": 0.6621533632278442
        },
        {
            "text": "oietin antibodies, antibodies targeting the \u03b14\u03b27 integrin, anti-interleukin-9 antibodies, and anti-",
            "probability": 0.049419622713742686,
            "start_logit": 1.0371463298797607,
            "end_logit": 0.7199471592903137
        },
        {
            "text": "munosuppressives, and monocl",
            "probability": 0.048661220824177086,
            "start_logit": 0.8454209566116333,
            "end_logit": 0.8962073922157288
        },
        {
            "text": "oietin antibodies, antibodies targeting the \u03b14\u03b27 integrin, anti-",
            "probability": 0.04664444165210812,
            "start_logit": 1.0371463298797607,
            "end_logit": 0.6621533632278442
        },
        {
            "text": "fliximab) that have been evaluated as treatments for EoE are summarized. Finally",
            "probability": 0.045806023500182876,
            "start_logit": 1.1433875560760498,
            "end_logit": 0.5377739667892456
        },
        {
            "text": "), a chronic allergic disorder of the es",
            "probability": 0.045146514317571856,
            "start_logit": 1.0362451076507568,
            "end_logit": 0.6304138898849487
        },
        {
            "text": "suboptimal for long-term management. Persistent, uncontrolled es",
            "probability": 0.044253656837245095,
            "start_logit": 0.8901805877685547,
            "end_logit": 0.7565033435821533
        },
        {
            "text": "ymphopoi",
            "probability": 0.04416114583380559,
            "start_logit": 1.0971214771270752,
            "end_logit": 0.5474697947502136
        },
        {
            "text": "ies, which include proton pump inhibitors and swallowed topical steroids. Additionally, anti-allergic targets, immunosuppressive",
            "probability": 0.04331714796987135,
            "start_logit": 0.833263099193573,
            "end_logit": 0.7920314073562622
        },
        {
            "text": "ies, which include proton pump inhibitors and swallowed topical steroids. Additionally, anti-",
            "probability": 0.042682651932094355,
            "start_logit": 0.833263099193573,
            "end_logit": 0.7772753834724426
        },
        {
            "text": "and pharmacotherapy. Given that EoE is a chronic progressive disease that is prone to re",
            "probability": 0.04264091629450067,
            "start_logit": 0.8501379489898682,
            "end_logit": 0.759422242641449
        },
        {
            "text": "is (EoE), a chronic allergic disorder of the esophagus, is characterized by symptoms of esophageal dysfunction and e",
            "probability": 0.042318615596505446,
            "start_logit": 0.8681159019470215,
            "end_logit": 0.7338570952415466
        }
    ],
    "550342a8f8aee20f27000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "550313aae9bde6963400001f": [
        {
            "text": "RA can induce neut",
            "probability": 0.06961223530165578,
            "start_logit": 1.2119371891021729,
            "end_logit": 0.8776592016220093
        },
        {
            "text": ". Medications are the most common causes, making detailed history-taking crucial. Many medications used to treat RA can induce neut",
            "probability": 0.05739331714412455,
            "start_logit": 1.0189247131347656,
            "end_logit": 0.8776592016220093
        },
        {
            "text": ".",
            "probability": 0.05475487290424916,
            "start_logit": 1.0189247131347656,
            "end_logit": 0.8305976986885071
        },
        {
            "text": "hotrexate",
            "probability": 0.05221762060592145,
            "start_logit": 1.2176764011383057,
            "end_logit": 0.5843996405601501
        },
        {
            "text": "RA can induce neutropenia. Folic acid deficiency should be sought routinely in patients taking methotrexate",
            "probability": 0.05191879095286348,
            "start_logit": 1.2119371891021729,
            "end_logit": 0.5843996405601501
        },
        {
            "text": "40% of cases. The",
            "probability": 0.051124358355936976,
            "start_logit": 0.9266384243965149,
            "end_logit": 0.8542786836624146
        },
        {
            "text": "s syndrome, which is accompanied with large granular lymphocytic (LGL) leukemia in 40% of cases. The",
            "probability": 0.05028901671022218,
            "start_logit": 0.9101640582084656,
            "end_logit": 0.8542786836624146
        },
        {
            "text": "making detailed history-taking crucial. Many medications used to treat RA can induce neut",
            "probability": 0.05016080824234524,
            "start_logit": 0.8842308521270752,
            "end_logit": 0.8776592016220093
        },
        {
            "text": "RA can induce neutropenia. Folic acid deficiency should be sought routinely in patients taking",
            "probability": 0.05010231968728708,
            "start_logit": 1.2119371891021729,
            "end_logit": 0.5487861633300781
        },
        {
            "text": "RA) are acquired. Medications are the most common causes, making detailed history-taking crucial. Many medications used to treat RA can induce neut",
            "probability": 0.0493485075075907,
            "start_logit": 0.8679043650627136,
            "end_logit": 0.8776592016220093
        },
        {
            "text": "RA-related autoimmune reaction. Splenomegaly suggests",
            "probability": 0.048873160645927824,
            "start_logit": 1.01762855052948,
            "end_logit": 0.718255877494812
        },
        {
            "text": "Many medications used to treat RA can induce neut",
            "probability": 0.04831184483045351,
            "start_logit": 0.8466736078262329,
            "end_logit": 0.8776592016220093
        },
        {
            "text": "neut",
            "probability": 0.04772600414632006,
            "start_logit": 0.8344732522964478,
            "end_logit": 0.8776592016220093
        },
        {
            "text": "RA) are acquired.",
            "probability": 0.047079893462284916,
            "start_logit": 0.8679043650627136,
            "end_logit": 0.8305976986885071
        },
        {
            "text": "40% of cases. The treatment depends on",
            "probability": 0.04681695334295164,
            "start_logit": 0.9266384243965149,
            "end_logit": 0.7662630081176758
        },
        {
            "text": "neutropenia in patients with rheumatoid arthritis (RA) are acquired.",
            "probability": 0.046435679004947376,
            "start_logit": 0.8541264533996582,
            "end_logit": 0.8305976986885071
        },
        {
            "text": "s syndrome, which is accompanied with large granular lymphocytic (LGL) leukemia in 40% of cases. The treatment depends on",
            "probability": 0.046051992136385944,
            "start_logit": 0.9101640582084656,
            "end_logit": 0.7662630081176758
        },
        {
            "text": "Felty's syndrome, which is accompanied with large granular lymphocytic (LGL) leukemia in 40% of cases. The",
            "probability": 0.04553821566633083,
            "start_logit": 0.8109292387962341,
            "end_logit": 0.8542786836624146
        },
        {
            "text": "lower than 1.5g/L, with categorization as mild, moderate, or severe when the",
            "probability": 0.04318322831077255,
            "start_logit": 0.8781564235687256,
            "end_logit": 0.7339518070220947
        },
        {
            "text": ". Medications are the most common causes, making detailed history-taking crucial.",
            "probability": 0.04306118104142894,
            "start_logit": 1.0189247131347656,
            "end_logit": 0.59035325050354
        }
    ],
    "56bdc79bef6e394741000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "534ebb59288f4dae47000004": [
        {
            "text": "pmental disease Rett syndrome. Repair is mediated by hippocamp",
            "probability": 0.33528542270904343,
            "start_logit": 0.8847863674163818,
            "end_logit": 0.8100367784500122
        },
        {
            "text": "pmental disease Rett syndrome.",
            "probability": 0.23764980105802902,
            "start_logit": 0.8847863674163818,
            "end_logit": 0.4658527672290802
        },
        {
            "text": "pmental disease Rett syndrome. Repair is mediated by hippocampal injection",
            "probability": 0.21874445980460794,
            "start_logit": 0.8847863674163818,
            "end_logit": 0.3829587996006012
        },
        {
            "text": "pmental disease Rett syndrome. Repair is mediated by hippocampal injections",
            "probability": 0.20832031642831958,
            "start_logit": 0.8847863674163818,
            "end_logit": 0.33413147926330566
        }
    ],
    "54d7ae1fe19bba8909000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "532f55fed6d3ac6a34000036": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5519110f622b19434500000c": [
        {
            "text": "GF",
            "probability": 0.06051436386294733,
            "start_logit": 1.1211395263671875,
            "end_logit": 0.8486279845237732
        },
        {
            "text": ". Thus, the risk of extreme blood loss should be anticipated any time midface distraction surgery is performed on an SGS",
            "probability": 0.05912275825447037,
            "start_logit": 1.0041254758834839,
            "end_logit": 0.9423772096633911
        },
        {
            "text": "year-old girl",
            "probability": 0.05831925154431852,
            "start_logit": 1.056434988975525,
            "end_logit": 0.8763840198516846
        },
        {
            "text": "year-old girl with SGS. The patient had severe cervical spinal instability that resolved after surgical occipital-",
            "probability": 0.05625223726701864,
            "start_logit": 1.056434988975525,
            "end_logit": 0.8402975797653198
        },
        {
            "text": "midface distraction surgery is performed on an SGS",
            "probability": 0.05573713114775348,
            "start_logit": 0.9451560974121094,
            "end_logit": 0.9423772096633911
        },
        {
            "text": "year-",
            "probability": 0.05450484652988438,
            "start_logit": 1.056434988975525,
            "end_logit": 0.8087413907051086
        },
        {
            "text": "lagenopathies involving mutations in the TGF",
            "probability": 0.05081065060109581,
            "start_logit": 0.9463647603988647,
            "end_logit": 0.8486279845237732
        },
        {
            "text": "GF-",
            "probability": 0.0507884168186806,
            "start_logit": 1.1211395263671875,
            "end_logit": 0.6734155416488647
        },
        {
            "text": ". Thus, the risk of extreme blood loss should be anticipated any time midface distraction surgery is performed on an SGS patient. Continued",
            "probability": 0.05028143970303127,
            "start_logit": 1.0041254758834839,
            "end_logit": 0.7803972959518433
        },
        {
            "text": "including Chiari 1 malformation",
            "probability": 0.04958055131953359,
            "start_logit": 0.9933531284332275,
            "end_logit": 0.7771322727203369
        },
        {
            "text": "involving mutations in the TGF",
            "probability": 0.04955820594326611,
            "start_logit": 0.921406626701355,
            "end_logit": 0.8486279845237732
        },
        {
            "text": ". Thus, the risk",
            "probability": 0.048656690767552045,
            "start_logit": 1.0041254758834839,
            "end_logit": 0.7475506067276001
        },
        {
            "text": "midface distraction surgery is performed on an SGS patient. Continued",
            "probability": 0.047402105073705826,
            "start_logit": 0.9451560974121094,
            "end_logit": 0.7803972959518433
        },
        {
            "text": "GF-\u00df signaling pathway, which makes accurate diagnosis difficult without genetic testing, especially in cases",
            "probability": 0.047221033782446444,
            "start_logit": 1.1211395263671875,
            "end_logit": 0.6005866527557373
        },
        {
            "text": "aniosynostosis, scoliosis,",
            "probability": 0.04651165027546194,
            "start_logit": 1.0397064685821533,
            "end_logit": 0.666883111000061
        },
        {
            "text": "lagenopathy, most",
            "probability": 0.044767080599172566,
            "start_logit": 1.0611554384231567,
            "end_logit": 0.6072043776512146
        },
        {
            "text": "lagenopathy, most often caused by autosomal-dominant mutations in the SKI proto-oncogen",
            "probability": 0.04313585041553387,
            "start_logit": 1.0611554384231567,
            "end_logit": 0.5700857639312744
        },
        {
            "text": "lagenopathies involving mutations in the TGF-",
            "probability": 0.04264429693752235,
            "start_logit": 0.9463647603988647,
            "end_logit": 0.6734155416488647
        },
        {
            "text": "aniosynostosis, scolio",
            "probability": 0.04259829234714559,
            "start_logit": 1.0397064685821533,
            "end_logit": 0.5789944529533386
        },
        {
            "text": "involving mutations in the TGF-",
            "probability": 0.0415931468094594,
            "start_logit": 0.921406626701355,
            "end_logit": 0.6734155416488647
        }
    ],
    "54ff45966ad7dcbc12000010": [
        {
            "text": ". Ultrastruct",
            "probability": 0.06710678905958985,
            "start_logit": 1.0157783031463623,
            "end_logit": 0.9292241334915161
        },
        {
            "text": ". Ultrastructural analysis revealed cell separation in the hair cortex and increased thickness of Huxley's layer.",
            "probability": 0.06479500820102745,
            "start_logit": 1.0157783031463623,
            "end_logit": 0.8941674828529358
        },
        {
            "text": "LK5 and KLK7 has been previously studied, the role of KLK14 in skin homeostasis",
            "probability": 0.0628417582775724,
            "start_logit": 0.8878892660140991,
            "end_logit": 0.9914477467536926
        },
        {
            "text": "ruct",
            "probability": 0.05711399422307955,
            "start_logit": 0.8545422554016113,
            "end_logit": 0.9292241334915161
        },
        {
            "text": "ructural analysis revealed cell separation in the hair cortex and increased thickness of Huxley's layer.",
            "probability": 0.0551464579953558,
            "start_logit": 0.8545422554016113,
            "end_logit": 0.8941674828529358
        },
        {
            "text": "'s layer.",
            "probability": 0.05412725317835715,
            "start_logit": 0.8358875513076782,
            "end_logit": 0.8941674828529358
        },
        {
            "text": "KLK14 mice displayed abnormal epidermal hyperproliferation and differentiation. Ultrastruct",
            "probability": 0.05396457001800482,
            "start_logit": 0.7978208065032959,
            "end_logit": 0.9292241334915161
        },
        {
            "text": "and increased thickness of Huxley's layer.",
            "probability": 0.05298174584153406,
            "start_logit": 0.814497172832489,
            "end_logit": 0.8941674828529358
        },
        {
            "text": ". Ultrastructural analysis revealed cell separation in the hair cortex and increased thickness of Hu",
            "probability": 0.04908316781797042,
            "start_logit": 1.0157783031463623,
            "end_logit": 0.616455078125
        },
        {
            "text": "LK5 and KLK7 has been previously studied, the",
            "probability": 0.04821322962741857,
            "start_logit": 0.8878892660140991,
            "end_logit": 0.7264614105224609
        },
        {
            "text": "14 directly cleaves recombinant human DSG3 and recombinant human DSG4, suggesting that their",
            "probability": 0.047084481726776574,
            "start_logit": 0.9216814041137695,
            "end_logit": 0.668979287147522
        },
        {
            "text": ". Ultrastructural analysis revealed cell",
            "probability": 0.04532136244388858,
            "start_logit": 1.0157783031463623,
            "end_logit": 0.536717414855957
        },
        {
            "text": "protein that results in unopposed activity of epidermal kallikrein-",
            "probability": 0.045008583390689846,
            "start_logit": 0.954805850982666,
            "end_logit": 0.590764582157135
        },
        {
            "text": "protein that results in unopposed activity of epidermal kallikrein-related peptidases (KLKs),",
            "probability": 0.0448614758909291,
            "start_logit": 0.954805850982666,
            "end_logit": 0.5874907970428467
        },
        {
            "text": "In\u00a0vitro studies showed that hKLK14",
            "probability": 0.042849861757913964,
            "start_logit": 1.0208854675292969,
            "end_logit": 0.4755341708660126
        },
        {
            "text": "activity of epidermal kallikrein-",
            "probability": 0.04208421873318193,
            "start_logit": 0.8876254558563232,
            "end_logit": 0.590764582157135
        },
        {
            "text": "human DSG4, suggesting that their",
            "probability": 0.04196119809318494,
            "start_logit": 0.806483268737793,
            "end_logit": 0.668979287147522
        },
        {
            "text": "activity of epidermal kallikrein-related peptidases (KLKs),",
            "probability": 0.04194666932080687,
            "start_logit": 0.8876254558563232,
            "end_logit": 0.5874907970428467
        },
        {
            "text": "ructural analysis revealed cell separation in the hair cortex and increased thickness of Hu",
            "probability": 0.04177424970693629,
            "start_logit": 0.8545422554016113,
            "end_logit": 0.616455078125
        },
        {
            "text": "autosomal recessive skin disease caused by loss-",
            "probability": 0.041733924695781965,
            "start_logit": 0.8750312328338623,
            "end_logit": 0.5950003266334534
        }
    ],
    "550c3754a103b78016000007": [
        {
            "text": "tzfeldt-",
            "probability": 0.1013029894548249,
            "start_logit": 1.080877661705017,
            "end_logit": 1.098262071609497
        },
        {
            "text": "urites and comprises a diagnostic spectrum that includes Parkinson's disease (PD), PD",
            "probability": 0.08125139901149792,
            "start_logit": 1.04385244846344,
            "end_logit": 0.9147194027900696
        },
        {
            "text": "\u03b1-synuclein and can be widely distributed throughout",
            "probability": 0.0753817016649056,
            "start_logit": 1.2757782936096191,
            "end_logit": 0.6078100800514221
        },
        {
            "text": ") and Lew",
            "probability": 0.07512086675943425,
            "start_logit": 0.9488686323165894,
            "end_logit": 0.9312535524368286
        },
        {
            "text": ") and Lewy neurites and comprises a diagnostic spectrum that includes Parkinson's disease (PD), PD",
            "probability": 0.07388901894809069,
            "start_logit": 0.9488686323165894,
            "end_logit": 0.9147194027900696
        },
        {
            "text": "\u03b1-synuclein and can be widely distributed throughout the central",
            "probability": 0.07344352446625173,
            "start_logit": 1.2757782936096191,
            "end_logit": 0.5817622542381287
        },
        {
            "text": "\u03b1-synuclein and can be widely distributed",
            "probability": 0.0722390528938687,
            "start_logit": 1.2757782936096191,
            "end_logit": 0.5652263164520264
        },
        {
            "text": "is characterized by the presence of Lewy bodies (LBs) and Lew",
            "probability": 0.07071890730084202,
            "start_logit": 0.8884832262992859,
            "end_logit": 0.9312535524368286
        },
        {
            "text": "is characterized by the presence of Lew",
            "probability": 0.06215695462410327,
            "start_logit": 0.8884832262992859,
            "end_logit": 0.8022032976150513
        },
        {
            "text": "urites and comprises a diagnostic spectrum that includes Parkinson's disease (PD), PD with dementia, and dementia with LBs.",
            "probability": 0.06071292135245596,
            "start_logit": 1.04385244846344,
            "end_logit": 0.623327910900116
        },
        {
            "text": "urites and comprises a diagnostic spectrum that includes Parkinson's disease (PD), PD with dementia,",
            "probability": 0.05849876414787428,
            "start_logit": 1.04385244846344,
            "end_logit": 0.5861769914627075
        },
        {
            "text": "nervous systems. The distribution of LBs may determine the LBD phenotype. Braak hyp",
            "probability": 0.05435303885769262,
            "start_logit": 0.8567104339599609,
            "end_logit": 0.6998139023780823
        },
        {
            "text": ") and Lewy neurites and comprises a diagnostic spectrum that includes Parkinson's disease (PD), PD with dementia,",
            "probability": 0.05319805375844056,
            "start_logit": 0.9488686323165894,
            "end_logit": 0.5861769914627075
        },
        {
            "text": "some cases. Alzheimer's disease, progressive supranuclear palsy",
            "probability": 0.04437598844299554,
            "start_logit": 0.8032179474830627,
            "end_logit": 0.5505043864250183
        },
        {
            "text": "some cases",
            "probability": 0.0433568183167221,
            "start_logit": 0.8032179474830627,
            "end_logit": 0.5272698402404785
        }
    ],
    "517a8b768ed59a060a00003f": [
        {
            "text": "15 days and hepatic type 1 deiodinase and brown adipose tissue",
            "probability": 0.0936921561706541,
            "start_logit": 1.155065894126892,
            "end_logit": 1.1659395694732666
        },
        {
            "text": ". Initially, we incubated rat liver type 1 deiodinase and brown adipose tissue",
            "probability": 0.07225089534733306,
            "start_logit": 1.073530673980713,
            "end_logit": 0.9876050353050232
        },
        {
            "text": "1 deiodinase and brown adipose tissue",
            "probability": 0.06835928701201727,
            "start_logit": 0.8398288488388062,
            "end_logit": 1.1659395694732666
        },
        {
            "text": "T4 levels were higher in bisphenol A group, while T3 remained unchanged. T3/T4 ratio was",
            "probability": 0.05991194291178524,
            "start_logit": 1.251474380493164,
            "end_logit": 0.622392475605011
        },
        {
            "text": "ocrine-",
            "probability": 0.05778578867456375,
            "start_logit": 0.9328882098197937,
            "end_logit": 0.904845654964447
        },
        {
            "text": "Initially, we incubated rat liver type 1 deiodinase and brown adipose tissue",
            "probability": 0.0577433394816542,
            "start_logit": 0.8493939638137817,
            "end_logit": 0.9876050353050232
        },
        {
            "text": "adipose tissue",
            "probability": 0.05598542104018409,
            "start_logit": 0.8184772729873657,
            "end_logit": 0.9876050353050232
        },
        {
            "text": "vitro and in vivo. Initially, we incubated rat liver type 1 deiodinase and brown adipose tissue",
            "probability": 0.05500323912250852,
            "start_logit": 0.8007780313491821,
            "end_logit": 0.9876050353050232
        },
        {
            "text": "daily life and some components of plastics are endocrine-",
            "probability": 0.0536978591208874,
            "start_logit": 0.8595184683799744,
            "end_logit": 0.904845654964447
        },
        {
            "text": "izers, and the deiodinase activity was measured. Among them,",
            "probability": 0.04573304983645161,
            "start_logit": 0.8207641243934631,
            "end_logit": 0.7830480933189392
        },
        {
            "text": "activity. Serum T4 levels were higher in bisphenol A group, while T3 remained unchanged. T3/T4 ratio was",
            "probability": 0.04450704140769444,
            "start_logit": 0.954245924949646,
            "end_logit": 0.622392475605011
        },
        {
            "text": "T3/T4 ratio was",
            "probability": 0.040822783519347566,
            "start_logit": 0.8678388595581055,
            "end_logit": 0.622392475605011
        },
        {
            "text": "izers, and the deiodinase activity was",
            "probability": 0.03898481274979838,
            "start_logit": 0.8207641243934631,
            "end_logit": 0.623399019241333
        },
        {
            "text": "adipose tissue type 2 deiodinase samples with 0.5 mM of the plasticizers, and the deiodinase activity was",
            "probability": 0.03889576213751293,
            "start_logit": 0.8184772729873657,
            "end_logit": 0.623399019241333
        },
        {
            "text": "1 deiodinase and brown adipose tissue type 2 deiodinase activities and serum thyroid hormone concentrations were measured. In vivo bisph",
            "probability": 0.03808702191843942,
            "start_logit": 0.8398288488388062,
            "end_logit": 0.5810357332229614
        },
        {
            "text": "daily life and some components of plastics are end",
            "probability": 0.03617856193594421,
            "start_logit": 0.8595184683799744,
            "end_logit": 0.5099392533302307
        },
        {
            "text": "izers, and the",
            "probability": 0.036081763175929246,
            "start_logit": 0.8207641243934631,
            "end_logit": 0.5460144281387329
        },
        {
            "text": "adipose tissue type 2 deiodinase samples with 0.5 mM of the plasticizers, and the",
            "probability": 0.03599934382140326,
            "start_logit": 0.8184772729873657,
            "end_logit": 0.5460144281387329
        },
        {
            "text": "izers, and the deiodinase activity was measured.",
            "probability": 0.035248724235069015,
            "start_logit": 0.8207641243934631,
            "end_logit": 0.5226562023162842
        },
        {
            "text": "izers, and the deiodinase",
            "probability": 0.03503120638082249,
            "start_logit": 0.8207641243934631,
            "end_logit": 0.5164661407470703
        }
    ],
    "56c1f003ef6e394741000039": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "571e14fbbb137a4b0c000001": [
        {
            "text": ".o.) was administered",
            "probability": 0.07092184941753964,
            "start_logit": 1.1142387390136719,
            "end_logit": 1.1800655126571655
        },
        {
            "text": "\u03b1-GST, and RBP excretions. In addition to decreasing urinary levels of cell cycle arrest indices i.e",
            "probability": 0.06706211064177718,
            "start_logit": 1.2011876106262207,
            "end_logit": 1.0371572971343994
        },
        {
            "text": "flozin capability in improving diabetic nephropathy via ameliorating indices of renal inflammation, injury, and cell",
            "probability": 0.056569269419150324,
            "start_logit": 1.2135264873504639,
            "end_logit": 0.8546651005744934
        },
        {
            "text": "\u03b1-",
            "probability": 0.055505926692263736,
            "start_logit": 1.2011876106262207,
            "end_logit": 0.8480278849601746
        },
        {
            "text": "capability in improving diabetic nephropathy via ameliorating indices of renal inflammation, injury, and cell",
            "probability": 0.05533387201053847,
            "start_logit": 1.1914458274841309,
            "end_logit": 0.8546651005744934
        },
        {
            "text": "flozin mitigated acetylated NF-",
            "probability": 0.05400514688467781,
            "start_logit": 1.3278756141662598,
            "end_logit": 0.6939294338226318
        },
        {
            "text": "nephropathy through its",
            "probability": 0.05197941336931592,
            "start_logit": 1.1812793016433716,
            "end_logit": 0.802294135093689
        },
        {
            "text": "flozin capability in improving diabetic nephropathy via ameliorating indices of renal inflammation, injury, and cell cycle arrest on",
            "probability": 0.051081417217123136,
            "start_logit": 1.2135264873504639,
            "end_logit": 0.7526199817657471
        },
        {
            "text": "capability in improving diabetic nephropathy via ameliorating indices of renal inflammation, injury, and cell cycle arrest on",
            "probability": 0.04996586718251562,
            "start_logit": 1.1914458274841309,
            "end_logit": 0.7526199817657471
        },
        {
            "text": "\u03b1-GST, and RB",
            "probability": 0.04929897951227116,
            "start_logit": 1.2011876106262207,
            "end_logit": 0.7294414639472961
        },
        {
            "text": ". In addition to decreasing urinary levels of cell cycle arrest indices i.e",
            "probability": 0.04920073941985148,
            "start_logit": 0.8914770483970642,
            "end_logit": 1.0371572971343994
        },
        {
            "text": ".e",
            "probability": 0.047415257112828936,
            "start_logit": 0.8545124530792236,
            "end_logit": 1.0371572971343994
        },
        {
            "text": "flozin mitigated ace",
            "probability": 0.045689729907994435,
            "start_logit": 1.3278756141662598,
            "end_logit": 0.5267236232757568
        },
        {
            "text": "kidney tissue homogenates and urine. Empaglifloz",
            "probability": 0.04506274340772127,
            "start_logit": 1.124734878540039,
            "end_logit": 0.7160466313362122
        },
        {
            "text": "levels. It also alleviated renal KIM-1/NGAL levels and urinary albumin, \u03b1-",
            "probability": 0.04382015394194424,
            "start_logit": 0.9647916555404663,
            "end_logit": 0.8480278849601746
        },
        {
            "text": "(p.o.) was administered for 4\u00a0weeks, beginning 8\u00a0weeks after induction of diabetes. Renal function",
            "probability": 0.04297448064866965,
            "start_logit": 1.1142387390136719,
            "end_logit": 0.6790934205055237
        },
        {
            "text": "levels. It also alleviated renal KIM-1/NGAL levels and urinary albumin,",
            "probability": 0.04246373047258575,
            "start_logit": 0.9647916555404663,
            "end_logit": 0.8165843486785889
        },
        {
            "text": "\u03b1-GST, and RBP excretions. In addition to decreasing urina",
            "probability": 0.04164202533847319,
            "start_logit": 1.2011876106262207,
            "end_logit": 0.5606479644775391
        },
        {
            "text": "kidney tissue homogenates and urine. Empagliflozin was able",
            "probability": 0.04108731974983417,
            "start_logit": 1.124734878540039,
            "end_logit": 0.6236903667449951
        },
        {
            "text": "levels. It also alleviated renal KIM-1/NGAL levels and urinary albumin, \u03b1-GST, and RB",
            "probability": 0.03891996765292403,
            "start_logit": 0.9647916555404663,
            "end_logit": 0.7294414639472961
        }
    ],
    "57136a7e1174fb1755000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56b469448525abca1e000007": [
        {
            "text": "is an early event in the",
            "probability": 0.10277856284556518,
            "start_logit": 1.0432406663894653,
            "end_logit": 0.7230715751647949
        },
        {
            "text": "neurodegenerative disease that specifically affects motor neurons in the",
            "probability": 0.092250387616244,
            "start_logit": 0.9633930325508118,
            "end_logit": 0.694848895072937
        },
        {
            "text": "neurodegenerative disease that specifically affects motor neurons in the brain and in the spinal cord. Patients with amyotrophic lateral scler",
            "probability": 0.08306129470589493,
            "start_logit": 0.9633930325508118,
            "end_logit": 0.589921236038208
        },
        {
            "text": "is an early event in the pathogenesis of amyotrophic lateral scler",
            "probability": 0.07976139540952115,
            "start_logit": 1.0432406663894653,
            "end_logit": 0.46953439712524414
        },
        {
            "text": "neurodegenerative disease that specifically affects motor neurons in the brain and in the spinal cord. Patients",
            "probability": 0.07563308311026529,
            "start_logit": 0.9633930325508118,
            "end_logit": 0.4962362051010132
        },
        {
            "text": "is an early event in the pathogenesis of amyotrophic lateral sclerosis.",
            "probability": 0.07033163278227733,
            "start_logit": 1.0432406663894653,
            "end_logit": 0.34371644258499146
        },
        {
            "text": "is no cure for amyotrophic lateral sclerosis. Accumulating evidence suggests that dismantling of ne",
            "probability": 0.06980315677231747,
            "start_logit": 0.8442744016647339,
            "end_logit": 0.5351402759552002
        },
        {
            "text": "neurode",
            "probability": 0.0681078107246805,
            "start_logit": 0.9633930325508118,
            "end_logit": 0.39143431186676025
        },
        {
            "text": "neurodegenerative disease that specifically affects motor neurons in the brain",
            "probability": 0.06708458519095446,
            "start_logit": 0.9633930325508118,
            "end_logit": 0.3762966990470886
        },
        {
            "text": "is an early event in the pathogenesis",
            "probability": 0.06354829928000216,
            "start_logit": 1.0432406663894653,
            "end_logit": 0.2422950118780136
        },
        {
            "text": "is no cure for amyotrophic",
            "probability": 0.061407985756220196,
            "start_logit": 0.8442744016647339,
            "end_logit": 0.40700092911720276
        },
        {
            "text": "is no cure for amyotrophic lateral sclerosis. Accumulating evidence suggests that dismantling of neuromus",
            "probability": 0.0593479158155166,
            "start_logit": 0.8442744016647339,
            "end_logit": 0.3728780448436737
        },
        {
            "text": "is no cure for amyotrophic lateral sclerosis. Accumulating evidence suggests that dismantling of neuromuscular",
            "probability": 0.053886453271088056,
            "start_logit": 0.8442744016647339,
            "end_logit": 0.27634015679359436
        },
        {
            "text": "is no cure for amyotrophic lateral sclerosis. Accumulating evidence suggests that dismantling of neuromuscular junction",
            "probability": 0.05299743671945282,
            "start_logit": 0.8442744016647339,
            "end_logit": 0.25970458984375
        }
    ],
    "53357193d6d3ac6a34000047": [
        {
            "text": ") inhibitor used in the treatment of moderate to severe r",
            "probability": 0.18176289771275592,
            "start_logit": 0.9181234240531921,
            "end_logit": 0.46345752477645874
        },
        {
            "text": ") inhibitor used in the treatment of moderate to severe rheumatoid arthritis (RA)",
            "probability": 0.15850213801440383,
            "start_logit": 0.9181234240531921,
            "end_logit": 0.3265225291252136
        },
        {
            "text": ") inhibitor used in the treatment of moderate",
            "probability": 0.13960957354630038,
            "start_logit": 0.9181234240531921,
            "end_logit": 0.19960421323776245
        },
        {
            "text": ") inhibitor used in the treatment of moderate to severe rheumatoid",
            "probability": 0.1373267109830912,
            "start_logit": 0.9181234240531921,
            "end_logit": 0.18311728537082672
        },
        {
            "text": ") inhibitor used",
            "probability": 0.13375416211834695,
            "start_logit": 0.9181234240531921,
            "end_logit": 0.15675795078277588
        },
        {
            "text": ") inhibitor used in the",
            "probability": 0.12892440004540281,
            "start_logit": 0.9181234240531921,
            "end_logit": 0.11998063325881958
        },
        {
            "text": ") inhibitor used in the treatment of moderate to severe rhe",
            "probability": 0.12012011757969912,
            "start_logit": 0.9181234240531921,
            "end_logit": 0.04924666881561279
        }
    ],
    "5708a845cf1c32585100000f": [
        {
            "text": "izzled-7 (Fz7, also known as FZD7) as the receptor for Wnt7b-",
            "probability": 0.07188499732810665,
            "start_logit": 0.9388127326965332,
            "end_logit": 1.0567848682403564
        },
        {
            "text": "neurites and at dendritic growth cones, suggesting a role in dendrite formation and maturation. Fz",
            "probability": 0.0685283760701894,
            "start_logit": 1.11620032787323,
            "end_logit": 0.8315775990486145
        },
        {
            "text": ") to modulate dendr",
            "probability": 0.059504103709331145,
            "start_logit": 1.0767691135406494,
            "end_logit": 0.7298061847686768
        },
        {
            "text": "ne",
            "probability": 0.05871209064274188,
            "start_logit": 1.11620032787323,
            "end_logit": 0.6769753694534302
        },
        {
            "text": "izzled-7 (Fz7, also known as FZD7) as",
            "probability": 0.056071209944121306,
            "start_logit": 0.9388127326965332,
            "end_logit": 0.8083397746086121
        },
        {
            "text": "dendrite formation and maturation. Fz",
            "probability": 0.054374946573612776,
            "start_logit": 0.8848559260368347,
            "end_logit": 0.8315775990486145
        },
        {
            "text": "neurites and at dendritic growth cones, suggesting a role in dendrite formation and maturation. Fz7 loss-of-",
            "probability": 0.05266933983013378,
            "start_logit": 1.11620032787323,
            "end_logit": 0.5683631896972656
        },
        {
            "text": "maturation. Fz",
            "probability": 0.05194528310694489,
            "start_logit": 0.8391433358192444,
            "end_logit": 0.8315775990486145
        },
        {
            "text": ") to modulate dendrite arborisation by activating a non-canonical Wnt signalling pathway. Here, we",
            "probability": 0.05132148790282658,
            "start_logit": 1.0767691135406494,
            "end_logit": 0.581870436668396
        },
        {
            "text": "ite formation underlies several ne",
            "probability": 0.04793812368968212,
            "start_logit": 1.0571544170379639,
            "end_logit": 0.5332866907119751
        },
        {
            "text": ") to modulate dendrite arborisation by activating a non-canonical Wnt signalling pathway",
            "probability": 0.047782230087659916,
            "start_logit": 1.0767691135406494,
            "end_logit": 0.510414719581604
        },
        {
            "text": ") to modulate dendrite arborisation by activating a non-canonical Wnt signalling pathway.",
            "probability": 0.04712839401952798,
            "start_logit": 1.0767691135406494,
            "end_logit": 0.4966365694999695
        },
        {
            "text": "of functional networks",
            "probability": 0.04352510575998383,
            "start_logit": 0.8499523997306824,
            "end_logit": 0.6439155340194702
        },
        {
            "text": "of complex dendritic arbors is crucial for the assembly of functional networks",
            "probability": 0.04328795817661037,
            "start_logit": 0.8444889783859253,
            "end_logit": 0.6439155340194702
        },
        {
            "text": "izzled-7 (Fz7, also known as FZD7) as the receptor for Wnt7b-mediated dendr",
            "probability": 0.04307964067855373,
            "start_logit": 0.9388127326965332,
            "end_logit": 0.5447677969932556
        },
        {
            "text": "izzled-7 (Fz7, also known as",
            "probability": 0.042400350762572515,
            "start_logit": 0.9388127326965332,
            "end_logit": 0.5288739204406738
        },
        {
            "text": "dendrite formation and maturation. Fz7 loss-of-",
            "probability": 0.04179133818080952,
            "start_logit": 0.8848559260368347,
            "end_logit": 0.5683631896972656
        },
        {
            "text": "maturation. Fz7 loss-of-",
            "probability": 0.03992395450506444,
            "start_logit": 0.8391433358192444,
            "end_logit": 0.5683631896972656
        },
        {
            "text": "of complex dendritic arbors is crucial for the assembly",
            "probability": 0.03916430524416445,
            "start_logit": 0.8444889783859253,
            "end_logit": 0.543806791305542
        },
        {
            "text": "of functional networks as abnormal dendrite formation underlies several ne",
            "probability": 0.03896676378736275,
            "start_logit": 0.8499523997306824,
            "end_logit": 0.5332866907119751
        }
    ],
    "51405cd123fec90375000005": [
        {
            "text": "restored ALP function, LC3-II accumulation and decreased LC3-",
            "probability": 0.06795451111625204,
            "start_logit": 1.328319787979126,
            "end_logit": 0.8107457160949707
        },
        {
            "text": "is the autophagy-",
            "probability": 0.06520528313623396,
            "start_logit": 1.178907036781311,
            "end_logit": 0.9188604354858398
        },
        {
            "text": "restored ALP function, LC3-II accumulation and decreased LC3-I/LC3-II ratios. Levels",
            "probability": 0.06448860890702932,
            "start_logit": 1.328319787979126,
            "end_logit": 0.758395791053772
        },
        {
            "text": "PBMCs.",
            "probability": 0.0630477979868309,
            "start_logit": 1.1587226390838623,
            "end_logit": 0.9053974747657776
        },
        {
            "text": "time data about cellular processes involved in the progression of lysosomal storage diseases in patients. Gaucher and Fa",
            "probability": 0.06200202590053143,
            "start_logit": 0.8791797161102295,
            "end_logit": 1.1682143211364746
        },
        {
            "text": "phagy-",
            "probability": 0.05673025921703263,
            "start_logit": 1.0396742820739746,
            "end_logit": 0.9188604354858398
        },
        {
            "text": "\u03b1-",
            "probability": 0.04881192724365184,
            "start_logit": 0.9885857105255127,
            "end_logit": 0.8196159601211548
        },
        {
            "text": "PBMCs derived from patients with Gaucher and Fa",
            "probability": 0.04843231807560479,
            "start_logit": 1.2031738758087158,
            "end_logit": 0.5972204208374023
        },
        {
            "text": "decreased. mTOR inhibition did not activate autophagy and led to ATP inhibition",
            "probability": 0.047886830529909476,
            "start_logit": 0.8025200963020325,
            "end_logit": 0.9865474104881287
        },
        {
            "text": "and led to ATP inhibition",
            "probability": 0.046864800304602244,
            "start_logit": 0.7809464335441589,
            "end_logit": 0.9865474104881287
        },
        {
            "text": "is the autophagy-lysosome pathway (ALP",
            "probability": 0.04580911055012216,
            "start_logit": 1.178907036781311,
            "end_logit": 0.5658029317855835
        },
        {
            "text": "diseases, and the effects",
            "probability": 0.045001108863556766,
            "start_logit": 0.8877072334289551,
            "end_logit": 0.839206874370575
        },
        {
            "text": "decreased. mTOR inhibition did not activate autophagy and led to ATP inhibition in PBMCs.",
            "probability": 0.04415431221292783,
            "start_logit": 0.8025200963020325,
            "end_logit": 0.9053974747657776
        },
        {
            "text": "decreased.",
            "probability": 0.043438627799286166,
            "start_logit": 0.8025200963020325,
            "end_logit": 0.8890559673309326
        },
        {
            "text": "and led to ATP inhibition in PBMCs.",
            "probability": 0.04321194369198178,
            "start_logit": 0.7809464335441589,
            "end_logit": 0.9053974747657776
        },
        {
            "text": "major cellular clearance pathway for organelle and unwanted proteins is the autophagy-",
            "probability": 0.043014238484913696,
            "start_logit": 0.7628977298736572,
            "end_logit": 0.9188604354858398
        },
        {
            "text": "cocerebrosidase and \u03b1-",
            "probability": 0.04201259325539613,
            "start_logit": 0.8385804295539856,
            "end_logit": 0.8196159601211548
        },
        {
            "text": "diseases, and the effects of enzyme replacement therapy (ERT). Studying blood mononuclear cells (PBM",
            "probability": 0.04082969878471925,
            "start_logit": 0.8877072334289551,
            "end_logit": 0.7419294714927673
        },
        {
            "text": "dysfunction. Little is known about ALP pathology and mitochondrial function in patients with Gaucher and Fabry diseases, and the effects",
            "probability": 0.040648576525080936,
            "start_logit": 0.7859839200973511,
            "end_logit": 0.839206874370575
        },
        {
            "text": "pathology and mitochondrial function in patients with Gaucher and Fabry diseases, and the effects",
            "probability": 0.04045542741433669,
            "start_logit": 0.7812209129333496,
            "end_logit": 0.839206874370575
        }
    ],
    "5503133ae9bde6963400001d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "513832a75274a5fb07000012": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52b2e409f828ad283c00000e": [
        {
            "text": "activity, thus shifting the equilibrium towards HDAC5-P and export from the nucleus. Treating Pkd1-/-mice with dom",
            "probability": 0.06514725150596813,
            "start_logit": 1.0805189609527588,
            "end_logit": 0.9320544004440308
        },
        {
            "text": "activity, thus shifting the equilibrium towards HDAC5-P and export from the nucleus. Treating Pkd1-",
            "probability": 0.06440776989120262,
            "start_logit": 1.0805189609527588,
            "end_logit": 0.9206385612487793
        },
        {
            "text": "of HDAC5, even in Pkd1-/-",
            "probability": 0.06314545189165108,
            "start_logit": 0.8321318030357361,
            "end_logit": 1.149232268333435
        },
        {
            "text": "Pkd1-/-mice with dom",
            "probability": 0.05849632975986951,
            "start_logit": 0.9728328585624695,
            "end_logit": 0.9320544004440308
        },
        {
            "text": "Pkd1-",
            "probability": 0.05783234226402371,
            "start_logit": 0.9728328585624695,
            "end_logit": 0.9206385612487793
        },
        {
            "text": ".",
            "probability": 0.05376268778445032,
            "start_logit": 1.0769327878952026,
            "end_logit": 0.7435701489448547
        },
        {
            "text": "activity, thus shifting the equilibrium towards HDAC5-P and export from the nucleus. Treating Pkd1-/-",
            "probability": 0.05225767863677703,
            "start_logit": 1.0805189609527588,
            "end_logit": 0.7115911245346069
        },
        {
            "text": "-mice with dom",
            "probability": 0.05152922135401397,
            "start_logit": 0.8460178971290588,
            "end_logit": 0.9320544004440308
        },
        {
            "text": "dom",
            "probability": 0.05093236058410462,
            "start_logit": 0.8343673348426819,
            "end_logit": 0.9320544004440308
        },
        {
            "text": "activity, thus shifting the equilibrium towards HDAC5",
            "probability": 0.049877157518232726,
            "start_logit": 1.0805189609527588,
            "end_logit": 0.66496741771698
        },
        {
            "text": "ithelial morphogen",
            "probability": 0.04703657048411624,
            "start_logit": 1.0855239629745483,
            "end_logit": 0.6013246774673462
        },
        {
            "text": "Pkd1-/-",
            "probability": 0.04692266106947208,
            "start_logit": 0.9728328585624695,
            "end_logit": 0.7115911245346069
        },
        {
            "text": "ithelial morphogenesis",
            "probability": 0.04461534641850965,
            "start_logit": 1.0855239629745483,
            "end_logit": 0.5484771728515625
        },
        {
            "text": "lation likely by reducing protein phosphatase 2A (PP2A) activity, thus shifting the equilibrium towards HDAC5",
            "probability": 0.0439555045154391,
            "start_logit": 0.9541336894035339,
            "end_logit": 0.66496741771698
        },
        {
            "text": "Domperidone targets Dr",
            "probability": 0.043350796906588863,
            "start_logit": 0.9615560173988342,
            "end_logit": 0.6436923146247864
        },
        {
            "text": "domperidone showed significantly reduced cystic growth and cell proliferation. Further, treated mice displayed a reduction in glomerular cyst",
            "probability": 0.042686998849564985,
            "start_logit": 0.8343673348426819,
            "end_logit": 0.7554503083229065
        },
        {
            "text": "kidney disease (ADPKD) is caused mostly by mutations in polycystin-1 or polycystin-2. Fluid flow",
            "probability": 0.04173314983451813,
            "start_logit": 1.01235830783844,
            "end_logit": 0.5548607110977173
        },
        {
            "text": "-",
            "probability": 0.041334015291109,
            "start_logit": 0.8460178971290588,
            "end_logit": 0.7115911245346069
        },
        {
            "text": "1 or polycystin-2. Fluid flow",
            "probability": 0.04101815270413632,
            "start_logit": 0.9950772523880005,
            "end_logit": 0.5548607110977173
        },
        {
            "text": "Pkd1-/-mice with domperidone showed significantly reduced cystic growth and cell proliferation. Further, treated mice displayed",
            "probability": 0.0399585527362518,
            "start_logit": 0.9728328585624695,
            "end_logit": 0.5509331226348877
        }
    ],
    "56c1f040ef6e394741000055": [
        {
            "text": "globulin, probaby due to colloid phagocytosis. The differing patterns of light chain restriction observed in multifocal granulo",
            "probability": 0.14312963623051062,
            "start_logit": 1.3472464084625244,
            "end_logit": 0.9037815928459167
        },
        {
            "text": "baby due to colloid phagocytosis. The differing patterns of light chain restriction observed in multifocal granulo",
            "probability": 0.10703088587557466,
            "start_logit": 1.0566130876541138,
            "end_logit": 0.9037815928459167
        },
        {
            "text": "globulin, probaby due to colloid phagocytosis",
            "probability": 0.09776727517339971,
            "start_logit": 1.3472464084625244,
            "end_logit": 0.5226207375526428
        },
        {
            "text": ". The differing patterns of light chain restriction observed in multifocal granulo",
            "probability": 0.09335259567896773,
            "start_logit": 0.9198793172836304,
            "end_logit": 0.9037815928459167
        },
        {
            "text": "T lymphocytes predominated over B lymphocytes as shown by the extent of the staining with UCHL-",
            "probability": 0.09150478484894137,
            "start_logit": 0.8679090738296509,
            "end_logit": 0.935759425163269
        },
        {
            "text": "oid cell populations from thyroid multifocal granulomatous folliculitis (palpation thyroiditis) with a panel",
            "probability": 0.07660867301737347,
            "start_logit": 0.945633053779602,
            "end_logit": 0.6803544759750366
        },
        {
            "text": "baby due to colloid phagocytosis",
            "probability": 0.0731093737609838,
            "start_logit": 1.0566130876541138,
            "end_logit": 0.5226207375526428
        },
        {
            "text": "oid cell populations from thyroid multifocal granulomatous folliculitis (palpation thyroiditis) with a",
            "probability": 0.06552720638819567,
            "start_logit": 0.945633053779602,
            "end_logit": 0.5241096019744873
        },
        {
            "text": "thyroiditis and Graves disease thyroiditis, for instance, may reflect differences in the nature",
            "probability": 0.06547814931527388,
            "start_logit": 0.8920916318893433,
            "end_logit": 0.5769020915031433
        },
        {
            "text": "thyroiditis and Graves disease thyroiditis, for instance, may reflect differences in the nature of the underlying immune response",
            "probability": 0.06354276348134312,
            "start_logit": 0.8920916318893433,
            "end_logit": 0.5468987226486206
        },
        {
            "text": "T lymphocytes predominated over B lymphocytes as shown by the",
            "probability": 0.06225179846907066,
            "start_logit": 0.8679090738296509,
            "end_logit": 0.5505555868148804
        },
        {
            "text": "T lymphocytes predominated over B lymphocytes as shown by the extent of the staining with",
            "probability": 0.06069685776036538,
            "start_logit": 0.8679090738296509,
            "end_logit": 0.5252600908279419
        }
    ],
    "56f24fec2ac5ed1459000015": [
        {
            "text": "biology of these subviral RNAs. In this review, we discuss the host involvement",
            "probability": 0.07463644845541559,
            "start_logit": 0.8751804828643799,
            "end_logit": 0.9970163106918335
        },
        {
            "text": "cting host DNA-dependent RNA",
            "probability": 0.07133526291757354,
            "start_logit": 0.9108335971832275,
            "end_logit": 0.9161249995231628
        },
        {
            "text": "biology of these subviral RNAs. In this review, we discuss the host involvement in HDV replication and its implication for HDV pathogenesis",
            "probability": 0.06644393771009181,
            "start_logit": 0.8751804828643799,
            "end_logit": 0.8807458877563477
        },
        {
            "text": "biology of these sub",
            "probability": 0.06505912126699177,
            "start_logit": 0.8751804828643799,
            "end_logit": 0.8596837520599365
        },
        {
            "text": "better understanding of viroids and might globally help understanding the pathogenesis and molecular biology of these sub",
            "probability": 0.06471669838513947,
            "start_logit": 0.8699033260345459,
            "end_logit": 0.8596837520599365
        },
        {
            "text": "cting host DNA-",
            "probability": 0.0631253064254671,
            "start_logit": 0.9108335971832275,
            "end_logit": 0.7938559651374817
        },
        {
            "text": "better understanding of viroids and might globally help understanding the pathogenesis and molecular",
            "probability": 0.0562552856079352,
            "start_logit": 0.8699033260345459,
            "end_logit": 0.7195644974708557
        },
        {
            "text": "is unique among animal viruses. HDV is a satellite virus of the",
            "probability": 0.054985962258438166,
            "start_logit": 0.9818437099456787,
            "end_logit": 0.5848020315170288
        },
        {
            "text": "cting host DNA-dependent RNA polymerases (RNAP), and relies heavily on host proteins for its replication due to its",
            "probability": 0.05351391504399959,
            "start_logit": 0.9108335971832275,
            "end_logit": 0.6286759376525879
        },
        {
            "text": ") is unique among animal viruses. HDV is a satellite virus of the",
            "probability": 0.051065748098380666,
            "start_logit": 0.9078797698020935,
            "end_logit": 0.5848020315170288
        },
        {
            "text": "cting host DNA-dependent RNA polymerases (RNAP), and relies heavily on host proteins for its replication due to its small size and limited",
            "probability": 0.05015191474849131,
            "start_logit": 0.9108335971832275,
            "end_logit": 0.5637909173965454
        },
        {
            "text": "cting host DNA-dependent RNA polymerases (RNAP), and relies heavily on host proteins for its",
            "probability": 0.047866873499909056,
            "start_logit": 0.9108335971832275,
            "end_logit": 0.5171579122543335
        },
        {
            "text": "biology of these subviral",
            "probability": 0.047749026499605135,
            "start_logit": 0.8751804828643799,
            "end_logit": 0.5503460168838501
        },
        {
            "text": "better understanding of viroids and might globally help understanding the pathogenesis and molecular biology of these subviral",
            "probability": 0.04749771109691874,
            "start_logit": 0.8699033260345459,
            "end_logit": 0.5503460168838501
        },
        {
            "text": "biology of these subviral RNAs. In this review, we discuss",
            "probability": 0.04717608683625716,
            "start_logit": 0.8751804828643799,
            "end_logit": 0.5382744669914246
        },
        {
            "text": "better understanding of viroids and might globally help understanding the pathogenesis and molecular biology of these subviral RNAs. In this review, we discuss",
            "probability": 0.04692778696232108,
            "start_logit": 0.8699033260345459,
            "end_logit": 0.5382744669914246
        },
        {
            "text": "biology of these subviral RNAs.",
            "probability": 0.0458671624276576,
            "start_logit": 0.8751804828643799,
            "end_logit": 0.5101367831230164
        },
        {
            "text": "better understanding of viroids and might globally help understanding the pathogenesis and molecular biology of these subviral RNAs.",
            "probability": 0.04562575175940692,
            "start_logit": 0.8699033260345459,
            "end_logit": 0.5101367831230164
        }
    ],
    "54e1bdacae9738404b000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56f146db2ac5ed145900000f": [
        {
            "text": "6237 inhibitors and predict their corresponding",
            "probability": 0.11667357599386372,
            "start_logit": 1.1962323188781738,
            "end_logit": 0.6551088094711304
        },
        {
            "text": "6237",
            "probability": 0.10306700380716416,
            "start_logit": 1.1962323188781738,
            "end_logit": 0.531108021736145
        },
        {
            "text": "kinases or epigenetic",
            "probability": 0.10011824092374995,
            "start_logit": 0.9209354519844055,
            "end_logit": 0.7773774862289429
        },
        {
            "text": "6237 inhibitors and predict their corresponding biomarkers of sensitivity in 30",
            "probability": 0.09967516079872296,
            "start_logit": 1.1962323188781738,
            "end_logit": 0.49764522910118103
        },
        {
            "text": "kinases or epigenetic agents.",
            "probability": 0.0779719506462956,
            "start_logit": 0.9209354519844055,
            "end_logit": 0.5273747444152832
        },
        {
            "text": "ated a large-scale bioinformatics tool named DrugSniper, which exploits loss-of-function experiments to model the",
            "probability": 0.07589676484989527,
            "start_logit": 0.8593271970748901,
            "end_logit": 0.5620079040527344
        },
        {
            "text": "agents.",
            "probability": 0.07416914212306827,
            "start_logit": 0.8709344863891602,
            "end_logit": 0.5273747444152832
        },
        {
            "text": "ated a large-scale bioinformatics tool named DrugSniper, which exploits loss-of-function experiments to model the sensitivity of 6237",
            "probability": 0.07358742663135974,
            "start_logit": 0.8593271970748901,
            "end_logit": 0.531108021736145
        },
        {
            "text": "kinases or epigenetic agents. Interestingly, the analysis suggested a remarkable vulnerability to polo-like",
            "probability": 0.0725388105452013,
            "start_logit": 0.9209354519844055,
            "end_logit": 0.45514732599258423
        },
        {
            "text": "kinases or epigenetic agents. Interestingly, the analysis suggested a remarkable vulnerability to polo",
            "probability": 0.07036640704907658,
            "start_logit": 0.9209354519844055,
            "end_logit": 0.42474156618118286
        },
        {
            "text": "agents. Interestingly, the analysis suggested a remarkable vulnerability to polo-like",
            "probability": 0.06900098438182353,
            "start_logit": 0.8709344863891602,
            "end_logit": 0.45514732599258423
        },
        {
            "text": "agents. Interestingly, the analysis suggested a remarkable vulnerability to polo",
            "probability": 0.0669345322497788,
            "start_logit": 0.8709344863891602,
            "end_logit": 0.42474156618118286
        }
    ],
    "5321bc309b2d7acc7e00000d": [
        {
            "text": "secondary to on",
            "probability": 0.06112581003086164,
            "start_logit": 1.1451189517974854,
            "end_logit": 0.8566895723342896
        },
        {
            "text": "secondary to on-target inhibition of p110\u03b4 in regulatory T cells",
            "probability": 0.06021655575653816,
            "start_logit": 1.1451189517974854,
            "end_logit": 0.8417026996612549
        },
        {
            "text": "secondary to on-target inhibition",
            "probability": 0.058824876911553504,
            "start_logit": 1.1451189517974854,
            "end_logit": 0.8183202147483826
        },
        {
            "text": "T cells",
            "probability": 0.05495948595611898,
            "start_logit": 1.0537679195404053,
            "end_logit": 0.8417026996612549
        },
        {
            "text": "secondary to drug-",
            "probability": 0.054250952098106736,
            "start_logit": 0.9144219756126404,
            "end_logit": 0.9680728912353516
        },
        {
            "text": "secondary to on-target inhibition of p110\u03b4 in regulatory T cells). We evaluate PI3K inhibitors that have entered trials for the",
            "probability": 0.05305474434289809,
            "start_logit": 1.1451189517974854,
            "end_logit": 0.715079665184021
        },
        {
            "text": "secondary to drug-induced neutropenia), opportunistic infections (possibly attributable to on-target inhibition",
            "probability": 0.0521919084350512,
            "start_logit": 0.9144219756126404,
            "end_logit": 0.9293798208236694
        },
        {
            "text": "K\u03b1 and PI3K\u03b4. Expert Opinion: PI3K inhibitors,",
            "probability": 0.05024260089595169,
            "start_logit": 1.0679397583007812,
            "end_logit": 0.7377978563308716
        },
        {
            "text": "secondary to drug-induced neut",
            "probability": 0.05015095117192589,
            "start_logit": 0.9144219756126404,
            "end_logit": 0.8894898295402527
        },
        {
            "text": "T cells). We evaluate PI3K inhibitors that have entered trials for the",
            "probability": 0.048422920241538284,
            "start_logit": 1.0537679195404053,
            "end_logit": 0.715079665184021
        },
        {
            "text": "ib, including bacterial infections (possibly secondary to drug-",
            "probability": 0.04817294472075377,
            "start_logit": 0.7955989837646484,
            "end_logit": 0.9680728912353516
        },
        {
            "text": "elalisib, including bacterial infections (possibly secondary to drug-",
            "probability": 0.047937327109278595,
            "start_logit": 0.7906959056854248,
            "end_logit": 0.9680728912353516
        },
        {
            "text": "ivity for PI3K\u03b1 and PI3K\u03b4. Expert Opinion: PI3K inhibitors,",
            "probability": 0.047522205308205584,
            "start_logit": 1.0122735500335693,
            "end_logit": 0.7377978563308716
        },
        {
            "text": "including bacterial infections (possibly secondary to drug-",
            "probability": 0.04632086355361828,
            "start_logit": 0.7563939094543457,
            "end_logit": 0.9680728912353516
        },
        {
            "text": "T cell function), and organ toxicities such as transamini",
            "probability": 0.04512930598053441,
            "start_logit": 0.8416885733604431,
            "end_logit": 0.856717586517334
        },
        {
            "text": "T cell function), and organ toxicities such as transaminitis and enterocolitis (possibly autoimmune, secondary to on",
            "probability": 0.04512804173760446,
            "start_logit": 0.8416885733604431,
            "end_logit": 0.8566895723342896
        },
        {
            "text": "ib, including bacterial infections (possibly secondary to drug-induced neut",
            "probability": 0.04453228754639162,
            "start_logit": 0.7955989837646484,
            "end_logit": 0.8894898295402527
        },
        {
            "text": "elalisib, including bacterial infections (possibly secondary to drug-induced neut",
            "probability": 0.04431447667171852,
            "start_logit": 0.7906959056854248,
            "end_logit": 0.8894898295402527
        },
        {
            "text": ". Whether newer PI3K inhibitors will demonstrate differentiated toxicity profiles",
            "probability": 0.043977654765438474,
            "start_logit": 0.7733457088470459,
            "end_logit": 0.8992102742195129
        },
        {
            "text": "newer PI3K inhibitors will demonstrate differentiated toxicity profiles",
            "probability": 0.04352408676591212,
            "start_logit": 0.7629785537719727,
            "end_logit": 0.8992102742195129
        }
    ],
    "51588bb2d24251bc05000091": [
        {
            "text": "using valproic acid or other antiep",
            "probability": 0.07285825167728209,
            "start_logit": 1.2035578489303589,
            "end_logit": 0.4947047829627991
        },
        {
            "text": "using valproic acid or other antiepileptic medicines during pregnancy has not clearly been",
            "probability": 0.07278223782429721,
            "start_logit": 1.2035578489303589,
            "end_logit": 0.49366092681884766
        },
        {
            "text": "model, we would like to determine if there is any dose",
            "probability": 0.06700035356188196,
            "start_logit": 0.8814831376075745,
            "end_logit": 0.7329615950584412
        },
        {
            "text": "using valproic acid or",
            "probability": 0.06608398821028087,
            "start_logit": 1.2035578489303589,
            "end_logit": 0.39711546897888184
        },
        {
            "text": "using valproic acid or other antiepileptic medicines during pregnancy has not",
            "probability": 0.06479146359352206,
            "start_logit": 1.2035578489303589,
            "end_logit": 0.37736284732818604
        },
        {
            "text": "using valproic acid or other antiepileptic medicines during pregnancy has not clearly been delineated uniformly in previous clinical series. In this",
            "probability": 0.06406091159221913,
            "start_logit": 1.2035578489303589,
            "end_logit": 0.36602336168289185
        },
        {
            "text": "using valproic acid or other antiepileptic medicines during pregnancy has not clearly been deline",
            "probability": 0.06403129394412593,
            "start_logit": 1.2035578489303589,
            "end_logit": 0.365560919046402
        },
        {
            "text": "congenital malformations and it involves a variety of malformations ranging from anencephaly to spina bifida. Folic acid",
            "probability": 0.0611899685165779,
            "start_logit": 1.0510982275009155,
            "end_logit": 0.47263187170028687
        },
        {
            "text": "model, we",
            "probability": 0.059521565264936606,
            "start_logit": 0.8814831376075745,
            "end_logit": 0.6146023869514465
        },
        {
            "text": "valproic acid or other antiep",
            "probability": 0.055099918087278314,
            "start_logit": 0.9241902828216553,
            "end_logit": 0.4947047829627991
        },
        {
            "text": "valproic acid or other antiepileptic medicines during pregnancy has not clearly been",
            "probability": 0.05504243170822661,
            "start_logit": 0.9241902828216553,
            "end_logit": 0.49366092681884766
        },
        {
            "text": "model, we would like to determine if there is any dose-response relationship between VA and NTDs and if there is any protective effect of FA",
            "probability": 0.05388010611488642,
            "start_logit": 0.8814831376075745,
            "end_logit": 0.5150250196456909
        },
        {
            "text": "valproic acid or",
            "probability": 0.04997680088997401,
            "start_logit": 0.9241902828216553,
            "end_logit": 0.39711546897888184
        },
        {
            "text": "valproic acid or other antiepileptic medicines during pregnancy has not",
            "probability": 0.0489993137986744,
            "start_logit": 0.9241902828216553,
            "end_logit": 0.37736284732818604
        },
        {
            "text": "valproic acid or other antiepileptic medicines during pregnancy has not clearly been delineated uniformly in previous clinical series. In this",
            "probability": 0.048446825171736346,
            "start_logit": 0.9241902828216553,
            "end_logit": 0.36602336168289185
        },
        {
            "text": "valproic acid or other antiepileptic medicines during pregnancy has not clearly been deline",
            "probability": 0.04842442647363004,
            "start_logit": 0.9241902828216553,
            "end_logit": 0.365560919046402
        },
        {
            "text": "model, we would like to determine if there is any dose-",
            "probability": 0.04781014357047002,
            "start_logit": 0.8814831376075745,
            "end_logit": 0.3955015242099762
        }
    ],
    "571cdd227de986d80d00000f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54f9b74306d9727f76000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "531d744c267d7dd053000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55241f9e2c8b63434a000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52ee9f55c8da898910000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52e92c6e98d0239505000024": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "550c3d45a103b78016000008": [
        {
            "text": "s disease (PD",
            "probability": 0.09284512343704138,
            "start_logit": 1.036116123199463,
            "end_logit": 1.2895958423614502
        },
        {
            "text": "tia nigra of 12 patients with typical Parkinson's disease (PD",
            "probability": 0.08158576685688894,
            "start_logit": 0.9068381786346436,
            "end_logit": 1.2895958423614502
        },
        {
            "text": "of 12 patients with typical Parkinson's disease (PD",
            "probability": 0.0787654063419506,
            "start_logit": 0.8716572523117065,
            "end_logit": 1.2895958423614502
        },
        {
            "text": "controls, probably representing \"incidental PD\". We conclude that there is a close relationship between pale bodies and typical Lewy",
            "probability": 0.07155215841293272,
            "start_logit": 1.1984964609146118,
            "end_logit": 0.8667094111442566
        },
        {
            "text": "controls, probably representing \"incidental PD",
            "probability": 0.0715421793809558,
            "start_logit": 1.1984964609146118,
            "end_logit": 0.8665699362754822
        },
        {
            "text": "controls, probably representing \"incidental PD\". We conclude that there is a close relationship between pale bodies and typical Lewy bodies in the sub",
            "probability": 0.05974360303387347,
            "start_logit": 1.1984964609146118,
            "end_logit": 0.6863448619842529
        },
        {
            "text": "s disease (PD), in 5 patients with diffuse Lew",
            "probability": 0.05583501575748739,
            "start_logit": 1.036116123199463,
            "end_logit": 0.7810642719268799
        },
        {
            "text": ". Alternatively, these observations may suggest that pale bodies represent a stage in the formation of Lew",
            "probability": 0.053953268425826276,
            "start_logit": 1.0315420627593994,
            "end_logit": 0.7513554096221924
        },
        {
            "text": "these observations may suggest that pale bodies represent a stage in the formation of Lew",
            "probability": 0.04963757874399377,
            "start_logit": 0.9481719732284546,
            "end_logit": 0.7513554096221924
        },
        {
            "text": "tia nigra of 12 patients with typical Parkinson's disease (PD), in 5 patients with diffuse Lew",
            "probability": 0.04906388628079192,
            "start_logit": 0.9068381786346436,
            "end_logit": 0.7810642719268799
        },
        {
            "text": "We conclude that there is a close relationship between pale bodies and typical Lewy",
            "probability": 0.048007207886084834,
            "start_logit": 0.799420952796936,
            "end_logit": 0.8667094111442566
        },
        {
            "text": "of 12 patients with typical Parkinson's disease (PD), in 5 patients with diffuse Lew",
            "probability": 0.04736778348116387,
            "start_logit": 0.8716572523117065,
            "end_logit": 0.7810642719268799
        },
        {
            "text": "probably occurs in parallel. Alternatively, these observations may suggest that pale bodies represent a stage in the formation of Lew",
            "probability": 0.0414534145528292,
            "start_logit": 0.7679940462112427,
            "end_logit": 0.7513554096221924
        },
        {
            "text": "munoreactive pale bodies and Lew",
            "probability": 0.040976402208034966,
            "start_logit": 0.822931170463562,
            "end_logit": 0.6848443746566772
        },
        {
            "text": "We conclude that there is a close relationship between pale bodies and typical Lewy bodies in the sub",
            "probability": 0.040084375291081255,
            "start_logit": 0.799420952796936,
            "end_logit": 0.6863448619842529
        },
        {
            "text": "munoreactive pale bodies and Lewy bodies. BF10, a monocl",
            "probability": 0.039751755539366496,
            "start_logit": 0.822931170463562,
            "end_logit": 0.6545020341873169
        },
        {
            "text": "probably occurs in parallel",
            "probability": 0.039326537229992846,
            "start_logit": 0.7679940462112427,
            "end_logit": 0.6986846923828125
        },
        {
            "text": "probably",
            "probability": 0.038508537139704195,
            "start_logit": 0.7679940462112427,
            "end_logit": 0.677665114402771
        }
    ],
    "56cdf5315795f9a73e000046": [
        {
            "text": "is poorly active on its",
            "probability": 0.07128208113176963,
            "start_logit": 1.0030940771102905,
            "end_logit": 0.8899028897285461
        },
        {
            "text": "is poorly active on its own and requires binding to stable or transient protein partners to sever the",
            "probability": 0.0668858435021944,
            "start_logit": 1.0030940771102905,
            "end_logit": 0.8262452483177185
        },
        {
            "text": "m7GpppN cap",
            "probability": 0.06614589195074029,
            "start_logit": 1.2149882316589355,
            "end_logit": 0.6032265424728394
        },
        {
            "text": "m7GpppN cap that promotes pre-mRNA splicing",
            "probability": 0.06452810154523575,
            "start_logit": 1.2149882316589355,
            "end_logit": 0.5784645676612854
        },
        {
            "text": "is poorly active on its own and requires binding to stable or transient protein partners to sever the cap",
            "probability": 0.05944175016019963,
            "start_logit": 1.0030940771102905,
            "end_logit": 0.7082547545433044
        },
        {
            "text": "P-bodies together with decapping factors. We report that Pby1 uses its C-terminal domain to directly bind to the decapp",
            "probability": 0.05355590321584316,
            "start_logit": 0.9633181095123291,
            "end_logit": 0.6437599062919617
        },
        {
            "text": "P-bodies together with decapping factors. We report that Pby1 uses its C-",
            "probability": 0.051021975149986507,
            "start_logit": 0.9633181095123291,
            "end_logit": 0.5952903032302856
        },
        {
            "text": "to the decapp",
            "probability": 0.05000300253752155,
            "start_logit": 0.7296407222747803,
            "end_logit": 0.8087943196296692
        },
        {
            "text": "Pby1 domain alone and bound to the Dcp",
            "probability": 0.04859318889567563,
            "start_logit": 0.7554358243942261,
            "end_logit": 0.7543995380401611
        },
        {
            "text": "is known to co-localize into P-bodies together with decapping factors. We report that Pby1 uses its C-",
            "probability": 0.04660657040059673,
            "start_logit": 0.8728032112121582,
            "end_logit": 0.5952903032302856
        },
        {
            "text": "is known to co",
            "probability": 0.04490014658411261,
            "start_logit": 0.8728032112121582,
            "end_logit": 0.5579898357391357
        },
        {
            "text": "mRNA splicing",
            "probability": 0.044618224569205445,
            "start_logit": 0.8460298180580139,
            "end_logit": 0.5784645676612854
        },
        {
            "text": ". Moreover, Pby1 binding to the",
            "probability": 0.04421747895217786,
            "start_logit": 0.8475581407546997,
            "end_logit": 0.5679140090942383
        },
        {
            "text": "is known to co-",
            "probability": 0.043622992606977676,
            "start_logit": 0.8728032112121582,
            "end_logit": 0.529133141040802
        },
        {
            "text": "mRNAs harbor a characteristic 5' m7GpppN cap",
            "probability": 0.04174252939276967,
            "start_logit": 0.7546459436416626,
            "end_logit": 0.6032265424728394
        },
        {
            "text": "Pby1 domain alone and bound to the Dcp1-Dcp2-Edc3 dec",
            "probability": 0.04172523357481015,
            "start_logit": 0.7554358243942261,
            "end_logit": 0.6020222306251526
        },
        {
            "text": "Pby1 domain alone and bound to the",
            "probability": 0.041195230311345636,
            "start_logit": 0.7554358243942261,
            "end_logit": 0.5892386436462402
        },
        {
            "text": "mRNAs harbor a characteristic 5' m7GpppN cap that promotes pre-mRNA splicing",
            "probability": 0.04072159428158537,
            "start_logit": 0.7546459436416626,
            "end_logit": 0.5784645676612854
        },
        {
            "text": "Moreover, Pby1 binding to the",
            "probability": 0.03989311698681241,
            "start_logit": 0.7446417808532715,
            "end_logit": 0.5679140090942383
        },
        {
            "text": "to the decapping enzyme is required for its recruitment into P-bodies. Moreover, Pby1 binding to the",
            "probability": 0.03929914425043982,
            "start_logit": 0.7296407222747803,
            "end_logit": 0.5679140090942383
        }
    ],
    "56f780cb09dd18d46b000011": [
        {
            "text": "programmed cell death protein",
            "probability": 0.0694842798521855,
            "start_logit": 1.2682793140411377,
            "end_logit": 0.7537869215011597
        },
        {
            "text": "programmed cell death protein 1 (PD",
            "probability": 0.06465702850940243,
            "start_logit": 1.2682793140411377,
            "end_logit": 0.6817831993103027
        },
        {
            "text": "programmed cell death protein 1 (PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have been",
            "probability": 0.06285296313078648,
            "start_logit": 1.2682793140411377,
            "end_logit": 0.6534844636917114
        },
        {
            "text": "However, 50% of patients could",
            "probability": 0.062301717294848354,
            "start_logit": 1.0118905305862427,
            "end_logit": 0.9010641574859619
        },
        {
            "text": "associated protein 4 (CTLA-4) and programmed cell death protein",
            "probability": 0.054125482506344885,
            "start_logit": 1.0184838771820068,
            "end_logit": 0.7537869215011597
        },
        {
            "text": "therapy in several",
            "probability": 0.051156249024767,
            "start_logit": 0.8749327659606934,
            "end_logit": 0.8409175872802734
        },
        {
            "text": "associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD",
            "probability": 0.05036524625343484,
            "start_logit": 1.0184838771820068,
            "end_logit": 0.6817831993103027
        },
        {
            "text": "ab and nivolumab, safety concerns",
            "probability": 0.04921856056767348,
            "start_logit": 0.8576882481575012,
            "end_logit": 0.8195482492446899
        },
        {
            "text": "ab and nivolumab combination therapy in several",
            "probability": 0.04869643963928353,
            "start_logit": 0.8256540298461914,
            "end_logit": 0.8409175872802734
        },
        {
            "text": "% of patients could",
            "probability": 0.04806746525955292,
            "start_logit": 0.7525070905685425,
            "end_logit": 0.9010641574859619
        },
        {
            "text": "associated protein 4 (CTLA-",
            "probability": 0.047199290805967756,
            "start_logit": 1.0184838771820068,
            "end_logit": 0.6168606877326965
        },
        {
            "text": "ab, safety concerns",
            "probability": 0.045989220740006345,
            "start_logit": 0.7898244857788086,
            "end_logit": 0.8195482492446899
        },
        {
            "text": "However, 50% of patients could not benefit from ICIs monotherapy. To overcome",
            "probability": 0.0457937095537885,
            "start_logit": 1.0118905305862427,
            "end_logit": 0.59322190284729
        },
        {
            "text": "development of such strategies. Herein, we review data concerning the clinical activity and the",
            "probability": 0.045772162352178174,
            "start_logit": 0.9218781590461731,
            "end_logit": 0.6827636361122131
        },
        {
            "text": "and nivolumab is frequently investigated as an approach to improve oncological outcomes. Despite promising results for the combination of ipilimum",
            "probability": 0.04384407442921806,
            "start_logit": 0.7615062594413757,
            "end_logit": 0.8000990152359009
        },
        {
            "text": "promising targets for the treatment of cancers. Immune checkpoint inhibitors (ICIs)targeting PD-1, including pe",
            "probability": 0.04372009167928753,
            "start_logit": 0.7873627543449402,
            "end_logit": 0.7714107036590576
        },
        {
            "text": "4) and programmed cell death protein",
            "probability": 0.04318590303972786,
            "start_logit": 0.7926928997039795,
            "end_logit": 0.7537869215011597
        },
        {
            "text": "ab and nivolumab, safety concerns slowed down the development of such strategies. Herein, we review data concerning the clinical activity and the",
            "probability": 0.04292636416756559,
            "start_logit": 0.8576882481575012,
            "end_logit": 0.6827636361122131
        },
        {
            "text": "development of such strategies. Herein, we review data concerning the clinical activity and the adverse events of ipilimumab and nivolumab combination",
            "probability": 0.04045808373100926,
            "start_logit": 0.9218781590461731,
            "end_logit": 0.5593540072441101
        },
        {
            "text": "4) and programmed cell death protein 1 (PD",
            "probability": 0.04018566746297144,
            "start_logit": 0.7926928997039795,
            "end_logit": 0.6817831993103027
        }
    ],
    "5717dbfe7de986d80d000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "517575558ed59a060a00002d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56cf20eb3975bb303a000001": [
        {
            "text": "1 patient discontinued medication and was withdrawn",
            "probability": 0.06423469009311632,
            "start_logit": 0.858209490776062,
            "end_logit": 1.1648378372192383
        },
        {
            "text": ". This study suggests that isradipine offers no clear cognitive and only minimal functional benefit; however, additional studies may",
            "probability": 0.06351392901158985,
            "start_logit": 0.9998016953468323,
            "end_logit": 1.0119614601135254
        },
        {
            "text": "is directly related to functional disability. A variant in the gene coding for the alpha 1C subunit of L-",
            "probability": 0.06214207608220648,
            "start_logit": 1.0842454433441162,
            "end_logit": 0.9056817889213562
        },
        {
            "text": "incidences at week 4); and decreased energy (3 new incidences at week 4). 1 patient discontinued medication and was withdrawn",
            "probability": 0.060154431792404366,
            "start_logit": 0.7925812005996704,
            "end_logit": 1.1648378372192383
        },
        {
            "text": "only minimal functional benefit; however, additional studies may",
            "probability": 0.058656931451959396,
            "start_logit": 0.9202482104301453,
            "end_logit": 1.0119614601135254
        },
        {
            "text": "p\u00a0=\u00a00.017) on functional capacity was noted. This open",
            "probability": 0.05794700120857618,
            "start_logit": 0.956369161605835,
            "end_logit": 0.9636635780334473
        },
        {
            "text": "Z), which is directly related to functional disability. A variant in the gene coding for the alpha 1C subunit of L-",
            "probability": 0.057466729582356955,
            "start_logit": 1.0060282945632935,
            "end_logit": 0.9056817889213562
        },
        {
            "text": "additional studies may",
            "probability": 0.0559596867883011,
            "start_logit": 0.8731740117073059,
            "end_logit": 1.0119614601135254
        },
        {
            "text": "is directly related to functional disability",
            "probability": 0.04802232214322785,
            "start_logit": 1.0842454433441162,
            "end_logit": 0.6479244232177734
        },
        {
            "text": "is directly related to functional disability.",
            "probability": 0.047950479342329454,
            "start_logit": 1.0842454433441162,
            "end_logit": 0.6464272737503052
        },
        {
            "text": "p\u00a0=\u00a00.017) on functional capacity was noted. This open label,",
            "probability": 0.047461187375267784,
            "start_logit": 0.956369161605835,
            "end_logit": 0.7640470266342163
        },
        {
            "text": "to functional disability. A variant in the gene coding for the alpha 1C subunit of L-",
            "probability": 0.0453861772787436,
            "start_logit": 0.7700297236442566,
            "end_logit": 0.9056817889213562
        },
        {
            "text": "Z), which is directly related to functional disability",
            "probability": 0.04440929519108721,
            "start_logit": 1.0060282945632935,
            "end_logit": 0.6479244232177734
        },
        {
            "text": "Z), which is directly related to functional disability.",
            "probability": 0.044342857584364744,
            "start_logit": 1.0060282945632935,
            "end_logit": 0.6464272737503052
        },
        {
            "text": "er, to determine its feasibility, safety, and efficacy in improving cognition",
            "probability": 0.04273406137853498,
            "start_logit": 1.0590558052062988,
            "end_logit": 0.5564444065093994
        },
        {
            "text": "er, to determine its feasibility, safety, and efficacy in improving cognition in SZ patients",
            "probability": 0.0414060715954146,
            "start_logit": 1.0590558052062988,
            "end_logit": 0.5248756408691406
        },
        {
            "text": "incidences at week 4",
            "probability": 0.04025964596924491,
            "start_logit": 0.7925812005996704,
            "end_logit": 0.7632723450660706
        },
        {
            "text": "5\u00a0mg/day (up to 10\u00a0mg/day) for 4\u00a0weeks. Weekly in-person visits tracked side",
            "probability": 0.040000811777551,
            "start_logit": 0.9306893348693848,
            "end_logit": 0.6187143325805664
        },
        {
            "text": "5\u00a0mg/day (up to 10\u00a0mg/day) for 4\u00a0weeks.",
            "probability": 0.03978505511259352,
            "start_logit": 0.9306893348693848,
            "end_logit": 0.613305926322937
        },
        {
            "text": ". This study suggests that isradipine offers no clear cognitive and only minimal",
            "probability": 0.03816655924112964,
            "start_logit": 0.9998016953468323,
            "end_logit": 0.502661943435669
        }
    ],
    "56ed0ffe2ac5ed1459000008": [
        {
            "text": "ability for patients with relapsed/refractory multiple myeloma (RRMM). This phase 2 study evaluated the all-",
            "probability": 0.19523787705617807,
            "start_logit": 1.1098426580429077,
            "end_logit": 0.838664710521698
        },
        {
            "text": "ability for patients with relapsed/refractory multiple myeloma (RRMM). This",
            "probability": 0.15102011488631611,
            "start_logit": 1.1098426580429077,
            "end_logit": 0.5818590521812439
        },
        {
            "text": "ability for patients with rela",
            "probability": 0.12572020470359904,
            "start_logit": 1.1098426580429077,
            "end_logit": 0.3985048532485962
        },
        {
            "text": "ability for patients with relapse",
            "probability": 0.11726269960039083,
            "start_logit": 1.1098426580429077,
            "end_logit": 0.328862726688385
        },
        {
            "text": "cyclophosphamide 300\u00a0mg/m",
            "probability": 0.11345764504325048,
            "start_logit": 1.1271309852600098,
            "end_logit": 0.278587281703949
        },
        {
            "text": "ability for patients with relapsed/refractory multiple myeloma (RRMM). This phase 2 study evaluated the",
            "probability": 0.10908384600714315,
            "start_logit": 1.1098426580429077,
            "end_logit": 0.25656282901763916
        },
        {
            "text": "ability for patients with re",
            "probability": 0.10827291169574392,
            "start_logit": 1.1098426580429077,
            "end_logit": 0.24910101294517517
        },
        {
            "text": "cl",
            "probability": 0.07994470100737852,
            "start_logit": 0.8847664594650269,
            "end_logit": 0.17085736989974976
        }
    ],
    "56b76d916e3f8eaf4c000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56f4011709dd18d46b000003": [
        {
            "text": "if Marfan syndrome (MFS), another common hereditary noninflammatory connective tissue disorder",
            "probability": 0.10576751737896489,
            "start_logit": 0.900210976600647,
            "end_logit": 0.7205277681350708
        },
        {
            "text": "Ds and pelvic floor",
            "probability": 0.1013384872546222,
            "start_logit": 1.0279759168624878,
            "end_logit": 0.5499856472015381
        },
        {
            "text": "Ds and pelvic floor symptoms in a national cohort of EDS and MFS patients",
            "probability": 0.09613053262808617,
            "start_logit": 1.0279759168624878,
            "end_logit": 0.497226357460022
        },
        {
            "text": "Ds and pe",
            "probability": 0.083616029591691,
            "start_logit": 1.0279759168624878,
            "end_logit": 0.3577546179294586
        },
        {
            "text": "if Marfan syndrome (MFS), another common hereditary noninflammatory connective tissue",
            "probability": 0.08321437272529207,
            "start_logit": 0.900210976600647,
            "end_logit": 0.4807043969631195
        },
        {
            "text": "if Marfan syndrome (MFS), another common hereditary noninflammatory connective",
            "probability": 0.08235989309127613,
            "start_logit": 0.900210976600647,
            "end_logit": 0.4703828990459442
        },
        {
            "text": "if Marfan syndrome (MFS), another common hereditary noninflammatory connective tissue disorder, is also associated these symptoms.",
            "probability": 0.08160838998919244,
            "start_logit": 0.900210976600647,
            "end_logit": 0.46121639013290405
        },
        {
            "text": "if Marfan syndrome (MFS), another",
            "probability": 0.07631571014440792,
            "start_logit": 0.900210976600647,
            "end_logit": 0.3941631317138672
        },
        {
            "text": "Ds and pelvic floor symptoms in a",
            "probability": 0.07388562084800791,
            "start_logit": 1.0279759168624878,
            "end_logit": 0.2340376079082489
        },
        {
            "text": "Ds and pelvic floor symptoms in a national cohort of EDS and MFS",
            "probability": 0.07288009399075408,
            "start_logit": 1.0279759168624878,
            "end_logit": 0.22033491730690002
        },
        {
            "text": "Ds and pelvic floor symptoms in a national cohort of EDS",
            "probability": 0.07154131610465501,
            "start_logit": 1.0279759168624878,
            "end_logit": 0.20179450511932373
        },
        {
            "text": "Ds and pelvic floor symptoms in a national cohort of EDS and M",
            "probability": 0.0713420362530502,
            "start_logit": 1.0279759168624878,
            "end_logit": 0.1990050971508026
        }
    ],
    "552033206b348bb82c00001b": [
        {
            "text": "n species. This suggests that deeper knowledge of the",
            "probability": 0.15520389816538463,
            "start_logit": 0.8726298213005066,
            "end_logit": 1.1772589683532715
        },
        {
            "text": "showed that different nemertean species harbor distinct bacterial communities, while members of the",
            "probability": 0.140846885464254,
            "start_logit": 0.8934739828109741,
            "end_logit": 1.059348464012146
        },
        {
            "text": "is of bacterial origin in these species. However, metagenomic studies of TTX-bearing animals addressing the whole microbial composition and estimating the",
            "probability": 0.0995526105219395,
            "start_logit": 0.8612719178199768,
            "end_logit": 0.7445634007453918
        },
        {
            "text": "n species. This suggests that deeper knowledge of the microbiome of TTX-",
            "probability": 0.09174160957755977,
            "start_logit": 0.8726298213005066,
            "end_logit": 0.6514952778816223
        },
        {
            "text": "showed that different nemertean species harbor",
            "probability": 0.08779795701006599,
            "start_logit": 0.8934739828109741,
            "end_logit": 0.5867133140563965
        },
        {
            "text": "n species. This suggests",
            "probability": 0.08607172875298912,
            "start_logit": 0.8726298213005066,
            "end_logit": 0.5877002477645874
        },
        {
            "text": "showed that different nemertean species harbor distinct bacterial communities, while members",
            "probability": 0.08593533059027578,
            "start_logit": 0.8934739828109741,
            "end_logit": 0.5652701258659363
        },
        {
            "text": "is of bacterial origin in these species. However, metagenomic studies of TTX-bearing animals",
            "probability": 0.08491926624396895,
            "start_logit": 0.8612719178199768,
            "end_logit": 0.5855781435966492
        },
        {
            "text": "bacterial species historically associated with TTX production were found in all studied samples but predominated in TTX-",
            "probability": 0.08435678607618757,
            "start_logit": 0.8266737461090088,
            "end_logit": 0.6135305762290955
        },
        {
            "text": "share more similar microbiomes. The bacterial species historically associated with TTX production were found in all studied samples but predominated in TTX-",
            "probability": 0.08357392759737473,
            "start_logit": 0.8173500895500183,
            "end_logit": 0.6135305762290955
        }
    ],
    "51635202298dcd4e5100004f": [
        {
            "text": "recommendations. As a rare disorder, large scale clinical trial data to guide the management of myotonic dystrophy are largely lacking. The",
            "probability": 0.11939972322844057,
            "start_logit": 0.8655920028686523,
            "end_logit": 0.8988413214683533
        },
        {
            "text": "care experts and organized",
            "probability": 0.11379223273001188,
            "start_logit": 0.8745579123497009,
            "end_logit": 0.8417727947235107
        },
        {
            "text": "of myotonic d",
            "probability": 0.09341792554034607,
            "start_logit": 0.9152657389640808,
            "end_logit": 0.6037739515304565
        },
        {
            "text": ". Genetic testing for myotonic dyst",
            "probability": 0.09196622714687587,
            "start_logit": 0.8404613137245178,
            "end_logit": 0.6629165410995483
        },
        {
            "text": "manner and contribute to morbidity and mortality.",
            "probability": 0.09015881881780553,
            "start_logit": 0.852286159992218,
            "end_logit": 0.6312430500984192
        },
        {
            "text": "care experts and organized the drafting of these recommendations. As a rare disorder",
            "probability": 0.08601113927090022,
            "start_logit": 0.8745579123497009,
            "end_logit": 0.5618753433227539
        },
        {
            "text": "recommendations. As a rare disorder",
            "probability": 0.08524341798454366,
            "start_logit": 0.8655920028686523,
            "end_logit": 0.5618753433227539
        },
        {
            "text": ". Genetic testing for myotonic dystrophy is diagnostic and identifies those at risk for cardiac complications. The 2 major genetic",
            "probability": 0.08360821986731395,
            "start_logit": 0.8404613137245178,
            "end_logit": 0.5676369667053223
        },
        {
            "text": "care experts and organized the drafting of these recommendations. As a",
            "probability": 0.07931875744701675,
            "start_logit": 0.8745579123497009,
            "end_logit": 0.480873167514801
        },
        {
            "text": "recommendations. As a",
            "probability": 0.07861077126039463,
            "start_logit": 0.8655920028686523,
            "end_logit": 0.480873167514801
        },
        {
            "text": "of myotonic dystrophy, in part supported by literature-based evidence where available",
            "probability": 0.07847276670635096,
            "start_logit": 0.9152657389640808,
            "end_logit": 0.4294423460960388
        }
    ],
    "553f72edab98a37113000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5506ce078e1671127b00000b": [
        {
            "text": "additional regulatory proteins, associated with PLN, that control SR Ca-transport. These",
            "probability": 0.07962219615990063,
            "start_logit": 1.3395986557006836,
            "end_logit": 0.9381469488143921
        },
        {
            "text": "additional regulatory proteins, associated with PLN, that control SR Ca-transport. These include the inhibitor-",
            "probability": 0.06925465994894049,
            "start_logit": 1.3395986557006836,
            "end_logit": 0.798644483089447
        },
        {
            "text": "variants in these Ca-cycling genes modulate their activity and interactions with other protein",
            "probability": 0.0677213666405984,
            "start_logit": 1.1603600978851318,
            "end_logit": 0.9554943442344666
        },
        {
            "text": "these inhibitory effects. Recent studies identified additional regulatory proteins, associated with PLN, that control SR Ca-transport. These",
            "probability": 0.05722972281125492,
            "start_logit": 1.0093791484832764,
            "end_logit": 0.9381469488143921
        },
        {
            "text": "variants in these Ca-cycling genes modulate their",
            "probability": 0.051703688952420224,
            "start_logit": 1.1603600978851318,
            "end_logit": 0.6856217384338379
        },
        {
            "text": "these inhibitory effects. Recent studies identified additional regulatory proteins, associated with PLN, that control SR Ca-transport. These include the inhibitor-",
            "probability": 0.049777890882412565,
            "start_logit": 1.0093791484832764,
            "end_logit": 0.798644483089447
        },
        {
            "text": "kinase A (PKA) or calcium-calmodulin-",
            "probability": 0.04813340268266988,
            "start_logit": 0.9753285646438599,
            "end_logit": 0.7991005182266235
        },
        {
            "text": ". SR Ca-transport is mediated by the",
            "probability": 0.04793851866767029,
            "start_logit": 1.0814770460128784,
            "end_logit": 0.6888949871063232
        },
        {
            "text": ". These",
            "probability": 0.04737836595670648,
            "start_logit": 0.820471465587616,
            "end_logit": 0.9381469488143921
        },
        {
            "text": "I) relieves these inhibitory effects. Recent studies identified additional regulatory proteins, associated with PLN, that control SR Ca-transport. These",
            "probability": 0.04707395543869392,
            "start_logit": 0.8140256404876709,
            "end_logit": 0.9381469488143921
        },
        {
            "text": ") of protein phosphatase 1 (PP1), the small heat shock protein 20 (Hsp20) and the HS-",
            "probability": 0.04593636484898852,
            "start_logit": 0.9273608922958374,
            "end_logit": 0.8003488779067993
        },
        {
            "text": "these",
            "probability": 0.04544829280639831,
            "start_logit": 1.0093791484832764,
            "end_logit": 0.7076488137245178
        },
        {
            "text": ". SR Ca-transport is mediated by the SR Ca-",
            "probability": 0.0453762626275553,
            "start_logit": 1.0814770460128784,
            "end_logit": 0.6339647769927979
        },
        {
            "text": "variants in these Ca-",
            "probability": 0.04432441723203007,
            "start_logit": 1.1603600978851318,
            "end_logit": 0.5316283106803894
        },
        {
            "text": "kinase A (PKA) or calcium-calmodulin-dependent protein kinases (CAMKII) relieves these",
            "probability": 0.043926802718552344,
            "start_logit": 0.9753285646438599,
            "end_logit": 0.7076488137245178
        },
        {
            "text": "mic reticulum (SR) calcium cycling, reflecting impaired SR Ca",
            "probability": 0.043238713428342096,
            "start_logit": 0.9241753220558167,
            "end_logit": 0.7430136203765869
        },
        {
            "text": "kinases (CAMKII) relieves these",
            "probability": 0.043100630012831743,
            "start_logit": 0.9563415050506592,
            "end_logit": 0.7076488137245178
        },
        {
            "text": "p20) and the HS-",
            "probability": 0.04154907317109374,
            "start_logit": 0.8269790410995483,
            "end_logit": 0.8003488779067993
        },
        {
            "text": ". These include the inhibitor-",
            "probability": 0.041209270549116446,
            "start_logit": 0.820471465587616,
            "end_logit": 0.798644483089447
        },
        {
            "text": "kinase A (PKA) or calcium-calmodulin-dependent protein kinases (CAM",
            "probability": 0.04005640446382363,
            "start_logit": 0.9753285646438599,
            "end_logit": 0.615412712097168
        }
    ],
    "54fc99f36ad7dcbc12000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "551d8b3a6b348bb82c000011": [
        {
            "text": "be aggravated in the presence of the OPTN mutation",
            "probability": 0.06735719986807151,
            "start_logit": 1.2254774570465088,
            "end_logit": 0.8723878860473633
        },
        {
            "text": "toplasm (TDP-43 proteinopathy). Interestingly, TD",
            "probability": 0.06695283518189388,
            "start_logit": 1.0036487579345703,
            "end_logit": 1.0881952047348022
        },
        {
            "text": "toplasm (TDP-",
            "probability": 0.06536187496772806,
            "start_logit": 1.0036487579345703,
            "end_logit": 1.0641459226608276
        },
        {
            "text": ". Interestingly, TD",
            "probability": 0.06519365770283987,
            "start_logit": 0.9770225286483765,
            "end_logit": 1.0881952047348022
        },
        {
            "text": "be aggravated in the presence of the OPTN mutation, which is the genetic factor that is responsible for such accumulation. Interaction of TDP-",
            "probability": 0.06315524453952799,
            "start_logit": 1.2254774570465088,
            "end_logit": 0.8079739809036255
        },
        {
            "text": ". Interestingly, TDP-43 proteinopathy is found to be aggravated in the presence of the OPTN mutation",
            "probability": 0.052538953768786464,
            "start_logit": 0.9770225286483765,
            "end_logit": 0.8723878860473633
        },
        {
            "text": "is responsible for such accumulation. Interaction of TDP-43 with progranulin",
            "probability": 0.05080314368092812,
            "start_logit": 0.9939979314804077,
            "end_logit": 0.8218158483505249
        },
        {
            "text": "is responsible for such accumulation. Interaction of TDP-",
            "probability": 0.05010477779460713,
            "start_logit": 0.9939979314804077,
            "end_logit": 0.8079739809036255
        },
        {
            "text": "is usually found inside the nucleus, but in large number of cases of ALS, it accumulates in the cytoplasm (TDP-",
            "probability": 0.05008821454229429,
            "start_logit": 0.7374953627586365,
            "end_logit": 1.0641459226608276
        },
        {
            "text": "pathobiology, but its link to angiogenesis has not been adequately",
            "probability": 0.04904047906301106,
            "start_logit": 0.9284000396728516,
            "end_logit": 0.8521015644073486
        },
        {
            "text": "is responsible for such accumulation. Interaction of TDP-43 with progranulin can further affect the angiogenesis in ALS patients",
            "probability": 0.044524222571205245,
            "start_logit": 0.9939979314804077,
            "end_logit": 0.68989098072052
        },
        {
            "text": "HRE) from the",
            "probability": 0.04436125401677628,
            "start_logit": 0.9034680128097534,
            "end_logit": 0.7767539620399475
        },
        {
            "text": "LN2 and UBQLN4 indicate that ubiquitination has a",
            "probability": 0.043207855140163384,
            "start_logit": 0.985045313835144,
            "end_logit": 0.668832540512085
        },
        {
            "text": "regulate the process of angiogenesis. Transactive response DNA-binding protein 43 (TDP-",
            "probability": 0.04248255996206104,
            "start_logit": 0.9408700466156006,
            "end_logit": 0.6960791349411011
        },
        {
            "text": "toplasm (TDP-43 proteinopathy). Interestingly, TDP-",
            "probability": 0.04186071037699352,
            "start_logit": 1.0036487579345703,
            "end_logit": 0.6185544729232788
        },
        {
            "text": "LN2 and UBQLN4 indicate that ubiquitination has a role in ALS pathobiology, but its link to angio",
            "probability": 0.04097976325623566,
            "start_logit": 0.985045313835144,
            "end_logit": 0.6158885955810547
        },
        {
            "text": "disease that is characterized with progressive muscle atrophy.",
            "probability": 0.04078393437152901,
            "start_logit": 0.9184548854827881,
            "end_logit": 0.6776888966560364
        },
        {
            "text": ". Interestingly, TDP-",
            "probability": 0.040760825379556935,
            "start_logit": 0.9770225286483765,
            "end_logit": 0.6185544729232788
        },
        {
            "text": "HRE) from the promoter of the",
            "probability": 0.04070987104326542,
            "start_logit": 0.9034680128097534,
            "end_logit": 0.6908581256866455
        },
        {
            "text": ". Interaction of TDP-43 with progranulin",
            "probability": 0.03973262277252506,
            "start_logit": 0.7482122778892517,
            "end_logit": 0.8218158483505249
        }
    ],
    "532f0bd6d6d3ac6a3400002d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "551173c26a8cde6b72000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "571e4293bb137a4b0c00000b": [
        {
            "text": "including fever, and association to chronic symptoms. We propose to add FGF14",
            "probability": 0.09796868201710314,
            "start_logit": 1.038590908050537,
            "end_logit": 0.7391972541809082
        },
        {
            "text": "dic ataxia associated with pathogenic mutations in the",
            "probability": 0.09277590606878054,
            "start_logit": 0.9704575538635254,
            "end_logit": 0.752869725227356
        },
        {
            "text": "including fever, and association to chronic symptoms.",
            "probability": 0.08259436559033315,
            "start_logit": 1.038590908050537,
            "end_logit": 0.5684908628463745
        },
        {
            "text": "dic ataxia associated with pathogenic mutations in the FGF14 gene. Attacks were triggered by fever, lasted",
            "probability": 0.08189552471309938,
            "start_logit": 0.9704575538635254,
            "end_logit": 0.6281270980834961
        },
        {
            "text": "including fever, and association to chronic symptoms. We propose to add",
            "probability": 0.07988046526475502,
            "start_logit": 1.038590908050537,
            "end_logit": 0.5350807309150696
        },
        {
            "text": "14-",
            "probability": 0.07866770130923545,
            "start_logit": 0.9157811403274536,
            "end_logit": 0.6425918340682983
        },
        {
            "text": "including fever, and association to chronic symptoms. We propose to add FGF14-",
            "probability": 0.07779072646078856,
            "start_logit": 1.038590908050537,
            "end_logit": 0.5085716247558594
        },
        {
            "text": "14-mutation-related episodic ataxia phenotype: wide range",
            "probability": 0.07509524179002666,
            "start_logit": 0.9157811403274536,
            "end_logit": 0.5961163640022278
        },
        {
            "text": "14-mutation-related episodic ataxia phenotype: wide range of age at onset",
            "probability": 0.07284721576930714,
            "start_logit": 0.9157811403274536,
            "end_logit": 0.5657234787940979
        },
        {
            "text": "including fever, and association to chronic symptoms. We propose to add FGF",
            "probability": 0.07037891778722999,
            "start_logit": 1.038590908050537,
            "end_logit": 0.4084431529045105
        },
        {
            "text": "dic ataxia associated with pathogenic mutations in the FGF14 gene. Attacks were triggered by fever, lasted several days, and",
            "probability": 0.06650737765726833,
            "start_logit": 0.9704575538635254,
            "end_logit": 0.41999563574790955
        },
        {
            "text": "14-mutation-",
            "probability": 0.06458911514939511,
            "start_logit": 0.9157811403274536,
            "end_logit": 0.4454050660133362
        },
        {
            "text": "14-mutation-related episodic ataxia phenotype:",
            "probability": 0.05900876042267745,
            "start_logit": 0.9157811403274536,
            "end_logit": 0.3550450801849365
        }
    ],
    "530cf22aa177c6630c000004": [
        {
            "text": "i,i+6 stapled peptide with improved, sub",
            "probability": 0.08438580800777538,
            "start_logit": 1.3236958980560303,
            "end_logit": 0.9358752369880676
        },
        {
            "text": "i,i+6 stapled peptide with improved,",
            "probability": 0.06469746900654502,
            "start_logit": 1.3236958980560303,
            "end_logit": 0.6701980829238892
        },
        {
            "text": "ox i,i+6 stapled peptide with improved, sub",
            "probability": 0.06275494287753153,
            "start_logit": 1.027534008026123,
            "end_logit": 0.9358752369880676
        },
        {
            "text": "i,i+6 stapled peptide with improved, submicromolar",
            "probability": 0.06015585935708677,
            "start_logit": 1.3236958980560303,
            "end_logit": 0.5974148511886597
        },
        {
            "text": "CIP) of the replicative helicase subunit Sld5. By screening stapling",
            "probability": 0.05594877805969884,
            "start_logit": 1.0797120332717896,
            "end_logit": 0.7688964605331421
        },
        {
            "text": "i,i+6 stapled peptide with improved, submicromolar binding to Ctf4. The",
            "probability": 0.053837017587733405,
            "start_logit": 1.3236958980560303,
            "end_logit": 0.48643729090690613
        },
        {
            "text": "sub",
            "probability": 0.05340771885335647,
            "start_logit": 0.8662519454956055,
            "end_logit": 0.9358752369880676
        },
        {
            "text": "P) of the replicative helicase subunit Sld5. By screening stapling",
            "probability": 0.0509139331879632,
            "start_logit": 0.985412061214447,
            "end_logit": 0.7688964605331421
        },
        {
            "text": "CIP) of the replicative helica",
            "probability": 0.05044510941816287,
            "start_logit": 1.0797120332717896,
            "end_logit": 0.6653456687927246
        },
        {
            "text": "ox i,i+6 stapled peptide with improved,",
            "probability": 0.04811337436565755,
            "start_logit": 1.027534008026123,
            "end_logit": 0.6701980829238892
        },
        {
            "text": "polymerase\u2005\u03b1 from the replisome in yeast extracts. Our study provides proof-of-principle evidence for the development of small-molecule",
            "probability": 0.047346515344799806,
            "start_logit": 0.8718124628067017,
            "end_logit": 0.809852659702301
        },
        {
            "text": "P) of the replicative helica",
            "probability": 0.04590554109752549,
            "start_logit": 0.985412061214447,
            "end_logit": 0.6653456687927246
        },
        {
            "text": "ox i,i+6 stapled peptide with improved, submicromolar",
            "probability": 0.044735929024403744,
            "start_logit": 1.027534008026123,
            "end_logit": 0.5974148511886597
        },
        {
            "text": "displace the Ctf4 partner DNA polymerase\u2005\u03b1 from the replisome in yeast extracts. Our study provides proof-of-principle",
            "probability": 0.04291799634678775,
            "start_logit": 0.9137692451477051,
            "end_logit": 0.6696938872337341
        },
        {
            "text": "polymerase\u2005\u03b1 from the replisome in yeast extracts. Our study provides proof-of-principle",
            "probability": 0.04115454830445687,
            "start_logit": 0.8718124628067017,
            "end_logit": 0.6696938872337341
        },
        {
            "text": "lace the",
            "probability": 0.04009406075629205,
            "start_logit": 0.9137692451477051,
            "end_logit": 0.6016308665275574
        },
        {
            "text": "ox i,i+6 stapled peptide with improved, submicromolar binding to Ctf4. The",
            "probability": 0.04003681475804046,
            "start_logit": 1.027534008026123,
            "end_logit": 0.48643729090690613
        },
        {
            "text": "lethality by small-molecule targeting of pathways that maintain gen",
            "probability": 0.03877082827666534,
            "start_logit": 0.894171953201294,
            "end_logit": 0.5876680612564087
        },
        {
            "text": "submicromolar",
            "probability": 0.03807260130316361,
            "start_logit": 0.8662519454956055,
            "end_logit": 0.5974148511886597
        },
        {
            "text": "submicromolar binding to Ctf4. The mode of interaction with Ctf4 was confirmed by a crystal structure",
            "probability": 0.036305154066353616,
            "start_logit": 0.8662519454956055,
            "end_logit": 0.5498796701431274
        }
    ],
    "53130a77e3eabad02100000f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55167dec46478f2f2c00000a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56c5feb75795f9a73e000006": [
        {
            "text": "obstructive azoospermia",
            "probability": 0.22721271152505448,
            "start_logit": 0.9995632171630859,
            "end_logit": 0.5268121957778931
        },
        {
            "text": "obstructive azoospermia. Mutations in CFTR and ADGRG2 are responsible for this disease. However,",
            "probability": 0.22657451847605564,
            "start_logit": 0.9995632171630859,
            "end_logit": 0.5239994525909424
        },
        {
            "text": "obstructive azoospermia. Mutations in CFTR and ADGRG2 are responsible for this disease. However, until now the",
            "probability": 0.20133351603763325,
            "start_logit": 0.9995632171630859,
            "end_logit": 0.4058883786201477
        },
        {
            "text": "obstructive azoospermia. Mutations in CFTR and ADGRG2 are responsible for this disease. However, until now the genetic",
            "probability": 0.17684912450508805,
            "start_logit": 0.9995632171630859,
            "end_logit": 0.2762225270271301
        },
        {
            "text": "obstructive az",
            "probability": 0.16803012945616844,
            "start_logit": 0.9995632171630859,
            "end_logit": 0.2250688672065735
        }
    ],
    "54d669003706e8952800000e": [
        {
            "text": "or mechanisms, switching to immune deactivation mechanisms and then restoring immunometabolic home",
            "probability": 0.06533823150899223,
            "start_logit": 1.2118442058563232,
            "end_logit": 0.7905720472335815
        },
        {
            "text": "rise in the K",
            "probability": 0.06525484202371602,
            "start_logit": 1.2623467445373535,
            "end_logit": 0.7387924194335938
        },
        {
            "text": "rise in the Krebs cycle cis-aconitate-derived itaconate and succinate with decreased fumara",
            "probability": 0.05903409125065888,
            "start_logit": 1.2623467445373535,
            "end_logit": 0.6386072635650635
        },
        {
            "text": "levels of fatty acid",
            "probability": 0.05497412552799357,
            "start_logit": 0.9838322401046753,
            "end_logit": 0.8458693027496338
        },
        {
            "text": "or mechanisms, switching to immune deactivation mechanisms and then restoring immunometabolic homeostasis",
            "probability": 0.05396769714487073,
            "start_logit": 1.2118442058563232,
            "end_logit": 0.599380373954773
        },
        {
            "text": "abolis",
            "probability": 0.05309105487358639,
            "start_logit": 0.9716882705688477,
            "end_logit": 0.8231590986251831
        },
        {
            "text": "biased metabolomics and a validated monocyte culture model",
            "probability": 0.05293304149741715,
            "start_logit": 0.9526622295379639,
            "end_logit": 0.8392044305801392
        },
        {
            "text": "biased metabolomics and a validated monocyte culture model of activation, deactivation",
            "probability": 0.05056287963611462,
            "start_logit": 0.9526622295379639,
            "end_logit": 0.7933943867683411
        },
        {
            "text": "urated fatty acids and increased levels of fatty acid",
            "probability": 0.049577714828021015,
            "start_logit": 0.8805110454559326,
            "end_logit": 0.8458693027496338
        },
        {
            "text": "hylation mediator",
            "probability": 0.04902340286433361,
            "start_logit": 1.0671348571777344,
            "end_logit": 0.6480018496513367
        },
        {
            "text": "metabolomics and a validated monocyte culture model",
            "probability": 0.045809647301865035,
            "start_logit": 0.8081291913986206,
            "end_logit": 0.8392044305801392
        },
        {
            "text": "abolism during deact",
            "probability": 0.045298895840165436,
            "start_logit": 0.9716882705688477,
            "end_logit": 0.6644333004951477
        },
        {
            "text": "hesis of nicotinamide adenine dinucleotide from quinolinic acid. Increased branched-chain amino acid catabolism parallel",
            "probability": 0.04521818040083538,
            "start_logit": 1.074116587638855,
            "end_logit": 0.5602215528488159
        },
        {
            "text": "hylation mediator, and homocysteine and",
            "probability": 0.04517710783940235,
            "start_logit": 1.0671348571777344,
            "end_logit": 0.5662945508956909
        },
        {
            "text": "concomitant with deactivation and subsided during early resolution. The data suggest that rewiring of metabolic and mitochondrial bioener",
            "probability": 0.0448052516615861,
            "start_logit": 1.0031402111053467,
            "end_logit": 0.6220240592956543
        },
        {
            "text": "survival. We used unbiased metabolomics and a validated monocyte culture model",
            "probability": 0.04455839618062246,
            "start_logit": 0.7804350852966309,
            "end_logit": 0.8392044305801392
        },
        {
            "text": "cogenolysis, hexosamine, g",
            "probability": 0.04421687911648076,
            "start_logit": 0.8728213310241699,
            "end_logit": 0.7391241788864136
        },
        {
            "text": ". We used unbiased metabolomics and a validated monocyte culture model",
            "probability": 0.043770850625197394,
            "start_logit": 0.7626025676727295,
            "end_logit": 0.8392044305801392
        },
        {
            "text": "metabolomics and a validated monocyte culture model of activation, deactivation",
            "probability": 0.04375844684477627,
            "start_logit": 0.8081291913986206,
            "end_logit": 0.7933943867683411
        },
        {
            "text": "hesis of nicotinamide adenine dinucleotide from quinolinic acid. Increased branched-",
            "probability": 0.0436292630333645,
            "start_logit": 1.074116587638855,
            "end_logit": 0.524450421333313
        }
    ],
    "56c1f010ef6e394741000041": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "51596a8ad24251bc0500009e": [
        {
            "text": "le component Asterless. This",
            "probability": 0.0633383970756588,
            "start_logit": 1.100730299949646,
            "end_logit": 0.6931939125061035
        },
        {
            "text": "le component Asterless. This interaction landscape affords a critical framework for research of",
            "probability": 0.05801322982551584,
            "start_logit": 1.100730299949646,
            "end_logit": 0.6053732633590698
        },
        {
            "text": "le component Asterless. This interaction landscape affords a critical framework",
            "probability": 0.057952192727984575,
            "start_logit": 1.100730299949646,
            "end_logit": 0.6043205857276917
        },
        {
            "text": "4 phosphorylates",
            "probability": 0.05767441592066891,
            "start_logit": 0.9139605760574341,
            "end_logit": 0.7862855792045593
        },
        {
            "text": "of many cells, best known for its role in mitotic spindle organization. How the proteins of the centrosome are accurately assembled to carry out",
            "probability": 0.05289565493103108,
            "start_logit": 0.8657795190811157,
            "end_logit": 0.747974157333374
        },
        {
            "text": "4 phosphorylates Cep135 to properly position the essential centriole component Asterless. This",
            "probability": 0.05254773582205525,
            "start_logit": 0.9139605760574341,
            "end_logit": 0.6931939125061035
        },
        {
            "text": ". To investigate this massive macromolecular organelle, we",
            "probability": 0.052476266345375965,
            "start_logit": 0.8502451181411743,
            "end_logit": 0.755548357963562
        },
        {
            "text": "level' centrosome interactome using direct protein-protein",
            "probability": 0.051896128659075016,
            "start_logit": 0.9973756670951843,
            "end_logit": 0.5973010063171387
        },
        {
            "text": "of many cells, best known for its",
            "probability": 0.05094495998486142,
            "start_logit": 0.8657795190811157,
            "end_logit": 0.71039879322052
        },
        {
            "text": ". To investigate this massive macromolecular organelle, we generated a 'domain-",
            "probability": 0.05085046810706356,
            "start_logit": 0.8502451181411743,
            "end_logit": 0.7240766882896423
        },
        {
            "text": "level' centrosome interactome using direct protein",
            "probability": 0.048068368035003625,
            "start_logit": 0.9973756670951843,
            "end_logit": 0.5206811428070068
        },
        {
            "text": "interaction landscape affords a critical framework for research of",
            "probability": 0.046519433441154966,
            "start_logit": 0.8799293637275696,
            "end_logit": 0.6053732633590698
        },
        {
            "text": "interaction landscape affords a critical framework",
            "probability": 0.04647048923989972,
            "start_logit": 0.8799293637275696,
            "end_logit": 0.6043205857276917
        },
        {
            "text": "critical framework for research of",
            "probability": 0.045771104074598154,
            "start_logit": 0.8637121915817261,
            "end_logit": 0.6053732633590698
        },
        {
            "text": "critical framework",
            "probability": 0.04572294720845025,
            "start_logit": 0.8637121915817261,
            "end_logit": 0.6043205857276917
        },
        {
            "text": "4 phosph",
            "probability": 0.04506633714268255,
            "start_logit": 0.9139605760574341,
            "end_logit": 0.5396074652671814
        },
        {
            "text": ". To investigate this massive macromolecular organelle, we generated a 'domain-level' centrosome interactome using direct protein-protein",
            "probability": 0.0447957669003446,
            "start_logit": 0.8502451181411743,
            "end_logit": 0.5973010063171387
        },
        {
            "text": "of many cells, best known for its role in mitotic spindle organization. How the proteins of the",
            "probability": 0.044162441698884884,
            "start_logit": 0.8657795190811157,
            "end_logit": 0.5675276517868042
        },
        {
            "text": ". To investigate this massive macromolecular organelle, we generated a 'domain",
            "probability": 0.04334194728449729,
            "start_logit": 0.8502451181411743,
            "end_logit": 0.5643082857131958
        },
        {
            "text": ". To investigate this massive macromolecular organelle, we generated a 'domain-level' centrosome interactome using direct protein",
            "probability": 0.041491715575193676,
            "start_logit": 0.8502451181411743,
            "end_logit": 0.5206811428070068
        }
    ],
    "56c1f00def6e39474100003f": [
        {
            "text": "randomization) before embarking on costly phase III randomized controlled trials could",
            "probability": 0.07795592455577041,
            "start_logit": 1.1042014360427856,
            "end_logit": 0.8644618988037109
        },
        {
            "text": "randomized controlled trials could",
            "probability": 0.06338078918054575,
            "start_logit": 0.897218644618988,
            "end_logit": 0.8644618988037109
        },
        {
            "text": "levels of both proinflammatory secret",
            "probability": 0.06290732808474629,
            "start_logit": 1.0760276317596436,
            "end_logit": 0.6781547665596008
        },
        {
            "text": "had little or no clinical utility. The concordance of findings from Men",
            "probability": 0.0621298067400401,
            "start_logit": 0.8282167911529541,
            "end_logit": 0.9135288000106812
        },
        {
            "text": "randomization) before embarking on",
            "probability": 0.0577035614623604,
            "start_logit": 1.1042014360427856,
            "end_logit": 0.5636371970176697
        },
        {
            "text": "levels of both proinflammatory secretory phospholipase A2-",
            "probability": 0.055138216207364754,
            "start_logit": 1.0760276317596436,
            "end_logit": 0.5463351607322693
        },
        {
            "text": "randomized controlled trials could increase efficiency and offset the high risk of drug development, thereby facilitating discovery of new therapeutics and mitigating against the",
            "probability": 0.054950725726426716,
            "start_logit": 0.897218644618988,
            "end_logit": 0.7217379808425903
        },
        {
            "text": "randomization) before embarking on costly phase III",
            "probability": 0.05386128913005286,
            "start_logit": 1.1042014360427856,
            "end_logit": 0.4947303235530853
        },
        {
            "text": "randomization) before embarking on costly phase III randomized controlled trials could increase efficiency and offset the high risk of drug development",
            "probability": 0.0535442614613735,
            "start_logit": 1.1042014360427856,
            "end_logit": 0.4888269305229187
        },
        {
            "text": "randomization) before embarking on costly phase III randomized controlled",
            "probability": 0.052082582625215125,
            "start_logit": 1.1042014360427856,
            "end_logit": 0.4611488878726959
        },
        {
            "text": "inflammatory secret",
            "probability": 0.04898272835700692,
            "start_logit": 0.825832724571228,
            "end_logit": 0.6781547665596008
        },
        {
            "text": "had little or no clinical utility. The concordance",
            "probability": 0.048181067235753106,
            "start_logit": 0.8282167911529541,
            "end_logit": 0.6592690944671631
        },
        {
            "text": "theses enzymes (var",
            "probability": 0.047998962940395566,
            "start_logit": 0.9624633193016052,
            "end_logit": 0.5212358236312866
        },
        {
            "text": "of theses enzymes (var",
            "probability": 0.04732068076503516,
            "start_logit": 0.9482313394546509,
            "end_logit": 0.5212358236312866
        },
        {
            "text": "had little or no clinical utility.",
            "probability": 0.04383735156678643,
            "start_logit": 0.8282167911529541,
            "end_logit": 0.5647891759872437
        },
        {
            "text": "randomized controlled trials could increase efficiency and offset the high risk of drug development",
            "probability": 0.043533285851589956,
            "start_logit": 0.897218644618988,
            "end_logit": 0.4888269305229187
        },
        {
            "text": "inflammatory secretory phospholipase A2-",
            "probability": 0.04293331713177875,
            "start_logit": 0.825832724571228,
            "end_logit": 0.5463351607322693
        },
        {
            "text": "randomized controlled",
            "probability": 0.04234489178542836,
            "start_logit": 0.897218644618988,
            "end_logit": 0.4611488878726959
        },
        {
            "text": "had little or no clinical utility. The concordance of findings from Mendelian randomization and clinical trials suggests",
            "probability": 0.04121322919232962,
            "start_logit": 0.8282167911529541,
            "end_logit": 0.5030622482299805
        }
    ],
    "571e12097de986d80d000017": [
        {
            "text": "flozin. Furthermore",
            "probability": 0.0662606541587619,
            "start_logit": 1.3127344846725464,
            "end_logit": 0.7369569540023804
        },
        {
            "text": "flozin. Furthermore, empagliflozin-treated diabetic mice presented",
            "probability": 0.0568733543452582,
            "start_logit": 1.3127344846725464,
            "end_logit": 0.5841876268386841
        },
        {
            "text": "flozin. Furthermore, empagliflozin-treated diabetic mice presented with ameli",
            "probability": 0.05656270645322343,
            "start_logit": 1.3127344846725464,
            "end_logit": 0.5787105560302734
        },
        {
            "text": "KG (cGMP-dependent protein kinase) pathway. However,",
            "probability": 0.05465805042813964,
            "start_logit": 1.03172767162323,
            "end_logit": 0.8254640102386475
        },
        {
            "text": "KG (cGMP-dependent protein kinase) pathway. However, when sGC-",
            "probability": 0.05394519958653809,
            "start_logit": 1.03172767162323,
            "end_logit": 0.8123362064361572
        },
        {
            "text": "flozin. Furthermore, empagliflozin-",
            "probability": 0.05277658245049432,
            "start_logit": 1.3127344846725464,
            "end_logit": 0.5094282627105713
        },
        {
            "text": ") pathway. However,",
            "probability": 0.05235379398614246,
            "start_logit": 0.9886555671691895,
            "end_logit": 0.8254640102386475
        },
        {
            "text": ") pathway. However, when sGC-",
            "probability": 0.051670995280156375,
            "start_logit": 0.9886555671691895,
            "end_logit": 0.8123362064361572
        },
        {
            "text": "diabetic mice presented with amelioration of cardiac hypertrophy and fibrosis",
            "probability": 0.05113561845455148,
            "start_logit": 1.0117079019546509,
            "end_logit": 0.778868556022644
        },
        {
            "text": "deterioration of oxidative stress, apoptosis and pyroptosis,",
            "probability": 0.049620512571055986,
            "start_logit": 1.143204689025879,
            "end_logit": 0.6172947883605957
        },
        {
            "text": "flozin were reversed through inhibiting sGC-cGMP",
            "probability": 0.0491783437751087,
            "start_logit": 0.8680188655853271,
            "end_logit": 0.8835296630859375
        },
        {
            "text": "flozin rescued diabetes-induced suppression of sGC (soluble guanylate cyclase enzyme)-cGMP",
            "probability": 0.04810251359195763,
            "start_logit": 0.864386796951294,
            "end_logit": 0.8650428056716919
        },
        {
            "text": "remains unclear. In the current study, we investigated the cardiac protective effects of empaglifloz",
            "probability": 0.04746976411988159,
            "start_logit": 0.9996698498725891,
            "end_logit": 0.7165182828903198
        },
        {
            "text": "-PKG (cGMP-dependent protein kinase) pathway. However,",
            "probability": 0.04599198290497774,
            "start_logit": 0.8590982556343079,
            "end_logit": 0.8254640102386475
        },
        {
            "text": "-PKG (cGMP-dependent protein kinase) pathway. However, when sGC-",
            "probability": 0.04539215500288595,
            "start_logit": 0.8590982556343079,
            "end_logit": 0.8123362064361572
        },
        {
            "text": "KG (cGMP-dependent protein kinase) pathway. However, when sGC-\u03b2 expression of hearts was inhibited by transvas",
            "probability": 0.04403916386969888,
            "start_logit": 1.03172767162323,
            "end_logit": 0.6094468235969543
        },
        {
            "text": "improved by empagliflozin. Furthermore",
            "probability": 0.043811813561820526,
            "start_logit": 0.8990417122840881,
            "end_logit": 0.7369569540023804
        },
        {
            "text": "flozin rescued diabetes-induced suppression of sGC (soluble guanylate cycl",
            "probability": 0.04364440999895958,
            "start_logit": 0.864386796951294,
            "end_logit": 0.7677835822105408
        },
        {
            "text": ". Moreover, empagliflozin rescued diabetes-induced suppression of sGC (soluble guanylate cycl",
            "probability": 0.043478913326978674,
            "start_logit": 0.8605876564979553,
            "end_logit": 0.7677835822105408
        },
        {
            "text": ". Furthermore, empagliflozin-treated diabetic mice presented with amelioration of cardiac hypertrophy and fibrosis",
            "probability": 0.043033472133408794,
            "start_logit": 0.8392048478126526,
            "end_logit": 0.778868556022644
        }
    ],
    "533ba218fd9a95ea0d000007": [
        {
            "text": ": conventional T1-weighted, T2-weighted, and post-contrast sequences",
            "probability": 0.06453248270889819,
            "start_logit": 0.9696138501167297,
            "end_logit": 0.9351261258125305
        },
        {
            "text": "agents, spectroscopy, and elastography. Finally, artificial intelligence is beginning to help clinicians deal with an increasing amount of information",
            "probability": 0.05864089502642631,
            "start_logit": 1.0734041929244995,
            "end_logit": 0.7355993986129761
        },
        {
            "text": ": conventional T1-weighted, T2-weighted, and post-contrast sequences are now complemented by quantitative mapping sequences",
            "probability": 0.057448820161247534,
            "start_logit": 0.9696138501167297,
            "end_logit": 0.818851888179779
        },
        {
            "text": ": conventional T1",
            "probability": 0.056780194617784295,
            "start_logit": 0.9696138501167297,
            "end_logit": 0.8071449995040894
        },
        {
            "text": "volumetric changes, strain analysis from myocardial tagging, tissue phase contrast, and feature tracking.",
            "probability": 0.05523357209579002,
            "start_logit": 0.9272574186325073,
            "end_logit": 0.82188481092453
        },
        {
            "text": "CMR allows quantification of biventricular volumes, mass, wall",
            "probability": 0.054091375867117514,
            "start_logit": 1.0399028062820435,
            "end_logit": 0.6883432269096375
        },
        {
            "text": "CMR allows quantification of biventricular volumes, mass, wall thickness,",
            "probability": 0.052917652277794804,
            "start_logit": 1.0399028062820435,
            "end_logit": 0.666405439376831
        },
        {
            "text": "volumetric changes, strain analysis from myocardial tagging, tissue phase contrast, and feature tracking. Moreover, CMR allows superior tissue",
            "probability": 0.052036270330988565,
            "start_logit": 0.9272574186325073,
            "end_logit": 0.7622548341751099
        },
        {
            "text": "astography. Finally, artificial intelligence is beginning to help clinicians deal with an increasing amount of information",
            "probability": 0.05018084043854027,
            "start_logit": 0.9176051616668701,
            "end_logit": 0.7355993986129761
        },
        {
            "text": "ocardium and the pericardium, which are crucial for a nonin",
            "probability": 0.04966988797559521,
            "start_logit": 0.9861874580383301,
            "end_logit": 0.6567826867103577
        },
        {
            "text": "volumetric changes, strain analysis from myocardial tagging, tissue phase contrast, and feature tracking. Moreover, CMR",
            "probability": 0.0461902568682525,
            "start_logit": 0.9272574186325073,
            "end_logit": 0.6430827379226685
        },
        {
            "text": "T2 mapping as well as extracellular volume quantification. Further experimental sequences comprise diffusion tensor analysis, blood oxygenation-",
            "probability": 0.04602163738153265,
            "start_logit": 0.9113775491714478,
            "end_logit": 0.6553053855895996
        },
        {
            "text": ": conventional T1-weighted, T2-",
            "probability": 0.04598384745498255,
            "start_logit": 0.9696138501167297,
            "end_logit": 0.5962476134300232
        },
        {
            "text": "ocardium and the",
            "probability": 0.04582830470556199,
            "start_logit": 0.9861874580383301,
            "end_logit": 0.576285719871521
        },
        {
            "text": "including T1 and T2 mapping as well as extracellular volume quantification. Further experimental sequences comprise diffusion tensor analysis, blood oxygenation-",
            "probability": 0.04554668178740785,
            "start_logit": 0.9010036587715149,
            "end_logit": 0.6553053855895996
        },
        {
            "text": "Indeed, CMR allows quantification of biventricular volumes, mass, wall",
            "probability": 0.045238764797461695,
            "start_logit": 0.8611823916435242,
            "end_logit": 0.6883432269096375
        },
        {
            "text": "volumetric changes, strain analysis from myocardial tagging, tissue phase contrast, and feature",
            "probability": 0.04443783793879143,
            "start_logit": 0.9272574186325073,
            "end_logit": 0.6044051647186279
        },
        {
            "text": "Indeed, CMR allows quantification of biventricular volumes, mass, wall thickness,",
            "probability": 0.04425713316869625,
            "start_logit": 0.8611823916435242,
            "end_logit": 0.666405439376831
        },
        {
            "text": "T",
            "probability": 0.042702120846843945,
            "start_logit": 0.9113775491714478,
            "end_logit": 0.5804423093795776
        },
        {
            "text": "including T1 and T",
            "probability": 0.04226142355028621,
            "start_logit": 0.9010036587715149,
            "end_logit": 0.5804423093795776
        }
    ],
    "5540fbce234c5a7c75000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5343bdd6aeec6fbd07000001": [
        {
            "text": "such transcripts remain largely elusive. Here we show that the Abelson tyrosine kinase c-",
            "probability": 0.06519280647306032,
            "start_logit": 1.0420997142791748,
            "end_logit": 1.001671314239502
        },
        {
            "text": "data provide novel insight in RNA-dependent DDR by coupling DSB-induced c-",
            "probability": 0.0623605623964447,
            "start_logit": 0.8629728555679321,
            "end_logit": 1.1363821029663086
        },
        {
            "text": "kinase c-",
            "probability": 0.055408611590561485,
            "start_logit": 0.8794856071472168,
            "end_logit": 1.001671314239502
        },
        {
            "text": "Bs",
            "probability": 0.05322231748856675,
            "start_logit": 0.9797066450119019,
            "end_logit": 0.861193060874939
        },
        {
            "text": "Bs. Interference with transcription, c-Abl activity, DNA-",
            "probability": 0.05312082156712856,
            "start_logit": 0.9797066450119019,
            "end_logit": 0.8592842221260071
        },
        {
            "text": "Bs. Interference with transcription, c-",
            "probability": 0.05306247119665621,
            "start_logit": 0.9797066450119019,
            "end_logit": 0.8581851720809937
        },
        {
            "text": "Bs. However, regulatory principles that control production of such transcripts remain largely elusive. Here we show that the Abelson tyrosine kinase c-",
            "probability": 0.053021045603459535,
            "start_logit": 0.8354395031929016,
            "end_logit": 1.001671314239502
        },
        {
            "text": "Bs) to maintain genome stability. Recent findings suggest that the",
            "probability": 0.052890991502960005,
            "start_logit": 1.1368403434753418,
            "end_logit": 0.6978145837783813
        },
        {
            "text": "p53-binding protein 1 (53BP1) and Mediator of DNA damage checkpoint 1 (MDC1) to endogen",
            "probability": 0.04999679858000873,
            "start_logit": 1.1565450429916382,
            "end_logit": 0.6218358278274536
        },
        {
            "text": "data provide novel insight in RNA-",
            "probability": 0.04730998270649886,
            "start_logit": 0.8629728555679321,
            "end_logit": 0.8601703643798828
        },
        {
            "text": "p53-binding",
            "probability": 0.047229289815988236,
            "start_logit": 1.1565450429916382,
            "end_logit": 0.5648910999298096
        },
        {
            "text": "DNA damage checkpoint 1 (MDC1) to endogenous DSBs",
            "probability": 0.046344277378814046,
            "start_logit": 0.8413266539573669,
            "end_logit": 0.861193060874939
        },
        {
            "text": "DNA damage checkpoint 1 (MDC1) to endogenous DSBs. Interference with transcription, c-Abl activity, DNA-",
            "probability": 0.046255898004184975,
            "start_logit": 0.8413266539573669,
            "end_logit": 0.8592842221260071
        },
        {
            "text": "DNA damage checkpoint 1 (MDC1) to endogenous DSBs. Interference with transcription, c-",
            "probability": 0.04620508838367365,
            "start_logit": 0.8413266539573669,
            "end_logit": 0.8581851720809937
        },
        {
            "text": "-Abl activity, DNA-",
            "probability": 0.04577254677775387,
            "start_logit": 0.8308221697807312,
            "end_logit": 0.8592842221260071
        },
        {
            "text": "-",
            "probability": 0.045722268092614,
            "start_logit": 0.8308221697807312,
            "end_logit": 0.8581851720809937
        },
        {
            "text": "transcripts (DARTs), which trigger formation of double-stranded (ds",
            "probability": 0.045206681083281186,
            "start_logit": 0.9006009101867676,
            "end_logit": 0.7770658731460571
        },
        {
            "text": "such transcripts remain largely elusive. Here we",
            "probability": 0.04476117342034773,
            "start_logit": 1.0420997142791748,
            "end_logit": 0.6256632804870605
        },
        {
            "text": "data provide novel insight in RNA",
            "probability": 0.044068103551886936,
            "start_logit": 0.8629728555679321,
            "end_logit": 0.7891852855682373
        },
        {
            "text": "-responsive transcripts (DARTs), which trigger formation of double-stranded (ds",
            "probability": 0.042848264386110155,
            "start_logit": 0.8470211625099182,
            "end_logit": 0.7770658731460571
        }
    ],
    "5518414a15fa47643f000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56ae57350a360a5e4500000a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56e6ec49edfc094c1f000005": [
        {
            "text": "resorption, are susceptible to BP or denosumab. However, such drugs may cause",
            "probability": 0.06777324346658506,
            "start_logit": 1.018378496170044,
            "end_logit": 0.7472941875457764
        },
        {
            "text": "orption, are susceptible to BP or denosumab. However, such drugs may cause",
            "probability": 0.06660839579053121,
            "start_logit": 1.0010416507720947,
            "end_logit": 0.7472941875457764
        },
        {
            "text": "denosumab. However, such drugs may cause",
            "probability": 0.0624058321600109,
            "start_logit": 0.9358697533607483,
            "end_logit": 0.7472941875457764
        },
        {
            "text": "vant therapies such as liquid nitrogen, phenol, argon beam, and alcohol have",
            "probability": 0.05694523557993128,
            "start_logit": 1.0242891311645508,
            "end_logit": 0.5673061013221741
        },
        {
            "text": "denosumab. However, such drugs may cause systemic side effects. We examined the effects of an alternative intraoperative local delivery of BP on",
            "probability": 0.05286941911224097,
            "start_logit": 0.9358697533607483,
            "end_logit": 0.5814605355262756
        },
        {
            "text": "resorption, are susceptible",
            "probability": 0.05138220276527273,
            "start_logit": 1.018378496170044,
            "end_logit": 0.4704185724258423
        },
        {
            "text": "orption, are susceptible",
            "probability": 0.05049907490506983,
            "start_logit": 1.0010416507720947,
            "end_logit": 0.4704185724258423
        },
        {
            "text": "vant therapies such as liquid nitrogen,",
            "probability": 0.0501263528762404,
            "start_logit": 1.0242891311645508,
            "end_logit": 0.4397629499435425
        },
        {
            "text": "resorption, are susceptible to BP or denosumab. However, such drugs may cause systemic side effects. We examined",
            "probability": 0.04909008972595709,
            "start_logit": 1.018378496170044,
            "end_logit": 0.4247838854789734
        },
        {
            "text": "orption, are susceptible to BP or denosumab. However, such drugs may cause systemic side effects. We examined",
            "probability": 0.04824635739134115,
            "start_logit": 1.0010416507720947,
            "end_logit": 0.4247838854789734
        },
        {
            "text": "denosumab. However, such drugs may cause systemic side effects. We examined",
            "probability": 0.045202320908079116,
            "start_logit": 0.9358697533607483,
            "end_logit": 0.4247838854789734
        },
        {
            "text": "resorption, are susceptible to BP or denosumab. However, such drugs may cause systemic side effects. We",
            "probability": 0.045023135006814916,
            "start_logit": 1.018378496170044,
            "end_logit": 0.33830317854881287
        },
        {
            "text": "resorption, are susceptible to BP or denosumab. However, such drugs may cause systemic side effects.",
            "probability": 0.04483536920218024,
            "start_logit": 1.018378496170044,
            "end_logit": 0.33412402868270874
        },
        {
            "text": "vant the",
            "probability": 0.04472680780973969,
            "start_logit": 1.0242891311645508,
            "end_logit": 0.32578912377357483
        },
        {
            "text": "resorption, are susceptible to BP or denosumab. However, such drugs may cause systemic side effects. We examined the",
            "probability": 0.044635663501993834,
            "start_logit": 1.018378496170044,
            "end_logit": 0.3296598792076111
        },
        {
            "text": "orption, are susceptible to BP or denosumab. However, such drugs may cause systemic side effects. We",
            "probability": 0.04424930315963167,
            "start_logit": 1.0010416507720947,
            "end_logit": 0.33830317854881287
        },
        {
            "text": "orption, are susceptible to BP or denosumab. However, such drugs may cause systemic side effects.",
            "probability": 0.04406476456606118,
            "start_logit": 1.0010416507720947,
            "end_logit": 0.33412402868270874
        },
        {
            "text": "resorption, are susceptible to BP or denosumab.",
            "probability": 0.043974627316473856,
            "start_logit": 1.018378496170044,
            "end_logit": 0.31473952531814575
        },
        {
            "text": "orption, are susceptible to BP or denosumab. However, such drugs may cause systemic side effects. We examined the",
            "probability": 0.043868491293022394,
            "start_logit": 1.0010416507720947,
            "end_logit": 0.3296598792076111
        },
        {
            "text": "resorption, are susceptible to BP or denosumab. However,",
            "probability": 0.04347331346282265,
            "start_logit": 1.018378496170044,
            "end_logit": 0.3032739758491516
        }
    ],
    "53357ca0d6d3ac6a3400004b": [
        {
            "text": "anib, idiopathic pulmonary fibrosis",
            "probability": 0.09657737736493334,
            "start_logit": 1.3722169399261475,
            "end_logit": 1.1369251012802124
        },
        {
            "text": "anib, idiopathic pulmonary fibrosis; sirolimus",
            "probability": 0.06638227760333706,
            "start_logit": 1.3722169399261475,
            "end_logit": 0.7620106935501099
        },
        {
            "text": "ntedanib, idiopathic pulmonary fibrosis",
            "probability": 0.057110347172415116,
            "start_logit": 0.8468577265739441,
            "end_logit": 1.1369251012802124
        },
        {
            "text": "g., leukemias). Seven drugs are used in the treatment of non-",
            "probability": 0.05568950006285323,
            "start_logit": 0.766252338886261,
            "end_logit": 1.1923367977142334
        },
        {
            "text": "phomas and seven against non-solid tumors, e.g., leukemias). Seven drugs are used in the treatment of non-",
            "probability": 0.055594952302226816,
            "start_logit": 0.7645531296730042,
            "end_logit": 1.1923367977142334
        },
        {
            "text": "anib, idiopathic pulmonary fibro",
            "probability": 0.0532319925562362,
            "start_logit": 1.3722169399261475,
            "end_logit": 0.5412401556968689
        },
        {
            "text": "protein-tyrosine kinases, and 13 target protein-",
            "probability": 0.052388986224816025,
            "start_logit": 0.9247324466705322,
            "end_logit": 0.9727614521980286
        },
        {
            "text": "), the average",
            "probability": 0.049068257341670064,
            "start_logit": 0.9402012825012207,
            "end_logit": 0.8918085694313049
        },
        {
            "text": "gulation of protein",
            "probability": 0.04594274161784648,
            "start_logit": 1.209833025932312,
            "end_logit": 0.5563603639602661
        },
        {
            "text": "GFR), and vascular",
            "probability": 0.045882662084233354,
            "start_logit": 0.7126995325088501,
            "end_logit": 1.052185297012329
        },
        {
            "text": "13 target protein-",
            "probability": 0.04558685080103175,
            "start_logit": 0.7856553792953491,
            "end_logit": 0.9727614521980286
        },
        {
            "text": "OR (mammalian target of rapamycin",
            "probability": 0.04536628850874589,
            "start_logit": 0.7556836605072021,
            "end_logit": 0.997883141040802
        },
        {
            "text": "). Most of the small molecule inhibitors (45) interact directly with the",
            "probability": 0.04467031342584335,
            "start_logit": 0.9411572217941284,
            "end_logit": 0.7969494462013245
        },
        {
            "text": "rheumatoid arthritis; fostamat",
            "probability": 0.04466445351971336,
            "start_logit": 0.8510262966156006,
            "end_logit": 0.8869491815567017
        },
        {
            "text": "protein-tyrosine kinases, and 13 target protein",
            "probability": 0.04243990066769962,
            "start_logit": 0.9247324466705322,
            "end_logit": 0.7621540427207947
        },
        {
            "text": "generate a complex that inhibits mTOR (mammalian target of rapamycin",
            "probability": 0.04240223118793228,
            "start_logit": 0.6881153583526611,
            "end_logit": 0.997883141040802
        },
        {
            "text": "is given intravenously). Of the 48 approved drugs, the majority (25) target receptor protein-",
            "probability": 0.040198444549158954,
            "start_logit": 0.9568902254104614,
            "end_logit": 0.675735592842102
        },
        {
            "text": "mus are larger molecules (MW \u2248 1000) that bind to FKBP",
            "probability": 0.039354698346155154,
            "start_logit": 0.7322592735290527,
            "end_logit": 0.8791536092758179
        },
        {
            "text": "ntedanib, idiopathic pulmonary fibrosis; sirolimus",
            "probability": 0.03925468907378662,
            "start_logit": 0.8468577265739441,
            "end_logit": 0.7620106935501099
        },
        {
            "text": "topenia; ruxolitinib, myelofibrosis and polycythe",
            "probability": 0.038193035589365563,
            "start_logit": 0.8415055274963379,
            "end_logit": 0.7399451732635498
        }
    ],
    "51542dabd24251bc0500007d": [
        {
            "text": "Duchenne muscular dyst",
            "probability": 0.06153800446063445,
            "start_logit": 1.031310796737671,
            "end_logit": 0.8766881823539734
        },
        {
            "text": "is currently tested in many phase 3 trials, and",
            "probability": 0.05940145649830914,
            "start_logit": 1.1528149843215942,
            "end_logit": 0.7198477983474731
        },
        {
            "text": "i.e., gene therapy in X-linked myotubular myopathy and",
            "probability": 0.0540050304988054,
            "start_logit": 1.1107091903686523,
            "end_logit": 0.6667120456695557
        },
        {
            "text": "is currently tested in many phase 3 trials, and eteplirsen received a conditional approval by FDA for patients",
            "probability": 0.052863020385199314,
            "start_logit": 1.1528149843215942,
            "end_logit": 0.6032330989837646
        },
        {
            "text": ".",
            "probability": 0.052470839595073954,
            "start_logit": 1.0294195413589478,
            "end_logit": 0.7191820740699768
        },
        {
            "text": "i.e., gene therapy in X-linked myotubular myopa",
            "probability": 0.0523106560636047,
            "start_logit": 1.1107091903686523,
            "end_logit": 0.6348349452018738
        },
        {
            "text": "yst",
            "probability": 0.05183587906014259,
            "start_logit": 0.8597384095191956,
            "end_logit": 0.8766881823539734
        },
        {
            "text": "Duchenne muscular dystrophy (DMD) patients with premature stop codon mutations and its",
            "probability": 0.05166846492057145,
            "start_logit": 1.031310796737671,
            "end_logit": 0.7018808722496033
        },
        {
            "text": "is the second part of a two-",
            "probability": 0.051600405730210686,
            "start_logit": 0.9967147707939148,
            "end_logit": 0.7351588010787964
        },
        {
            "text": "two-",
            "probability": 0.05149211301133609,
            "start_logit": 0.9946138858795166,
            "end_logit": 0.7351588010787964
        },
        {
            "text": "kinase 2 deficiency.",
            "probability": 0.05120351748434042,
            "start_logit": 1.0049701929092407,
            "end_logit": 0.7191820740699768
        },
        {
            "text": "sdiplam, which increases SMN protein levels similarly but also in peripheral organs, is tested in ongoing",
            "probability": 0.04797803031062419,
            "start_logit": 0.8919955492019653,
            "end_logit": 0.767091691493988
        },
        {
            "text": "is ongoing. Ataluren is the first approved drug for Duchenne muscular dyst",
            "probability": 0.047683779596292886,
            "start_logit": 0.7762471437454224,
            "end_logit": 0.8766881823539734
        },
        {
            "text": "Duchenne muscular dystrophy (DMD) patients with premature stop codon mutations and its indication has been recently extended since the age of",
            "probability": 0.04630531201847229,
            "start_logit": 1.031310796737671,
            "end_logit": 0.592289924621582
        },
        {
            "text": "i.e.",
            "probability": 0.04500436949995054,
            "start_logit": 1.1107091903686523,
            "end_logit": 0.4843944311141968
        },
        {
            "text": "most innovative therapeutic approaches. Nusinersen, an SMN2 mRNA splicing modifier, was",
            "probability": 0.04494543403212111,
            "start_logit": 0.8235339522361755,
            "end_logit": 0.7702592611312866
        },
        {
            "text": "Duchen",
            "probability": 0.04490938170617593,
            "start_logit": 1.031310796737671,
            "end_logit": 0.5616799592971802
        },
        {
            "text": "des in mitochondrial DNA depletion induced by thymidine kinase 2 deficiency.",
            "probability": 0.044866340538526374,
            "start_logit": 0.8728498220443726,
            "end_logit": 0.7191820740699768
        },
        {
            "text": "Duchenne muscular dystrophy (DMD) patients with premature stop codon mutations and its indication has been recently extended since",
            "probability": 0.04416300217143367,
            "start_logit": 1.031310796737671,
            "end_logit": 0.5449206233024597
        },
        {
            "text": "sdiplam",
            "probability": 0.043754962418174864,
            "start_logit": 0.8919955492019653,
            "end_logit": 0.6749535202980042
        }
    ],
    "550718e9fd1abe1741000001": [
        {
            "text": "is placed at its",
            "probability": 0.08873460381462403,
            "start_logit": 0.9979152679443359,
            "end_logit": 1.099642276763916
        },
        {
            "text": "rubella virus is translated from a 24S sub",
            "probability": 0.059027181069805555,
            "start_logit": 0.9513798356056213,
            "end_logit": 0.7385258078575134
        },
        {
            "text": "containing all three structural proteins of the virus. It is separated from the",
            "probability": 0.05866870086566983,
            "start_logit": 0.9044249653816223,
            "end_logit": 0.7793890237808228
        },
        {
            "text": "is still a part of the C protein in the mature virion. Furthermore, we also showed that, when the",
            "probability": 0.05628716916194026,
            "start_logit": 1.066251516342163,
            "end_logit": 0.5761227011680603
        },
        {
            "text": "is still a part of the C protein in the mature virion. Furthermore, we",
            "probability": 0.05567545954931339,
            "start_logit": 1.066251516342163,
            "end_logit": 0.5651955604553223
        },
        {
            "text": "is still a part of the C protein in the",
            "probability": 0.054671251080880036,
            "start_logit": 1.066251516342163,
            "end_logit": 0.5469940900802612
        },
        {
            "text": "is still a part of the C protein",
            "probability": 0.0545090057137942,
            "start_logit": 1.066251516342163,
            "end_logit": 0.5440220236778259
        },
        {
            "text": "rubella virus is translated from a 24S subgenomic mRNA as the first part of a polypro",
            "probability": 0.05333632857183592,
            "start_logit": 0.9513798356056213,
            "end_logit": 0.637145459651947
        },
        {
            "text": "rubella virus is translated from a 24S subgenomic mRNA as the",
            "probability": 0.05253849059872876,
            "start_logit": 0.9513798356056213,
            "end_logit": 0.6220738291740417
        },
        {
            "text": "protein is membrane associated. This association is not",
            "probability": 0.051219439155991184,
            "start_logit": 0.9063116908073425,
            "end_logit": 0.6417150497436523
        },
        {
            "text": "sequence is still a part of the C protein in the mature virion. Furthermore, we also showed that, when the",
            "probability": 0.0484413361633871,
            "start_logit": 0.9161384105682373,
            "end_logit": 0.5761227011680603
        },
        {
            "text": "sequence is still a part of the C protein in the mature virion. Furthermore, we",
            "probability": 0.047914892367743704,
            "start_logit": 0.9161384105682373,
            "end_logit": 0.5651955604553223
        },
        {
            "text": "sequence is still a part of the C protein in the",
            "probability": 0.047050659884181674,
            "start_logit": 0.9161384105682373,
            "end_logit": 0.5469940900802612
        },
        {
            "text": "protein is membrane associated. This association is not seen with",
            "probability": 0.04698634203616862,
            "start_logit": 0.9063116908073425,
            "end_logit": 0.5554528832435608
        },
        {
            "text": "sequence is still a part of the C protein",
            "probability": 0.046911029796455186,
            "start_logit": 0.9161384105682373,
            "end_logit": 0.5440220236778259
        },
        {
            "text": "containing all three structural proteins of the virus. It is separated from the following protein (E2) by signal peptidase",
            "probability": 0.04646160706050853,
            "start_logit": 0.9044249653816223,
            "end_logit": 0.5461089611053467
        },
        {
            "text": "protein",
            "probability": 0.044374938465806125,
            "start_logit": 0.9063116908073425,
            "end_logit": 0.49827077984809875
        },
        {
            "text": "protein is membrane associated. This association is not seen with a variant C protein which lacks the signal sequence, and",
            "probability": 0.0436270904774179,
            "start_logit": 0.9063116908073425,
            "end_logit": 0.48127421736717224
        },
        {
            "text": "protein is membrane associated. This association is not seen with a variant C",
            "probability": 0.04356447416574822,
            "start_logit": 0.9063116908073425,
            "end_logit": 0.47983792424201965
        }
    ],
    "56c1f039ef6e394741000052": [
        {
            "text": "er jejuni diarrhea with positive titers of anti-GQ1b and anti-QGT1a",
            "probability": 0.1202330038330975,
            "start_logit": 1.1359760761260986,
            "end_logit": 0.6803265810012817
        },
        {
            "text": "established as efficacious at improving it. A twelveyear- old boy suffering from Miller-Fisher-Bi",
            "probability": 0.10918060119897056,
            "start_logit": 1.067906379699707,
            "end_logit": 0.6519681215286255
        },
        {
            "text": "established as efficacious at improving it. A twelveyear- old",
            "probability": 0.09964793961951549,
            "start_logit": 1.067906379699707,
            "end_logit": 0.5606080889701843
        },
        {
            "text": "phalitis, among others,",
            "probability": 0.08759682470872887,
            "start_logit": 0.9486843943595886,
            "end_logit": 0.550931453704834
        },
        {
            "text": ". In spite of having a good natural outcome, the",
            "probability": 0.08758535975302559,
            "start_logit": 0.826252818107605,
            "end_logit": 0.6732321381568909
        },
        {
            "text": ". In spite of having a good natural outcome, the immunoglobulin",
            "probability": 0.08581809178365203,
            "start_logit": 0.826252818107605,
            "end_logit": 0.6528481245040894
        },
        {
            "text": "per 100 000 people-year but there are not epidemiological studies about Bickerstaff brainstem ence",
            "probability": 0.08433307084554353,
            "start_logit": 0.8789547681808472,
            "end_logit": 0.582690417766571
        },
        {
            "text": "per 100 000 people-year but there are not epidemiological studies about Bickerstaff",
            "probability": 0.08302612738553343,
            "start_logit": 0.8789547681808472,
            "end_logit": 0.5670716762542725
        },
        {
            "text": "per 100 000 people-year",
            "probability": 0.08265309041227405,
            "start_logit": 0.8789547681808472,
            "end_logit": 0.5625685453414917
        },
        {
            "text": ". In spite of having a good natural outcome, the im",
            "probability": 0.0802268062020433,
            "start_logit": 0.826252818107605,
            "end_logit": 0.5854759812355042
        },
        {
            "text": ". In spite of having a good natural outcome, the immunoglobu",
            "probability": 0.07969908425761567,
            "start_logit": 0.826252818107605,
            "end_logit": 0.5788763761520386
        }
    ],
    "55203ae78e534a4535000001": [
        {
            "text": "controls to identify potential markers for the purpose of early detection of malignancy. From among the matched and prior",
            "probability": 0.06165038467192596,
            "start_logit": 0.9621607065200806,
            "end_logit": 1.0820742845535278
        },
        {
            "text": "plastic leukoplakia (LP) of the oral cavity is a potentially malignant condition for oral squamous cell",
            "probability": 0.0582380113760579,
            "start_logit": 1.0592137575149536,
            "end_logit": 0.9280800223350525
        },
        {
            "text": "ymph node negative and positive OSCC in comparison to healthy controls with risk habits. Ninety three proteins",
            "probability": 0.05471253900559658,
            "start_logit": 1.3930976390838623,
            "end_logit": 0.5317507982254028
        },
        {
            "text": "gulated",
            "probability": 0.05433305350204809,
            "start_logit": 0.9792913198471069,
            "end_logit": 0.9385969638824463
        },
        {
            "text": ". From among the matched and prior",
            "probability": 0.05333279491015274,
            "start_logit": 0.8172326683998108,
            "end_logit": 1.0820742845535278
        },
        {
            "text": "plastic leukoplakia (LP) - a potentially malignant lesion, patients diagnosed with oral squa",
            "probability": 0.05289362264773269,
            "start_logit": 1.0811518430709839,
            "end_logit": 0.8098864555358887
        },
        {
            "text": ".",
            "probability": 0.05261003049592503,
            "start_logit": 1.0304968357086182,
            "end_logit": 0.8551654815673828
        },
        {
            "text": "squamous cell",
            "probability": 0.05217444635121331,
            "start_logit": 0.9492683410644531,
            "end_logit": 0.9280800223350525
        },
        {
            "text": "improved early detection and the subsequent",
            "probability": 0.050303909172324725,
            "start_logit": 0.902328610420227,
            "end_logit": 0.9385097026824951
        },
        {
            "text": "gulated proteins using ELISA.",
            "probability": 0.04998391629306752,
            "start_logit": 0.9792913198471069,
            "end_logit": 0.8551654815673828
        },
        {
            "text": "be investigated in a targeted manner to expand the portfolio of biomarkers for early detection.",
            "probability": 0.04947235331669282,
            "start_logit": 1.0301200151443481,
            "end_logit": 0.7940495014190674
        },
        {
            "text": "ia (LP) of the oral cavity is a potentially malignant condition for oral squamous cell",
            "probability": 0.0493707866615386,
            "start_logit": 0.8940343856811523,
            "end_logit": 0.9280800223350525
        },
        {
            "text": "met clinical need for non-invasive, biomarker based methods for the improved early detection and the subsequent",
            "probability": 0.047957251774614684,
            "start_logit": 0.8545558452606201,
            "end_logit": 0.9385097026824951
        },
        {
            "text": "condition for oral squamous cell",
            "probability": 0.04726120279192161,
            "start_logit": 0.8503652215003967,
            "end_logit": 0.9280800223350525
        },
        {
            "text": "horts for 8 selected, representative, upregulated",
            "probability": 0.046190283913577344,
            "start_logit": 0.8169280290603638,
            "end_logit": 0.9385969638824463
        },
        {
            "text": ". Verification was carried out in independent patient cohorts for 8 selected, representative, upregulated",
            "probability": 0.0460004266251709,
            "start_logit": 0.8128092288970947,
            "end_logit": 0.9385969638824463
        },
        {
            "text": "plastic leukoplakia (LP) - a potentially malignant lesion, patients",
            "probability": 0.044704713612970355,
            "start_logit": 1.0811518430709839,
            "end_logit": 0.6416826248168945
        },
        {
            "text": "trometry data are available via ProteomeXchange",
            "probability": 0.04399904910935324,
            "start_logit": 1.1089212894439697,
            "end_logit": 0.5980022549629211
        },
        {
            "text": "horts for 8 selected, representative, upregulated proteins using ELISA.",
            "probability": 0.04249294188117448,
            "start_logit": 0.8169280290603638,
            "end_logit": 0.8551654815673828
        },
        {
            "text": ". Verification was carried out in independent patient cohorts for 8 selected, representative, upregulated proteins using ELISA.",
            "probability": 0.04231828188694133,
            "start_logit": 0.8128092288970947,
            "end_logit": 0.8551654815673828
        }
    ],
    "532670e7d6d3ac6a34000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56b76f496e3f8eaf4c000002": [
        {
            "text": "SAGA complex is bound to target genes in the",
            "probability": 0.061233181410808905,
            "start_logit": 1.0518019199371338,
            "end_logit": 0.7509235739707947
        },
        {
            "text": "toplasmic",
            "probability": 0.06030086511625015,
            "start_logit": 1.1568111181259155,
            "end_logit": 0.6305716037750244
        },
        {
            "text": "SAGA complex is bound to target genes in the absence Nup170. Consistent with this observation,",
            "probability": 0.05927038318804587,
            "start_logit": 1.0518019199371338,
            "end_logit": 0.7183440923690796
        },
        {
            "text": "is bound to target genes in the",
            "probability": 0.05406540357960856,
            "start_logit": 0.9273071885108948,
            "end_logit": 0.7509235739707947
        },
        {
            "text": "is bound to target genes in the absence Nup170. Consistent with this observation,",
            "probability": 0.05233236479877054,
            "start_logit": 0.9273071885108948,
            "end_logit": 0.7183440923690796
        },
        {
            "text": "toplasmic compartments, including access of transcriptional regulators to the nucleoplasm.",
            "probability": 0.052100994141540465,
            "start_logit": 1.1568111181259155,
            "end_logit": 0.4844091832637787
        },
        {
            "text": "toplasmic compartments, including access of transcriptional regulators to the nucleoplasm. Here we show that the yeast nu",
            "probability": 0.05205744738706555,
            "start_logit": 1.1568111181259155,
            "end_logit": 0.4835730195045471
        },
        {
            "text": "SAGA complex is bound to target",
            "probability": 0.050509256854602426,
            "start_logit": 1.0518019199371338,
            "end_logit": 0.5583909749984741
        },
        {
            "text": "NPCs) control gene expression by regulating the bi-directional exchange of proteins and RNAs between nuclear and cytoplasmic",
            "probability": 0.05029116650765182,
            "start_logit": 0.9752941131591797,
            "end_logit": 0.6305716037750244
        },
        {
            "text": "NPCs) control gene expression by regulating the bi-",
            "probability": 0.050265280014747615,
            "start_logit": 0.9752941131591797,
            "end_logit": 0.6300567388534546
        },
        {
            "text": "complex is bound to target genes in the",
            "probability": 0.0500770652518787,
            "start_logit": 0.8506758213043213,
            "end_logit": 0.7509235739707947
        },
        {
            "text": "SAGA complex",
            "probability": 0.04856503394935815,
            "start_logit": 1.0518019199371338,
            "end_logit": 0.5191381573677063
        },
        {
            "text": "complex is bound to target genes in the absence Nup170. Consistent with this observation,",
            "probability": 0.0484718706104612,
            "start_logit": 0.8506758213043213,
            "end_logit": 0.7183440923690796
        },
        {
            "text": "SAGA complex is bound to target genes in the absence Nup170. Consistent with this",
            "probability": 0.048226103408579094,
            "start_logit": 1.0518019199371338,
            "end_logit": 0.5121347904205322
        },
        {
            "text": "SAGA complex is bound to target genes in the absence Nup170. Consistent with this observation, levels",
            "probability": 0.047068283456661676,
            "start_logit": 1.0518019199371338,
            "end_logit": 0.48783373832702637
        },
        {
            "text": "including access of transcriptional regulators to the nucleoplasm. Here we show that the yeast nucleoporin Nup",
            "probability": 0.04507128790904364,
            "start_logit": 0.9258861541748047,
            "end_logit": 0.5703955292701721
        },
        {
            "text": "is bound to target",
            "probability": 0.04459679039097172,
            "start_logit": 0.9273071885108948,
            "end_logit": 0.5583909749984741
        },
        {
            "text": "is bound to target genes in the absence Nup170. Consistent with this",
            "probability": 0.04258089623604812,
            "start_logit": 0.9273071885108948,
            "end_logit": 0.5121347904205322
        },
        {
            "text": "is bound to target genes in the absence Nup170. Consistent with this observation, levels",
            "probability": 0.04155860731473644,
            "start_logit": 0.9273071885108948,
            "end_logit": 0.48783373832702637
        },
        {
            "text": "including access of transcriptional regulators to the nucleoplasm.",
            "probability": 0.04135771847316943,
            "start_logit": 0.9258861541748047,
            "end_logit": 0.4844091832637787
        }
    ],
    "5319a7f2b166e2b80600002a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56cae60f5795f9a73e00002b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56bb621fac7ad10019000009": [
        {
            "text": "sis",
            "probability": 0.07135149738153614,
            "start_logit": 0.9979531764984131,
            "end_logit": 0.9922582507133484
        },
        {
            "text": "ettsiae.",
            "probability": 0.06981519000406747,
            "start_logit": 1.0622129440307617,
            "end_logit": 0.9062317609786987
        },
        {
            "text": "1984, it has been known that spotted fever group rickettsiosis",
            "probability": 0.06421306031949144,
            "start_logit": 0.8878923654556274,
            "end_logit": 0.9969073534011841
        },
        {
            "text": "group rickettsiosis",
            "probability": 0.05987770317772251,
            "start_logit": 0.8179899454116821,
            "end_logit": 0.9969073534011841
        },
        {
            "text": "ettsiae. Moreover, these",
            "probability": 0.05596473239442704,
            "start_logit": 1.0622129440307617,
            "end_logit": 0.6851018667221069
        },
        {
            "text": "of other spotted fever group rickettsiae.",
            "probability": 0.05582417024437778,
            "start_logit": 0.8385682702064514,
            "end_logit": 0.9062317609786987
        },
        {
            "text": "ettsiae. Moreover, these strain-specific antibodies also reacted with the Misaka and Abe strains. These",
            "probability": 0.05263772451931541,
            "start_logit": 1.0622129440307617,
            "end_logit": 0.6238132119178772
        },
        {
            "text": "only with the homolog",
            "probability": 0.049449273382692394,
            "start_logit": 1.0373655557632446,
            "end_logit": 0.5861749053001404
        },
        {
            "text": "antibodies. Seven of these antibodies reacted with all",
            "probability": 0.046473003320280475,
            "start_logit": 0.876579225063324,
            "end_logit": 0.6848854422569275
        },
        {
            "text": "antibodies. Seven of these antibodies reacted with all representative strains of spotted fever group",
            "probability": 0.04552893608421088,
            "start_logit": 0.876579225063324,
            "end_logit": 0.6643619537353516
        },
        {
            "text": "of other spotted fever group rickettsiae. Moreover, these",
            "probability": 0.04474935538649286,
            "start_logit": 0.8385682702064514,
            "end_logit": 0.6851018667221069
        },
        {
            "text": "clonal antibodies. Seven of these antibodies reacted with all",
            "probability": 0.0446772692066972,
            "start_logit": 0.8371725082397461,
            "end_logit": 0.6848854422569275
        },
        {
            "text": "1984, it has been",
            "probability": 0.044333495998399496,
            "start_logit": 0.8878923654556274,
            "end_logit": 0.626441240310669
        },
        {
            "text": "clonal antibodies. Seven of these antibodies reacted with all representative strains of spotted fever group",
            "probability": 0.043769681079361834,
            "start_logit": 0.8371725082397461,
            "end_logit": 0.6643619537353516
        },
        {
            "text": "showed that these isolates were closely related serologically. To reveal their",
            "probability": 0.04296568685287947,
            "start_logit": 0.9342659711837769,
            "end_logit": 0.5487289428710938
        },
        {
            "text": "of other spotted fever group rickettsiae. Moreover, these strain-specific antibodies also reacted with the Misaka and Abe strains. These",
            "probability": 0.04208908254309306,
            "start_logit": 0.8385682702064514,
            "end_logit": 0.6238132119178772
        },
        {
            "text": "of the ca",
            "probability": 0.04207982894841916,
            "start_logit": 0.908013105392456,
            "end_logit": 0.5541484951972961
        },
        {
            "text": "of the causative",
            "probability": 0.04157946879901811,
            "start_logit": 0.908013105392456,
            "end_logit": 0.5421864986419678
        },
        {
            "text": "of the causative rickettsiae, designated",
            "probability": 0.041379227659638675,
            "start_logit": 0.908013105392456,
            "end_logit": 0.5373589992523193
        },
        {
            "text": "1984, it has been known that spotted fever group rickettsiosis exists in Japan. We isolated three strains of the ca",
            "probability": 0.04124161269787886,
            "start_logit": 0.8878923654556274,
            "end_logit": 0.5541484951972961
        }
    ],
    "554140ad182542114d000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "554148c23f2354b713000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56cb9b065795f9a73e000032": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "53188480b166e2b806000018": [
        {
            "text": "gulated between the two conditions, were mainly involved in cellular metabolism",
            "probability": 0.059060379157852706,
            "start_logit": 1.0486303567886353,
            "end_logit": 0.7526800036430359
        },
        {
            "text": "subcellular fractionation of H358-",
            "probability": 0.05673778945245689,
            "start_logit": 0.7844906449317932,
            "end_logit": 0.9766998887062073
        },
        {
            "text": ". The inhibition by siRNA of eEF1A2 expression resulted in a slight decrease in H358-",
            "probability": 0.056576667892393705,
            "start_logit": 0.9079012274742126,
            "end_logit": 0.8504455089569092
        },
        {
            "text": "gefitinib through KDACi in H358 KRAS mutated and amphiregulin-",
            "probability": 0.05537044772198841,
            "start_logit": 0.8684349060058594,
            "end_logit": 0.8683611750602722
        },
        {
            "text": "treatment. Moreover, 57 dysregulated proteins were upstream of apoptosis (such as eEF1A",
            "probability": 0.05360965024008167,
            "start_logit": 0.8617383241653442,
            "end_logit": 0.8427408337593079
        },
        {
            "text": "-",
            "probability": 0.05293152469128353,
            "start_logit": 0.8413036465644836,
            "end_logit": 0.8504455089569092
        },
        {
            "text": ". The inhibition by siRNA of eEF1A2 expression resulted in a",
            "probability": 0.0514415034813583,
            "start_logit": 0.9079012274742126,
            "end_logit": 0.755294144153595
        },
        {
            "text": "ib resistance in NSCL",
            "probability": 0.05078468556996703,
            "start_logit": 0.9846183657646179,
            "end_logit": 0.6657265424728394
        },
        {
            "text": "CLC) including mutant-KRAS lung adenocarcinoma. To identify which proteins are involved in the restoration of this",
            "probability": 0.05046009744349734,
            "start_logit": 1.0643930435180664,
            "end_logit": 0.5795398950576782
        },
        {
            "text": "gulated proteins were upstream of apoptosis (such as eEF1A",
            "probability": 0.04936332082880346,
            "start_logit": 0.7792168855667114,
            "end_logit": 0.8427408337593079
        },
        {
            "text": "gulated between the two conditions, were mainly involved in cellular metabolism and cell transcription",
            "probability": 0.04872116754445065,
            "start_logit": 1.0486303567886353,
            "end_logit": 0.5602332949638367
        },
        {
            "text": "overcome gefitinib primary resistance in non-",
            "probability": 0.0476868357123129,
            "start_logit": 0.9747834205627441,
            "end_logit": 0.6126220226287842
        },
        {
            "text": ". The",
            "probability": 0.04731530795867903,
            "start_logit": 0.9079012274742126,
            "end_logit": 0.6716827154159546
        },
        {
            "text": "ib resistance in NSCLC. Therefore, altogether our data provide new",
            "probability": 0.047180406832804056,
            "start_logit": 0.9846183657646179,
            "end_logit": 0.5921103954315186
        },
        {
            "text": "overcome gefitinib primary resistance in non-small cell",
            "probability": 0.04660302208338421,
            "start_logit": 0.9747834205627441,
            "end_logit": 0.5896320343017578
        },
        {
            "text": "subcellular fractionation of H358-NSCL",
            "probability": 0.04578458092918543,
            "start_logit": 0.7844906449317932,
            "end_logit": 0.7622067928314209
        },
        {
            "text": "ib resistance in NSCLC. Therefore, altogether our data provide new insights into proteome regulations in the context of overcoming the",
            "probability": 0.04577067073486618,
            "start_logit": 0.9846183657646179,
            "end_logit": 0.5617752075195312
        },
        {
            "text": ") overcome gefitinib primary resistance in non-",
            "probability": 0.0457561756703176,
            "start_logit": 0.9334548115730286,
            "end_logit": 0.6126220226287842
        },
        {
            "text": ") overcome gefitinib primary resistance in non-small cell",
            "probability": 0.044716241565687105,
            "start_logit": 0.9334548115730286,
            "end_logit": 0.5896320343017578
        },
        {
            "text": "prevent AKT phosphorylation known for enhancing gefitinib resistance in NSCL",
            "probability": 0.044129524488629855,
            "start_logit": 0.844152569770813,
            "end_logit": 0.6657265424728394
        }
    ],
    "54ede76294afd61504000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52c7311903868f1b0600001d": [
        {
            "text": "not have craniosynostosis and one individual presented with a normal phenotype. In addition, 3 unrelated cases",
            "probability": 0.08667805318169514,
            "start_logit": 1.0970051288604736,
            "end_logit": 1.0998456478118896
        },
        {
            "text": "p.Pro250Arg mutation in FGF",
            "probability": 0.06529164091342773,
            "start_logit": 1.219679832458496,
            "end_logit": 0.6938342452049255
        },
        {
            "text": "aniosynostosis syndrome associated with the p.Pro250Arg mutation in FGF",
            "probability": 0.06192302357656205,
            "start_logit": 1.1667078733444214,
            "end_logit": 0.6938342452049255
        },
        {
            "text": "not",
            "probability": 0.05454496567756906,
            "start_logit": 1.0970051288604736,
            "end_logit": 0.6366703510284424
        },
        {
            "text": "p.Pro250Arg mutation in FGFR3. An increasing number of individuals with this mutation are reported to not",
            "probability": 0.054102180207615966,
            "start_logit": 1.219679832458496,
            "end_logit": 0.5058447122573853
        },
        {
            "text": "associated with the p.Pro250Arg mutation in FGF",
            "probability": 0.05349555983620526,
            "start_logit": 1.0204144716262817,
            "end_logit": 0.6938342452049255
        },
        {
            "text": "not have craniosynostosis and one individual presented with a normal phenotype. In addition, 3 unrelated cases had incomplete cleft",
            "probability": 0.05170731872446163,
            "start_logit": 1.0970051288604736,
            "end_logit": 0.583244264125824
        },
        {
            "text": "aniosynostosis syndrome associated with the",
            "probability": 0.050714471959717254,
            "start_logit": 1.1667078733444214,
            "end_logit": 0.4941534996032715
        },
        {
            "text": "graphs, clinical photographs, and follow-up.",
            "probability": 0.04753631288979375,
            "start_logit": 1.0558736324310303,
            "end_logit": 0.5402703285217285
        },
        {
            "text": "enke syndrome is a craniosynostosis syndrome associated with the p.Pro250Arg mutation in FGF",
            "probability": 0.047141786786427005,
            "start_logit": 0.8939756155014038,
            "end_logit": 0.6938342452049255
        },
        {
            "text": "variation was seen both within and across families. The most striking observations were that 6/16 (38%",
            "probability": 0.04567405793514777,
            "start_logit": 0.842870831489563,
            "end_logit": 0.7133097052574158
        },
        {
            "text": "is a craniosynostosis syndrome associated with the p.Pro250Arg mutation in FGF",
            "probability": 0.04437700923385312,
            "start_logit": 0.8335373401641846,
            "end_logit": 0.6938342452049255
        },
        {
            "text": "associated with the p.Pro250Arg mutation in FGFR3. An increasing number of individuals with this mutation are reported to not",
            "probability": 0.044327671629561693,
            "start_logit": 1.0204144716262817,
            "end_logit": 0.5058447122573853
        },
        {
            "text": "GF",
            "probability": 0.0440658855245205,
            "start_logit": 0.826501727104187,
            "end_logit": 0.6938342452049255
        },
        {
            "text": "associated with the",
            "probability": 0.04381244507429838,
            "start_logit": 1.0204144716262817,
            "end_logit": 0.4941534996032715
        },
        {
            "text": "variation was seen both within and across families. The most striking observations were that 6/16 (38%) cases did not",
            "probability": 0.04230440096765523,
            "start_logit": 0.842870831489563,
            "end_logit": 0.6366703510284424
        },
        {
            "text": "argue that many studies on Muenke syndrome have",
            "probability": 0.04163660309569855,
            "start_logit": 0.9166456460952759,
            "end_logit": 0.546984076499939
        },
        {
            "text": "argue that many studies on Muenke syndrome have been influenced by ascertainment bias in regard to craniosynostosis",
            "probability": 0.04057516535056239,
            "start_logit": 0.9166456460952759,
            "end_logit": 0.5211606025695801
        },
        {
            "text": "GFR3. An increasing number of individuals with this mutation are reported to not have craniosynostosis. The purpose of this",
            "probability": 0.04014162246304482,
            "start_logit": 0.826501727104187,
            "end_logit": 0.6005620956420898
        },
        {
            "text": "osis. Verified diagnosis entails detailed family history, drawing",
            "probability": 0.03994982497218275,
            "start_logit": 0.8560374975204468,
            "end_logit": 0.5662368535995483
        }
    ],
    "54f1e031c409818c32000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "513ce494bee46bd34c000009": [
        {
            "text": "LUZP1 and EPLIN",
            "probability": 0.08801819733337106,
            "start_logit": 0.9234544038772583,
            "end_logit": 1.28385329246521
        },
        {
            "text": "basal body. Like EPLIN, LUZP1 is an actin-",
            "probability": 0.0705812157211875,
            "start_logit": 0.8486806154251099,
            "end_logit": 1.1378475427627563
        },
        {
            "text": "centrosome to basal body conversion. Ciliogenesis deregulation caused by LUZP1 or EPLIN",
            "probability": 0.062477180390095,
            "start_logit": 1.0257644653320312,
            "end_logit": 0.8388010263442993
        },
        {
            "text": "sensory and motility functions. Their",
            "probability": 0.058288805885690784,
            "start_logit": 0.9739315509796143,
            "end_logit": 0.82124263048172
        },
        {
            "text": "lia and flagella are microtubule-based cellular projections with important sensory and motility functions. Their",
            "probability": 0.054462168736103975,
            "start_logit": 0.9060277938842773,
            "end_logit": 0.82124263048172
        },
        {
            "text": "basal body. Like",
            "probability": 0.05374935120581089,
            "start_logit": 0.8486806154251099,
            "end_logit": 0.865415096282959
        },
        {
            "text": "cellular projections with important sensory and motility functions. Their",
            "probability": 0.05141816845478639,
            "start_logit": 0.8485130667686462,
            "end_logit": 0.82124263048172
        },
        {
            "text": "of MyosinVa at the centrosome and primary cilia formation. We",
            "probability": 0.05094944490231458,
            "start_logit": 0.961824357509613,
            "end_logit": 0.6987736225128174
        },
        {
            "text": "lia and flagella are microtubule-",
            "probability": 0.04953475794706633,
            "start_logit": 0.9060277938842773,
            "end_logit": 0.7264109253883362
        },
        {
            "text": "centrosome to basal body conversion. Ciliogenesis dereg",
            "probability": 0.049256862612837446,
            "start_logit": 1.0257644653320312,
            "end_logit": 0.6010483503341675
        },
        {
            "text": "LUZP1 and EPLIN interact with known ciliogenesis and cilia-",
            "probability": 0.048413091731039824,
            "start_logit": 0.9234544038772583,
            "end_logit": 0.6860799789428711
        },
        {
            "text": "ciliogenesis and cilia-",
            "probability": 0.046890368106010695,
            "start_logit": 0.8914964199066162,
            "end_logit": 0.6860799789428711
        },
        {
            "text": "centrosome to basal body conversion. Ciliogenesis deregulation caused by LUZP1 or EPLIN loss may thus contribute to the",
            "probability": 0.04667004124249275,
            "start_logit": 1.0257644653320312,
            "end_logit": 0.5471020936965942
        },
        {
            "text": "regulators and as such represent novel players in actin-dependent centrosome to basal body conversion. Ciliogenesis dereg",
            "probability": 0.041226021559541824,
            "start_logit": 0.8477854132652283,
            "end_logit": 0.6010483503341675
        },
        {
            "text": "of MyosinVa at the centrosome and primary cilia formation. We further show that LUZ",
            "probability": 0.04043434116074306,
            "start_logit": 0.961824357509613,
            "end_logit": 0.4676192104816437
        },
        {
            "text": "LUZP1 and EPLIN interact with known ciliogenesis and cilia-length regulators and as such represent",
            "probability": 0.038841853055429226,
            "start_logit": 0.9234544038772583,
            "end_logit": 0.46580806374549866
        },
        {
            "text": "LUZP1 and",
            "probability": 0.03869353065478698,
            "start_logit": 0.9234544038772583,
            "end_logit": 0.4619821310043335
        },
        {
            "text": "ciliogenesis and cilia-length regulators and as such represent",
            "probability": 0.0376201709613379,
            "start_logit": 0.8914964199066162,
            "end_logit": 0.46580806374549866
        },
        {
            "text": "basal body.",
            "probability": 0.036463251369739526,
            "start_logit": 0.8486806154251099,
            "end_logit": 0.4773884415626526
        },
        {
            "text": "regulators and as such represent",
            "probability": 0.036011176969614124,
            "start_logit": 0.8477854132652283,
            "end_logit": 0.46580806374549866
        }
    ],
    "56c86aa95795f9a73e000018": [
        {
            "text": "H. We investigated the effect of treprostinil on",
            "probability": 0.09171214551421913,
            "start_logit": 1.018117904663086,
            "end_logit": 0.8663951754570007
        },
        {
            "text": "H. We investigated the effect of treprostinil on established severe PAH and underlying",
            "probability": 0.07416337839442406,
            "start_logit": 1.018117904663086,
            "end_logit": 0.6540108323097229
        },
        {
            "text": "H. We investigated the effect of treprostinil on established severe PAH and underlying mechanisms",
            "probability": 0.06933521914645427,
            "start_logit": 1.018117904663086,
            "end_logit": 0.5866933465003967
        },
        {
            "text": "H. We investigated the effect of treprostinil on established severe PAH and underlying mechanisms using the",
            "probability": 0.06651090606293805,
            "start_logit": 1.018117904663086,
            "end_logit": 0.5451062917709351
        },
        {
            "text": "16 (SU, a VEGF receptor-2 inhibitor)-",
            "probability": 0.06437280907039436,
            "start_logit": 0.8659571409225464,
            "end_logit": 0.664592444896698
        },
        {
            "text": "H. We investigated the effect of treprostinil on established severe PAH and underlying mechanisms using the rat SU5416 (SU, a",
            "probability": 0.06108741888475249,
            "start_logit": 1.018117904663086,
            "end_logit": 0.46004629135131836
        },
        {
            "text": "H. We investigated the effect of treprostinil on established",
            "probability": 0.059895471867654364,
            "start_logit": 1.018117904663086,
            "end_logit": 0.4403412640094757
        },
        {
            "text": "16 (SU, a VEGF receptor-2 inhibitor)-chronic hypoxia (Hx) model",
            "probability": 0.05728207540686285,
            "start_logit": 0.8659571409225464,
            "end_logit": 0.5478888750076294
        },
        {
            "text": "H. We investigated",
            "probability": 0.054065819503948474,
            "start_logit": 1.018117904663086,
            "end_logit": 0.33794254064559937
        },
        {
            "text": "H. We investigated the",
            "probability": 0.05361708279500594,
            "start_logit": 1.018117904663086,
            "end_logit": 0.32960808277130127
        },
        {
            "text": "H. We investigated the effect of treprostinil on established severe PAH and underlying mechanisms using the rat",
            "probability": 0.053344453561784994,
            "start_logit": 1.018117904663086,
            "end_logit": 0.3245103657245636
        },
        {
            "text": "16 (SU, a",
            "probability": 0.052464941784423895,
            "start_logit": 0.8659571409225464,
            "end_logit": 0.46004629135131836
        },
        {
            "text": "16 (SU, a VEGF",
            "probability": 0.050858203697500534,
            "start_logit": 0.8659571409225464,
            "end_logit": 0.42894256114959717
        },
        {
            "text": "failure and death. Parenteral prostaglandins (PGs), including treprostinil",
            "probability": 0.04982349351100698,
            "start_logit": 0.9290275573730469,
            "end_logit": 0.3453173339366913
        },
        {
            "text": "failure and death. Parenteral prostaglandins (PGs)",
            "probability": 0.047912979098302076,
            "start_logit": 0.9290275573730469,
            "end_logit": 0.30621713399887085
        },
        {
            "text": "failure and death. Parenteral prostaglandins (PGs), including treprostinil, a prostacycl",
            "probability": 0.04731706742970272,
            "start_logit": 0.9290275573730469,
            "end_logit": 0.29370176792144775
        },
        {
            "text": "16 (SU, a VEGF receptor-",
            "probability": 0.04623653427062476,
            "start_logit": 0.8659571409225464,
            "end_logit": 0.3336713910102844
        }
    ],
    "571f5e740fd6f91b6800000b": [
        {
            "text": "is a lysosomal storage disease caused by an autosomal recessive inherited deficiency of the lysosomal enzyme glucocereb",
            "probability": 0.1222981029164228,
            "start_logit": 0.9016915559768677,
            "end_logit": 0.5651087760925293
        },
        {
            "text": "is a lysosomal storage disease caused by an autosomal recessive inherited deficiency of the l",
            "probability": 0.11688562075613626,
            "start_logit": 0.9016915559768677,
            "end_logit": 0.5198431015014648
        },
        {
            "text": "is a lysosomal storage disease caused by an autosomal recessive inherited deficiency of the",
            "probability": 0.11196790466131734,
            "start_logit": 0.9016915559768677,
            "end_logit": 0.47685950994491577
        },
        {
            "text": "I",
            "probability": 0.10170679475386811,
            "start_logit": 0.9707353711128235,
            "end_logit": 0.3116975426673889
        },
        {
            "text": "I and type III).",
            "probability": 0.09977779300632164,
            "start_logit": 0.9707353711128235,
            "end_logit": 0.2925490736961365
        },
        {
            "text": "is a lysosomal storage disease caused by an autosomal recessive inherited deficiency of the lys",
            "probability": 0.09674570755865684,
            "start_logit": 0.9016915559768677,
            "end_logit": 0.33073320984840393
        },
        {
            "text": "is a lysosomal storage disease caused by an autosomal recess",
            "probability": 0.09295137950444354,
            "start_logit": 0.9016915559768677,
            "end_logit": 0.2907238006591797
        },
        {
            "text": "is a",
            "probability": 0.09146025751150987,
            "start_logit": 0.9016915559768677,
            "end_logit": 0.27455177903175354
        },
        {
            "text": "is a lysosomal storage disease caused by an autosomal recessive",
            "probability": 0.08352822473440995,
            "start_logit": 0.9016915559768677,
            "end_logit": 0.1838318407535553
        },
        {
            "text": "is a lysosomal storage disease caused by an",
            "probability": 0.0826782145969136,
            "start_logit": 0.9016915559768677,
            "end_logit": 0.1736033856868744
        }
    ],
    "55376f19bc4f83e82800000c": [
        {
            "text": "departments (CEDs) due to lower pediatric volume, a lack of pediatric expertise among staff, and a lack of pediatric-",
            "probability": 0.09799413211756763,
            "start_logit": 1.0642586946487427,
            "end_logit": 0.528840184211731
        },
        {
            "text": "departments (CEDs) due to lower pediatric volume, a lack of pediatric expertise among staff, and a lack of pediatric-specific equipment and resources.",
            "probability": 0.0880624995058754,
            "start_logit": 1.0642586946487427,
            "end_logit": 0.4219793677330017
        },
        {
            "text": ") due to lower pediatric volume, a lack of pediatric expertise among staff, and a lack of pediatric-",
            "probability": 0.08602370807144988,
            "start_logit": 0.933974027633667,
            "end_logit": 0.528840184211731
        },
        {
            "text": "way management provided by CEDs in simulated settings and the",
            "probability": 0.079002955901342,
            "start_logit": 0.9188727736473083,
            "end_logit": 0.45880377292633057
        },
        {
            "text": ") due to lower pediatric volume, a lack of pediatric expertise among staff, and a lack of pediatric-specific equipment and resources.",
            "probability": 0.07730526905883534,
            "start_logit": 0.933974027633667,
            "end_logit": 0.4219793677330017
        },
        {
            "text": "management provided by CEDs in simulated settings and the",
            "probability": 0.07228671133234443,
            "start_logit": 0.8300278186798096,
            "end_logit": 0.45880377292633057
        },
        {
            "text": "way management provided by CEDs",
            "probability": 0.06720069383598512,
            "start_logit": 0.9188727736473083,
            "end_logit": 0.29700207710266113
        },
        {
            "text": "way management provided",
            "probability": 0.0646241956227548,
            "start_logit": 0.9188727736473083,
            "end_logit": 0.2579073905944824
        },
        {
            "text": "way management provided by CEDs in simulated settings and the CEDs' pediatric emergency",
            "probability": 0.06458765910665469,
            "start_logit": 0.9188727736473083,
            "end_logit": 0.2573418617248535
        },
        {
            "text": "way management provided by CEDs in simulated",
            "probability": 0.06433314460004354,
            "start_logit": 0.9188727736473083,
            "end_logit": 0.2533934712409973
        },
        {
            "text": "management provided by CEDs",
            "probability": 0.06148778993435862,
            "start_logit": 0.8300278186798096,
            "end_logit": 0.29700207710266113
        },
        {
            "text": "management provided",
            "probability": 0.059130326463996026,
            "start_logit": 0.8300278186798096,
            "end_logit": 0.2579073905944824
        },
        {
            "text": "management provided by CEDs in simulated settings and the CEDs' pediatric emergency",
            "probability": 0.059096896011144144,
            "start_logit": 0.8300278186798096,
            "end_logit": 0.2573418617248535
        },
        {
            "text": "management provided by CEDs in simulated",
            "probability": 0.05886401843764842,
            "start_logit": 0.8300278186798096,
            "end_logit": 0.2533934712409973
        }
    ],
    "5319a7d2b166e2b806000029": [
        {
            "text": "two previously identified ubiquitin E3 ligases for HSP90",
            "probability": 0.06394941526735104,
            "start_logit": 1.1240736246109009,
            "end_logit": 0.7346499562263489
        },
        {
            "text": "two previously identified ubi",
            "probability": 0.06247137234713224,
            "start_logit": 1.1240736246109009,
            "end_logit": 0.7112659811973572
        },
        {
            "text": "17-dimethylaminoethylamino-",
            "probability": 0.06015024839761863,
            "start_logit": 0.823460042476654,
            "end_logit": 0.9740167260169983
        },
        {
            "text": "RF1 interacts with HSP90 chaperone complex and is a novel HSP90 client protein. Pharmacological inhibition",
            "probability": 0.05968628210064927,
            "start_logit": 1.0811591148376465,
            "end_logit": 0.7085742950439453
        },
        {
            "text": "ses for HSP90",
            "probability": 0.05609976490573248,
            "start_logit": 0.9931128621101379,
            "end_logit": 0.7346499562263489
        },
        {
            "text": "evidence that HSP90 inhibitors may suppress cancer cell proliferation in part through its",
            "probability": 0.055580986042688865,
            "start_logit": 1.027970552444458,
            "end_logit": 0.6905018091201782
        },
        {
            "text": "evidence that HSP90 inhibitors may suppress cancer cell proliferation in part through its induced UHRF1 degradation. Taken together,",
            "probability": 0.05340803417775799,
            "start_logit": 1.027970552444458,
            "end_logit": 0.6506218314170837
        },
        {
            "text": "evidence that HSP90 inhibitors may",
            "probability": 0.05202778692749121,
            "start_logit": 1.027970552444458,
            "end_logit": 0.6244385838508606
        },
        {
            "text": "oxygeldanamycin (17-AAG). We",
            "probability": 0.050880307769257754,
            "start_logit": 0.8915289640426636,
            "end_logit": 0.738578200340271
        },
        {
            "text": "is independent of CHIP and CUL5, two previously identified ubiquitin E3 ligases for HSP90",
            "probability": 0.04758345494286544,
            "start_logit": 0.8284663558006287,
            "end_logit": 0.7346499562263489
        },
        {
            "text": "is independent of CHIP and CUL5, two previously identified ubi",
            "probability": 0.04648367336700857,
            "start_logit": 0.8284663558006287,
            "end_logit": 0.7112659811973572
        },
        {
            "text": "ligase of UHRF1 nor on the E3 ligase SCF(\u03b2-TRCP) that has been implicated in regulation of UHRF",
            "probability": 0.04607973622202789,
            "start_logit": 0.9200009107589722,
            "end_logit": 0.611003577709198
        },
        {
            "text": "17-dimethylaminoethylamino-17-",
            "probability": 0.045749006274139414,
            "start_logit": 0.823460042476654,
            "end_logit": 0.7003412246704102
        },
        {
            "text": "ligase of UHRF1 nor on the E3 ligase SCF(\u03b2-TRCP) that has been",
            "probability": 0.045214232791116374,
            "start_logit": 0.9200009107589722,
            "end_logit": 0.5920422077178955
        },
        {
            "text": "We also provide evidence that HSP90 inhibitors may suppress cancer cell proliferation in part through its",
            "probability": 0.04434093930865329,
            "start_logit": 0.80203777551651,
            "end_logit": 0.6905018091201782
        },
        {
            "text": "17-",
            "probability": 0.04392684094178392,
            "start_logit": 0.823460042476654,
            "end_logit": 0.6596966981887817
        },
        {
            "text": "We also provide evidence that HSP90 inhibitors may suppress cancer cell proliferation in part through its induced UHRF1 degradation. Taken together,",
            "probability": 0.04260741974335586,
            "start_logit": 0.80203777551651,
            "end_logit": 0.6506218314170837
        },
        {
            "text": "We also provide evidence that HSP90 inhibitors may",
            "probability": 0.04150629750871235,
            "start_logit": 0.80203777551651,
            "end_logit": 0.6244385838508606
        },
        {
            "text": "17-dimethylaminoethylamino-17-demethoxygeldanamycin",
            "probability": 0.04144611243194957,
            "start_logit": 0.823460042476654,
            "end_logit": 0.6015652418136597
        },
        {
            "text": "ligase SCF(\u03b2-TRCP) that has been implicated in regulation of UHRF",
            "probability": 0.04080808853270793,
            "start_logit": 0.7985079288482666,
            "end_logit": 0.611003577709198
        }
    ],
    "5547a01cf35db75526000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "51656c94298dcd4e51000058": [
        {
            "text": "inae rupture.",
            "probability": 0.06349151442541295,
            "start_logit": 0.7966846227645874,
            "end_logit": 1.014892578125
        },
        {
            "text": "gate, lumbar lordosis and heel contractures. Both electrophysiology and muscle biopsy were consistent with a neurogenic disorder",
            "probability": 0.05887454109988053,
            "start_logit": 1.043744444847107,
            "end_logit": 0.6923352479934692
        },
        {
            "text": "severe muscular weakness and atrophy in scapulohumeroperone",
            "probability": 0.05850709709549327,
            "start_logit": 0.9502159953117371,
            "end_logit": 0.7796030044555664
        },
        {
            "text": "inae rupture. A new",
            "probability": 0.05724402258685461,
            "start_logit": 0.7966846227645874,
            "end_logit": 0.911309540271759
        },
        {
            "text": "urogenic disorder and he received a diagnosis of spinal muscular atrophy type 3. At the age of 30 the patient developed heart involvement",
            "probability": 0.057122295682096584,
            "start_logit": 0.7703467011451721,
            "end_logit": 0.935518741607666
        },
        {
            "text": "ulohumeroperone",
            "probability": 0.05435856504013093,
            "start_logit": 0.8766701221466064,
            "end_logit": 0.7796030044555664
        },
        {
            "text": "severe muscular weakness and atrophy in scapulohumero",
            "probability": 0.05181716898933185,
            "start_logit": 0.9502159953117371,
            "end_logit": 0.6581764817237854
        },
        {
            "text": "severe muscular weakness and atrophy in scapulohumeroperoneal pattern with significant involvement of the lower facial and",
            "probability": 0.05165896251568096,
            "start_logit": 0.9502159953117371,
            "end_logit": 0.6551186442375183
        },
        {
            "text": "inae rupture. A new clinical examination showed severe muscular weakness and atrophy in scapulohumeroperone",
            "probability": 0.05018000759051073,
            "start_logit": 0.7966846227645874,
            "end_logit": 0.7796030044555664
        },
        {
            "text": "severe muscular weakness and atrophy in scapulohumeroperoneal pattern with significant involvement of the lower facial and intrinsic hand",
            "probability": 0.04819770929682163,
            "start_logit": 0.9502159953117371,
            "end_logit": 0.5857664346694946
        },
        {
            "text": "ulohumero",
            "probability": 0.048142996158307416,
            "start_logit": 0.8766701221466064,
            "end_logit": 0.6581764817237854
        },
        {
            "text": "ulohumeroperoneal pattern with significant involvement of the lower facial and",
            "probability": 0.0479960075481276,
            "start_logit": 0.8766701221466064,
            "end_logit": 0.6551186442375183
        },
        {
            "text": "EDMD) is an inherited myopathy characterized by early contractures, slow progressive muscle weakness and cardiac involvement",
            "probability": 0.04495805958390833,
            "start_logit": 0.846278190612793,
            "end_logit": 0.6201227903366089
        },
        {
            "text": "of the lower facial and",
            "probability": 0.04479459776227064,
            "start_logit": 0.8076398372650146,
            "end_logit": 0.6551186442375183
        },
        {
            "text": "urogenic disorder",
            "probability": 0.0447911696569965,
            "start_logit": 0.7703467011451721,
            "end_logit": 0.6923352479934692
        },
        {
            "text": "ulohumeroperoneal pattern with significant involvement of the lower facial and intrinsic hand",
            "probability": 0.044780179596338475,
            "start_logit": 0.8766701221466064,
            "end_logit": 0.5857664346694946
        },
        {
            "text": "inae rupture. A new clinical examination showed severe muscular weakness and atrophy in scapulohumero",
            "probability": 0.04444223115290639,
            "start_logit": 0.7966846227645874,
            "end_logit": 0.6581764817237854
        },
        {
            "text": "frame deletion spanning from the beginning of exon 1 to the half of intron 2 (p.Asp6Glyfs",
            "probability": 0.04356743614442405,
            "start_logit": 0.8537075519561768,
            "end_logit": 0.5812733769416809
        },
        {
            "text": "urogenic disorder and he received a diagnosis of spinal muscular atrophy type 3",
            "probability": 0.04271881721831395,
            "start_logit": 0.7703467011451721,
            "end_logit": 0.6449637413024902
        },
        {
            "text": "p.Asp6Glyfs",
            "probability": 0.04235662085619248,
            "start_logit": 0.8255223035812378,
            "end_logit": 0.5812733769416809
        }
    ],
    "5319a6e9b166e2b806000023": [
        {
            "text": "striatal histone deacetylation. In PC12 cells with inducible expression of mutant huntingtin protein,",
            "probability": 0.06523307001909363,
            "start_logit": 0.9645814895629883,
            "end_logit": 0.9727970957756042
        },
        {
            "text": "huntingtin protein,",
            "probability": 0.06418618119137097,
            "start_logit": 0.9484028816223145,
            "end_logit": 0.9727970957756042
        },
        {
            "text": "be instrumental in Huntington's disease (HD), a fatal genetic disorder",
            "probability": 0.05919342324012553,
            "start_logit": 0.8677442073822021,
            "end_logit": 0.9724782705307007
        },
        {
            "text": ".",
            "probability": 0.057690999320719985,
            "start_logit": 1.057126522064209,
            "end_logit": 0.7573866844177246
        },
        {
            "text": "etic regulation are thought to be instrumental in Huntington's disease (HD), a fatal genetic disorder",
            "probability": 0.056482816270083655,
            "start_logit": 0.8208702206611633,
            "end_logit": 0.9724782705307007
        },
        {
            "text": "huntingtin protein, we further demonstrate that D\u03b2HB prevents histone deacetylation via a mechanism independent of its",
            "probability": 0.05399820810189585,
            "start_logit": 0.9484028816223145,
            "end_logit": 0.7999600172042847
        },
        {
            "text": "huntingtin protein, we further demonstrate that D\u03b2HB prevents histone deacetylation via a mechanism",
            "probability": 0.05137040008073246,
            "start_logit": 0.9484028816223145,
            "end_logit": 0.7500712871551514
        },
        {
            "text": "HB prevents histone deacetylation via a mechanism independent of its",
            "probability": 0.049362829997449904,
            "start_logit": 0.858649730682373,
            "end_logit": 0.7999600172042847
        },
        {
            "text": ". These pre-clinical findings suggest that by simultaneously targeting the mitochondrial and the",
            "probability": 0.04893650135631172,
            "start_logit": 1.057126522064209,
            "end_logit": 0.5928090810775757
        },
        {
            "text": "HB prevents histone deacetylation via a mechanism independent of its mitochondrial effects and independent of histone deacetylase inhibition.",
            "probability": 0.047305396456945696,
            "start_logit": 0.858649730682373,
            "end_logit": 0.7573866844177246
        },
        {
            "text": "HB prevents histone deacetylation via a mechanism",
            "probability": 0.04696060138331058,
            "start_logit": 0.858649730682373,
            "end_logit": 0.7500712871551514
        },
        {
            "text": "fusion of D\u03b2HB extends life span, attenuates motor",
            "probability": 0.04692445691443172,
            "start_logit": 0.8875638246536255,
            "end_logit": 0.7203872203826904
        },
        {
            "text": "huntingtin protein, we further demonstrate that D\u03b2HB prevents histone deace",
            "probability": 0.04648422239048623,
            "start_logit": 0.9484028816223145,
            "end_logit": 0.6501221060752869
        },
        {
            "text": "HB prevents histone deacetylation via a mechanism independent of its mitochondrial effects and independent of histone deacetylase inhibition",
            "probability": 0.045242504284611115,
            "start_logit": 0.858649730682373,
            "end_logit": 0.7127993106842041
        },
        {
            "text": "HB extends life span, attenuates motor",
            "probability": 0.04522757262725543,
            "start_logit": 0.8507317304611206,
            "end_logit": 0.7203872203826904
        },
        {
            "text": "model of toxin induced-striatal neurodegeneration. In transgenic R6/2",
            "probability": 0.04486048812337632,
            "start_logit": 0.8892813920974731,
            "end_logit": 0.6736880540847778
        },
        {
            "text": "span, attenuates motor",
            "probability": 0.04353347314433288,
            "start_logit": 0.8125549554824829,
            "end_logit": 0.7203872203826904
        },
        {
            "text": "neurodegeneration. In transgenic R6/2",
            "probability": 0.04250336792413692,
            "start_logit": 0.8353073000907898,
            "end_logit": 0.6736880540847778
        },
        {
            "text": "HB prevents histone deace",
            "probability": 0.042493868742741935,
            "start_logit": 0.858649730682373,
            "end_logit": 0.6501221060752869
        },
        {
            "text": "model of toxin induced-",
            "probability": 0.04200961843058751,
            "start_logit": 0.8892813920974731,
            "end_logit": 0.6080292463302612
        }
    ],
    "56c703445795f9a73e00000a": [
        {
            "text": "Ig-",
            "probability": 0.09290392268908208,
            "start_logit": 1.266275405883789,
            "end_logit": 1.044211506843567
        },
        {
            "text": "romatin situated close to the promoter of an actively transcribed gene. Chromatin positioned near a cell",
            "probability": 0.06891581885086108,
            "start_logit": 1.0772203207015991,
            "end_logit": 0.9345864653587341
        },
        {
            "text": "romatin situated close to the",
            "probability": 0.060672574902175556,
            "start_logit": 1.0772203207015991,
            "end_logit": 0.8071925044059753
        },
        {
            "text": "Ig-beta/growth hormone locus. Marked enhancement of the",
            "probability": 0.05917822984969214,
            "start_logit": 1.266275405883789,
            "end_logit": 0.5931993722915649
        },
        {
            "text": "4 was found at prominently enhanced targets. However,",
            "probability": 0.05630991564434555,
            "start_logit": 0.9806962013244629,
            "end_logit": 0.8290954828262329
        },
        {
            "text": "romatin situated close to the promoter of an actively transcribed gene. Chromatin positioned near a cell-",
            "probability": 0.05345264328298151,
            "start_logit": 1.0772203207015991,
            "end_logit": 0.6804968118667603
        },
        {
            "text": "of histones H3 and H4 was found at prominently enhanced targets. However,",
            "probability": 0.0526850959018639,
            "start_logit": 0.9141581654548645,
            "end_logit": 0.8290954828262329
        },
        {
            "text": "4 residue",
            "probability": 0.05085616813383145,
            "start_logit": 1.0397223234176636,
            "end_logit": 0.6682001352310181
        },
        {
            "text": "ciable difference in the acetylation of histones H3 and H4 was found at prominently enhanced targets. However,",
            "probability": 0.0495467188179458,
            "start_logit": 0.8527415990829468,
            "end_logit": 0.8290954828262329
        },
        {
            "text": "I-hypersensitive site with enhancer activity had the same histone modifications as the active promoter",
            "probability": 0.04654307601154468,
            "start_logit": 1.0297143459320068,
            "end_logit": 0.5895849466323853
        },
        {
            "text": "4 residue coincided with those with prominently",
            "probability": 0.04539143799276989,
            "start_logit": 1.0397223234176636,
            "end_logit": 0.5545222163200378
        },
        {
            "text": "I-hypersensitive site with enhancer activity had the same histone modifications as the active promoter. In one transcribed",
            "probability": 0.044776006368322054,
            "start_logit": 1.0297143459320068,
            "end_logit": 0.5508791208267212
        },
        {
            "text": "4 was found at prominently enhanced targets. However, different acetylation levels of H3 and H4 were found at one target.",
            "probability": 0.04271154678741898,
            "start_logit": 0.9806962013244629,
            "end_logit": 0.5526941418647766
        },
        {
            "text": "4 histones and dimethylation in the",
            "probability": 0.04114944242411601,
            "start_logit": 0.9128850698471069,
            "end_logit": 0.5832463502883911
        },
        {
            "text": "dimethylation in the",
            "probability": 0.04060914734263494,
            "start_logit": 0.8996680378913879,
            "end_logit": 0.5832463502883911
        },
        {
            "text": "4 histones and dimethylation in the H3 histone L",
            "probability": 0.04034678195050172,
            "start_logit": 0.9128850698471069,
            "end_logit": 0.5635476112365723
        },
        {
            "text": "dimethylation in the H3 histone L",
            "probability": 0.0398170258576544,
            "start_logit": 0.8996680378913879,
            "end_logit": 0.5635476112365723
        },
        {
            "text": "activity had the same histone modifications as the active promoter",
            "probability": 0.039192068846162324,
            "start_logit": 0.8578104972839355,
            "end_logit": 0.5895849466323853
        },
        {
            "text": "activity had the same histone modifications as the active promoter. In one transcribed",
            "probability": 0.03770408994472559,
            "start_logit": 0.8578104972839355,
            "end_logit": 0.5508791208267212
        },
        {
            "text": "cia",
            "probability": 0.03723828840137015,
            "start_logit": 0.8527415990829468,
            "end_logit": 0.5435169339179993
        }
    ],
    "52bf208003868f1b06000019": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "514a51c2d24251bc0500005c": [
        {
            "text": "is similar. Lactotroph adenomas are histologically classified into three subtypes",
            "probability": 0.06575234479047073,
            "start_logit": 1.0415611267089844,
            "end_logit": 0.9685816764831543
        },
        {
            "text": "oma. We will review the main pathological features of the lactotroph adenomas and some of their characteristics that may predict",
            "probability": 0.06284093238053061,
            "start_logit": 1.0257859230041504,
            "end_logit": 0.9390681982040405
        },
        {
            "text": "is similar",
            "probability": 0.05925596158569166,
            "start_logit": 1.0415611267089844,
            "end_logit": 0.8645527362823486
        },
        {
            "text": "both sexes. Most lactotroph adenomas are microadenomas occurring in reproductive-",
            "probability": 0.05656687945647122,
            "start_logit": 0.8515152931213379,
            "end_logit": 1.0081558227539062
        },
        {
            "text": "s gender and age, the histopathology of the tumors is similar",
            "probability": 0.05644002538575018,
            "start_logit": 0.9928733110427856,
            "end_logit": 0.8645527362823486
        },
        {
            "text": "three subtypes",
            "probability": 0.05594992898726196,
            "start_logit": 0.8801229596138,
            "end_logit": 0.9685816764831543
        },
        {
            "text": "is similar. Lactotroph adenomas are histologically classified into three sub",
            "probability": 0.05537181437862831,
            "start_logit": 1.0415611267089844,
            "end_logit": 0.7967570424079895
        },
        {
            "text": "visual loss. Although clinical and laboratory features may differ depending on patient's gender and age, the histopathology of the tumors is similar",
            "probability": 0.05329753005540448,
            "start_logit": 0.9355847239494324,
            "end_logit": 0.8645527362823486
        },
        {
            "text": "patient's gender and age, the histopathology of the tumors is similar",
            "probability": 0.05309453062347133,
            "start_logit": 0.9317686557769775,
            "end_logit": 0.8645527362823486
        },
        {
            "text": "visual",
            "probability": 0.048337977106884686,
            "start_logit": 0.9355847239494324,
            "end_logit": 0.7668802738189697
        },
        {
            "text": "oma. We will review the main pathological features of the lactotroph adenomas and some of their characteristics that may",
            "probability": 0.04783816960133444,
            "start_logit": 1.0257859230041504,
            "end_logit": 0.6662853956222534
        },
        {
            "text": "three sub",
            "probability": 0.04711693692829482,
            "start_logit": 0.8801229596138,
            "end_logit": 0.7967570424079895
        },
        {
            "text": "including headaches, neurologic defects, and visual",
            "probability": 0.04620037493032497,
            "start_logit": 0.890355110168457,
            "end_logit": 0.7668802738189697
        },
        {
            "text": "including headaches, neurologic defects,",
            "probability": 0.044790288993184955,
            "start_logit": 0.890355110168457,
            "end_logit": 0.7358837127685547
        },
        {
            "text": "oma. We will review the main",
            "probability": 0.043281188097700325,
            "start_logit": 1.0257859230041504,
            "end_logit": 0.566179633140564
        },
        {
            "text": "adenomas, also called prolactinomas and prolactin-",
            "probability": 0.04181132766418994,
            "start_logit": 0.8426983952522278,
            "end_logit": 0.714716374874115
        },
        {
            "text": "ph adenomas, also called prolactinomas and prolactin-",
            "probability": 0.04142093471842555,
            "start_logit": 0.8333175182342529,
            "end_logit": 0.714716374874115
        },
        {
            "text": "visual loss. Although clinical and laboratory features may differ depending on",
            "probability": 0.04050692016276446,
            "start_logit": 0.9355847239494324,
            "end_logit": 0.5901355743408203
        },
        {
            "text": "three subtypes: the common sparsely granulated lactotroph adenoma,",
            "probability": 0.04023055642843477,
            "start_logit": 0.8801229596138,
            "end_logit": 0.6387513279914856
        },
        {
            "text": "s gender and age,",
            "probability": 0.039895377724780676,
            "start_logit": 0.9928733110427856,
            "end_logit": 0.5176346302032471
        }
    ],
    "56b397a98525abca1e000003": [
        {
            "text": "visualization of intracellular lipid droplets with indirect immunofluorescent detection of lipid droplet-",
            "probability": 0.07492206125218655,
            "start_logit": 1.0013054609298706,
            "end_logit": 0.8654401302337646
        },
        {
            "text": "is presented as an example. Finally, a simple protocol for enhancing",
            "probability": 0.07148922128134193,
            "start_logit": 1.168004035949707,
            "end_logit": 0.6518398523330688
        },
        {
            "text": "is presented as an example. Finally, a simple protocol for enhancing lipid droplet accumulation",
            "probability": 0.06829898010861904,
            "start_logit": 1.168004035949707,
            "end_logit": 0.6061879992485046
        },
        {
            "text": "is presented as an example. Finally, a simple protocol for enhancing lipid droplet accumulation through supplementation",
            "probability": 0.06809914578951723,
            "start_logit": 1.168004035949707,
            "end_logit": 0.6032578349113464
        },
        {
            "text": "is presented as an example. Finally, a simple protocol for enhancing lipid droplet accumulation through supplementation with excess fatty acid",
            "probability": 0.06259967679330107,
            "start_logit": 1.168004035949707,
            "end_logit": 0.5190532803535461
        },
        {
            "text": "is presented as an example. Finally, a simple protocol for enhancing lipid droplet accumulation through supplementation with excess",
            "probability": 0.06122276812308563,
            "start_logit": 1.168004035949707,
            "end_logit": 0.4968123137950897
        },
        {
            "text": "visualization of intracellular lipid droplets with indirect immunofluorescent detection of lipid",
            "probability": 0.05966543800221086,
            "start_logit": 1.0013054609298706,
            "end_logit": 0.637744665145874
        },
        {
            "text": "visualization of lipid",
            "probability": 0.0595217432469503,
            "start_logit": 0.9072421193122864,
            "end_logit": 0.7293967604637146
        },
        {
            "text": "This unit discusses techniques for the visualization of lipid",
            "probability": 0.059500510069741545,
            "start_logit": 0.9068853259086609,
            "end_logit": 0.7293967604637146
        },
        {
            "text": "is described. Techniques",
            "probability": 0.0563082696381078,
            "start_logit": 1.0690301656723022,
            "end_logit": 0.5121084451675415
        },
        {
            "text": "visualization of intracellular lipid droplets with indirect immunofluorescent detection of lip",
            "probability": 0.0552080949376927,
            "start_logit": 1.0013054609298706,
            "end_logit": 0.560101330280304
        },
        {
            "text": "visualization of lipid droplets and associated proteins in cultured mammalian cells. Protocols for the detection of lipid droplets in fixed or live",
            "probability": 0.05441439003070204,
            "start_logit": 0.9072421193122864,
            "end_logit": 0.639683723449707
        },
        {
            "text": "visualization of intracellular lipid droplets with indirect immunofluorescent detection of lipid droplet-associated proteins is described. Techniques",
            "probability": 0.0526210749969805,
            "start_logit": 1.0013054609298706,
            "end_logit": 0.5121084451675415
        },
        {
            "text": "visualization of lip",
            "probability": 0.04915513826737956,
            "start_logit": 0.9072421193122864,
            "end_logit": 0.5380364656448364
        },
        {
            "text": "This unit discusses techniques for the visualization of lip",
            "probability": 0.04913760316668161,
            "start_logit": 0.9068853259086609,
            "end_logit": 0.5380364656448364
        },
        {
            "text": "visualization of lipid droplets and associated proteins in cultured mammalian cells. Protocols for the detection of lipid droplets",
            "probability": 0.04892666894719681,
            "start_logit": 0.9072421193122864,
            "end_logit": 0.5333777070045471
        },
        {
            "text": "This unit discusses techniques for the visualization of lipid droplets and associated proteins in cultured mammalian cells. Protocols for the detection of lipid droplets",
            "probability": 0.04890921534830471,
            "start_logit": 0.9068853259086609,
            "end_logit": 0.5333777070045471
        }
    ],
    "54edf72c94afd61504000013": [
        {
            "text": "crosslinks (ICLs) repair in the genome. Several FA",
            "probability": 0.061832265661569165,
            "start_logit": 1.032424807548523,
            "end_logit": 0.916299045085907
        },
        {
            "text": "DNA interstrand crosslinks (ICLs) repair in the genome. Several FA",
            "probability": 0.0554792659816706,
            "start_logit": 0.924008846282959,
            "end_logit": 0.916299045085907
        },
        {
            "text": "be associated with haploinsufficiency.",
            "probability": 0.05464702737176117,
            "start_logit": 0.99851393699646,
            "end_logit": 0.8266794085502625
        },
        {
            "text": "crosslinks (ICLs",
            "probability": 0.05399108702167181,
            "start_logit": 1.032424807548523,
            "end_logit": 0.7806926965713501
        },
        {
            "text": "is mainly involved in DNA interstrand crosslinks (ICLs) repair in the genome. Several FA",
            "probability": 0.05326439836229677,
            "start_logit": 0.8832676410675049,
            "end_logit": 0.916299045085907
        },
        {
            "text": ".Gln350Valfs*18)",
            "probability": 0.05255679985998787,
            "start_logit": 1.028554916381836,
            "end_logit": 0.7576380968093872
        },
        {
            "text": "). Fanconi anemia group L protein (FANCL",
            "probability": 0.051212697882799744,
            "start_logit": 0.8052260279655457,
            "end_logit": 0.9550600051879883
        },
        {
            "text": "Two novel heterozy",
            "probability": 0.051104941643361386,
            "start_logit": 1.1134105920791626,
            "end_logit": 0.6447691321372986
        },
        {
            "text": "Two novel heterozygous frames",
            "probability": 0.050902398203322,
            "start_logit": 1.1134105920791626,
            "end_logit": 0.6407979726791382
        },
        {
            "text": "mainly involved in DNA interstrand crosslinks (ICLs) repair in the genome. Several FA",
            "probability": 0.05042103865496367,
            "start_logit": 0.8284080028533936,
            "end_logit": 0.916299045085907
        },
        {
            "text": "CL mutations in POI pathogenesis has not been confirmed. In the present work, potentially pathogenic mutations in the FANCL",
            "probability": 0.04967765146890573,
            "start_logit": 1.0230357646942139,
            "end_logit": 0.7068179249763489
        },
        {
            "text": "DNA interstrand crosslinks (ICLs",
            "probability": 0.04844373476316891,
            "start_logit": 0.924008846282959,
            "end_logit": 0.7806926965713501
        },
        {
            "text": "controls. Two novel heterozy",
            "probability": 0.04786984298882213,
            "start_logit": 1.0480151176452637,
            "end_logit": 0.6447691321372986
        },
        {
            "text": "controls. Two novel heterozygous frames",
            "probability": 0.04768012116620929,
            "start_logit": 1.0480151176452637,
            "end_logit": 0.6407979726791382
        },
        {
            "text": "present work, potentially pathogenic mutations in the FANCL gene were screened in 200 Chinese patients with idio",
            "probability": 0.046973955791779806,
            "start_logit": 0.9134876132011414,
            "end_logit": 0.7604042291641235
        },
        {
            "text": "is mainly involved in DNA interstrand crosslinks (ICLs",
            "probability": 0.04650974271064381,
            "start_logit": 0.8832676410675049,
            "end_logit": 0.7806926965713501
        },
        {
            "text": "present work, potentially pathogenic mutations in the FANCL",
            "probability": 0.044523049076072525,
            "start_logit": 0.9134876132011414,
            "end_logit": 0.7068179249763489
        },
        {
            "text": "CL",
            "probability": 0.044486160893820535,
            "start_logit": 0.9669462442398071,
            "end_logit": 0.6525304317474365
        },
        {
            "text": "s with FANCT/UBE2T to ubiquitinate the FANCI-D",
            "probability": 0.0443968605173575,
            "start_logit": 0.8913069367408752,
            "end_logit": 0.7261603474617004
        },
        {
            "text": "mainly involved in DNA interstrand crosslinks (ICLs",
            "probability": 0.04402695997981543,
            "start_logit": 0.8284080028533936,
            "end_logit": 0.7806926965713501
        }
    ],
    "56d138fe3975bb303a000015": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5326a85ad6d3ac6a3400000b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "515db3d8298dcd4e51000015": [
        {
            "text": "I obtained after dissociation of the",
            "probability": 0.06156559279032156,
            "start_logit": 1.083446979522705,
            "end_logit": 0.5912227630615234
        },
        {
            "text": "I obtained after dissociation of the proteins in 1 M NaCl. The",
            "probability": 0.06033791387262601,
            "start_logit": 1.083446979522705,
            "end_logit": 0.5710802674293518
        },
        {
            "text": "M NaCl. The",
            "probability": 0.05862695795858762,
            "start_logit": 1.0546809434890747,
            "end_logit": 0.5710802674293518
        },
        {
            "text": "rotein complexes containing viral DNA and cellular histones were extracted from nuclei of permissive cells infected with polyoma virus or simi",
            "probability": 0.057253094373138906,
            "start_logit": 1.0192338228225708,
            "end_logit": 0.5828144550323486
        },
        {
            "text": "replicative",
            "probability": 0.056144353911758586,
            "start_logit": 0.9705080986022949,
            "end_logit": 0.6119846105575562
        },
        {
            "text": "of the",
            "probability": 0.055417218473426684,
            "start_logit": 0.9246946573257446,
            "end_logit": 0.6447622776031494
        },
        {
            "text": "replicative intermediates were studied. Isopy",
            "probability": 0.05323649282698532,
            "start_logit": 0.9705080986022949,
            "end_logit": 0.558802604675293
        },
        {
            "text": "R1 endonuc",
            "probability": 0.05316021758470137,
            "start_logit": 0.9272540807723999,
            "end_logit": 0.600622832775116
        },
        {
            "text": "R1 endonuclease suggests that the nucleosomes are not formed at specific sites on the viral genome. Faster sediment",
            "probability": 0.053089240932246116,
            "start_logit": 0.9272540807723999,
            "end_logit": 0.5992867946624756
        },
        {
            "text": "of the nucleoprotein complex to cleavage by EcoR1 endonuc",
            "probability": 0.05302433204588104,
            "start_logit": 0.9246946573257446,
            "end_logit": 0.600622832775116
        },
        {
            "text": "R1 endonuclease suggests that the nucleosomes are not formed at specific sites on",
            "probability": 0.05130994557547165,
            "start_logit": 0.9272540807723999,
            "end_logit": 0.5651971101760864
        },
        {
            "text": "R1 endonuclease suggests that the nucleosomes are not formed at specific sites on the",
            "probability": 0.05093108691048463,
            "start_logit": 0.9272540807723999,
            "end_logit": 0.5577859878540039
        },
        {
            "text": "rotein complexes containing replicative",
            "probability": 0.050551400747511195,
            "start_logit": 0.8655726313591003,
            "end_logit": 0.6119846105575562
        },
        {
            "text": "containing viral DNA and cellular histones were extracted from nuclei of permissive cells infected with polyoma virus or simi",
            "probability": 0.04830130062082681,
            "start_logit": 0.8492106199264526,
            "end_logit": 0.5828144550323486
        },
        {
            "text": "times shorter than that of viral DNA form I obtained after dissociation of the",
            "probability": 0.04799946227148439,
            "start_logit": 0.8345336318016052,
            "end_logit": 0.5912227630615234
        },
        {
            "text": "rotein complexes containing replicative intermediates were studied. Isopy",
            "probability": 0.04793321315120367,
            "start_logit": 0.8655726313591003,
            "end_logit": 0.558802604675293
        },
        {
            "text": "obtained after dissociation of the",
            "probability": 0.04751164994458531,
            "start_logit": 0.8243187665939331,
            "end_logit": 0.5912227630615234
        },
        {
            "text": "times shorter than that of viral DNA form I obtained after dissociation of the proteins in 1 M NaCl. The",
            "probability": 0.047042305437274744,
            "start_logit": 0.8345336318016052,
            "end_logit": 0.5710802674293518
        },
        {
            "text": "obtained after dissociation of the proteins in 1 M NaCl. The",
            "probability": 0.04656422057148475,
            "start_logit": 0.8243187665939331,
            "end_logit": 0.5710802674293518
        }
    ],
    "5540ca8a0083d1bf0e000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "51585b28d24251bc0500008d": [
        {
            "text": "is therefore intrinsically",
            "probability": 0.08545456491952283,
            "start_logit": 1.223134994506836,
            "end_logit": 0.8412206768989563
        },
        {
            "text": "ditis elegans lacks DNA methylation, more basal nemat",
            "probability": 0.07276803364195686,
            "start_logit": 1.0695255994796753,
            "end_logit": 0.8341220021247864
        },
        {
            "text": "methylcytosine into DNA both in vitro and in vivo. Alkylation damage is therefore intrinsically",
            "probability": 0.060444651635474765,
            "start_logit": 0.8768782615661621,
            "end_logit": 0.8412206768989563
        },
        {
            "text": "ditis elegans lacks DNA methylation,",
            "probability": 0.06028618240345593,
            "start_logit": 1.0695255994796753,
            "end_logit": 0.6459481716156006
        },
        {
            "text": "is therefore intrinsically associated with D",
            "probability": 0.05995220478337812,
            "start_logit": 1.223134994506836,
            "end_logit": 0.486783504486084
        },
        {
            "text": "abditis elegans lacks DNA methylation, more basal nemat",
            "probability": 0.05879658067796312,
            "start_logit": 0.856332540512085,
            "end_logit": 0.8341220021247864
        },
        {
            "text": "is therefore intrinsically associated with DNMT activity, and this may promote the loss of DNA methylation in many species.",
            "probability": 0.05794789018777378,
            "start_logit": 1.223134994506836,
            "end_logit": 0.45278000831604004
        },
        {
            "text": "confined to transcribed genes or lost altogether in several lineages. We used comparative epigenomics to investigate the evolution of DNA methylation. Although the",
            "probability": 0.05434371235322421,
            "start_logit": 1.071605920791626,
            "end_logit": 0.5400938391685486
        },
        {
            "text": "ditis elegans lacks DNA methylation, more basal nematodes retain cytosine DNA methyl",
            "probability": 0.05266169299774209,
            "start_logit": 1.0695255994796753,
            "end_logit": 0.5107335448265076
        },
        {
            "text": "confined to transcribed genes or lost altogether in several lineages. We used comparative epigenomics to investigate the",
            "probability": 0.049862568957651385,
            "start_logit": 1.071605920791626,
            "end_logit": 0.45403552055358887
        },
        {
            "text": "abditis elegans lacks DNA methylation,",
            "probability": 0.048711243248538545,
            "start_logit": 0.856332540512085,
            "end_logit": 0.6459481716156006
        },
        {
            "text": "ditis elegans lacks DNA methylation",
            "probability": 0.04760349739287692,
            "start_logit": 1.0695255994796753,
            "end_logit": 0.4097514748573303
        },
        {
            "text": "comparative epigenomics to investigate the evolution of DNA methylation. Although the",
            "probability": 0.04591863624563109,
            "start_logit": 0.9031480550765991,
            "end_logit": 0.5400938391685486
        },
        {
            "text": "abditis elegans lacks DNA methylation, more basal nematodes retain cytosine DNA methyl",
            "probability": 0.04255065481382716,
            "start_logit": 0.856332540512085,
            "end_logit": 0.5107335448265076
        },
        {
            "text": "methylcytosine into DNA both in vitro and in vivo. Alkylation damage is therefore intrinsically associated with D",
            "probability": 0.042406045087499455,
            "start_logit": 0.8768782615661621,
            "end_logit": 0.486783504486084
        },
        {
            "text": "comparative epigenomics to investigate the",
            "probability": 0.0421322185602075,
            "start_logit": 0.9031480550765991,
            "end_logit": 0.45403552055358887
        },
        {
            "text": "methylcy",
            "probability": 0.04188349051957982,
            "start_logit": 0.8768782615661621,
            "end_logit": 0.4743843078613281
        },
        {
            "text": "abditis elegans lacks DNA methylation",
            "probability": 0.03846363210506875,
            "start_logit": 0.856332540512085,
            "end_logit": 0.4097514748573303
        },
        {
            "text": "). Despite their",
            "probability": 0.03781249946862772,
            "start_logit": 0.8083754777908325,
            "end_logit": 0.440635085105896
        }
    ],
    "515dd3d5298dcd4e5100001c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54e262daae9738404b000018": [
        {
            "text": "n A but not",
            "probability": 0.07027276705435347,
            "start_logit": 1.0423463582992554,
            "end_logit": 0.8747391104698181
        },
        {
            "text": "4C1 cells revealed that PSP co-fractionates with chromogranin A but not",
            "probability": 0.06202834562289752,
            "start_logit": 0.9175534844398499,
            "end_logit": 0.8747391104698181
        },
        {
            "text": "ates with chromogranin A but not",
            "probability": 0.06136971392849225,
            "start_logit": 0.9068784713745117,
            "end_logit": 0.8747391104698181
        },
        {
            "text": "H4C1 and PC12. PSP undergoes stimulated secret",
            "probability": 0.06105115595953522,
            "start_logit": 1.1442277431488037,
            "end_logit": 0.6321855187416077
        },
        {
            "text": ". Subcellular fractionation of GH4C1 cells revealed that PSP co-fractionates with chromogranin A but not",
            "probability": 0.05920335025437496,
            "start_logit": 0.8709401488304138,
            "end_logit": 0.8747391104698181
        },
        {
            "text": "parotid secretory protein (PSP), which is stored efficiently in parotid",
            "probability": 0.05368468418330836,
            "start_logit": 0.875046968460083,
            "end_logit": 0.7727819085121155
        },
        {
            "text": "H4C1 and PC12. PSP undergoes stimulated",
            "probability": 0.05341669853463204,
            "start_logit": 1.1442277431488037,
            "end_logit": 0.49859678745269775
        },
        {
            "text": "H4C1 and PC12. PSP undergoes stimulated secretion in both cell types. Secretion is similar to that of the",
            "probability": 0.051593171756134135,
            "start_logit": 1.1442277431488037,
            "end_logit": 0.46386271715164185
        },
        {
            "text": "lines GH4C1 and PC12. PSP undergoes stimulated secret",
            "probability": 0.04949248085583357,
            "start_logit": 0.9343363642692566,
            "end_logit": 0.6321855187416077
        },
        {
            "text": "4C1 and PC12. PSP undergoes stimulated secret",
            "probability": 0.04617292391882294,
            "start_logit": 0.8649091720581055,
            "end_logit": 0.6321855187416077
        },
        {
            "text": "tutive secretory pathway in endocrine cells. Subcellular fractionation of GH4C",
            "probability": 0.0459854540273115,
            "start_logit": 0.9319571256637573,
            "end_logit": 0.561069130897522
        },
        {
            "text": "4C",
            "probability": 0.04532784340890958,
            "start_logit": 0.9175534844398499,
            "end_logit": 0.561069130897522
        },
        {
            "text": "tutive secretory pathway in endocrine cells",
            "probability": 0.04389507360028623,
            "start_logit": 0.9319571256637573,
            "end_logit": 0.5145460963249207
        },
        {
            "text": "lines GH4C1 and PC12. PSP undergoes stimulated",
            "probability": 0.04330343771638614,
            "start_logit": 0.9343363642692566,
            "end_logit": 0.49859678745269775
        },
        {
            "text": ". Subcellular fractionation of GH4C",
            "probability": 0.04326344935794177,
            "start_logit": 0.8709401488304138,
            "end_logit": 0.561069130897522
        },
        {
            "text": "secretory proteins are stored in secretory granules. While the",
            "probability": 0.04234889764368381,
            "start_logit": 0.8985370397567749,
            "end_logit": 0.5121064782142639
        },
        {
            "text": "tutive secretory pathway in endocrine cells. Subcellular fractionation of GH4C1 cells revealed that PSP co-",
            "probability": 0.04222698213613783,
            "start_logit": 0.9319571256637573,
            "end_logit": 0.475803405046463
        },
        {
            "text": "parotid secretory protein (PSP), which is stored efficiently in parotid acinar cells, was expressed in the",
            "probability": 0.041915295779224204,
            "start_logit": 0.875046968460083,
            "end_logit": 0.5253049731254578
        },
        {
            "text": "lines GH4C1 and PC12. PSP undergoes stimulated secretion in both cell types. Secretion is similar to that of the",
            "probability": 0.04182515507363444,
            "start_logit": 0.9343363642692566,
            "end_logit": 0.46386271715164185
        },
        {
            "text": "4C1 cells revealed that PSP co-",
            "probability": 0.04162311918809996,
            "start_logit": 0.9175534844398499,
            "end_logit": 0.475803405046463
        }
    ],
    "56d1f790f22319765a000001": [
        {
            "text": "not respond to TKI treatment. We detected a significant rate of low-",
            "probability": 0.06424326502596547,
            "start_logit": 1.0783013105392456,
            "end_logit": 1.0531022548675537
        },
        {
            "text": ". Median variant allele frequency was 0.14% (range 0.02-",
            "probability": 0.05865153878883553,
            "start_logit": 0.9453333020210266,
            "end_logit": 1.0950071811676025
        },
        {
            "text": "kinase inhibitors (TKI) was 67% regardless of T790M status. The median progression free survival was 10.7 (IQR",
            "probability": 0.05809782738717366,
            "start_logit": 1.1483185291290283,
            "end_logit": 0.8825364112854004
        },
        {
            "text": "kinase inhibitors (TKI) was 67% regardless",
            "probability": 0.0580723841053262,
            "start_logit": 1.1483185291290283,
            "end_logit": 0.882098376750946
        },
        {
            "text": "%). Overall response rate to first generation EGFR tyrosine kinase inhibitors (TKI) was 67% regardless",
            "probability": 0.05803570502508305,
            "start_logit": 1.1476867198944092,
            "end_logit": 0.882098376750946
        },
        {
            "text": "GFR tyrosine kinase inhibitors (TKI) was 67% regardless",
            "probability": 0.05536777889483527,
            "start_logit": 1.1006261110305786,
            "end_logit": 0.882098376750946
        },
        {
            "text": ". Median variant allele frequency was 0.14% (range 0.",
            "probability": 0.054349349144836176,
            "start_logit": 0.9453333020210266,
            "end_logit": 1.0188260078430176
        },
        {
            "text": "detected a significant rate of low-",
            "probability": 0.05276675596887753,
            "start_logit": 0.8815057873725891,
            "end_logit": 1.0531022548675537
        },
        {
            "text": ".5%). Median variant allele frequency was 0.14% (range 0.02-",
            "probability": 0.050210516793504946,
            "start_logit": 0.7899439930915833,
            "end_logit": 1.0950071811676025
        },
        {
            "text": ") was 67% regardless of T790M status. The median progression free survival was 10.7 (IQR",
            "probability": 0.04914873513562165,
            "start_logit": 0.9810413718223572,
            "end_logit": 0.8825364112854004
        },
        {
            "text": ") was 67% regardless",
            "probability": 0.04912721100680753,
            "start_logit": 0.9810413718223572,
            "end_logit": 0.882098376750946
        },
        {
            "text": "extracted from pre-treatment NSCLC tumor tissue with known activating EGFR mutations, diagnosed",
            "probability": 0.04739282379446376,
            "start_logit": 0.916668176651001,
            "end_logit": 0.9105293154716492
        },
        {
            "text": ".5%). Median variant allele frequency was 0.14% (range 0.",
            "probability": 0.046527490400172,
            "start_logit": 0.7899439930915833,
            "end_logit": 1.0188260078430176
        },
        {
            "text": "not respond to TKI treatment. We detected a significant rate of low-level pre-",
            "probability": 0.046488079741050584,
            "start_logit": 1.0783013105392456,
            "end_logit": 0.7296212911605835
        },
        {
            "text": "not",
            "probability": 0.04336849574861993,
            "start_logit": 1.0783013105392456,
            "end_logit": 0.660158634185791
        },
        {
            "text": ". Low-level pre-treatment T790",
            "probability": 0.04208006184377748,
            "start_logit": 0.9863458871841431,
            "end_logit": 0.7219548225402832
        },
        {
            "text": "not respond to TKI treatment. We detected a significant rate of low-level pre-treatment T790M mutations in NSCL",
            "probability": 0.0420084694954742,
            "start_logit": 1.0783013105392456,
            "end_logit": 0.6282966136932373
        },
        {
            "text": ". Low-level pre-treatment T790M did not impact treatment response rate or overall survival, but was",
            "probability": 0.04179256906975942,
            "start_logit": 0.9863458871841431,
            "end_logit": 0.7150993347167969
        },
        {
            "text": "790M mutations in NSCLC using highly sensitive dPCR. Low-level pre-treatment T790",
            "probability": 0.041655324865402646,
            "start_logit": 0.976201057434082,
            "end_logit": 0.7219548225402832
        },
        {
            "text": "kinase inhibitors (TKI) was 67% regardless of T790M status. The median",
            "probability": 0.04061561776441296,
            "start_logit": 1.1483185291290283,
            "end_logit": 0.524560809135437
        }
    ],
    "57138eb21174fb175500000a": [
        {
            "text": "first described in 2013 and lead to disorders with symptoms including ataxia and dysarthria, such as spinocerebellar autosomal-",
            "probability": 0.18484867446953807,
            "start_logit": 0.958980143070221,
            "end_logit": 0.4219738245010376
        },
        {
            "text": "first described in 2013",
            "probability": 0.18007803738293304,
            "start_logit": 0.958980143070221,
            "end_logit": 0.3958266079425812
        },
        {
            "text": "first described in 2013 and lead",
            "probability": 0.16296841712445514,
            "start_logit": 0.958980143070221,
            "end_logit": 0.29599273204803467
        },
        {
            "text": "first described in 2013 and lead to disorders with symptoms including ataxia and",
            "probability": 0.16240186334806922,
            "start_logit": 0.958980143070221,
            "end_logit": 0.2925102114677429
        },
        {
            "text": "first described in 2013 and lead to disorders with symptoms including ataxia and dysarthria, such as spin",
            "probability": 0.15962026397267376,
            "start_logit": 0.958980143070221,
            "end_logit": 0.2752339541912079
        },
        {
            "text": "first described in 2013 and lead to disorders with symptoms including ataxia and dysarthria, such as spinocerebellar",
            "probability": 0.15008274370233068,
            "start_logit": 0.958980143070221,
            "end_logit": 0.2136230766773224
        }
    ],
    "513ce5f2bee46bd34c00000a": [
        {
            "text": "specimen, we have to distinguish between a simple colonization and an NTM-related disease. The start of treatment depends on",
            "probability": 0.0768299234238332,
            "start_logit": 0.9494374394416809,
            "end_logit": 1.1744115352630615
        },
        {
            "text": "mpetence, drug adverse effects, and compliance with a very long therapy that can last",
            "probability": 0.0718764040465674,
            "start_logit": 1.193763256072998,
            "end_logit": 0.8634395599365234
        },
        {
            "text": "patient's specimen, we have to distinguish between a simple colonization and an NTM-related disease. The start of treatment depends on",
            "probability": 0.07021715600349362,
            "start_logit": 0.8594359159469604,
            "end_logit": 1.1744115352630615
        },
        {
            "text": "depends on",
            "probability": 0.06702013134846165,
            "start_logit": 0.8128362894058228,
            "end_logit": 1.1744115352630615
        },
        {
            "text": "ties, HIV infection, the",
            "probability": 0.056514125621615986,
            "start_logit": 1.0362334251403809,
            "end_logit": 0.7805119752883911
        },
        {
            "text": "specimen, we have to distinguish between a simple colonization and an NTM-",
            "probability": 0.05189191473754334,
            "start_logit": 0.9494374394416809,
            "end_logit": 0.7819803357124329
        },
        {
            "text": "is isolated from a patient's specimen, we have to distinguish between a simple colonization and an NTM-",
            "probability": 0.051613696375812625,
            "start_logit": 0.9440615177154541,
            "end_logit": 0.7819803357124329
        },
        {
            "text": "co",
            "probability": 0.050398155184491825,
            "start_logit": 0.9926682710647583,
            "end_logit": 0.7095410823822021
        },
        {
            "text": "patient's specimen, we have to distinguish between a simple colonization and an NTM-",
            "probability": 0.04742556688942069,
            "start_logit": 0.8594359159469604,
            "end_logit": 0.7819803357124329
        },
        {
            "text": "several countries. The increased prevalence of NTM infection can be explained by an ageing population with rising comorbidities, HIV infection, the",
            "probability": 0.04299692652567105,
            "start_logit": 0.7628714442253113,
            "end_logit": 0.7805119752883911
        },
        {
            "text": "ubiquitous and opportunistic emerging bacteria with the",
            "probability": 0.04281240868252961,
            "start_logit": 0.873093843460083,
            "end_logit": 0.6659889221191406
        },
        {
            "text": "idities, HIV infection, the",
            "probability": 0.0425764160753175,
            "start_logit": 0.7530432939529419,
            "end_logit": 0.7805119752883911
        },
        {
            "text": "specimen",
            "probability": 0.04224340933781098,
            "start_logit": 0.9494374394416809,
            "end_logit": 0.5762656927108765
        },
        {
            "text": "is isolated from a patient's specimen",
            "probability": 0.04201692141191099,
            "start_logit": 0.9440615177154541,
            "end_logit": 0.5762656927108765
        },
        {
            "text": "cobacteria\", \"paediatric\",",
            "probability": 0.041899788733763474,
            "start_logit": 0.9926682710647583,
            "end_logit": 0.5248672962188721
        },
        {
            "text": "be explained by an ageing population with rising comorbidities, HIV infection, the",
            "probability": 0.041432459566496584,
            "start_logit": 0.7258074283599854,
            "end_logit": 0.7805119752883911
        },
        {
            "text": "cobacteria\", \"paediatric\", \"NT",
            "probability": 0.041296624394087114,
            "start_logit": 0.9926682710647583,
            "end_logit": 0.5103672742843628
        },
        {
            "text": "improved diagnostic methods. The aim of this review is to demonstrate the clinical relevance of NTMs in children, describing their",
            "probability": 0.04016721567220947,
            "start_logit": 0.7030139565467834,
            "end_logit": 0.7722919583320618
        },
        {
            "text": "explained by an ageing population with rising comorbidities, HIV infection, the",
            "probability": 0.040050352641484314,
            "start_logit": 0.6918802857398987,
            "end_logit": 0.7805119752883911
        },
        {
            "text": "sis\", and \"children\". Recent literature points out that NTMs are ubiquitous, with several species",
            "probability": 0.038720403327478524,
            "start_logit": 0.7637117505073547,
            "end_logit": 0.6749097108840942
        }
    ],
    "5505a587f73303d458000005": [
        {
            "text": "kinase that gets inputs from the",
            "probability": 0.06976125603357408,
            "start_logit": 1.1764159202575684,
            "end_logit": 0.7152315378189087
        },
        {
            "text": "kinase that gets inputs from the amino acids, nutrients, growth factor,",
            "probability": 0.060454248201345706,
            "start_logit": 1.1764159202575684,
            "end_logit": 0.5720396041870117
        },
        {
            "text": "kinase that gets inputs from the amino acids, nutrients, growth factor, and environmental cues to regulate varieties of fundamental cellular processes which include protein synthesis,",
            "probability": 0.0564566651210411,
            "start_logit": 1.1764159202575684,
            "end_logit": 0.5036261081695557
        },
        {
            "text": "Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that gets inputs from the",
            "probability": 0.056324061976540295,
            "start_logit": 0.9624589681625366,
            "end_logit": 0.7152315378189087
        },
        {
            "text": "OR including amplifications and somatic mutations, mTOR-mediated cell",
            "probability": 0.05536060912932437,
            "start_logit": 0.9485146999359131,
            "end_logit": 0.711922287940979
        },
        {
            "text": "Mammalian target of rapamy",
            "probability": 0.05434085046553069,
            "start_logit": 0.9624589681625366,
            "end_logit": 0.6793859601020813
        },
        {
            "text": "kinase that gets inputs from the amino acids, nutrients, growth factor, and environmental cues to regulate varieties of fundamental cellular processes which include protein",
            "probability": 0.05142625055130568,
            "start_logit": 1.1764159202575684,
            "end_logit": 0.4103015065193176
        },
        {
            "text": "is a serine/threonine kinase that gets inputs from the",
            "probability": 0.050888528949387675,
            "start_logit": 0.8609746694564819,
            "end_logit": 0.7152315378189087
        },
        {
            "text": "is approved for the treatment of human malignancies. This review briefly focuses on",
            "probability": 0.04913428993580758,
            "start_logit": 0.9334326982498169,
            "end_logit": 0.6076931357383728
        },
        {
            "text": "further understanding the",
            "probability": 0.04847458026216068,
            "start_logit": 0.9662610292434692,
            "end_logit": 0.5613471865653992
        },
        {
            "text": "regulate varieties of fundamental cellular processes which include protein synthesis,",
            "probability": 0.04799035979369739,
            "start_logit": 1.0139427185058594,
            "end_logit": 0.5036261081695557
        },
        {
            "text": "regulate varieties of fundamental cellular processes which include protein synthesis, growth, metabolism, aging, regeneration, autophagy, etc. The mTOR is frequently",
            "probability": 0.047107118578178016,
            "start_logit": 1.0139427185058594,
            "end_logit": 0.4850500822067261
        },
        {
            "text": "regulate varieties of fundamental cellular processes which include protein synthesis, growth, metabolism, aging, regeneration, autophagy,",
            "probability": 0.04704218238951627,
            "start_logit": 1.0139427185058594,
            "end_logit": 0.4836706519126892
        },
        {
            "text": "advances in further understanding the",
            "probability": 0.04520194973495886,
            "start_logit": 0.8963617086410522,
            "end_logit": 0.5613471865653992
        },
        {
            "text": "is approved for the",
            "probability": 0.04440135972837863,
            "start_logit": 0.9334326982498169,
            "end_logit": 0.5064060688018799
        },
        {
            "text": "regulate varieties of fundamental cellular processes which include protein synthesis, growth, metabolism, aging, regeneration",
            "probability": 0.04417146822441181,
            "start_logit": 1.0139427185058594,
            "end_logit": 0.42070502042770386
        },
        {
            "text": "is a serine/threonine kinase that gets inputs from the amino acids, nutrients, growth factor,",
            "probability": 0.04409937456153387,
            "start_logit": 0.8609746694564819,
            "end_logit": 0.5720396041870117
        },
        {
            "text": "regulate varieties of fundamental cellular processes which include protein",
            "probability": 0.04371431187985972,
            "start_logit": 1.0139427185058594,
            "end_logit": 0.4103015065193176
        },
        {
            "text": "OR including amplifications and somatic mutations, mTOR-mediated cell growth promoting signaling, therapeutic targeting of mTOR and the mechanisms",
            "probability": 0.04201014794193081,
            "start_logit": 0.9485146999359131,
            "end_logit": 0.4359651803970337
        },
        {
            "text": "OR including amplifications and somatic mutations, mTOR-mediated cell growth promoting",
            "probability": 0.04164038654151679,
            "start_logit": 0.9485146999359131,
            "end_logit": 0.4271245002746582
        }
    ],
    "5722027a0fd6f91b68000014": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56cf236f3975bb303a000002": [
        {
            "text": "idities with a marked intensity ranging from partial reduction to a complete suppression of symptoms. These results make",
            "probability": 0.09130379829093205,
            "start_logit": 0.9739705324172974,
            "end_logit": 1.0538649559020996
        },
        {
            "text": "T-",
            "probability": 0.07375688321136109,
            "start_logit": 0.9327625036239624,
            "end_logit": 0.8816549181938171
        },
        {
            "text": "neuropathic, chemotherapy-",
            "probability": 0.06941020972373116,
            "start_logit": 0.949629545211792,
            "end_logit": 0.8040475249290466
        },
        {
            "text": "armacological treatment for chronic pain. Assessment of the",
            "probability": 0.06520075756544952,
            "start_logit": 1.2040674686431885,
            "end_logit": 0.4870467185974121
        },
        {
            "text": "armacological treatment for chronic pain. Assessment of the effect of ethosux",
            "probability": 0.06513121299543752,
            "start_logit": 1.2040674686431885,
            "end_logit": 0.48597952723503113
        },
        {
            "text": "idities as anxiety and depression are frequently encountered in chronic pain patients",
            "probability": 0.06294236150869953,
            "start_logit": 0.9964867830276489,
            "end_logit": 0.6593757271766663
        },
        {
            "text": "pain, likely to improve not only pain but also the accompanying anxiety and depression.",
            "probability": 0.061597009559322305,
            "start_logit": 0.8683803081512451,
            "end_logit": 0.7658761143684387
        },
        {
            "text": "T-type calcium channels, a",
            "probability": 0.06150560282581238,
            "start_logit": 0.9327625036239624,
            "end_logit": 0.7000088691711426
        },
        {
            "text": "idities with a marked intensity ranging from partial reduction",
            "probability": 0.0613778136744519,
            "start_logit": 0.9739705324172974,
            "end_logit": 0.6567209959030151
        },
        {
            "text": "idities as anxiety and depression are frequently encountered in chronic pain patients.",
            "probability": 0.0572729082970958,
            "start_logit": 0.9964867830276489,
            "end_logit": 0.5649840235710144
        },
        {
            "text": "T-type calcium channels, a new strategy for the management of uncontrolled chronic pain,",
            "probability": 0.05620206383817197,
            "start_logit": 0.9327625036239624,
            "end_logit": 0.6098340749740601
        },
        {
            "text": "idities with a marked intensity ranging from",
            "probability": 0.05619278536993269,
            "start_logit": 0.9739705324172974,
            "end_logit": 0.5684609413146973
        },
        {
            "text": "associated with adverse effects. New",
            "probability": 0.05606500910202655,
            "start_logit": 1.0056843757629395,
            "end_logit": 0.5344706177711487
        },
        {
            "text": "neuropathic, chemotherapy-induced neuropathic and inflammatory pain conditions. Administration of ethosuximi",
            "probability": 0.05590150630785338,
            "start_logit": 0.949629545211792,
            "end_logit": 0.5876048803329468
        },
        {
            "text": "idities as anxiety and depression are frequently encountered in chronic pain patients. Our results show that",
            "probability": 0.05344240552666437,
            "start_logit": 0.9964867830276489,
            "end_logit": 0.49576085805892944
        },
        {
            "text": "pain,",
            "probability": 0.05269767220305786,
            "start_logit": 0.8683803081512451,
            "end_logit": 0.6098340749740601
        }
    ],
    "55201a316b348bb82c000019": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55032efde9bde69634000035": [
        {
            "text": "xi",
            "probability": 0.05818053995947924,
            "start_logit": 0.8852165341377258,
            "end_logit": 0.8351051807403564
        },
        {
            "text": "dosing regimens used in clinical trials. In contrast, DILIsym predicted no hepatotoxi",
            "probability": 0.0560806638665304,
            "start_logit": 0.8484566807746887,
            "end_logit": 0.8351051807403564
        },
        {
            "text": "injury. A subsequent effort to identify novel CGRP receptor antagonists less likely to cause hepatotoxi",
            "probability": 0.05427762390046439,
            "start_logit": 0.8889650702476501,
            "end_logit": 0.761917769908905
        },
        {
            "text": "reactive metabolites",
            "probability": 0.05419887165195627,
            "start_logit": 1.0184407234191895,
            "end_logit": 0.6309901475906372
        },
        {
            "text": "7 at the dosing regimens used in clinical trials. In contrast, DILIsym predicted no hepatotoxi",
            "probability": 0.05302875425747046,
            "start_logit": 0.7924998998641968,
            "end_logit": 0.8351051807403564
        },
        {
            "text": "calcitonin gene-",
            "probability": 0.052417583093211345,
            "start_logit": 0.9351863265037537,
            "end_logit": 0.6808265447616577
        },
        {
            "text": "injury. A subsequent effort to identify novel CGRP receptor antagonists less likely to cause hepatotoxicity led to the",
            "probability": 0.051645169083182535,
            "start_logit": 0.8889650702476501,
            "end_logit": 0.7122023701667786
        },
        {
            "text": "modeled liver toxicity for telcagepant and MK-",
            "probability": 0.051406345770575367,
            "start_logit": 0.8616337776184082,
            "end_logit": 0.7348986268043518
        },
        {
            "text": "treatment of migraine. However, previously investigated CGRP receptor antagonists, telcagepant and MK-",
            "probability": 0.05123965003612548,
            "start_logit": 0.7973134517669678,
            "end_logit": 0.7959709763526917
        },
        {
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated therapeutic potential for the treatment of mig",
            "probability": 0.05118394873127102,
            "start_logit": 0.9351863265037537,
            "end_logit": 0.6570104360580444
        },
        {
            "text": "of ubrogepant. The",
            "probability": 0.05038380488176074,
            "start_logit": 0.974014401435852,
            "end_logit": 0.6024261713027954
        },
        {
            "text": "of bile acid homeostasis, and oxidative stress, along with estimates of dose-",
            "probability": 0.04990602866784726,
            "start_logit": 0.9268808960914612,
            "end_logit": 0.6400316953659058
        },
        {
            "text": "hepatotoxicity during treatment with ubrogepant, even at daily doses up to 1000\u2009mg (10-fold",
            "probability": 0.04788593859167197,
            "start_logit": 0.8852165341377258,
            "end_logit": 0.6403761506080627
        },
        {
            "text": "of bile acid homeostasis, and oxidative stress, along with estimates of",
            "probability": 0.04760179352190204,
            "start_logit": 0.9268808960914612,
            "end_logit": 0.5927603244781494
        },
        {
            "text": ") receptor antagonists have demonstrated therapeutic potential for the treatment of mig",
            "probability": 0.04634944886230909,
            "start_logit": 0.8359697461128235,
            "end_logit": 0.6570104360580444
        },
        {
            "text": "xicity during treatment with ubro",
            "probability": 0.04590578658208406,
            "start_logit": 0.8852165341377258,
            "end_logit": 0.5981454253196716
        },
        {
            "text": "incorporates quantitative assessments of mitochondrial dysfunction, disruption of bile acid homeostasis, and oxidative stress, along with estimates of dose-",
            "probability": 0.045790698841680556,
            "start_logit": 0.8408200740814209,
            "end_logit": 0.6400316953659058
        },
        {
            "text": "treatment of mig",
            "probability": 0.044591939179893514,
            "start_logit": 0.7973134517669678,
            "end_logit": 0.6570104360580444
        },
        {
            "text": "dosing regimens used in clinical trials. In contrast, DILIsym predicted no hepatotoxicity during treatment with ubro",
            "probability": 0.044248935960916454,
            "start_logit": 0.8484566807746887,
            "end_logit": 0.5981454253196716
        },
        {
            "text": "incorporates quantitative assessments of mitochondrial dysfunction, disruption of bile acid homeostasis, and oxidative stress, along with estimates of",
            "probability": 0.04367647455966768,
            "start_logit": 0.8408200740814209,
            "end_logit": 0.5927603244781494
        }
    ],
    "553656c4bc4f83e828000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56bdcc4cef6e394741000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56c1d856ef6e394741000032": [
        {
            "text": "associated serine proteases, but later, they were found to interact with ficolins, and later still, collectin-",
            "probability": 0.08740110563145616,
            "start_logit": 1.1576212644577026,
            "end_logit": 1.0528969764709473
        },
        {
            "text": "associated serine proteases, but later, they were found to interact with ficolins, and later still,",
            "probability": 0.07998215803330364,
            "start_logit": 1.1576212644577026,
            "end_logit": 0.9641926288604736
        },
        {
            "text": "), the group includes non-enzymatic factors (MAp19, MAp44). In this review, the association-",
            "probability": 0.07863808132688489,
            "start_logit": 1.1583272218704224,
            "end_logit": 0.9465391635894775
        },
        {
            "text": "), the group includes non-",
            "probability": 0.07378383910965305,
            "start_logit": 1.1583272218704224,
            "end_logit": 0.8828228116035461
        },
        {
            "text": "), the group includes non-enzymatic factors (MAp19, MAp44). In this review, the",
            "probability": 0.07367169105111555,
            "start_logit": 1.1583272218704224,
            "end_logit": 0.8813017010688782
        },
        {
            "text": "1, MASP-",
            "probability": 0.06626954017047085,
            "start_logit": 0.8534420132637024,
            "end_logit": 1.080298662185669
        },
        {
            "text": "-binding lectin-",
            "probability": 0.06620486725049518,
            "start_logit": 0.971520185470581,
            "end_logit": 0.9612441062927246
        },
        {
            "text": ") or lectin pathway (LP). The unique factors associated with the latter are collectins (mannose-",
            "probability": 0.05681827045945016,
            "start_logit": 0.9672654867172241,
            "end_logit": 0.8126027584075928
        },
        {
            "text": "ins (mannose-binding lectin, collectin-10, collectin-11",
            "probability": 0.056399936575448444,
            "start_logit": 0.9285324811935425,
            "end_logit": 0.8439458608627319
        },
        {
            "text": "ins (mannose-binding lectin, collectin-10, collectin-11), ficolins (ficolin-",
            "probability": 0.05563276780677613,
            "start_logit": 0.9285324811935425,
            "end_logit": 0.8302502036094666
        },
        {
            "text": "ins (mannose-",
            "probability": 0.05465960377107062,
            "start_logit": 0.9285324811935425,
            "end_logit": 0.8126027584075928
        },
        {
            "text": "1, MASP-2, MASP-3), the group includes non-",
            "probability": 0.054394036068899754,
            "start_logit": 0.8534420132637024,
            "end_logit": 0.8828228116035461
        },
        {
            "text": "-binding lectin-associated serine protease (MASP) family (MASP-",
            "probability": 0.05190405825882316,
            "start_logit": 0.971520185470581,
            "end_logit": 0.7178871035575867
        },
        {
            "text": "-binding lectin-associated serine protease (MASP) family (MASP-1, MASP-",
            "probability": 0.050889440474598584,
            "start_logit": 0.971520185470581,
            "end_logit": 0.6981455683708191
        },
        {
            "text": "ins are both pattern-rec",
            "probability": 0.048251544725278504,
            "start_logit": 0.820410966873169,
            "end_logit": 0.7960271835327148
        },
        {
            "text": "ins are both pattern-",
            "probability": 0.04509905928627535,
            "start_logit": 0.820410966873169,
            "end_logit": 0.7284607291221619
        }
    ],
    "56c1f01aef6e394741000043": [
        {
            "text": "clonal antibody targeting programmed cell death protein 1 (PD",
            "probability": 0.06297685807476126,
            "start_logit": 0.9469139575958252,
            "end_logit": 0.8442856073379517
        },
        {
            "text": "programmed cell death protein 1 (PD",
            "probability": 0.059960041888188924,
            "start_logit": 0.8978250026702881,
            "end_logit": 0.8442856073379517
        },
        {
            "text": "protein 1 (PD",
            "probability": 0.05867146146163483,
            "start_logit": 0.8761000633239746,
            "end_logit": 0.8442856073379517
        },
        {
            "text": "PD",
            "probability": 0.058124525187203756,
            "start_logit": 0.8667343258857727,
            "end_logit": 0.8442856073379517
        },
        {
            "text": "clonal antibody targeting programmed cell death protein 1 (PD-",
            "probability": 0.05213488860093436,
            "start_logit": 0.9469139575958252,
            "end_logit": 0.6553526520729065
        },
        {
            "text": "s potent antitumor immune responses, and antibodies blocking",
            "probability": 0.05037867443471089,
            "start_logit": 0.8314042687416077,
            "end_logit": 0.7365959286689758
        },
        {
            "text": "programmed cell death protein 1 (PD-",
            "probability": 0.04963744143344098,
            "start_logit": 0.8978250026702881,
            "end_logit": 0.6553526520729065
        },
        {
            "text": "protein 1 (PD-",
            "probability": 0.04857070042657793,
            "start_logit": 0.8761000633239746,
            "end_logit": 0.6553526520729065
        },
        {
            "text": "programmed cell death protein 1 (PD-1) found on T and pro-B cells. Pembrolizumab prevents PD-",
            "probability": 0.04839820833607206,
            "start_logit": 0.8978250026702881,
            "end_logit": 0.6300700306892395
        },
        {
            "text": "PD-",
            "probability": 0.04811792360329749,
            "start_logit": 0.8667343258857727,
            "end_logit": 0.6553526520729065
        },
        {
            "text": "clonal antibody targeting programmed cell",
            "probability": 0.04773409971904868,
            "start_logit": 0.9469139575958252,
            "end_logit": 0.5671643018722534
        },
        {
            "text": "PD-1) found on T and pro-B cells. Pembrolizumab prevents PD-1 ligation by both PD",
            "probability": 0.04766527625353644,
            "start_logit": 0.8667343258857727,
            "end_logit": 0.645901083946228
        },
        {
            "text": "clonal antibody targeting programmed cell death protein",
            "probability": 0.04751607555653183,
            "start_logit": 0.9469139575958252,
            "end_logit": 0.5625863671302795
        },
        {
            "text": "protein 1 (PD-1) found on T and pro-B cells. Pembrolizumab prevents PD-",
            "probability": 0.047358099257121686,
            "start_logit": 0.8761000633239746,
            "end_logit": 0.6300700306892395
        },
        {
            "text": "PD-1) found on T and pro-B cells. Pembrolizumab prevents PD-",
            "probability": 0.04691662632076465,
            "start_logit": 0.8667343258857727,
            "end_logit": 0.6300700306892395
        },
        {
            "text": "including pembrolizumab, have recently received Food and Drug Administration approval for the treatment of advanced melanoma, renal cell",
            "probability": 0.04621434445456082,
            "start_logit": 0.8700211048126221,
            "end_logit": 0.6117013692855835
        },
        {
            "text": "programmed cell",
            "probability": 0.045447466039849685,
            "start_logit": 0.8978250026702881,
            "end_logit": 0.5671643018722534
        },
        {
            "text": "programmed cell death protein",
            "probability": 0.045239886012569994,
            "start_logit": 0.8978250026702881,
            "end_logit": 0.5625863671302795
        },
        {
            "text": "s potent antitumor immune responses, and antibodies blocking PD",
            "probability": 0.04466975159790766,
            "start_logit": 0.8314042687416077,
            "end_logit": 0.6163245439529419
        },
        {
            "text": "protein",
            "probability": 0.04426765134128603,
            "start_logit": 0.8761000633239746,
            "end_logit": 0.5625863671302795
        }
    ],
    "52e8e93498d023950500001e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56bb68f9ac7ad1001900000b": [
        {
            "text": "% fluorescein solution",
            "probability": 0.09704218528713687,
            "start_logit": 1.2598552703857422,
            "end_logit": 0.7131244540214539
        },
        {
            "text": "% fluorescein solution over the eyelashes and eyebrows of both the",
            "probability": 0.08889272777609557,
            "start_logit": 1.2598552703857422,
            "end_logit": 0.6254090070724487
        },
        {
            "text": "% fluorescein solution over the",
            "probability": 0.08772442533710309,
            "start_logit": 1.2598552703857422,
            "end_logit": 0.6121790409088135
        },
        {
            "text": "% fluorescein solution over the eyelashes and eyebrows of both the eyes, followed by the mechanical removal of all parasites and trimming of the",
            "probability": 0.08576225381874124,
            "start_logit": 1.2598552703857422,
            "end_logit": 0.5895576477050781
        },
        {
            "text": "% fluorescein solution over the eyelashes and eyebrows of both the eyes, followed by the mechanical",
            "probability": 0.08482709945015961,
            "start_logit": 1.2598552703857422,
            "end_logit": 0.5785937309265137
        },
        {
            "text": "toparasite",
            "probability": 0.072582165075447,
            "start_logit": 1.1457114219665527,
            "end_logit": 0.5368417501449585
        },
        {
            "text": "toparasite Phthirus pubis, frequently misdiagnosed as allergic conjun",
            "probability": 0.06959180085385516,
            "start_logit": 1.1457114219665527,
            "end_logit": 0.49476927518844604
        },
        {
            "text": "fluorescein solution",
            "probability": 0.06607608022844716,
            "start_logit": 0.8755162954330444,
            "end_logit": 0.7131244540214539
        },
        {
            "text": "fluorescein solution over the eyelashes and eyebrows of both the",
            "probability": 0.06052710988400805,
            "start_logit": 0.8755162954330444,
            "end_logit": 0.6254090070724487
        },
        {
            "text": "fluorescein solution over the",
            "probability": 0.05973161207589974,
            "start_logit": 0.8755162954330444,
            "end_logit": 0.6121790409088135
        },
        {
            "text": "fluorescein solution over the eyelashes and eyebrows of both the eyes, followed by the mechanical removal of all parasites and trimming of the",
            "probability": 0.058395568351352276,
            "start_logit": 0.8755162954330444,
            "end_logit": 0.5895576477050781
        },
        {
            "text": "hthalmic ointment.",
            "probability": 0.05783245223418812,
            "start_logit": 0.8501710891723633,
            "end_logit": 0.605212926864624
        },
        {
            "text": "fluorescein solution over the eyelashes and eyebrows of both the eyes, followed by the mechanical",
            "probability": 0.05775882119956927,
            "start_logit": 0.8755162954330444,
            "end_logit": 0.5785937309265137
        },
        {
            "text": "hthalmic",
            "probability": 0.05325569842799692,
            "start_logit": 0.8501710891723633,
            "end_logit": 0.5227676630020142
        }
    ],
    "54f9ae2506d9727f76000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56c1f020ef6e394741000047": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5713c8d71174fb1755000015": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "51bdd9c2047fa84d1d000002": [
        {
            "text": "different ubiquitin receptors incited a debate over how pathway choice is achieved. Here, we",
            "probability": 0.0682042057075145,
            "start_logit": 0.9924735426902771,
            "end_logit": 0.9025629162788391
        },
        {
            "text": "artificial receptors harbouring identical",
            "probability": 0.06239321858180514,
            "start_logit": 1.0433412790298462,
            "end_logit": 0.7626455426216125
        },
        {
            "text": "somal degradation and selective autophagy are two branches of an adaptive protein quality control pathway, which uses substrate ubi",
            "probability": 0.059278428698318016,
            "start_logit": 0.9062528014183044,
            "end_logit": 0.8485229015350342
        },
        {
            "text": "bundling. Indeed, by using sets of modular artificial receptors harbouring identical",
            "probability": 0.05894798194022063,
            "start_logit": 0.9865400791168213,
            "end_logit": 0.7626455426216125
        },
        {
            "text": "artificial receptors harbouring identical ubiquitin-binding modules we found that proteasome/autophagy pathway choice",
            "probability": 0.05415962987646463,
            "start_logit": 1.0433412790298462,
            "end_logit": 0.6211247444152832
        },
        {
            "text": "artificial receptors harbouring identical ubiquitin-binding modules we found that proteasome/autophagy",
            "probability": 0.05394772904945081,
            "start_logit": 1.0433412790298462,
            "end_logit": 0.6172045469284058
        },
        {
            "text": "phagy pathway choice is independent of the ubiquitin-binding properties of the",
            "probability": 0.053945536098998804,
            "start_logit": 0.9901801347732544,
            "end_logit": 0.6703250408172607
        },
        {
            "text": "phagy pathway choice",
            "probability": 0.05135563412597135,
            "start_logit": 0.9901801347732544,
            "end_logit": 0.6211247444152832
        },
        {
            "text": "phagy",
            "probability": 0.051154703998347976,
            "start_logit": 0.9901801347732544,
            "end_logit": 0.6172045469284058
        },
        {
            "text": "artificial receptors harbouring identical ubiquitin-",
            "probability": 0.0498226728688204,
            "start_logit": 1.0433412790298462,
            "end_logit": 0.5376591086387634
        },
        {
            "text": "protein 8 (Atg8/LC3)-binding modules. Proteasome pathway receptors bind ubiquitin moieties more efficiently",
            "probability": 0.04811513825160493,
            "start_logit": 0.8322097063064575,
            "end_logit": 0.7139173746109009
        },
        {
            "text": "bundling. Indeed, by using sets of modular artificial receptors harbouring identical ubiquitin-",
            "probability": 0.04707155821163561,
            "start_logit": 0.9865400791168213,
            "end_logit": 0.5376591086387634
        },
        {
            "text": "receptors gain the upper hand following substrate aggregation and receptor bundling. Indeed, by using sets of modular artificial receptors harbouring identical",
            "probability": 0.045985274404373874,
            "start_logit": 0.7382059097290039,
            "end_logit": 0.7626455426216125
        },
        {
            "text": "bundling.",
            "probability": 0.045552941485971485,
            "start_logit": 0.9865400791168213,
            "end_logit": 0.5048653483390808
        },
        {
            "text": "phagy pathway choice is independent of the ubiquitin-",
            "probability": 0.04511437571081926,
            "start_logit": 0.9901801347732544,
            "end_logit": 0.4915510416030884
        },
        {
            "text": "bundling. Indeed,",
            "probability": 0.04496768899048211,
            "start_logit": 0.9865400791168213,
            "end_logit": 0.4919343590736389
        },
        {
            "text": "som",
            "probability": 0.0439000016855018,
            "start_logit": 0.9062528014183044,
            "end_logit": 0.5481917858123779
        },
        {
            "text": "protein 8 (Atg8/LC3)-",
            "probability": 0.03959790959649866,
            "start_logit": 0.8322097063064575,
            "end_logit": 0.519096851348877
        },
        {
            "text": "and are ca",
            "probability": 0.038691391095866126,
            "start_logit": 0.7761819958686829,
            "end_logit": 0.5519653558731079
        },
        {
            "text": "and are causative",
            "probability": 0.03779397962133394,
            "start_logit": 0.7761819958686829,
            "end_logit": 0.5284980535507202
        }
    ],
    "52f509512059c6d71c000020": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "57279ef20fd6f91b68000018": [
        {
            "text": "regulate retrograde IFT in the cilium. As a core protein of IFT complex A, IFT140 has been",
            "probability": 0.0988507901735853,
            "start_logit": 1.135029911994934,
            "end_logit": 0.7232849597930908
        },
        {
            "text": "ies caused in humans. However, the effects and mechanisms",
            "probability": 0.08882649590897153,
            "start_logit": 0.9360721707344055,
            "end_logit": 0.8153161406517029
        },
        {
            "text": "further investigate the potential role of IFT140 in osteogenesis,",
            "probability": 0.08772862433020845,
            "start_logit": 0.998429000377655,
            "end_logit": 0.740522563457489
        },
        {
            "text": "regulate retrograde IFT in the cilium. As a core protein",
            "probability": 0.08419109886935273,
            "start_logit": 1.135029911994934,
            "end_logit": 0.5627626180648804
        },
        {
            "text": "regulate retrograde IFT in the cilium.",
            "probability": 0.07625418026130457,
            "start_logit": 1.135029911994934,
            "end_logit": 0.463745653629303
        },
        {
            "text": "further investigate the potential role of IFT140 in osteogenesis, we established a mouse model by conditional del",
            "probability": 0.0695501758804709,
            "start_logit": 0.998429000377655,
            "end_logit": 0.5083227753639221
        },
        {
            "text": "further investigate the",
            "probability": 0.06727399761094373,
            "start_logit": 0.998429000377655,
            "end_logit": 0.47504812479019165
        },
        {
            "text": "further investigate the potential role of IFT140 in osteogenesis, we established",
            "probability": 0.06454095546363936,
            "start_logit": 0.998429000377655,
            "end_logit": 0.4335743188858032
        },
        {
            "text": "Ift140 is essential",
            "probability": 0.06376694975085496,
            "start_logit": 1.0081183910369873,
            "end_logit": 0.4118199646472931
        },
        {
            "text": "ies caused in humans. However, the",
            "probability": 0.06372222235173176,
            "start_logit": 0.9360721707344055,
            "end_logit": 0.483164519071579
        },
        {
            "text": "ies caused in humans. However, the effects and mechanisms of IFT140 in bone formation have not been systematically disclosed. To further investigate the",
            "probability": 0.06320712088167789,
            "start_logit": 0.9360721707344055,
            "end_logit": 0.47504812479019165
        },
        {
            "text": "model by conditional del",
            "probability": 0.059319944999624286,
            "start_logit": 0.8393261432647705,
            "end_logit": 0.5083227753639221
        },
        {
            "text": "model by conditional deletion of IFT140 in pre-osteoblasts. The adult knock-",
            "probability": 0.058198953017813713,
            "start_logit": 0.8393261432647705,
            "end_logit": 0.4892445504665375
        },
        {
            "text": "model by conditional deletion of IFT140 in pre-osteoblasts. The adult knock-out mice exhibited dwarf ph",
            "probability": 0.054568490499820876,
            "start_logit": 0.8393261432647705,
            "end_logit": 0.4248338043689728
        }
    ],
    "5353aedb288f4dae47000006": [
        {
            "text": "depends on its transcription level that can be regulated by temperature using the GAL4 transcription activator and its temperature",
            "probability": 0.06115679614579603,
            "start_logit": 0.9887649416923523,
            "end_logit": 0.8929183483123779
        },
        {
            "text": "romatic compartment of the nucleus. Previously, we have shown that the degree of trans-ina",
            "probability": 0.060534993315182875,
            "start_logit": 0.999116063117981,
            "end_logit": 0.8723478317260742
        },
        {
            "text": "GFP reporter gene in adult flies depends on its transcription level that can be regulated by temperature using the GAL4 transcription activator and its temperature",
            "probability": 0.06039929815089391,
            "start_logit": 0.9763014316558838,
            "end_logit": 0.8929183483123779
        },
        {
            "text": "romatic compartment of the nucleus. Previously, we have shown that the degree of trans-inact",
            "probability": 0.05906982486402996,
            "start_logit": 0.999116063117981,
            "end_logit": 0.8478464484214783
        },
        {
            "text": "some cases",
            "probability": 0.05849728138040035,
            "start_logit": 1.1065610647201538,
            "end_logit": 0.7306615114212036
        },
        {
            "text": "romatic compartment of the nucleus. Previously, we have shown that the degree of trans-",
            "probability": 0.058067969933455685,
            "start_logit": 0.999116063117981,
            "end_logit": 0.8307404518127441
        },
        {
            "text": "romatic compartment of the nucleus. Previously, we have shown that the degree of trans-inactivation of the",
            "probability": 0.057156653361879986,
            "start_logit": 0.999116063117981,
            "end_logit": 0.814922034740448
        },
        {
            "text": "be regulated by temperature using the GAL4 transcription activator and its temperature",
            "probability": 0.05588027656430861,
            "start_logit": 0.898535430431366,
            "end_logit": 0.8929183483123779
        },
        {
            "text": "some cases, gene transfer from euchromatin to constitutive",
            "probability": 0.04925074234679103,
            "start_logit": 1.1065610647201538,
            "end_logit": 0.5586056709289551
        },
        {
            "text": "depends on its transcription level that can be regulated by temperature using the GAL4 transcription activator and its",
            "probability": 0.04582629049270618,
            "start_logit": 0.9887649416923523,
            "end_logit": 0.6043353080749512
        },
        {
            "text": "GFP reporter gene in adult flies depends on its transcription level that can be regulated by temperature using the GAL4 transcription activator and its",
            "probability": 0.045258678626982025,
            "start_logit": 0.9763014316558838,
            "end_logit": 0.6043353080749512
        },
        {
            "text": "tutive heterochromatin as a result of chromosomal rearrangement is accompanied by epigenetic inactivation of this",
            "probability": 0.04471552465131545,
            "start_logit": 0.9321421384811401,
            "end_logit": 0.6364209055900574
        },
        {
            "text": "depends on its transcription level that can be regulated by temperature using the GAL4 transcription activator",
            "probability": 0.04467595516722985,
            "start_logit": 0.9887649416923523,
            "end_logit": 0.5789127945899963
        },
        {
            "text": "inactivation, transgenes in the normal chromosome are repressed by the",
            "probability": 0.04458044617851683,
            "start_logit": 0.8960819244384766,
            "end_logit": 0.6694557070732117
        },
        {
            "text": "GFP reporter gene in adult flies depends on its transcription level that can be regulated by temperature using the GAL4 transcription activator",
            "probability": 0.044122591541397735,
            "start_logit": 0.9763014316558838,
            "end_logit": 0.5789127945899963
        },
        {
            "text": "constitutive heterochromatin as a result of chromosomal rearrangement is accompanied by epigenetic inactivation of this",
            "probability": 0.04333343375290856,
            "start_logit": 0.9007458686828613,
            "end_logit": 0.6364209055900574
        },
        {
            "text": "romatic compartment of the nucleus. Previously, we",
            "probability": 0.04255562307743513,
            "start_logit": 0.999116063117981,
            "end_logit": 0.5199382305145264
        },
        {
            "text": "be regulated by temperature using the GAL4 transcription activator and its",
            "probability": 0.04187246468150373,
            "start_logit": 0.898535430431366,
            "end_logit": 0.6043353080749512
        },
        {
            "text": "euchromatin to constitutive",
            "probability": 0.04167724350030923,
            "start_logit": 0.9395918846130371,
            "end_logit": 0.5586056709289551
        },
        {
            "text": "tutive",
            "probability": 0.04136791226695681,
            "start_logit": 0.9321421384811401,
            "end_logit": 0.5586056709289551
        }
    ],
    "56c83f365795f9a73e000011": [
        {
            "text": "we present the current structural understanding of RNA-",
            "probability": 0.08435482788191806,
            "start_logit": 0.998487114906311,
            "end_logit": 0.7385073900222778
        },
        {
            "text": "present the current structural understanding of RNA-",
            "probability": 0.08151808830530285,
            "start_logit": 0.9642800092697144,
            "end_logit": 0.7385073900222778
        },
        {
            "text": "we present the current structural understanding of RNA-binding and self-association mechanisms. Both globular and intrinsically disorder",
            "probability": 0.07990887683570772,
            "start_logit": 0.998487114906311,
            "end_logit": 0.6843622922897339
        },
        {
            "text": "pre-mRNA splicing,",
            "probability": 0.07878147763676109,
            "start_logit": 1.0984984636306763,
            "end_logit": 0.5701419115066528
        },
        {
            "text": "present the current structural understanding of RNA-binding and self-association mechanisms. Both globular and intrinsically disorder",
            "probability": 0.07722164862204774,
            "start_logit": 0.9642800092697144,
            "end_logit": 0.6843622922897339
        },
        {
            "text": "ities, affinities and kinetics. Self-",
            "probability": 0.07398746050906686,
            "start_logit": 0.7956656217575073,
            "end_logit": 0.8101924657821655
        },
        {
            "text": "play essential roles in pre-mRNA splicing,",
            "probability": 0.07342403472371273,
            "start_logit": 1.0280718803405762,
            "end_logit": 0.5701419115066528
        },
        {
            "text": "splicing,",
            "probability": 0.07188267641308856,
            "start_logit": 1.006855845451355,
            "end_logit": 0.5701419115066528
        },
        {
            "text": "we present the current structural understanding of RNA-binding and self-association mechanisms. Both globular",
            "probability": 0.07061189436505973,
            "start_logit": 0.998487114906311,
            "end_logit": 0.5606739521026611
        },
        {
            "text": "present the current structural understanding of RNA-binding and self-association mechanisms. Both globular",
            "probability": 0.06823731118642373,
            "start_logit": 0.9642800092697144,
            "end_logit": 0.5606739521026611
        },
        {
            "text": "ities, affinities and kinetics. Self-ass",
            "probability": 0.06322110897554632,
            "start_logit": 0.7956656217575073,
            "end_logit": 0.6529350876808167
        },
        {
            "text": "ities, affinities",
            "probability": 0.06290591266241936,
            "start_logit": 0.7956656217575073,
            "end_logit": 0.647936999797821
        },
        {
            "text": "ities, affinities and kinetics.",
            "probability": 0.05787312665271137,
            "start_logit": 0.7956656217575073,
            "end_logit": 0.56454998254776
        },
        {
            "text": "ities, affinities and kinetics. Self-associating Prion-like",
            "probability": 0.05607155523023397,
            "start_logit": 0.7956656217575073,
            "end_logit": 0.5329254865646362
        }
    ],
    "56d042ae3975bb303a00000d": [
        {
            "text": "ceritinib, and alectinib",
            "probability": 0.06576920672646017,
            "start_logit": 0.9365926384925842,
            "end_logit": 0.5518850088119507
        },
        {
            "text": "improved survival in patients with anaplastic lymphoma kinase (ALK) arrangement non-small-",
            "probability": 0.06561551871845106,
            "start_logit": 0.9999450445175171,
            "end_logit": 0.48619309067726135
        },
        {
            "text": "improved survival in patients with anaplastic lymphoma kinase (ALK) arrangement non-small-cell lung cancer (NSCL",
            "probability": 0.06162883572279669,
            "start_logit": 0.9999450445175171,
            "end_logit": 0.42351073026657104
        },
        {
            "text": "improved survival in patients with anaplastic lymphoma kinase (ALK) arrangement non-",
            "probability": 0.058057819268557395,
            "start_logit": 0.9999450445175171,
            "end_logit": 0.36382025480270386
        },
        {
            "text": "ceritinib, and alectinib improved survival in patients with anaplastic lymphoma kinase (ALK) arrangement non-",
            "probability": 0.054493803170086126,
            "start_logit": 0.9365926384925842,
            "end_logit": 0.36382025480270386
        },
        {
            "text": "improved survival in patients with",
            "probability": 0.05425576743661331,
            "start_logit": 0.9999450445175171,
            "end_logit": 0.29609015583992004
        },
        {
            "text": "improved survival in patients with anaplastic l",
            "probability": 0.054117341170827823,
            "start_logit": 0.9999450445175171,
            "end_logit": 0.2935355305671692
        },
        {
            "text": "improved survival in patients with anaplastic lymph",
            "probability": 0.05384222441274982,
            "start_logit": 0.9999450445175171,
            "end_logit": 0.2884388566017151
        },
        {
            "text": "ce",
            "probability": 0.05336852401735757,
            "start_logit": 0.9365926384925842,
            "end_logit": 0.3429543972015381
        },
        {
            "text": "ceritinib, and alectinib improved survival in patients with",
            "probability": 0.05092514925261744,
            "start_logit": 0.9365926384925842,
            "end_logit": 0.29609015583992004
        },
        {
            "text": "ceritinib, and alectinib improved survival in patients with anaplastic l",
            "probability": 0.05079522060947652,
            "start_logit": 0.9365926384925842,
            "end_logit": 0.2935355305671692
        },
        {
            "text": "ceritinib, and alectinib improved survival in patients with anaplastic lymph",
            "probability": 0.050536992542139954,
            "start_logit": 0.9365926384925842,
            "end_logit": 0.2884388566017151
        },
        {
            "text": "improved survival in patients with anaplastic lymphoma kinase (ALK) arrangement non-small-cell",
            "probability": 0.04989024273170126,
            "start_logit": 0.9999450445175171,
            "end_logit": 0.21220630407333374
        },
        {
            "text": "improved survival in patients with anaplastic lymphoma kinase (AL",
            "probability": 0.048067090654810206,
            "start_logit": 0.9999450445175171,
            "end_logit": 0.1749786138534546
        },
        {
            "text": "improved survival in patients",
            "probability": 0.04804512382312619,
            "start_logit": 0.9999450445175171,
            "end_logit": 0.17452150583267212
        },
        {
            "text": "ceritini",
            "probability": 0.04683241916807264,
            "start_logit": 0.9365926384925842,
            "end_logit": 0.21230894327163696
        },
        {
            "text": "ceritinib, and alectinib improved survival in patients with anaplastic lymphoma kinase (AL",
            "probability": 0.04511637898395006,
            "start_logit": 0.9365926384925842,
            "end_logit": 0.1749786138534546
        },
        {
            "text": "ceritinib, and alectinib improved survival in patients",
            "probability": 0.045095760638012496,
            "start_logit": 0.9365926384925842,
            "end_logit": 0.17452150583267212
        },
        {
            "text": "cerit",
            "probability": 0.04354658095219328,
            "start_logit": 0.9365926384925842,
            "end_logit": 0.13956445455551147
        }
    ],
    "52bf1f1303868f1b06000014": [
        {
            "text": "flammation are closely related to the",
            "probability": 0.1741882623043885,
            "start_logit": 1.106558918952942,
            "end_logit": 0.537321150302887
        },
        {
            "text": "flammation are closely related to the pathological processes of neurological disorders. Peroxiredoxin 2",
            "probability": 0.1545849264236189,
            "start_logit": 1.106558918952942,
            "end_logit": 0.4179280996322632
        },
        {
            "text": "flammation are closely related to the pathological processes of neurological disorders",
            "probability": 0.13999190907274206,
            "start_logit": 1.106558918952942,
            "end_logit": 0.31876909732818604
        },
        {
            "text": "flammation are closely related to the pathological processes of neurological",
            "probability": 0.13940447648374643,
            "start_logit": 1.106558918952942,
            "end_logit": 0.3145640790462494
        },
        {
            "text": "flammation are closely related to the pathological processes of neurological disorders. Peroxiredoxin 2 (Prdx2) is an",
            "probability": 0.13520461325371688,
            "start_logit": 1.106558918952942,
            "end_logit": 0.283973753452301
        },
        {
            "text": "flammation are closely related to the pathological processes of neurological disorders. Peroxired",
            "probability": 0.1327038610635752,
            "start_logit": 1.106558918952942,
            "end_logit": 0.2653045058250427
        },
        {
            "text": "flammation",
            "probability": 0.12392195139821201,
            "start_logit": 1.106558918952942,
            "end_logit": 0.1968364119529724
        }
    ],
    "550f0e4c6a8cde6b72000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5319ac36b166e2b806000031": [
        {
            "text": "ia formation was suppressed by WT Hic-5. This effect required localization to focal adhesions as well as",
            "probability": 0.06605464861360298,
            "start_logit": 1.208570957183838,
            "end_logit": 0.9001784920692444
        },
        {
            "text": "ia formation was suppressed by WT Hic-",
            "probability": 0.061165947961744675,
            "start_logit": 1.208570957183838,
            "end_logit": 0.8232867121696472
        },
        {
            "text": "hesions as well as",
            "probability": 0.056162152983709586,
            "start_logit": 1.0463316440582275,
            "end_logit": 0.9001784920692444
        },
        {
            "text": "ia formation was suppressed by WT Hic-5. This",
            "probability": 0.0544646641707267,
            "start_logit": 1.208570957183838,
            "end_logit": 0.7072482109069824
        },
        {
            "text": "-",
            "probability": 0.05329527892893937,
            "start_logit": 0.9170423746109009,
            "end_logit": 0.9770724177360535
        },
        {
            "text": "determined that EGF",
            "probability": 0.05166493787251511,
            "start_logit": 0.9581643342971802,
            "end_logit": 0.9048820734024048
        },
        {
            "text": "-induced lamellipodia were Rac-",
            "probability": 0.05113342121389869,
            "start_logit": 0.8756329417228699,
            "end_logit": 0.9770724177360535
        },
        {
            "text": "indicating that this effect is specific to Hic-5. The EGF-induced lamellipodia were Rac-",
            "probability": 0.0500211687664521,
            "start_logit": 0.8536409139633179,
            "end_logit": 0.9770724177360535
        },
        {
            "text": "c-5. This effect required localization to focal adhesions as well as",
            "probability": 0.049964457145516575,
            "start_logit": 0.9294004440307617,
            "end_logit": 0.9001784920692444
        },
        {
            "text": "is specific to Hic-5. The EGF-induced lamellipodia were Rac-",
            "probability": 0.0499553360158368,
            "start_logit": 0.8523239493370056,
            "end_logit": 0.9770724177360535
        },
        {
            "text": "determined that EGF-induced lamellipodia formation was suppressed by WT Hic-",
            "probability": 0.04761672218382424,
            "start_logit": 0.9581643342971802,
            "end_logit": 0.8232867121696472
        },
        {
            "text": "osphorylated on residues 38 and 60",
            "probability": 0.04746517243975443,
            "start_logit": 1.0890638828277588,
            "end_logit": 0.6891993880271912
        },
        {
            "text": "osphorylated on residues 38 and 60 following epidermal growth factor (EGF) treatment of COS-",
            "probability": 0.0472276790766357,
            "start_logit": 1.0890638828277588,
            "end_logit": 0.6841832995414734
        },
        {
            "text": "GF) treatment of COS-7 cells, coincident with an increase in peripheral actin reorganization. To explore the role of Hic-",
            "probability": 0.04704163789835643,
            "start_logit": 0.9373997449874878,
            "end_logit": 0.831900417804718
        },
        {
            "text": "c-",
            "probability": 0.04626659061615423,
            "start_logit": 0.9294004440307617,
            "end_logit": 0.8232867121696472
        },
        {
            "text": "determined that EGF-induced",
            "probability": 0.046152661463469996,
            "start_logit": 0.9581643342971802,
            "end_logit": 0.7920573353767395
        },
        {
            "text": "hesions as well as phosphorylation of Hic-",
            "probability": 0.04554755336462892,
            "start_logit": 1.0463316440582275,
            "end_logit": 0.6906923055648804
        },
        {
            "text": "is unclear. Herein, we show that Hic-5 is tyrosine-",
            "probability": 0.04468188433700341,
            "start_logit": 0.8073126077651978,
            "end_logit": 0.9105225801467896
        },
        {
            "text": "determined that EGF-induced lamellipodia formation was suppressed by WT Hic-5. This",
            "probability": 0.0423998788390364,
            "start_logit": 0.9581643342971802,
            "end_logit": 0.7072482109069824
        },
        {
            "text": "indicating that this effect is specific to Hic-5. The EGF-",
            "probability": 0.041718206108193795,
            "start_logit": 0.8536409139633179,
            "end_logit": 0.7955637574195862
        }
    ],
    "52bf217003868f1b0600001b": [
        {
            "text": "vertebrates",
            "probability": 0.06329536181174251,
            "start_logit": 0.9113550186157227,
            "end_logit": 0.9517817497253418
        },
        {
            "text": "colocalized in specific nuclei; (b) in course of aging, HCRT and NPY expressing neurons are localized",
            "probability": 0.060663933596299936,
            "start_logit": 1.0694154500961304,
            "end_logit": 0.7512586116790771
        },
        {
            "text": "short-lived vertebrate model Nothobranchius furzer",
            "probability": 0.05815151106646885,
            "start_logit": 0.8928449153900146,
            "end_logit": 0.8855316638946533
        },
        {
            "text": "changes in expression and distribution of orexin A (its",
            "probability": 0.05509277185612878,
            "start_logit": 1.0471270084381104,
            "end_logit": 0.6772162318229675
        },
        {
            "text": "colocalized in specific",
            "probability": 0.05480734505900691,
            "start_logit": 1.0694154500961304,
            "end_logit": 0.6497334837913513
        },
        {
            "text": "short-lived vertebrate model",
            "probability": 0.054398888233404205,
            "start_logit": 0.8928449153900146,
            "end_logit": 0.818823516368866
        },
        {
            "text": "short-lived vertebrate model Nothobranchius furzeri. Our experiments, conducted on",
            "probability": 0.05235047171853038,
            "start_logit": 0.8928449153900146,
            "end_logit": 0.7804407477378845
        },
        {
            "text": "is also known as hypocretin-HCRT) and NPY, and their regulation by food intake in the short-",
            "probability": 0.05084186661396625,
            "start_logit": 0.9752550721168518,
            "end_logit": 0.668789803981781
        },
        {
            "text": "phalon; (c) HCRT expressing neurons increased slightly in the dience",
            "probability": 0.0488092521286291,
            "start_logit": 1.029829502105713,
            "end_logit": 0.5734151005744934
        },
        {
            "text": "changes in expression and distribution of orexin",
            "probability": 0.048800862549272246,
            "start_logit": 1.0471270084381104,
            "end_logit": 0.5559456944465637
        },
        {
            "text": "projecting through the entire neuroaxis, and are colocalized in specific",
            "probability": 0.04873865480907092,
            "start_logit": 0.9520636796951294,
            "end_logit": 0.6497334837913513
        },
        {
            "text": "phalon; (c) HCRT expressing neurons increased slightly in the die",
            "probability": 0.04752105894473113,
            "start_logit": 1.029829502105713,
            "end_logit": 0.5466681718826294
        },
        {
            "text": "short-",
            "probability": 0.04681997857129898,
            "start_logit": 0.8928449153900146,
            "end_logit": 0.668789803981781
        },
        {
            "text": "lon; (c) HCRT expressing neurons increased slightly in the dience",
            "probability": 0.04632312836143504,
            "start_logit": 0.9775509834289551,
            "end_logit": 0.5734151005744934
        },
        {
            "text": "NPY) are two hypothalamic neuropeptides involved in the regulation of feeding behavior and food intake in all",
            "probability": 0.04556061155713787,
            "start_logit": 0.9162707328796387,
            "end_logit": 0.6180975437164307
        },
        {
            "text": "lon; (c) HCRT expressing neurons increased slightly in the die",
            "probability": 0.04510054994423717,
            "start_logit": 0.9775509834289551,
            "end_logit": 0.5466681718826294
        },
        {
            "text": "Accumulating evidences document that they undergo age-",
            "probability": 0.043567853528705916,
            "start_logit": 0.905381977558136,
            "end_logit": 0.5842623114585876
        },
        {
            "text": "through the entire neuroaxis, and are colocalized in specific",
            "probability": 0.04315138541376871,
            "start_logit": 0.8303057551383972,
            "end_logit": 0.6497334837913513
        },
        {
            "text": "central NPY levels are augmented in course of aging, and regulated by food intake only in young",
            "probability": 0.04313138999708026,
            "start_logit": 0.929912805557251,
            "end_logit": 0.5496629476547241
        },
        {
            "text": "vertebrates', demonstrating an uncommon and unprecedented described regulation of these two orexigenic",
            "probability": 0.042873124239084744,
            "start_logit": 0.9113550186157227,
            "end_logit": 0.5622148513793945
        }
    ],
    "54f2228e64850a5854000002": [
        {
            "text": "LRLRGG tag from a gluC-digested protein.A ubiquitinated peptide has two N-",
            "probability": 0.06765647351048937,
            "start_logit": 0.9770185947418213,
            "end_logit": 0.9676957130432129
        },
        {
            "text": "-",
            "probability": 0.06051986308965961,
            "start_logit": 0.8655471801757812,
            "end_logit": 0.9676957130432129
        },
        {
            "text": "is the one that includes fragments containing portions of the ubiquitin side chain,",
            "probability": 0.05895523488391301,
            "start_logit": 1.2010045051574707,
            "end_logit": 0.6060451865196228
        },
        {
            "text": "ubiquitinated peptide has two N-",
            "probability": 0.05416296188839358,
            "start_logit": 0.754572868347168,
            "end_logit": 0.9676957130432129
        },
        {
            "text": "ted peptide has two N-",
            "probability": 0.05389056828481214,
            "start_logit": 0.7495310306549072,
            "end_logit": 0.9676957130432129
        },
        {
            "text": "involving any part of the \"normal\" peptide will vary in mass according to the peptide being modified and will therefore not be of general diagnostic use. These",
            "probability": 0.05284651046730661,
            "start_logit": 1.0626378059387207,
            "end_logit": 0.635025143623352
        },
        {
            "text": "involving any part of the \"normal\" peptide will vary in mass according to the peptide being modified and will therefore not be of general diagnostic",
            "probability": 0.05191241818381861,
            "start_logit": 1.0626378059387207,
            "end_logit": 0.6171914935112
        },
        {
            "text": "involving any part of the \"normal\" peptide will vary in mass according to the peptide being modified and will therefore not be of general diagnostic use.",
            "probability": 0.05173771603300888,
            "start_logit": 1.0626378059387207,
            "end_logit": 0.613820493221283
        },
        {
            "text": "LRLRGG tag from a gluC-digested protein.A ubiquitinated peptide",
            "probability": 0.04982070739806587,
            "start_logit": 0.9770185947418213,
            "end_logit": 0.6616833806037903
        },
        {
            "text": "LRLRGG tag from a gluC-digested protein.A ubiquitinated peptide has two N-termini-",
            "probability": 0.04963204799257179,
            "start_logit": 0.9770185947418213,
            "end_logit": 0.6578894257545471
        },
        {
            "text": ". Thus, it is",
            "probability": 0.04851547406911319,
            "start_logit": 0.9583467841148376,
            "end_logit": 0.6538072824478149
        },
        {
            "text": "be used to distinguish",
            "probability": 0.048248018869791104,
            "start_logit": 0.9741597175598145,
            "end_logit": 0.6324663162231445
        },
        {
            "text": "portions of this side chain",
            "probability": 0.04801361663325809,
            "start_logit": 0.7875721454620361,
            "end_logit": 0.81418377161026
        },
        {
            "text": "LRLRGG tag from a gluC-digested protein",
            "probability": 0.04771238444164485,
            "start_logit": 0.9770185947418213,
            "end_logit": 0.6184436678886414
        },
        {
            "text": "LRLRGG tag from a gluC-",
            "probability": 0.04528819529684947,
            "start_logit": 0.9770185947418213,
            "end_logit": 0.5662990808486938
        },
        {
            "text": "-termini-",
            "probability": 0.04439670874811657,
            "start_logit": 0.8655471801757812,
            "end_logit": 0.6578894257545471
        },
        {
            "text": "-termini-one from the original peptide and the other from the ubiquitin side chain. Thus, it is",
            "probability": 0.04421584442885324,
            "start_logit": 0.8655471801757812,
            "end_logit": 0.6538072824478149
        },
        {
            "text": "termini-",
            "probability": 0.040939798765672546,
            "start_logit": 0.7844845056533813,
            "end_logit": 0.6578894257545471
        },
        {
            "text": "termini-one from the original peptide and the other from the ubiquitin side chain. Thus, it is",
            "probability": 0.04077301728471772,
            "start_logit": 0.7844845056533813,
            "end_logit": 0.6538072824478149
        },
        {
            "text": "-termini-one from the original peptide and the other from",
            "probability": 0.040762439729943624,
            "start_logit": 0.8655471801757812,
            "end_logit": 0.5724851489067078
        }
    ],
    "5323640b9b2d7acc7e000014": [
        {
            "text": "ncephalopathy (CADASIL) is an autosomal-dominant, inherited, systemic, vascular disorder primarily involving the",
            "probability": 0.07060877219160588,
            "start_logit": 1.00600266456604,
            "end_logit": 0.7517132759094238
        },
        {
            "text": ") are 2 genetic causes for CADASIL. The NOTCH3 gene, located on",
            "probability": 0.06686594606841172,
            "start_logit": 1.0060161352157593,
            "end_logit": 0.6972352266311646
        },
        {
            "text": "ncephalopathy (CADASIL) is an autosomal-dominant, inherited, systemic, vascular",
            "probability": 0.06608871075332141,
            "start_logit": 1.00600266456604,
            "end_logit": 0.6855568289756775
        },
        {
            "text": "1) are 2 genetic causes for CADASIL. The NOTCH3 gene, located on",
            "probability": 0.06177242440436916,
            "start_logit": 0.9267833828926086,
            "end_logit": 0.6972352266311646
        },
        {
            "text": ") are 2 genetic causes for CADASIL. The NOTCH3 gene, located on chromosome 19p13.12, is the most common disease-",
            "probability": 0.059506119970538084,
            "start_logit": 1.0060161352157593,
            "end_logit": 0.5806245803833008
        },
        {
            "text": ") are 2 genetic causes",
            "probability": 0.056914069251376466,
            "start_logit": 1.0060161352157593,
            "end_logit": 0.5360879898071289
        },
        {
            "text": "1) are 2 genetic causes",
            "probability": 0.05257863302762052,
            "start_logit": 0.9267833828926086,
            "end_logit": 0.5360879898071289
        },
        {
            "text": "ncephalopathy (CADASIL) is an autosomal-",
            "probability": 0.051037468533939354,
            "start_logit": 1.00600266456604,
            "end_logit": 0.4271189272403717
        },
        {
            "text": ") are 2 genetic causes for CADASIL. The NOTCH3 gene, located on chromosome 19",
            "probability": 0.04961019245346706,
            "start_logit": 1.0060161352157593,
            "end_logit": 0.3987417221069336
        },
        {
            "text": "ncephalopathy (CADASIL) is an autosomal-dominant, inherited, systemic, vascular disorder",
            "probability": 0.04878985699045862,
            "start_logit": 1.00600266456604,
            "end_logit": 0.3820813298225403
        },
        {
            "text": ") are 2 genetic causes for CADASIL. The NOTCH3 gene, located on chromosome 19p13.12, is the",
            "probability": 0.04865535398114035,
            "start_logit": 1.0060161352157593,
            "end_logit": 0.37930727005004883
        },
        {
            "text": ") are 2 genetic causes for CADASIL.",
            "probability": 0.04837542251847344,
            "start_logit": 1.0060161352157593,
            "end_logit": 0.3735373020172119
        },
        {
            "text": ") are 2 genetic causes for CADASIL. The NOTCH3 gene,",
            "probability": 0.04822413547174829,
            "start_logit": 1.0060161352157593,
            "end_logit": 0.37040504813194275
        },
        {
            "text": ") are 2 genetic causes for CADASIL. The NOTCH3 gene, located on chromosome 19p",
            "probability": 0.04727647736337796,
            "start_logit": 1.0060161352157593,
            "end_logit": 0.3505582809448242
        },
        {
            "text": "1) are 2 genetic causes for CADASIL. The NOTCH3 gene, located on chromosome 19",
            "probability": 0.04583112994292511,
            "start_logit": 0.9267833828926086,
            "end_logit": 0.3987417221069336
        },
        {
            "text": "1) are 2 genetic causes for CADASIL. The NOTCH3 gene, located on chromosome 19p13.12, is the",
            "probability": 0.044949026408641166,
            "start_logit": 0.9267833828926086,
            "end_logit": 0.37930727005004883
        },
        {
            "text": "1) are 2 genetic causes for CADASIL.",
            "probability": 0.04469041875956514,
            "start_logit": 0.9267833828926086,
            "end_logit": 0.3735373020172119
        },
        {
            "text": "1) are 2 genetic causes for CADASIL. The NOTCH3 gene,",
            "probability": 0.04455065602222755,
            "start_logit": 0.9267833828926086,
            "end_logit": 0.37040504813194275
        },
        {
            "text": "1) are 2 genetic causes for CADASIL. The NOTCH3 gene, located on chromosome 19p",
            "probability": 0.04367518588679267,
            "start_logit": 0.9267833828926086,
            "end_logit": 0.3505582809448242
        }
    ],
    "52bf1d2e03868f1b0600000c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56bc77a3ac7ad10019000015": [
        {
            "text": "is highly appealing as a pragmatic and powerful",
            "probability": 0.0903859232811116,
            "start_logit": 1.1585063934326172,
            "end_logit": 1.2215001583099365
        },
        {
            "text": "prevent malaria disease as well as",
            "probability": 0.06613879523202289,
            "start_logit": 1.3574700355529785,
            "end_logit": 0.7102034687995911
        },
        {
            "text": "prevent malaria disease as well as transmission by preventing blood stage infection and therefore gametocytogenesis.",
            "probability": 0.06077268935547419,
            "start_logit": 1.3574700355529785,
            "end_logit": 0.6255884766578674
        },
        {
            "text": "be translatable to human vaccination this could greatly aid efforts to eliminate and eventually eradicate",
            "probability": 0.05500889421732012,
            "start_logit": 0.9055861830711365,
            "end_logit": 0.977826714515686
        },
        {
            "text": "showed no reduction in biological activity against parasites of both lifecycle stages. Should this findings be translatable to human vaccination this",
            "probability": 0.052621235952805996,
            "start_logit": 1.1379166841506958,
            "end_logit": 0.7011210918426514
        },
        {
            "text": "showed no reduction in biological activity against parasites of both lifecycle stages. Should this findings be translatable to human va",
            "probability": 0.051607767728312416,
            "start_logit": 1.1379166841506958,
            "end_logit": 0.681673526763916
        },
        {
            "text": "ergise in eliminating malaria from a population over multiple generations. Hence, the combination of RTS,S/AS01 with a transmission blocking",
            "probability": 0.050376224294363135,
            "start_logit": 1.1080524921417236,
            "end_logit": 0.687384843826294
        },
        {
            "text": "ocytic and the",
            "probability": 0.04699352458148079,
            "start_logit": 0.8516317009925842,
            "end_logit": 0.8742961287498474
        },
        {
            "text": "sporozoite invasion",
            "probability": 0.04524505289406553,
            "start_logit": 0.9871773719787598,
            "end_logit": 0.7008339762687683
        },
        {
            "text": "membrane feeding ass",
            "probability": 0.04505355392224782,
            "start_logit": 1.0691336393356323,
            "end_logit": 0.614636242389679
        },
        {
            "text": "SMFA). Upon co-formulation of Pfs25-IMX313 with RTS,S/AS01, the immun",
            "probability": 0.04480290022935773,
            "start_logit": 1.0037078857421875,
            "end_logit": 0.6744830012321472
        },
        {
            "text": "has been stalling recently, indicating control measures are starting",
            "probability": 0.04476737315782227,
            "start_logit": 1.114424467086792,
            "end_logit": 0.562973141670227
        },
        {
            "text": "ISI) showed no reduction in biological activity against parasites of both lifecycle stages. Should this findings be translatable to human vaccination this",
            "probability": 0.04468023526500419,
            "start_logit": 0.9743281602859497,
            "end_logit": 0.7011210918426514
        },
        {
            "text": "ergise in eliminating malaria from a population over multiple generations. Hence, the combination of RTS,S/AS01",
            "probability": 0.044462376553281856,
            "start_logit": 1.1080524921417236,
            "end_logit": 0.5625088810920715
        },
        {
            "text": "ISI) showed no reduction in biological activity against parasites of both lifecycle stages. Should this findings be translatable to human va",
            "probability": 0.04381970818151662,
            "start_logit": 0.9743281602859497,
            "end_logit": 0.681673526763916
        },
        {
            "text": "Pfs25-IMX313, one of the TBV candidates currently",
            "probability": 0.04344822958414693,
            "start_logit": 0.9518842697143555,
            "end_logit": 0.6956038475036621
        },
        {
            "text": "ocytic and the sexual life",
            "probability": 0.04326538004713673,
            "start_logit": 0.8516317009925842,
            "end_logit": 0.7916390895843506
        },
        {
            "text": "membrane feeding assays (SMFA). Upon co-formulation of P",
            "probability": 0.04254028814010355,
            "start_logit": 1.0691336393356323,
            "end_logit": 0.5572359561920166
        },
        {
            "text": "membrane feeding assays (SMFA). Upon co-",
            "probability": 0.04229783047503328,
            "start_logit": 1.0691336393356323,
            "end_logit": 0.5515201687812805
        },
        {
            "text": "be translatable to human vaccination this",
            "probability": 0.041712016907392416,
            "start_logit": 0.9055861830711365,
            "end_logit": 0.7011210918426514
        }
    ],
    "54cb9c94f693c3b16b000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5519113b622b19434500000f": [
        {
            "text": "associated with a novel heterozygous de novo frame-shift variant in the",
            "probability": 0.058856988391626675,
            "start_logit": 1.1022194623947144,
            "end_logit": 0.684711217880249
        },
        {
            "text": "associated with a novel heterozygous de novo frame-shift variant in the ZEB2 gene, as well as an additional novel hetero",
            "probability": 0.057711752282255765,
            "start_logit": 1.1022194623947144,
            "end_logit": 0.6650614738464355
        },
        {
            "text": ". Here, we report",
            "probability": 0.05632092193203917,
            "start_logit": 0.9982649683952332,
            "end_logit": 0.744621217250824
        },
        {
            "text": "associated with a novel heterozy",
            "probability": 0.05531967322837189,
            "start_logit": 1.1022194623947144,
            "end_logit": 0.6227292418479919
        },
        {
            "text": "syndrome, to date, a distinctive genotype-",
            "probability": 0.053851160677102876,
            "start_logit": 0.8816471695899963,
            "end_logit": 0.8163968920707703
        },
        {
            "text": "is a genetic disorder associated with a variable phenotype including peculiar facial features associated with intellectual disability",
            "probability": 0.05333766219503093,
            "start_logit": 1.0143433809280396,
            "end_logit": 0.6741194128990173
        },
        {
            "text": "associated with a novel",
            "probability": 0.05322696082096808,
            "start_logit": 1.1022194623947144,
            "end_logit": 0.5841656923294067
        },
        {
            "text": "patient may be influenced by the",
            "probability": 0.05117917021269004,
            "start_logit": 1.0725212097167969,
            "end_logit": 0.5746315121650696
        },
        {
            "text": "syndrome, to date, a distinctive genotype-phenotype correlation has not been delineated. Here, we report",
            "probability": 0.0501214110188839,
            "start_logit": 0.8816471695899963,
            "end_logit": 0.744621217250824
        },
        {
            "text": ". Here, we report a patient with a severe phenotype of Mowat-Wilson syndrome, associated with a novel heterozy",
            "probability": 0.049857757734010785,
            "start_logit": 0.9982649683952332,
            "end_logit": 0.6227292418479919
        },
        {
            "text": "is a genetic disorder associated with a variable phenotype including peculiar facial features associated with intellectual disability,",
            "probability": 0.049128759966955565,
            "start_logit": 1.0143433809280396,
            "end_logit": 0.591921329498291
        },
        {
            "text": "not been delineated. Here, we report",
            "probability": 0.04835947887637766,
            "start_logit": 0.8458611369132996,
            "end_logit": 0.744621217250824
        },
        {
            "text": ". Here, we report a patient with a severe phenotype of Mowat-Wilson syndrome, associated with a novel",
            "probability": 0.04797166654571748,
            "start_logit": 0.9982649683952332,
            "end_logit": 0.5841656923294067
        },
        {
            "text": "syndrome, to date, a distinctive genotype-phenotype correlation has",
            "probability": 0.047752266984291206,
            "start_logit": 0.8816471695899963,
            "end_logit": 0.6961994767189026
        },
        {
            "text": "syndrome, to date, a distinctive",
            "probability": 0.04755941086513472,
            "start_logit": 0.8816471695899963,
            "end_logit": 0.6921526193618774
        },
        {
            "text": "additional novel heterozy",
            "probability": 0.045664971781092176,
            "start_logit": 0.8180781602859497,
            "end_logit": 0.7150734663009644
        },
        {
            "text": "including peculiar facial features associated with intellectual disability",
            "probability": 0.04430315701334065,
            "start_logit": 0.8287566304206848,
            "end_logit": 0.6741194128990173
        },
        {
            "text": "enotype including peculiar facial features associated with intellectual disability",
            "probability": 0.043667084378247255,
            "start_logit": 0.8142952919006348,
            "end_logit": 0.6741194128990173
        },
        {
            "text": "additional novel hetero",
            "probability": 0.04343734390367447,
            "start_logit": 0.8180781602859497,
            "end_logit": 0.6650614738464355
        },
        {
            "text": "be influenced by the",
            "probability": 0.04237240119218847,
            "start_logit": 0.883685827255249,
            "end_logit": 0.5746315121650696
        }
    ],
    "531d6bfc267d7dd053000007": [
        {
            "text": "um neurotoxin (BoNT) gene of Clostridium botulinum. Degenerate oligonucleotide primers",
            "probability": 0.23442320297480967,
            "start_logit": 0.8510266542434692,
            "end_logit": 0.880922794342041
        },
        {
            "text": "of the botulinum neurotoxin (BoNT) gene of Clostrid",
            "probability": 0.22815992088184478,
            "start_logit": 0.8920180797576904,
            "end_logit": 0.8128501176834106
        },
        {
            "text": "um neurotoxin (BoNT) gene of Clostrid",
            "probability": 0.21899641612258489,
            "start_logit": 0.8510266542434692,
            "end_logit": 0.8128501176834106
        },
        {
            "text": "/E, and BoN",
            "probability": 0.1688295882063445,
            "start_logit": 0.7791962623596191,
            "end_logit": 0.6245149970054626
        },
        {
            "text": "/E, and BoNT/F genes. An additional probe was designed for the detection of the BoNT/F",
            "probability": 0.1495908718144161,
            "start_logit": 0.7791962623596191,
            "end_logit": 0.5035291910171509
        }
    ],
    "56d19a363975bb303a000017": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5149f494d24251bc0500004c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56cdf3e55795f9a73e00003c": [
        {
            "text": "dependency of mTORC1 activation. Furthermore, ablation of Gator1, a suppressor of Rag GTPases, induced amino acid-",
            "probability": 0.07658960338840334,
            "start_logit": 0.9256741404533386,
            "end_logit": 1.1785809993743896
        },
        {
            "text": "restored the amino acid",
            "probability": 0.07030077505473627,
            "start_logit": 1.2249350547790527,
            "end_logit": 0.7936415672302246
        },
        {
            "text": "restored the amino acid dependency of mTORC1 activation. Furthermore, ablation of Gator1, a suppressor of Rag GT",
            "probability": 0.05993956965511022,
            "start_logit": 1.2249350547790527,
            "end_logit": 0.6341956257820129
        },
        {
            "text": "restored the amino acid dependency of mTORC1 activation. Furthermore, ablation of Gator",
            "probability": 0.057971885599590794,
            "start_logit": 1.2249350547790527,
            "end_logit": 0.6008169054985046
        },
        {
            "text": "we disrupted Ragulator structure by directly anchoring RagC to lysosomes and monitored the effect on",
            "probability": 0.05600322527735084,
            "start_logit": 1.0344932079315186,
            "end_logit": 0.7567098736763
        },
        {
            "text": "restored the amino acid dependency of mTORC1",
            "probability": 0.05473064363846766,
            "start_logit": 1.2249350547790527,
            "end_logit": 0.5432825088500977
        },
        {
            "text": "two roadblock hetero",
            "probability": 0.05168373997897323,
            "start_logit": 1.185166358947754,
            "end_logit": 0.5257706642150879
        },
        {
            "text": "we disrupted Ragulator structure by directly anchoring RagC to lysosomes and monitored the effect on amino acid-",
            "probability": 0.050833295175904396,
            "start_logit": 1.0344932079315186,
            "end_logit": 0.659852147102356
        },
        {
            "text": "ORC1. However, the roles of Ragulator structure in the regulation of mTORC1 function remain elusive. In this",
            "probability": 0.0504616794253732,
            "start_logit": 0.8942703008651733,
            "end_logit": 0.7927377223968506
        },
        {
            "text": "ORC1 as follows: amino acids could",
            "probability": 0.0485886349034758,
            "start_logit": 0.9098423719406128,
            "end_logit": 0.7393410801887512
        },
        {
            "text": "of amino acids in the regulation of mTORC1 as follows: amino acids could",
            "probability": 0.04841755091336901,
            "start_logit": 0.9063150882720947,
            "end_logit": 0.7393410801887512
        },
        {
            "text": "dependency of mTORC1 activation. Furthermore, ablation of Gator1, a suppressor of Rag GT",
            "probability": 0.04443715607192923,
            "start_logit": 0.9256741404533386,
            "end_logit": 0.6341956257820129
        },
        {
            "text": "dependency of mTORC1 activation. Furthermore, ablation of Gator",
            "probability": 0.04297838211044637,
            "start_logit": 0.9256741404533386,
            "end_logit": 0.6008169054985046
        },
        {
            "text": "These results demonstrate that Ragulator structure",
            "probability": 0.04199299486317391,
            "start_logit": 0.9012261629104614,
            "end_logit": 0.6020704507827759
        },
        {
            "text": "ORC1. However, the roles of Ragulator structure in the regulation of mTORC1 function remain elusive.",
            "probability": 0.04172058714279928,
            "start_logit": 0.8942703008651733,
            "end_logit": 0.6025182008743286
        },
        {
            "text": "osphatases. These",
            "probability": 0.04151757279804637,
            "start_logit": 0.9714095592498779,
            "end_logit": 0.5205010175704956
        },
        {
            "text": "ORC1 as follows: amino acids could activate a fraction of mTORC1 in a",
            "probability": 0.04083779337470163,
            "start_logit": 0.9098423719406128,
            "end_logit": 0.5655593872070312
        },
        {
            "text": "of amino acids in the regulation of mTORC1 as follows: amino acids could activate a fraction of mTORC1 in a",
            "probability": 0.040694000641039105,
            "start_logit": 0.9063150882720947,
            "end_logit": 0.5655593872070312
        },
        {
            "text": "dependency of mTORC1",
            "probability": 0.040575435680866266,
            "start_logit": 0.9256741404533386,
            "end_logit": 0.5432825088500977
        },
        {
            "text": "protein",
            "probability": 0.039725474306243,
            "start_logit": 0.8904327154159546,
            "end_logit": 0.5573537349700928
        }
    ],
    "54df695b1388e8454a000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "51724fca8ed59a060a000013": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5506c3e38e1671127b00000a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56d85e7751531f7e33000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56e47e0051531f7e3300001c": [
        {
            "text": "and one that was site-",
            "probability": 0.12410674500507624,
            "start_logit": 0.8742215037345886,
            "end_logit": 0.9202659130096436
        },
        {
            "text": "metabolism",
            "probability": 0.12036578984922537,
            "start_logit": 1.0135287046432495,
            "end_logit": 0.7503520250320435
        },
        {
            "text": "agents more proven in their ability to reverse obesity and improve metabolism. INSL5 was",
            "probability": 0.11913460294244227,
            "start_logit": 1.0981570482254028,
            "end_logit": 0.6554422974586487
        },
        {
            "text": "is a member of the insulin-like",
            "probability": 0.10704403889620673,
            "start_logit": 1.0057032108306885,
            "end_logit": 0.6408824920654297
        },
        {
            "text": "agents more proven in their ability to reverse obesity and improve metabolism. INSL5 was chemically synthesized by two alternative methods to a",
            "probability": 0.09814276875013579,
            "start_logit": 1.0981570482254028,
            "end_logit": 0.4616115689277649
        },
        {
            "text": ") is a member of the insulin-like",
            "probability": 0.09745809572376968,
            "start_logit": 0.9118853807449341,
            "end_logit": 0.6408824920654297
        },
        {
            "text": "agents more proven in their ability to reverse obesity and improve metabolism. INSL5 was chemically synthesized",
            "probability": 0.08936753950684248,
            "start_logit": 1.0981570482254028,
            "end_logit": 0.3679458498954773
        },
        {
            "text": "of peptides. It has been reported to be orexigenic in rodent models of obesity with impaired glucose metabolism. We attempted",
            "probability": 0.08231892103813888,
            "start_logit": 0.9105451107025146,
            "end_logit": 0.4734012484550476
        },
        {
            "text": "and one that was site-specifically conjugated to a 20 KDa polyethyle",
            "probability": 0.08209384019392181,
            "start_logit": 0.8742215037345886,
            "end_logit": 0.5069868564605713
        },
        {
            "text": "and one that was site-specifically conjugated to a 20 KDa polyethylene g",
            "probability": 0.07996765809424071,
            "start_logit": 0.8742215037345886,
            "end_logit": 0.48074615001678467
        }
    ],
    "5721f4b30fd6f91b68000011": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "553c9f96f32186855800000c": [
        {
            "text": "is the so-",
            "probability": 0.07225530802701281,
            "start_logit": 1.0825388431549072,
            "end_logit": 1.0917572975158691
        },
        {
            "text": "plants, its underlying biogeographic mechanisms remain poorly understood. The Variable Antshrike (Tha",
            "probability": 0.06700371728044154,
            "start_logit": 1.1160264015197754,
            "end_logit": 0.9828120470046997
        },
        {
            "text": "T. caerulescens and assess its demographic history using DNA sequences",
            "probability": 0.060704988659483976,
            "start_logit": 0.8092583417892456,
            "end_logit": 1.1908578872680664
        },
        {
            "text": "northern Atlantic Forest; b) southeastern Cerrado and central-southern Atlantic Forest, and c) Chaco",
            "probability": 0.05669891178697044,
            "start_logit": 1.0608868598937988,
            "end_logit": 0.8709585070610046
        },
        {
            "text": "Neotropics show a wealth of distributional patterns shared by many co-distributed species. A distinctive pattern is the so-",
            "probability": 0.055095948507255646,
            "start_logit": 0.8114092350006104,
            "end_logit": 1.0917572975158691
        },
        {
            "text": ": a) northern Atlantic Forest; b) southeastern Cerrado and central-southern Atlantic Forest, and c) Chaco",
            "probability": 0.05243462393193195,
            "start_logit": 0.9826989769935608,
            "end_logit": 0.8709585070610046
        },
        {
            "text": "and plants, its underlying biogeographic mechanisms remain poorly understood. The Variable Antshrike (Tha",
            "probability": 0.05173117220701997,
            "start_logit": 0.8573388457298279,
            "end_logit": 0.9828120470046997
        },
        {
            "text": "two clusters. There were no genetic",
            "probability": 0.04900185848555827,
            "start_logit": 0.9371799826622009,
            "end_logit": 0.8487685918807983
        },
        {
            "text": ". The Variable Antshrike (Tha",
            "probability": 0.04855800101267886,
            "start_logit": 0.7940372824668884,
            "end_logit": 0.9828120470046997
        },
        {
            "text": "northern Atlantic",
            "probability": 0.04810153494736552,
            "start_logit": 1.0608868598937988,
            "end_logit": 0.7065175771713257
        },
        {
            "text": "plants, its underlying biogeographic mechanisms remain poorly understood. The",
            "probability": 0.04685987266985268,
            "start_logit": 1.1160264015197754,
            "end_logit": 0.6252256631851196
        },
        {
            "text": "is widespread across animals and plants, its underlying biogeographic mechanisms remain poorly understood. The Variable Antshrike (Tha",
            "probability": 0.046454679358644786,
            "start_logit": 0.7497555017471313,
            "end_logit": 0.9828120470046997
        },
        {
            "text": "or bottlenecks. The population from the northern Atlantic Forest was the most genetically divergent group within the species. The",
            "probability": 0.04512666356617678,
            "start_logit": 0.8070807456970215,
            "end_logit": 0.8964828848838806
        },
        {
            "text": "suboscine passerine that exhibits extreme plumage variation and occurs",
            "probability": 0.04505003023783381,
            "start_logit": 0.9850550889968872,
            "end_logit": 0.7168089151382446
        },
        {
            "text": ": a) northern Atlantic",
            "probability": 0.044483850148485535,
            "start_logit": 0.9826989769935608,
            "end_logit": 0.7065175771713257
        },
        {
            "text": "elements (UCEs). We",
            "probability": 0.04409945181065485,
            "start_logit": 0.7920355796813965,
            "end_logit": 0.8885021209716797
        },
        {
            "text": "group within the species. The",
            "probability": 0.043657527403821526,
            "start_logit": 0.7739831805229187,
            "end_logit": 0.8964828848838806
        },
        {
            "text": "two clusters. There were no genetic signatures of rapid population expansions or bottlenecks. The population from the northern Atlantic Forest was the",
            "probability": 0.041951181075285934,
            "start_logit": 0.9371799826622009,
            "end_logit": 0.693416953086853
        },
        {
            "text": "is a sexually dimorphic suboscine passerine that exhibits extreme plumage variation and occurs",
            "probability": 0.04128602308555709,
            "start_logit": 0.8978054523468018,
            "end_logit": 0.7168089151382446
        },
        {
            "text": "Amazonia, the Andean foothills, and often into the Venezuelan Coastal Range and the",
            "probability": 0.03944465579796804,
            "start_logit": 0.816931962966919,
            "end_logit": 0.7520569562911987
        }
    ],
    "56cf36263975bb303a000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "517170c48ed59a060a00000d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "534eb34b288f4dae47000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5710e131a5ed216440000001": [
        {
            "text": "48A(NPL4) complex actively removes sumoylated CenH3 from centromeres and disrupts centromeric hetero",
            "probability": 0.06814899753119359,
            "start_logit": 1.0169847011566162,
            "end_logit": 1.029113531112671
        },
        {
            "text": "NPL4) complex actively removes sumoylated CenH3 from centromeres and disrupts centromeric hetero",
            "probability": 0.06677509601112029,
            "start_logit": 0.9966184496879578,
            "end_logit": 1.029113531112671
        },
        {
            "text": "disrupts centromeric hetero",
            "probability": 0.060238725706381266,
            "start_logit": 0.8936036825180054,
            "end_logit": 1.029113531112671
        },
        {
            "text": "us. Here, we show that these processes are blocked by mutations in the evolution",
            "probability": 0.05029876398816206,
            "start_logit": 0.867827296257019,
            "end_logit": 0.8745549917221069
        },
        {
            "text": "48A, homologous to yeast Cdc48 and human p97 proteins, both of which are implicated in ubiquitin/small u",
            "probability": 0.04978377987428911,
            "start_logit": 0.9642382264137268,
            "end_logit": 0.767852783203125
        },
        {
            "text": ")-targeted protein degradation. We demonstrate that CDC48A physically associates with its heterodimeric cofactor UFD1-",
            "probability": 0.049096230989159564,
            "start_logit": 0.913907527923584,
            "end_logit": 0.8042765259742737
        },
        {
            "text": "CenH3)/centromere protein A (CENP-A). Removal of CenH3 from",
            "probability": 0.04868795162510042,
            "start_logit": 1.2061190605163574,
            "end_logit": 0.5037143230438232
        },
        {
            "text": "ctor UFD1-NPL4, known to bind ubi",
            "probability": 0.048561017255557705,
            "start_logit": 0.8352687358856201,
            "end_logit": 0.8719541430473328
        },
        {
            "text": "48 and human p97 proteins, both of which are implicated in ubiquitin/small ubiquitin-",
            "probability": 0.04850724189483189,
            "start_logit": 0.8908780813217163,
            "end_logit": 0.8152368068695068
        },
        {
            "text": "We demonstrate that CDC48A physically associates with its heterodimeric cofactor UFD1-",
            "probability": 0.04821098688848848,
            "start_logit": 0.8957121968269348,
            "end_logit": 0.8042765259742737
        },
        {
            "text": "Ce",
            "probability": 0.04810883824557839,
            "start_logit": 1.2061190605163574,
            "end_logit": 0.4917486310005188
        },
        {
            "text": "48A",
            "probability": 0.048074557910094795,
            "start_logit": 0.9642382264137268,
            "end_logit": 0.7329166531562805
        },
        {
            "text": "sation; and bulk activation of silent rRNA genes, accompanied by their translocation into",
            "probability": 0.04805889208985541,
            "start_logit": 0.8011883497238159,
            "end_logit": 0.8956406116485596
        },
        {
            "text": "major rRNA gene variants, including those rDNA variants silenced in leaves, are transcribed",
            "probability": 0.047443335573823756,
            "start_logit": 1.1406450271606445,
            "end_logit": 0.5432928204536438
        },
        {
            "text": "48 and human p97 proteins, both of which are implicated in ubiquitin/small u",
            "probability": 0.04626237892366714,
            "start_logit": 0.8908780813217163,
            "end_logit": 0.767852783203125
        },
        {
            "text": "major",
            "probability": 0.04547994877293349,
            "start_logit": 1.1406450271606445,
            "end_logit": 0.501028299331665
        },
        {
            "text": "ctor UFD1-",
            "probability": 0.04538326741104556,
            "start_logit": 0.8352687358856201,
            "end_logit": 0.8042765259742737
        },
        {
            "text": "4, known to bind ubi",
            "probability": 0.045016062242348276,
            "start_logit": 0.7594670057296753,
            "end_logit": 0.8719541430473328
        },
        {
            "text": "CenH3; centromeric heterochromatin decondensation; and bulk activation of silent rRNA genes, accompanied by their",
            "probability": 0.04477590971271526,
            "start_logit": 0.839613676071167,
            "end_logit": 0.7864583730697632
        },
        {
            "text": "sation; and bulk activation of silent rRNA genes, accompanied by their",
            "probability": 0.043088017353653627,
            "start_logit": 0.8011883497238159,
            "end_logit": 0.7864583730697632
        }
    ],
    "56e2acfe51531f7e33000014": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "517818508ed59a060a000035": [
        {
            "text": "uncertain variants. Two subjects with RTT-causing mutations were previously diagnosed as",
            "probability": 0.09562955455315349,
            "start_logit": 1.4279481172561646,
            "end_logit": 0.9044122695922852
        },
        {
            "text": "uncertain variants. Two subjects",
            "probability": 0.08706983193885326,
            "start_logit": 1.4279481172561646,
            "end_logit": 0.810640811920166
        },
        {
            "text": "uncertain variants.",
            "probability": 0.06463892731212853,
            "start_logit": 1.4279481172561646,
            "end_logit": 0.5127471685409546
        },
        {
            "text": "atal encephalopathy to cognitive impairment. Two males with a somatic",
            "probability": 0.06101011395121757,
            "start_logit": 0.976128876209259,
            "end_logit": 0.906789243221283
        },
        {
            "text": "cephalopathy to cognitive impairment. Two males with a somatic",
            "probability": 0.05196455728161355,
            "start_logit": 0.8156511187553406,
            "end_logit": 0.906789243221283
        },
        {
            "text": "atal encephalopathy to cognitive impairment. Two males with a somatic mutation in MECP2 had classic RT",
            "probability": 0.05064381142198555,
            "start_logit": 0.976128876209259,
            "end_logit": 0.7205666303634644
        },
        {
            "text": "severe neonatal encephalopathy to cognitive impairment. Two males with a somatic",
            "probability": 0.05064013489285946,
            "start_logit": 0.789833664894104,
            "end_logit": 0.906789243221283
        },
        {
            "text": "females with RTT, leading to the",
            "probability": 0.04556751654085664,
            "start_logit": 1.0192131996154785,
            "end_logit": 0.5718603730201721
        },
        {
            "text": "careful review of the clinical history determined that an additional 12/28 subjects met criteria for atypical RTT,",
            "probability": 0.04531382247533238,
            "start_logit": 0.9490070343017578,
            "end_logit": 0.6364835500717163
        },
        {
            "text": "these individuals, we identified 30 males with MECP2 mutations in the RT",
            "probability": 0.044582468798252256,
            "start_logit": 1.0015275478363037,
            "end_logit": 0.5676916241645813
        },
        {
            "text": "females with RTT, leading to the designation of a new diagnostic entity, male RT",
            "probability": 0.04434164804269218,
            "start_logit": 1.0192131996154785,
            "end_logit": 0.544589638710022
        },
        {
            "text": "cephalopathy to cognitive impairment. Two males with a somatic mutation in MECP2 had classic RT",
            "probability": 0.04313519626764249,
            "start_logit": 0.8156511187553406,
            "end_logit": 0.7205666303634644
        },
        {
            "text": "atal encephalopathy to cognitive impairment. Two males with",
            "probability": 0.04219598028943349,
            "start_logit": 0.976128876209259,
            "end_logit": 0.5380745530128479
        },
        {
            "text": "severe neonatal encephalopathy to cognitive impairment. Two males with a somatic mutation in MECP2 had classic RT",
            "probability": 0.042035808094843,
            "start_logit": 0.789833664894104,
            "end_logit": 0.7205666303634644
        },
        {
            "text": "these individuals, we identified",
            "probability": 0.0416384358574335,
            "start_logit": 1.0015275478363037,
            "end_logit": 0.4993745982646942
        },
        {
            "text": "atal ence",
            "probability": 0.04048004978036182,
            "start_logit": 0.976128876209259,
            "end_logit": 0.4965588450431824
        },
        {
            "text": "determined that an additional 12/28 subjects met criteria for atypical RTT, but with more severe clinical presentation and course, and less distinctive",
            "probability": 0.03944286230908492,
            "start_logit": 0.7727505564689636,
            "end_logit": 0.6739810109138489
        },
        {
            "text": "determined that an additional 12/28 subjects met criteria for atypical RTT,",
            "probability": 0.037991241260678266,
            "start_logit": 0.7727505564689636,
            "end_logit": 0.6364835500717163
        },
        {
            "text": "cephalopathy to cognitive impairment. Two males with",
            "probability": 0.03593986788087853,
            "start_logit": 0.8156511187553406,
            "end_logit": 0.5380745530128479
        },
        {
            "text": "Study databases. A wide phenotypic spectrum was observed, ranging from severe neonatal encephalopathy to cognitive impairment. Two males with",
            "probability": 0.03573817105069924,
            "start_logit": 0.8100232481956482,
            "end_logit": 0.5380745530128479
        }
    ],
    "56a8ee75a17756b72f000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "534abe8aaeec6fbd07000013": [
        {
            "text": "urin. Active calcineurin blocked prosurvival heat shock responses upon Hsp90 inhibition by preventing nuclear trans",
            "probability": 0.09753801914101606,
            "start_logit": 1.577103853225708,
            "end_logit": 0.6951824426651001
        },
        {
            "text": "uri",
            "probability": 0.08748796113829374,
            "start_logit": 1.577103853225708,
            "end_logit": 0.5864413976669312
        },
        {
            "text": "N401 inhibited all Hsp90 paralogs simultaneously and showed stronger anticancer activity than other Hsp90 inhibitors. Pan-",
            "probability": 0.05950414334435161,
            "start_logit": 1.0485332012176514,
            "end_logit": 0.7295567989349365
        },
        {
            "text": "xi",
            "probability": 0.05616927666637705,
            "start_logit": 0.8900845050811768,
            "end_logit": 0.8303294777870178
        },
        {
            "text": "N401 inhibit",
            "probability": 0.05229081903080445,
            "start_logit": 1.0485332012176514,
            "end_logit": 0.6003316640853882
        },
        {
            "text": "p94, and TRAP1 are present in the",
            "probability": 0.04951613003503909,
            "start_logit": 0.9017691612243652,
            "end_logit": 0.6925733685493469
        },
        {
            "text": "p94, and TRAP1 are present in the cell cytoplasm, endoplasmic reticulum, and mitochond",
            "probability": 0.047470635576831614,
            "start_logit": 0.9017691612243652,
            "end_logit": 0.6503862142562866
        },
        {
            "text": "p94, and TRAP1 are present in the cell cytoplasm, end",
            "probability": 0.04472234382171559,
            "start_logit": 0.9017691612243652,
            "end_logit": 0.590748131275177
        },
        {
            "text": "present in the",
            "probability": 0.04446733029572804,
            "start_logit": 0.7942254543304443,
            "end_logit": 0.6925733685493469
        },
        {
            "text": "blocked prosurvival heat shock responses upon Hsp90 inhibition by preventing nuclear trans",
            "probability": 0.04416997996653571,
            "start_logit": 0.7849069833755493,
            "end_logit": 0.6951824426651001
        },
        {
            "text": "inhibition by preventing nuclear trans",
            "probability": 0.04415843955992116,
            "start_logit": 0.784645676612854,
            "end_logit": 0.6951824426651001
        },
        {
            "text": "urin blocked prosurvival heat shock responses upon Hsp90 inhibition by preventing nuclear trans",
            "probability": 0.04304794625698161,
            "start_logit": 0.7591761350631714,
            "end_logit": 0.6951824426651001
        },
        {
            "text": "present in the cell cytoplasm, endoplasmic reticulum, and mitochond",
            "probability": 0.04263040003427932,
            "start_logit": 0.7942254543304443,
            "end_logit": 0.6503862142562866
        },
        {
            "text": "p90 family proteins Hsp90, Grp94, and TRAP1 are present in the",
            "probability": 0.04250430830051278,
            "start_logit": 0.7490761280059814,
            "end_logit": 0.6925733685493469
        },
        {
            "text": "rine scaffold derivative",
            "probability": 0.042395026607148965,
            "start_logit": 0.837125301361084,
            "end_logit": 0.6019498109817505
        },
        {
            "text": "rine scaffold derivative DN401 inhibit",
            "probability": 0.042326480700053536,
            "start_logit": 0.837125301361084,
            "end_logit": 0.6003316640853882
        },
        {
            "text": "inhibition by preventing nuclear translocation of HSF1. The purine scaffold derivative",
            "probability": 0.04022752382504479,
            "start_logit": 0.784645676612854,
            "end_logit": 0.6019498109817505
        },
        {
            "text": "inhibition by preventing nuclear translocation of HSF1. The purine scaffold derivative DN401 inhibit",
            "probability": 0.04016248241968509,
            "start_logit": 0.784645676612854,
            "end_logit": 0.6003316640853882
        },
        {
            "text": "present in the cell cytoplasm, end",
            "probability": 0.04016233160612688,
            "start_logit": 0.7942254543304443,
            "end_logit": 0.590748131275177
        },
        {
            "text": "-Hsp90 inhibitor with potent",
            "probability": 0.03904842167355285,
            "start_logit": 0.7856287956237793,
            "end_logit": 0.5712177157402039
        }
    ],
    "571f33bd0fd6f91b68000003": [
        {
            "text": "is a complex anatomical structure with the",
            "probability": 0.11182365394439224,
            "start_logit": 1.098350167274475,
            "end_logit": 0.6864179372787476
        },
        {
            "text": "is a complex anatomical structure with the component bones susceptible to a combination of environmental and genetic factors that may",
            "probability": 0.11040134308163409,
            "start_logit": 1.098350167274475,
            "end_logit": 0.6736171245574951
        },
        {
            "text": "combination of environmental and genetic factors that may affect the bone length and width. The alterations may involve a single bone or specific group of bones. The",
            "probability": 0.09827798845883645,
            "start_logit": 0.9014148712158203,
            "end_logit": 0.7542302012443542
        },
        {
            "text": "combination of environmental and genetic factors that may affect the bone length and width. The alterations may involve a single",
            "probability": 0.09643228905009871,
            "start_logit": 0.9014148712158203,
            "end_logit": 0.7352712154388428
        },
        {
            "text": ". The current status of MCPP analysis in clinical genetics, particularly with the Prade",
            "probability": 0.09289630057723251,
            "start_logit": 0.8439229130744934,
            "end_logit": 0.7554059028625488
        },
        {
            "text": "combination of environmental and genetic factors that may",
            "probability": 0.09066641512839364,
            "start_logit": 0.9014148712158203,
            "end_logit": 0.6736171245574951
        },
        {
            "text": ". The current status of MCPP analysis in clinical genetics, particularly with the Prader-",
            "probability": 0.083588025561623,
            "start_logit": 0.8439229130744934,
            "end_logit": 0.6498223543167114
        },
        {
            "text": "poster",
            "probability": 0.08078303332180542,
            "start_logit": 0.8480163216590881,
            "end_logit": 0.611595630645752
        },
        {
            "text": ". The",
            "probability": 0.08073130742621164,
            "start_logit": 0.8439229130744934,
            "end_logit": 0.6150485277175903
        },
        {
            "text": "posteroanterior hand radiographs and are standardized for age and",
            "probability": 0.07798367325758399,
            "start_logit": 0.8480163216590881,
            "end_logit": 0.5763281583786011
        },
        {
            "text": ". The current status of MCPP analysis in clinical genetics, particularly with the Prader-Labhart-",
            "probability": 0.07641597019218815,
            "start_logit": 0.8439229130744934,
            "end_logit": 0.560113787651062
        }
    ],
    "53617eeb7d100faa0900000a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "534e364e288f4dae47000001": [
        {
            "text": "Bs. Here, we investigate this possibility by generating a high-",
            "probability": 0.07334470954376372,
            "start_logit": 1.1339141130447388,
            "end_logit": 1.1215623617172241
        },
        {
            "text": "possibility by generating a high-",
            "probability": 0.0626039423376843,
            "start_logit": 0.9755719900131226,
            "end_logit": 1.1215623617172241
        },
        {
            "text": "Bs are associated with crossovers, the evolutionary conservation of the crossover landscape could differ from that of DSBs. Here, we investigate this possibility by generating",
            "probability": 0.05391362321794257,
            "start_logit": 1.1840699911117554,
            "end_logit": 0.7636193037033081
        },
        {
            "text": "crossover landscape could differ from that of DSBs. Here, we investigate this possibility by generating a high-",
            "probability": 0.05285064306996978,
            "start_logit": 0.8062136173248291,
            "end_logit": 1.1215623617172241
        },
        {
            "text": "associated with crossovers, the evolutionary conservation of the crossover landscape could differ from that of DSBs. Here, we investigate this possibility by generating",
            "probability": 0.05283731334264296,
            "start_logit": 1.1639044284820557,
            "end_logit": 0.7636193037033081
        },
        {
            "text": "Bs. Here, we investigate this possibility by generating",
            "probability": 0.05127623132354265,
            "start_logit": 1.1339141130447388,
            "end_logit": 0.7636193037033081
        },
        {
            "text": "Bs), which initiate recombination, is evolutionarily conserved among divergent yeast species, casting doubt on the hot",
            "probability": 0.05104969889461098,
            "start_logit": 1.2074217796325684,
            "end_logit": 0.6856839656829834
        },
        {
            "text": "casting doubt on the hot",
            "probability": 0.050069255445600334,
            "start_logit": 1.1880292892456055,
            "end_logit": 0.6856839656829834
        },
        {
            "text": "Bs), which initiate recombination, is evolution",
            "probability": 0.04934143537021527,
            "start_logit": 1.2074217796325684,
            "end_logit": 0.6516485214233398
        },
        {
            "text": "casting doubt on the hotspot paradox hypothesis. Nonetheless,",
            "probability": 0.049233144021883786,
            "start_logit": 1.1880292892456055,
            "end_logit": 0.6688438653945923
        },
        {
            "text": "Bs), which initiate rec",
            "probability": 0.04876267504792236,
            "start_logit": 1.2074217796325684,
            "end_logit": 0.6398494839668274
        },
        {
            "text": "Bs), which initiate recombination, is evolutionarily conserved among divergent yeast species, casting doubt on",
            "probability": 0.048598358450574475,
            "start_logit": 1.2074217796325684,
            "end_logit": 0.636474072933197
        },
        {
            "text": "casting doubt on",
            "probability": 0.047664994626550695,
            "start_logit": 1.1880292892456055,
            "end_logit": 0.636474072933197
        },
        {
            "text": "associated with crossovers, the evolutionary conservation of the crossover landscape could differ from that of DSBs. Here, we investigate this possibility by generating a",
            "probability": 0.046064695927393186,
            "start_logit": 1.1639044284820557,
            "end_logit": 0.6264485120773315
        },
        {
            "text": "Bs. Here, we investigate this possibility by generating a",
            "probability": 0.044703711350807224,
            "start_logit": 1.1339141130447388,
            "end_logit": 0.6264485120773315
        },
        {
            "text": "cold spots. The hotspot paradox hypothesis asserts that recombination hotspots are evolutionarily unstable due to self-",
            "probability": 0.04449309950097781,
            "start_logit": 0.8420332670211792,
            "end_logit": 0.9136069416999817
        },
        {
            "text": "possibility by generating",
            "probability": 0.04376722259916251,
            "start_logit": 0.9755719900131226,
            "end_logit": 0.7636193037033081
        },
        {
            "text": "possibility by generating a high-resolution recombination map of the budding yeast Saccharomyces paradoxus through whole-",
            "probability": 0.04363720656863347,
            "start_logit": 0.9755719900131226,
            "end_logit": 0.760644257068634
        },
        {
            "text": ". However, the genomic landscape of double-strand breaks (DSBs), which initiate recombination, is evolution",
            "probability": 0.043147070816742863,
            "start_logit": 1.0732721090316772,
            "end_logit": 0.6516485214233398
        },
        {
            "text": ". However, the genomic landscape of double-strand breaks (DSBs), which initiate rec",
            "probability": 0.04264096854337918,
            "start_logit": 1.0732721090316772,
            "end_logit": 0.6398494839668274
        }
    ],
    "533ea8fcc45e133714000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54edf81f94afd61504000014": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55200c606b348bb82c000013": [
        {
            "text": "time or ecarin clotting time can be used, whereas for anti-",
            "probability": 0.07527634997008159,
            "start_logit": 1.2285888195037842,
            "end_logit": 0.8708272576332092
        },
        {
            "text": "additional interindividual PD differences",
            "probability": 0.05880647564920627,
            "start_logit": 0.9245774149894714,
            "end_logit": 0.927924633026123
        },
        {
            "text": "rombin formation and for anti-",
            "probability": 0.05828445166415572,
            "start_logit": 0.833145797252655,
            "end_logit": 1.0104396343231201
        },
        {
            "text": "is the inhibition of thrombin formation and for anti-",
            "probability": 0.056975343373538156,
            "start_logit": 0.810429036617279,
            "end_logit": 1.0104396343231201
        },
        {
            "text": "fixed-dose conditions suggests additional interindividual PD differences",
            "probability": 0.05350079329627345,
            "start_logit": 0.8300219178199768,
            "end_logit": 0.927924633026123
        },
        {
            "text": "bin inhibitor dabigat",
            "probability": 0.05249515742728641,
            "start_logit": 1.0883586406707764,
            "end_logit": 0.6506123542785645
        },
        {
            "text": "bin inhibitor dabigatran etexilate, a calib",
            "probability": 0.052280619018889904,
            "start_logit": 1.0883586406707764,
            "end_logit": 0.6465171575546265
        },
        {
            "text": "oxaban, apixa",
            "probability": 0.05200257617591933,
            "start_logit": 0.836616039276123,
            "end_logit": 0.8929272890090942
        },
        {
            "text": "oxaban, apixaban, edoxaban, and betrixaban, calibrated anti-",
            "probability": 0.04843624210464547,
            "start_logit": 0.836616039276123,
            "end_logit": 0.8218823671340942
        },
        {
            "text": "rated diluted thrombin time or ecarin clotting time can be used, whereas for anti-",
            "probability": 0.047699074854317285,
            "start_logit": 0.7723348140716553,
            "end_logit": 0.8708272576332092
        },
        {
            "text": "be followed using the functional assays mentioned above",
            "probability": 0.04722649390722302,
            "start_logit": 0.8260973691940308,
            "end_logit": 0.8071077466011047
        },
        {
            "text": "concentrations is LC-MS/MS. The variation in bleeding and thrombotic events noted with both drug classes under fixed-",
            "probability": 0.045665208945692405,
            "start_logit": 0.9351571798324585,
            "end_logit": 0.6644296050071716
        },
        {
            "text": "bleeding or thrombosis, therapeutic drug monitoring could",
            "probability": 0.04516618102992873,
            "start_logit": 0.834168553352356,
            "end_logit": 0.7544301152229309
        },
        {
            "text": "perform",
            "probability": 0.04512526328742896,
            "start_logit": 0.8824073672294617,
            "end_logit": 0.7052849531173706
        },
        {
            "text": "additional interindivid",
            "probability": 0.04495591176956444,
            "start_logit": 0.9245774149894714,
            "end_logit": 0.6593549251556396
        },
        {
            "text": "additional interindividual PD differences. Therefore, PD",
            "probability": 0.04382068288824005,
            "start_logit": 0.9245774149894714,
            "end_logit": 0.6337785720825195
        },
        {
            "text": "ban, and betrixaban, calib",
            "probability": 0.043751858149849554,
            "start_logit": 0.8952076435089111,
            "end_logit": 0.661576509475708
        },
        {
            "text": "time or the activated partial thrombin time are not suitable for this purpose. To measure drug concentrations, more specific coagulation test can",
            "probability": 0.043660024005971014,
            "start_logit": 0.9325704574584961,
            "end_logit": 0.622112512588501
        },
        {
            "text": "rombin formation and",
            "probability": 0.04280379191183679,
            "start_logit": 0.833145797252655,
            "end_logit": 0.7017309665679932
        },
        {
            "text": "ban, and betrixaban, calibrated anti-factor X",
            "probability": 0.0420675005699515,
            "start_logit": 0.8952076435089111,
            "end_logit": 0.622317910194397
        }
    ],
    "56a8b8b5a17756b72f000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5324bdba9b2d7acc7e00001a": [
        {
            "text": "be a useful tool for segmentation and wall thickness measurement of the bladder from",
            "probability": 0.12474516541852188,
            "start_logit": 1.1794801950454712,
            "end_logit": 0.905888020992279
        },
        {
            "text": "be a useful tool for segmentation and wall thickness measurement of the bladder from transabdominal",
            "probability": 0.09639888480936253,
            "start_logit": 1.1794801950454712,
            "end_logit": 0.6481096744537354
        },
        {
            "text": "performance of our method, we compared the results of automated methods to the manually obtained reference bladder segmentations and wall thickness measurements",
            "probability": 0.08797781249341134,
            "start_logit": 0.8958950638771057,
            "end_logit": 0.8402848243713379
        },
        {
            "text": "thickness have",
            "probability": 0.08073989891242116,
            "start_logit": 0.9839236736297607,
            "end_logit": 0.6664044260978699
        },
        {
            "text": "performance of our method, we compared the results of automated methods to the manually obtained",
            "probability": 0.07961476817266244,
            "start_logit": 0.8958950638771057,
            "end_logit": 0.7403997778892517
        },
        {
            "text": "mm, which is comparable to the manual ground truth. The proposed fully automated and fast method could",
            "probability": 0.07837856352695365,
            "start_logit": 0.9042421579360962,
            "end_logit": 0.7164035439491272
        },
        {
            "text": "mm, which is comparable to the manual",
            "probability": 0.07711524932351214,
            "start_logit": 0.9042421579360962,
            "end_logit": 0.7001541256904602
        },
        {
            "text": "Ultrasound measurements of detrusor muscle thickness have",
            "probability": 0.07622074097349359,
            "start_logit": 0.9263244271278381,
            "end_logit": 0.6664044260978699
        },
        {
            "text": "performance of our method, we compared the results of automated methods to the",
            "probability": 0.07568782503613128,
            "start_logit": 0.8958950638771057,
            "end_logit": 0.689817488193512
        },
        {
            "text": "or muscle thickness from transabdominal 2D B-mode ultrasound images. To assess the",
            "probability": 0.07443878202751382,
            "start_logit": 0.8657166361808777,
            "end_logit": 0.7033556699752808
        },
        {
            "text": "mm, which is comparable to the manual ground truth",
            "probability": 0.07434589590658507,
            "start_logit": 0.9042421579360962,
            "end_logit": 0.6635815501213074
        },
        {
            "text": ") and dynamic programming (DP) to segment the bladder sac and measure the det",
            "probability": 0.07433641339943121,
            "start_logit": 0.8683456778526306,
            "end_logit": 0.6993504762649536
        }
    ],
    "54f35ad864850a5854000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5727ab040fd6f91b68000019": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "516e7fda298dcd4e51000081": [
        {
            "text": "restored epigenetic control and alleviated neurological disability in cuprizone mice. Betaine increased the",
            "probability": 0.08059174563415093,
            "start_logit": 1.4077506065368652,
            "end_logit": 0.8293784856796265
        },
        {
            "text": "etic control and activate neuroprotective transcriptional programs. ChIP-seq data suggest that BHMT acts on",
            "probability": 0.08032749909840041,
            "start_logit": 0.9313793182373047,
            "end_logit": 1.302465558052063
        },
        {
            "text": "etic control and activate neuroprotective transcriptional programs. ChIP-",
            "probability": 0.06481104579595785,
            "start_logit": 0.9313793182373047,
            "end_logit": 1.08782958984375
        },
        {
            "text": "restored epigenetic control and alleviated neurological disability in cuprizone mice. Betaine increased the methyl",
            "probability": 0.06124440131409749,
            "start_logit": 1.4077506065368652,
            "end_logit": 0.554854691028595
        },
        {
            "text": "transferase activity locally to increase H3K4me3 and activate transcriptional programs that support neuronal energetic",
            "probability": 0.05191654753739935,
            "start_logit": 1.1567413806915283,
            "end_logit": 0.6406290531158447
        },
        {
            "text": "K4me3, enhanced neuronal respiration, and prevented axonal",
            "probability": 0.05147563386825674,
            "start_logit": 1.020753264427185,
            "end_logit": 0.768088161945343
        },
        {
            "text": "H ratio and histone methyltra",
            "probability": 0.05056531750720749,
            "start_logit": 1.1794450283050537,
            "end_logit": 0.5915537476539612
        },
        {
            "text": "disability in cuprizone mice. Betaine increased the",
            "probability": 0.05013211133740751,
            "start_logit": 0.9330161213874817,
            "end_logit": 0.8293784856796265
        },
        {
            "text": "tra",
            "probability": 0.04943023437741544,
            "start_logit": 1.1567413806915283,
            "end_logit": 0.5915537476539612
        },
        {
            "text": "H ratio and histone methyltransferase",
            "probability": 0.047210021676972726,
            "start_logit": 1.1794450283050537,
            "end_logit": 0.522894024848938
        },
        {
            "text": "K4me3, enhanced neuronal respiration,",
            "probability": 0.04677838499572326,
            "start_logit": 1.020753264427185,
            "end_logit": 0.6724008321762085
        },
        {
            "text": "transferase",
            "probability": 0.046150257755683995,
            "start_logit": 1.1567413806915283,
            "end_logit": 0.522894024848938
        },
        {
            "text": "4me3, enhanced neuronal respiration, and prevented axonal",
            "probability": 0.044143624357660526,
            "start_logit": 0.8670932054519653,
            "end_logit": 0.768088161945343
        },
        {
            "text": "energetic",
            "probability": 0.04129767831168266,
            "start_logit": 0.9279100894927979,
            "end_logit": 0.6406290531158447
        },
        {
            "text": "K4me3, enhanced neuronal respiration, and prevented axonal damage. We show that the methyl",
            "probability": 0.04101600998242805,
            "start_logit": 1.020753264427185,
            "end_logit": 0.5409420728683472
        },
        {
            "text": "K4me3, enhanced neuronal respiration",
            "probability": 0.04018143505067007,
            "start_logit": 1.020753264427185,
            "end_logit": 0.520384669303894
        },
        {
            "text": "4me3, enhanced neuronal respiration,",
            "probability": 0.040115435209485115,
            "start_logit": 0.8670932054519653,
            "end_logit": 0.6724008321762085
        },
        {
            "text": "disability in cuprizone mice. Betaine increased the methyl",
            "probability": 0.038097091970299146,
            "start_logit": 0.9330161213874817,
            "end_logit": 0.554854691028595
        },
        {
            "text": "etic",
            "probability": 0.037880924587844235,
            "start_logit": 0.9313793182373047,
            "end_logit": 0.5508012175559998
        },
        {
            "text": "etic control and activate neuroprotective transcriptional programs.",
            "probability": 0.03663459963125729,
            "start_logit": 0.9313793182373047,
            "end_logit": 0.5173466801643372
        }
    ],
    "5171438a8ed59a060a000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56ffd08bcf1c325851000009": [
        {
            "text": "ivating the GFP gene. Sequence and structural analyses showed that 17ntAT and 3F38d9 included imperfect pali",
            "probability": 0.06545442286321844,
            "start_logit": 0.9232340455055237,
            "end_logit": 1.0564765930175781
        },
        {
            "text": "into pAlu14",
            "probability": 0.059242750790082406,
            "start_logit": 1.0012562274932861,
            "end_logit": 0.8787437677383423
        },
        {
            "text": "variety of unstable stem-loops",
            "probability": 0.057151905390191785,
            "start_logit": 0.8709888458251953,
            "end_logit": 0.9730804562568665
        },
        {
            "text": "into pAlu14, only two (2F2R and 3F3R) eliminated the inhibition",
            "probability": 0.053583663000335666,
            "start_logit": 1.0012562274932861,
            "end_logit": 0.7783445715904236
        },
        {
            "text": ") or pORF2. Antisense SV40PolyA (PolyAas) induced",
            "probability": 0.0527754969131996,
            "start_logit": 0.898568868637085,
            "end_logit": 0.8658347129821777
        },
        {
            "text": "ndromes and unstable stem-loops",
            "probability": 0.051122608274468156,
            "start_logit": 0.9271389245986938,
            "end_logit": 0.8054444789886475
        },
        {
            "text": ") or pORF2. Antisense SV40PolyA (PolyAas) induced stronger gene expression than its sense",
            "probability": 0.04927467973999191,
            "start_logit": 0.898568868637085,
            "end_logit": 0.7971980571746826
        },
        {
            "text": "into pAlu14, only two (2F2R and 3F3R",
            "probability": 0.04916079135250269,
            "start_logit": 1.0012562274932861,
            "end_logit": 0.6921967267990112
        },
        {
            "text": "ndromes and unstable stem-loops in DNA enhancer",
            "probability": 0.04848302829479486,
            "start_logit": 0.9271389245986938,
            "end_logit": 0.7524314522743225
        },
        {
            "text": "variety of unstable stem-loops. We suggest that the presence of imperfect palindromes and unstable stem-loops",
            "probability": 0.04833117282484039,
            "start_logit": 0.8709888458251953,
            "end_logit": 0.8054444789886475
        },
        {
            "text": "F4R) inserted independently into pAlu14",
            "probability": 0.04827903899835567,
            "start_logit": 0.7966102957725525,
            "end_logit": 0.8787437677383423
        },
        {
            "text": "sense PolyA of simian virus 40 (SV40PolyA, 240 bp) eliminated the",
            "probability": 0.047954830845309035,
            "start_logit": 0.9200478792190552,
            "end_logit": 0.7485682368278503
        },
        {
            "text": ") in 2F2R and the fragment 3F38d9 (5'-ATAAACA",
            "probability": 0.0478929507871092,
            "start_logit": 0.8924126029014587,
            "end_logit": 0.7749122977256775
        },
        {
            "text": ") in 2F2R and the fragment 3F38d9 (5'-",
            "probability": 0.04710603656966544,
            "start_logit": 0.8924126029014587,
            "end_logit": 0.7583451271057129
        },
        {
            "text": "into pAlu14, only two (2F2R and 3F3R) eliminated the inhibition of GFP",
            "probability": 0.047034656221251574,
            "start_logit": 1.0012562274932861,
            "end_logit": 0.64798504114151
        },
        {
            "text": ". We found that sense and antisense PolyA of simian virus 40 (SV40PolyA, 240 bp) eliminated the",
            "probability": 0.0462223584260256,
            "start_logit": 0.883251965045929,
            "end_logit": 0.7485682368278503
        },
        {
            "text": "variety of unstable stem-loops. We suggest that the presence of imperfect palindromes and unstable stem-loops in DNA enhancer",
            "probability": 0.045835721194171286,
            "start_logit": 0.8709888458251953,
            "end_logit": 0.7524314522743225
        },
        {
            "text": "protein (GFP) gene when inserted downstream of this gene in the vector pEGFP-C1. In this",
            "probability": 0.045155876398548976,
            "start_logit": 0.9233661890029907,
            "end_logit": 0.6851108074188232
        },
        {
            "text": "or Line-1-",
            "probability": 0.044997804699266127,
            "start_logit": 0.8018676042556763,
            "end_logit": 0.8031026721000671
        },
        {
            "text": "sense orientation (PolyA). Of four 60-bp segments of PolyAas (1F1R, 2F",
            "probability": 0.044940206416671236,
            "start_logit": 0.7951266765594482,
            "end_logit": 0.8085627555847168
        }
    ],
    "5313058de3eabad02100000e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5348307daeec6fbd07000011": [
        {
            "text": "profiled and functionally annotated the",
            "probability": 0.09353509107289987,
            "start_logit": 0.8862465023994446,
            "end_logit": 1.1262797117233276
        },
        {
            "text": "time, comprehensively profiled and functionally annotated the",
            "probability": 0.08606895638041137,
            "start_logit": 0.8030586242675781,
            "end_logit": 1.1262797117233276
        },
        {
            "text": "signal peptides using SignalP4 software, and 75 were confirmed in previous studies.",
            "probability": 0.08088597087497487,
            "start_logit": 0.9688520431518555,
            "end_logit": 0.8983778953552246
        },
        {
            "text": ". The functions of the high-abundance proteins were mainly related to glucose and fatty acid oxidation to produce heat for therm",
            "probability": 0.06722680443660532,
            "start_logit": 0.7735531330108643,
            "end_logit": 0.9087084531784058
        },
        {
            "text": ". A total of 4949 nonredundant proteins were identified, and 4495 were quantified using the",
            "probability": 0.06263598708235062,
            "start_logit": 0.8261657953262329,
            "end_logit": 0.7853637337684631
        },
        {
            "text": "profiled and functional",
            "probability": 0.05650274483225062,
            "start_logit": 0.8862465023994446,
            "end_logit": 0.6222322583198547
        },
        {
            "text": ". A total of 4949 nonredundant proteins were identified, and 4495 were quantified using the iBAQ method. According",
            "probability": 0.053403315163241274,
            "start_logit": 0.8261657953262329,
            "end_logit": 0.6258965730667114
        },
        {
            "text": ". A total of 4949 nonredundant proteins were identified,",
            "probability": 0.05244982946453348,
            "start_logit": 0.8261657953262329,
            "end_logit": 0.6078808307647705
        },
        {
            "text": "time, comprehensively profiled and functional",
            "probability": 0.051992596837803245,
            "start_logit": 0.8030586242675781,
            "end_logit": 0.6222322583198547
        },
        {
            "text": "trometry to construct a comprehensive proteome dataset of mouse BAT proteins. A total of 4949 nonredundant proteins were identified,",
            "probability": 0.05195558935754474,
            "start_logit": 0.8166980147361755,
            "end_logit": 0.6078808307647705
        },
        {
            "text": "comprehensive proteome dataset of mouse BAT proteins. A total of 4949 nonredundant proteins were identified,",
            "probability": 0.05160879302154926,
            "start_logit": 0.8100007772445679,
            "end_logit": 0.6078808307647705
        },
        {
            "text": ". A total of 4949 nonredundant proteins were identified",
            "probability": 0.0497445564124122,
            "start_logit": 0.8261657953262329,
            "end_logit": 0.5549247860908508
        },
        {
            "text": "trometry to construct a comprehensive proteome dataset of mouse BAT proteins. A total of 4949 nonredundant proteins were identified",
            "probability": 0.049275808370056746,
            "start_logit": 0.8166980147361755,
            "end_logit": 0.5549247860908508
        },
        {
            "text": "comprehensive proteome dataset of mouse BAT proteins. A total of 4949 nonredundant proteins were identified",
            "probability": 0.048946899199604425,
            "start_logit": 0.8100007772445679,
            "end_logit": 0.5549247860908508
        },
        {
            "text": ". A total of 4949 nonredundant proteins were identified, and 44",
            "probability": 0.04849722304354248,
            "start_logit": 0.8261657953262329,
            "end_logit": 0.5295302867889404
        },
        {
            "text": "comprehensive proteome dataset of mouse BAT proteins. A total of 4949 nonredundant proteins were identified, and 44",
            "probability": 0.047719566902815966,
            "start_logit": 0.8100007772445679,
            "end_logit": 0.5295302867889404
        },
        {
            "text": ". The functions of the",
            "probability": 0.047550267547403643,
            "start_logit": 0.7735531330108643,
            "end_logit": 0.562423825263977
        }
    ],
    "54da32bc0f63c58e6e000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54d8ea2c4b1fd0d33c000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "51542e44d24251bc05000081": [
        {
            "text": "GFR) and its downstream",
            "probability": 0.21351758366857865,
            "start_logit": 1.0665605068206787,
            "end_logit": 0.7271420955657959
        },
        {
            "text": "GFR) and its downstream factors KRAS and BRAF are mutated in several types of cancer, affecting the clinical response to EGFR",
            "probability": 0.187881542998986,
            "start_logit": 1.0665605068206787,
            "end_logit": 0.5992345809936523
        },
        {
            "text": "cl",
            "probability": 0.1531290572195319,
            "start_logit": 0.9338823556900024,
            "end_logit": 0.5273821353912354
        },
        {
            "text": "clonal antibody cetuximab in colorectal cancer. The",
            "probability": 0.1530379765765576,
            "start_logit": 0.9338823556900024,
            "end_logit": 0.5267871618270874
        },
        {
            "text": "GFR) and its downstream factors KRAS and BRAF are mu",
            "probability": 0.14826213010897238,
            "start_logit": 1.0665605068206787,
            "end_logit": 0.3624047636985779
        },
        {
            "text": "clonal antibody cetuximab in colorect",
            "probability": 0.14417170942737342,
            "start_logit": 0.9338823556900024,
            "end_logit": 0.46710607409477234
        }
    ],
    "5148e1d6d24251bc0500003a": [
        {
            "text": "sequencing of various spinal sections as well as the germline/blood sample were performed using a RASopathy gene panel",
            "probability": 0.07532181782146648,
            "start_logit": 0.9070584774017334,
            "end_logit": 1.286895751953125
        },
        {
            "text": "some of the surgical spinal samples corresponding to the allelic imbalance. Contra analysis did not show any deletion in Chromosome 17 next generation",
            "probability": 0.05966199231850614,
            "start_logit": 1.109318733215332,
            "end_logit": 0.8515608310699463
        },
        {
            "text": "Variants were compared between the spinal tissue samples and the germline data. In addition, the next generation sequencing allele",
            "probability": 0.05663119285763942,
            "start_logit": 1.0706720352172852,
            "end_logit": 0.8380722999572754
        },
        {
            "text": "Variants were compared between the spinal tissue samples and the",
            "probability": 0.05541198488214374,
            "start_logit": 1.0706720352172852,
            "end_logit": 0.8163082599639893
        },
        {
            "text": "sequencing data. Microarray analysis verified somatic copy neutral loss of heterozygosity for these two individuals for the majority of the chromosome 17",
            "probability": 0.05154372010386192,
            "start_logit": 0.9608910083770752,
            "end_logit": 0.8537237644195557
        },
        {
            "text": "is multifactorial and that a somatic NF1 mutation contributes to the etiology.",
            "probability": 0.05126393706816522,
            "start_logit": 0.9812788963317871,
            "end_logit": 0.8278930187225342
        },
        {
            "text": "-associated dystrophic scoliosis",
            "probability": 0.05094010834322933,
            "start_logit": 0.9296287298202515,
            "end_logit": 0.8732062578201294
        },
        {
            "text": ". Contra analysis did not show any deletion in Chromosome 17 next generation",
            "probability": 0.050490261273328244,
            "start_logit": 0.94240403175354,
            "end_logit": 0.8515608310699463
        },
        {
            "text": "of heterozygosity for these two individuals for the majority of the chromosome 17",
            "probability": 0.04952056809954094,
            "start_logit": 0.9208487272262573,
            "end_logit": 0.8537237644195557
        },
        {
            "text": "associated dystrophic scoliosis",
            "probability": 0.04944477450908102,
            "start_logit": 0.8998345136642456,
            "end_logit": 0.8732062578201294
        },
        {
            "text": "these two individuals for the majority of the chromosome 17",
            "probability": 0.04800378968145281,
            "start_logit": 0.8897405862808228,
            "end_logit": 0.8537237644195557
        },
        {
            "text": "-associated dystrophic",
            "probability": 0.04700848102538832,
            "start_logit": 0.9296287298202515,
            "end_logit": 0.7928836941719055
        },
        {
            "text": "is a common manifestation of neurofibromatosis type 1, causing significant morbidity.",
            "probability": 0.04677447154518445,
            "start_logit": 0.9943325519561768,
            "end_logit": 0.7231894135475159
        },
        {
            "text": "associated dystrophic",
            "probability": 0.04562855910422647,
            "start_logit": 0.8998345136642456,
            "end_logit": 0.7928836941719055
        },
        {
            "text": "two individuals with neurofibromatosis type 1 and dystrophic scoliosis",
            "probability": 0.04507269890710525,
            "start_logit": 0.8696929812431335,
            "end_logit": 0.8107681274414062
        },
        {
            "text": "neurofibromatosis type 1, causing significant morbidity.",
            "probability": 0.04387199942292821,
            "start_logit": 0.9302712678909302,
            "end_logit": 0.7231894135475159
        },
        {
            "text": "sequencing data. In addition, for the same two individuals, there was an increase in the % variant reads for the germ",
            "probability": 0.04377825089414709,
            "start_logit": 0.8982949256896973,
            "end_logit": 0.7530266046524048
        },
        {
            "text": "is a common manifestation of neurofibro",
            "probability": 0.04354601259391581,
            "start_logit": 0.9943325519561768,
            "end_logit": 0.651669979095459
        },
        {
            "text": "some of the",
            "probability": 0.04318178027085595,
            "start_logit": 1.109318733215332,
            "end_logit": 0.5282843112945557
        },
        {
            "text": "neurofibromatosis type 1, causing significant morbidity. The etiology of dystrophic scoliosis",
            "probability": 0.04290359927783319,
            "start_logit": 0.9302712678909302,
            "end_logit": 0.7008688449859619
        }
    ],
    "54d662113706e8952800000d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "550739cf3b8a5dc045000002": [
        {
            "text": "gulated in differentiating plasma cells by innate signaling. Compared with wild-",
            "probability": 0.09979047762831389,
            "start_logit": 1.1374210119247437,
            "end_logit": 0.7426795363426208
        },
        {
            "text": "gulated in differentiating",
            "probability": 0.09577391121929535,
            "start_logit": 1.1374210119247437,
            "end_logit": 0.7015970945358276
        },
        {
            "text": "regulated in differentiating plasma cells by innate signaling. Compared with wild-",
            "probability": 0.08431588274077449,
            "start_logit": 0.96891850233078,
            "end_logit": 0.7426795363426208
        },
        {
            "text": "regulated in differentiating",
            "probability": 0.08092216872705127,
            "start_logit": 0.96891850233078,
            "end_logit": 0.7015970945358276
        },
        {
            "text": ") polymerase highly expressed by activated B cells to suppress their proliferation. Here we measure the",
            "probability": 0.07535491720446619,
            "start_logit": 1.0455118417739868,
            "end_logit": 0.5537251234054565
        },
        {
            "text": "gulated in differentiating plasma cells by innate signaling. Compared with wild-type, Tent5",
            "probability": 0.07411763655772162,
            "start_logit": 1.1374210119247437,
            "end_logit": 0.44526028633117676
        },
        {
            "text": ") polymerase",
            "probability": 0.06989780130040049,
            "start_logit": 1.0455118417739868,
            "end_logit": 0.47855013608932495
        },
        {
            "text": "gulated in differentiating plasma cells by innate signaling. Compared with wild-type,",
            "probability": 0.06599680754139499,
            "start_logit": 1.1374210119247437,
            "end_logit": 0.32921314239501953
        },
        {
            "text": "gulated in differentiating plasma cells",
            "probability": 0.06392360375667802,
            "start_logit": 1.1374210119247437,
            "end_logit": 0.2972954511642456
        },
        {
            "text": "gulated",
            "probability": 0.06369301545210701,
            "start_logit": 1.1374210119247437,
            "end_logit": 0.29368168115615845
        },
        {
            "text": "regulated in differentiating plasma cells by innate signaling. Compared with wild-type, Tent5",
            "probability": 0.0626241511369524,
            "start_logit": 0.96891850233078,
            "end_logit": 0.44526028633117676
        },
        {
            "text": "regulated in differentiating plasma cells by innate signaling. Compared with wild-type,",
            "probability": 0.05576262603584196,
            "start_logit": 0.96891850233078,
            "end_logit": 0.32921314239501953
        },
        {
            "text": "regulated in differentiating plasma cells",
            "probability": 0.054010915738783236,
            "start_logit": 0.96891850233078,
            "end_logit": 0.2972954511642456
        },
        {
            "text": "regulated",
            "probability": 0.05381608496021918,
            "start_logit": 0.96891850233078,
            "end_logit": 0.29368168115615845
        }
    ],
    "56f961b3cf1c325851000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "53372ba3d6d3ac6a34000058": [
        {
            "text": "changes. The transcription factor ELONGATED HYPOCOTYL5 (HY5) acts downstream",
            "probability": 0.11148765403368,
            "start_logit": 1.0318405628204346,
            "end_logit": 0.8741680383682251
        },
        {
            "text": "changes. The",
            "probability": 0.09924831660243047,
            "start_logit": 1.0318405628204346,
            "end_logit": 0.7578791379928589
        },
        {
            "text": "is a critical plant developmental process that involves light-",
            "probability": 0.0951746981825117,
            "start_logit": 0.8918437361717224,
            "end_logit": 0.8559651374816895
        },
        {
            "text": "mediated transcriptome and histone modification changes. The transcription factor ELONGATED HYPOCOTYL5 (HY5) acts downstream",
            "probability": 0.09435464950537027,
            "start_logit": 0.8649872541427612,
            "end_logit": 0.8741680383682251
        },
        {
            "text": "changes. The transcription factor ELONGATED HYPOCOTYL5 (HY5) acts downstream of multiple families of photo",
            "probability": 0.09199336147448436,
            "start_logit": 1.0318405628204346,
            "end_logit": 0.6819705963134766
        },
        {
            "text": "is a critical plant developmental process that involves light-mediated transcriptome and histone modification changes. The",
            "probability": 0.08628261519240456,
            "start_logit": 0.8918437361717224,
            "end_logit": 0.7578791379928589
        },
        {
            "text": "mediated transcriptome and histone modification changes. The",
            "probability": 0.08399620754591675,
            "start_logit": 0.8649872541427612,
            "end_logit": 0.7578791379928589
        },
        {
            "text": "changes. The transcription factor ELONGATED HYPOCOTYL5 (HY5) acts downstream of multiple families of photorece",
            "probability": 0.07985197733862828,
            "start_logit": 1.0318405628204346,
            "end_logit": 0.5404288172721863
        },
        {
            "text": "A15, both in vitro and in vivo. Phenotypic analysis revealed that",
            "probability": 0.06949802593740094,
            "start_logit": 0.9337959289550781,
            "end_logit": 0.4995971620082855
        },
        {
            "text": "is a critical plant developmental process that involves light-mediated transcriptome",
            "probability": 0.06331545561451869,
            "start_logit": 0.8918437361717224,
            "end_logit": 0.4483804702758789
        },
        {
            "text": "A15, both in vitro and in vivo. Phenotypic analysis revealed that HDA15 is a negative regulator of",
            "probability": 0.06315938261146138,
            "start_logit": 0.9337959289550781,
            "end_logit": 0.4039602279663086
        },
        {
            "text": "mediated transcriptome",
            "probability": 0.06163765596119249,
            "start_logit": 0.8649872541427612,
            "end_logit": 0.4483804702758789
        }
    ],
    "56c1f02aef6e39474100004b": [
        {
            "text": "\u03b1 (IL-",
            "probability": 0.06405946341749592,
            "start_logit": 1.2086161375045776,
            "end_logit": 0.7878746390342712
        },
        {
            "text": "do not cross-react with pig IL-6R and pig IL-",
            "probability": 0.058083534861255365,
            "start_logit": 0.8267083168029785,
            "end_logit": 1.0718529224395752
        },
        {
            "text": "amycin partially inhibited human, baboon, and pig IL-",
            "probability": 0.0570368918544576,
            "start_logit": 0.8249974250793457,
            "end_logit": 1.055379867553711
        },
        {
            "text": "and pig cells, respectively. Activation of the IL-6/IL-",
            "probability": 0.05701154619554322,
            "start_logit": 0.8010422587394714,
            "end_logit": 1.0788905620574951
        },
        {
            "text": "R\u03b1/STAT3 pathways and suppressed inflammatory gene expression. TCZ treatment increased serum IL-",
            "probability": 0.05526528841749752,
            "start_logit": 0.9568312168121338,
            "end_logit": 0.8919928073883057
        },
        {
            "text": "human IL-6 inhibitor) bound to both human and baboon, but not pig, IL-6 and suppressed activation of the IL-",
            "probability": 0.05160418805823063,
            "start_logit": 0.9197574853897095,
            "end_logit": 0.8605243563652039
        },
        {
            "text": "human, baboon, and pig IL-6 can activate the IL-",
            "probability": 0.051221153967467105,
            "start_logit": 0.9471039175987244,
            "end_logit": 0.8257277011871338
        },
        {
            "text": "likely to bind to pig IL-",
            "probability": 0.05063354711150584,
            "start_logit": 0.9110992550849915,
            "end_logit": 0.8501940965652466
        },
        {
            "text": ". We suggest that increased serum IL-6 may be detrimental to the pig xenograft because it is likely to bind to pig IL-",
            "probability": 0.0504906117933185,
            "start_logit": 0.9082723259925842,
            "end_logit": 0.8501940965652466
        },
        {
            "text": "6/IL-6R\u03b1/STAT3 pathways and suppressed inflammatory gene expression. TCZ treatment increased serum IL-",
            "probability": 0.049868172423884694,
            "start_logit": 0.854069173336029,
            "end_logit": 0.8919928073883057
        },
        {
            "text": "be detrimental to the pig xenograft because it is likely to bind to pig IL-",
            "probability": 0.04894436670705978,
            "start_logit": 0.8771691918373108,
            "end_logit": 0.8501940965652466
        },
        {
            "text": "R\u03b1/STAT3 pathways and suppressed inflammatory gene expression. TCZ treatment increased serum IL-6 because it could no",
            "probability": 0.0479854138890363,
            "start_logit": 0.9568312168121338,
            "end_logit": 0.7507448792457581
        },
        {
            "text": "transplant. In vitro observations demonstrated that human, baboon, and pig IL-6 can activate the IL-",
            "probability": 0.045614020608880534,
            "start_logit": 0.8311664462089539,
            "end_logit": 0.8257277011871338
        },
        {
            "text": "do not cross-react with pig IL-6R and pig IL-6, respectively. Rapamy",
            "probability": 0.045493833930291584,
            "start_logit": 0.8267083168029785,
            "end_logit": 0.8275474905967712
        },
        {
            "text": "amy",
            "probability": 0.04541606545203683,
            "start_logit": 0.8249974250793457,
            "end_logit": 0.8275474905967712
        },
        {
            "text": ". We",
            "probability": 0.044915845941483824,
            "start_logit": 0.9082723259925842,
            "end_logit": 0.7331973314285278
        },
        {
            "text": "do not cross-react with pig IL-6R and pig IL-6,",
            "probability": 0.04467979116424382,
            "start_logit": 0.8267083168029785,
            "end_logit": 0.8094919919967651
        },
        {
            "text": "do not cross-react with pig IL-",
            "probability": 0.0442789280479102,
            "start_logit": 0.8267083168029785,
            "end_logit": 0.8004795908927917
        },
        {
            "text": "plant. In vitro observations demonstrated that human, baboon, and pig IL-6 can activate the IL-",
            "probability": 0.04371781611531213,
            "start_logit": 0.7887070178985596,
            "end_logit": 0.8257277011871338
        },
        {
            "text": "leukin (IL)-6/IL-6 receptor-\u03b1 (IL-",
            "probability": 0.043679520043088504,
            "start_logit": 0.8256837129592896,
            "end_logit": 0.7878746390342712
        }
    ],
    "551fd9c06b348bb82c000012": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54d7a1047035c08008000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55054f8af73303d458000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56f7c15a09dd18d46b000012": [
        {
            "text": "recessive autoinflammatory disorder",
            "probability": 0.0798305743997666,
            "start_logit": 0.8959277272224426,
            "end_logit": 0.7767972946166992
        },
        {
            "text": "starts during infancy with recurrent relapses of osteomyelitis typically associated with fever, congenital dyseryth",
            "probability": 0.07322962095411333,
            "start_logit": 0.9461004734039307,
            "end_logit": 0.640317976474762
        },
        {
            "text": "starts during infancy with",
            "probability": 0.059294279230883304,
            "start_logit": 0.9461004734039307,
            "end_logit": 0.42923080921173096
        },
        {
            "text": "first described in 1989. The syndrome starts during infancy with",
            "probability": 0.05787490663703296,
            "start_logit": 0.921871542930603,
            "end_logit": 0.42923080921173096
        },
        {
            "text": "starts during infancy with recurrent relapses of osteomyelitis typically associated with",
            "probability": 0.0573326602508535,
            "start_logit": 0.9461004734039307,
            "end_logit": 0.3955884277820587
        },
        {
            "text": "recessive autoinflammatory disorder first described in 1989. The syndrome starts during infancy with",
            "probability": 0.05639272064036053,
            "start_logit": 0.8959277272224426,
            "end_logit": 0.42923080921173096
        },
        {
            "text": "first described in 1989. The syndrome starts during infancy with recurrent relapses of osteomyelitis typically associated with",
            "probability": 0.05596024443354123,
            "start_logit": 0.921871542930603,
            "end_logit": 0.3955884277820587
        },
        {
            "text": "starts during infancy",
            "probability": 0.055272654500867074,
            "start_logit": 0.9461004734039307,
            "end_logit": 0.35899627208709717
        },
        {
            "text": "first described in 1989. The syndrome starts during infancy",
            "probability": 0.05394955061959031,
            "start_logit": 0.921871542930603,
            "end_logit": 0.35899627208709717
        },
        {
            "text": "starts during infancy with recurrent relapses of osteomyelitis typically associated with fever, congenital",
            "probability": 0.053841473507601795,
            "start_logit": 0.9461004734039307,
            "end_logit": 0.3327620327472687
        },
        {
            "text": "recessive autoinflammatory disorder first described in 1989. The syndrome starts during infancy",
            "probability": 0.05256789364419987,
            "start_logit": 0.8959277272224426,
            "end_logit": 0.35899627208709717
        },
        {
            "text": "first described in 1989. The syndrome starts during infancy with recurrent relapses of osteomyelitis typically associated with fever, congenital",
            "probability": 0.05255262890234676,
            "start_logit": 0.921871542930603,
            "end_logit": 0.3327620327472687
        },
        {
            "text": "recess",
            "probability": 0.051196236764605337,
            "start_logit": 0.8959277272224426,
            "end_logit": 0.33255675435066223
        },
        {
            "text": "starts",
            "probability": 0.05026544691774956,
            "start_logit": 0.9461004734039307,
            "end_logit": 0.2640358805656433
        },
        {
            "text": "first described in 1989. The syndrome starts",
            "probability": 0.049062204400965016,
            "start_logit": 0.921871542930603,
            "end_logit": 0.2640358805656433
        },
        {
            "text": "recessive autoinflammatory disorder first described in 1989. The syndrome starts",
            "probability": 0.04780571317610558,
            "start_logit": 0.8959277272224426,
            "end_logit": 0.2640358805656433
        },
        {
            "text": "first described in 1989. The",
            "probability": 0.047392459904837175,
            "start_logit": 0.921871542930603,
            "end_logit": 0.2294100522994995
        },
        {
            "text": "recessive autoinflammatory disorder first described in 1989. The",
            "probability": 0.04617873111458007,
            "start_logit": 0.8959277272224426,
            "end_logit": 0.2294100522994995
        }
    ],
    "5523e7837b523f2123000006": [
        {
            "text": "concanavalin A and lipopolysaccharide mitogens was observed after a single",
            "probability": 0.0899163861614189,
            "start_logit": 1.0120126008987427,
            "end_logit": 1.2545474767684937
        },
        {
            "text": "Trypan blue treatment of either donor or recipient",
            "probability": 0.05566163613339699,
            "start_logit": 0.9503101706504822,
            "end_logit": 0.8366608619689941
        },
        {
            "text": "trypan blue-treated donors on a nylon wool column before use in the graft-versus-host assay abrogated",
            "probability": 0.05450173476873646,
            "start_logit": 1.0236274003982544,
            "end_logit": 0.7422850131988525
        },
        {
            "text": "trypan blue-treated donors on",
            "probability": 0.05408870423004743,
            "start_logit": 1.0236274003982544,
            "end_logit": 0.7346778512001038
        },
        {
            "text": "trypan blue-treated donors on a nylon wool column before use in the graft-",
            "probability": 0.053232514538438094,
            "start_logit": 1.0236274003982544,
            "end_logit": 0.718721866607666
        },
        {
            "text": ". Treatment of mice with trypan blue delayed their rejection of skin all",
            "probability": 0.05322419583126937,
            "start_logit": 1.0589311122894287,
            "end_logit": 0.6832618713378906
        },
        {
            "text": "blue. A transient reduction in the",
            "probability": 0.05264630701152815,
            "start_logit": 0.9435338973999023,
            "end_logit": 0.7877420783042908
        },
        {
            "text": "tumors and inhibits the in vitro cytotoxi",
            "probability": 0.0510256714653783,
            "start_logit": 1.035247802734375,
            "end_logit": 0.664760947227478
        },
        {
            "text": "Trypan blue treatment of either donor or recipient decreased the local graft-",
            "probability": 0.04864592694382952,
            "start_logit": 0.9503101706504822,
            "end_logit": 0.7019377946853638
        },
        {
            "text": "Trypan blue treatment of either donor or recipient decreased the",
            "probability": 0.0477029993705891,
            "start_logit": 0.9503101706504822,
            "end_logit": 0.6823639869689941
        },
        {
            "text": "tumors and inhibits the",
            "probability": 0.046600799225715875,
            "start_logit": 1.035247802734375,
            "end_logit": 0.5740497708320618
        },
        {
            "text": "trypan blue-treated donors on a nylon wool column before use in the graft-versus-host assay abrogated the depressive",
            "probability": 0.04659132571303442,
            "start_logit": 1.0236274003982544,
            "end_logit": 0.5854668617248535
        },
        {
            "text": "ymph node cells was unaffected. The depressed response",
            "probability": 0.046548509257276355,
            "start_logit": 1.0000089406967163,
            "end_logit": 0.6081659197807312
        },
        {
            "text": "phage functions",
            "probability": 0.04647525891899775,
            "start_logit": 0.8867376446723938,
            "end_logit": 0.7198623418807983
        },
        {
            "text": "trypan blue selectively inhibits certain macrophage functions",
            "probability": 0.045728550513366835,
            "start_logit": 0.8705403804779053,
            "end_logit": 0.7198623418807983
        },
        {
            "text": "blue. A transient reduction in the blastogenic response",
            "probability": 0.04243515414359827,
            "start_logit": 0.9435338973999023,
            "end_logit": 0.572123110294342
        },
        {
            "text": "specific resistance of mice to transplanted tumors and inhibits the in vitro cytotoxi",
            "probability": 0.04176204869268149,
            "start_logit": 0.8349069356918335,
            "end_logit": 0.664760947227478
        },
        {
            "text": "blue.",
            "probability": 0.04139912952114,
            "start_logit": 0.9435338973999023,
            "end_logit": 0.5474058389663696
        },
        {
            "text": ". We therefore tested",
            "probability": 0.041272209535895964,
            "start_logit": 0.8656247854232788,
            "end_logit": 0.6222444772720337
        },
        {
            "text": "pan blue treatment decreases the nonspecific resistance of mice to transplanted tumors and inhibits the in vitro cytotoxi",
            "probability": 0.04054093802366077,
            "start_logit": 0.8052312135696411,
            "end_logit": 0.664760947227478
        }
    ],
    "56c1f045ef6e394741000058": [
        {
            "text": "symptoms. Finally, doses of selexipag up to 3200 mcg twice",
            "probability": 0.07996085223470396,
            "start_logit": 1.0223608016967773,
            "end_logit": 1.132151484489441
        },
        {
            "text": "lexipag up to 3200 mcg twice",
            "probability": 0.06968669042659748,
            "start_logit": 0.8848329782485962,
            "end_logit": 1.132151484489441
        },
        {
            "text": "TAPSE, and right heart catheterization hemodynamics were similar pre- and post-transition. The transition from parenteral prostan",
            "probability": 0.05800141753063383,
            "start_logit": 1.0017237663269043,
            "end_logit": 0.8317188024520874
        },
        {
            "text": "TAPSE, and right heart catheterization hemodynamics were similar pre- and post-",
            "probability": 0.055807951446880485,
            "start_logit": 1.0017237663269043,
            "end_logit": 0.7931677103042603
        },
        {
            "text": "xipag. From January",
            "probability": 0.04955879911891742,
            "start_logit": 0.9684953689575195,
            "end_logit": 0.7076395750045776
        },
        {
            "text": "clin therapy were offered the opportunity to transition to selexi",
            "probability": 0.04906809410330847,
            "start_logit": 1.0006623268127441,
            "end_logit": 0.6655218005180359
        },
        {
            "text": "clin therapy were offered the opportunity to transition to selexipag. A standardized protocol was developed to guide titra",
            "probability": 0.04820614304146167,
            "start_logit": 1.0006623268127441,
            "end_logit": 0.6477992534637451
        },
        {
            "text": "clin therapy were offered the opportunity to transition to selexipa",
            "probability": 0.047399816029397863,
            "start_logit": 1.0006623268127441,
            "end_logit": 0.6309311389923096
        },
        {
            "text": "lexipag up to 3200 mcg twice daily were well-tolerated in patients who had been treated with prior parenteral pro",
            "probability": 0.04700627708391065,
            "start_logit": 0.8848329782485962,
            "end_logit": 0.7384232878684998
        },
        {
            "text": "at study completion and",
            "probability": 0.04651934077309293,
            "start_logit": 0.9117038249969482,
            "end_logit": 0.7011394500732422
        },
        {
            "text": "and right heart catheterization hemodynamics were similar pre- and post-transition. The transition from parenteral prostan",
            "probability": 0.04651544796860985,
            "start_logit": 0.7810407876968384,
            "end_logit": 0.8317188024520874
        },
        {
            "text": "lexipag. A standardized protocol was developed to guide titration of therapies. Patients underwent pre- and post-",
            "probability": 0.046477452016604186,
            "start_logit": 0.8013750314712524,
            "end_logit": 0.8105673789978027
        },
        {
            "text": "lexipag up to 3200 mcg twice daily were well-tolerated in patients who had been treated with prior parenteral prostacycl",
            "probability": 0.045734968940372094,
            "start_logit": 0.8848329782485962,
            "end_logit": 0.7110053300857544
        },
        {
            "text": "functional status. We studied 14 patients with PAH (11 women; median",
            "probability": 0.04571945508585166,
            "start_logit": 0.8103998899459839,
            "end_logit": 0.7850991487503052
        },
        {
            "text": "6MWD, RV function, TAPSE, and right heart catheterization hemodynamics were similar pre- and post-",
            "probability": 0.04526666269606033,
            "start_logit": 0.7923782467842102,
            "end_logit": 0.7931677103042603
        },
        {
            "text": "and right heart catheterization hemodynamics were similar pre- and post-",
            "probability": 0.044756352039,
            "start_logit": 0.7810407876968384,
            "end_logit": 0.7931677103042603
        },
        {
            "text": "H (11 women; median",
            "probability": 0.044398953497302426,
            "start_logit": 0.7810918688774109,
            "end_logit": 0.7850991487503052
        },
        {
            "text": "lexipag up to 3200 mcg twice daily were well-tolerated in patients who had been treated with prior",
            "probability": 0.04407019644970114,
            "start_logit": 0.8848329782485962,
            "end_logit": 0.6739258766174316
        },
        {
            "text": "at study completion and 1 patient passed",
            "probability": 0.04362685414085863,
            "start_logit": 0.9117038249969482,
            "end_logit": 0.6369441747665405
        },
        {
            "text": "6MWD, RV function,",
            "probability": 0.04221827537673488,
            "start_logit": 0.7923782467842102,
            "end_logit": 0.7234500646591187
        }
    ],
    "5708992ccf1c32585100000d": [
        {
            "text": "CMS) Open Payments Database. The purpose of this study is to review reporting of orthopedic surgery residents and identify the",
            "probability": 0.0711632016217681,
            "start_logit": 1.1828315258026123,
            "end_logit": 0.8132816553115845
        },
        {
            "text": "CMS) Open Payments Database. The purpose of this",
            "probability": 0.06969413273162768,
            "start_logit": 1.1828315258026123,
            "end_logit": 0.7924219369888306
        },
        {
            "text": "Residents receiving industry payments are not legally required to be reported on",
            "probability": 0.059564300293243395,
            "start_logit": 1.0100367069244385,
            "end_logit": 0.8081570267677307
        },
        {
            "text": "required to be reported on",
            "probability": 0.055267233869871014,
            "start_logit": 0.9351605176925659,
            "end_logit": 0.8081570267677307
        },
        {
            "text": "required to be reported on the Centers for Medicare & Medicaid Services (CMS) Open Payments Database. The purpose of this",
            "probability": 0.054404405129404504,
            "start_logit": 0.9351605176925659,
            "end_logit": 0.7924219369888306
        },
        {
            "text": "CMS) Open Payments Database. The",
            "probability": 0.05374976552452073,
            "start_logit": 1.1828315258026123,
            "end_logit": 0.5326451063156128
        },
        {
            "text": "be reported on",
            "probability": 0.051639404955754815,
            "start_logit": 0.8672653436660767,
            "end_logit": 0.8081570267677307
        },
        {
            "text": "be reported on the Centers for Medicare & Medicaid Services (CMS) Open Payments Database. The purpose of this",
            "probability": 0.05083321366271267,
            "start_logit": 0.8672653436660767,
            "end_logit": 0.7924219369888306
        },
        {
            "text": "CMS) Open Payments",
            "probability": 0.05008351221204921,
            "start_logit": 1.1828315258026123,
            "end_logit": 0.4619976580142975
        },
        {
            "text": "CMS) Open",
            "probability": 0.04859255956982161,
            "start_logit": 1.1828315258026123,
            "end_logit": 0.431776225566864
        },
        {
            "text": "CMS) Open Payments Database. The purpose of this study is to review reporting of orth",
            "probability": 0.045890968048493616,
            "start_logit": 1.1828315258026123,
            "end_logit": 0.37457412481307983
        },
        {
            "text": "Residents receiving industry payments are not legally required to be reported on the Centers",
            "probability": 0.04588842701135167,
            "start_logit": 1.0100367069244385,
            "end_logit": 0.5473135709762573
        },
        {
            "text": "Residents receiving industry payments are not legally required to be reported on the Centers for Medicare & Medicaid Services (CMS) Open Payments Database. The",
            "probability": 0.045220226956844675,
            "start_logit": 1.0100367069244385,
            "end_logit": 0.5326451063156128
        },
        {
            "text": "CMS) Open Payments Database. The purpose of this study is to review reporting of or",
            "probability": 0.04513852840946167,
            "start_logit": 1.1828315258026123,
            "end_logit": 0.3580419719219208
        },
        {
            "text": "Residents receiving industry payments are not legally required to be reported on the",
            "probability": 0.043190023904291726,
            "start_logit": 1.0100367069244385,
            "end_logit": 0.48671016097068787
        },
        {
            "text": "required to be reported on the Centers",
            "probability": 0.04257796054131708,
            "start_logit": 0.9351605176925659,
            "end_logit": 0.5473135709762573
        },
        {
            "text": "Residents receiving industry payments are not legally required to be reported on the Centers for Medicare & Medicaid Services (CMS) Open Payments",
            "probability": 0.04213577058287943,
            "start_logit": 1.0100367069244385,
            "end_logit": 0.4619976580142975
        },
        {
            "text": "CMS) Open Payments Database. The purpose of this study is to review reporting of orthoped",
            "probability": 0.042126982548454824,
            "start_logit": 1.1828315258026123,
            "end_logit": 0.2889942526817322
        },
        {
            "text": "required to be reported on the Centers for Medicare & Medicaid Services (CMS) Open Payments Database. The",
            "probability": 0.041957965535877766,
            "start_logit": 0.9351605176925659,
            "end_logit": 0.5326451063156128
        },
        {
            "text": "Residents receiving industry payments are not legally required to be reported on the Centers for Medicare & Medicaid Services (CMS) Open",
            "probability": 0.04088141689025388,
            "start_logit": 1.0100367069244385,
            "end_logit": 0.431776225566864
        }
    ],
    "550ea8f1b305b40c5c000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5319a708b166e2b806000024": [
        {
            "text": "cancer cells and their 3D spheroids.",
            "probability": 0.3617835257151603,
            "start_logit": 0.8990263342857361,
            "end_logit": 0.33410853147506714
        },
        {
            "text": "cancer cells and their",
            "probability": 0.3198566288175671,
            "start_logit": 0.8990263342857361,
            "end_logit": 0.21093535423278809
        },
        {
            "text": "cancer cells and their 3D spheroids",
            "probability": 0.3183598454672726,
            "start_logit": 0.8990263342857361,
            "end_logit": 0.2062448263168335
        }
    ],
    "56cf3f4f3975bb303a000008": [
        {
            "text": "c expression which correlated",
            "probability": 0.07961973010174594,
            "start_logit": 0.7364492416381836,
            "end_logit": 1.0229743719100952
        },
        {
            "text": "regulation in the human female cell line, SH-",
            "probability": 0.07916159300919864,
            "start_logit": 0.9489734172821045,
            "end_logit": 0.8046795129776001
        },
        {
            "text": "active under basal growth conditions; however, the alleles showed distinct transcription factor binding and epigenetic marks at their respective promoters",
            "probability": 0.0779957452758705,
            "start_logit": 0.7771257162094116,
            "end_logit": 0.9616902470588684
        },
        {
            "text": "c expression which correlated with allele",
            "probability": 0.07302365256258928,
            "start_logit": 0.7364492416381836,
            "end_logit": 0.936495840549469
        },
        {
            "text": "promoter function has implications for gender differences",
            "probability": 0.0710042905202927,
            "start_logit": 0.8634302616119385,
            "end_logit": 0.7814717292785645
        },
        {
            "text": "c expression which correlated with allele-specific changes in distinct transcription factor binding and epigenetic marks at the region encompassing",
            "probability": 0.06836010756156775,
            "start_logit": 0.7364492416381836,
            "end_logit": 0.8705018758773804
        },
        {
            "text": "is on the X chromosome suggesting gender could play a role in regulation. We analysed MAOA regulation in the human female cell line, SH-",
            "probability": 0.06577104451957314,
            "start_logit": 0.7636618614196777,
            "end_logit": 0.8046795129776001
        },
        {
            "text": "these disorders. MAOA is on the X chromosome suggesting gender could play a role in regulation. We",
            "probability": 0.0655481446880879,
            "start_logit": 0.8163273930549622,
            "end_logit": 0.7486191987991333
        },
        {
            "text": "promoter function has implications for gender differences in gene \u00d7 environment responses in which the uVNTR has been implicated as a genetic",
            "probability": 0.0635021563833541,
            "start_logit": 0.8634302616119385,
            "end_logit": 0.6698052883148193
        },
        {
            "text": "is on the X chromosome suggesting gender could play a role in regulation. We",
            "probability": 0.06218534583048832,
            "start_logit": 0.7636618614196777,
            "end_logit": 0.7486191987991333
        },
        {
            "text": "these disorders. MAOA is on the X chromosome suggesting gender could",
            "probability": 0.06045249031451759,
            "start_logit": 0.8163273930549622,
            "end_logit": 0.6676920652389526
        },
        {
            "text": "has been implicated as a genetic",
            "probability": 0.06044358734136199,
            "start_logit": 0.8140668869018555,
            "end_logit": 0.6698052883148193
        },
        {
            "text": "active under basal growth conditions; however, the all",
            "probability": 0.05884431654639519,
            "start_logit": 0.7771257162094116,
            "end_logit": 0.6799312233924866
        },
        {
            "text": "is on the X chromosome suggesting gender could",
            "probability": 0.057351112444311396,
            "start_logit": 0.7636618614196777,
            "end_logit": 0.6676920652389526
        },
        {
            "text": "c expression which correlated with allele-specific changes in distinct transcription factor binding and epigenetic marks at the region encompassing the",
            "probability": 0.056736682900645596,
            "start_logit": 0.7364492416381836,
            "end_logit": 0.6841334104537964
        }
    ],
    "56c079b1ef6e394741000022": [
        {
            "text": "is a specific antidote for the anticoagulant dabigatran. Although its",
            "probability": 0.11532052154751085,
            "start_logit": 0.9791072607040405,
            "end_logit": 0.8031672835350037
        },
        {
            "text": "ran; however, the safety and efficacy of this therapy are equivocal because of the limited",
            "probability": 0.11504955848201487,
            "start_logit": 1.1648719310760498,
            "end_logit": 0.615050196647644
        },
        {
            "text": "Idarucizumab is a specific antidote for the anticoagulant dabigatran. Although its",
            "probability": 0.11244399156718014,
            "start_logit": 0.9538471102714539,
            "end_logit": 0.8031672835350037
        },
        {
            "text": "ran; however, the safety and efficacy of this therapy are equivocal because of the limited number of reported cases",
            "probability": 0.11114040494956753,
            "start_logit": 1.1648719310760498,
            "end_logit": 0.5804815292358398
        },
        {
            "text": "ran; however, the safety",
            "probability": 0.10614700829697295,
            "start_logit": 1.1648719310760498,
            "end_logit": 0.5345122218132019
        },
        {
            "text": "ran; however, the safety and efficacy of this therapy are equivocal because of the limited number of reported cases. We",
            "probability": 0.09827506127617752,
            "start_logit": 1.1648719310760498,
            "end_logit": 0.4574575126171112
        },
        {
            "text": "ran; however, the safety and efficacy of this therapy are equivocal because of the limited number",
            "probability": 0.09377503995981516,
            "start_logit": 1.1648719310760498,
            "end_logit": 0.4105859398841858
        },
        {
            "text": "ran; however, the safety and efficacy of this therapy",
            "probability": 0.0905044778196741,
            "start_logit": 1.1648719310760498,
            "end_logit": 0.37508654594421387
        },
        {
            "text": "is a specific antidote for the antico",
            "probability": 0.07966554809343208,
            "start_logit": 0.9791072607040405,
            "end_logit": 0.433289110660553
        },
        {
            "text": "Idarucizumab is a specific antidote for the antico",
            "probability": 0.07767838800765478,
            "start_logit": 0.9538471102714539,
            "end_logit": 0.433289110660553
        }
    ],
    "5709f027cf1c32585100001f": [
        {
            "text": "entifiers. This effectively permits authors to claim credit",
            "probability": 0.06910567814342367,
            "start_logit": 0.9175721406936646,
            "end_logit": 0.9114657640457153
        },
        {
            "text": "contributors, we",
            "probability": 0.060178288207116085,
            "start_logit": 0.7883096933364868,
            "end_logit": 0.902402937412262
        },
        {
            "text": "authors to claim credit",
            "probability": 0.06004965239386563,
            "start_logit": 0.7771070003509521,
            "end_logit": 0.9114657640457153
        },
        {
            "text": "contributors, we recently enabled the linking between authorship of all Pfam entries",
            "probability": 0.05968631800375878,
            "start_logit": 0.7883096933364868,
            "end_logit": 0.8941941261291504
        },
        {
            "text": "many community contributors, we",
            "probability": 0.05951779535500182,
            "start_logit": 0.777273416519165,
            "end_logit": 0.902402937412262
        },
        {
            "text": "many community contributors, we recently enabled the linking between authorship of all Pfam entries",
            "probability": 0.059031224820070644,
            "start_logit": 0.777273416519165,
            "end_logit": 0.8941941261291504
        },
        {
            "text": "Pfam clans, as well as their functional annotation. We recently began to collaborate with the RepeatsDB resource to improve the definition of tandem",
            "probability": 0.05272599426460749,
            "start_logit": 0.8259533643722534,
            "end_logit": 0.7325562238693237
        },
        {
            "text": "Pfam. We carried out",
            "probability": 0.05180183711474969,
            "start_logit": 0.919887363910675,
            "end_logit": 0.6209392547607422
        },
        {
            "text": "Pfam entries to the Sequence Ontology (SO) through mapping of the Pfam type definitions to SO terms. Since",
            "probability": 0.04946220724012494,
            "start_logit": 0.7922713160514832,
            "end_logit": 0.7023385763168335
        },
        {
            "text": "Pfam clans, as well as their functional annotation. We recently began to collaborate with the RepeatsDB",
            "probability": 0.04878540037308742,
            "start_logit": 0.8259533643722534,
            "end_logit": 0.6548787355422974
        },
        {
            "text": "Pfam. We",
            "probability": 0.047513772750964044,
            "start_logit": 0.919887363910675,
            "end_logit": 0.5345332622528076
        },
        {
            "text": "Pfam entries to the Sequence Ontology (SO) through mapping of the Pfam",
            "probability": 0.046105731814998656,
            "start_logit": 0.7922713160514832,
            "end_logit": 0.6320669651031494
        },
        {
            "text": "Pfam clans, as well as their functional annotation. We recently began to collaborate with the Repeats",
            "probability": 0.04575587052959929,
            "start_logit": 0.8259533643722534,
            "end_logit": 0.5907677412033081
        },
        {
            "text": "contributors, we recently enabled the linking",
            "probability": 0.04300850080496483,
            "start_logit": 0.7883096933364868,
            "end_logit": 0.5664891004562378
        },
        {
            "text": "many community contributors, we recently enabled the linking",
            "probability": 0.04253645668061118,
            "start_logit": 0.777273416519165,
            "end_logit": 0.5664891004562378
        },
        {
            "text": "Pfam entries to the",
            "probability": 0.041338711439002813,
            "start_logit": 0.7922713160514832,
            "end_logit": 0.5229290723800659
        },
        {
            "text": "contributors, we recently enabled the linking between authorship of all",
            "probability": 0.04112235824507025,
            "start_logit": 0.7883096933364868,
            "end_logit": 0.5216432809829712
        },
        {
            "text": "Pfam entries to the Sequence Ontology (SO",
            "probability": 0.04082024016170099,
            "start_logit": 0.7922713160514832,
            "end_logit": 0.5103077292442322
        },
        {
            "text": "Pfam entries to the Sequence Ontology (SO) through mapping of the Pfam type definitions to SO",
            "probability": 0.04078294598927985,
            "start_logit": 0.7922713160514832,
            "end_logit": 0.5093936920166016
        },
        {
            "text": "many community contributors, we recently enabled the linking between authorship of all",
            "probability": 0.040671015668002075,
            "start_logit": 0.777273416519165,
            "end_logit": 0.5216432809829712
        }
    ],
    "5178d6be8ed59a060a000038": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "531dd4af267d7dd05300000d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52ece29f98d023950500002c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5148691bd24251bc0500002d": [
        {
            "text": "21-5p bound directly to DUSP8. MiR-",
            "probability": 0.06352746998212731,
            "start_logit": 1.0735628604888916,
            "end_logit": 1.0144788026809692
        },
        {
            "text": "21-5p",
            "probability": 0.06102490936182953,
            "start_logit": 1.096027135848999,
            "end_logit": 0.9518242478370667
        },
        {
            "text": "21-5p bound directly to DUSP8",
            "probability": 0.057125718688409814,
            "start_logit": 1.0735628604888916,
            "end_logit": 0.9082608222961426
        },
        {
            "text": "bleeding within the brain tissue. Inflammation has been implicated",
            "probability": 0.05567526537130314,
            "start_logit": 1.1807546615600586,
            "end_logit": 0.7753505706787109
        },
        {
            "text": "Importantly, intracereb",
            "probability": 0.053630003239124785,
            "start_logit": 1.0205092430114746,
            "end_logit": 0.898168683052063
        },
        {
            "text": "bleeding within the",
            "probability": 0.05323450571658393,
            "start_logit": 1.1807546615600586,
            "end_logit": 0.7305213809013367
        },
        {
            "text": "21-",
            "probability": 0.05261926327893391,
            "start_logit": 1.096027135848999,
            "end_logit": 0.8036243915557861
        },
        {
            "text": "Importantly, intracerebroventricularly injecting antagomir for miR-21-5p (A-",
            "probability": 0.04916668144922232,
            "start_logit": 1.0205092430114746,
            "end_logit": 0.8112761974334717
        },
        {
            "text": "21-5p levels were notably elevated in patients relative to healthy individuals and were correlated",
            "probability": 0.04889948345464194,
            "start_logit": 1.096027135848999,
            "end_logit": 0.7303089499473572
        },
        {
            "text": "Importantly, intracerebroventricularly inject",
            "probability": 0.048512652170523994,
            "start_logit": 1.0205092430114746,
            "end_logit": 0.7978846430778503
        },
        {
            "text": "NAs that respond strongly to HO-",
            "probability": 0.04828134119565051,
            "start_logit": 0.9232931137084961,
            "end_logit": 0.8903213143348694
        },
        {
            "text": "gulation in vitro downregulated DUSP8 expression. Importantly, intracereb",
            "probability": 0.048119071038874396,
            "start_logit": 0.9120791554450989,
            "end_logit": 0.898168683052063
        },
        {
            "text": "Importantly, intracerebroventricularly injecting antagomir for miR-21-5p (A-miR-",
            "probability": 0.04718372894278648,
            "start_logit": 1.0205092430114746,
            "end_logit": 0.7701091170310974
        },
        {
            "text": "blood-",
            "probability": 0.04603608449634109,
            "start_logit": 1.097610354423523,
            "end_logit": 0.6683844327926636
        },
        {
            "text": "is known about the",
            "probability": 0.04541649261897259,
            "start_logit": 0.9728030562400818,
            "end_logit": 0.7796415090560913
        },
        {
            "text": "NAs that respond strongly to HO-1 regulation in ICH",
            "probability": 0.0451297548922793,
            "start_logit": 0.9232931137084961,
            "end_logit": 0.8228179216384888
        },
        {
            "text": "vitro downregulated DUSP8 expression. Importantly, intracereb",
            "probability": 0.04496983665437375,
            "start_logit": 0.8443925380706787,
            "end_logit": 0.898168683052063
        },
        {
            "text": "activity and has been shown to distinctly affect anti-inflammatory functions after central nervous system (CNS) injury. However, less is known about the",
            "probability": 0.04452111125803826,
            "start_logit": 0.9528912305831909,
            "end_logit": 0.7796415090560913
        },
        {
            "text": "gulation in vitro downregulated DUSP8 expression. Importantly, intracerebroventricularly inject",
            "probability": 0.043527570671012775,
            "start_logit": 0.9120791554450989,
            "end_logit": 0.7978846430778503
        },
        {
            "text": "gulated DUSP8 expression. Importantly, intracereb",
            "probability": 0.04339905551897043,
            "start_logit": 0.8088382482528687,
            "end_logit": 0.898168683052063
        }
    ],
    "56c3320a50c68dd416000008": [
        {
            "text": "variants, respectively, confirming the peculiarity of the CFTR allelic spectrum with only few population-",
            "probability": 0.0765877911831082,
            "start_logit": 1.059078335762024,
            "end_logit": 1.0283327102661133
        },
        {
            "text": "-",
            "probability": 0.06553146485217635,
            "start_logit": 0.9031710624694824,
            "end_logit": 1.0283327102661133
        },
        {
            "text": "sequencing data in the Genome Aggregation Database (gnomAD). We selected",
            "probability": 0.05624681721555382,
            "start_logit": 1.0156426429748535,
            "end_logit": 0.7630801796913147
        },
        {
            "text": ") also depends on the variable prevalence/incidence of the",
            "probability": 0.05588891041975393,
            "start_logit": 1.0417771339416504,
            "end_logit": 0.7305622100830078
        },
        {
            "text": "variants submitted to the ClinVar database. Only 14 of these variants were found in the",
            "probability": 0.05412867408049864,
            "start_logit": 0.8926680088043213,
            "end_logit": 0.8476694226264954
        },
        {
            "text": "variants, respectively, confirming the peculiarity of the CFTR allelic spectrum with",
            "probability": 0.05371630628715055,
            "start_logit": 1.059078335762024,
            "end_logit": 0.6736116409301758
        },
        {
            "text": "used to optimize CFTR carrier screening in non-Caucasian subjects, choosing between the full gene sequencing and cost and time-",
            "probability": 0.05182631819316158,
            "start_logit": 0.9729186296463013,
            "end_logit": 0.7239528298377991
        },
        {
            "text": ") also depends on the",
            "probability": 0.05074027767872611,
            "start_logit": 1.0417771339416504,
            "end_logit": 0.6339162588119507
        },
        {
            "text": ") also depends on",
            "probability": 0.04990842721691173,
            "start_logit": 1.0417771339416504,
            "end_logit": 0.6173861026763916
        },
        {
            "text": "Caucasian subjects, choosing between the full gene sequencing and cost and time-",
            "probability": 0.04810201652281198,
            "start_logit": 0.8983446359634399,
            "end_logit": 0.7239528298377991
        },
        {
            "text": "variants, respectively, confirming the peculiarity of the CFTR allelic spectrum with only few population-specific variants. These data could",
            "probability": 0.04809315512188847,
            "start_logit": 1.059078335762024,
            "end_logit": 0.5630348920822144
        },
        {
            "text": ") also depends on the variable prevalence/incidence of the disease associated with the wide CFTR allelic heterogeneity",
            "probability": 0.04754519582249072,
            "start_logit": 1.0417771339416504,
            "end_logit": 0.5688769817352295
        },
        {
            "text": "depends on the variable prevalence/incidence of the",
            "probability": 0.0464222084820083,
            "start_logit": 0.8561891317367554,
            "end_logit": 0.7305622100830078
        },
        {
            "text": "variants submitted to the ClinVar database. Only 14 of these variants were found in the East-Asian population, while for South-",
            "probability": 0.04635675197341793,
            "start_logit": 0.8926680088043213,
            "end_logit": 0.6926723122596741
        },
        {
            "text": "variants submitted to the ClinVar database. Only 14 of these variants were found in the East-",
            "probability": 0.04410829499177743,
            "start_logit": 0.8926680088043213,
            "end_logit": 0.6429532170295715
        },
        {
            "text": "depends on the",
            "probability": 0.042145673106632496,
            "start_logit": 0.8561891317367554,
            "end_logit": 0.6339162588119507
        },
        {
            "text": "depends on",
            "probability": 0.04145472502276086,
            "start_logit": 0.8561891317367554,
            "end_logit": 0.6173861026763916
        },
        {
            "text": "-specific variants. These data could",
            "probability": 0.04115035641862724,
            "start_logit": 0.9031710624694824,
            "end_logit": 0.5630348920822144
        },
        {
            "text": "variants submitted to the ClinVar database. Only 14 of these variants were found in the East-Asian population, while for South",
            "probability": 0.04055484757262148,
            "start_logit": 0.8926680088043213,
            "end_logit": 0.5589606761932373
        },
        {
            "text": "depends on the variable prevalence/incidence of the disease associated with the wide CFTR allelic heterogeneity",
            "probability": 0.039491787837922426,
            "start_logit": 0.8561891317367554,
            "end_logit": 0.5688769817352295
        }
    ],
    "5318929fb166e2b80600001b": [
        {
            "text": "Overall, our results showed that the identification of HER2+ breast tumors diagnosed",
            "probability": 0.07038221251783155,
            "start_logit": 1.1494765281677246,
            "end_logit": 0.86057049036026
        },
        {
            "text": "i syndrome, caused by germ",
            "probability": 0.06630955181427164,
            "start_logit": 1.161759614944458,
            "end_logit": 0.7886807918548584
        },
        {
            "text": "Overall, our results showed that the identification of HER2+ breast tumors diagnosed before the age of 40 can be conservatively incorporated",
            "probability": 0.0603598746383216,
            "start_logit": 1.1494765281677246,
            "end_logit": 0.7069544792175293
        },
        {
            "text": "Overall, our results showed that the identification of HER2+ breast tumors diagnosed before the age",
            "probability": 0.05856554803138477,
            "start_logit": 1.1494765281677246,
            "end_logit": 0.6767765283584595
        },
        {
            "text": "of HER2+ breast tumors diagnosed",
            "probability": 0.056459902616027846,
            "start_logit": 0.9290666580200195,
            "end_logit": 0.86057049036026
        },
        {
            "text": "groups, we investigated if breast tumor HER2+ status has utility as a predict",
            "probability": 0.05236657515535282,
            "start_logit": 0.8523755669593811,
            "end_logit": 0.8619993925094604
        },
        {
            "text": "is the most common malignancy in women with Li-Fraumeni syndrome, caused by germ",
            "probability": 0.051220366946518735,
            "start_logit": 0.9035629034042358,
            "end_logit": 0.7886807918548584
        },
        {
            "text": "of HER2+ breast tumors diagnosed before the age of 40 can be conservatively incorporated",
            "probability": 0.04842008402523409,
            "start_logit": 0.9290666580200195,
            "end_logit": 0.7069544792175293
        },
        {
            "text": "caused by germ",
            "probability": 0.04771819922206571,
            "start_logit": 0.8327385187149048,
            "end_logit": 0.7886807918548584
        },
        {
            "text": "TP53 germline variant pathogenicity,",
            "probability": 0.04759942449745788,
            "start_logit": 0.9209352731704712,
            "end_logit": 0.6979918479919434
        },
        {
            "text": "TP53 germline variant pathogenicity, considering age",
            "probability": 0.0469973298117766,
            "start_logit": 0.9209352731704712,
            "end_logit": 0.6852619647979736
        },
        {
            "text": "of HER2+ breast tumors diagnosed before the age",
            "probability": 0.046980693277702046,
            "start_logit": 0.9290666580200195,
            "end_logit": 0.6767765283584595
        },
        {
            "text": "of HER2+ breast tumors diagnosed before the age of 40 can be conservatively incorporated into the current TP53-",
            "probability": 0.04599055834768941,
            "start_logit": 0.9290666580200195,
            "end_logit": 0.655475914478302
        },
        {
            "text": "is the",
            "probability": 0.04594506239479082,
            "start_logit": 0.9035629034042358,
            "end_logit": 0.6799899339675903
        },
        {
            "text": "groups, we investigated if breast tumor HER2+ status has utility as a predictor of TP53 germline variant pathogenicity,",
            "probability": 0.04444537755610152,
            "start_logit": 0.8523755669593811,
            "end_logit": 0.6979918479919434
        },
        {
            "text": "groups, we",
            "probability": 0.04425835004150934,
            "start_logit": 0.8523755669593811,
            "end_logit": 0.693774938583374
        },
        {
            "text": "icity of germline variants in other genes, and it has",
            "probability": 0.043579707190678274,
            "start_logit": 0.9956529140472412,
            "end_logit": 0.5350451469421387
        },
        {
            "text": "TP53 germ",
            "probability": 0.042808635261244496,
            "start_logit": 0.9209352731704712,
            "end_logit": 0.5919110178947449
        },
        {
            "text": "groups, we investigated if breast tumor HER2+ status has utility as a predictor of TP53 germ",
            "probability": 0.039972036992780575,
            "start_logit": 0.8523755669593811,
            "end_logit": 0.5919110178947449
        },
        {
            "text": "groups, we investigated",
            "probability": 0.03962050966126033,
            "start_logit": 0.8523755669593811,
            "end_logit": 0.5830777883529663
        }
    ],
    "51475d5cd24251bc0500001b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54e0c3e71388e8454a000013": [
        {
            "text": "clinical studies demonstrate that orteronel treatment suppresses androgen levels and causes shrinkage of androgen-",
            "probability": 0.11498994721087769,
            "start_logit": 0.9792838096618652,
            "end_logit": 0.9154245853424072
        },
        {
            "text": "es alone. Treatment with single-agent orteronel has been well tolerated with fatigue as the most",
            "probability": 0.1136014227801688,
            "start_logit": 0.8696497082710266,
            "end_logit": 1.012910008430481
        },
        {
            "text": "age of androgen-",
            "probability": 0.10148951716842214,
            "start_logit": 0.8543946146965027,
            "end_logit": 0.9154245853424072
        },
        {
            "text": "es alone. Treatment with single-",
            "probability": 0.09453928820667583,
            "start_logit": 0.8696497082710266,
            "end_logit": 0.829229474067688
        },
        {
            "text": "es alone. Treatment with single-agent orteronel has been well tolerated with fatigue as",
            "probability": 0.0928445693746952,
            "start_logit": 0.8696497082710266,
            "end_logit": 0.811140775680542
        },
        {
            "text": "es alone. Treatment with single",
            "probability": 0.09101561320937865,
            "start_logit": 0.8696497082710266,
            "end_logit": 0.7912450432777405
        },
        {
            "text": "survival primary end point was not",
            "probability": 0.08984436688575889,
            "start_logit": 0.8047043085098267,
            "end_logit": 0.8432382941246033
        },
        {
            "text": "clinical studies demonstrate that orteronel treatment suppresses androgen levels",
            "probability": 0.08162826441361867,
            "start_logit": 0.9792838096618652,
            "end_logit": 0.5727554559707642
        },
        {
            "text": "es alone. Treatment with single-agent orteronel has been well tolerated with fatigue as the most common adverse event,",
            "probability": 0.0764584990450375,
            "start_logit": 0.8696497082710266,
            "end_logit": 0.6169620752334595
        },
        {
            "text": "prostate gland. Early reports of clinical studies demonstrate that orter",
            "probability": 0.0722990282163932,
            "start_logit": 0.8684564828872681,
            "end_logit": 0.5622178912162781
        },
        {
            "text": "age of androgen-dependent organs, such as the prostate gland. Early reports of clinical studies demonstrate that orter",
            "probability": 0.0712894834889734,
            "start_logit": 0.8543946146965027,
            "end_logit": 0.5622178912162781
        }
    ],
    "54db5e24bcba1b1817000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "515d692c298dcd4e5100000a": [
        {
            "text": "promoter inactivated or an octamer",
            "probability": 0.13954564422535712,
            "start_logit": 1.0510286092758179,
            "end_logit": 0.7092038989067078
        },
        {
            "text": "promoter inactivated or an octamer motif deleted were at most modestly impaired for tk expression. Thus,",
            "probability": 0.11899253056719063,
            "start_logit": 1.0510286092758179,
            "end_logit": 0.549872875213623
        },
        {
            "text": "tk TATA box is solely required for trans induction",
            "probability": 0.10864787745637855,
            "start_logit": 1.0773299932479858,
            "end_logit": 0.4326229393482208
        },
        {
            "text": "tk TATA",
            "probability": 0.10082001148140941,
            "start_logit": 1.0773299932479858,
            "end_logit": 0.3578476309776306
        },
        {
            "text": "promoter",
            "probability": 0.09889560839417118,
            "start_logit": 1.0510286092758179,
            "end_logit": 0.36487698554992676
        },
        {
            "text": "tk TATA box is solely required for trans induction of this",
            "probability": 0.0870330068253766,
            "start_logit": 1.0773299932479858,
            "end_logit": 0.2107982039451599
        },
        {
            "text": "tk TATA box is solely required for trans induction of this gene.",
            "probability": 0.08691268135765794,
            "start_logit": 1.0773299932479858,
            "end_logit": 0.20941472053527832
        },
        {
            "text": "tk",
            "probability": 0.08683712441986823,
            "start_logit": 1.0773299932479858,
            "end_logit": 0.2085449993610382
        },
        {
            "text": "promoter inactivated or an oct",
            "probability": 0.08624442266030634,
            "start_logit": 1.0510286092758179,
            "end_logit": 0.2279975414276123
        },
        {
            "text": "promoter inactivated or an octamer motif deleted were at most modestly impaired for tk expression.",
            "probability": 0.08607109261228407,
            "start_logit": 1.0510286092758179,
            "end_logit": 0.22598576545715332
        }
    ],
    "55149f156a8cde6b72000013": [
        {
            "text": "TKIs), associated with these mutations, the resistance problem seems to diminish",
            "probability": 0.08349245678969135,
            "start_logit": 1.196527361869812,
            "end_logit": 0.995283305644989
        },
        {
            "text": "prone to resistance. The aim of this review is to focus on",
            "probability": 0.0602120463300204,
            "start_logit": 0.9394263029098511,
            "end_logit": 0.9255005121231079
        },
        {
            "text": "), associated with these mutations, the resistance problem seems to diminish",
            "probability": 0.05925146163373457,
            "start_logit": 0.853561520576477,
            "end_logit": 0.995283305644989
        },
        {
            "text": "TKIs), associated with these",
            "probability": 0.05681675599345484,
            "start_logit": 1.196527361869812,
            "end_logit": 0.6103582978248596
        },
        {
            "text": "is the first-line treatment for CML-patients. However, it became clear that Philadelphia-positive (Ph+) cells could",
            "probability": 0.053428462382871016,
            "start_logit": 0.8719416260719299,
            "end_logit": 0.8734563589096069
        },
        {
            "text": "kinase. It is the first-line treatment for CML-patients. However, it became clear that Philadelphia-positive (Ph+) cells could",
            "probability": 0.05256657911020801,
            "start_logit": 0.8556785583496094,
            "end_logit": 0.8734563589096069
        },
        {
            "text": "prone to resistance. The",
            "probability": 0.05023702077795477,
            "start_logit": 0.9394263029098511,
            "end_logit": 0.7443802952766418
        },
        {
            "text": ". This fusion gene codes tyrosine kinase which accelerates the cell",
            "probability": 0.04734974954048279,
            "start_logit": 0.8459744453430176,
            "end_logit": 0.7786414623260498
        },
        {
            "text": "prone to resistance. The aim of this review is",
            "probability": 0.046368286393498485,
            "start_logit": 0.9394263029098511,
            "end_logit": 0.6642438173294067
        },
        {
            "text": "), associated with these mutations, the resistance problem seems to diminish, as some of the new drugs are less prone to resistance. The",
            "probability": 0.046103434036857675,
            "start_logit": 0.853561520576477,
            "end_logit": 0.7443802952766418
        },
        {
            "text": "CML) arises from the fusion of the BCR and the ABL1 genes. The BCR gene (chromosome 22q11",
            "probability": 0.046072859175515124,
            "start_logit": 0.9688389301300049,
            "end_logit": 0.6284394860267639
        },
        {
            "text": "is the first-line treatment for CML-patients. However, it became clear that Philadelphia-",
            "probability": 0.0457823349450624,
            "start_logit": 0.8719416260719299,
            "end_logit": 0.7190110683441162
        },
        {
            "text": "kinase. It is the first-line treatment for CML-patients. However, it became clear that Philadelphia-",
            "probability": 0.045043795467923066,
            "start_logit": 0.8556785583496094,
            "end_logit": 0.7190110683441162
        },
        {
            "text": "CML) arises from the",
            "probability": 0.044563347572831785,
            "start_logit": 0.9688389301300049,
            "end_logit": 0.5951271653175354
        },
        {
            "text": ". This fusion gene codes tyrosine kinase which accelerates the",
            "probability": 0.0445542218642662,
            "start_logit": 0.8459744453430176,
            "end_logit": 0.7177868485450745
        },
        {
            "text": "is the first-",
            "probability": 0.0442132295950432,
            "start_logit": 0.8719416260719299,
            "end_logit": 0.6841368079185486
        },
        {
            "text": "CML) arises from the fusion of the BCR and the ABL1 genes. The",
            "probability": 0.04367037613122674,
            "start_logit": 0.9688389301300049,
            "end_logit": 0.5748854279518127
        },
        {
            "text": "kinase. It is the first-",
            "probability": 0.043500002200526355,
            "start_logit": 0.8556785583496094,
            "end_logit": 0.6841368079185486
        },
        {
            "text": "is a selective inhibitor of this tyrosine kinase. It is the first-",
            "probability": 0.04348845539240743,
            "start_logit": 0.8554130792617798,
            "end_logit": 0.6841368079185486
        },
        {
            "text": "prone to resistance. The aim of this",
            "probability": 0.04328512466642362,
            "start_logit": 0.9394263029098511,
            "end_logit": 0.5954371094703674
        }
    ],
    "571e40a8bb137a4b0c000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "530cf4fe960c95ad0c00000b": [
        {
            "text": "T790M-",
            "probability": 0.07646490559005313,
            "start_logit": 1.1554127931594849,
            "end_logit": 0.9146709442138672
        },
        {
            "text": ".5 months, P = .76). T790M patients",
            "probability": 0.06111433019006588,
            "start_logit": 0.9650812745094299,
            "end_logit": 0.880916953086853
        },
        {
            "text": "T790M was 12.9 months for afatinib and 15",
            "probability": 0.0592625848317159,
            "start_logit": 1.107105016708374,
            "end_logit": 0.7081249952316284
        },
        {
            "text": "time to acquire T790M was 12.9 months for afatinib and 15",
            "probability": 0.05617586202614304,
            "start_logit": 1.0536140203475952,
            "end_logit": 0.7081249952316284
        },
        {
            "text": "59.3%",
            "probability": 0.05481301498546331,
            "start_logit": 1.078508973121643,
            "end_logit": 0.6586705446243286
        },
        {
            "text": "of T790M-",
            "probability": 0.052134674227027375,
            "start_logit": 0.8702917695045471,
            "end_logit": 0.8167903423309326
        },
        {
            "text": "balance covariates. Afatinib inhibited the growth of lung cancer cells with low T790M all",
            "probability": 0.051329669978436646,
            "start_logit": 1.2102031707763672,
            "end_logit": 0.46131762862205505
        },
        {
            "text": "versible pan-HER inhibitor, shows better suppression of T790M-",
            "probability": 0.04996560604688136,
            "start_logit": 0.8277963995933533,
            "end_logit": 0.8167903423309326
        },
        {
            "text": "T790M. There was no significant difference in the cumulative T790M acquisition ratio over time between afatinib and gefitinib",
            "probability": 0.0489083708231887,
            "start_logit": 1.0039904117584229,
            "end_logit": 0.6192100048065186
        },
        {
            "text": "T790M were used. In total, 398 patients",
            "probability": 0.04836098912175029,
            "start_logit": 0.9643619656562805,
            "end_logit": 0.6475833654403687
        },
        {
            "text": "survival (PFS) (11",
            "probability": 0.0470148368220315,
            "start_logit": 1.0132237672805786,
            "end_logit": 0.5704913139343262
        },
        {
            "text": "T790M were used. In total, 398 patients with second biopsy at progression with stage IIIB/IV non-",
            "probability": 0.0468286459836194,
            "start_logit": 0.9643619656562805,
            "end_logit": 0.6153849959373474
        },
        {
            "text": "better suppression of T790M-",
            "probability": 0.04597453449720482,
            "start_logit": 0.7445491552352905,
            "end_logit": 0.8167903423309326
        },
        {
            "text": "-HER inhibitor, shows better suppression of T790M-",
            "probability": 0.04567793487217132,
            "start_logit": 0.7380768656730652,
            "end_logit": 0.8167903423309326
        },
        {
            "text": "T790M allele",
            "probability": 0.04442159859571965,
            "start_logit": 0.7998652458190918,
            "end_logit": 0.7271124124526978
        },
        {
            "text": "reviewed. Propensity score matching was",
            "probability": 0.0429920747360256,
            "start_logit": 0.9978779554367065,
            "end_logit": 0.4963896870613098
        },
        {
            "text": "T790M acquisition differs from that of gefitinib when used clinically as first-",
            "probability": 0.04245784449500568,
            "start_logit": 0.8016602993011475,
            "end_logit": 0.6801032423973083
        },
        {
            "text": "to gefitinib, but not those with high T790M allele",
            "probability": 0.042242220263849266,
            "start_logit": 0.7495596408843994,
            "end_logit": 0.7271124124526978
        },
        {
            "text": ". There was no significant difference in the cumulative T790M acquisition ratio over time between afatinib and gefitinib",
            "probability": 0.042219789815492306,
            "start_logit": 0.8569309115409851,
            "end_logit": 0.6192100048065186
        },
        {
            "text": "score matching was",
            "probability": 0.04164051209815488,
            "start_logit": 0.9659357070922852,
            "end_logit": 0.4963896870613098
        }
    ],
    "56c1f009ef6e39474100003c": [
        {
            "text": "glustat was first approved. In treatment-",
            "probability": 0.06600574237208634,
            "start_logit": 1.1661434173583984,
            "end_logit": 0.7231119871139526
        },
        {
            "text": "glustat was first approved. In treatment-na\u00efve patients, mean hemoglobin increased from",
            "probability": 0.057474188077351385,
            "start_logit": 1.1661434173583984,
            "end_logit": 0.58470618724823
        },
        {
            "text": ") with extensive, intermediate, or poor CYP2D6-",
            "probability": 0.05621849230808081,
            "start_logit": 0.9797303676605225,
            "end_logit": 0.7490290403366089
        },
        {
            "text": "-year data (\u00b11 year) were available for 231 eliglustat-",
            "probability": 0.054289296058752406,
            "start_logit": 0.9466956257820129,
            "end_logit": 0.7471451163291931
        },
        {
            "text": "glustat",
            "probability": 0.053961474433963624,
            "start_logit": 1.0937577486038208,
            "end_logit": 0.5940262675285339
        },
        {
            "text": "n\u2009=\u200918), mean platelet",
            "probability": 0.05381422194207662,
            "start_logit": 0.8874231576919556,
            "end_logit": 0.7976282835006714
        },
        {
            "text": ") with extensive, intermediate, or poor CYP2D6-metabolizer phenotypes (90% of patients). We",
            "probability": 0.053481627424021384,
            "start_logit": 0.9797303676605225,
            "end_logit": 0.6991214752197266
        },
        {
            "text": "is a first-line oral therapy",
            "probability": 0.05341977617236447,
            "start_logit": 1.1159394979476929,
            "end_logit": 0.5617551803588867
        },
        {
            "text": "year data (\u00b11 year) were available for 231 eliglustat-",
            "probability": 0.05318506084703665,
            "start_logit": 0.9261460900306702,
            "end_logit": 0.7471451163291931
        },
        {
            "text": "disease type 1 (GD1) with extensive, intermediate, or poor CYP2D6-",
            "probability": 0.05228871149870082,
            "start_logit": 0.9072651267051697,
            "end_logit": 0.7490290403366089
        },
        {
            "text": "-year data (\u00b11 year) were available for 231 eliglustat-treated GD1 patients: 19 treatment-",
            "probability": 0.04982081726698128,
            "start_logit": 0.9466956257820129,
            "end_logit": 0.6612509489059448
        },
        {
            "text": "year data (\u00b11 year) were available for 231 eliglustat-treated GD1 patients: 19 treatment-",
            "probability": 0.04880747016734086,
            "start_logit": 0.9261460900306702,
            "end_logit": 0.6612509489059448
        },
        {
            "text": "is a first-line oral therapy for adults with Gaucher disease type 1 (GD1) with extensive, intermediate,",
            "probability": 0.0474936243535407,
            "start_logit": 1.1159394979476929,
            "end_logit": 0.44416964054107666
        },
        {
            "text": "glustat therapy in the International Collaborative Gaucher Group Gaucher Registry (NCT00358943). As of January",
            "probability": 0.04695569202676932,
            "start_logit": 0.9642907381057739,
            "end_logit": 0.5844273567199707
        },
        {
            "text": ") with extensive, intermediate, or poor CYP2D6-meta",
            "probability": 0.04668129871648482,
            "start_logit": 0.9797303676605225,
            "end_logit": 0.5631269216537476
        },
        {
            "text": "disease type 1 (GD1) with extensive, intermediate, or poor CYP2D6-meta",
            "probability": 0.04341818609425947,
            "start_logit": 0.9072651267051697,
            "end_logit": 0.5631269216537476
        },
        {
            "text": ") with extensive, intermediate,",
            "probability": 0.04144579163048021,
            "start_logit": 0.9797303676605225,
            "end_logit": 0.44416964054107666
        },
        {
            "text": "-",
            "probability": 0.04057995169411955,
            "start_logit": 0.9466956257820129,
            "end_logit": 0.4560921788215637
        },
        {
            "text": "-year data (\u00b11 year) were available for 231 eliglustat-treated GD",
            "probability": 0.040390188410691134,
            "start_logit": 0.9466956257820129,
            "end_logit": 0.4514049291610718
        },
        {
            "text": "-year data (\u00b11 year) were available for 231 eliglustat",
            "probability": 0.040268388504898014,
            "start_logit": 0.9466956257820129,
            "end_logit": 0.4483847916126251
        }
    ],
    "56afe6d40a360a5e45000017": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52e62bae98d0239505000015": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56cdf4675795f9a73e00003f": [
        {
            "text": "sensitivities as",
            "probability": 0.0656318573326098,
            "start_logit": 0.8567123413085938,
            "end_logit": 0.9056521654129028
        },
        {
            "text": "causing the same salt sensitivities as",
            "probability": 0.06442347909129086,
            "start_logit": 0.8381292819976807,
            "end_logit": 0.9056521654129028
        },
        {
            "text": "level causing the same salt sensitivities as",
            "probability": 0.06374166064748946,
            "start_logit": 0.8274894952774048,
            "end_logit": 0.9056521654129028
        },
        {
            "text": "show that genetic loss of RACK1A-",
            "probability": 0.052664221064639104,
            "start_logit": 0.8277942538261414,
            "end_logit": 0.7144453525543213
        },
        {
            "text": "show that genetic loss of RACK1A- the predominant member of the three",
            "probability": 0.052560643959105716,
            "start_logit": 0.8277942538261414,
            "end_logit": 0.7124766707420349
        },
        {
            "text": "ation to salinity. Our findings fill up a molecular gap in our understanding of the role of miR393 mediated ABA and auxin-",
            "probability": 0.05199582308421726,
            "start_logit": 0.8028156757354736,
            "end_logit": 0.7266510128974915
        },
        {
            "text": "show that genetic loss of RACK1A- the",
            "probability": 0.050183903851635084,
            "start_logit": 0.8277942538261414,
            "end_logit": 0.6662033796310425
        },
        {
            "text": "antagonistic response between the stress hormone ABA-",
            "probability": 0.05009138785851875,
            "start_logit": 0.7402424216270447,
            "end_logit": 0.7519099712371826
        },
        {
            "text": "mir393ab",
            "probability": 0.049532306955032385,
            "start_logit": 0.922920286655426,
            "end_logit": 0.5580081343650818
        },
        {
            "text": "is implicated in salt stress response pathway through an antagonistic response between the stress hormone ABA-",
            "probability": 0.04907557066634569,
            "start_logit": 0.719754695892334,
            "end_logit": 0.7519099712371826
        },
        {
            "text": "show that genetic loss of RACK1A- the predominant member of the three genes family of RACK1 in Arabidopsis, results in the",
            "probability": 0.04789464448666391,
            "start_logit": 0.8277942538261414,
            "end_logit": 0.6195127367973328
        },
        {
            "text": "mir393ab phenotype",
            "probability": 0.04710717457000616,
            "start_logit": 0.922920286655426,
            "end_logit": 0.5078083276748657
        },
        {
            "text": "sensitivities as the individual mir393a or mir393b or the double mutant mir393ab",
            "probability": 0.04635908016278679,
            "start_logit": 0.8567123413085938,
            "end_logit": 0.5580081343650818
        },
        {
            "text": "antagonistic response between the stress hormone ABA-mediated salt stress and growth hormone auxin. Specifically,",
            "probability": 0.04581621953727995,
            "start_logit": 0.7402424216270447,
            "end_logit": 0.6626990437507629
        },
        {
            "text": "ation to salinity. Our findings fill up a molecular gap in our understanding of the role of miR393 mediated",
            "probability": 0.045537290045072266,
            "start_logit": 0.8028156757354736,
            "end_logit": 0.5940191745758057
        },
        {
            "text": "causing the same salt sensitivities as the individual mir393a or mir393b or the double mutant mir393ab",
            "probability": 0.045505541865487394,
            "start_logit": 0.8381292819976807,
            "end_logit": 0.5580081343650818
        },
        {
            "text": "level causing the same salt sensitivities as the individual mir393a or mir393b or the double mutant mir393ab",
            "probability": 0.0450239392234584,
            "start_logit": 0.8274894952774048,
            "end_logit": 0.5580081343650818
        },
        {
            "text": "is implicated in salt stress response pathway through an antagonistic response between the stress hormone ABA-mediated salt stress and growth hormone auxin. Specifically,",
            "probability": 0.04488709967304705,
            "start_logit": 0.719754695892334,
            "end_logit": 0.6626990437507629
        },
        {
            "text": "sensitivities as the individual mir393a or mir393b or the double mutant mir393ab phenotype",
            "probability": 0.04408931092419939,
            "start_logit": 0.8567123413085938,
            "end_logit": 0.5078083276748657
        },
        {
            "text": "is implicated in salt stress response pathway",
            "probability": 0.03787884500111446,
            "start_logit": 0.719754695892334,
            "end_logit": 0.49294137954711914
        }
    ],
    "56c1f00cef6e39474100003e": [
        {
            "text": "\u03b1\u03b3 agonist",
            "probability": 0.13382546724484046,
            "start_logit": 1.7529106140136719,
            "end_logit": 0.37795427441596985
        },
        {
            "text": "\u03b1\u03b3 agonist aleglitazar in patients with type 2 diabetes mellitus and acute coronary syndrome. The",
            "probability": 0.12931710701809887,
            "start_logit": 1.7529106140136719,
            "end_logit": 0.3436853885650635
        },
        {
            "text": "\u03b1\u03b3 agonist aleglitazar in patients with type 2 diabetes mellitus and acute coronary syndrome. The trial terminated",
            "probability": 0.12434181111674335,
            "start_logit": 1.7529106140136719,
            "end_logit": 0.304452121257782
        },
        {
            "text": "\u03b1\u03b3 agonist aleglitazar in patients with",
            "probability": 0.11857991010516614,
            "start_logit": 1.7529106140136719,
            "end_logit": 0.25700488686561584
        },
        {
            "text": "\u03b1\u03b3 ago",
            "probability": 0.11416463817087251,
            "start_logit": 1.7529106140136719,
            "end_logit": 0.21905940771102905
        },
        {
            "text": "oxisome proliferator-",
            "probability": 0.0697645441926739,
            "start_logit": 0.9117032289505005,
            "end_logit": 0.5677511096000671
        },
        {
            "text": "oxisome proliferator-activated receptor-\u03b1\u03b3 agonist",
            "probability": 0.05770414930758201,
            "start_logit": 0.9117032289505005,
            "end_logit": 0.37795427441596985
        },
        {
            "text": "oxisome proliferator-activated receptor-",
            "probability": 0.051556007151529665,
            "start_logit": 0.9117032289505005,
            "end_logit": 0.2652939260005951
        },
        {
            "text": "oxisome proliferator-activated receptor-\u03b1\u03b3 agonist aleglitazar in patients with",
            "probability": 0.05113042366644132,
            "start_logit": 0.9117032289505005,
            "end_logit": 0.25700488686561584
        },
        {
            "text": "oxisome",
            "probability": 0.05096849287933036,
            "start_logit": 0.9117032289505005,
            "end_logit": 0.2538328468799591
        },
        {
            "text": "oxisome pro",
            "probability": 0.04942084480686556,
            "start_logit": 0.9117032289505005,
            "end_logit": 0.2229974865913391
        },
        {
            "text": "oxisome proliferator-activated receptor-\u03b1\u03b3 ago",
            "probability": 0.04922660433985588,
            "start_logit": 0.9117032289505005,
            "end_logit": 0.21905940771102905
        }
    ],
    "532f49f8d6d3ac6a34000035": [
        {
            "text": "model (namely \"the",
            "probability": 0.0701494212133771,
            "start_logit": 1.107103943824768,
            "end_logit": 1.1495764255523682
        },
        {
            "text": "Medicine Foundation (FMF) first trimester prediction model (namely \"the",
            "probability": 0.0619669585821946,
            "start_logit": 0.9830777049064636,
            "end_logit": 1.1495764255523682
        },
        {
            "text": "be easily identified. Target plot is a tool to evaluate deviation from expected multiple of median and expected median of standard deviation. Target",
            "probability": 0.06012772859040953,
            "start_logit": 1.185550332069397,
            "end_logit": 0.9169735908508301
        },
        {
            "text": "has suboptimal",
            "probability": 0.05814560476089439,
            "start_logit": 0.9972119331359863,
            "end_logit": 1.071791172027588
        },
        {
            "text": "performance. Tools frequently used to assess quality control include the cumulative sums and target plot",
            "probability": 0.055144249168029784,
            "start_logit": 1.0590976476669312,
            "end_logit": 0.9569076299667358
        },
        {
            "text": ") first trimester prediction model (namely \"the",
            "probability": 0.05208997800112387,
            "start_logit": 0.8094489574432373,
            "end_logit": 1.1495764255523682
        },
        {
            "text": "ia screening based on the NICE and ACOG approach has suboptimal",
            "probability": 0.050323511218889054,
            "start_logit": 0.8527340292930603,
            "end_logit": 1.071791172027588
        },
        {
            "text": "eclampsia screening based on the NICE and ACOG approach has suboptimal",
            "probability": 0.05012680155131059,
            "start_logit": 0.8488174676895142,
            "end_logit": 1.071791172027588
        },
        {
            "text": "evaluate deviation from expected multiple of median and expected median of standard deviation. Target",
            "probability": 0.049697364110039194,
            "start_logit": 0.9950311183929443,
            "end_logit": 0.9169735908508301
        },
        {
            "text": "rate. Evidence has shown that preeclampsia screening based on the NICE and ACOG approach has suboptimal",
            "probability": 0.04907688112323577,
            "start_logit": 0.827649712562561,
            "end_logit": 1.071791172027588
        },
        {
            "text": "eclampsia, respectively. Screening based on the ACOG (2013",
            "probability": 0.048304513817765425,
            "start_logit": 0.9998781681060791,
            "end_logit": 0.8836996555328369
        },
        {
            "text": ") and National Institute for Health and Care Excellence (NICE) have proposed screening for preeclampsia based on",
            "probability": 0.04677058126143731,
            "start_logit": 0.9397875666618347,
            "end_logit": 0.9115196466445923
        },
        {
            "text": "ia during the first trimester of pregnancy, thus allowing timely therapeutic intervention. Several professional organizations such as",
            "probability": 0.045575821299559824,
            "start_logit": 1.0806798934936523,
            "end_logit": 0.7447502613067627
        },
        {
            "text": "tool to evaluate deviation from expected multiple of median and expected median of standard deviation. Target",
            "probability": 0.045060040523084405,
            "start_logit": 0.8970750570297241,
            "end_logit": 0.9169735908508301
        },
        {
            "text": "is insensitive to detect small",
            "probability": 0.04442022271469636,
            "start_logit": 0.8118399977684021,
            "end_logit": 0.9879076480865479
        },
        {
            "text": "of the FMF prediction model, followed by the administration of low dose as",
            "probability": 0.04358652598006345,
            "start_logit": 1.029334545135498,
            "end_logit": 0.7514663338661194
        },
        {
            "text": "model (namely \"the triple test\"), which consists of a combination of maternal factors, and measurements of mean arterial",
            "probability": 0.04321002334371056,
            "start_logit": 1.107103943824768,
            "end_logit": 0.6650213599205017
        },
        {
            "text": "be easily identified. Target plot is a tool to evaluate deviation from",
            "probability": 0.04298100693235132,
            "start_logit": 1.185550332069397,
            "end_logit": 0.5812608003616333
        },
        {
            "text": "ia during the first trimester",
            "probability": 0.042391595703277475,
            "start_logit": 1.0806798934936523,
            "end_logit": 0.6723230481147766
        },
        {
            "text": ") and National Institute for Health and Care Excellence (NICE) have proposed screening",
            "probability": 0.040851170104550145,
            "start_logit": 0.9397875666618347,
            "end_logit": 0.7762007117271423
        }
    ],
    "56caea805795f9a73e00002c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56c1f021ef6e394741000048": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52bf1d9e03868f1b06000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5549de44f35db7552600000c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56fcf1b8cf1c325851000005": [
        {
            "text": "ry, qRT-PCR and Western blotting. MiR-",
            "probability": 0.06296104992134886,
            "start_logit": 0.8192570209503174,
            "end_logit": 1.0607819557189941
        },
        {
            "text": "MTT assay, Edu staining, Flow cytometry, qRT-PCR and Western blotting. MiR-",
            "probability": 0.0600464570773918,
            "start_logit": 0.7718592882156372,
            "end_logit": 1.0607819557189941
        },
        {
            "text": "of genes in A549 cells targeted by miR-448, followed by Dual-",
            "probability": 0.0553938202023858,
            "start_logit": 0.9940958619117737,
            "end_logit": 0.7578948736190796
        },
        {
            "text": "of genes in A549 cells targeted by miR-",
            "probability": 0.05496486498506379,
            "start_logit": 0.9940958619117737,
            "end_logit": 0.750120997428894
        },
        {
            "text": "showed low",
            "probability": 0.054082948545610604,
            "start_logit": 0.9206470251083374,
            "end_logit": 0.8073946237564087
        },
        {
            "text": "reporter gene assay. A549/DDP cells were transfected with miR-",
            "probability": 0.0512377646646536,
            "start_logit": 1.0371193885803223,
            "end_logit": 0.6368801593780518
        },
        {
            "text": "-resistant patients and A549/DDP cells. And the patients showed low",
            "probability": 0.05095533851866598,
            "start_logit": 0.861077606678009,
            "end_logit": 0.8073946237564087
        },
        {
            "text": "expressions in DDP-sensitive and -resistant lung cancer patients. A microarray was",
            "probability": 0.050794958304451354,
            "start_logit": 0.9017059206962585,
            "end_logit": 0.7636138796806335
        },
        {
            "text": "ry, qRT-PCR and Western blotting. MiR-448",
            "probability": 0.04936846230921324,
            "start_logit": 0.8192570209503174,
            "end_logit": 0.8175774812698364
        },
        {
            "text": "mic/nucleic ratio (C/N ratios) of genes in A549 cells targeted by miR-448, followed by Dual-",
            "probability": 0.048681994744690114,
            "start_logit": 0.8649370670318604,
            "end_logit": 0.7578948736190796
        },
        {
            "text": "mic/nucleic ratio (C/N ratios) of genes in A549 cells targeted by miR-",
            "probability": 0.04830501414362158,
            "start_logit": 0.8649370670318604,
            "end_logit": 0.750120997428894
        },
        {
            "text": "above effect caused by miR-448 inhibitors. MiR-",
            "probability": 0.047495844326278264,
            "start_logit": 0.8719353675842285,
            "end_logit": 0.7262295484542847
        },
        {
            "text": "miR-448, followed by Dual-",
            "probability": 0.04703154185020345,
            "start_logit": 0.8304463028907776,
            "end_logit": 0.7578948736190796
        },
        {
            "text": "miR-",
            "probability": 0.04666734192353954,
            "start_logit": 0.8304463028907776,
            "end_logit": 0.750120997428894
        },
        {
            "text": "of genes in A549 cells targeted by miR-448, followed by Dual-luciferase",
            "probability": 0.046602800848924666,
            "start_logit": 0.9940958619117737,
            "end_logit": 0.5850874781608582
        },
        {
            "text": "SATB1 was increased in DDP-resistant patients and A549/DDP cells. And the patients showed low",
            "probability": 0.04626251186952344,
            "start_logit": 0.764460027217865,
            "end_logit": 0.8073946237564087
        },
        {
            "text": "miR-448 mimics/inhibitors with or without SATB1",
            "probability": 0.045973526409267725,
            "start_logit": 0.9074103832244873,
            "end_logit": 0.6581780314445496
        },
        {
            "text": "B1 siRNA could reverse the above effect caused by miR-448 inhibitors. MiR-",
            "probability": 0.045938618105250774,
            "start_logit": 0.8385992646217346,
            "end_logit": 0.7262295484542847
        },
        {
            "text": "showed low miR-",
            "probability": 0.04401560605516425,
            "start_logit": 0.9206470251083374,
            "end_logit": 0.6014199256896973
        },
        {
            "text": "showed low miR-448 expression or SATB1 positive expression had poor prognosis",
            "probability": 0.04321953519475124,
            "start_logit": 0.9206470251083374,
            "end_logit": 0.5831682682037354
        }
    ],
    "56cafa845795f9a73e00002e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "531af8cbb166e2b80600003a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5544de7a5beec11c10000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55421ee7ccca0ce74b000002": [
        {
            "text": "guardian\" and controls the",
            "probability": 0.15200583097690912,
            "start_logit": 0.8450224995613098,
            "end_logit": 0.5872582793235779
        },
        {
            "text": "guardian\" and controls the cell cycle and the integrity of DNA, as well as other important cellular functions. Its",
            "probability": 0.1448171696297548,
            "start_logit": 0.8450224995613098,
            "end_logit": 0.538811445236206
        },
        {
            "text": "guardian\" and controls the cell cycle and the",
            "probability": 0.14211741044124457,
            "start_logit": 0.8450224995613098,
            "end_logit": 0.5199929475784302
        },
        {
            "text": "guardian\" and controls the cell cycle and the integrity",
            "probability": 0.12700458853012064,
            "start_logit": 0.8450224995613098,
            "end_logit": 0.40756261348724365
        },
        {
            "text": "guardian\" and controls the cell",
            "probability": 0.11662392949368358,
            "start_logit": 0.8450224995613098,
            "end_logit": 0.32229387760162354
        },
        {
            "text": "guardian\" and controls the cell cycle and the integrity of DNA, as well as other important",
            "probability": 0.1106834034759415,
            "start_logit": 0.8450224995613098,
            "end_logit": 0.27001330256462097
        },
        {
            "text": "guardian\" and controls the cell cycle and the integrity of DNA, as well as other important cellular functions. Its main function is to trigger the process",
            "probability": 0.10362490142461872,
            "start_logit": 0.8450224995613098,
            "end_logit": 0.2041170597076416
        },
        {
            "text": "guardian\" and controls the cell cycle and the integrity of",
            "probability": 0.10312276602772716,
            "start_logit": 0.8450224995613098,
            "end_logit": 0.19925957918167114
        }
    ],
    "514a0a57d24251bc05000051": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "53036faab24d855b11000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52fb7c512059c6d71c000069": [
        {
            "text": "programmed electrical stimulation. The safest treatment suggested is an implantable cardioverter defibrill",
            "probability": 0.06197534199742844,
            "start_logit": 1.0574376583099365,
            "end_logit": 0.7826461791992188
        },
        {
            "text": "is frequently associated with tall-",
            "probability": 0.05334447208161271,
            "start_logit": 0.9258426427841187,
            "end_logit": 0.7642749547958374
        },
        {
            "text": "death. Short QT syndrome is characterized by short QT and heart-rate-",
            "probability": 0.0528583113860753,
            "start_logit": 0.7557847499847412,
            "end_logit": 0.9251774549484253
        },
        {
            "text": "programmed electrical stimulation. The",
            "probability": 0.051749867747675454,
            "start_logit": 1.0574376583099365,
            "end_logit": 0.6023314595222473
        },
        {
            "text": "be an effective therapy for patients with short QT syndrome. This is particularly important in developing countries, where the implantable cardioverter-",
            "probability": 0.05173046967487351,
            "start_logit": 0.8354963064193726,
            "end_logit": 0.8238978981971741
        },
        {
            "text": "safest treatment suggested is an implantable cardioverter defibrill",
            "probability": 0.05017721779353229,
            "start_logit": 0.8462621569633484,
            "end_logit": 0.7826461791992188
        },
        {
            "text": "electrocardio",
            "probability": 0.05016030171691705,
            "start_logit": 0.8657763004302979,
            "end_logit": 0.7627948522567749
        },
        {
            "text": "short QT syndrome. This is particularly important in developing countries, where the implantable cardioverter-",
            "probability": 0.049742820822001405,
            "start_logit": 0.7963154911994934,
            "end_logit": 0.8238978981971741
        },
        {
            "text": "be an effective therapy for patients with short QT syndrome.",
            "probability": 0.04933418079830759,
            "start_logit": 0.8354963064193726,
            "end_logit": 0.7764680981636047
        },
        {
            "text": "is frequently associated with tall-, peaked-",
            "probability": 0.049089679446160356,
            "start_logit": 0.9258426427841187,
            "end_logit": 0.681153416633606
        },
        {
            "text": ". The safest treatment suggested is an implantable cardioverter defibrill",
            "probability": 0.04888691978275775,
            "start_logit": 0.8202109336853027,
            "end_logit": 0.7826461791992188
        },
        {
            "text": "some concern, especially in teenagers. The ability of quini",
            "probability": 0.048736988801191705,
            "start_logit": 0.8640086650848389,
            "end_logit": 0.7357768416404724
        },
        {
            "text": "some concern, especially in teenagers. The ability of quinidine to prolong the QT interval has the potential to be an effective therapy for patients",
            "probability": 0.04863288503055685,
            "start_logit": 0.8640086650848389,
            "end_logit": 0.7336385250091553
        },
        {
            "text": "young children, the utility of quinidine has to be evaluated further. Clinicians need to be aware of this deadly electrocardio",
            "probability": 0.04792328784667559,
            "start_logit": 0.8201539516448975,
            "end_logit": 0.7627948522567749
        },
        {
            "text": "has the potential to be an effective therapy for patients with short QT syndrome.",
            "probability": 0.047914339422653336,
            "start_logit": 0.8062939643859863,
            "end_logit": 0.7764680981636047
        },
        {
            "text": "teenagers. The ability of quini",
            "probability": 0.047673356864492256,
            "start_logit": 0.841943085193634,
            "end_logit": 0.7357768416404724
        },
        {
            "text": "teenagers. The ability of quinidine to prolong the QT interval has the potential to be an effective therapy for patients",
            "probability": 0.04757152504577527,
            "start_logit": 0.841943085193634,
            "end_logit": 0.7336385250091553
        },
        {
            "text": "countries, where the implantable cardioverter-defibrillator therapy is not always available. Since these patients",
            "probability": 0.047568216151202644,
            "start_logit": 0.7470049858093262,
            "end_logit": 0.8285070657730103
        },
        {
            "text": "short QT syndrome is a clinical-electrocardiographic entity with autosomal-dominant mode of transmission and it is the",
            "probability": 0.04749121261950055,
            "start_logit": 0.8069421648979187,
            "end_logit": 0.7669497728347778
        },
        {
            "text": "short QT syndrome.",
            "probability": 0.04743860497060984,
            "start_logit": 0.7963154911994934,
            "end_logit": 0.7764680981636047
        }
    ],
    "56c58f1b5795f9a73e000001": [
        {
            "text": "tumor activity of resveratrol may be a consequence of its effect on",
            "probability": 0.0806498519570092,
            "start_logit": 0.9775290489196777,
            "end_logit": 1.2987415790557861
        },
        {
            "text": "-inflammatory and anti-tumor. The anti-tumor activity of resveratrol may be a consequence of its effect on",
            "probability": 0.07473960822600546,
            "start_logit": 0.9014222621917725,
            "end_logit": 1.2987415790557861
        },
        {
            "text": "is a non-flavonoid polyphenol that exhibits significant pharmacological effects such as antioxidant, anti-",
            "probability": 0.06837396988541138,
            "start_logit": 1.011672019958496,
            "end_logit": 1.0994738340377808
        },
        {
            "text": "is a non-",
            "probability": 0.06583227532701119,
            "start_logit": 1.011672019958496,
            "end_logit": 1.0615918636322021
        },
        {
            "text": "diabetic, anti-inflammatory and anti-tumor. The anti-tumor activity of resveratrol may be a consequence of its effect on",
            "probability": 0.0637880860106487,
            "start_logit": 0.7429785132408142,
            "end_logit": 1.2987415790557861
        },
        {
            "text": "-",
            "probability": 0.05512142345530406,
            "start_logit": 0.9014222621917725,
            "end_logit": 0.994269847869873
        },
        {
            "text": "enol that exhibits significant pharmacological effects such as antioxidant, anti-",
            "probability": 0.05366681606868451,
            "start_logit": 0.7694746851921082,
            "end_logit": 1.0994738340377808
        },
        {
            "text": "of apoptosis, this organelle is a promising target in cancer therapy. Resveratrol is a non-",
            "probability": 0.051781556839105757,
            "start_logit": 0.77159583568573,
            "end_logit": 1.0615918636322021
        },
        {
            "text": "enol that exhibits significant pharmacological effects such as antioxidant, anti-diabetic, anti-",
            "probability": 0.04830769544896966,
            "start_logit": 0.7694746851921082,
            "end_logit": 0.994269847869873
        },
        {
            "text": "diabetic, anti-",
            "probability": 0.047044534803607777,
            "start_logit": 0.7429785132408142,
            "end_logit": 0.994269847869873
        },
        {
            "text": "-inflammatory and anti-tumor. The anti-",
            "probability": 0.046315577183410214,
            "start_logit": 0.9014222621917725,
            "end_logit": 0.8202097415924072
        },
        {
            "text": "of apoptosis, this organelle is a promising target in cancer therapy.",
            "probability": 0.04481029626845513,
            "start_logit": 0.77159583568573,
            "end_logit": 0.9169957637786865
        },
        {
            "text": "tumor activity of resveratrol may",
            "probability": 0.04111683750189238,
            "start_logit": 0.9775290489196777,
            "end_logit": 0.6250423192977905
        },
        {
            "text": "diabetic, anti-inflammatory and anti-tumor. The anti-",
            "probability": 0.0395290006347697,
            "start_logit": 0.7429785132408142,
            "end_logit": 0.8202097415924072
        },
        {
            "text": "optosis. So, there have been efforts to sustain mitochondrial homeostasis and inhibit its dysfunction.",
            "probability": 0.03874484057153061,
            "start_logit": 0.8912162780761719,
            "end_logit": 0.6519349813461304
        },
        {
            "text": "optosis. So, there have been efforts to sustain mitochondrial homeostasis",
            "probability": 0.03841849964811115,
            "start_logit": 0.8912162780761719,
            "end_logit": 0.6434764862060547
        },
        {
            "text": "-inflammatory and anti-tumor. The anti-tumor activity of resveratrol may",
            "probability": 0.038103682174418285,
            "start_logit": 0.9014222621917725,
            "end_logit": 0.6250423192977905
        },
        {
            "text": "reactive oxygen species, leading to mitochondrial dysfunction and consequently, apoptosis induction. A number of signaling pathways such as sirtuin and NF-",
            "probability": 0.03561383182620344,
            "start_logit": 0.7914782166481018,
            "end_logit": 0.6674095392227173
        },
        {
            "text": "of apoptosis",
            "probability": 0.03412854058637097,
            "start_logit": 0.77159583568573,
            "end_logit": 0.6446918249130249
        },
        {
            "text": "optosis induction. A number of signaling pathways such as sirtuin and NF-kB may contribute to the mitochondrial",
            "probability": 0.033913075583080605,
            "start_logit": 0.7242535352706909,
            "end_logit": 0.6857007741928101
        }
    ],
    "56f7fe3709dd18d46b000015": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54db62a3034aea571d000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5344155faeec6fbd07000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52c7275103868f1b0600001c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5139b31dbee46bd34c000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52f21b722059c6d71c00000b": [
        {
            "text": "tumors, this patient has shown an unexpectedly favorable evolution",
            "probability": 0.08021007236097362,
            "start_logit": 0.9313757419586182,
            "end_logit": 1.2649449110031128
        },
        {
            "text": "TP53, a tumor suppressor gene, are involved in the",
            "probability": 0.057054945034809894,
            "start_logit": 1.0814032554626465,
            "end_logit": 0.7742830514907837
        },
        {
            "text": "us glioblastoma, epidermal growth factor receptor-mutated",
            "probability": 0.054491854170789514,
            "start_logit": 1.0332515239715576,
            "end_logit": 0.7764712572097778
        },
        {
            "text": "inarily high sensitivity to systemic treatment played a major role in this evolution",
            "probability": 0.05388531918609748,
            "start_logit": 0.8174561858177185,
            "end_logit": 0.9810734391212463
        },
        {
            "text": "team and the patient's own extraordinarily high sensitivity to systemic treatment played a major role in this evolution",
            "probability": 0.05357565234510777,
            "start_logit": 0.8116928339004517,
            "end_logit": 0.9810734391212463
        },
        {
            "text": "evolution",
            "probability": 0.052912746314405575,
            "start_logit": 0.799242377281189,
            "end_logit": 0.9810734391212463
        },
        {
            "text": ": the lung adenocarcinoma showed excellent response to erlotinib; the breast cancer responded extremely well to eribulin and peg",
            "probability": 0.051393809940610415,
            "start_logit": 0.8585463762283325,
            "end_logit": 0.8926429152488708
        },
        {
            "text": "p.R282W) was diagnosed with two metachronous breast tumors, one HER2-",
            "probability": 0.04898408872305061,
            "start_logit": 0.9168368577957153,
            "end_logit": 0.7863302230834961
        },
        {
            "text": "be partly due to the pronged multidisciplin",
            "probability": 0.04857106727146238,
            "start_logit": 0.9224668741226196,
            "end_logit": 0.772232711315155
        },
        {
            "text": "2W) was diagnosed with two metachronous breast tumors, one HER2-",
            "probability": 0.04787985448212607,
            "start_logit": 0.8940361738204956,
            "end_logit": 0.7863302230834961
        },
        {
            "text": "us glioblastoma, epidermal growth factor receptor-mutated lung adenocarcinoma, and HER2-",
            "probability": 0.04757994361476898,
            "start_logit": 1.0332515239715576,
            "end_logit": 0.6408313512802124
        },
        {
            "text": "therapy,",
            "probability": 0.04638494651556213,
            "start_logit": 0.8217151761054993,
            "end_logit": 0.826931357383728
        },
        {
            "text": "tumors, this patient has shown an unexpectedly favorable evolution. The coordinated participation of a multidis",
            "probability": 0.045856854567734924,
            "start_logit": 0.9313757419586182,
            "end_logit": 0.7058205008506775
        },
        {
            "text": "p.R282W) was diagnosed with two meta",
            "probability": 0.04568318356547345,
            "start_logit": 0.9168368577957153,
            "end_logit": 0.716564953327179
        },
        {
            "text": "performance status. This surprising positive evolution may well be partly due to the pronged multidisciplin",
            "probability": 0.045451596496288924,
            "start_logit": 0.856086790561676,
            "end_logit": 0.772232711315155
        },
        {
            "text": "2W) was diagnosed with two meta",
            "probability": 0.04465336068129883,
            "start_logit": 0.8940361738204956,
            "end_logit": 0.716564953327179
        },
        {
            "text": "including brain surgery and radiotherapy,",
            "probability": 0.044514850758717854,
            "start_logit": 0.7761346697807312,
            "end_logit": 0.8313597440719604
        },
        {
            "text": "p.",
            "probability": 0.04393755063481006,
            "start_logit": 0.9168368577957153,
            "end_logit": 0.6776040196418762
        },
        {
            "text": "metastases. The patient was treated with local therapies, including brain surgery and radiotherapy,",
            "probability": 0.04357879346031474,
            "start_logit": 0.7548824548721313,
            "end_logit": 0.8313597440719604
        },
        {
            "text": "and a bilateral mastectomy, as well as with targeted systemic treatment. She proved to be highly sensitive to systemic therapy,",
            "probability": 0.04339950987559711,
            "start_logit": 0.7551883459091187,
            "end_logit": 0.826931357383728
        }
    ],
    "55192892622b194345000012": [
        {
            "text": "I antiviral efficacy. PARP11 does not",
            "probability": 0.06801991572297629,
            "start_logit": 1.5253238677978516,
            "end_logit": 0.6232815980911255
        },
        {
            "text": "I antiviral efficacy. PARP11",
            "probability": 0.06404133543247574,
            "start_logit": 1.5253238677978516,
            "end_logit": 0.5630097985267639
        },
        {
            "text": ". Mono-ADP-ribosylation of \u03b2-",
            "probability": 0.06024105939023047,
            "start_logit": 1.0355271100997925,
            "end_logit": 0.9916319847106934
        },
        {
            "text": "Sendai virus but inhibits the strength of IFN-I-activated signalling. Mechan",
            "probability": 0.0563017661543881,
            "start_logit": 1.1877310276031494,
            "end_logit": 0.7717998027801514
        },
        {
            "text": "Sendai virus but inhibits the",
            "probability": 0.05461652088672701,
            "start_logit": 1.1877310276031494,
            "end_logit": 0.7414103150367737
        },
        {
            "text": "11",
            "probability": 0.05367492719459223,
            "start_logit": 1.2192026376724243,
            "end_logit": 0.6925482749938965
        },
        {
            "text": "Sendai virus but inhibits the strength of IFN-I-activated signalling. Mechanistically, PARP11",
            "probability": 0.05201199563586542,
            "start_logit": 1.1877310276031494,
            "end_logit": 0.6925482749938965
        },
        {
            "text": "is upregulated",
            "probability": 0.050406208252705656,
            "start_logit": 1.2585140466690063,
            "end_logit": 0.5904052257537842
        },
        {
            "text": "is upregulated by virus infections, including vesicular st",
            "probability": 0.04964400369834433,
            "start_logit": 1.2585140466690063,
            "end_logit": 0.5751684904098511
        },
        {
            "text": "exhibits efficient enhancement of IFN-I signalling and",
            "probability": 0.04963956537694721,
            "start_logit": 1.1560744047164917,
            "end_logit": 0.6775187253952026
        },
        {
            "text": "11 mono-ADP-ribosylates the ubiquitin E3 ligase \u03b2-transducin repeat",
            "probability": 0.04925289144327505,
            "start_logit": 1.2192026376724243,
            "end_logit": 0.6065703630447388
        },
        {
            "text": "exhibits efficient enhancement of IFN-",
            "probability": 0.04833150066698031,
            "start_logit": 1.1560744047164917,
            "end_logit": 0.6508140563964844
        },
        {
            "text": "Sendai virus but inhibits the strength of IFN-I-activated signalling. Mechanistically",
            "probability": 0.047523649030352486,
            "start_logit": 1.1877310276031494,
            "end_logit": 0.6023013591766357
        },
        {
            "text": "I signalling and",
            "probability": 0.04722587366433769,
            "start_logit": 1.1062281131744385,
            "end_logit": 0.6775187253952026
        },
        {
            "text": "including vesicular stomatitis virus, herpes simplex virus-1 and influenza A virus, thus promoting",
            "probability": 0.04519063920001914,
            "start_logit": 0.9366663694381714,
            "end_logit": 0.8030285239219666
        },
        {
            "text": "I can be improved remains to be explored. Here, we",
            "probability": 0.04143826987613671,
            "start_logit": 0.9191908240318298,
            "end_logit": 0.7338189482688904
        },
        {
            "text": "I can be improved remains to be explored. Here, we identified the ADP-ribosyltransferase poly(ADP-",
            "probability": 0.041371929295919666,
            "start_logit": 0.9191908240318298,
            "end_logit": 0.7322167158126831
        },
        {
            "text": "I-activated signalling. Mechan",
            "probability": 0.040717229768587056,
            "start_logit": 0.8636564612388611,
            "end_logit": 0.7717998027801514
        },
        {
            "text": "istically, PARP11",
            "probability": 0.04053883902881451,
            "start_logit": 0.938517153263092,
            "end_logit": 0.6925482749938965
        },
        {
            "text": "be improved remains to be explored. Here, we",
            "probability": 0.03981188028032489,
            "start_logit": 0.8791513442993164,
            "end_logit": 0.7338189482688904
        }
    ],
    "56cdf4875795f9a73e000040": [
        {
            "text": "including viral infections. Here we report that hepatitis C virus (HCV) triggers the appearance of SGs in a PKR-",
            "probability": 0.06550601637798358,
            "start_logit": 1.0790679454803467,
            "end_logit": 0.9460999369621277
        },
        {
            "text": "translation of antiviral interferon-stimulated genes, and by co-opting SG proteins for its replication, assembly",
            "probability": 0.05608919095875705,
            "start_logit": 0.9492561221122742,
            "end_logit": 0.9207128882408142
        },
        {
            "text": "translation of antivira",
            "probability": 0.05418477488529644,
            "start_logit": 0.9492561221122742,
            "end_logit": 0.8861697316169739
        },
        {
            "text": "at early time points in the infection and that G3BP1 and TIA-",
            "probability": 0.05369986617859471,
            "start_logit": 0.9151941537857056,
            "end_logit": 0.9112422466278076
        },
        {
            "text": "), TIA1-related protein (TIAR), and RasGAP-SH3 domain binding protein 1 (G",
            "probability": 0.05150583315280463,
            "start_logit": 1.0066064596176147,
            "end_logit": 0.7781144976615906
        },
        {
            "text": ") triggers the appearance of SGs in a PKR-",
            "probability": 0.051018721595445606,
            "start_logit": 0.8291186094284058,
            "end_logit": 0.9460999369621277
        },
        {
            "text": "including viral infections.",
            "probability": 0.0510163983604216,
            "start_logit": 1.0790679454803467,
            "end_logit": 0.6961050629615784
        },
        {
            "text": "TIA-",
            "probability": 0.05052439838550916,
            "start_logit": 0.8542400002479553,
            "end_logit": 0.9112422466278076
        },
        {
            "text": "translation is inhibited in stress granule-",
            "probability": 0.04983188991745813,
            "start_logit": 0.9134514331817627,
            "end_logit": 0.8382295966148376
        },
        {
            "text": "ivity late in the infection, suggesting that it is required for infectious particle release. Collectively, these",
            "probability": 0.04912649110943749,
            "start_logit": 1.0000330209732056,
            "end_logit": 0.7373912930488586
        },
        {
            "text": "ivity late in the infection, suggesting that it is required for infectious",
            "probability": 0.04887196008905223,
            "start_logit": 1.0000330209732056,
            "end_logit": 0.7321966886520386
        },
        {
            "text": "formation of SGs by triggering PKR phosphorylation, thereby downregulating the translation of antivira",
            "probability": 0.04855040828578269,
            "start_logit": 0.8394587635993958,
            "end_logit": 0.8861697316169739
        },
        {
            "text": "translation of antiviral interferon-stimulated genes, and by co-opting SG proteins for its",
            "probability": 0.04846045599109837,
            "start_logit": 0.9492561221122742,
            "end_logit": 0.7745178937911987
        },
        {
            "text": "TIAR), and RasGAP-SH3 domain binding protein 1 (G",
            "probability": 0.04787848619226167,
            "start_logit": 0.9335776567459106,
            "end_logit": 0.7781144976615906
        },
        {
            "text": "these",
            "probability": 0.04783557031504904,
            "start_logit": 0.9734041094779968,
            "end_logit": 0.7373912930488586
        },
        {
            "text": "is required for infectious particle release. Collectively, these",
            "probability": 0.046477416162599754,
            "start_logit": 0.9446011185646057,
            "end_logit": 0.7373912930488586
        },
        {
            "text": "is required for infectious",
            "probability": 0.04623661035918132,
            "start_logit": 0.9446011185646057,
            "end_logit": 0.7321966886520386
        },
        {
            "text": "translation is inhibited in stress granule-containing HCV-",
            "probability": 0.04457663979305828,
            "start_logit": 0.9134514331817627,
            "end_logit": 0.7267844080924988
        },
        {
            "text": "), and RasGAP-SH3 domain binding protein 1 (G",
            "probability": 0.04449557489703498,
            "start_logit": 0.86030113697052,
            "end_logit": 0.7781144976615906
        },
        {
            "text": ") are cytoplasmic structures that are induced in response to environmental stress, including viral infections.",
            "probability": 0.044113296993173026,
            "start_logit": 0.9336820840835571,
            "end_logit": 0.6961050629615784
        }
    ],
    "532dcfc9d6d3ac6a34000021": [
        {
            "text": "transferases mediate posttranslational modifications of both histone and nonhistone proteins. Whereas histone methylation is well-",
            "probability": 0.26907550555944704,
            "start_logit": 1.1344190835952759,
            "end_logit": 0.3347480297088623
        },
        {
            "text": "transfera",
            "probability": 0.25945155929339886,
            "start_logit": 1.1344190835952759,
            "end_logit": 0.2983260154724121
        },
        {
            "text": "transferases mediate posttranslational modifications of both histone and nonhistone proteins",
            "probability": 0.23821933997077824,
            "start_logit": 1.1344190835952759,
            "end_logit": 0.21294784545898438
        },
        {
            "text": "transferases mediate posttranslational modifications",
            "probability": 0.23325359517637587,
            "start_logit": 1.1344190835952759,
            "end_logit": 0.19188225269317627
        }
    ],
    "5543829fed966d112c000009": [
        {
            "text": "plasts, but could be further induced by treatment with fungal elicitor.",
            "probability": 0.06363443310421057,
            "start_logit": 1.1095372438430786,
            "end_logit": 0.8851008415222168
        },
        {
            "text": "asts as a",
            "probability": 0.060303751485984255,
            "start_logit": 1.2519466876983643,
            "end_logit": 0.6889309883117676
        },
        {
            "text": "or.",
            "probability": 0.05828061094906505,
            "start_logit": 1.0216519832611084,
            "end_logit": 0.8851008415222168
        },
        {
            "text": "further induced by treatment with fungal elicitor.",
            "probability": 0.05711243596314532,
            "start_logit": 1.0014044046401978,
            "end_logit": 0.8851008415222168
        },
        {
            "text": "asts, but could be further induced by treatment with fungal elicitor.",
            "probability": 0.056949473162794695,
            "start_logit": 0.9985469579696655,
            "end_logit": 0.8851008415222168
        },
        {
            "text": "asts as a system for functional",
            "probability": 0.05194302805493333,
            "start_logit": 1.2519466876983643,
            "end_logit": 0.5396841764450073
        },
        {
            "text": "ast",
            "probability": 0.051562887789612016,
            "start_logit": 1.2519466876983643,
            "end_logit": 0.5323388576507568
        },
        {
            "text": "including three cytochrome P450 activities) were induced by treatment with elicitor, and their",
            "probability": 0.05123252268880878,
            "start_logit": 0.9991744756698608,
            "end_logit": 0.7786834239959717
        },
        {
            "text": "or, and their",
            "probability": 0.04950605936396478,
            "start_logit": 0.9648950099945068,
            "end_logit": 0.7786834239959717
        },
        {
            "text": "or, and their induction kinetics correlated with the rate of medicarpin accumulation. However, protoplast",
            "probability": 0.048902449336485604,
            "start_logit": 0.9648950099945068,
            "end_logit": 0.7664158344268799
        },
        {
            "text": "or. The results are discussed in relation to the use of alfalfa protoplasts as a",
            "probability": 0.04789923871418892,
            "start_logit": 1.0216519832611084,
            "end_logit": 0.6889309883117676
        },
        {
            "text": "plast",
            "probability": 0.04742189321211339,
            "start_logit": 1.1095372438430786,
            "end_logit": 0.5910301208496094
        },
        {
            "text": "further induced by treatment with fungal elicitor. The results are discussed in relation to the use of alfalfa protoplasts as a",
            "probability": 0.04693914767191389,
            "start_logit": 1.0014044046401978,
            "end_logit": 0.6889309883117676
        },
        {
            "text": "including three cytochrome P450 activities) were induced by treatment with elicitor, and their induction kinetics correlated with the",
            "probability": 0.04601012445159036,
            "start_logit": 0.9991744756698608,
            "end_logit": 0.6711703538894653
        },
        {
            "text": "including three cytochrome P450 activities) were induced by treatment with elicitor, and their induction kinetics correlated",
            "probability": 0.044682455301227934,
            "start_logit": 0.9991744756698608,
            "end_logit": 0.6418898105621338
        },
        {
            "text": ". The extractable activities of six enzymes involved in medicarpin biosy",
            "probability": 0.04449415434128437,
            "start_logit": 1.072277307510376,
            "end_logit": 0.5645638704299927
        },
        {
            "text": "or, and their induction kinetics correlated with the",
            "probability": 0.04445964853769337,
            "start_logit": 0.9648950099945068,
            "end_logit": 0.6711703538894653
        },
        {
            "text": "asts prepared from these cultures accumulated neither medicarpin nor other secondary products after treatment with elicitor. The cyto",
            "probability": 0.0434872601248675,
            "start_logit": 0.8909489512443542,
            "end_logit": 0.7230024337768555
        },
        {
            "text": "or, and their induction kinetics correlated",
            "probability": 0.04317671995397356,
            "start_logit": 0.9648950099945068,
            "end_logit": 0.6418898105621338
        },
        {
            "text": ". The extractable activities of six enzymes involved in med",
            "probability": 0.04200170579214229,
            "start_logit": 1.072277307510376,
            "end_logit": 0.5069162845611572
        }
    ],
    "56f564f909dd18d46b000009": [
        {
            "text": "6J and DBA/2J mice. Accelerating rotarod performance also distinguished phenotypes in Lyst-",
            "probability": 0.06669171393874779,
            "start_logit": 0.9809513688087463,
            "end_logit": 1.1921899318695068
        },
        {
            "text": "Purkinje cell quantifications likewise distinguished phenotypes of Lyst-mutant mice, as well as background differences between wild-",
            "probability": 0.059477658663295886,
            "start_logit": 1.1097543239593506,
            "end_logit": 0.9489070177078247
        },
        {
            "text": "yst-",
            "probability": 0.05806001101552678,
            "start_logit": 0.8423478007316589,
            "end_logit": 1.1921899318695068
        },
        {
            "text": "Purkinje cell quantifications likewise",
            "probability": 0.054741897305651946,
            "start_logit": 1.1097543239593506,
            "end_logit": 0.8659356236457825
        },
        {
            "text": "uncovered a previously unrecognized background difference between wild-",
            "probability": 0.054413671328986724,
            "start_logit": 0.8850862979888916,
            "end_logit": 1.0845897197723389
        },
        {
            "text": "s in Lyst-",
            "probability": 0.05243204965628802,
            "start_logit": 0.7403886914253235,
            "end_logit": 1.1921899318695068
        },
        {
            "text": "lethal disorder caused by mutations in the LYST gene that involves progressive neurologic dysfunction. Lyst-",
            "probability": 0.05222848632532147,
            "start_logit": 1.1759856939315796,
            "end_logit": 0.7527029514312744
        },
        {
            "text": "yst-mutants, but at more advanced ages. These results establish that genetic background, Lyst genotype",
            "probability": 0.05032051706320488,
            "start_logit": 0.8423478007316589,
            "end_logit": 1.0491256713867188
        },
        {
            "text": "neurologic deficits. Purkinje cell quantifications likewise",
            "probability": 0.05010931633963834,
            "start_logit": 1.0213319063186646,
            "end_logit": 0.8659356236457825
        },
        {
            "text": "associated neurologic deficits. Purkinje cell quantifications likewise",
            "probability": 0.048706418400614564,
            "start_logit": 0.9929357767105103,
            "end_logit": 0.8659356236457825
        },
        {
            "text": "lethal disorder caused by mutations in the LYST gene that involves progressive ne",
            "probability": 0.048491614847282274,
            "start_logit": 1.1759856939315796,
            "end_logit": 0.6784657835960388
        },
        {
            "text": "Lyst-mutant mice, as well as background differences between wild-",
            "probability": 0.046998222395616567,
            "start_logit": 0.874263346195221,
            "end_logit": 0.9489070177078247
        },
        {
            "text": "Purkinje cell quantifications likewise distinguished phenotypes of Lyst-mutant mice, as well as background differences",
            "probability": 0.045674052868814374,
            "start_logit": 1.1097543239593506,
            "end_logit": 0.6848366260528564
        },
        {
            "text": "s in Lyst-mutants, but at more advanced ages. These results establish that genetic background, Lyst genotype",
            "probability": 0.04544277211181492,
            "start_logit": 0.7403886914253235,
            "end_logit": 1.0491256713867188
        },
        {
            "text": "establish that genetic background, Lyst genotype",
            "probability": 0.04531232121068071,
            "start_logit": 0.7375138998031616,
            "end_logit": 1.0491256713867188
        },
        {
            "text": "likewise distinguished phenotypes of Lyst-mutant mice, as well as background differences between wild-",
            "probability": 0.04522340019198665,
            "start_logit": 0.8357682228088379,
            "end_logit": 0.9489070177078247
        },
        {
            "text": "lethal disorder",
            "probability": 0.044968142793758915,
            "start_logit": 1.1759856939315796,
            "end_logit": 0.603029191493988
        },
        {
            "text": "for cerebellar-",
            "probability": 0.0441140486330623,
            "start_logit": 0.8884347081184387,
            "end_logit": 0.8714041709899902
        },
        {
            "text": "Purkinje cell quantifications likewise distinguished phenotypes of L",
            "probability": 0.04346583827213511,
            "start_logit": 1.1097543239593506,
            "end_logit": 0.6352815628051758
        },
        {
            "text": "je cell quantifications likewise distinguished phenotypes of Lyst-mutant mice, as well as background differences between wild-",
            "probability": 0.04312784663757187,
            "start_logit": 0.7883224487304688,
            "end_logit": 0.9489070177078247
        }
    ],
    "550618f58e1671127b000007": [
        {
            "text": "PP1 inhibitor protein, CPI-17, selectively inhibits a specific form of PP1,",
            "probability": 0.0777378729344627,
            "start_logit": 1.2607749700546265,
            "end_logit": 0.6753817200660706
        },
        {
            "text": "circuit controlling cellular protein phosphatase-",
            "probability": 0.07359172418172188,
            "start_logit": 1.0248441696166992,
            "end_logit": 0.8565025329589844
        },
        {
            "text": "PP1 cross-talk mediated by CPI-17 and its related proteins, PHI, KEPI, and",
            "probability": 0.0701605687390626,
            "start_logit": 1.1351418495178223,
            "end_logit": 0.698458731174469
        },
        {
            "text": "PP1 inhibitor protein, CPI-17, selectively inhibits a specific form",
            "probability": 0.0640355235657934,
            "start_logit": 1.2607749700546265,
            "end_logit": 0.48147714138031006
        },
        {
            "text": "kinase signals into the phosphorylation of myosin II and other",
            "probability": 0.06322911310721585,
            "start_logit": 0.9838208556175232,
            "end_logit": 0.7457581162452698
        },
        {
            "text": "PP1 cross-talk mediated by CPI-17 and its related proteins, PHI, KEPI",
            "probability": 0.06144153856583843,
            "start_logit": 1.1351418495178223,
            "end_logit": 0.5657584071159363
        },
        {
            "text": "PP1 cross-talk mediated",
            "probability": 0.05709344255989622,
            "start_logit": 1.1351418495178223,
            "end_logit": 0.49236154556274414
        },
        {
            "text": "), an abundant group of Ser/Thr phosphatases, involves phosphorylation of PP1-",
            "probability": 0.054935381225386846,
            "start_logit": 0.9479824900627136,
            "end_logit": 0.6409892439842224
        },
        {
            "text": "kinase signals into the phosphorylation of myosin II and other proteins. Here, the mechanisms underlying PP1 inhibition",
            "probability": 0.05454554196664624,
            "start_logit": 0.9838208556175232,
            "end_logit": 0.5980292558670044
        },
        {
            "text": "1 (PP1), an abundant group of Ser/Thr phosphatases, involves phosphorylation of PP1-",
            "probability": 0.053154460322678766,
            "start_logit": 0.9150269031524658,
            "end_logit": 0.6409892439842224
        },
        {
            "text": "functions of these inhibitor proteins have been linked to a variety of diseases, including cardiovascular disease and cancer.",
            "probability": 0.050603526862887556,
            "start_logit": 0.9769105315208435,
            "end_logit": 0.5299248695373535
        },
        {
            "text": "kinase signals into the phosphorylation of myosi",
            "probability": 0.04868747080489078,
            "start_logit": 0.9838208556175232,
            "end_logit": 0.4844149947166443
        },
        {
            "text": "circuit controlling cellular protein phosphatase-1 (PP1), an abundant group of Ser/Thr phosphatase",
            "probability": 0.04779784351504188,
            "start_logit": 1.0248441696166992,
            "end_logit": 0.4249504804611206
        },
        {
            "text": "kinase signals into the phosphorylation of myosin II and other proteins. Here, the mechanisms underlying",
            "probability": 0.04608917146060349,
            "start_logit": 0.9838208556175232,
            "end_logit": 0.4295713007450104
        },
        {
            "text": "kinase signals into the",
            "probability": 0.045236255946418,
            "start_logit": 0.9838208556175232,
            "end_logit": 0.41089215874671936
        },
        {
            "text": "), an abundant group of Ser/Thr phosphatases, involves phosphorylation of PP1-specific inhibitor proteins",
            "probability": 0.04457213905188075,
            "start_logit": 0.9479824900627136,
            "end_logit": 0.43194061517715454
        },
        {
            "text": "), an abundant group of Ser/Thr phosphatase",
            "probability": 0.044261660204029454,
            "start_logit": 0.9479824900627136,
            "end_logit": 0.4249504804611206
        },
        {
            "text": "1 (PP1), an abundant group of Ser/Thr phosphatase",
            "probability": 0.04282676498554519,
            "start_logit": 0.9150269031524658,
            "end_logit": 0.4249504804611206
        }
    ],
    "56cdf5195795f9a73e000045": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "51487dead24251bc05000030": [
        {
            "text": "be predicted through pharmacogenetic screening, thereby avoiding serious morbidity and mortality associated with",
            "probability": 0.065517479234472,
            "start_logit": 1.311753273010254,
            "end_logit": 0.5089784860610962
        },
        {
            "text": "ivity syndrome is an example of a test now in widespread routine clinical use in the developed world.",
            "probability": 0.06384616412532987,
            "start_logit": 0.9877301454544067,
            "end_logit": 0.8071611523628235
        },
        {
            "text": ".",
            "probability": 0.06330086025017215,
            "start_logit": 0.9791525602340698,
            "end_logit": 0.8071611523628235
        },
        {
            "text": "sensitivity reactions and severe cutaneous adverse drug reactions, such as Stevens-",
            "probability": 0.0617881754199112,
            "start_logit": 0.8922441005706787,
            "end_logit": 0.8698827028274536
        },
        {
            "text": "be predicted through pharmacogenetic screening, thereby avoiding serious morbidity and mortality",
            "probability": 0.06003804046054799,
            "start_logit": 1.311753273010254,
            "end_logit": 0.42163988947868347
        },
        {
            "text": "sensitivity syndrome is an example of a test now in widespread routine clinical use in the developed world.",
            "probability": 0.05757121763344812,
            "start_logit": 0.8842763900756836,
            "end_logit": 0.8071611523628235
        },
        {
            "text": "associations into pharmacogenetic tests that could",
            "probability": 0.05634787075052693,
            "start_logit": 0.864833652973175,
            "end_logit": 0.8051255941390991
        },
        {
            "text": "be predicted through pharmacogenetic screening",
            "probability": 0.055404506286188204,
            "start_logit": 1.311753273010254,
            "end_logit": 0.3413224518299103
        },
        {
            "text": "be predicted through pharmacogenetic screening, thereby avoiding serious morbidity and mortality associated with these",
            "probability": 0.055000008783845526,
            "start_logit": 1.311753273010254,
            "end_logit": 0.33399486541748047
        },
        {
            "text": "be predicted through pharmacogenetic",
            "probability": 0.05496666755644918,
            "start_logit": 1.311753273010254,
            "end_logit": 0.33338847756385803
        },
        {
            "text": "be predicted through pharmaco",
            "probability": 0.05460267569410374,
            "start_logit": 1.311753273010254,
            "end_logit": 0.32674440741539
        },
        {
            "text": "be routinely used in the clinical setting. HLA-",
            "probability": 0.051653352962962126,
            "start_logit": 0.9178398847579956,
            "end_logit": 0.6651300191879272
        },
        {
            "text": "associations into pharmacogenetic tests that could be routinely used in the clinical setting. HLA-",
            "probability": 0.048986702252227864,
            "start_logit": 0.864833652973175,
            "end_logit": 0.6651300191879272
        },
        {
            "text": "sensitivity reactions and severe cutaneous adverse drug reactions, such as Stevens-Johnson syndrome and toxic epidermal",
            "probability": 0.047623893654968316,
            "start_logit": 0.8922441005706787,
            "end_logit": 0.609505295753479
        },
        {
            "text": "associations into pharmacogenetic",
            "probability": 0.04411906244004815,
            "start_logit": 0.864833652973175,
            "end_logit": 0.5604730844497681
        },
        {
            "text": "ivity syndrome is an example of a test now in widespread routine clinical use in the developed",
            "probability": 0.04383212620277832,
            "start_logit": 0.9877301454544067,
            "end_logit": 0.43105167150497437
        },
        {
            "text": "sensitivity syndrome is an example of a test now in widespread routine clinical use in the developed",
            "probability": 0.03952420496246809,
            "start_logit": 0.8842763900756836,
            "end_logit": 0.43105167150497437
        },
        {
            "text": "be routinely used in the clinical setting. HLA-B",
            "probability": 0.0389437486548738,
            "start_logit": 0.9178398847579956,
            "end_logit": 0.38269317150115967
        },
        {
            "text": "associations into pharmacogenetic tests that could be routinely used in the clinical setting. HLA-B",
            "probability": 0.036933242674678464,
            "start_logit": 0.864833652973175,
            "end_logit": 0.38269317150115967
        }
    ],
    "53147b52e3eabad021000015": [
        {
            "text": "activity in females and its",
            "probability": 0.07858689516878149,
            "start_logit": 1.1128509044647217,
            "end_logit": 0.7440571784973145
        },
        {
            "text": "females and its",
            "probability": 0.07241906437738192,
            "start_logit": 1.0311155319213867,
            "end_logit": 0.7440571784973145
        },
        {
            "text": "operational research, and appropriate pharmacovigilance, the health benefits from",
            "probability": 0.0681141587278291,
            "start_logit": 1.0549834966659546,
            "end_logit": 0.6589047312736511
        },
        {
            "text": "qualitative tests, do not discriminate intermediate G6PD activities. This has resulted in poor",
            "probability": 0.06729231368694004,
            "start_logit": 0.8330941200256348,
            "end_logit": 0.8686550259590149
        },
        {
            "text": "activity in females and its corresponding treatment ramifications. New simple-",
            "probability": 0.065488392848791,
            "start_logit": 1.1128509044647217,
            "end_logit": 0.5617251396179199
        },
        {
            "text": "qualitative tests, do not discriminate intermediate G6PD activities. This has resulted",
            "probability": 0.06192316007036806,
            "start_logit": 0.8330941200256348,
            "end_logit": 0.7855032682418823
        },
        {
            "text": "females and its corresponding treatment ramifications. New simple-",
            "probability": 0.06034858773211676,
            "start_logit": 1.0311155319213867,
            "end_logit": 0.5617251396179199
        },
        {
            "text": "gilance, the health benefits from",
            "probability": 0.060086544427274555,
            "start_logit": 0.9295843243598938,
            "end_logit": 0.6589047312736511
        },
        {
            "text": "operational research, and appropriate pharmacovigilance, the health benefits from this investment go beyond the immediate intervention",
            "probability": 0.059238710932968903,
            "start_logit": 1.0549834966659546,
            "end_logit": 0.5192948579788208
        },
        {
            "text": "6PD) deficiency is a common X-linked genetic trait, with",
            "probability": 0.058651548764080165,
            "start_logit": 1.0593019723892212,
            "end_logit": 0.5050151348114014
        },
        {
            "text": "Plasmodium vivax malaria. Individuals with this deficiency are at greater risk of serious adverse events following treatment with the",
            "probability": 0.05478932031485897,
            "start_logit": 0.9655417203903198,
            "end_logit": 0.5306566953659058
        },
        {
            "text": "gilance, the health benefits from this investment go beyond the immediate intervention",
            "probability": 0.05225711515444502,
            "start_logit": 0.9295843243598938,
            "end_logit": 0.5192948579788208
        },
        {
            "text": "X-linked genetic trait, with an associated enzyme phenotype, whereby males are either G6PD deficient or normal, but females exhibit",
            "probability": 0.0496737183949217,
            "start_logit": 0.8792056441307068,
            "end_logit": 0.5189734697341919
        },
        {
            "text": "X-linked genetic trait, with",
            "probability": 0.04898517265211989,
            "start_logit": 0.8792056441307068,
            "end_logit": 0.5050151348114014
        },
        {
            "text": "is a common X-linked genetic trait, with",
            "probability": 0.04770009197841453,
            "start_logit": 0.85262131690979,
            "end_logit": 0.5050151348114014
        },
        {
            "text": "qualitative tests, do not discriminate intermediate G6PD activities. This has resulted in poor understanding of the epidemiology",
            "probability": 0.047303682162284505,
            "start_logit": 0.8330941200256348,
            "end_logit": 0.516197144985199
        },
        {
            "text": "qualitative tests, do not",
            "probability": 0.04714152260642332,
            "start_logit": 0.8330941200256348,
            "end_logit": 0.5127632021903992
        }
    ],
    "52bf1f2d03868f1b06000015": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "52bf19f703868f1b06000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5519a7d5622b194345000015": [
        {
            "text": "only or protein-",
            "probability": 0.07056516275157435,
            "start_logit": 0.9787145256996155,
            "end_logit": 1.1321630477905273
        },
        {
            "text": "structures, for example, proteinoid capsules. Here, we present a protocell model",
            "probability": 0.06902469379488485,
            "start_logit": 0.8380910158157349,
            "end_logit": 1.2507143020629883
        },
        {
            "text": "dynamic protein membrane-based compartments (PMBCs) are impressively stable and compatible with prevalent cellular membrane constituents forming protein-only or protein-",
            "probability": 0.06327050394694812,
            "start_logit": 0.8695971965789795,
            "end_logit": 1.1321630477905273
        },
        {
            "text": "amphiphilic proteins based on prebiotic amino acids. Self-assembled dynamic protein membrane-based compartments (PMBCs",
            "probability": 0.05969464117611015,
            "start_logit": 1.1098949909210205,
            "end_logit": 0.8336882591247559
        },
        {
            "text": ") under early earth conditions, and the requirement for different classes of molecules for the formation of compartments and the catalysis",
            "probability": 0.05578748808527013,
            "start_logit": 1.14557683467865,
            "end_logit": 0.730313777923584
        },
        {
            "text": "be used to design artificial cells, important for the study of structural, catalytic, and evolutionary",
            "probability": 0.053122891897807015,
            "start_logit": 1.1916837692260742,
            "end_logit": 0.6352651715278625
        },
        {
            "text": "importance in the origin of life scenarios. Current protocell model",
            "probability": 0.051676964768547606,
            "start_logit": 0.9246490001678467,
            "end_logit": 0.874704122543335
        },
        {
            "text": ") under early earth conditions,",
            "probability": 0.05119946081793483,
            "start_logit": 1.14557683467865,
            "end_logit": 0.6444931626319885
        },
        {
            "text": "first prebiotic compartments and their possible minimal molecular composition is of great importance in the origin of life scenarios. Current protocell model",
            "probability": 0.05064613377166794,
            "start_logit": 0.9044997692108154,
            "end_logit": 0.874704122543335
        },
        {
            "text": ") under early earth conditions, and the",
            "probability": 0.04975862128046527,
            "start_logit": 1.14557683467865,
            "end_logit": 0.6159479022026062
        },
        {
            "text": "dynamic protein membrane-based compartments (PMBCs",
            "probability": 0.04694348631916207,
            "start_logit": 0.8695971965789795,
            "end_logit": 0.8336882591247559
        },
        {
            "text": "amphiphilic proteins based on",
            "probability": 0.04651113435625449,
            "start_logit": 1.1098949909210205,
            "end_logit": 0.5841377377510071
        },
        {
            "text": "dynamic protein membrane-based compartments (PMBCs) are impressively stable and compatible with prevalent cellular membrane constituents forming protein",
            "probability": 0.04379191706128145,
            "start_logit": 0.8695971965789795,
            "end_logit": 0.764193058013916
        },
        {
            "text": "under early earth conditions, and the requirement for different classes of molecules for the formation of compartments and the catalysis",
            "probability": 0.04327874621688586,
            "start_logit": 0.891688883304596,
            "end_logit": 0.730313777923584
        },
        {
            "text": "structures, for example, protein",
            "probability": 0.04294854734182674,
            "start_logit": 0.8380910158157349,
            "end_logit": 0.776252806186676
        },
        {
            "text": "missing pathways to synthesize protocell membrane components (e.g., phospholipids) under early earth conditions,",
            "probability": 0.04158328074017627,
            "start_logit": 0.9375460147857666,
            "end_logit": 0.6444931626319885
        },
        {
            "text": "only or protein-lipid hybrid membranes. They can embed processes essential for extant living cells, such as",
            "probability": 0.041037333359263364,
            "start_logit": 0.9787145256996155,
            "end_logit": 0.5901086926460266
        },
        {
            "text": "pholipids) under early earth conditions, and the requirement for different classes of molecules for the formation of compartments and the catalysis",
            "probability": 0.04083786039630005,
            "start_logit": 0.8336368203163147,
            "end_logit": 0.730313777923584
        },
        {
            "text": "under early earth conditions,",
            "probability": 0.039719452286396374,
            "start_logit": 0.891688883304596,
            "end_logit": 0.6444931626319885
        },
        {
            "text": "under early earth conditions, and the",
            "probability": 0.03860167963124317,
            "start_logit": 0.891688883304596,
            "end_logit": 0.6159479022026062
        }
    ],
    "52f21e8f2059c6d71c00000c": [
        {
            "text": "staining immunofluorescence assay. Patients received escalating doses of veliparib on a 7-",
            "probability": 0.14074968784070022,
            "start_logit": 0.9091039896011353,
            "end_logit": 1.1862142086029053
        },
        {
            "text": ") DNA-repair pathway based on FA triple staining immunofluorescence assay. Patients received es",
            "probability": 0.1100704904078752,
            "start_logit": 0.9540776014328003,
            "end_logit": 0.8953785300254822
        },
        {
            "text": "staining immunofluorescence assay. Patients received es",
            "probability": 0.1052298884414358,
            "start_logit": 0.9091039896011353,
            "end_logit": 0.8953785300254822
        },
        {
            "text": ") DNA-repair pathway based on FA",
            "probability": 0.10346761782945006,
            "start_logit": 0.9540776014328003,
            "end_logit": 0.8335162401199341
        },
        {
            "text": ") DNA-",
            "probability": 0.09162805096344495,
            "start_logit": 0.9540776014328003,
            "end_logit": 0.711995005607605
        },
        {
            "text": "with defective DNA repair beyond BRCA, we sought to find the recommended phase II dose (RP",
            "probability": 0.07752225264744221,
            "start_logit": 0.8841296434402466,
            "end_logit": 0.6147705316543579
        },
        {
            "text": "with defective DNA repair beyond BRCA, we",
            "probability": 0.07664078210563172,
            "start_logit": 0.8841296434402466,
            "end_logit": 0.6033348441123962
        },
        {
            "text": ") DNA-repair pathway based on FA triple",
            "probability": 0.07615392254116736,
            "start_logit": 0.9540776014328003,
            "end_logit": 0.5270141363143921
        },
        {
            "text": ") DNA-repair pathway based on FA triple staining immunofluorescence assay.",
            "probability": 0.07583475271340823,
            "start_logit": 0.9540776014328003,
            "end_logit": 0.5228142142295837
        },
        {
            "text": "staining immunofluorescence assay.",
            "probability": 0.07249974573970708,
            "start_logit": 0.9091039896011353,
            "end_logit": 0.5228142142295837
        },
        {
            "text": "with defective DNA repair beyond BR",
            "probability": 0.07020280876973727,
            "start_logit": 0.8841296434402466,
            "end_logit": 0.5155938267707825
        }
    ],
    "5147c8a6d24251bc05000027": [
        {
            "text": "We present the case of an 18-month-old",
            "probability": 0.06703379937813402,
            "start_logit": 0.8116934299468994,
            "end_logit": 0.8802195191383362
        },
        {
            "text": "AP) gene that serves as an activator protein",
            "probability": 0.06682325087506671,
            "start_logit": 0.9521315097808838,
            "end_logit": 0.7366355657577515
        },
        {
            "text": "n A deficiency, to report a novel presumed pathogenic variant within PSAP, and to suggest that individuals with saposi",
            "probability": 0.06242510031045401,
            "start_logit": 0.9252960681915283,
            "end_logit": 0.6953873634338379
        },
        {
            "text": ". Psychosine determination on dried blood spot at 18 months of age was elevated to 12 nmol/L (normal",
            "probability": 0.058988193191258656,
            "start_logit": 0.9929171800613403,
            "end_logit": 0.5711361169815063
        },
        {
            "text": "was elevated to 12 nmol/L (normal <3 nmol/L). We present this case to add to the literature on",
            "probability": 0.05693392471532658,
            "start_logit": 0.8074647784233093,
            "end_logit": 0.721142590045929
        },
        {
            "text": "AP) gene that serves as an activator",
            "probability": 0.056240154941102606,
            "start_logit": 0.9521315097808838,
            "end_logit": 0.5642154812812805
        },
        {
            "text": "osylsphingosine, also known as psychosine, is a substrate of the GAL",
            "probability": 0.05592320160997608,
            "start_logit": 1.0543166399002075,
            "end_logit": 0.456378698348999
        },
        {
            "text": "AP) gene that serves as an activator protein of the galactocerebro",
            "probability": 0.05436654486557334,
            "start_logit": 0.9521315097808838,
            "end_logit": 0.5303334593772888
        },
        {
            "text": "We present the case of an 18-month-old male with clinical and radio",
            "probability": 0.050768274816052755,
            "start_logit": 0.8116934299468994,
            "end_logit": 0.6022942066192627
        },
        {
            "text": "was elevated to 12 nmol/L (normal",
            "probability": 0.049003165929988726,
            "start_logit": 0.8074647784233093,
            "end_logit": 0.5711361169815063
        },
        {
            "text": "We present the case of an 18-month",
            "probability": 0.048567387023358576,
            "start_logit": 0.8116934299468994,
            "end_logit": 0.5579748153686523
        },
        {
            "text": "sequencing, but was found to have",
            "probability": 0.04850625462658501,
            "start_logit": 0.9205533266067505,
            "end_logit": 0.4478554129600525
        },
        {
            "text": "sequencing, but was found to have a homozygous variant, c.257 T >",
            "probability": 0.047996504500165356,
            "start_logit": 0.9205533266067505,
            "end_logit": 0.43729084730148315
        },
        {
            "text": "We present the",
            "probability": 0.04753770260533276,
            "start_logit": 0.8116934299468994,
            "end_logit": 0.5365456938743591
        },
        {
            "text": "We present the case of an 18-month-old male with",
            "probability": 0.04729411506502143,
            "start_logit": 0.8116934299468994,
            "end_logit": 0.531408429145813
        },
        {
            "text": "We",
            "probability": 0.04662909214948445,
            "start_logit": 0.8116934299468994,
            "end_logit": 0.517247200012207
        },
        {
            "text": "activity and negative GALC gene sequencing, but was found to have",
            "probability": 0.04602920967805146,
            "start_logit": 0.8681367635726929,
            "end_logit": 0.4478554129600525
        },
        {
            "text": "activity and negative GALC gene sequencing, but was found to have a homozygous variant, c.257 T >",
            "probability": 0.045545490709580035,
            "start_logit": 0.8681367635726929,
            "end_logit": 0.43729084730148315
        },
        {
            "text": ">",
            "probability": 0.04338863300948745,
            "start_logit": 0.8196226358413696,
            "end_logit": 0.43729084730148315
        }
    ],
    "51631154298dcd4e5100004e": [
        {
            "text": "meta-analysis of bortezomib anti-myeloma activity and th",
            "probability": 0.058438641760124074,
            "start_logit": 0.9806917905807495,
            "end_logit": 0.8912980556488037
        },
        {
            "text": "M-",
            "probability": 0.057721268640396214,
            "start_logit": 1.0738661289215088,
            "end_logit": 0.7857720851898193
        },
        {
            "text": "M-protein concentrations, and platelet counts following bortezomib monotherapy were extracted from published clinical studies. A population-based meta-",
            "probability": 0.05740370373075104,
            "start_logit": 1.0738661289215088,
            "end_logit": 0.7802551984786987
        },
        {
            "text": "topenia. This study aims to develop a quantitative and predict",
            "probability": 0.056549364602809675,
            "start_logit": 1.020240306854248,
            "end_logit": 0.8188861608505249
        },
        {
            "text": "Expectation Maximization algorithm",
            "probability": 0.055367687199380074,
            "start_logit": 0.7725228071212769,
            "end_logit": 1.0454858541488647
        },
        {
            "text": "namic model integrates drug-",
            "probability": 0.05469624660528101,
            "start_logit": 1.0214011669158936,
            "end_logit": 0.7844064235687256
        },
        {
            "text": "meta-",
            "probability": 0.05229676360659505,
            "start_logit": 0.9806917905807495,
            "end_logit": 0.7802551984786987
        },
        {
            "text": "M-protein concentrations, and platelet counts following bortezomib monotherapy were extracted from published clinical studies. A population-",
            "probability": 0.05112356282463112,
            "start_logit": 1.0738661289215088,
            "end_logit": 0.6643918752670288
        },
        {
            "text": "published clinical studies. A population-based meta-analysis of bortezomib anti-myeloma activity and th",
            "probability": 0.049207149385615684,
            "start_logit": 0.8087533712387085,
            "end_logit": 0.8912980556488037
        },
        {
            "text": "M-protein concentrations, and platelet counts following bortezomib monotherapy were extracted from published clinical studies. A population-based meta",
            "probability": 0.048463662486792305,
            "start_logit": 1.0738661289215088,
            "end_logit": 0.6109606623649597
        },
        {
            "text": "limiting toxicities such as thrombocytopenia. This study aims to develop a quantitative and predict",
            "probability": 0.04791670803694481,
            "start_logit": 0.8545905947685242,
            "end_logit": 0.8188861608505249
        },
        {
            "text": "platelet dynamic profiles were well characterized in MM patients, and a local sensitivity analysis of the final model suggests that increased proteasome concentration could",
            "probability": 0.04749856833109708,
            "start_logit": 0.8085888624191284,
            "end_logit": 0.8561232089996338
        },
        {
            "text": "activity in MM patients.",
            "probability": 0.04717150586288691,
            "start_logit": 1.1703797578811646,
            "end_logit": 0.48742276430130005
        },
        {
            "text": "limiting toxicities such as th",
            "probability": 0.046577561297218885,
            "start_logit": 0.8545905947685242,
            "end_logit": 0.7905408143997192
        },
        {
            "text": "topenia. This study aims to develop a quantitative and predictive pharmacodynamic model to investigate bortezomib dosing-",
            "probability": 0.04629301995552473,
            "start_logit": 1.020240306854248,
            "end_logit": 0.6187633872032166
        },
        {
            "text": "activity, M-",
            "probability": 0.045476103373551166,
            "start_logit": 0.8354274034500122,
            "end_logit": 0.7857720851898193
        },
        {
            "text": "). Although clinically successful, bortezomib exhibits a relatively narrow therapeutic index and can induce dose-limiting toxicities such as th",
            "probability": 0.045301949079972446,
            "start_logit": 0.8268217444419861,
            "end_logit": 0.7905408143997192
        },
        {
            "text": "MM patients.",
            "probability": 0.04430895960035418,
            "start_logit": 1.1077766418457031,
            "end_logit": 0.48742276430130005
        },
        {
            "text": "meta",
            "probability": 0.04415207618779245,
            "start_logit": 0.9806917905807495,
            "end_logit": 0.6109606623649597
        },
        {
            "text": "published clinical studies. A population-based meta-",
            "probability": 0.04403549743228133,
            "start_logit": 0.8087533712387085,
            "end_logit": 0.7802551984786987
        }
    ],
    "52fb78572059c6d71c000067": [
        {
            "text": "of these electrocardiographic abnormalities. In addition, the use of genetic analysis in neonates could identify the cause of these",
            "probability": 0.15728910078500782,
            "start_logit": 1.0314579010009766,
            "end_logit": 0.928925633430481
        },
        {
            "text": "of these electrocardiographic abnormalities. In addition, the use of genetic",
            "probability": 0.1264211456914889,
            "start_logit": 1.0314579010009766,
            "end_logit": 0.7104588747024536
        },
        {
            "text": "community towards the initiation of a newborn electrocardiogram-screening program,",
            "probability": 0.11921293028782509,
            "start_logit": 0.8869724869728088,
            "end_logit": 0.7962367534637451
        },
        {
            "text": "cardiogram and the first symptom of the disease may be an unexpected death. Despite the",
            "probability": 0.11778522755931156,
            "start_logit": 0.8754240870475769,
            "end_logit": 0.7957367897033691
        },
        {
            "text": "community towards the initiation of a newborn electrocardiogram-screening",
            "probability": 0.11504713502002135,
            "start_logit": 0.8869724869728088,
            "end_logit": 0.7606674432754517
        },
        {
            "text": "community towards the initiation of a newborn electrocardiogram-",
            "probability": 0.1076011322471694,
            "start_logit": 0.8869724869728088,
            "end_logit": 0.6937566995620728
        },
        {
            "text": "community towards the initiation of a newborn electrocardiogram-screening program, for the",
            "probability": 0.08620919261848539,
            "start_logit": 0.8869724869728088,
            "end_logit": 0.4721023440361023
        },
        {
            "text": "cardiogram and the first symptom of the",
            "probability": 0.08568781569492297,
            "start_logit": 0.8754240870475769,
            "end_logit": 0.477584570646286
        },
        {
            "text": "cardiogram and the first sympt",
            "probability": 0.0847463200957675,
            "start_logit": 0.8754240870475769,
            "end_logit": 0.4665362536907196
        }
    ],
    "54cf45e7f693c3b16b00000a": [
        {
            "text": "plasmic reticulum calcium release. Since dantrolene is lipophilic it could also affect intra-",
            "probability": 0.24508831513111118,
            "start_logit": 0.9317147135734558,
            "end_logit": 0.7437610626220703
        },
        {
            "text": "plasmic re",
            "probability": 0.22033252838473166,
            "start_logit": 0.9317147135734558,
            "end_logit": 0.6372803449630737
        },
        {
            "text": "plasmic",
            "probability": 0.20522003069003655,
            "start_logit": 0.9317147135734558,
            "end_logit": 0.5662251710891724
        },
        {
            "text": "plasmic reticulum calcium release. Since dantrolene is lipophilic it could also affect intra-sarco",
            "probability": 0.17820567997930226,
            "start_logit": 0.9317147135734558,
            "end_logit": 0.4250808358192444
        },
        {
            "text": "plasmic reticulum calcium release. Since dantrolene is lip",
            "probability": 0.1511534458148182,
            "start_logit": 0.9317147135734558,
            "end_logit": 0.2604379653930664
        }
    ],
    "54ede95c94afd6150400000a": [
        {
            "text": "kidney cancer, develops in association with an underlying germline predis",
            "probability": 0.06532817677266757,
            "start_logit": 1.1588642597198486,
            "end_logit": 0.7999099493026733
        },
        {
            "text": "igenesis, when known. Despite these described associations, many cases of familial WT remain unexplaine",
            "probability": 0.0603141398492503,
            "start_logit": 1.114848256111145,
            "end_logit": 0.7640690803527832
        },
        {
            "text": "of rare fami",
            "probability": 0.059821982530943105,
            "start_logit": 0.8252565860748291,
            "end_logit": 1.0454673767089844
        },
        {
            "text": "p15 locus, and the recently identified genes CTR9, REST, and TRIM28 in WT predisposition.",
            "probability": 0.05872483573825867,
            "start_logit": 0.9234911203384399,
            "end_logit": 0.9287223815917969
        },
        {
            "text": "kidney cancer, develops in association with an underlying germline predisposition in up to 15% of cases",
            "probability": 0.0575975320343375,
            "start_logit": 1.1588642597198486,
            "end_logit": 0.6739662289619446
        },
        {
            "text": "igenesis, when known. Despite these described associations, many cases of familia",
            "probability": 0.05503709410992044,
            "start_logit": 1.114848256111145,
            "end_logit": 0.6725099086761475
        },
        {
            "text": "genes CTR9, REST, and TRIM28 in WT predisposition.",
            "probability": 0.054432376817653214,
            "start_logit": 0.847587525844574,
            "end_logit": 0.9287223815917969
        },
        {
            "text": "), the most common childhood kidney cancer, develops in association with an underlying germline predis",
            "probability": 0.05324960341543337,
            "start_logit": 0.9544311761856079,
            "end_logit": 0.7999099493026733
        },
        {
            "text": "p",
            "probability": 0.04897756607830158,
            "start_logit": 0.9234911203384399,
            "end_logit": 0.7472220063209534
        },
        {
            "text": "lial WT remain unexplaine",
            "probability": 0.04795173101196678,
            "start_logit": 0.8854765892028809,
            "end_logit": 0.7640690803527832
        },
        {
            "text": "), the most common childhood kidney cancer, develops in association with an underlying germline predisposition in up to 15% of cases",
            "probability": 0.04694828311540145,
            "start_logit": 0.9544311761856079,
            "end_logit": 0.6739662289619446
        },
        {
            "text": "p15 locus, and the recently identified genes CTR9, REST, and TRIM28 in WT predisposition. We discuss",
            "probability": 0.045887849034140754,
            "start_logit": 0.9234911203384399,
            "end_logit": 0.6820600032806396
        },
        {
            "text": "underlying germline predis",
            "probability": 0.04512913746777378,
            "start_logit": 0.7889689207077026,
            "end_logit": 0.7999099493026733
        },
        {
            "text": "lial WT remain unexplained. Continued investigations are needed to fully elucidate the landscape of germ",
            "probability": 0.04430682627962616,
            "start_logit": 0.8854765892028809,
            "end_logit": 0.685012936592102
        },
        {
            "text": "aspects of tumorigenesis, when known. Despite these described associations, many cases of familial WT remain unexplaine",
            "probability": 0.04403783143875637,
            "start_logit": 0.8003307580947876,
            "end_logit": 0.7640690803527832
        },
        {
            "text": "lia",
            "probability": 0.04375630555348142,
            "start_logit": 0.8854765892028809,
            "end_logit": 0.6725099086761475
        },
        {
            "text": "genes CTR9, REST, and TRIM28 in WT predisposition. We discuss",
            "probability": 0.042533702454456604,
            "start_logit": 0.847587525844574,
            "end_logit": 0.6820600032806396
        },
        {
            "text": "lial WT remain unexplained. Continued investigations are needed to fully elucidate the",
            "probability": 0.04242065599115401,
            "start_logit": 0.8854765892028809,
            "end_logit": 0.6415095925331116
        },
        {
            "text": "lial WT remain unexplained. Continued investigations are needed",
            "probability": 0.04198026360137809,
            "start_logit": 0.8854765892028809,
            "end_logit": 0.6310737729072571
        },
        {
            "text": "is imperative for WT families",
            "probability": 0.041564106705098976,
            "start_logit": 0.8332865834236145,
            "end_logit": 0.6733011603355408
        }
    ],
    "56c04412ef6e39474100001b": [
        {
            "text": "agents. We",
            "probability": 0.06259527438517651,
            "start_logit": 1.1170103549957275,
            "end_logit": 0.7605642676353455
        },
        {
            "text": "levels suggesting that the upregulation of CD38 expression on",
            "probability": 0.059331172003743465,
            "start_logit": 1.054852843284607,
            "end_logit": 0.7691668272018433
        },
        {
            "text": "agents.",
            "probability": 0.057809106482316734,
            "start_logit": 1.1170103549957275,
            "end_logit": 0.6810207962989807
        },
        {
            "text": "performance of CD38-specific therapies. Using quantitative reverse transcription polymerase chain reaction and flow cytometry, we",
            "probability": 0.05297901877264231,
            "start_logit": 0.9606446027755737,
            "end_logit": 0.7501361966133118
        },
        {
            "text": "homogeneous distribution of CD38 molecules on the cell membrane. Particularly important is that combining ricolinostat with daratumumab induced enhanced l",
            "probability": 0.05285748536243924,
            "start_logit": 0.8213011026382446,
            "end_logit": 0.8871830701828003
        },
        {
            "text": "regulate CD38 on MM cells, thereby enhancing the performance of CD38-",
            "probability": 0.05143997352533611,
            "start_logit": 0.9749249815940857,
            "end_logit": 0.7063754200935364
        },
        {
            "text": "performance of CD38-",
            "probability": 0.05071061139554672,
            "start_logit": 0.9606446027755737,
            "end_logit": 0.7063754200935364
        },
        {
            "text": "agents. We therefore investigated the potential of the histone deace",
            "probability": 0.05064342150011148,
            "start_logit": 1.1170103549957275,
            "end_logit": 0.5486838221549988
        },
        {
            "text": "surface expression on MM cells. Super-resolution microscopy imaging of MM cells by direct stochastic optical reconstruction microscopy confirmed this rise",
            "probability": 0.050634758907430404,
            "start_logit": 0.8860267400741577,
            "end_logit": 0.7794963717460632
        },
        {
            "text": "levels suggesting that the upregulation of CD38 expression on MM cells by HDAC6 inhibitors is a class effect. This",
            "probability": 0.05039952357333569,
            "start_logit": 1.054852843284607,
            "end_logit": 0.6060137152671814
        },
        {
            "text": "of CD38 levels suggesting that the upregulation of CD38 expression on",
            "probability": 0.05026525068117965,
            "start_logit": 0.8890320062637329,
            "end_logit": 0.7691668272018433
        },
        {
            "text": "agents. We therefore investigated the potential of the histone deacetylase (HDAC) inhibitor ricolinostat to up-",
            "probability": 0.04973517142114548,
            "start_logit": 1.1170103549957275,
            "end_logit": 0.530586838722229
        },
        {
            "text": "this rise",
            "probability": 0.04881064952832577,
            "start_logit": 0.8493369817733765,
            "end_logit": 0.7794963717460632
        },
        {
            "text": "levels",
            "probability": 0.048707395811495975,
            "start_logit": 1.054852843284607,
            "end_logit": 0.5718628764152527
        },
        {
            "text": "regulate CD38 on MM cells, thereby enhancing the performance of CD38-specific the",
            "probability": 0.04497083034502378,
            "start_logit": 0.9749249815940857,
            "end_logit": 0.5719739198684692
        },
        {
            "text": "performance of CD38-specific the",
            "probability": 0.04433319353553576,
            "start_logit": 0.9606446027755737,
            "end_logit": 0.5719739198684692
        },
        {
            "text": "significantly increases CD38 RNA levels and CD38 surface expression on MM cells. Super-resolution microscopy",
            "probability": 0.04419288976975085,
            "start_logit": 0.8892873525619507,
            "end_logit": 0.640161395072937
        },
        {
            "text": "surface expression on MM cells. Super-resolution microscopy",
            "probability": 0.04404902854680213,
            "start_logit": 0.8860267400741577,
            "end_logit": 0.640161395072937
        },
        {
            "text": "6 inhibitors is a class effect. This",
            "probability": 0.04283686852194695,
            "start_logit": 0.8922702670097351,
            "end_logit": 0.6060137152671814
        },
        {
            "text": "of CD38 levels suggesting that the upregulation of CD38 expression on MM cells by HDAC6 inhibitors is a class effect. This",
            "probability": 0.042698375930714835,
            "start_logit": 0.8890320062637329,
            "end_logit": 0.6060137152671814
        }
    ],
    "52f899952059c6d71c00004b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "53161545b166e2b806000002": [
        {
            "text": "H2 play important roles in therapeutic resistance to certain cytotoxic drugs such as cisplatin that is used normally",
            "probability": 0.07814875790618446,
            "start_logit": 1.3696430921554565,
            "end_logit": 0.7803609371185303
        },
        {
            "text": "H",
            "probability": 0.07220744650068393,
            "start_logit": 1.3696430921554565,
            "end_logit": 0.7012899518013
        },
        {
            "text": "including apoptosis. Thus, differential expression of mismatch repair genes particularly the contributions of MLH",
            "probability": 0.0603076564556177,
            "start_logit": 1.1758737564086914,
            "end_logit": 0.7149751782417297
        },
        {
            "text": "including apoptosis. Thus, differential expression of mismatch repair genes particularly the contributions of MLH1 and MSH",
            "probability": 0.05948795421943889,
            "start_logit": 1.1758737564086914,
            "end_logit": 0.7012899518013
        },
        {
            "text": ". Thus, differential expression of mismatch repair genes particularly the contributions of MLH",
            "probability": 0.0482517807173646,
            "start_logit": 0.952847421169281,
            "end_logit": 0.7149751782417297
        },
        {
            "text": "H1 and MSH2 play important roles in therapeutic resistance to certain cytotoxic drugs such as cisplatin that is used normally",
            "probability": 0.0482300686993323,
            "start_logit": 0.8870115876197815,
            "end_logit": 0.7803609371185303
        },
        {
            "text": "used normally as chemoprevention. An understanding of the role of mismatch repair genes in molecular signaling mechanism",
            "probability": 0.047832612945811225,
            "start_logit": 0.8470208644866943,
            "end_logit": 0.8120766878128052
        },
        {
            "text": "of the role of mismatch repair genes in molecular signaling mechanism",
            "probability": 0.04766617970853079,
            "start_logit": 0.843535304069519,
            "end_logit": 0.8120766878128052
        },
        {
            "text": ". Thus, differential expression of mismatch repair genes particularly the contributions of MLH1 and MSH",
            "probability": 0.04759594205809352,
            "start_logit": 0.952847421169281,
            "end_logit": 0.7012899518013
        },
        {
            "text": "or apoptosis",
            "probability": 0.047084618201864714,
            "start_logit": 0.9344058036804199,
            "end_logit": 0.7089304327964783
        },
        {
            "text": "or apoptosis; it is rather intended to focus primarily on the current state of knowledge of the",
            "probability": 0.04647921338033957,
            "start_logit": 0.9344058036804199,
            "end_logit": 0.6959892511367798
        },
        {
            "text": "used normally",
            "probability": 0.04633937053808883,
            "start_logit": 0.8470208644866943,
            "end_logit": 0.7803609371185303
        },
        {
            "text": "forms of colorectal cancer is hereditary non-polyposis",
            "probability": 0.04580600897449941,
            "start_logit": 1.0821900367736816,
            "end_logit": 0.5336151123046875
        },
        {
            "text": "is hereditary non-polyposis colorectal cancer (HNPCC), also known as \"Lynch syndrome\". It is the",
            "probability": 0.04494230098155219,
            "start_logit": 0.8153931498527527,
            "end_logit": 0.7813761830329895
        },
        {
            "text": "H1 and MSH",
            "probability": 0.04456334558141132,
            "start_logit": 0.8870115876197815,
            "end_logit": 0.7012899518013
        },
        {
            "text": "ectal cancer is hereditary non-polyposis",
            "probability": 0.04404095895691134,
            "start_logit": 1.0428948402404785,
            "end_logit": 0.5336151123046875
        },
        {
            "text": "loss of mismatch repair function. Recent studies have",
            "probability": 0.043751090898144496,
            "start_logit": 0.8971534371376038,
            "end_logit": 0.6727529764175415
        },
        {
            "text": "to accomplish that goal of linkage of apoptosis",
            "probability": 0.04305713518596568,
            "start_logit": 0.8815849423408508,
            "end_logit": 0.6723328828811646
        },
        {
            "text": "DNA, the inactivation of which results in an increased rate of mutation and often a loss of mismatch repair function. Recent studies have",
            "probability": 0.042236565543786325,
            "start_logit": 0.8619232177734375,
            "end_logit": 0.6727529764175415
        },
        {
            "text": ".",
            "probability": 0.04197099254637873,
            "start_logit": 0.9675694704055786,
            "end_logit": 0.5607991218566895
        }
    ],
    "56ae6e650a360a5e4500000e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5314bd7ddae131f847000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "55180ef46487737b43000006": [
        {
            "text": "diet. Knowledge of the various EIM, as well as the associated conditions which do not improve on",
            "probability": 0.1496133599071924,
            "start_logit": 1.1854135990142822,
            "end_logit": 1.0657799243927002
        },
        {
            "text": "diet. Knowledge of the various",
            "probability": 0.10093501053338713,
            "start_logit": 1.1854135990142822,
            "end_logit": 0.6722024083137512
        },
        {
            "text": "diet. Knowledge of the various EIM, as well as the associated conditions which do not improve on a gluten-",
            "probability": 0.08268210305763507,
            "start_logit": 1.1854135990142822,
            "end_logit": 0.4727287292480469
        },
        {
            "text": "diet. Knowledge of the various EIM, as well as the associated conditions which do not",
            "probability": 0.08061661373260284,
            "start_logit": 1.1854135990142822,
            "end_logit": 0.4474303126335144
        },
        {
            "text": "diet. Knowledge of the various EIM, as well as the associated",
            "probability": 0.07491914004075344,
            "start_logit": 1.1854135990142822,
            "end_logit": 0.37413495779037476
        },
        {
            "text": "diet. Knowledge of the various EIM, as well as the associated conditions which do not improve on a gluten-free diet, will",
            "probability": 0.07276809901427785,
            "start_logit": 1.1854135990142822,
            "end_logit": 0.345003217458725
        },
        {
            "text": "is a common form of enteropathy with frequent extraintestinal manifestations (EIM",
            "probability": 0.06869870355576778,
            "start_logit": 1.109238862991333,
            "end_logit": 0.36363062262535095
        },
        {
            "text": "is a common form of enteropathy with frequent extraintestinal manifestations",
            "probability": 0.06667473208401939,
            "start_logit": 1.109238862991333,
            "end_logit": 0.33372634649276733
        },
        {
            "text": "management of celia",
            "probability": 0.0641141115640799,
            "start_logit": 0.9974367618560791,
            "end_logit": 0.40636688470840454
        },
        {
            "text": "cognition of these presentations may lead to significant delays in diagnosis. Any organ may be involved",
            "probability": 0.06322948741825564,
            "start_logit": 0.9441275596618652,
            "end_logit": 0.4457823634147644
        },
        {
            "text": ". Misrecognition of these presentations may lead to significant delays in diagnosis. Any organ may be involved",
            "probability": 0.059856297722299036,
            "start_logit": 0.88930344581604,
            "end_logit": 0.4457823634147644
        },
        {
            "text": "cognition of these presentations may lead to significant delays in diagnosis. Any organ may",
            "probability": 0.05953419667544621,
            "start_logit": 0.9441275596618652,
            "end_logit": 0.3855624794960022
        },
        {
            "text": ". Misrecognition of these presentations may lead to significant delays in diagnosis. Any organ may",
            "probability": 0.056358144694283255,
            "start_logit": 0.88930344581604,
            "end_logit": 0.3855624794960022
        }
    ],
    "51716e808ed59a060a00000b": [
        {
            "text": "some other tick-",
            "probability": 0.09602381761120228,
            "start_logit": 1.223201036453247,
            "end_logit": 0.6860112547874451
        },
        {
            "text": "Sindbis virus. Infection with this recombinant Sindb",
            "probability": 0.0865969224773029,
            "start_logit": 0.9628493785858154,
            "end_logit": 0.8430309295654297
        },
        {
            "text": "i) that the antibody fragment was antigen binding and (ii)",
            "probability": 0.08631363422378305,
            "start_logit": 1.1616170406341553,
            "end_logit": 0.6409865617752075
        },
        {
            "text": "i) that the antibody fragment was antigen binding and (ii) that louping ill virus infectivity was significantly reduced in the",
            "probability": 0.08279696430544065,
            "start_logit": 1.1616170406341553,
            "end_logit": 0.5993903875350952
        },
        {
            "text": "some other tick-borne flaviviruses was previously expressed in soluble form from bacteria and shown to be functional",
            "probability": 0.0817063083133442,
            "start_logit": 1.223201036453247,
            "end_logit": 0.524546205997467
        },
        {
            "text": "some other tick-borne flaviviruses was previously expressed in soluble form from bacteria and shown to be functionally active in vitro. To see",
            "probability": 0.07743029668447805,
            "start_logit": 1.223201036453247,
            "end_logit": 0.47079312801361084
        },
        {
            "text": ". The variable genes and interchain linker encoding the single-",
            "probability": 0.07742038847263354,
            "start_logit": 1.0146775245666504,
            "end_logit": 0.6791886687278748
        },
        {
            "text": ". The variable genes and interchain linker encoding the single-chain antibody were cloned into",
            "probability": 0.07642983388338957,
            "start_logit": 1.0146775245666504,
            "end_logit": 0.6663116216659546
        },
        {
            "text": ". We",
            "probability": 0.0716309509070189,
            "start_logit": 0.907864511013031,
            "end_logit": 0.7082787752151489
        },
        {
            "text": "ivity was significantly reduced in the",
            "probability": 0.06766699628387407,
            "start_logit": 0.9598242044448853,
            "end_logit": 0.5993903875350952
        },
        {
            "text": ". We demonstrate (i) that the antibody fragment was antigen binding and (ii)",
            "probability": 0.06696934935199834,
            "start_logit": 0.907864511013031,
            "end_logit": 0.6409865617752075
        },
        {
            "text": "ivity was significantly reduced in the presence of intracellular antibody expressed by the superinfecting recombina",
            "probability": 0.0647737153058081,
            "start_logit": 0.9598242044448853,
            "end_logit": 0.5556917190551758
        },
        {
            "text": ". We demonstrate (i) that the antibody fragment was antigen binding and (ii) that louping ill virus infectivity was significantly reduced in the",
            "probability": 0.06424082217972638,
            "start_logit": 0.907864511013031,
            "end_logit": 0.5993903875350952
        }
    ],
    "554101d0234c5a7c75000002": [
        {
            "text": "ceroid is a characteristic of all NCLs, a common pathogenic link for these",
            "probability": 0.06898552861064099,
            "start_logit": 1.1462359428405762,
            "end_logit": 0.9342249631881714
        },
        {
            "text": "M6PR transports soluble proteins such as PPT1 from the T",
            "probability": 0.0682190588349038,
            "start_logit": 1.2433381080627441,
            "end_logit": 0.825950026512146
        },
        {
            "text": "is a characteristic of all NCLs, a common pathogenic link for these",
            "probability": 0.05981911765185461,
            "start_logit": 1.003664493560791,
            "end_logit": 0.9342249631881714
        },
        {
            "text": "ceroid is a characteristic of all",
            "probability": 0.05894651064873537,
            "start_logit": 1.1462359428405762,
            "end_logit": 0.7769586443901062
        },
        {
            "text": "PPT1-deficiency causes lysosomal accumulation of autofluorescent ce",
            "probability": 0.058218718003011254,
            "start_logit": 0.9916734099388123,
            "end_logit": 0.9190976619720459
        },
        {
            "text": "is a characteristic of all NCLs, a common pathogenic link for these diseases has been suggested. It has been reported that CLN3-",
            "probability": 0.05741372877527155,
            "start_logit": 1.003664493560791,
            "end_logit": 0.8931831121444702
        },
        {
            "text": "PPT1 depalmitoylates S-palmitoylated proteins",
            "probability": 0.051377026791695056,
            "start_logit": 0.9328495264053345,
            "end_logit": 0.8529057502746582
        },
        {
            "text": "is a characteristic of all",
            "probability": 0.05111402821256483,
            "start_logit": 1.003664493560791,
            "end_logit": 0.7769586443901062
        },
        {
            "text": "PPT1 depalmitoylates S-",
            "probability": 0.04954105759215697,
            "start_logit": 0.9328495264053345,
            "end_logit": 0.8165163993835449
        },
        {
            "text": "autofluorescent ce",
            "probability": 0.04949442704552266,
            "start_logit": 0.8293265700340271,
            "end_logit": 0.9190976619720459
        },
        {
            "text": ". PPT1 depalmitoylates S-palmitoylated proteins",
            "probability": 0.04737004403177316,
            "start_logit": 0.8516484498977661,
            "end_logit": 0.8529057502746582
        },
        {
            "text": "PPT1-",
            "probability": 0.046889673660421814,
            "start_logit": 0.9916734099388123,
            "end_logit": 0.7026882171630859
        },
        {
            "text": ". PPT1 depalmitoylates S-",
            "probability": 0.04567726523054528,
            "start_logit": 0.8516484498977661,
            "end_logit": 0.8165163993835449
        },
        {
            "text": "significantly reduced levels of Ppt1-protein and Ppt1-enzyme activity and progressively accumulate autofluorescent ce",
            "probability": 0.04310795704020671,
            "start_logit": 1.0679097175598145,
            "end_logit": 0.5423620343208313
        },
        {
            "text": "autofluorescent ceroid leading to INCL. Because intracellular accumulation of ceroid is a characteristic of all",
            "probability": 0.0429364476462462,
            "start_logit": 0.8293265700340271,
            "end_logit": 0.7769586443901062
        },
        {
            "text": "neuronal ceroid lip",
            "probability": 0.04117644793082937,
            "start_logit": 0.8899815082550049,
            "end_logit": 0.67444908618927
        },
        {
            "text": "fluorescent ceroid. Furthermore, in J",
            "probability": 0.04075931318870714,
            "start_logit": 0.9164288640022278,
            "end_logit": 0.6378196477890015
        },
        {
            "text": "fluorescent ceroid. Furthermore, in JNCL fibroblasts the",
            "probability": 0.039982296417796805,
            "start_logit": 0.9164288640022278,
            "end_logit": 0.6185720562934875
        },
        {
            "text": "PPT1-deficiency causes lysosomal accumulation of autofluorescent ceroid leading to INCL. Because intracellular accumulation",
            "probability": 0.03962975526279618,
            "start_logit": 0.9916734099388123,
            "end_logit": 0.5344709753990173
        },
        {
            "text": "underlie various forms of neuronal ceroid lip",
            "probability": 0.03934159742432024,
            "start_logit": 0.8443974852561951,
            "end_logit": 0.67444908618927
        }
    ],
    "53592c1e9a4572de6f000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "533c390bc45e13371400000b": [
        {
            "text": "sequencing datasets including ~\u20094300 whole-genomes from the 1000 Genomes and the pan-cancer",
            "probability": 0.06217524973584756,
            "start_logit": 1.2585508823394775,
            "end_logit": 0.6937962770462036
        },
        {
            "text": "sequencing datasets including ~\u20094300 whole-genomes from the",
            "probability": 0.05810745983057259,
            "start_logit": 1.2585508823394775,
            "end_logit": 0.6261333227157593
        },
        {
            "text": "is the most frequent substitution type in genome evolution. The mutational process is obviously ongoing in the",
            "probability": 0.05703314288553074,
            "start_logit": 1.089261770248413,
            "end_logit": 0.7767609357833862
        },
        {
            "text": "CpG dinucleotide contexts is the most frequent substitution type in genome evolution. The mutational process is obviously ongoing in the",
            "probability": 0.05563058112366489,
            "start_logit": 1.0643622875213623,
            "end_logit": 0.7767609357833862
        },
        {
            "text": "leotide contexts is the most frequent substitution type in genome evolution. The mutational process is obviously ongoing in the",
            "probability": 0.05514520278006841,
            "start_logit": 1.0555989742279053,
            "end_logit": 0.7767609357833862
        },
        {
            "text": "is the most frequent",
            "probability": 0.05066265563334059,
            "start_logit": 1.089261770248413,
            "end_logit": 0.6583174467086792
        },
        {
            "text": "CpG dinucleotide contexts is the most frequent",
            "probability": 0.04941675719690833,
            "start_logit": 1.0643622875213623,
            "end_logit": 0.6583174467086792
        },
        {
            "text": "is the most frequent substitution type in genome evolution. The mutational process is obviously ongoing",
            "probability": 0.04910604865171715,
            "start_logit": 1.089261770248413,
            "end_logit": 0.6271106004714966
        },
        {
            "text": "leotide contexts is the most frequent",
            "probability": 0.0489855946372215,
            "start_logit": 1.0555989742279053,
            "end_logit": 0.6583174467086792
        },
        {
            "text": "is the most frequent substitution type in genome evolution. The mutational process is obviously ongoing in the human germline; however,",
            "probability": 0.04799358952422813,
            "start_logit": 1.089261770248413,
            "end_logit": 0.6041958332061768
        },
        {
            "text": "CpG dinucleotide contexts is the most frequent substitution type in genome evolution. The mutational process is obviously ongoing",
            "probability": 0.047898430368196326,
            "start_logit": 1.0643622875213623,
            "end_logit": 0.6271106004714966
        },
        {
            "text": "is the most",
            "probability": 0.04759886275493921,
            "start_logit": 1.089261770248413,
            "end_logit": 0.5959372520446777
        },
        {
            "text": "leotide contexts is the most frequent substitution type in genome evolution. The mutational process is obviously ongoing",
            "probability": 0.04748051525166527,
            "start_logit": 1.0555989742279053,
            "end_logit": 0.6271106004714966
        },
        {
            "text": "is the most frequent substitution type in genome evolution. The",
            "probability": 0.04707634124849229,
            "start_logit": 1.089261770248413,
            "end_logit": 0.5848989486694336
        },
        {
            "text": "CpG dinucleotide contexts is the most",
            "probability": 0.04642830925866125,
            "start_logit": 1.0643622875213623,
            "end_logit": 0.5959372520446777
        },
        {
            "text": "leotide contexts is the most frequent substitution type in genome evolution. The mutational process is obviously ongoing in the human germline; however,",
            "probability": 0.046404881312062,
            "start_logit": 1.0555989742279053,
            "end_logit": 0.6041958332061768
        },
        {
            "text": "leotide contexts is the most",
            "probability": 0.04602322098906617,
            "start_logit": 1.0555989742279053,
            "end_logit": 0.5959372520446777
        },
        {
            "text": "CpG dinucleotide contexts is the most frequent substitution type in genome evolution. The",
            "probability": 0.04591863762594768,
            "start_logit": 1.0643622875213623,
            "end_logit": 0.5848989486694336
        },
        {
            "text": "leotide contexts is the most frequent substitution type in genome evolution. The",
            "probability": 0.045517996255304005,
            "start_logit": 1.0555989742279053,
            "end_logit": 0.5848989486694336
        },
        {
            "text": "is the",
            "probability": 0.045396522936566056,
            "start_logit": 1.089261770248413,
            "end_logit": 0.5485638976097107
        }
    ],
    "531a3a58b166e2b806000037": [
        {
            "text": "levels of antibodies against HPV16. Since approximately 50% of cervical cancers are associated with HPV16 infection, the",
            "probability": 0.06365378911938795,
            "start_logit": 1.0810165405273438,
            "end_logit": 0.8722589015960693
        },
        {
            "text": "tract. HPV types are stratified into low",
            "probability": 0.06011201061126541,
            "start_logit": 1.0509603023529053,
            "end_logit": 0.8450659513473511
        },
        {
            "text": "or prevention of cervical cancer in humans. The HPV type 16 (HPV16) L1 virus-",
            "probability": 0.054686215184641146,
            "start_logit": 0.9883334040641785,
            "end_logit": 0.8130948543548584
        },
        {
            "text": "levels of antibodies against HPV16. Since approximately 50% of cervical cancers are associated with HPV16 infection, the administration of this",
            "probability": 0.05426668224373941,
            "start_logit": 1.0810165405273438,
            "end_logit": 0.7127104997634888
        },
        {
            "text": ". Virus-like particles",
            "probability": 0.05157860575787218,
            "start_logit": 0.9977560639381409,
            "end_logit": 0.7451674938201904
        },
        {
            "text": ". Virus-like particles are empty viral capsids, and are the leading candidate vaccines for the",
            "probability": 0.05098229426857949,
            "start_logit": 0.9977560639381409,
            "end_logit": 0.7335389256477356
        },
        {
            "text": "tract. HPV",
            "probability": 0.05006492289554971,
            "start_logit": 1.0509603023529053,
            "end_logit": 0.6621769070625305
        },
        {
            "text": "V16) L1 virus-",
            "probability": 0.049610859589081485,
            "start_logit": 0.8909314870834351,
            "end_logit": 0.8130948543548584
        },
        {
            "text": "accepted worldwide that cervical carcinoma is a consequence of infection with HPV viruses. Therefore it is reasonable to assume that vaccine",
            "probability": 0.04883611368796632,
            "start_logit": 1.005436658859253,
            "end_logit": 0.6828500032424927
        },
        {
            "text": "or prevention of cervical cancer in humans. The HPV type 16 (HPV16) L1 virus-like",
            "probability": 0.0485160469688005,
            "start_logit": 0.9883334040641785,
            "end_logit": 0.6933777928352356
        },
        {
            "text": "16) L1 virus-",
            "probability": 0.047943567471127095,
            "start_logit": 0.8567463755607605,
            "end_logit": 0.8130948543548584
        },
        {
            "text": "tract. HPV types are st",
            "probability": 0.047940229841236186,
            "start_logit": 1.0509603023529053,
            "end_logit": 0.618811309337616
        },
        {
            "text": "of reproductive age in parts of the developing world. Thanks to the",
            "probability": 0.04762080031419559,
            "start_logit": 0.9030557870864868,
            "end_logit": 0.7600304484367371
        },
        {
            "text": "80 types infect the genital tract. HPV types are stratified into low",
            "probability": 0.04742395788401997,
            "start_logit": 0.8138781785964966,
            "end_logit": 0.8450659513473511
        },
        {
            "text": "is reasonable to assume that vaccine that prevents infection will reduce the incidence of cervical cancer. Virus-like particles",
            "probability": 0.04735797239710533,
            "start_logit": 0.9123842716217041,
            "end_logit": 0.7451674938201904
        },
        {
            "text": "developing world. Thanks to the",
            "probability": 0.04690929756340922,
            "start_logit": 0.8880020380020142,
            "end_logit": 0.7600304484367371
        },
        {
            "text": "levels",
            "probability": 0.046272183085794255,
            "start_logit": 1.0810165405273438,
            "end_logit": 0.5533410310745239
        },
        {
            "text": "viruses. Therefore it is reasonable to assume that vaccine that prevents infection will reduce the incidence of cervical cancer. Virus-like particles",
            "probability": 0.04582903914046455,
            "start_logit": 0.87956702709198,
            "end_logit": 0.7451674938201904
        },
        {
            "text": "accepted worldwide that cervical carcinoma is a consequence of infection",
            "probability": 0.04568812416319765,
            "start_logit": 1.005436658859253,
            "end_logit": 0.6162183284759521
        },
        {
            "text": "accepted worldwide that cervical carcinoma is a consequence of infection with HPV viruses. Therefore it is reasonable to assume that vaccine that prevents infection will reduce",
            "probability": 0.04470728781256648,
            "start_logit": 1.005436658859253,
            "end_logit": 0.5945164561271667
        }
    ],
    "5156be17d24251bc05000086": [
        {
            "text": "randomised feasibility trial of mirtazapine over 28 days in adults with a modified medical research council breathlessness scale score \u22653. Sixty-",
            "probability": 0.07809294384395264,
            "start_logit": 1.0738475322723389,
            "end_logit": 0.9144338965415955
        },
        {
            "text": "trial of mirtazapine over 28 days in adults with a modified medical research council breathlessness scale score \u22653. Sixty-",
            "probability": 0.07444292798994656,
            "start_logit": 1.0259805917739868,
            "end_logit": 0.9144338965415955
        },
        {
            "text": "28 days in adults with a modified medical research council breathlessness scale score \u22653. Sixty-",
            "probability": 0.06657523402944343,
            "start_logit": 0.9142804741859436,
            "end_logit": 0.9144338965415955
        },
        {
            "text": "EudraCT no: 2015-",
            "probability": 0.06648600556319219,
            "start_logit": 1.1480216979980469,
            "end_logit": 0.6793515086174011
        },
        {
            "text": "Eu",
            "probability": 0.059483569640543354,
            "start_logit": 1.1480216979980469,
            "end_logit": 0.5680601596832275
        },
        {
            "text": "blinding was",
            "probability": 0.05812741942362392,
            "start_logit": 1.1458427906036377,
            "end_logit": 0.5471764206886292
        },
        {
            "text": "EudraCT no: 2015-004064",
            "probability": 0.05464823282497926,
            "start_logit": 1.1480216979980469,
            "end_logit": 0.483276903629303
        },
        {
            "text": "blinding was maintained. Worst breathlessness ratings at day 28 (primary clinical activity endpoint) were, 7.1 (SD 2.",
            "probability": 0.05376962442876156,
            "start_logit": 1.1458427906036377,
            "end_logit": 0.46924763917922974
        },
        {
            "text": "mirtazapine in tolerability or safety, and blinding was",
            "probability": 0.05367569986316736,
            "start_logit": 1.0661656856536865,
            "end_logit": 0.5471764206886292
        },
        {
            "text": "indicated. Trial registration: ISRCTN 32236160; European Clinical Trials Database (EudraCT no: 2015-",
            "probability": 0.05256387720569172,
            "start_logit": 0.9130593538284302,
            "end_logit": 0.6793515086174011
        },
        {
            "text": "indicated. Trial registration: ISRCTN 32236160; European Clinical Trials Database (Eu",
            "probability": 0.04702774702519835,
            "start_logit": 0.9130593538284302,
            "end_logit": 0.5680601596832275
        },
        {
            "text": "randomised feasibility trial of mirtazapine over 28 days in adults with a modified medical research council breathless",
            "probability": 0.0449872474423136,
            "start_logit": 1.0738475322723389,
            "end_logit": 0.36291325092315674
        },
        {
            "text": "indicated. Trial registration: ISRCTN 322",
            "probability": 0.043987058786659,
            "start_logit": 0.9130593538284302,
            "end_logit": 0.5012178421020508
        },
        {
            "text": "28 days in adults with a modified medical research council breathlessness scale score \u22653. Sixty-four patients were randomised (40",
            "probability": 0.043517106738142346,
            "start_logit": 0.9142804741859436,
            "end_logit": 0.4892553687095642
        },
        {
            "text": "indicated. Trial registration: ISRCTN 32236160; European Clinical Trials Database (EudraCT no: 2015-004064",
            "probability": 0.04320492674191485,
            "start_logit": 0.9130593538284302,
            "end_logit": 0.483276903629303
        },
        {
            "text": "trial of mirtazapine over 28 days in adults with a modified medical research council breathless",
            "probability": 0.0428845713449615,
            "start_logit": 1.0259805917739868,
            "end_logit": 0.36291325092315674
        },
        {
            "text": "indicated.",
            "probability": 0.03920336807894064,
            "start_logit": 0.9130593538284302,
            "end_logit": 0.38608503341674805
        },
        {
            "text": "indicated. Trial registration: ISRCTN 32236160; European Clinical Trials Database",
            "probability": 0.03897023485507318,
            "start_logit": 0.9130593538284302,
            "end_logit": 0.38012051582336426
        },
        {
            "text": "28 days in adults with a modified medical research council breathless",
            "probability": 0.03835220417349445,
            "start_logit": 0.9142804741859436,
            "end_logit": 0.36291325092315674
        }
    ],
    "5540b9800083d1bf0e000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "516545a8298dcd4e51000056": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "514c3fd7d24251bc05000062": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56c1f01cef6e394741000044": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56b1f4300a360a5e4500001b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5325fdf0600967d132000001": [
        {
            "text": "lusions and perfusion deficits led to severe hypoxic brain damage and a poor prognosis for the",
            "probability": 0.08112448180351783,
            "start_logit": 0.9799264073371887,
            "end_logit": 0.7365302443504333
        },
        {
            "text": "iatrogenic) arterial gas embolism and point out the necessity of immediate HBOT. Furthermore, we discuss",
            "probability": 0.07842323821461047,
            "start_logit": 0.9835956692695618,
            "end_logit": 0.6989964842796326
        },
        {
            "text": "hysiology leading to arterial gas embolism on",
            "probability": 0.0733416064077767,
            "start_logit": 0.9411921501159668,
            "end_logit": 0.6744077801704407
        },
        {
            "text": "is primarily used to reduce acute bubble effects and to avoid secondary bubble effects. Unfortunately, the long persisting gas occ",
            "probability": 0.0722590085566017,
            "start_logit": 0.9674639701843262,
            "end_logit": 0.6332648992538452
        },
        {
            "text": "lusions and perfusion deficits led to severe",
            "probability": 0.07036187568117,
            "start_logit": 0.9799264073371887,
            "end_logit": 0.5941970348358154
        },
        {
            "text": "iatrogenic) arterial gas embolism and point out the",
            "probability": 0.06897326803760472,
            "start_logit": 0.9835956692695618,
            "end_logit": 0.5705952048301697
        },
        {
            "text": "lusions and perfusion deficits led to severe hypoxic brain damage and a poor prognosis",
            "probability": 0.06728056697362925,
            "start_logit": 0.9799264073371887,
            "end_logit": 0.5494168996810913
        },
        {
            "text": "Iatrogenic arterial gas embolism (AGE) can be life-threatening. The",
            "probability": 0.06683536651898447,
            "start_logit": 0.9311176538467407,
            "end_logit": 0.5915865898132324
        },
        {
            "text": "hysiology leading to arterial gas embolism on the basis of the",
            "probability": 0.06572841164151343,
            "start_logit": 0.9411921501159668,
            "end_logit": 0.5648109912872314
        },
        {
            "text": "is primarily used to",
            "probability": 0.06492994938903203,
            "start_logit": 0.9674639701843262,
            "end_logit": 0.5263168811798096
        },
        {
            "text": ". In the treatment of gas embolism, HBOT is considered the gold",
            "probability": 0.0598035954023036,
            "start_logit": 0.8323535919189453,
            "end_logit": 0.5791840553283691
        },
        {
            "text": ") can be life-threatening. The",
            "probability": 0.05934729756071747,
            "start_logit": 0.8122918605804443,
            "end_logit": 0.5915865898132324
        },
        {
            "text": ". In this case report we present the management of (iatrogenic) arterial gas embolism and point out the",
            "probability": 0.05766637376923722,
            "start_logit": 0.8045508861541748,
            "end_logit": 0.5705952048301697
        },
        {
            "text": "is indispensable. It is primarily used to",
            "probability": 0.057200891566846594,
            "start_logit": 0.8407244682312012,
            "end_logit": 0.5263168811798096
        },
        {
            "text": ". In the treatment of gas embolism, HBOT is considered the gold standard and is indispensable. It is primarily used to",
            "probability": 0.056724068476454656,
            "start_logit": 0.8323535919189453,
            "end_logit": 0.5263168811798096
        }
    ],
    "5357b36cf1005d6b58000006": [
        {
            "text": "K2 (checkpoint kinase 2) gene have been associated with hereditary predisposition to various cancers including breast and ovarian cancer. CHEK",
            "probability": 0.06475723872408588,
            "start_logit": 1.0903339385986328,
            "end_logit": 0.5091428160667419
        },
        {
            "text": "family with multiple affected women having breast cancer, with a novel, miss",
            "probability": 0.06359584944015723,
            "start_logit": 0.9479660987854004,
            "end_logit": 0.6334133744239807
        },
        {
            "text": "family with multiple affected women having breast cancer, with a novel, missense,",
            "probability": 0.0626245736951528,
            "start_logit": 0.9479660987854004,
            "end_logit": 0.6180229187011719
        },
        {
            "text": "K2 (checkpoint kinase 2) gene have been associated with hereditary predis",
            "probability": 0.06144735704951947,
            "start_logit": 1.0903339385986328,
            "end_logit": 0.4566781520843506
        },
        {
            "text": "associated with hereditary predisposition to various cancers including breast and ovarian cancer. CHEK",
            "probability": 0.05845980135713427,
            "start_logit": 0.988027811050415,
            "end_logit": 0.5091428160667419
        },
        {
            "text": "K2 (checkpoint kinase 2",
            "probability": 0.05763092813358221,
            "start_logit": 1.0903339385986328,
            "end_logit": 0.39255669713020325
        },
        {
            "text": "associated with hereditary predisposition to various cancers including breast and ovarian cancer. CHEK2 tumor suppressor gene encodes",
            "probability": 0.05673061424413805,
            "start_logit": 0.988027811050415,
            "end_logit": 0.4791174530982971
        },
        {
            "text": "variant in the CHEK2 gene (c.1376T>G; p.Ile",
            "probability": 0.055636830068481385,
            "start_logit": 0.9498884081840515,
            "end_logit": 0.4977882504463196
        },
        {
            "text": "associated with hereditary predis",
            "probability": 0.05547179524348257,
            "start_logit": 0.988027811050415,
            "end_logit": 0.4566781520843506
        },
        {
            "text": "family with multiple affected women having breast cancer, with a novel,",
            "probability": 0.05505354947546996,
            "start_logit": 0.9479660987854004,
            "end_logit": 0.48917150497436523
        },
        {
            "text": "variant in the CHEK",
            "probability": 0.05331825013462425,
            "start_logit": 0.9498884081840515,
            "end_logit": 0.4552215337753296
        },
        {
            "text": "family with multiple affected women having breast cancer, with a novel, missense, likely pathogenic variant in the CHEK",
            "probability": 0.05321585441093352,
            "start_logit": 0.9479660987854004,
            "end_logit": 0.4552215337753296
        },
        {
            "text": "family with multiple affected",
            "probability": 0.05272647214936968,
            "start_logit": 0.9479660987854004,
            "end_logit": 0.44598281383514404
        },
        {
            "text": "variant in the",
            "probability": 0.050487187680710616,
            "start_logit": 0.9498884081840515,
            "end_logit": 0.40066245198249817
        },
        {
            "text": "family with multiple affected women having breast cancer, with a novel, missense, likely pathogenic variant in the",
            "probability": 0.050390228907558406,
            "start_logit": 0.9479660987854004,
            "end_logit": 0.40066245198249817
        },
        {
            "text": "variant in the CHEK2 gene (c.",
            "probability": 0.0496089431593377,
            "start_logit": 0.9498884081840515,
            "end_logit": 0.3831139802932739
        },
        {
            "text": "family with multiple affected women having breast cancer, with a novel, missense, likely pathogenic variant in the CHEK2 gene (c.",
            "probability": 0.04951367102224569,
            "start_logit": 0.9479660987854004,
            "end_logit": 0.3831139802932739
        },
        {
            "text": "variant in the CHEK2 gene (c.1376T>G",
            "probability": 0.04933085510401644,
            "start_logit": 0.9498884081840515,
            "end_logit": 0.37749260663986206
        }
    ],
    "52f88d292059c6d71c000036": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5509ba931180f13250000001": [
        {
            "text": "of patients Chemotherapy may play a lesser role. This report presents a case of gastric adenocarc",
            "probability": 0.20061874978856764,
            "start_logit": 0.9328868389129639,
            "end_logit": 0.8230628967285156
        },
        {
            "text": "treated with partial gastrectomy for primary gastric lymphoma is difficult.",
            "probability": 0.15596682024794215,
            "start_logit": 0.9197295904159546,
            "end_logit": 0.5844570994377136
        },
        {
            "text": "of patients Chemotherapy may play a",
            "probability": 0.14010739882093734,
            "start_logit": 0.9328868389129639,
            "end_logit": 0.464065819978714
        },
        {
            "text": "treated with partial gastre",
            "probability": 0.1311928697490951,
            "start_logit": 0.9197295904159546,
            "end_logit": 0.4114823341369629
        },
        {
            "text": "of patients Chemotherapy may play a lesser role.",
            "probability": 0.1307191881827846,
            "start_logit": 0.9328868389129639,
            "end_logit": 0.39470797777175903
        },
        {
            "text": "treated with partial gastrectomy for primary",
            "probability": 0.12333096397709122,
            "start_logit": 0.9197295904159546,
            "end_logit": 0.34968531131744385
        },
        {
            "text": "of patients",
            "probability": 0.11806400923358185,
            "start_logit": 0.9328868389129639,
            "end_logit": 0.2928834855556488
        }
    ],
    "530f900ee3eabad021000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54e8c7220fc566b149000002": [
        {
            "text": "S100A4 interacts with p53, the S100A4 destabilizes wild",
            "probability": 0.07908050148336426,
            "start_logit": 1.2032175064086914,
            "end_logit": 0.5136864185333252
        },
        {
            "text": "is a small calcium-binding protein typically overexpressed in several",
            "probability": 0.0739257253370071,
            "start_logit": 1.138069748878479,
            "end_logit": 0.511428713798523
        },
        {
            "text": "S100A4 interacts with p53, the",
            "probability": 0.07199781162588366,
            "start_logit": 1.2032175064086914,
            "end_logit": 0.4198558032512665
        },
        {
            "text": "S100A4 interacts with p53, the S100A4 destabil",
            "probability": 0.07075516908739923,
            "start_logit": 1.2032175064086914,
            "end_logit": 0.4024456739425659
        },
        {
            "text": "is a small calcium-binding protein typically overexpressed in several tumor",
            "probability": 0.06959852199125169,
            "start_logit": 1.138069748878479,
            "end_logit": 0.45111116766929626
        },
        {
            "text": "is a small",
            "probability": 0.06899935187162017,
            "start_logit": 1.138069748878479,
            "end_logit": 0.4424649477005005
        },
        {
            "text": "S100A4 interacts with p53, the S100A4 destabilizes wild type p53. In the",
            "probability": 0.06871763816851201,
            "start_logit": 1.2032175064086914,
            "end_logit": 0.37322598695755005
        },
        {
            "text": "is a small calcium-binding protein",
            "probability": 0.06733859397496793,
            "start_logit": 1.138069748878479,
            "end_logit": 0.41810137033462524
        },
        {
            "text": "associated S100A4 protein is a small calcium-binding protein typically overexpressed in several",
            "probability": 0.06726114617622984,
            "start_logit": 1.0435916185379028,
            "end_logit": 0.511428713798523
        },
        {
            "text": "associated S100A4 protein is a small calcium-binding protein typically overexpressed in several tumor",
            "probability": 0.06332405045689402,
            "start_logit": 1.0435916185379028,
            "end_logit": 0.45111116766929626
        },
        {
            "text": "associated S100A4 protein is a small",
            "probability": 0.06277889694210273,
            "start_logit": 1.0435916185379028,
            "end_logit": 0.4424649477005005
        },
        {
            "text": "is a small calcium-binding protein typically overexpressed in several tumor forms, and it is widely accepted",
            "probability": 0.061427277003856876,
            "start_logit": 1.138069748878479,
            "end_logit": 0.3262218236923218
        },
        {
            "text": "associated S100A4 protein is a small calcium-binding protein",
            "probability": 0.06126786030173397,
            "start_logit": 1.0435916185379028,
            "end_logit": 0.41810137033462524
        },
        {
            "text": "associated",
            "probability": 0.05763799302836572,
            "start_logit": 1.0435916185379028,
            "end_logit": 0.35702791810035706
        },
        {
            "text": "associated S100A4 protein is a small calcium-binding protein typically overexpressed in several tumor forms, and it is widely accepted",
            "probability": 0.05588946255081073,
            "start_logit": 1.0435916185379028,
            "end_logit": 0.3262218236923218
        }
    ],
    "517194ef8ed59a060a000011": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "53551206a0726bee57000001": [
        {
            "text": "conducted in scientific databases including Web of Science, PubMed, Scopus, and Google",
            "probability": 0.09894994076073273,
            "start_logit": 0.9549895524978638,
            "end_logit": 0.9732946157455444
        },
        {
            "text": "glycemia and chemotherapy efficacy may be different depending upon the particular cancer type and the condition of the",
            "probability": 0.09496524178944699,
            "start_logit": 1.0444362163543701,
            "end_logit": 0.8427448272705078
        },
        {
            "text": "including nerves and vascular structures, insulin-",
            "probability": 0.09187378819785023,
            "start_logit": 0.781795084476471,
            "end_logit": 1.0722907781600952
        },
        {
            "text": "Science, PubMed, Scopus, and Google",
            "probability": 0.08720574113430711,
            "start_logit": 0.828645646572113,
            "end_logit": 0.9732946157455444
        },
        {
            "text": "glycemia and chemotherapy efficacy may be different depending upon the particular cancer type and the",
            "probability": 0.07082169062802333,
            "start_logit": 1.0444362163543701,
            "end_logit": 0.549399197101593
        },
        {
            "text": "1, the function of the innate immune system, drug pharmacokinetics, the expression levels of hepatic CYP",
            "probability": 0.06823833281777866,
            "start_logit": 0.7942260503768921,
            "end_logit": 0.7624505162239075
        },
        {
            "text": ") is associated with an increased risk for a number of cancers",
            "probability": 0.06697921083591518,
            "start_logit": 0.8561556339263916,
            "end_logit": 0.6818967461585999
        },
        {
            "text": "levels of hepatic CYP",
            "probability": 0.06656216443142171,
            "start_logit": 0.7693558931350708,
            "end_logit": 0.7624505162239075
        },
        {
            "text": "1, the function",
            "probability": 0.061166535774214305,
            "start_logit": 0.7942260503768921,
            "end_logit": 0.6530442833900452
        },
        {
            "text": ") is associated with an increased risk for a number of cancers, including breast, pancreatic, and liver cancer.",
            "probability": 0.060974924750482384,
            "start_logit": 0.8561556339263916,
            "end_logit": 0.5879771709442139
        },
        {
            "text": "including nerves and vascular structures, insulin-like growth factor 1, the function",
            "probability": 0.060410883130703606,
            "start_logit": 0.781795084476471,
            "end_logit": 0.6530442833900452
        },
        {
            "text": "of the effectiveness of anticancer the",
            "probability": 0.057932889783515046,
            "start_logit": 0.8504773378372192,
            "end_logit": 0.5424780249595642
        },
        {
            "text": "of the effectiveness of anticancer therapies in patients with DM are, however, inconsistent because DM can negatively impact multiple diverse",
            "probability": 0.057236833003464514,
            "start_logit": 0.8504773378372192,
            "end_logit": 0.5303903818130493
        },
        {
            "text": "Science, PubMed, Scopus, and Google Scholar including the relevant keywords. The results of the effectiveness of anticancer the",
            "probability": 0.05668182296214435,
            "start_logit": 0.828645646572113,
            "end_logit": 0.5424780249595642
        }
    ],
    "56ffdc1ccf1c32585100000b": [
        {
            "text": "eukaryotes. Studies of fetal and adult tissues showed that adenosine-to-",
            "probability": 0.09378543412840427,
            "start_logit": 1.0499460697174072,
            "end_logit": 0.9249951243400574
        },
        {
            "text": "regulate stem cell pluripotency. We",
            "probability": 0.0734084897755602,
            "start_logit": 1.2091623544692993,
            "end_logit": 0.5208088755607605
        },
        {
            "text": "regulate stem cell pluripotency. We observed that although most of the",
            "probability": 0.07331861982397248,
            "start_logit": 1.2091623544692993,
            "end_logit": 0.5195838809013367
        },
        {
            "text": "regulate stem cell pluripotency. We observed that although",
            "probability": 0.06954088276865923,
            "start_logit": 1.2091623544692993,
            "end_logit": 0.46668410301208496
        },
        {
            "text": "regulate stem cell pluripotency. We observed that although most of the RNA editing sites are located in intergenic, intron and UTR",
            "probability": 0.0690899618802635,
            "start_logit": 1.2091623544692993,
            "end_logit": 0.4601787328720093
        },
        {
            "text": "regulate stem cell pluri",
            "probability": 0.06879145050765557,
            "start_logit": 1.2091623544692993,
            "end_logit": 0.455848753452301
        },
        {
            "text": "eukaryotes. Studies of fetal and adult tissues showed that adenosine-",
            "probability": 0.06737776054579268,
            "start_logit": 1.0499460697174072,
            "end_logit": 0.5943005681037903
        },
        {
            "text": "eukar",
            "probability": 0.06417494186372431,
            "start_logit": 1.0499460697174072,
            "end_logit": 0.5455983877182007
        },
        {
            "text": "eukaryotes. Studies of fetal and adult tissues showed that adenosine-to-inosine RNA",
            "probability": 0.05888166760494098,
            "start_logit": 1.0499460697174072,
            "end_logit": 0.45951536297798157
        },
        {
            "text": "development. Therefore, here we used RNA sequencing data from human, pig and mouse during early embryonic development to detect edited genes that may",
            "probability": 0.056022419593856794,
            "start_logit": 0.9175828695297241,
            "end_logit": 0.542100727558136
        },
        {
            "text": "development to detect edited genes that may",
            "probability": 0.052700057637862674,
            "start_logit": 0.8564474582672119,
            "end_logit": 0.542100727558136
        },
        {
            "text": "development. Therefore, here we used RNA sequencing data from human,",
            "probability": 0.05257494288419063,
            "start_logit": 0.9175828695297241,
            "end_logit": 0.47858840227127075
        },
        {
            "text": "development to detect edited genes that may regulate stem cell pluripotency. We",
            "probability": 0.05158983707854037,
            "start_logit": 0.8564474582672119,
            "end_logit": 0.5208088755607605
        },
        {
            "text": "development to detect edited genes that may regulate stem cell pluripotency. We observed that although most of the",
            "probability": 0.05152667849599981,
            "start_logit": 0.8564474582672119,
            "end_logit": 0.5195838809013367
        },
        {
            "text": "development to detect edited genes that may regulate stem cell pluripotency. We observed that although",
            "probability": 0.04887176978169384,
            "start_logit": 0.8564474582672119,
            "end_logit": 0.46668410301208496
        },
        {
            "text": "development to detect edited genes that may regulate stem cell pluri",
            "probability": 0.048345085628882775,
            "start_logit": 0.8564474582672119,
            "end_logit": 0.455848753452301
        }
    ],
    "56cae3eb5795f9a73e000021": [
        {
            "text": "ulcerative colitis (UC",
            "probability": 0.15866590064664227,
            "start_logit": 1.3206615447998047,
            "end_logit": 0.44485265016555786
        },
        {
            "text": "ulcerative colitis (UC) is important for measuring treatment value. We estimated lifetime health care costs incurred",
            "probability": 0.13029984851220475,
            "start_logit": 1.3206615447998047,
            "end_logit": 0.24789023399353027
        },
        {
            "text": "ulcerative colitis (UC) is important for measuring treatment value",
            "probability": 0.1266978772714597,
            "start_logit": 1.3206615447998047,
            "end_logit": 0.21985724568367004
        },
        {
            "text": "ulcerative colitis (UC) is important for measuring treatment value. We estimated lifetime health care costs incurred by patients",
            "probability": 0.12221677589028038,
            "start_logit": 1.3206615447998047,
            "end_logit": 0.18384823203086853
        },
        {
            "text": "ulcerative colitis (UC) is important for measuring treatment value.",
            "probability": 0.12159074698613857,
            "start_logit": 1.3206615447998047,
            "end_logit": 0.17871278524398804
        },
        {
            "text": "ulcerative coli",
            "probability": 0.11815841982826351,
            "start_logit": 1.3206615447998047,
            "end_logit": 0.1500781774520874
        },
        {
            "text": "ulcerative colitis (UC) is important for measuring treatment value. We",
            "probability": 0.1160371694054107,
            "start_logit": 1.3206615447998047,
            "end_logit": 0.13196247816085815
        },
        {
            "text": "ulcerative colitis",
            "probability": 0.10633326145960018,
            "start_logit": 1.3206615447998047,
            "end_logit": 0.04463005065917969
        }
    ],
    "5509bd6a1180f13250000002": [
        {
            "text": "be delivered directly to the inflamed site without exposure to the rest",
            "probability": 0.08147819363801172,
            "start_logit": 1.143982172012329,
            "end_logit": 1.0174951553344727
        },
        {
            "text": "be delivered directly to the",
            "probability": 0.06586227334218576,
            "start_logit": 1.143982172012329,
            "end_logit": 0.8047255277633667
        },
        {
            "text": "is needed, and it can be delivered directly to the inflamed site without exposure to the rest",
            "probability": 0.062422172511384946,
            "start_logit": 0.8775672912597656,
            "end_logit": 1.0174951553344727
        },
        {
            "text": "prevent patients-",
            "probability": 0.06042388365597882,
            "start_logit": 0.98494553565979,
            "end_logit": 0.8775808215141296
        },
        {
            "text": "failure of current medical the",
            "probability": 0.0577553985604179,
            "start_logit": 1.2375707626342773,
            "end_logit": 0.5797879695892334
        },
        {
            "text": "failure of current medical therapies in many patients",
            "probability": 0.05760093440669348,
            "start_logit": 1.2375707626342773,
            "end_logit": 0.5771099328994751
        },
        {
            "text": "is needed, and it can be delivered directly to the",
            "probability": 0.05045848471829518,
            "start_logit": 0.8775672912597656,
            "end_logit": 0.8047255277633667
        },
        {
            "text": "deliver medications directly to the area of inflammation thus avoiding drug-associated systemic side effects. When using nanoparticles (NPs),",
            "probability": 0.05043221751297405,
            "start_logit": 0.8554240465164185,
            "end_logit": 0.826348066329956
        },
        {
            "text": "prevent patients-and sometimes providers-",
            "probability": 0.04989501214236111,
            "start_logit": 0.98494553565979,
            "end_logit": 0.68611741065979
        },
        {
            "text": "systemic side effects. When using nanoparticles (NPs),",
            "probability": 0.04964912215708965,
            "start_logit": 0.8397745490074158,
            "end_logit": 0.826348066329956
        },
        {
            "text": "prevent patients-and sometimes providers-in using effective therapies for treatment. Some patients develop",
            "probability": 0.04892171987929995,
            "start_logit": 0.98494553565979,
            "end_logit": 0.6664178371429443
        },
        {
            "text": "deliver medications directly to the area of inflammation thus avoiding drug-associated systemic side effects. When using nanoparticles (NPs",
            "probability": 0.046773291593572706,
            "start_logit": 0.8554240465164185,
            "end_logit": 0.7510302066802979
        },
        {
            "text": "systemic side effects. When using nanoparticles (NPs",
            "probability": 0.04604701087000685,
            "start_logit": 0.8397745490074158,
            "end_logit": 0.7510302066802979
        },
        {
            "text": "prevent patients-and sometimes providers-in using effective the",
            "probability": 0.04241919968417153,
            "start_logit": 0.98494553565979,
            "end_logit": 0.5237974524497986
        },
        {
            "text": "prevent patients-and sometimes providers-in using effective therapies for treatment. Some patients develop systemic side effects that preclude them",
            "probability": 0.04219460356224349,
            "start_logit": 0.98494553565979,
            "end_logit": 0.5184887051582336
        },
        {
            "text": "deliver medications directly to the area of inflammation thus avoiding drug-",
            "probability": 0.0392862453710462,
            "start_logit": 0.8554240465164185,
            "end_logit": 0.5765923261642456
        },
        {
            "text": "deliver medications directly to the area of inflammation thus avoiding drug-associated systemic side effects. When using nanoparticles",
            "probability": 0.038096472365054174,
            "start_logit": 0.8554240465164185,
            "end_logit": 0.5458395481109619
        },
        {
            "text": "systemic side effects. When using nanoparticles",
            "probability": 0.03750492251743985,
            "start_logit": 0.8397745490074158,
            "end_logit": 0.5458395481109619
        },
        {
            "text": "deliver medications directly to the area of inflammation thus avoiding drug-associated systemic side effects. When using nano",
            "probability": 0.03667415301957516,
            "start_logit": 0.8554240465164185,
            "end_logit": 0.5077900886535645
        },
        {
            "text": "systemic side effects. When using nano",
            "probability": 0.0361046884921977,
            "start_logit": 0.8397745490074158,
            "end_logit": 0.5077900886535645
        }
    ],
    "54e0d7471388e8454a000015": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54f9c40ddd3fc62544000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "532ff917d6d3ac6a34000038": [
        {
            "text": "K36me3 profiles from four cytoreductive nephrectomies and SETD2 isogenic renal cell",
            "probability": 0.0800291991549314,
            "start_logit": 1.1970936059951782,
            "end_logit": 1.0637948513031006
        },
        {
            "text": "omies and SETD2 isogenic renal cell",
            "probability": 0.07443326051965514,
            "start_logit": 1.1246049404144287,
            "end_logit": 1.0637948513031006
        },
        {
            "text": "K36me3 profiles",
            "probability": 0.06929183866618774,
            "start_logit": 1.1970936059951782,
            "end_logit": 0.9197304248809814
        },
        {
            "text": "transferase, have been",
            "probability": 0.057538478808798955,
            "start_logit": 1.1560401916503906,
            "end_logit": 0.7749106287956238
        },
        {
            "text": "% positive nuclei in uninvolved vs 70% positive nuclei in ccRCC) and reduced by ~60% in meta",
            "probability": 0.05489552079743823,
            "start_logit": 0.9404406547546387,
            "end_logit": 0.9434880018234253
        },
        {
            "text": "nuclei in uninvolved vs 70% positive nuclei in ccRCC) and reduced by ~60% in meta",
            "probability": 0.05305926756798669,
            "start_logit": 0.9064184427261353,
            "end_logit": 0.9434880018234253
        },
        {
            "text": "sequencing. SETD2 loss of methyltransferase activity leads to regional alterations of H3K36me3 associated with aberrant RNA",
            "probability": 0.04991233829662339,
            "start_logit": 1.015190601348877,
            "end_logit": 0.7735745310783386
        },
        {
            "text": "tra",
            "probability": 0.04767434433499486,
            "start_logit": 1.1560401916503906,
            "end_logit": 0.586850106716156
        },
        {
            "text": "se, have been",
            "probability": 0.04572970061763102,
            "start_logit": 0.9263342618942261,
            "end_logit": 0.7749106287956238
        },
        {
            "text": "36me3 profile, we generated genome-wide H3K36me3 profiles",
            "probability": 0.04564334205732062,
            "start_logit": 0.7796242237091064,
            "end_logit": 0.9197304248809814
        },
        {
            "text": "K36me3 profiles from four cytoreductive nephrectomies and SETD2 isogenic",
            "probability": 0.04518804431667114,
            "start_logit": 1.1970936059951782,
            "end_logit": 0.49223583936691284
        },
        {
            "text": "omies and SETD2 isogenic renal cell carcinoma (RCC) cell lines",
            "probability": 0.044392135031266426,
            "start_logit": 1.1246049404144287,
            "end_logit": 0.5469542741775513
        },
        {
            "text": "transferase activity leads to regional alterations of H3K36me3 associated with aberrant RNA",
            "probability": 0.04320188577580186,
            "start_logit": 0.8708065152168274,
            "end_logit": 0.7735745310783386
        },
        {
            "text": "omies and SETD2 isogenic",
            "probability": 0.042028328541498926,
            "start_logit": 1.1246049404144287,
            "end_logit": 0.49223583936691284
        },
        {
            "text": "2, a histone H3 lysine trimethyltransferase, have been",
            "probability": 0.04200800971151662,
            "start_logit": 0.841446578502655,
            "end_logit": 0.7749106287956238
        },
        {
            "text": "% in primary ccRCC (90% positive nuclei in uninvolved vs 70",
            "probability": 0.04198109169467768,
            "start_logit": 0.8988591432571411,
            "end_logit": 0.7168570756912231
        },
        {
            "text": "omies and SETD2 isogenic renal cell carcinoma (RCC) cell",
            "probability": 0.04191327376170993,
            "start_logit": 1.1246049404144287,
            "end_logit": 0.48949453234672546
        },
        {
            "text": "% positive nuclei in uninvolved vs 70% positive nuclei in ccRCC)",
            "probability": 0.040961399114708565,
            "start_logit": 0.9404406547546387,
            "end_logit": 0.6506863832473755
        },
        {
            "text": "romatin immunoprecipitation coupled with high-",
            "probability": 0.04052729946777668,
            "start_logit": 0.8637128472328186,
            "end_logit": 0.7167598605155945
        },
        {
            "text": "nuclei in uninvolved vs 70% positive nuclei in ccRCC)",
            "probability": 0.03959124176280405,
            "start_logit": 0.9064184427261353,
            "end_logit": 0.6506863832473755
        }
    ],
    "52f89a002059c6d71c00004c": [
        {
            "text": "(n\u00a0=\u00a033, 70%",
            "probability": 0.08481025592450371,
            "start_logit": 1.0387914180755615,
            "end_logit": 1.0737472772598267
        },
        {
            "text": "adjusting for potential confounders. The prevalence of restless legs syndrome at age 22\u00a0years was 3.0% (n\u00a0=\u00a033, 70%",
            "probability": 0.07231729708260122,
            "start_logit": 0.8794382810592651,
            "end_logit": 1.0737472772598267
        },
        {
            "text": "confounders. The prevalence of restless legs syndrome at age 22\u00a0years was 3.0% (n\u00a0=\u00a033, 70%",
            "probability": 0.06949890359368759,
            "start_logit": 0.8396859169006348,
            "end_logit": 1.0737472772598267
        },
        {
            "text": "investigating this relationship have had inconsistent results and there are no studies in young adults. Therefore, we investigated the",
            "probability": 0.06092001801110711,
            "start_logit": 1.2376559972763062,
            "end_logit": 0.5440280437469482
        },
        {
            "text": "(Raine) Study answered questions on restless legs syndrome (n\u00a0=\u00a01,100, 54% female) at age 22\u00a0years, and provided",
            "probability": 0.058393554255406425,
            "start_logit": 0.9392457008361816,
            "end_logit": 0.8000820279121399
        },
        {
            "text": "adjusting for potential confounders. The prevalence of restless legs syndrome at age 22\u00a0years was",
            "probability": 0.05711469460745355,
            "start_logit": 0.8794382810592651,
            "end_logit": 0.8377453684806824
        },
        {
            "text": "confounders. The prevalence of restless legs syndrome at age 22\u00a0years was",
            "probability": 0.05488878614714322,
            "start_logit": 0.8396859169006348,
            "end_logit": 0.8377453684806824
        },
        {
            "text": "adjusting",
            "probability": 0.05467691661638354,
            "start_logit": 0.8794382810592651,
            "end_logit": 0.7941255569458008
        },
        {
            "text": "[29.5-103.5]\u00a0\u00b5g\u00a0L",
            "probability": 0.051620999795364664,
            "start_logit": 1.0846185684204102,
            "end_logit": 0.5314322113990784
        },
        {
            "text": "of iron stores (ferritin and transferrin saturation) at ages 17 and 22\u00a0years.",
            "probability": 0.05102766839695296,
            "start_logit": 0.9963335394859314,
            "end_logit": 0.608156681060791
        },
        {
            "text": "of iron stores (ferritin and transferrin saturation) at ages 17 and 22\u00a0years. Restless legs syndrome was",
            "probability": 0.04945763544258106,
            "start_logit": 0.9963335394859314,
            "end_logit": 0.5769051313400269
        },
        {
            "text": "(Raine) Study answered questions on restless legs syndrome (n\u00a0=\u00a01,100, 54% female) at age 22\u00a0years,",
            "probability": 0.04727004638678138,
            "start_logit": 0.9392457008361816,
            "end_logit": 0.588753342628479
        },
        {
            "text": "(n\u00a0=\u00a033, 70% female). Among those who",
            "probability": 0.04510804698156119,
            "start_logit": 1.0387914180755615,
            "end_logit": 0.44239145517349243
        },
        {
            "text": "(interquartile range) ferritin was not different between the restless legs syndrome (55 [29.5-103.5]\u00a0\u00b5g\u00a0L",
            "probability": 0.04406837324503591,
            "start_logit": 0.9264323711395264,
            "end_logit": 0.5314322113990784
        },
        {
            "text": "no studies in young adults. Therefore, we investigated the",
            "probability": 0.04198500698628636,
            "start_logit": 0.8654067516326904,
            "end_logit": 0.5440280437469482
        },
        {
            "text": "adjusting for potential confounders. The prevalence of restless legs syndrome at age 22\u00a0years",
            "probability": 0.040153683411488214,
            "start_logit": 0.8794382810592651,
            "end_logit": 0.4853981137275696
        },
        {
            "text": "adjusting for potential confounders.",
            "probability": 0.03982571767480274,
            "start_logit": 0.8794382810592651,
            "end_logit": 0.4771968126296997
        },
        {
            "text": "confounders. The prevalence of restless legs syndrome at age 22\u00a0years",
            "probability": 0.03858878974913831,
            "start_logit": 0.8396859169006348,
            "end_logit": 0.4853981137275696
        },
        {
            "text": "founders.",
            "probability": 0.03827360569172115,
            "start_logit": 0.8396859169006348,
            "end_logit": 0.4771968126296997
        }
    ],
    "5156be04d24251bc05000085": [
        {
            "text": "platelet therapy for AIMS and TIA based on the genetic testing and clinical features. Therefore, we",
            "probability": 0.09411924939272794,
            "start_logit": 1.3046979904174805,
            "end_logit": 0.907004177570343
        },
        {
            "text": "platelet therapy selected on the basis of a combination of genetic",
            "probability": 0.07324819394665624,
            "start_logit": 1.2075315713882446,
            "end_logit": 0.7534615993499756
        },
        {
            "text": "is considered to be a key",
            "probability": 0.06683594363084987,
            "start_logit": 1.14882230758667,
            "end_logit": 0.7205582857131958
        },
        {
            "text": "platelet therapy selected",
            "probability": 0.06578453680297427,
            "start_logit": 1.2075315713882446,
            "end_logit": 0.6459928154945374
        },
        {
            "text": "be a key",
            "probability": 0.06335999254298605,
            "start_logit": 1.0954139232635498,
            "end_logit": 0.7205582857131958
        },
        {
            "text": "platelet therapy for AIMS and TIA based on the",
            "probability": 0.06304037250247552,
            "start_logit": 1.3046979904174805,
            "end_logit": 0.5062169432640076
        },
        {
            "text": "platelet therapy for AIMS and TIA based on",
            "probability": 0.06132792384171313,
            "start_logit": 1.3046979904174805,
            "end_logit": 0.47867685556411743
        },
        {
            "text": "is considered to be a key intervention for acute ischaemic minor",
            "probability": 0.05946952588365316,
            "start_logit": 1.14882230758667,
            "end_logit": 0.6037812829017639
        },
        {
            "text": "platelet therapy selected on the basis of a combination of genetic information and clinical features would lead to better clinical outcomes compared",
            "probability": 0.057436085909246454,
            "start_logit": 1.2075315713882446,
            "end_logit": 0.5102807879447937
        },
        {
            "text": "platelet therapy for AIMS and TIA based on the genetic testing and clinical features. Therefore, we conduct this randomised controlled trial to validate",
            "probability": 0.05655933430834585,
            "start_logit": 1.3046979904174805,
            "end_logit": 0.39773184061050415
        },
        {
            "text": "be a key intervention for acute ischaemic minor",
            "probability": 0.056376681645053724,
            "start_logit": 1.0954139232635498,
            "end_logit": 0.6037812829017639
        },
        {
            "text": "platelet therapy selected on the basis of a combination",
            "probability": 0.054348530513441524,
            "start_logit": 1.2075315713882446,
            "end_logit": 0.4550255835056305
        },
        {
            "text": "is considered to be a key intervention for acute ischaemic minor stroke (AIMS) and transient ischaemic attack (TIA).",
            "probability": 0.05146583032262497,
            "start_logit": 1.14882230758667,
            "end_logit": 0.45923537015914917
        },
        {
            "text": "be a key intervention for acute ischaemic minor stroke (AIMS) and transient ischaemic attack (TIA).",
            "probability": 0.048789235975639944,
            "start_logit": 1.0954139232635498,
            "end_logit": 0.45923537015914917
        },
        {
            "text": "be a key intervention for acute ischaemic minor stroke (AIMS) and transient ischaemic attack (TIA). However, the",
            "probability": 0.047248351708239544,
            "start_logit": 1.0954139232635498,
            "end_logit": 0.4271434247493744
        },
        {
            "text": "better clinical outcomes compared",
            "probability": 0.04130085743376906,
            "start_logit": 0.8777420520782471,
            "end_logit": 0.5102807879447937
        },
        {
            "text": "better clinical outcomes compared with the standard care based only on clinical features in patients with",
            "probability": 0.039289353639602766,
            "start_logit": 0.8777420520782471,
            "end_logit": 0.4603511095046997
        }
    ],
    "5324ce779b2d7acc7e00001e": [
        {
            "text": "amitriptyline for the treatment of fibromy",
            "probability": 1.0,
            "start_logit": 0.9317748546600342,
            "end_logit": 0.7773003578186035
        }
    ],
    "56b773a96e3f8eaf4c000003": [
        {
            "text": "\u03b1-helical structure which is stable at various pH conditions. We",
            "probability": 0.10249203054492606,
            "start_logit": 1.447360634803772,
            "end_logit": 1.0284066200256348
        },
        {
            "text": "\u03b1-",
            "probability": 0.07286460490516003,
            "start_logit": 1.447360634803772,
            "end_logit": 0.6872245669364929
        },
        {
            "text": "is stable at various pH conditions. We",
            "probability": 0.05481067721354384,
            "start_logit": 0.8214606046676636,
            "end_logit": 1.0284066200256348
        },
        {
            "text": ".",
            "probability": 0.05454665132611509,
            "start_logit": 1.0689458847045898,
            "end_logit": 0.7760926485061646
        },
        {
            "text": "% alcohol concentration.",
            "probability": 0.052492908510203704,
            "start_logit": 1.0305676460266113,
            "end_logit": 0.7760926485061646
        },
        {
            "text": "transportation of the mRNA with cooperation",
            "probability": 0.05174318547746996,
            "start_logit": 0.8835851550102234,
            "end_logit": 0.9086897969245911
        },
        {
            "text": "s1. Here, we",
            "probability": 0.05148291832920199,
            "start_logit": 0.8811154365539551,
            "end_logit": 0.9061168432235718
        },
        {
            "text": ". Further increase in the alcohol concentration destabilizes the secondary as well as tertiary structure. The 300 mM concentration of ammonium",
            "probability": 0.05011590056016454,
            "start_logit": 1.0689458847045898,
            "end_logit": 0.691374659538269
        },
        {
            "text": "mRNA with cooperation",
            "probability": 0.04984925441202588,
            "start_logit": 0.846295952796936,
            "end_logit": 0.9086897969245911
        },
        {
            "text": "unfolding of tertiary structure of the",
            "probability": 0.04927058393267093,
            "start_logit": 0.8895302414894104,
            "end_logit": 0.8537791967391968
        },
        {
            "text": "of tertiary structure of the",
            "probability": 0.048824283621693804,
            "start_logit": 0.8804308176040649,
            "end_logit": 0.8537791967391968
        },
        {
            "text": "% alcohol concentration. Further increase in the alcohol concentration destabilizes the secondary as well as tertiary structure. The 300 mM concentration of ammonium",
            "probability": 0.04822898049750085,
            "start_logit": 1.0305676460266113,
            "end_logit": 0.691374659538269
        },
        {
            "text": "protein. The fluorescence studies demonstrated the unfolding of tertiary structure of the",
            "probability": 0.04779832845641468,
            "start_logit": 0.8591936826705933,
            "end_logit": 0.8537791967391968
        },
        {
            "text": "of tertiary structure of the protein with variation in pH as compared to neutral pH. The same results were obtained in the ANS binding and acryl",
            "probability": 0.047401574081504846,
            "start_logit": 0.8804308176040649,
            "end_logit": 0.8242068290710449
        },
        {
            "text": "SAGA, a transcriptional coactivator and TREX-2 are the two major",
            "probability": 0.046718120527227396,
            "start_logit": 0.9889273643493652,
            "end_logit": 0.7011869549751282
        },
        {
            "text": "be stable till 55% alcohol concentration while tertiary structure was stable up to 20% alcohol concentration.",
            "probability": 0.04464513655479031,
            "start_logit": 0.8686349391937256,
            "end_logit": 0.7760926485061646
        },
        {
            "text": "protein",
            "probability": 0.04454765682940914,
            "start_logit": 0.8591936826705933,
            "end_logit": 0.7833480834960938
        },
        {
            "text": "be stable till 55% alcohol concentration while tertiary structure was stable",
            "probability": 0.04132605236058665,
            "start_logit": 0.8686349391937256,
            "end_logit": 0.6988403797149658
        },
        {
            "text": "secondary as well as tertiary structure. The 300 mM concentration of ammonium",
            "probability": 0.04084115185939049,
            "start_logit": 0.8642977476119995,
            "end_logit": 0.691374659538269
        }
    ],
    "56c3184050c68dd416000003": [
        {
            "text": "week 4); and decreased energy (3 new incidences at week 4). 1 patient discontinued medication and was withdrawn",
            "probability": 0.10713693416063554,
            "start_logit": 1.038609266281128,
            "end_logit": 1.3944038152694702
        },
        {
            "text": "determine its",
            "probability": 0.05799970719086363,
            "start_logit": 1.2080481052398682,
            "end_logit": 0.6112951636314392
        },
        {
            "text": "determine its feasibility, safety,",
            "probability": 0.057350585653766495,
            "start_logit": 1.2080481052398682,
            "end_logit": 0.6000402569770813
        },
        {
            "text": "isradipine is a relatively safe medication when used adjunctively",
            "probability": 0.055477884307895124,
            "start_logit": 1.185410976409912,
            "end_logit": 0.5894787907600403
        },
        {
            "text": "determine its feasibility, safety, and efficacy in improving cognition",
            "probability": 0.05374022761029939,
            "start_logit": 1.2080481052398682,
            "end_logit": 0.535019040107727
        },
        {
            "text": "determine its feasibility, safety, and efficacy in improving cognition in SZ patients. Ten adults with stable",
            "probability": 0.053318299430064615,
            "start_logit": 1.2080481052398682,
            "end_logit": 0.5271368026733398
        },
        {
            "text": "week 4); and",
            "probability": 0.05068556539618913,
            "start_logit": 1.038609266281128,
            "end_logit": 0.6459372043609619
        },
        {
            "text": "week 4); difficulty sleeping (2 new incidences at week 4); and",
            "probability": 0.049253779790381265,
            "start_logit": 1.0099542140960693,
            "end_logit": 0.6459372043609619
        },
        {
            "text": "isradipine is a relatively safe medication when used adjunctively in SZ patients. This study suggests that isradip",
            "probability": 0.04825396646646653,
            "start_logit": 1.185410976409912,
            "end_logit": 0.44997236132621765
        },
        {
            "text": "isradipine is a relatively safe medication when used adjunctively in SZ patients. This study suggests that isradipine offers no clear",
            "probability": 0.0477263827113391,
            "start_logit": 1.185410976409912,
            "end_logit": 0.4389786720275879
        },
        {
            "text": "); difficulty sleeping (2 new incidences at week 4); and",
            "probability": 0.04416658997516835,
            "start_logit": 0.9009367227554321,
            "end_logit": 0.6459372043609619
        },
        {
            "text": "week 4); and decreased energy (3 new incidences at week 4). 1 patient discontinued medication and was withdrawn. Treatment did",
            "probability": 0.0436481387996015,
            "start_logit": 1.038609266281128,
            "end_logit": 0.49645668268203735
        },
        {
            "text": "improving cognition",
            "probability": 0.04321587558831341,
            "start_logit": 0.9900941848754883,
            "end_logit": 0.535019040107727
        },
        {
            "text": "improving cognition in SZ patients. Ten adults with stable",
            "probability": 0.04287657676962484,
            "start_logit": 0.9900941848754883,
            "end_logit": 0.5271368026733398
        },
        {
            "text": "used adjunctively",
            "probability": 0.04233777278880673,
            "start_logit": 0.9151061773300171,
            "end_logit": 0.5894787907600403
        },
        {
            "text": "is a relatively safe medication when used adjunctively",
            "probability": 0.041604944445775074,
            "start_logit": 0.8976455330848694,
            "end_logit": 0.5894787907600403
        },
        {
            "text": "used adjunctively in SZ patients. This study suggests that isradipine offers no clear cognitive and only minimal",
            "probability": 0.04091036714442681,
            "start_logit": 0.9151061773300171,
            "end_logit": 0.5551826357841492
        },
        {
            "text": "is a relatively safe medication when used adjunctively in SZ patients. This study suggests that isradipine offers no clear cognitive and only minimal",
            "probability": 0.04020224589495018,
            "start_logit": 0.8976455330848694,
            "end_logit": 0.5551826357841492
        },
        {
            "text": "p\u00a0=\u00a00.017) on functional capacity was noted. This open",
            "probability": 0.040181463881212874,
            "start_logit": 0.9492616057395935,
            "end_logit": 0.5030494928359985
        },
        {
            "text": "mpt",
            "probability": 0.03991269199421912,
            "start_logit": 0.8541621565818787,
            "end_logit": 0.5914375185966492
        }
    ],
    "55421398ccca0ce74b000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "54d7b457e19bba8909000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "530cf4c54a5037880c000008": [
        {
            "text": "kinase (BTK) inhibitors have demonstrated a high degree of efficacy in the treatment of B cell",
            "probability": 0.20223833914524944,
            "start_logit": 1.1572695970535278,
            "end_logit": 0.6367278695106506
        },
        {
            "text": "kinase (BTK",
            "probability": 0.16322343680745963,
            "start_logit": 1.1572695970535278,
            "end_logit": 0.4224010109901428
        },
        {
            "text": "kinase (BTK) inhibitors have demonstrated a high degree of efficacy in the",
            "probability": 0.1522259297499919,
            "start_logit": 1.1572695970535278,
            "end_logit": 0.35264676809310913
        },
        {
            "text": "kinase (BTK) inhibitors have demonstrated a high degree of efficacy in the treatment of B cell malignancies characterized by constitutive B cell",
            "probability": 0.14522928962354395,
            "start_logit": 1.1572695970535278,
            "end_logit": 0.3055947721004486
        },
        {
            "text": "kinase (BTK) inhibitors have demonstrated a high degree of efficacy in the treatment of B cell malignancies characterized by consti",
            "probability": 0.11408359176200458,
            "start_logit": 1.1572695970535278,
            "end_logit": 0.06421241164207458
        },
        {
            "text": "kinase (BT",
            "probability": 0.11181928533161595,
            "start_logit": 1.1572695970535278,
            "end_logit": 0.04416501522064209
        },
        {
            "text": "kinase (BTK) inhibitors have demonstrated a high degree of efficacy in the treatment of B cell malignancies",
            "probability": 0.11118012758013454,
            "start_logit": 1.1572695970535278,
            "end_logit": 0.03843262791633606
        }
    ],
    "54f2210164850a5854000001": [
        {
            "text": "or matriptase",
            "probability": 0.06342607543280045,
            "start_logit": 1.1689739227294922,
            "end_logit": 0.7857093214988708
        },
        {
            "text": "idin. This enhancement of iron hampers the absorption of iron from the",
            "probability": 0.062264305932170284,
            "start_logit": 0.9306060671806335,
            "end_logit": 1.0055904388427734
        },
        {
            "text": "is characterized",
            "probability": 0.05704426187466056,
            "start_logit": 1.0521987676620483,
            "end_logit": 0.7964369058609009
        },
        {
            "text": "idin-ferroportin (Fpn) as an exporter. Hepcidin (hepatic bactericidal",
            "probability": 0.05674855897972399,
            "start_logit": 0.992091715335846,
            "end_logit": 0.8513467311859131
        },
        {
            "text": "is characterized by increased hepcidin production due to a gene mutation in the suppressor matriptase",
            "probability": 0.05643558539442619,
            "start_logit": 1.0521987676620483,
            "end_logit": 0.7857093214988708
        },
        {
            "text": "enterocytes, macrophages",
            "probability": 0.0549585943248056,
            "start_logit": 0.9637244939804077,
            "end_logit": 0.8476637601852417
        },
        {
            "text": "idin (hepatic bactericidal",
            "probability": 0.054074564186956005,
            "start_logit": 0.943825364112854,
            "end_logit": 0.8513467311859131
        },
        {
            "text": "is characterized by increased hepcidin production due to a gene mutation in the",
            "probability": 0.05298893583771944,
            "start_logit": 1.0521987676620483,
            "end_logit": 0.7226925492286682
        },
        {
            "text": "idin-",
            "probability": 0.05241841895927997,
            "start_logit": 0.992091715335846,
            "end_logit": 0.771974503993988
        },
        {
            "text": "idin (hepatic bactericidal protein) is a cysteine rich peptide, was initially identified as",
            "probability": 0.04849360308589514,
            "start_logit": 0.943825364112854,
            "end_logit": 0.7424147129058838
        },
        {
            "text": "amino acids and four disulfide",
            "probability": 0.04798581639267995,
            "start_logit": 0.9376649856567383,
            "end_logit": 0.7380486726760864
        },
        {
            "text": "idin is a peptide hormone which helps in regulating iron home",
            "probability": 0.04743025033904318,
            "start_logit": 1.0116883516311646,
            "end_logit": 0.6523800492286682
        },
        {
            "text": "is a cysteine rich peptide, was initially identified as",
            "probability": 0.04663911694234708,
            "start_logit": 0.9048330783843994,
            "end_logit": 0.7424147129058838
        },
        {
            "text": "idin. This enhancement of iron hampers the absorption of iron from the diet. The cause",
            "probability": 0.04576394694950785,
            "start_logit": 0.9306060671806335,
            "end_logit": 0.697698712348938
        },
        {
            "text": "is a peptide hormone which helps in regulating iron home",
            "probability": 0.043651517232467074,
            "start_logit": 0.9286661744117737,
            "end_logit": 0.6523800492286682
        },
        {
            "text": "idin. This enhancement of iron hampers the",
            "probability": 0.04329453042149392,
            "start_logit": 0.9306060671806335,
            "end_logit": 0.6422284245491028
        },
        {
            "text": "idin-ferroportin (Fpn) as an exporter. He",
            "probability": 0.04328728740924195,
            "start_logit": 0.992091715335846,
            "end_logit": 0.5805754661560059
        },
        {
            "text": "amino acids and four disulfide bridges. It has",
            "probability": 0.04231387549830126,
            "start_logit": 0.9376649856567383,
            "end_logit": 0.61225825548172
        },
        {
            "text": "enterocytes, macrophages and also decrease its transport across the placenta.The current review highlights the significant role of hepcidin in the",
            "probability": 0.04093555560575123,
            "start_logit": 0.9637244939804077,
            "end_logit": 0.5530827045440674
        },
        {
            "text": "amino acids and four disulfide bridges. It has significant role in regulation of iron in the body. Stimulation of iron in plasma and further its",
            "probability": 0.03984519920072894,
            "start_logit": 0.9376649856567383,
            "end_logit": 0.5521451234817505
        }
    ],
    "54e0ba781388e8454a000011": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56f6c11109dd18d46b00000e": [
        {
            "text": ") ligands: rosiglitazone and 15-deoxy-",
            "probability": 0.2492275619342168,
            "start_logit": 1.0697381496429443,
            "end_logit": 0.6729314923286438
        },
        {
            "text": ") ligands: rosiglitazone and 15-",
            "probability": 0.22256065976044517,
            "start_logit": 1.0697381496429443,
            "end_logit": 0.5597648024559021
        },
        {
            "text": ") ligands: rosiglitazone and 15",
            "probability": 0.18516216577081657,
            "start_logit": 1.0697381496429443,
            "end_logit": 0.3757971227169037
        },
        {
            "text": ") ligands: rosi",
            "probability": 0.18436135948328342,
            "start_logit": 1.0697381496429443,
            "end_logit": 0.3714628517627716
        },
        {
            "text": ") ligands: rosiglitazone",
            "probability": 0.15868825305123802,
            "start_logit": 1.0697381496429443,
            "end_logit": 0.22150671482086182
        }
    ],
    "536e46f27d100faa09000012": [
        {
            "text": "neurodegenerative disorder caused by a lysosomal \u03b2-",
            "probability": 0.15233988399100598,
            "start_logit": 0.9231218099594116,
            "end_logit": 0.8367461562156677
        },
        {
            "text": "Sachs disease (TSD) is an inherited neurodegenerative disorder caused by a lysosomal \u03b2-",
            "probability": 0.15146374375569338,
            "start_logit": 0.9173539876937866,
            "end_logit": 0.8367461562156677
        },
        {
            "text": "neurodegenerative disorder caused by a lysosomal \u03b2-he",
            "probability": 0.12119625825035056,
            "start_logit": 0.9231218099594116,
            "end_logit": 0.6080432534217834
        },
        {
            "text": "Sachs disease (TSD) is an inherited neurodegenerative disorder caused by a lysosomal \u03b2-he",
            "probability": 0.12049923186802286,
            "start_logit": 0.9173539876937866,
            "end_logit": 0.6080432534217834
        },
        {
            "text": "neurodegen",
            "probability": 0.1070707888463405,
            "start_logit": 0.9231218099594116,
            "end_logit": 0.48412224650382996
        },
        {
            "text": "Sachs disease (TSD) is an inherited neurodegen",
            "probability": 0.10645500115058198,
            "start_logit": 0.9173539876937866,
            "end_logit": 0.48412224650382996
        },
        {
            "text": "neurodegenerative disorder caused by a l",
            "probability": 0.08133546601077396,
            "start_logit": 0.9231218099594116,
            "end_logit": 0.2092142105102539
        },
        {
            "text": "Sachs disease (TSD) is an inherited neurodegenerative disorder caused by a l",
            "probability": 0.08086768782647294,
            "start_logit": 0.9173539876937866,
            "end_logit": 0.2092142105102539
        },
        {
            "text": "neurodegenerative disorder caused by a lysosomal \u03b2-hexosaminidase A deficiency due to mutations in the HE",
            "probability": 0.07877193830075788,
            "start_logit": 0.9231218099594116,
            "end_logit": 0.17718887329101562
        }
    ],
    "531e2695267d7dd05300000f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "515df199298dcd4e5100002a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "53148a07dae131f847000002": [
        {
            "text": "we show that SLC26A7 is a novel iodide transporter in the thyroid. We",
            "probability": 0.08565768766836865,
            "start_logit": 1.0059150457382202,
            "end_logit": 0.7800458073616028
        },
        {
            "text": "toplasmic localisation and lacks the iodide transport function. These results reveal that SLC26",
            "probability": 0.08053731059209679,
            "start_logit": 0.8921507000923157,
            "end_logit": 0.8321717381477356
        },
        {
            "text": "ln500Ter)",
            "probability": 0.0799909905537784,
            "start_logit": 1.0568039417266846,
            "end_logit": 0.660711944103241
        },
        {
            "text": "ln500Ter",
            "probability": 0.07963930851260263,
            "start_logit": 1.0568039417266846,
            "end_logit": 0.656305730342865
        },
        {
            "text": "is a novel iodide transporter in the thyroid. We",
            "probability": 0.07512065412806476,
            "start_logit": 0.8746516108512878,
            "end_logit": 0.7800458073616028
        },
        {
            "text": "we show that SLC26A7 is a novel iodide transporter in the thyroid.",
            "probability": 0.07436277504841007,
            "start_logit": 1.0059150457382202,
            "end_logit": 0.6386423110961914
        },
        {
            "text": "we show that SLC26",
            "probability": 0.07352854023051651,
            "start_logit": 1.0059150457382202,
            "end_logit": 0.627360463142395
        },
        {
            "text": "is a novel iodide transporter in the thyroid. We observe that SLC26A7 is specifically expressed in normal thyroid tissues and demonstrate its",
            "probability": 0.06948461964082965,
            "start_logit": 0.8746516108512878,
            "end_logit": 0.7020556926727295
        },
        {
            "text": "we show that SLC26A7 is a novel iodide transporter in the",
            "probability": 0.06766191626392745,
            "start_logit": 1.0059150457382202,
            "end_logit": 0.5442103147506714
        },
        {
            "text": "is a novel iodide transporter in the thyroid.",
            "probability": 0.0652151658125782,
            "start_logit": 0.8746516108512878,
            "end_logit": 0.6386423110961914
        },
        {
            "text": ". Pendr",
            "probability": 0.06426367964361825,
            "start_logit": 0.8818748593330383,
            "end_logit": 0.6167216300964355
        },
        {
            "text": "toplas",
            "probability": 0.06312315064313168,
            "start_logit": 0.8921507000923157,
            "end_logit": 0.5885387659072876
        },
        {
            "text": "C\u2009>\u2009T; p.Gln500Ter)",
            "probability": 0.06207559958299463,
            "start_logit": 0.8032429218292236,
            "end_logit": 0.660711944103241
        },
        {
            "text": "is a novel iodide transporter in the",
            "probability": 0.05933860167908237,
            "start_logit": 0.8746516108512878,
            "end_logit": 0.5442103147506714
        }
    ],
    "52eea4dcc8da89891000000c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "533c38b3c45e133714000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "51542e6fd24251bc05000082": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "53442023aeec6fbd07000007": [
        {
            "text": "kinase-",
            "probability": 0.07911667040834514,
            "start_logit": 1.003321647644043,
            "end_logit": 0.7657516598701477
        },
        {
            "text": "is concentrated at the",
            "probability": 0.07767772463811942,
            "start_logit": 1.0817806720733643,
            "end_logit": 0.6689375638961792
        },
        {
            "text": "is concentrated",
            "probability": 0.0767762067019402,
            "start_logit": 1.0817806720733643,
            "end_logit": 0.6572638154029846
        },
        {
            "text": ")metaphase, Aurora B is concentrated at the",
            "probability": 0.07276644687804555,
            "start_logit": 1.0164670944213867,
            "end_logit": 0.6689375638961792
        },
        {
            "text": ")metaphase, Aurora B is concentrated",
            "probability": 0.07192192861598001,
            "start_logit": 1.0164670944213867,
            "end_logit": 0.6572638154029846
        },
        {
            "text": "is sufficient to recruit Aurora B to a distinct chromosomal locus. Moreover, we identified a small, Bub1 kinase-",
            "probability": 0.07189715042609093,
            "start_logit": 0.9076346755027771,
            "end_logit": 0.7657516598701477
        },
        {
            "text": "did not compromise the mitotic checkpoint, nor the phosphorylation of the Aurora B kineto",
            "probability": 0.07142442000986512,
            "start_logit": 0.8007591962814331,
            "end_logit": 0.8660303354263306
        },
        {
            "text": "is sufficient to recruit Aurora B to a distinct chromosomal locus. Moreover, we identified a small,",
            "probability": 0.06287400085046915,
            "start_logit": 0.9076346755027771,
            "end_logit": 0.6316477656364441
        },
        {
            "text": "did not compromise the mitotic checkpoint, nor the phosphorylation of the Aurora B kinetochore substrates He",
            "probability": 0.06214875666405274,
            "start_logit": 0.8007591962814331,
            "end_logit": 0.7269213199615479
        },
        {
            "text": "chromosome segregation during mitosis. During (pro)metaphase, Aurora B is concentrated at the",
            "probability": 0.0604915353577211,
            "start_logit": 0.8317155838012695,
            "end_logit": 0.6689375638961792
        },
        {
            "text": "chromosome segregation during mitosis. During (pro)metaphase, Aurora B is concentrated",
            "probability": 0.05978947818024757,
            "start_logit": 0.8317155838012695,
            "end_logit": 0.6572638154029846
        },
        {
            "text": "did not compromise the mitotic checkpoint, nor the phosphorylation of the Aurora B",
            "probability": 0.05952445177432724,
            "start_logit": 0.8007591962814331,
            "end_logit": 0.6837776899337769
        },
        {
            "text": "is essential for faithful chromosome segregation during mitosis. During (pro)metaphase, Aurora B is concentrated at the",
            "probability": 0.05924886377865354,
            "start_logit": 0.810958743095398,
            "end_logit": 0.6689375638961792
        },
        {
            "text": "is essential for faithful chromosome segregation during mitosis. During (pro)metaphase, Aurora B is concentrated",
            "probability": 0.05856122889177269,
            "start_logit": 0.810958743095398,
            "end_logit": 0.6572638154029846
        },
        {
            "text": "is sufficient to recruit Aurora B to a distinct chromosomal locus.",
            "probability": 0.055781136824369554,
            "start_logit": 0.9076346755027771,
            "end_logit": 0.5119507908821106
        }
    ],
    "533abc76d6d3ac6a34000064": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "571f5c150fd6f91b68000009": [
        {
            "text": "DA) is a devastating, multisystemic disorder",
            "probability": 0.15198554699084654,
            "start_logit": 0.9616276025772095,
            "end_logit": 0.694136381149292
        },
        {
            "text": "DA) is a devastating, multisystemic disorder caused by recess",
            "probability": 0.1343005851902457,
            "start_logit": 0.9616276025772095,
            "end_logit": 0.5704314112663269
        },
        {
            "text": "DA) is a devastating, multisy",
            "probability": 0.1183135291709061,
            "start_logit": 0.9616276025772095,
            "end_logit": 0.4436890780925751
        },
        {
            "text": "DA) is a devastating, multisystemic disorder caused by recessive mutations in the",
            "probability": 0.10656161508227727,
            "start_logit": 0.9616276025772095,
            "end_logit": 0.3390743136405945
        },
        {
            "text": "DA) is a devastating,",
            "probability": 0.10503290764725966,
            "start_logit": 0.9616276025772095,
            "end_logit": 0.3246246576309204
        },
        {
            "text": "DA) is a devastating, multisystemic disorder caused by recessive mutations in the mitochondrial protein fra",
            "probability": 0.10353570795688828,
            "start_logit": 0.9616276025772095,
            "end_logit": 0.31026750802993774
        },
        {
            "text": "DA) is a devastating, multisystemic disorder caused by recessive mutations in the mitochondrial protein frataxin",
            "probability": 0.10048966325301777,
            "start_logit": 0.9616276025772095,
            "end_logit": 0.28040581941604614
        },
        {
            "text": "DA) is",
            "probability": 0.09121890263120502,
            "start_logit": 0.9616276025772095,
            "end_logit": 0.18361309170722961
        },
        {
            "text": "DA) is a devastating, multisystemic disorder caused by recessive mutations in the mitochondrial protein frataxin (FXN). FX",
            "probability": 0.08856154207735369,
            "start_logit": 0.9616276025772095,
            "end_logit": 0.15404865145683289
        }
    ],
    "51387022bee46bd34c000002": [
        {
            "text": "including axon guidance and cell",
            "probability": 0.07995086658114586,
            "start_logit": 1.3165627717971802,
            "end_logit": 0.8939155340194702
        },
        {
            "text": "including axon guidance and cell adhesion, and newly identified processes, including transcription and homeobox",
            "probability": 0.062277734284334814,
            "start_logit": 1.3165627717971802,
            "end_logit": 0.6441072225570679
        },
        {
            "text": "including axon guidance and cell adhesion, and newly identified processes, including transcription and homeobox genes. We identified mutations in protein",
            "probability": 0.05686250001711306,
            "start_logit": 1.3165627717971802,
            "end_logit": 0.553139328956604
        },
        {
            "text": "ding alterations identifies regulatory mutations as candidates for diagnostic and prognostic markers,",
            "probability": 0.05578910950194506,
            "start_logit": 1.0197155475616455,
            "end_logit": 0.830929160118103
        },
        {
            "text": "including axon guidance and cell adhesion, and newly identified processes, including transcription and home",
            "probability": 0.055630042008037936,
            "start_logit": 1.3165627717971802,
            "end_logit": 0.531226634979248
        },
        {
            "text": ".",
            "probability": 0.05454650647625964,
            "start_logit": 0.990292489528656,
            "end_logit": 0.837827205657959
        },
        {
            "text": ". Our detailed single-cancer analysis of noncoding alterations identifies regulatory mutations as candidates for diagnostic and prognostic markers,",
            "probability": 0.05417153695580814,
            "start_logit": 0.990292489528656,
            "end_logit": 0.830929160118103
        },
        {
            "text": "most frequently mutated, suggesting a selective advantage.",
            "probability": 0.05323870007491747,
            "start_logit": 0.9660243988037109,
            "end_logit": 0.837827205657959
        },
        {
            "text": ". Our detailed single",
            "probability": 0.05233519814992467,
            "start_logit": 0.990292489528656,
            "end_logit": 0.7964426875114441
        },
        {
            "text": "regulation imposed by each class of regulatory elements, and found the strongest elements were most frequently mutated, suggesting a selective advantage.",
            "probability": 0.05155848773816096,
            "start_logit": 0.9339556694030762,
            "end_logit": 0.837827205657959
        },
        {
            "text": "most frequently mutated, suggesting a selective advantage. Our detailed single",
            "probability": 0.05108041005115299,
            "start_logit": 0.9660243988037109,
            "end_logit": 0.7964426875114441
        },
        {
            "text": "regulation imposed by each class of regulatory elements, and found the strongest elements were most frequently mutated, suggesting a selective advantage. Our detailed single",
            "probability": 0.04946831330548201,
            "start_logit": 0.9339556694030762,
            "end_logit": 0.7964426875114441
        },
        {
            "text": "most frequently mutated",
            "probability": 0.04736191267678246,
            "start_logit": 0.9660243988037109,
            "end_logit": 0.7208600044250488
        },
        {
            "text": "regulation imposed by each class of regulatory elements, and found the strongest elements were most frequently mutated",
            "probability": 0.0458671716357741,
            "start_logit": 0.9339556694030762,
            "end_logit": 0.7208600044250488
        },
        {
            "text": "ding alterations identifies regulatory mutations as candidates for diagnostic and prognostic markers, and suggests new mechanisms for tumor evolution",
            "probability": 0.04295757361183246,
            "start_logit": 1.0197155475616455,
            "end_logit": 0.5695634484291077
        },
        {
            "text": "ox",
            "probability": 0.039101961587428076,
            "start_logit": 0.8511314392089844,
            "end_logit": 0.6441072225570679
        },
        {
            "text": "most",
            "probability": 0.038063922546812054,
            "start_logit": 0.9660243988037109,
            "end_logit": 0.5023085474967957
        },
        {
            "text": "regulation imposed by each class of regulatory elements, and found the strongest",
            "probability": 0.037173497201754994,
            "start_logit": 0.9339556694030762,
            "end_logit": 0.5107064247131348
        },
        {
            "text": "regulation imposed by each class of regulatory elements, and found the strongest elements were most",
            "probability": 0.036862625893090244,
            "start_logit": 0.9339556694030762,
            "end_logit": 0.5023085474967957
        },
        {
            "text": "ox genes. We identified mutations in protein",
            "probability": 0.03570192970224289,
            "start_logit": 0.8511314392089844,
            "end_logit": 0.553139328956604
        }
    ],
    "533be71dfd9a95ea0d000009": [
        {
            "text": "PPAR\u03b3, and C/EBP\u03b1, but not by C/EBP",
            "probability": 0.06541677351002367,
            "start_logit": 1.2792656421661377,
            "end_logit": 0.6546721458435059
        },
        {
            "text": "initiation and maintenance of cellular differentiation.",
            "probability": 0.058247023540668935,
            "start_logit": 1.1058974266052246,
            "end_logit": 0.711954653263092
        },
        {
            "text": "be rescued by exogen",
            "probability": 0.056783182576204023,
            "start_logit": 0.9013872146606445,
            "end_logit": 0.8910120725631714
        },
        {
            "text": "4D",
            "probability": 0.05497542476129369,
            "start_logit": 0.9451488256454468,
            "end_logit": 0.8148965239524841
        },
        {
            "text": "ethylation of tri-methylated H3K9 by KDM4D",
            "probability": 0.05492400975903008,
            "start_logit": 0.9442131519317627,
            "end_logit": 0.8148965239524841
        },
        {
            "text": "ethylation of tri-methyl",
            "probability": 0.05435861461590878,
            "start_logit": 0.9442131519317627,
            "end_logit": 0.8045490384101868
        },
        {
            "text": "ated H3K9 by KDM4D",
            "probability": 0.05104372065504045,
            "start_logit": 0.8709450960159302,
            "end_logit": 0.8148965239524841
        },
        {
            "text": "H10T1/2 mesenchymal",
            "probability": 0.05015145592513303,
            "start_logit": 0.9639660120010376,
            "end_logit": 0.704240620136261
        },
        {
            "text": "complex to the target promoters, the demethylation of tri-methylated H3K9 by KDM4D",
            "probability": 0.04901160369760796,
            "start_logit": 0.8303196430206299,
            "end_logit": 0.8148965239524841
        },
        {
            "text": "methylated",
            "probability": 0.04857244338888449,
            "start_logit": 1.0145564079284668,
            "end_logit": 0.6216590404510498
        },
        {
            "text": "complex to the target promoters, the demethylation of tri-methyl",
            "probability": 0.04850707165763508,
            "start_logit": 0.8303196430206299,
            "end_logit": 0.8045490384101868
        },
        {
            "text": "initiation and maintenance of cellular differentiation. We here report KDM4D histone demethylase as a",
            "probability": 0.04819123241635207,
            "start_logit": 1.1058974266052246,
            "end_logit": 0.5224387645721436
        },
        {
            "text": "methylated H3K4 and activate PPAR\u03b3 and C/EBP",
            "probability": 0.04764627338693256,
            "start_logit": 1.0145564079284668,
            "end_logit": 0.6024070978164673
        },
        {
            "text": "igenetic regulators are essential for the initiation and maintenance of cellular differentiation.",
            "probability": 0.04647103330331297,
            "start_logit": 0.8800336122512817,
            "end_logit": 0.711954653263092
        },
        {
            "text": "methylated H3",
            "probability": 0.04642100004522177,
            "start_logit": 1.0145564079284668,
            "end_logit": 0.5763546228408813
        },
        {
            "text": "4D is required for NFIB and MLL1 complex to deposit tri-methylated",
            "probability": 0.045315483778608646,
            "start_logit": 0.9451488256454468,
            "end_logit": 0.6216590404510498
        },
        {
            "text": "of cellular differentiation.",
            "probability": 0.045046518751524794,
            "start_logit": 0.8489001393318176,
            "end_logit": 0.711954653263092
        },
        {
            "text": "methyl",
            "probability": 0.043534197312061394,
            "start_logit": 1.0145564079284668,
            "end_logit": 0.512149453163147
        },
        {
            "text": "4D is required for NFIB and MLL1 complex to deposit tri-methylated H3",
            "probability": 0.04330830256353611,
            "start_logit": 0.9451488256454468,
            "end_logit": 0.5763546228408813
        },
        {
            "text": "ated H3K9 by KDM4D is required for NFIB and MLL1 complex to deposit tri-methylated",
            "probability": 0.042074634355019486,
            "start_logit": 0.8709450960159302,
            "end_logit": 0.6216590404510498
        }
    ],
    "56c8274f5795f9a73e00000d": [
        {
            "text": "le protein inclusions accumulate in somatic cells in amyotrophic lateral sclerosis. The most",
            "probability": 0.0751528476034163,
            "start_logit": 0.8800098896026611,
            "end_logit": 0.8465502858161926
        },
        {
            "text": "cytes",
            "probability": 0.07226751956915717,
            "start_logit": 0.8904815912246704,
            "end_logit": 0.7969293594360352
        },
        {
            "text": "phagy activation in lymphomonocytes",
            "probability": 0.07012472140822366,
            "start_logit": 0.8603821992874146,
            "end_logit": 0.7969293594360352
        },
        {
            "text": "le protein inclusions accumulate in somatic cells in amyotrophic lateral sclerosis. The",
            "probability": 0.06946963051420892,
            "start_logit": 0.8800098896026611,
            "end_logit": 0.7679159641265869
        },
        {
            "text": "cytes was found. We also obtained evidence that protein product of the mutant C9orf72 gene can disturb the late stages",
            "probability": 0.06378141617332561,
            "start_logit": 0.8904815912246704,
            "end_logit": 0.672016441822052
        },
        {
            "text": "le protein",
            "probability": 0.06370936205955056,
            "start_logit": 0.8800098896026611,
            "end_logit": 0.6813578009605408
        },
        {
            "text": "cytes was found. We also obtained evidence that protein product of the",
            "probability": 0.05933474115491096,
            "start_logit": 0.8904815912246704,
            "end_logit": 0.5997495651245117
        },
        {
            "text": "phagy activation in lymphomonocytes was found. We also obtained evidence that protein product of the",
            "probability": 0.05757541172193468,
            "start_logit": 0.8603821992874146,
            "end_logit": 0.5997495651245117
        },
        {
            "text": "cytes was found. We also obtained evidence that protein",
            "probability": 0.05719090273081872,
            "start_logit": 0.8904815912246704,
            "end_logit": 0.5629494190216064
        },
        {
            "text": "phagy activation in lymphomonocytes was found. We also obtained evidence that protein",
            "probability": 0.05549514007112966,
            "start_logit": 0.8603821992874146,
            "end_logit": 0.5629494190216064
        },
        {
            "text": "cytes was found.",
            "probability": 0.05383431819617273,
            "start_logit": 0.8904815912246704,
            "end_logit": 0.5024657249450684
        },
        {
            "text": "le protein inclusions accumulate in somatic cells in amyotrophic lateral sclerosis. The most common gene mutations associated with this pathology",
            "probability": 0.053667873733266404,
            "start_logit": 0.8800098896026611,
            "end_logit": 0.5098408460617065
        },
        {
            "text": "phagy activation in lymphomonocytes was found.",
            "probability": 0.052238081342969596,
            "start_logit": 0.8603821992874146,
            "end_logit": 0.5024657249450684
        },
        {
            "text": "cytes was found. We also obtained evidence that protein product of the mutant C9orf72 gene can disturb the late stages of autophagy",
            "probability": 0.05012065202741003,
            "start_logit": 0.8904815912246704,
            "end_logit": 0.43098771572113037
        },
        {
            "text": "cytes was",
            "probability": 0.04982680149300132,
            "start_logit": 0.8904815912246704,
            "end_logit": 0.42510759830474854
        },
        {
            "text": "phagy activation in lymphomonocytes was",
            "probability": 0.04834939118141275,
            "start_logit": 0.8603821992874146,
            "end_logit": 0.42510759830474854
        },
        {
            "text": "phagy activation in lymphomono",
            "probability": 0.047861189019090915,
            "start_logit": 0.8603821992874146,
            "end_logit": 0.4149588942527771
        }
    ],
    "5545e65bd355485447000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "531464a6e3eabad021000014": [
        {
            "text": "disease, including Chorea-",
            "probability": 0.06955336419379365,
            "start_logit": 0.9112598896026611,
            "end_logit": 0.8786869645118713
        },
        {
            "text": "Chorea-",
            "probability": 0.06860830500240087,
            "start_logit": 0.8975791931152344,
            "end_logit": 0.8786869645118713
        },
        {
            "text": "hocytosis is a rare progressive neurodegenerative disease, including Chorea-",
            "probability": 0.06860473098292635,
            "start_logit": 0.8975270986557007,
            "end_logit": 0.8786869645118713
        },
        {
            "text": "rea-",
            "probability": 0.0667266834969419,
            "start_logit": 0.8697705268859863,
            "end_logit": 0.8786869645118713
        },
        {
            "text": "disease, including Chorea-acanthocytosis, McLeod syndrome, Huntington's disease-like",
            "probability": 0.06433386170089246,
            "start_logit": 0.9112598896026611,
            "end_logit": 0.8006787896156311
        },
        {
            "text": "Chorea-acanthocytosis, McLeod syndrome, Huntington's disease-like",
            "probability": 0.06345972271390085,
            "start_logit": 0.8975791931152344,
            "end_logit": 0.8006787896156311
        },
        {
            "text": "anthocytosis, McLeod syndrome, Huntington's disease-like",
            "probability": 0.06266423862598408,
            "start_logit": 0.8849647045135498,
            "end_logit": 0.8006787896156311
        },
        {
            "text": "rea-acanthocytosis, McLeod syndrome, Huntington's disease-like",
            "probability": 0.06171930398493269,
            "start_logit": 0.8697705268859863,
            "end_logit": 0.8006787896156311
        },
        {
            "text": ". Several suggestive features are summarized",
            "probability": 0.05475500833157185,
            "start_logit": 1.0049676895141602,
            "end_logit": 0.5457537174224854
        },
        {
            "text": ". Several suggestive features are summarized to provide diagnostic clues for Chorea-acanthocytosis and facilitate future diagnosis",
            "probability": 0.05274628750115186,
            "start_logit": 1.0049676895141602,
            "end_logit": 0.508378267288208
        },
        {
            "text": ". Several suggestive features are summarized to provide diagnostic clues for Chorea-acanthocytosis and facilitate",
            "probability": 0.05185407368593744,
            "start_logit": 1.0049676895141602,
            "end_logit": 0.49131837487220764
        },
        {
            "text": ". Several suggestive features are summarized to provide diagnostic clues for Chorea-acanthocytosis and facilitate future diagnosis and treatment.",
            "probability": 0.04999105177201702,
            "start_logit": 1.0049676895141602,
            "end_logit": 0.454728901386261
        },
        {
            "text": "anthocytosis, McLeod syndrome, Huntington's disease-like 2, and pantothenate kinase-associated neurodegeneration",
            "probability": 0.04506768633035016,
            "start_logit": 0.8849647045135498,
            "end_logit": 0.4710533618927002
        },
        {
            "text": "disease, including Chorea-acanthocytosis",
            "probability": 0.04482421251844532,
            "start_logit": 0.9112598896026611,
            "end_logit": 0.43934112787246704
        },
        {
            "text": "Chorea-acanthocytosis",
            "probability": 0.044215161690659754,
            "start_logit": 0.8975791931152344,
            "end_logit": 0.43934112787246704
        },
        {
            "text": "hocytosis is a rare progressive neurodegenerative disease, including Chorea-acanthocytosis",
            "probability": 0.04421285838570352,
            "start_logit": 0.8975270986557007,
            "end_logit": 0.43934112787246704
        },
        {
            "text": "anthocytosis",
            "probability": 0.04366091316788953,
            "start_logit": 0.8849647045135498,
            "end_logit": 0.43934112787246704
        },
        {
            "text": "rea-acanthocytosis",
            "probability": 0.04300253591450074,
            "start_logit": 0.8697705268859863,
            "end_logit": 0.43934112787246704
        }
    ],
    "53124bdae3eabad02100000b": [
        {
            "text": "OR inhibition also promotes infection by another IFITM-",
            "probability": 0.06256524924108463,
            "start_logit": 0.8710272312164307,
            "end_logit": 1.065179467201233
        },
        {
            "text": "IFITM-",
            "probability": 0.061589031297777486,
            "start_logit": 0.855301022529602,
            "end_logit": 1.065179467201233
        },
        {
            "text": "we show that mTOR inhibition also promotes infection by another IFITM-",
            "probability": 0.05965883994404635,
            "start_logit": 0.8234595656394958,
            "end_logit": 1.065179467201233
        },
        {
            "text": "OR inhibitor treatment results in down-regulation of the IFN-",
            "probability": 0.05333708116115383,
            "start_logit": 1.0886445045471191,
            "end_logit": 0.6879839897155762
        },
        {
            "text": "not infection",
            "probability": 0.05322338937231413,
            "start_logit": 0.9498372077941895,
            "end_logit": 0.8246574401855469
        },
        {
            "text": "OR inhibitor treatment results in down-",
            "probability": 0.05154727946864922,
            "start_logit": 1.0886445045471191,
            "end_logit": 0.6538516283035278
        },
        {
            "text": "selective, as many other endosome-",
            "probability": 0.05122229288555247,
            "start_logit": 0.9025052189826965,
            "end_logit": 0.8336663246154785
        },
        {
            "text": "IFITM3 manifests at the level of protein, but not mRNA, and is selective, as many other endosome-",
            "probability": 0.05103944398831319,
            "start_logit": 0.8989291191101074,
            "end_logit": 0.8336663246154785
        },
        {
            "text": "mTOR inhibitor treatment results in down-regulation of the IFN-",
            "probability": 0.05072330943737356,
            "start_logit": 1.038398265838623,
            "end_logit": 0.6879839897155762
        },
        {
            "text": "OR inhibition also promotes infection by another IFITM-sensitive virus, Influenza A virus, but not infection",
            "probability": 0.049189883036178696,
            "start_logit": 0.8710272312164307,
            "end_logit": 0.8246574401855469
        },
        {
            "text": "mTOR inhibitor treatment results in down-",
            "probability": 0.04902121657619604,
            "start_logit": 1.038398265838623,
            "end_logit": 0.6538516283035278
        },
        {
            "text": "depends on basal expression of IFITM proteins, with a major contribution from IF",
            "probability": 0.04866905552257392,
            "start_logit": 1.0158840417861938,
            "end_logit": 0.6691560745239258
        },
        {
            "text": "IFITM-sensitive virus, Influenza A virus, but not infection",
            "probability": 0.04842236357399195,
            "start_logit": 0.855301022529602,
            "end_logit": 0.8246574401855469
        },
        {
            "text": "agents. Additionally, this class of drug promotes gene delivery by facilitating lentiviral vector entry into cells, revealing its",
            "probability": 0.047648037795417666,
            "start_logit": 0.9571261405944824,
            "end_logit": 0.706712007522583
        },
        {
            "text": "we show that mTOR inhibition also promotes infection by another IFITM-sensitive virus, Influenza A virus, but not infection",
            "probability": 0.04690481368680746,
            "start_logit": 0.8234595656394958,
            "end_logit": 0.8246574401855469
        },
        {
            "text": "mRNA, and is selective, as many other endosome-",
            "probability": 0.04499689078820803,
            "start_logit": 0.7729237675666809,
            "end_logit": 0.8336663246154785
        },
        {
            "text": "we",
            "probability": 0.0449875958542454,
            "start_logit": 0.8234595656394958,
            "end_logit": 0.7829239368438721
        },
        {
            "text": "OR inhibition",
            "probability": 0.04211346433297801,
            "start_logit": 0.8710272312164307,
            "end_logit": 0.6693369746208191
        },
        {
            "text": "addition, this study uncover",
            "probability": 0.041595814268205,
            "start_logit": 0.8387507200241089,
            "end_logit": 0.6892455220222473
        },
        {
            "text": "selective,",
            "probability": 0.04154494776893298,
            "start_logit": 0.9025052189826965,
            "end_logit": 0.6242673993110657
        }
    ],
    "54fc91e96ad7dcbc12000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "53318685d6d3ac6a3400003d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "511a3573df1ebcce7d000018": [
        {
            "text": "be studied in-",
            "probability": 0.12849893487395644,
            "start_logit": 0.987220823764801,
            "end_logit": 0.9662303924560547
        },
        {
            "text": "LKs), and plasma kallikrein form the largest group of serine proteases in the",
            "probability": 0.10134556546340445,
            "start_logit": 0.9489177465438843,
            "end_logit": 0.7671489715576172
        },
        {
            "text": "be studied in-depth due to the development of Next-",
            "probability": 0.10068695651621758,
            "start_logit": 0.987220823764801,
            "end_logit": 0.7223260402679443
        },
        {
            "text": "two KLK1 and nine KLK2 transcripts).",
            "probability": 0.0964925802332699,
            "start_logit": 0.8195072412490845,
            "end_logit": 0.8474894762039185
        },
        {
            "text": "two KLK1 and nine KLK2 transcripts). In addition, the",
            "probability": 0.0923902307008271,
            "start_logit": 0.8195072412490845,
            "end_logit": 0.8040446043014526
        },
        {
            "text": "two KLK1 and nine KLK2 transcripts",
            "probability": 0.0903697341049716,
            "start_logit": 0.8195072412490845,
            "end_logit": 0.7819327712059021
        },
        {
            "text": "be studied in-depth due to the development of Next-Generation Sequencing (NGS).",
            "probability": 0.0815144417168351,
            "start_logit": 0.987220823764801,
            "end_logit": 0.5110899806022644
        },
        {
            "text": "be studied in-depth due to the development of Next-Generation Sequencing",
            "probability": 0.08099097399384556,
            "start_logit": 0.987220823764801,
            "end_logit": 0.5046474933624268
        },
        {
            "text": "two KLK1 and nine KLK2 transcripts). In addition, the expression profiles of each novel transcript were investigated with nested PC",
            "probability": 0.07831828308137653,
            "start_logit": 0.8195072412490845,
            "end_logit": 0.6388044357299805
        },
        {
            "text": "ein, kallikrein-",
            "probability": 0.07665592645279164,
            "start_logit": 0.8392616510391235,
            "end_logit": 0.5975958704948425
        },
        {
            "text": "kallikrein, kallikrein-",
            "probability": 0.07273637286250415,
            "start_logit": 0.7867763042449951,
            "end_logit": 0.5975958704948425
        }
    ],
    "56be143eef6e394741000009": [
        {
            "text": "consideration of thiamine deficiency as a potential cause in high-",
            "probability": 0.0890677795549351,
            "start_logit": 1.0793616771697998,
            "end_logit": 1.030046820640564
        },
        {
            "text": "consideration of thiamine deficiency as a potential cause",
            "probability": 0.08460074763378825,
            "start_logit": 1.0793616771697998,
            "end_logit": 0.9785922765731812
        },
        {
            "text": "-",
            "probability": 0.057465616953586776,
            "start_logit": 0.8700828552246094,
            "end_logit": 0.8011147975921631
        },
        {
            "text": "is to summarize the clinical features, diagnosis and treatment of Wern",
            "probability": 0.05575478269483419,
            "start_logit": 1.033815622329712,
            "end_logit": 0.6071584224700928
        },
        {
            "text": "s encephalopathy is vital, as prompt treatment can restore cognitive or ocular function and can prevent permanent",
            "probability": 0.05449634972428933,
            "start_logit": 0.962681233882904,
            "end_logit": 0.6554633378982544
        },
        {
            "text": "consideration of thiamine deficiency as a potential cause in high-risk patient groups. The",
            "probability": 0.05359840683414781,
            "start_logit": 1.0793616771697998,
            "end_logit": 0.5221685171127319
        },
        {
            "text": "review is to summarize the clinical features, diagnosis and treatment of Wern",
            "probability": 0.05193969418132552,
            "start_logit": 0.962935745716095,
            "end_logit": 0.6071584224700928
        },
        {
            "text": "phalopathy and to highlight some non-traditional causes, such as",
            "probability": 0.05180478859075157,
            "start_logit": 1.0414073467254639,
            "end_logit": 0.5260860919952393
        },
        {
            "text": "s encephalopathy is vital, as",
            "probability": 0.04840719452853397,
            "start_logit": 0.962681233882904,
            "end_logit": 0.5369780659675598
        },
        {
            "text": "pathy is also well recognized in many other patient groups, including patients",
            "probability": 0.04642270651037077,
            "start_logit": 0.857284426689148,
            "end_logit": 0.6005151271820068
        },
        {
            "text": "- presumably because it is relatively uncommon and has a",
            "probability": 0.04633464982858229,
            "start_logit": 0.8700828552246094,
            "end_logit": 0.5858180522918701
        },
        {
            "text": "recognized in many other patient groups, including patients",
            "probability": 0.04593011866274422,
            "start_logit": 0.846616804599762,
            "end_logit": 0.6005151271820068
        },
        {
            "text": "s encephalopathy and to highlight some non-traditional causes, such as",
            "probability": 0.0456958716093267,
            "start_logit": 0.9159327149391174,
            "end_logit": 0.5260860919952393
        },
        {
            "text": "including gait disturbance, altered cognitive state, nystagmus and other eye movement disorders. In the past,",
            "probability": 0.04562178754281452,
            "start_logit": 0.837203323841095,
            "end_logit": 0.603192925453186
        },
        {
            "text": "pathy is also well recognized in many other patient groups, including patients following bariatric surgery, gastrointestinal surgery",
            "probability": 0.04514773455516841,
            "start_logit": 0.857284426689148,
            "end_logit": 0.5726665258407593
        },
        {
            "text": "including gait disturbance, altered cognitive state",
            "probability": 0.04514204610852533,
            "start_logit": 0.837203323841095,
            "end_logit": 0.5926216244697571
        },
        {
            "text": "- presumably because it is relatively",
            "probability": 0.044821524532216765,
            "start_logit": 0.8700828552246094,
            "end_logit": 0.5526164770126343
        },
        {
            "text": "recognized in many other patient groups, including patients following bariatric surgery, gastrointestinal surgery",
            "probability": 0.044668675339076015,
            "start_logit": 0.846616804599762,
            "end_logit": 0.5726665258407593
        },
        {
            "text": "- presumably because it is relatively uncommon and has a variable clinical presentation. Clinical biochemists have",
            "probability": 0.04307952461498249,
            "start_logit": 0.8700828552246094,
            "end_logit": 0.512975811958313
        }
    ],
    "56c865d25795f9a73e000016": [
        {
            "text": "at least two isoforms of NADPH oxidase - Nox1 and Nox2 -",
            "probability": 0.06894425022695196,
            "start_logit": 1.0434706211090088,
            "end_logit": 0.983945369720459
        },
        {
            "text": "be viewed with caution. Here, we review the literature on studies utilising genetically-",
            "probability": 0.0648744606208454,
            "start_logit": 0.7759197950363159,
            "end_logit": 1.1906520128250122
        },
        {
            "text": "PH oxidase mean that findings obtained with these compounds must be viewed with caution. Here, we review the literature on studies utilising genetically-",
            "probability": 0.06338223763763892,
            "start_logit": 0.7526494264602661,
            "end_logit": 1.1906520128250122
        },
        {
            "text": "review the literature on studies utilising genetically-",
            "probability": 0.06198702807882764,
            "start_logit": 0.7303909063339233,
            "end_logit": 1.1906520128250122
        },
        {
            "text": "two isoforms of NADPH oxidase - Nox1 and Nox2 -",
            "probability": 0.05673082129854247,
            "start_logit": 0.8484900593757629,
            "end_logit": 0.983945369720459
        },
        {
            "text": "PH oxidases in experimental models of vascular disease. While several studies on transgenic over-expressing or knockout mice support roles for Nox1-",
            "probability": 0.055641384188920506,
            "start_logit": 0.9740597605705261,
            "end_logit": 0.8389852643013
        },
        {
            "text": "Nox1 and Nox2 -",
            "probability": 0.05054403087824894,
            "start_logit": 0.7330172657966614,
            "end_logit": 0.983945369720459
        },
        {
            "text": "Nox2-",
            "probability": 0.050353394738811084,
            "start_logit": 0.6724568009376526,
            "end_logit": 1.0407270193099976
        },
        {
            "text": "at least two isoforms of NADPH oxidase -",
            "probability": 0.04940625389084302,
            "start_logit": 1.0434706211090088,
            "end_logit": 0.6507241725921631
        },
        {
            "text": "containing oxidases as sources of excessive vascular ROS production and causes of endothelial dysfunction in hypertension, atherosclerosis and diabetes",
            "probability": 0.04908515673412253,
            "start_logit": 0.9869676232337952,
            "end_logit": 0.7007068395614624
        },
        {
            "text": "be viewed with caution. Here, we",
            "probability": 0.04731986961381397,
            "start_logit": 0.7759197950363159,
            "end_logit": 0.8751282691955566
        },
        {
            "text": "cardiovascular diseases and a likely contributor to oxidative stress, endothelial dysfunction and vascular",
            "probability": 0.04719579025447855,
            "start_logit": 0.9664756655693054,
            "end_logit": 0.6819468140602112
        },
        {
            "text": "PH oxidase mean that findings obtained with these compounds must be viewed with caution. Here, we",
            "probability": 0.04623143209426752,
            "start_logit": 0.7526494264602661,
            "end_logit": 0.8751282691955566
        },
        {
            "text": "at least two isoforms of NADPH oxidase - Nox1 and Nox2 - are up-",
            "probability": 0.04321589290250528,
            "start_logit": 1.0434706211090088,
            "end_logit": 0.5168554782867432
        },
        {
            "text": "indeed any other contexts. Further understanding of the roles of specific isoforms of NADPH oxidase in vascular",
            "probability": 0.04202408191137169,
            "start_logit": 0.9422308206558228,
            "end_logit": 0.5901297926902771
        },
        {
            "text": "PH oxidases in experimental models of vascular disease. While several",
            "probability": 0.041382890259981986,
            "start_logit": 0.9740597605705261,
            "end_logit": 0.5429255366325378
        },
        {
            "text": "of excessive vascular ROS production and causes of endothelial dysfunction in hypertension, atherosclerosis and diabetes",
            "probability": 0.040698554703437036,
            "start_logit": 0.7996035218238831,
            "end_logit": 0.7007068395614624
        },
        {
            "text": "reactive oxygen species (ROS) formation in the vascular wall",
            "probability": 0.04067208303345912,
            "start_logit": 0.8898845314979553,
            "end_logit": 0.609775185585022
        },
        {
            "text": "two isoforms of NADPH oxidase -",
            "probability": 0.04065396826109989,
            "start_logit": 0.8484900593757629,
            "end_logit": 0.6507241725921631
        },
        {
            "text": "PH oxidases in experimental models of vascular",
            "probability": 0.03965641867183264,
            "start_logit": 0.9740597605705261,
            "end_logit": 0.5003108382225037
        }
    ],
    "550e828c71445a662f000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5133b9455274a5fb0700000c": [
        {
            "text": "I (HTLV-",
            "probability": 0.09082101585355125,
            "start_logit": 1.516754388809204,
            "end_logit": 0.9824202656745911
        },
        {
            "text": "I (HTLV-I) long terminal repeat (LTR",
            "probability": 0.07150247188940928,
            "start_logit": 1.516754388809204,
            "end_logit": 0.7432615756988525
        },
        {
            "text": "T-cell leukemia virus type I (HTLV-",
            "probability": 0.06058524093476927,
            "start_logit": 1.1119149923324585,
            "end_logit": 0.9824202656745911
        },
        {
            "text": "two cis-acting signals are required for efficient RNA processing in HTLV-",
            "probability": 0.05815736086115463,
            "start_logit": 0.9966281652450562,
            "end_logit": 1.0568082332611084
        },
        {
            "text": "I RNA in the U3 and R regions juxtaposes the",
            "probability": 0.05493145490913439,
            "start_logit": 1.173965334892273,
            "end_logit": 0.8224047422409058
        },
        {
            "text": "secondary structure. Thus, the genetic",
            "probability": 0.05028371361732623,
            "start_logit": 1.0729581117630005,
            "end_logit": 0.8350070714950562
        },
        {
            "text": "secondary structure. Thus, the genetic analysis supports the hypothesis that folding of the HTLV-",
            "probability": 0.049652405734240734,
            "start_logit": 1.0729581117630005,
            "end_logit": 0.8223726749420166
        },
        {
            "text": "I RNA in the U3 and R regions juxtaposes",
            "probability": 0.0490055132971558,
            "start_logit": 1.173965334892273,
            "end_logit": 0.708251416683197
        },
        {
            "text": "introduced deletions and point mutations within the U3 and R regions of the LTR. RNA 3'-end",
            "probability": 0.048057987417700364,
            "start_logit": 0.8798161745071411,
            "end_logit": 0.9828761219978333
        },
        {
            "text": "I RNA",
            "probability": 0.048006036676550005,
            "start_logit": 1.173965334892273,
            "end_logit": 0.6876453757286072
        },
        {
            "text": "T-cell leukemia virus type I (HTLV-I) long terminal repeat (LTR",
            "probability": 0.04769815054520821,
            "start_logit": 1.1119149923324585,
            "end_logit": 0.7432615756988525
        },
        {
            "text": "of the LTR. RNA 3'-end",
            "probability": 0.04474029518411661,
            "start_logit": 0.8082823753356934,
            "end_logit": 0.9828761219978333
        },
        {
            "text": "human T-cell leukemia virus type I (HTLV-",
            "probability": 0.04469653157216486,
            "start_logit": 0.8077595829963684,
            "end_logit": 0.9824202656745911
        },
        {
            "text": "secondary structure. Thus, the genetic analysis supports the hypothesis that folding of the HTLV-I RNA",
            "probability": 0.04339392888877386,
            "start_logit": 1.0729581117630005,
            "end_logit": 0.6876453757286072
        },
        {
            "text": "secondary structure. Thus, the genetic analysis supports the hypothesis that folding",
            "probability": 0.04309430790605373,
            "start_logit": 1.0729581117630005,
            "end_logit": 0.6807167530059814
        },
        {
            "text": ") long terminal repeat (LTR",
            "probability": 0.040889203560227357,
            "start_logit": 0.9578884243965149,
            "end_logit": 0.7432615756988525
        },
        {
            "text": "I poly(A) site after deletion of the sequences predicted to form the",
            "probability": 0.04080353614739761,
            "start_logit": 0.8365421295166016,
            "end_logit": 0.8625105619430542
        },
        {
            "text": "I poly(A) site after deletion of the sequences predicted to form the secondary structure. Thus, the genetic",
            "probability": 0.0396965887173374,
            "start_logit": 0.8365421295166016,
            "end_logit": 0.8350070714950562
        },
        {
            "text": "introduced deletions and",
            "probability": 0.03795861574082471,
            "start_logit": 0.8798161745071411,
            "end_logit": 0.7469642758369446
        },
        {
            "text": "introduced deletions and point mutations within the U3 and R regions of the LTR.",
            "probability": 0.036025640546903714,
            "start_logit": 0.8798161745071411,
            "end_logit": 0.694698691368103
        }
    ],
    "54f608f85f206a0c06000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "56c048acef6e39474100001c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "512d0e635274a5fb07000005": [
        {
            "text": "associated with increased drug clearance and loss of response. We",
            "probability": 0.1042992688694087,
            "start_logit": 1.0134233236312866,
            "end_logit": 0.6518241763114929
        },
        {
            "text": ") drugs are associated with increased drug clearance and loss of response. We",
            "probability": 0.10220278797279626,
            "start_logit": 0.9931179285049438,
            "end_logit": 0.6518241763114929
        },
        {
            "text": "associated with increased drug clearance and loss of response. We aimed to assess the",
            "probability": 0.08554996357051887,
            "start_logit": 1.0134233236312866,
            "end_logit": 0.45366039872169495
        },
        {
            "text": ") drugs are associated with increased drug clearance and loss of response. We aimed to assess the",
            "probability": 0.08383035550158745,
            "start_logit": 0.9931179285049438,
            "end_logit": 0.45366039872169495
        },
        {
            "text": "associated with increased drug clearance and loss of response. We aimed to assess the effectiveness of starting an",
            "probability": 0.0741987481124711,
            "start_logit": 1.0134233236312866,
            "end_logit": 0.3113071024417877
        },
        {
            "text": ") drugs are associated with increased drug clearance and loss of response. We aimed to assess the effectiveness of starting an",
            "probability": 0.07270730661286554,
            "start_logit": 0.9931179285049438,
            "end_logit": 0.3113071024417877
        },
        {
            "text": "associated with increased drug clearance and loss of response. We aimed to assess the effectiveness of starting an immunomodulat",
            "probability": 0.07234154509582111,
            "start_logit": 1.0134233236312866,
            "end_logit": 0.2859584093093872
        },
        {
            "text": ") drugs are associated with increased drug clearance and loss of response. We aimed to assess the effectiveness of starting an immunomodulat",
            "probability": 0.07088743454481895,
            "start_logit": 0.9931179285049438,
            "end_logit": 0.2859584093093872
        },
        {
            "text": "associated with increased drug",
            "probability": 0.0704724612721463,
            "start_logit": 1.0134233236312866,
            "end_logit": 0.2597818374633789
        },
        {
            "text": ") drugs are associated with increased drug",
            "probability": 0.06905592048144045,
            "start_logit": 0.9931179285049438,
            "end_logit": 0.2597818374633789
        },
        {
            "text": "associated",
            "probability": 0.06741466444908223,
            "start_logit": 1.0134233236312866,
            "end_logit": 0.2154223918914795
        },
        {
            "text": ") drugs are associated",
            "probability": 0.06605958729752519,
            "start_logit": 0.9931179285049438,
            "end_logit": 0.2154223918914795
        },
        {
            "text": ")",
            "probability": 0.060979956219517746,
            "start_logit": 0.9931179285049438,
            "end_logit": 0.13541044294834137
        }
    ],
    "56ffd805cf1c32585100000a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "533ba85ffd9a95ea0d000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58a2e5f760087bc10a000007": [
        {
            "text": "\u03b1syn is hypothesized to spread through the brain in a prion-like",
            "probability": 0.08652459338244897,
            "start_logit": 1.4390580654144287,
            "end_logit": 0.9030791521072388
        },
        {
            "text": "\u03b1syn) is the primary component of proteinaceous aggregates termed Lew",
            "probability": 0.07912349043056131,
            "start_logit": 1.4196810722351074,
            "end_logit": 0.833037257194519
        },
        {
            "text": "\u03b1syn is hypothesized to spread through the brain in a prion-like fashion by misfolded protein",
            "probability": 0.06748964099208862,
            "start_logit": 1.4390580654144287,
            "end_logit": 0.6546245813369751
        },
        {
            "text": "\u03b1syn is hypothesized to spread through the",
            "probability": 0.06519088256648986,
            "start_logit": 1.4390580654144287,
            "end_logit": 0.6199700832366943
        },
        {
            "text": "is implicated in protein",
            "probability": 0.053601811028740065,
            "start_logit": 0.8858543634414673,
            "end_logit": 0.9774370193481445
        },
        {
            "text": "\u03b1syn are considered important processes for its prion-like",
            "probability": 0.053354928629193964,
            "start_logit": 1.279123306274414,
            "end_logit": 0.5795515775680542
        },
        {
            "text": "\u03b1syn are considered important processes for its prion-like spread. Rab27b is one of several GTPases essential to the end",
            "probability": 0.051849808396967186,
            "start_logit": 1.279123306274414,
            "end_logit": 0.5509364604949951
        },
        {
            "text": "\u03b1syn are considered important processes for its prion-",
            "probability": 0.04930973426308346,
            "start_logit": 1.279123306274414,
            "end_logit": 0.5007067322731018
        },
        {
            "text": ") is the primary component of proteinaceous aggregates termed Lew",
            "probability": 0.047334445636964664,
            "start_logit": 0.905909538269043,
            "end_logit": 0.833037257194519
        },
        {
            "text": "\u03b1syn. The cell-",
            "probability": 0.04707442150029724,
            "start_logit": 1.0471041202545166,
            "end_logit": 0.6863341927528381
        },
        {
            "text": "\u03b1syn spread has yet to be characterized. In this",
            "probability": 0.04522835265341013,
            "start_logit": 1.1629905700683594,
            "end_logit": 0.5304421186447144
        },
        {
            "text": "\u03b1syn. The",
            "probability": 0.04309272619903109,
            "start_logit": 1.0471041202545166,
            "end_logit": 0.5979586243629456
        },
        {
            "text": "\u03b1syn. The cell-to-cell release and uptake of \u03b1syn are considered important processes for its prion-like",
            "probability": 0.04230677210946597,
            "start_logit": 1.0471041202545166,
            "end_logit": 0.5795515775680542
        },
        {
            "text": "cell-",
            "probability": 0.04158493649222893,
            "start_logit": 0.9231123328208923,
            "end_logit": 0.6863341927528381
        },
        {
            "text": "\u03b1syn.",
            "probability": 0.04105852136560436,
            "start_logit": 1.0471041202545166,
            "end_logit": 0.5496028065681458
        },
        {
            "text": "\u03b1syn. The cell-to-cell release and uptake of \u03b1syn are considered important processes for its prion-",
            "probability": 0.039099212459730234,
            "start_logit": 1.0471041202545166,
            "end_logit": 0.5007067322731018
        },
        {
            "text": "\u03b1syn. The cell-to-",
            "probability": 0.03858057639087017,
            "start_logit": 1.0471041202545166,
            "end_logit": 0.4873533546924591
        },
        {
            "text": "cell-to-cell release and uptake of \u03b1syn are considered important processes for its prion-like",
            "probability": 0.03737325654341255,
            "start_logit": 0.9231123328208923,
            "end_logit": 0.5795515775680542
        },
        {
            "text": "is implicated in protein secretion and clearance, but its",
            "probability": 0.03566496294098579,
            "start_logit": 0.8858543634414673,
            "end_logit": 0.5700229406356812
        },
        {
            "text": ". In this",
            "probability": 0.03515692601842539,
            "start_logit": 0.9110880494117737,
            "end_logit": 0.5304421186447144
        }
    ],
    "5891f9e549702f2e01000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58a9c532396a458e50000002": [
        {
            "text": "-defensins were found to be constitutively or inducibly expressed at mucos",
            "probability": 0.10425448314035288,
            "start_logit": 0.9554258584976196,
            "end_logit": 1.1519427299499512
        },
        {
            "text": "appear to be absent in birds, several beta-",
            "probability": 0.0870256521856078,
            "start_logit": 1.01789128780365,
            "end_logit": 0.9088453650474548
        },
        {
            "text": "ins are small",
            "probability": 0.07677602275545743,
            "start_logit": 1.1527605056762695,
            "end_logit": 0.6486656069755554
        },
        {
            "text": "ins are small,",
            "probability": 0.07529956266771796,
            "start_logit": 1.1527605056762695,
            "end_logit": 0.6292475461959839
        },
        {
            "text": "appear to be absent in birds, several beta-defensins have been isolated from avian heterophils",
            "probability": 0.06731212252665232,
            "start_logit": 1.01789128780365,
            "end_logit": 0.6519827842712402
        },
        {
            "text": "appear to be absent in birds, several beta-defensins have been isolated from avian heterophils.",
            "probability": 0.06538043930468597,
            "start_logit": 1.01789128780365,
            "end_logit": 0.6228655576705933
        },
        {
            "text": "be one way to improve animal health and to reduce zoonotic diseases. Defensins are small",
            "probability": 0.06418792571649141,
            "start_logit": 0.97368323802948,
            "end_logit": 0.6486656069755554
        },
        {
            "text": "be one way to improve animal health and to reduce zoonotic diseases. Defensins are small,",
            "probability": 0.06295354410835519,
            "start_logit": 0.97368323802948,
            "end_logit": 0.6292475461959839
        },
        {
            "text": ". Defensins are small",
            "probability": 0.05980146707256197,
            "start_logit": 0.9028983116149902,
            "end_logit": 0.6486656069755554
        },
        {
            "text": ". Defensins are small,",
            "probability": 0.05865144033046132,
            "start_logit": 0.9028983116149902,
            "end_logit": 0.6292475461959839
        },
        {
            "text": "appear to be absent in birds, several beta-defensins have been isolated from",
            "probability": 0.05819064081165563,
            "start_logit": 1.01789128780365,
            "end_logit": 0.5063669681549072
        },
        {
            "text": "-defensins were found to be constitutively or inducibly expressed at mucosal surfaces of the",
            "probability": 0.05778077314504033,
            "start_logit": 0.9554258584976196,
            "end_logit": 0.5617639422416687
        },
        {
            "text": "appear to be absent in birds, several beta-defensins have been isolated from avian heterophils. In addition, beta-",
            "probability": 0.057202843199614606,
            "start_logit": 1.01789128780365,
            "end_logit": 0.48924604058265686
        },
        {
            "text": "-",
            "probability": 0.053738955892675154,
            "start_logit": 0.9554258584976196,
            "end_logit": 0.48924604058265686
        },
        {
            "text": "-defensins were found",
            "probability": 0.05144412714266996,
            "start_logit": 0.9554258584976196,
            "end_logit": 0.4456041753292084
        }
    ],
    "58a874c338c171fb5b000003": [
        {
            "text": "Mff network from punctate distribution of higher-order oligomers to filamentous distribution of lower-order oligomers.",
            "probability": 0.12005302221041335,
            "start_logit": 1.0628564357757568,
            "end_logit": 1.042823076248169
        },
        {
            "text": "showed that Bcl-xl interacted with Mff to form heterogenous",
            "probability": 0.1092990053601625,
            "start_logit": 1.0221776962280273,
            "end_logit": 0.989655613899231
        },
        {
            "text": "showed that Bcl-",
            "probability": 0.10345478051373737,
            "start_logit": 1.0221776962280273,
            "end_logit": 0.9347029328346252
        },
        {
            "text": "toplasm, but with two Mff molecules on mitochond",
            "probability": 0.08137599311385199,
            "start_logit": 1.0661780834197998,
            "end_logit": 0.6506482362747192
        },
        {
            "text": "toplasm,",
            "probability": 0.07932112038155846,
            "start_logit": 1.0661780834197998,
            "end_logit": 0.6250723600387573
        },
        {
            "text": "stoichiometry in cytoplasm and 1\u00a0:\u00a01 stoichiometry on mitochondria,",
            "probability": 0.07473283193222674,
            "start_logit": 0.9857761859893799,
            "end_logit": 0.6458893418312073
        },
        {
            "text": "Mff network from punctate distribution of higher-order oligomers to filamentous distribution of lower-",
            "probability": 0.07424089465763035,
            "start_logit": 1.0628564357757568,
            "end_logit": 0.5622047185897827
        },
        {
            "text": "stoichiometry in cytoplasm and 1\u00a0:\u00a01 stoichiometry on",
            "probability": 0.07358612276468306,
            "start_logit": 0.9857761859893799,
            "end_logit": 0.630426287651062
        },
        {
            "text": "showed that overexpress",
            "probability": 0.07267698197300608,
            "start_logit": 0.8967517018318176,
            "end_logit": 0.707019031047821
        },
        {
            "text": "showed that Bcl-xl interact",
            "probability": 0.07147029381830926,
            "start_logit": 1.0221776962280273,
            "end_logit": 0.5648502111434937
        },
        {
            "text": "analysis showed that overexpress",
            "probability": 0.07116585415045872,
            "start_logit": 0.875740110874176,
            "end_logit": 0.707019031047821
        },
        {
            "text": "stoichiometry in cytoplasm and 1\u00a0:\u00a01 stoichiometry on mitochondria, indicating that two Bcl-xl",
            "probability": 0.06862309912396218,
            "start_logit": 0.9857761859893799,
            "end_logit": 0.5605990290641785
        }
    ],
    "5880be1dc872c95565000007": [
        {
            "text": "P-ribose) polymerase (PARP) acts as an essential DNA repair enzyme. PARP inhibitors are a novel small",
            "probability": 0.21817475562248237,
            "start_logit": 0.9186755418777466,
            "end_logit": 0.7458187341690063
        },
        {
            "text": "DNA repair enzyme. PARP inhibitors are a novel small",
            "probability": 0.21779285695827852,
            "start_logit": 0.9169235825538635,
            "end_logit": 0.7458187341690063
        },
        {
            "text": "P-",
            "probability": 0.20181847692832036,
            "start_logit": 0.9186755418777466,
            "end_logit": 0.6678910255432129
        },
        {
            "text": "P-ribose) polymerase (PARP) acts as an essential",
            "probability": 0.20112574526469185,
            "start_logit": 0.9186755418777466,
            "end_logit": 0.6644526720046997
        },
        {
            "text": "DNA repair enzyme. PARP inhibitors are a novel small molecule targeted drugs based on the principle of 'Synthetic Lethality\", which",
            "probability": 0.161088165226227,
            "start_logit": 0.9169235825538635,
            "end_logit": 0.44422614574432373
        }
    ],
    "587f760792a5b8ad44000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "589a246078275d0c4a00002a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58a2df9c60087bc10a000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5880aef4c872c95565000001": [
        {
            "text": "first intravenous infusion of daratumumab over 2\u00a0days is an approved alternative dosing regimen to reduce the duration of the",
            "probability": 0.13549384649656845,
            "start_logit": 0.9810783863067627,
            "end_logit": 0.5440351366996765
        },
        {
            "text": "daratumumab over 2\u00a0days is an approved alternative dosing regimen to reduce the duration of the",
            "probability": 0.12468705922029946,
            "start_logit": 0.8979592323303223,
            "end_logit": 0.5440351366996765
        },
        {
            "text": "first intravenous infusion of daratumumab over 2\u00a0days is an approved alternative dosing regimen to reduce the",
            "probability": 0.1211429627071134,
            "start_logit": 0.9810783863067627,
            "end_logit": 0.4320802688598633
        },
        {
            "text": "daratumumab over 2\u00a0days is an approved alternative dosing regimen to reduce the",
            "probability": 0.11148078053542401,
            "start_logit": 0.8979592323303223,
            "end_logit": 0.4320802688598633
        },
        {
            "text": "first intravenous infusion of daratumumab over 2\u00a0days is an approved",
            "probability": 0.10789255816003315,
            "start_logit": 0.9810783863067627,
            "end_logit": 0.31624481081962585
        },
        {
            "text": "first intravenous infusion of daratumumab over 2\u00a0days is an approved alternative dosing regimen to reduce the duration",
            "probability": 0.10451222700146606,
            "start_logit": 0.9810783863067627,
            "end_logit": 0.2844129800796509
        },
        {
            "text": "daratumumab over 2\u00a0days is an approved alternative dosing regimen to reduce the duration of the first infusion and provide flexibility for patients and healthcare",
            "probability": 0.0993268698449174,
            "start_logit": 0.8979592323303223,
            "end_logit": 0.31664419174194336
        },
        {
            "text": "daratumumab over 2\u00a0days is an approved",
            "probability": 0.09928720850854555,
            "start_logit": 0.8979592323303223,
            "end_logit": 0.31624481081962585
        },
        {
            "text": "daratumumab over 2\u00a0days is an approved alternative dosing regimen to reduce the duration",
            "probability": 0.0961764875256325,
            "start_logit": 0.8979592323303223,
            "end_logit": 0.2844129800796509
        }
    ],
    "58a872bd38c171fb5b000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5884c72fe56acf517600000f": [
        {
            "text": "28, and PD",
            "probability": 0.068005952410099,
            "start_logit": 0.9783517718315125,
            "end_logit": 1.1069456338882446
        },
        {
            "text": "aspects. While so far only a few of these SMPPIIs have",
            "probability": 0.0564014947488121,
            "start_logit": 1.1672016382217407,
            "end_logit": 0.7309961915016174
        },
        {
            "text": "28, and PD-1-PD-",
            "probability": 0.05476745587195443,
            "start_logit": 0.9783517718315125,
            "end_logit": 0.8904465436935425
        },
        {
            "text": "for BAFFR-BAFF) or reached clinical development (RhuDex for CD80-CD28, CA-170 for PD",
            "probability": 0.05154354389048226,
            "start_logit": 0.8736373782157898,
            "end_logit": 0.934491753578186
        },
        {
            "text": "aspects. While so far only a few of these SMPPIIs have shown activity in animal models (DRI-C2",
            "probability": 0.05132151993211671,
            "start_logit": 1.1672016382217407,
            "end_logit": 0.6366106867790222
        },
        {
            "text": "170 for PD",
            "probability": 0.05114537971463112,
            "start_logit": 0.8658825755119324,
            "end_logit": 0.934491753578186
        },
        {
            "text": "omodulation. They can result in products",
            "probability": 0.05091872428480775,
            "start_logit": 0.8140586614608765,
            "end_logit": 0.9818742275238037
        },
        {
            "text": "aspects",
            "probability": 0.050818407472697405,
            "start_logit": 1.1672016382217407,
            "end_logit": 0.6267591714859009
        },
        {
            "text": "SMPPIIs have",
            "probability": 0.049838772925842045,
            "start_logit": 1.043499231338501,
            "end_logit": 0.7309961915016174
        },
        {
            "text": "for BAFFR",
            "probability": 0.0497673064814023,
            "start_logit": 0.8736373782157898,
            "end_logit": 0.8994230628013611
        },
        {
            "text": "SMPP",
            "probability": 0.0494064990604877,
            "start_logit": 1.008458137512207,
            "end_logit": 0.7573260068893433
        },
        {
            "text": "PPIs) that are part of the costimulatory and coin",
            "probability": 0.04856558643897143,
            "start_logit": 1.0610151290893555,
            "end_logit": 0.6876022219657898
        },
        {
            "text": "gable. Nevertheless, substantial progress has been achieved during the last decade. SMPP",
            "probability": 0.04769095350531625,
            "start_logit": 0.9731178879737854,
            "end_logit": 0.7573260068893433
        },
        {
            "text": "170 for PD-1-PD-L1), there is proof-of-",
            "probability": 0.0471080873236244,
            "start_logit": 0.8658825755119324,
            "end_logit": 0.8522642850875854
        },
        {
            "text": "SMPPIIs proving the feasibility of such approaches have been identified through various strategies for a number of cosignaling interactions including CD40-",
            "probability": 0.04699840258667778,
            "start_logit": 1.008458137512207,
            "end_logit": 0.70735764503479
        },
        {
            "text": "of these SMPPIIs have",
            "probability": 0.045641886483119995,
            "start_logit": 0.9555318355560303,
            "end_logit": 0.7309961915016174
        },
        {
            "text": "SMPPIIs have shown activity in animal models (DRI-C2",
            "probability": 0.04534988991864816,
            "start_logit": 1.043499231338501,
            "end_logit": 0.6366106867790222
        },
        {
            "text": "170 for PD-1-PD-",
            "probability": 0.04520015813844094,
            "start_logit": 0.8658825755119324,
            "end_logit": 0.8109201788902283
        },
        {
            "text": "28, and PD-",
            "probability": 0.04518431129507227,
            "start_logit": 0.9783517718315125,
            "end_logit": 0.6981003284454346
        },
        {
            "text": ". Nevertheless, substantial progress has been achieved during the last decade. SMPP",
            "probability": 0.044325667516796056,
            "start_logit": 0.8999400734901428,
            "end_logit": 0.7573260068893433
        }
    ],
    "5880a8ec0a76a87357000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58aa0c6f396a458e50000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5891c90949702f2e01000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58a32edd60087bc10a000012": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58a2ced760087bc10a000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58a877cf38c171fb5b000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58a3428d60087bc10a00001b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "587e07023ec846c24f000001": [
        {
            "text": "visual display of GWAS results, along with LD and gene structure information, in a publication-ready format. The main",
            "probability": 0.165791838048309,
            "start_logit": 1.3607118129730225,
            "end_logit": 1.1024240255355835
        },
        {
            "text": "visual display of GWAS results, along with LD and gene structure information, in a publication-",
            "probability": 0.1349550203605885,
            "start_logit": 1.3607118129730225,
            "end_logit": 0.8966325521469116
        },
        {
            "text": "visual display of GWAS results, along with LD and gene structure information, in a publication-ready format. The main panel",
            "probability": 0.11853478101878576,
            "start_logit": 1.3607118129730225,
            "end_logit": 0.766897439956665
        },
        {
            "text": "format. The main",
            "probability": 0.09488900427854287,
            "start_logit": 0.8026866316795349,
            "end_logit": 1.1024240255355835
        },
        {
            "text": "R package, IntAss",
            "probability": 0.07828477141017162,
            "start_logit": 1.0721235275268555,
            "end_logit": 0.6406323909759521
        },
        {
            "text": "association analysis. Here, we present an R package, IntAss",
            "probability": 0.07803767035938601,
            "start_logit": 1.0689620971679688,
            "end_logit": 0.6406323909759521
        },
        {
            "text": "format. The main panel of an IntAssoPlot plot has a connecting line linking",
            "probability": 0.07744379858473685,
            "start_logit": 0.8026866316795349,
            "end_logit": 0.8992686867713928
        },
        {
            "text": "format. The main panel",
            "probability": 0.06784198471803132,
            "start_logit": 0.8026866316795349,
            "end_logit": 0.766897439956665
        },
        {
            "text": "format. The main panel of an IntAssoPlot plot",
            "probability": 0.06317225385788815,
            "start_logit": 0.8026866316795349,
            "end_logit": 0.6955813765525818
        },
        {
            "text": ") in a single view, multiple tools are required. It is tedious to generate these three results and manually",
            "probability": 0.062393310086537236,
            "start_logit": 0.8046410083770752,
            "end_logit": 0.6812198758125305
        },
        {
            "text": ") in a single view, multiple tools are required. It is tedious to generate these",
            "probability": 0.058655567277022806,
            "start_logit": 0.8046410083770752,
            "end_logit": 0.6194443106651306
        }
    ],
    "5895bc397d9090f35300000b": [
        {
            "text": "secondary to GPC3/GPC4 haploinsufficiency can be overpowered by a disruption to the distal Xq26.",
            "probability": 0.09566193756039067,
            "start_logit": 1.196771264076233,
            "end_logit": 0.9000937342643738
        },
        {
            "text": "secondary to GPC3/GPC4 haploinsufficiency can be overpowered by a disruption to the",
            "probability": 0.08068496055426322,
            "start_logit": 1.196771264076233,
            "end_logit": 0.7298254370689392
        },
        {
            "text": "4 haploinsufficiency can be overpowered by a disruption to the distal Xq26.",
            "probability": 0.07211180095218127,
            "start_logit": 0.9141684770584106,
            "end_logit": 0.9000937342643738
        },
        {
            "text": "secondary to GPC3/GPC4 ha",
            "probability": 0.07195308437902113,
            "start_logit": 1.196771264076233,
            "end_logit": 0.6152875423431396
        },
        {
            "text": "ly inherited Xq26 microduplications; the first was 0.8 Mb",
            "probability": 0.06132970905161853,
            "start_logit": 0.8319849967956543,
            "end_logit": 0.8203238844871521
        },
        {
            "text": "4 haploinsufficiency can be overpowered by a disruption to the",
            "probability": 0.060821868798659376,
            "start_logit": 0.9141684770584106,
            "end_logit": 0.7298254370689392
        },
        {
            "text": "roles, which potentially leads to macrosomia or microsomia if disrupted. One region of Xq26.2 comprises the",
            "probability": 0.060014279793098924,
            "start_logit": 0.8811253905296326,
            "end_logit": 0.749501645565033
        },
        {
            "text": "human growth with multiple genes and regions playing important roles, which potentially leads to macrosomia or microsomia if disrupted. One region",
            "probability": 0.05525040121623976,
            "start_logit": 0.9928878545761108,
            "end_logit": 0.5550322532653809
        },
        {
            "text": "months of age. This finding suggests that the molecular pathway leading to overgrowth secondary to GPC3/GPC4 ha",
            "probability": 0.05438687895311747,
            "start_logit": 0.9168798923492432,
            "end_logit": 0.6152875423431396
        },
        {
            "text": "4 ha",
            "probability": 0.05423961327732788,
            "start_logit": 0.9141684770584106,
            "end_logit": 0.6152875423431396
        },
        {
            "text": "is the most",
            "probability": 0.050757179032654094,
            "start_logit": 0.8906624913215637,
            "end_logit": 0.5724350810050964
        },
        {
            "text": "is the",
            "probability": 0.05011676030704591,
            "start_logit": 0.8906624913215637,
            "end_logit": 0.559737503528595
        },
        {
            "text": "roles, which potentially leads to macrosomia or microsomia if disrupted. One region",
            "probability": 0.04940803872378715,
            "start_logit": 0.8811253905296326,
            "end_logit": 0.5550322532653809
        },
        {
            "text": "is the most likely to play an important role",
            "probability": 0.04770191533682633,
            "start_logit": 0.8906624913215637,
            "end_logit": 0.5103535652160645
        },
        {
            "text": "ly inherited Xq26 microduplications; the first was 0.8 Mb at Xq",
            "probability": 0.04563412516553435,
            "start_logit": 0.8319849967956543,
            "end_logit": 0.5247153043746948
        },
        {
            "text": "ly inherited Xq26 microduplications; the first was 0.8 Mb at Xq26",
            "probability": 0.045268314144730995,
            "start_logit": 0.8319849967956543,
            "end_logit": 0.516666829586029
        },
        {
            "text": "ly inherited Xq26 microduplications; the",
            "probability": 0.04465913275350261,
            "start_logit": 0.8319849967956543,
            "end_logit": 0.5031183362007141
        }
    ],
    "58a95c711978bbde22000001": [
        {
            "text": "ab may be explained by the",
            "probability": 0.06580848487346395,
            "start_logit": 1.287811517715454,
            "end_logit": 0.7889504432678223
        },
        {
            "text": "ab may be explained by the limited brain penetration and lack of selectivity for the soluble A\u03b2 ol",
            "probability": 0.06401852609742353,
            "start_logit": 1.287811517715454,
            "end_logit": 0.7613741755485535
        },
        {
            "text": "prevent oligomer formation or inhibit their toxicity. A late-stage candidate with these attributes is ALZ-",
            "probability": 0.059623223644847574,
            "start_logit": 1.0379993915557861,
            "end_logit": 0.9400589466094971
        },
        {
            "text": ". A late-stage candidate with these attributes is ALZ-",
            "probability": 0.0576771995089951,
            "start_logit": 1.0048161745071411,
            "end_logit": 0.9400589466094971
        },
        {
            "text": "prevent oligomer formation or inhibit their toxicity.",
            "probability": 0.05444567990708425,
            "start_logit": 1.0379993915557861,
            "end_logit": 0.8492172956466675
        },
        {
            "text": "prevent oligomer formation or inhibit their",
            "probability": 0.053795272952429994,
            "start_logit": 1.0379993915557861,
            "end_logit": 0.8371993899345398
        },
        {
            "text": "ab may be explained by the limited brain penetration and lack of selectivity for the",
            "probability": 0.05271143117217856,
            "start_logit": 1.287811517715454,
            "end_logit": 0.5670340061187744
        },
        {
            "text": ".",
            "probability": 0.052668644035572136,
            "start_logit": 1.0048161745071411,
            "end_logit": 0.8492172956466675
        },
        {
            "text": "ALZ-",
            "probability": 0.04981603470473806,
            "start_logit": 0.8582911491394043,
            "end_logit": 0.9400589466094971
        },
        {
            "text": "attributes is ALZ-",
            "probability": 0.04942851644759508,
            "start_logit": 0.8504817485809326,
            "end_logit": 0.9400589466094971
        },
        {
            "text": "be explained by the",
            "probability": 0.04795817025841418,
            "start_logit": 0.9713919162750244,
            "end_logit": 0.7889504432678223
        },
        {
            "text": "be explained by the limited brain penetration and lack of selectivity for the soluble A\u03b2 ol",
            "probability": 0.0466537313566229,
            "start_logit": 0.9713919162750244,
            "end_logit": 0.7613741755485535
        },
        {
            "text": "prevent oligomer formation or inhibit their toxicity. A late-",
            "probability": 0.0457091966309583,
            "start_logit": 1.0379993915557861,
            "end_logit": 0.6743133068084717
        },
        {
            "text": "cross the blood-brain barrier efficiently and achieve sustained brain levels that can continuously prevent oligomer formation or inhibit their toxicity.",
            "probability": 0.045492486429856836,
            "start_logit": 0.8583430647850037,
            "end_logit": 0.8492172956466675
        },
        {
            "text": "cross the blood-brain barrier efficiently and achieve sustained brain levels that can continuously prevent oligomer formation or inhibit their",
            "probability": 0.0449490341374254,
            "start_logit": 0.8583430647850037,
            "end_logit": 0.8371993899345398
        },
        {
            "text": ". A late-stage candidate with these attributes is ALZ-801, an oral drug with a favorable safety profile and",
            "probability": 0.044292414088282675,
            "start_logit": 1.0048161745071411,
            "end_logit": 0.6760104298591614
        },
        {
            "text": ". A late-",
            "probability": 0.044217308161389475,
            "start_logit": 1.0048161745071411,
            "end_logit": 0.6743133068084717
        },
        {
            "text": "profile and high brain penetration that can robustly inhibit A\u03b2 oligomer formation. An upcoming phase 3",
            "probability": 0.04266386041767229,
            "start_logit": 0.8942737579345703,
            "end_logit": 0.749091625213623
        },
        {
            "text": "profile and",
            "probability": 0.03965713995011048,
            "start_logit": 0.8942737579345703,
            "end_logit": 0.6760104298591614
        },
        {
            "text": "be explained by the limited brain penetration and lack of selectivity for the",
            "probability": 0.03841364522493917,
            "start_logit": 0.9713919162750244,
            "end_logit": 0.5670340061187744
        }
    ],
    "58a1c0f178275d0c4a000056": [
        {
            "text": "DPVs, after many years of these countries remaining free of polio due to wild polioviruses. The only ethical",
            "probability": 0.1443174152645779,
            "start_logit": 1.210612416267395,
            "end_logit": 0.637060821056366
        },
        {
            "text": "DP",
            "probability": 0.1311613976629094,
            "start_logit": 1.210612416267395,
            "end_logit": 0.5414742827415466
        },
        {
            "text": ") polio",
            "probability": 0.11437525932875471,
            "start_logit": 0.96214359998703,
            "end_logit": 0.6529992818832397
        },
        {
            "text": "es. The only ethical",
            "probability": 0.10790278341892566,
            "start_logit": 0.919827938079834,
            "end_logit": 0.637060821056366
        },
        {
            "text": ") polioviruses, posing a moral dilemma.",
            "probability": 0.10620240405850663,
            "start_logit": 0.96214359998703,
            "end_logit": 0.5788612365722656
        },
        {
            "text": "Guinea due to circulating VDPVs, after many years of these countries remaining free of polio due to wild polioviruses. The only ethical",
            "probability": 0.1044781106132211,
            "start_logit": 0.8875748515129089,
            "end_logit": 0.637060821056366
        },
        {
            "text": "free of polio due to wild polioviruses. The only ethical",
            "probability": 0.09926123165577587,
            "start_logit": 0.8363523483276367,
            "end_logit": 0.637060821056366
        },
        {
            "text": "Guinea due",
            "probability": 0.09734754237229955,
            "start_logit": 0.8875748515129089,
            "end_logit": 0.5663707256317139
        },
        {
            "text": "Guinea due to circulating VDP",
            "probability": 0.09495385562502931,
            "start_logit": 0.8875748515129089,
            "end_logit": 0.5414742827415466
        }
    ],
    "58a9bbe81978bbde22000007": [
        {
            "text": "murine Paneth cells results in a NEC-like phenotype suggesting again that Paneth cell function is critical to homeostasis",
            "probability": 0.06943970467859442,
            "start_logit": 0.997534453868866,
            "end_logit": 1.0653526782989502
        },
        {
            "text": "estine of premature infants. While Paneth",
            "probability": 0.060284368721301926,
            "start_logit": 1.0122933387756348,
            "end_logit": 0.909207820892334
        },
        {
            "text": "review will provide an up to date and comprehensive look at Paneth cell ontogeny",
            "probability": 0.058262229201553536,
            "start_logit": 0.9761866927146912,
            "end_logit": 0.9111956357955933
        },
        {
            "text": "murine Paneth cells",
            "probability": 0.05566893459018255,
            "start_logit": 0.997534453868866,
            "end_logit": 0.8443161249160767
        },
        {
            "text": "biology during the greatest window of susceptibility to develop intestinal pathology such as necrotizing enteroco",
            "probability": 0.055275731500386,
            "start_logit": 0.9902470707893372,
            "end_logit": 0.8445152044296265
        },
        {
            "text": "estine. This review will provide an up to date and comprehensive look at Paneth cell ontogeny",
            "probability": 0.05417165429946106,
            "start_logit": 0.9033904671669006,
            "end_logit": 0.9111956357955933
        },
        {
            "text": "maintaining intestinal homeostasis",
            "probability": 0.05308653208536387,
            "start_logit": 0.8200920820236206,
            "end_logit": 0.9742594957351685
        },
        {
            "text": "estine and its associated microbial flora. Paneth cells are highly specialized secret",
            "probability": 0.04961210209972109,
            "start_logit": 1.032997727394104,
            "end_logit": 0.6936653852462769
        },
        {
            "text": "dulating proteins that function to regulate the composition of the",
            "probability": 0.04930117030443526,
            "start_logit": 0.9028939008712769,
            "end_logit": 0.8174822330474854
        },
        {
            "text": "review will provide an up to date and comprehensive look at Paneth cell ontogeny, the impact Paneth cells have on the host-",
            "probability": 0.04920332176552115,
            "start_logit": 0.9761866927146912,
            "end_logit": 0.7422027587890625
        },
        {
            "text": "review will provide an up to date and comprehensive look at Paneth cell ontogeny, the impact Paneth cells have on the host-microbial",
            "probability": 0.04891378233262053,
            "start_logit": 0.9761866927146912,
            "end_logit": 0.7363008260726929
        },
        {
            "text": "munomodulating proteins that function to regulate the composition of the",
            "probability": 0.04736324046592304,
            "start_logit": 0.8627924919128418,
            "end_logit": 0.8174822330474854
        },
        {
            "text": "infants. While Paneth",
            "probability": 0.04680630835213428,
            "start_logit": 0.7592384815216064,
            "end_logit": 0.909207820892334
        },
        {
            "text": "estine and its associated microbial",
            "probability": 0.045902768038746065,
            "start_logit": 1.032997727394104,
            "end_logit": 0.6159560084342957
        },
        {
            "text": "omodulating proteins that function to regulate the composition of the",
            "probability": 0.04371707860620414,
            "start_logit": 0.7826849222183228,
            "end_logit": 0.8174822330474854
        },
        {
            "text": "columnar epithelial cells possessing prominent eosino",
            "probability": 0.04353731175081067,
            "start_logit": 0.9650024771690369,
            "end_logit": 0.6310441493988037
        },
        {
            "text": "become immune competent or",
            "probability": 0.043061876227735586,
            "start_logit": 1.0217351913452148,
            "end_logit": 0.5633311867713928
        },
        {
            "text": "estine of premature infants. While Paneth cells begin to develop in the middle of human gestation, they do not become immune competent or",
            "probability": 0.04265720576675168,
            "start_logit": 1.0122933387756348,
            "end_logit": 0.5633311867713928
        },
        {
            "text": "become immune competent or reach their adult density until closer to term gestation. This leaves preterm infants deficient in normal Paneth cell",
            "probability": 0.041983383239924815,
            "start_logit": 1.0217351913452148,
            "end_logit": 0.5379670262336731
        },
        {
            "text": "term gestation. This leaves preterm infants deficient in normal Paneth cell biology during the",
            "probability": 0.04175129597262824,
            "start_logit": 0.7586899995803833,
            "end_logit": 0.795468807220459
        }
    ],
    "58a9c152396a458e50000001": [
        {
            "text": "even though tumor necrosis factor alpha (TNF-alpha) production was induced. Nonbacterial inflammatory particles had little effect on beta-",
            "probability": 0.07570319589442213,
            "start_logit": 1.02848219871521,
            "end_logit": 1.1184278726577759
        },
        {
            "text": "ins were expressed constitutively in BAM, with bovine neutrophil beta-",
            "probability": 0.06433760783665476,
            "start_logit": 0.9818865656852722,
            "end_logit": 1.002347469329834
        },
        {
            "text": "constitutively in BAM, with bovine neutrophil beta-",
            "probability": 0.06299963517057028,
            "start_logit": 0.960871160030365,
            "end_logit": 1.002347469329834
        },
        {
            "text": "is the first evidence of beta-defensin gene expression in a mature myeloid cell. LPS had no effect on beta-",
            "probability": 0.06048665233550751,
            "start_logit": 0.9251956939697266,
            "end_logit": 0.9973167181015015
        },
        {
            "text": ") were examined for the expression of beta-",
            "probability": 0.05610257037836852,
            "start_logit": 0.9519162178039551,
            "end_logit": 0.8953551054000854
        },
        {
            "text": "is the first evidence of beta-defensin gene expression in a mature myeloid cell. LPS had no effect on",
            "probability": 0.0539677687060389,
            "start_logit": 0.9251956939697266,
            "end_logit": 0.8832809925079346
        },
        {
            "text": "of beta-",
            "probability": 0.05335980244513038,
            "start_logit": 0.9017922878265381,
            "end_logit": 0.8953551054000854
        },
        {
            "text": "in (BNBD)-4 and BNBD-5 being the most predominant. This",
            "probability": 0.04946833361552204,
            "start_logit": 0.9241044521331787,
            "end_logit": 0.7973179817199707
        },
        {
            "text": "be upregulated by bacterial lip",
            "probability": 0.048313208051477895,
            "start_logit": 0.9962363243103027,
            "end_logit": 0.7015583515167236
        },
        {
            "text": "is the first evidence of beta-",
            "probability": 0.04646040851928324,
            "start_logit": 0.9251956939697266,
            "end_logit": 0.7334945201873779
        },
        {
            "text": "in (BNBD)-4 and BNBD-5 being the most predominant. This is the first evidence of beta-",
            "probability": 0.0464097366304348,
            "start_logit": 0.9241044521331787,
            "end_logit": 0.7334945201873779
        },
        {
            "text": ") were examined for the expression of beta-defensins and to determine whether their expression could be upregulated by bacterial lip",
            "probability": 0.046218718362391026,
            "start_logit": 0.9519162178039551,
            "end_logit": 0.7015583515167236
        },
        {
            "text": "of beta-defensins and to determine whether their expression could be upregulated by bacterial lip",
            "probability": 0.04395915667413354,
            "start_logit": 0.9017922878265381,
            "end_logit": 0.7015583515167236
        },
        {
            "text": "even though tumor necrosis factor alpha (TNF-",
            "probability": 0.04321543336787429,
            "start_logit": 1.02848219871521,
            "end_logit": 0.5578051805496216
        },
        {
            "text": "even though tumor necrosis factor alpha (TNF-alpha) production was induced",
            "probability": 0.042172271854645886,
            "start_logit": 1.02848219871521,
            "end_logit": 0.5333704352378845
        },
        {
            "text": "is the first evidence of beta-defensin gene expression in a mature myeloid cell. LPS had no effect on beta",
            "probability": 0.041987406163841064,
            "start_logit": 0.9251956939697266,
            "end_logit": 0.632263720035553
        },
        {
            "text": "is the first evidence of beta-defensin gene expression in a mature myeloid cell",
            "probability": 0.04177760234749119,
            "start_logit": 0.9251956939697266,
            "end_logit": 0.6272543668746948
        },
        {
            "text": ") were examined for the expression of beta-defensins and to determine whether their expression could",
            "probability": 0.04166039684488464,
            "start_logit": 0.9519162178039551,
            "end_logit": 0.597724437713623
        },
        {
            "text": "be upregulated by bacterial lipopolysaccharide (LPS), as observed with beta-",
            "probability": 0.04156211057406646,
            "start_logit": 0.9962363243103027,
            "end_logit": 0.5510423183441162
        },
        {
            "text": "in (BNBD)-4 and BNBD-5 being the",
            "probability": 0.039837984227261515,
            "start_logit": 0.9241044521331787,
            "end_logit": 0.5808060765266418
        }
    ],
    "58bc5e2202b8c60953000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58b6bd2622d300530900000c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "589480b47d9090f353000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58b56fe422d3005309000007": [
        {
            "text": "demonstration of FGF2 effects in melanocyte commitment of NC and in the proliferation of Mitf-",
            "probability": 0.07567604649742563,
            "start_logit": 1.3559818267822266,
            "end_logit": 0.8373166918754578
        },
        {
            "text": "demonstration of FGF2 effects in melanocyte commitment of NC and in the proliferation of Mitf-positive melanoblasts",
            "probability": 0.061774535862746435,
            "start_logit": 1.3559818267822266,
            "end_logit": 0.6343462467193604
        },
        {
            "text": "of NC, the effect of FGF2 on",
            "probability": 0.058551626434476735,
            "start_logit": 1.0361649990081787,
            "end_logit": 0.9005807042121887
        },
        {
            "text": "origin of the",
            "probability": 0.052164915216022595,
            "start_logit": 1.03725266456604,
            "end_logit": 0.7839943170547485
        },
        {
            "text": "of NC, the effect of FGF2 on NCC differentiation was investigated",
            "probability": 0.05094714418031154,
            "start_logit": 1.0361649990081787,
            "end_logit": 0.761460542678833
        },
        {
            "text": "2 on",
            "probability": 0.05051663129261742,
            "start_logit": 0.8885587453842163,
            "end_logit": 0.9005807042121887
        },
        {
            "text": ". Moreover, following FGF2 treatment, reduced expression of the early NC markers",
            "probability": 0.04962890034100839,
            "start_logit": 0.8103806972503662,
            "end_logit": 0.9610294699668884
        },
        {
            "text": "Moreover, following FGF2 treatment, reduced expression of the early NC markers",
            "probability": 0.04906958192986603,
            "start_logit": 0.7990466952323914,
            "end_logit": 0.9610294699668884
        },
        {
            "text": "GF2 on",
            "probability": 0.04888058229154648,
            "start_logit": 0.8556363582611084,
            "end_logit": 0.9005807042121887
        },
        {
            "text": "f-",
            "probability": 0.04859928548885288,
            "start_logit": 0.9131289720535278,
            "end_logit": 0.8373166918754578
        },
        {
            "text": ") comprise a population of multipotent progenitors and stem cells at the origin of the",
            "probability": 0.04753355587324619,
            "start_logit": 0.9442784190177917,
            "end_logit": 0.7839943170547485
        },
        {
            "text": "prevent, or treat, injuries caused by NC-",
            "probability": 0.047208450050307514,
            "start_logit": 0.8920692205429077,
            "end_logit": 0.8293405175209045
        },
        {
            "text": "GF2 effects in melanocyte commitment of NC and in the proliferation of Mitf-",
            "probability": 0.04589239057297874,
            "start_logit": 0.8558194637298584,
            "end_logit": 0.8373166918754578
        },
        {
            "text": ". This is the first demonstration of FGF2 effects in melanocyte commitment of NC and in the proliferation of Mitf-",
            "probability": 0.04574988460595582,
            "start_logit": 0.8527094125747681,
            "end_logit": 0.8373166918754578
        },
        {
            "text": "PNS and then undertaking the search for advanced technologies to prevent, or treat, injuries caused by NC-",
            "probability": 0.04559954969468471,
            "start_logit": 0.8573941588401794,
            "end_logit": 0.8293405175209045
        },
        {
            "text": "GF2, followed by differentiation medium, resulted in increased expression of melanin and improved proportion of melanin-",
            "probability": 0.04550100037409061,
            "start_logit": 0.8356367349624634,
            "end_logit": 0.8489344120025635
        },
        {
            "text": "then undertaking the search for advanced technologies to prevent, or treat, injuries caused by NC-",
            "probability": 0.04471912850585087,
            "start_logit": 0.8378976583480835,
            "end_logit": 0.8293405175209045
        },
        {
            "text": ". Moreover, following FGF2 treatment, reduced expression of the",
            "probability": 0.04426497567014338,
            "start_logit": 0.8103806972503662,
            "end_logit": 0.8466498851776123
        },
        {
            "text": "2 on NCC differentiation was investigated",
            "probability": 0.043955706351705516,
            "start_logit": 0.8885587453842163,
            "end_logit": 0.761460542678833
        },
        {
            "text": "Moreover, following FGF2 treatment, reduced expression of the",
            "probability": 0.0437661087661628,
            "start_logit": 0.7990466952323914,
            "end_logit": 0.8466498851776123
        }
    ],
    "58a87bd338c171fb5b000005": [
        {
            "text": "challenge with B16 cells, but not with irrelevant tumors. Finally, we extended",
            "probability": 0.07071076463722757,
            "start_logit": 1.177272081375122,
            "end_logit": 0.9130949974060059
        },
        {
            "text": "purified from B16 melanoma cells can protect mice from a challenge with B16 cells, but not with irrelevant tumors. Finally, we extended",
            "probability": 0.06631742817631185,
            "start_logit": 1.1131269931793213,
            "end_logit": 0.9130949974060059
        },
        {
            "text": ". Finally, we extended these findings to cancer patients by demonstrating the presence of T-cell responses specific for mutated mitochondrial",
            "probability": 0.06623961108617475,
            "start_logit": 1.0040162801742554,
            "end_logit": 1.0210316181182861
        },
        {
            "text": ". Finally, we extended",
            "probability": 0.0594622714447547,
            "start_logit": 1.0040162801742554,
            "end_logit": 0.9130949974060059
        },
        {
            "text": "T-cell responses specific for mutated mitochondrial",
            "probability": 0.059141582195537334,
            "start_logit": 0.8906719088554382,
            "end_logit": 1.0210316181182861
        },
        {
            "text": "for mutated mitochondrial",
            "probability": 0.057182657932361575,
            "start_logit": 0.8569883108139038,
            "end_logit": 1.0210316181182861
        },
        {
            "text": "of T-cell responses specific for mutated mitochondrial",
            "probability": 0.05656134456546368,
            "start_logit": 0.8460634350776672,
            "end_logit": 1.0210316181182861
        },
        {
            "text": "tumors expressing mitochondrial-localized NY-ES",
            "probability": 0.05300317637147372,
            "start_logit": 1.1120049953460693,
            "end_logit": 0.6901161074638367
        },
        {
            "text": "T-cell responses specific for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing epitopes derived from mitochondrial-",
            "probability": 0.04942090961218275,
            "start_logit": 0.8906719088554382,
            "end_logit": 0.8414709568023682
        },
        {
            "text": "for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing epitopes derived from mitochondrial-",
            "probability": 0.047783959511195656,
            "start_logit": 0.8569883108139038,
            "end_logit": 0.8414709568023682
        },
        {
            "text": "of T-cell responses specific for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing epitopes derived from mitochondrial-",
            "probability": 0.04726476691258069,
            "start_logit": 0.8460634350776672,
            "end_logit": 0.8414709568023682
        },
        {
            "text": ". Consistent with these findings, we showed that injection of mitochond",
            "probability": 0.04610707373405077,
            "start_logit": 0.9609911441802979,
            "end_logit": 0.7017444968223572
        },
        {
            "text": ". Consistent with these findings, we showed that injection of mitochondria",
            "probability": 0.04488210703684138,
            "start_logit": 0.9609911441802979,
            "end_logit": 0.6748173236846924
        },
        {
            "text": "mutated cancer proteins elicit strong antitumor T-cell responses that correlate with clinical efficacy in a proportion of patients",
            "probability": 0.044632343334897275,
            "start_logit": 0.8803285956382751,
            "end_logit": 0.7498994469642639
        },
        {
            "text": "T-cell responses that correlate with clinical efficacy in a proportion of patients",
            "probability": 0.0444908515127757,
            "start_logit": 0.8771533966064453,
            "end_logit": 0.7498994469642639
        },
        {
            "text": "T-cell responses specific for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing",
            "probability": 0.038545356872920856,
            "start_logit": 0.8906719088554382,
            "end_logit": 0.5929329991340637
        },
        {
            "text": "for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing",
            "probability": 0.03726863359281844,
            "start_logit": 0.8569883108139038,
            "end_logit": 0.5929329991340637
        },
        {
            "text": "mutated cancer proteins elicit strong antitumor T-",
            "probability": 0.03711957109603003,
            "start_logit": 0.8803285956382751,
            "end_logit": 0.5655850172042847
        },
        {
            "text": "T-",
            "probability": 0.03700189598963152,
            "start_logit": 0.8771533966064453,
            "end_logit": 0.5655850172042847
        },
        {
            "text": "of T-cell responses specific for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing",
            "probability": 0.036863694384769954,
            "start_logit": 0.8460634350776672,
            "end_logit": 0.5929329991340637
        }
    ],
    "58a9a8631978bbde22000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "588f2de394c1512c50000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58bc363622d300530900001f": [
        {
            "text": "tract. Akkermansia mu",
            "probability": 0.23168733866684602,
            "start_logit": 1.1238747835159302,
            "end_logit": 0.3376869857311249
        },
        {
            "text": "tract. Akkermansia muciniphila has a high abundance in human feces and plays an important role",
            "probability": 0.212151832486039,
            "start_logit": 1.1238747835159302,
            "end_logit": 0.24960041046142578
        },
        {
            "text": "tract. Akkermansia muciniphila has a high abundance in human feces and plays an important role in human health.",
            "probability": 0.19164456539949282,
            "start_logit": 1.1238747835159302,
            "end_logit": 0.14794063568115234
        },
        {
            "text": "tract.",
            "probability": 0.1867010248090501,
            "start_logit": 1.1238747835159302,
            "end_logit": 0.12180674076080322
        },
        {
            "text": "tract. Akkermansia",
            "probability": 0.1778152386385721,
            "start_logit": 1.1238747835159302,
            "end_logit": 0.07304322719573975
        }
    ],
    "58a5a51060087bc10a000021": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58a57f9460087bc10a00001f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58bcabc702b8c6095300000e": [
        {
            "text": ") is a common hematological disease affecting humans. Detection of a single",
            "probability": 0.1722064049762253,
            "start_logit": 0.9614037871360779,
            "end_logit": 0.5097386837005615
        },
        {
            "text": ") is a common hematological disease affecting humans. Detection of a single base pair mutation in \u03b2-",
            "probability": 0.15494418697052062,
            "start_logit": 0.9614037871360779,
            "end_logit": 0.4041098654270172
        },
        {
            "text": ") is a common hematological disease affecting humans. Detection of a single base pair mutation",
            "probability": 0.14607363564972212,
            "start_logit": 0.9614037871360779,
            "end_logit": 0.3451557457447052
        },
        {
            "text": ") is a common hematological disease affecting humans. Detection of a single base pair mutation in \u03b2",
            "probability": 0.13585910257789321,
            "start_logit": 0.9614037871360779,
            "end_logit": 0.2726632356643677
        },
        {
            "text": ") is a common hematological disease affecting humans",
            "probability": 0.1317236081292528,
            "start_logit": 0.9614037871360779,
            "end_logit": 0.24175074696540833
        },
        {
            "text": ") is a common hematological disease affecting humans. Detection of a single base pair mutation in \u03b2-globin",
            "probability": 0.1314301580132382,
            "start_logit": 0.9614037871360779,
            "end_logit": 0.23952049016952515
        },
        {
            "text": ")",
            "probability": 0.12776290368314777,
            "start_logit": 0.9614037871360779,
            "end_logit": 0.2112211287021637
        }
    ],
    "5891b125621ea6ff7e00000e": [
        {
            "text": "se alfa, a plant cell-",
            "probability": 0.07876293968976496,
            "start_logit": 0.9929741621017456,
            "end_logit": 1.0680744647979736
        },
        {
            "text": "(55.2% male; mean age, 46.1\u00a0years; mean bi-weekly dose,",
            "probability": 0.06989619835675705,
            "start_logit": 0.9563039541244507,
            "end_logit": 0.985313355922699
        },
        {
            "text": "(55.2% male; mean age, 46.1\u00a0years; mean bi-weekly",
            "probability": 0.06835691898351183,
            "start_logit": 0.9563039541244507,
            "end_logit": 0.9630448818206787
        },
        {
            "text": "taliglucerase alfa, a plant cell-",
            "probability": 0.0670293986465552,
            "start_logit": 0.8316628932952881,
            "end_logit": 1.0680744647979736
        },
        {
            "text": "center, open-label, expanded-access study followed the safety of taliglucerase alfa, a plant cell-",
            "probability": 0.06281347604093956,
            "start_logit": 0.7667012214660645,
            "end_logit": 1.0680744647979736
        },
        {
            "text": "for up to 33\u00a0months (Part B), and a later amendment allowed treatment-na\u00efve",
            "probability": 0.05376421998878317,
            "start_logit": 0.9347181916236877,
            "end_logit": 0.7444960474967957
        },
        {
            "text": "mean\u00a0\u00b1\u00a0SE hemoglobin concentration (13.0\u00a0\u00b1\u00a00.3\u00a0g/dL",
            "probability": 0.04944150978110329,
            "start_logit": 0.9378737211227417,
            "end_logit": 0.6575226783752441
        },
        {
            "text": "se alfa, a plant cell",
            "probability": 0.04819779048196132,
            "start_logit": 0.9929741621017456,
            "end_logit": 0.5769450664520264
        },
        {
            "text": "for up to 33\u00a0months (Part B), and a later amendment allowed treatment-na\u00efve patients.",
            "probability": 0.04785909795134456,
            "start_logit": 0.9347181916236877,
            "end_logit": 0.6281490921974182
        },
        {
            "text": "center, open-",
            "probability": 0.04632089065286174,
            "start_logit": 0.7667012214660645,
            "end_logit": 0.7634978890419006
        },
        {
            "text": "transient. In previously treated patients, increases from baseline to last follow-up were observed for mean\u00a0\u00b1\u00a0SE hemoglobin concentration (13.0\u00a0\u00b1\u00a00.3\u00a0g/dL",
            "probability": 0.04435091006747577,
            "start_logit": 0.8292165994644165,
            "end_logit": 0.6575226783752441
        },
        {
            "text": "mean\u00a0\u00b1\u00a0SE hemoglobin",
            "probability": 0.044248684174664744,
            "start_logit": 0.9378737211227417,
            "end_logit": 0.5465579628944397
        },
        {
            "text": ". In previously treated patients, increases from baseline to",
            "probability": 0.04380885978816952,
            "start_logit": 0.8292165994644165,
            "end_logit": 0.6452255249023438
        },
        {
            "text": "for up to 33\u00a0months (Part B), and a later amendment allowed treatment-na\u00efve patients. Fifty-eight",
            "probability": 0.041556559853614505,
            "start_logit": 0.9347181916236877,
            "end_logit": 0.48694324493408203
        },
        {
            "text": "taliglucerase alfa, a plant cell",
            "probability": 0.04101762738698726,
            "start_logit": 0.8316628932952881,
            "end_logit": 0.5769450664520264
        },
        {
            "text": "center, open-label, expanded-",
            "probability": 0.0402949758410883,
            "start_logit": 0.7667012214660645,
            "end_logit": 0.6241316199302673
        },
        {
            "text": "transient. In previously treated patients, increases from baseline to last follow-up were observed for mean\u00a0\u00b1\u00a0SE hemoglobin",
            "probability": 0.039692748484488165,
            "start_logit": 0.8292165994644165,
            "end_logit": 0.5465579628944397
        },
        {
            "text": "center, open-label, expanded-access study followed the safety of taliglucerase alfa, a plant cell",
            "probability": 0.03843775726997546,
            "start_logit": 0.7667012214660645,
            "end_logit": 0.5769450664520264
        },
        {
            "text": "taliglu",
            "probability": 0.03827851281448315,
            "start_logit": 0.8316628932952881,
            "end_logit": 0.507831871509552
        },
        {
            "text": "center, open-label, expanded-access study followed the safety of taliglu",
            "probability": 0.03587092374547065,
            "start_logit": 0.7667012214660645,
            "end_logit": 0.507831871509552
        }
    ],
    "587f795d92a5b8ad44000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002": [
        {
            "text": "coverage of 194 individuals, combined 10\u00d7 and 20\u00d7 coverage of 135",
            "probability": 0.07209053587582051,
            "start_logit": 0.9487396478652954,
            "end_logit": 1.1802390813827515
        },
        {
            "text": "variants. The DNA samples were obtained from four different origins",
            "probability": 0.06453381706333228,
            "start_logit": 1.0824544429779053,
            "end_logit": 0.9357908964157104
        },
        {
            "text": "KNIH) has been sequencing complete genomes of 1722 Korean individuals. As a result, more than 32 million variant sites have been",
            "probability": 0.06135051927107093,
            "start_logit": 1.225229024887085,
            "end_logit": 0.742430567741394
        },
        {
            "text": "KNIH) has been",
            "probability": 0.05969352325748271,
            "start_logit": 1.225229024887085,
            "end_logit": 0.715050458908081
        },
        {
            "text": "cleotide and short insertion/deletion variants. The DNA samples were obtained from four different origins",
            "probability": 0.05862503180464401,
            "start_logit": 0.986426830291748,
            "end_logit": 0.9357908964157104
        },
        {
            "text": "KNIH) has been sequencing complete genomes of 1722",
            "probability": 0.055537846811962326,
            "start_logit": 1.225229024887085,
            "end_logit": 0.6428916454315186
        },
        {
            "text": ".go.kr/coda/KRGDB/index.jsp.",
            "probability": 0.04960896723082087,
            "start_logit": 1.081272840499878,
            "end_logit": 0.6739547252655029
        },
        {
            "text": ".kr",
            "probability": 0.04943659480617706,
            "start_logit": 0.8896753787994385,
            "end_logit": 0.8620715141296387
        },
        {
            "text": "variants. The DNA samples were obtained",
            "probability": 0.049072416679523105,
            "start_logit": 1.0824544429779053,
            "end_logit": 0.6618986129760742
        },
        {
            "text": "contains both single nucleotide and short insertion/deletion variants. The DNA samples were obtained from four different origins",
            "probability": 0.04718033460563523,
            "start_logit": 0.7692422270774841,
            "end_logit": 0.9357908964157104
        },
        {
            "text": ". The association results are displayed on our browser. The KRGDB uses the MySQL database and Apache-Tomcat web",
            "probability": 0.04559050307456382,
            "start_logit": 1.0663120746612549,
            "end_logit": 0.6044433116912842
        },
        {
            "text": "30\u00d7230 individuals and three major common diseases",
            "probability": 0.044724900127076084,
            "start_logit": 0.9104645848274231,
            "end_logit": 0.741121768951416
        },
        {
            "text": "cleotide and short insertion/deletion variants. The DNA samples were obtained",
            "probability": 0.04457929376383358,
            "start_logit": 0.986426830291748,
            "end_logit": 0.6618986129760742
        },
        {
            "text": "coda.nih.go.kr",
            "probability": 0.04363585986058476,
            "start_logit": 0.7648637294769287,
            "end_logit": 0.8620715141296387
        },
        {
            "text": "of Health (KNIH) has been sequencing complete genomes of 1722 Korean individuals. As a result, more than 32 million variant sites have been",
            "probability": 0.04350827493507708,
            "start_logit": 0.8815765380859375,
            "end_logit": 0.742430567741394
        },
        {
            "text": "information on the Korean genomic variant frequency, frequency",
            "probability": 0.04330523355750353,
            "start_logit": 0.9141998887062073,
            "end_logit": 0.7051295638084412
        },
        {
            "text": "contains both single",
            "probability": 0.043012695421741486,
            "start_logit": 0.7692422270774841,
            "end_logit": 0.8433090448379517
        },
        {
            "text": "of Health (KNIH) has been",
            "probability": 0.04233317423532608,
            "start_logit": 0.8815765380859375,
            "end_logit": 0.715050458908081
        },
        {
            "text": "-wide association study (GWAS) between Korean genome variant sites for the 30\u00d7230 individuals and three major common diseases",
            "probability": 0.04109039188198038,
            "start_logit": 0.8257085084915161,
            "end_logit": 0.741121768951416
        },
        {
            "text": "-",
            "probability": 0.04109008573584439,
            "start_logit": 0.8257085084915161,
            "end_logit": 0.7411143183708191
        }
    ],
    "58a9d8a1396a458e50000005": [
        {
            "text": "I and II stimulated disruption of the",
            "probability": 0.07352733225052913,
            "start_logit": 1.0546751022338867,
            "end_logit": 1.02205228805542
        },
        {
            "text": "I, III, and IV. However, silencing of the",
            "probability": 0.07207497767622552,
            "start_logit": 0.9193201065063477,
            "end_logit": 1.137457013130188
        },
        {
            "text": "respirasome and reduced the activity of complexes I, III, and IV. However, silencing of the",
            "probability": 0.07068258132124743,
            "start_logit": 0.8998123407363892,
            "end_logit": 1.137457013130188
        },
        {
            "text": "I and II stimulated disruption",
            "probability": 0.06170738614531568,
            "start_logit": 1.0546751022338867,
            "end_logit": 0.8467987179756165
        },
        {
            "text": "I and II stimulated disruption of the respirasome. Likewise, knockdown of the complex I subunit NDUFA11",
            "probability": 0.05984388115267995,
            "start_logit": 1.0546751022338867,
            "end_logit": 0.8161342740058899
        },
        {
            "text": "I and II in respirasome formation remain unclear. Here, we investigated whether genetic and pharmacological inhibition of complexes I",
            "probability": 0.054973081557285614,
            "start_logit": 1.22477388381958,
            "end_logit": 0.5611399412155151
        },
        {
            "text": "I subunit NDUFA11",
            "probability": 0.05438730903147888,
            "start_logit": 0.9590667486190796,
            "end_logit": 0.8161342740058899
        },
        {
            "text": "I, III, and IV. However, silencing of the membrane-anchored SDHC subunit of complex II had no effect on",
            "probability": 0.0518606930895559,
            "start_logit": 0.9193201065063477,
            "end_logit": 0.8083112239837646
        },
        {
            "text": "I subunit NDUFA11 stimulated dissociation of respirasome and",
            "probability": 0.047668705363508035,
            "start_logit": 0.9590667486190796,
            "end_logit": 0.6842785477638245
        },
        {
            "text": "complex I subunit NDUFA11",
            "probability": 0.045397005788442725,
            "start_logit": 0.7783820629119873,
            "end_logit": 0.8161342740058899
        },
        {
            "text": "respirasome and",
            "probability": 0.044926180194743454,
            "start_logit": 0.8998123407363892,
            "end_logit": 0.6842785477638245
        },
        {
            "text": "armacological inhibition of complexes I and II affect respirasome",
            "probability": 0.04416843928527478,
            "start_logit": 0.8901320099830627,
            "end_logit": 0.6769486665725708
        },
        {
            "text": "I, III, and IV. However, silencing of the membrane-",
            "probability": 0.04171686012846226,
            "start_logit": 0.9193201065063477,
            "end_logit": 0.5906554460525513
        },
        {
            "text": "is associated with human diseases",
            "probability": 0.0412898477003175,
            "start_logit": 0.8824448585510254,
            "end_logit": 0.6172419786453247
        },
        {
            "text": "respirasome and reduced the activity of complexes I, III, and IV. However, silencing of the membrane-",
            "probability": 0.04091094376391011,
            "start_logit": 0.8998123407363892,
            "end_logit": 0.5906554460525513
        },
        {
            "text": "complex I subunit NDUFA11 stimulated dissociation of respirasome and",
            "probability": 0.039788997320353396,
            "start_logit": 0.7783820629119873,
            "end_logit": 0.6842785477638245
        },
        {
            "text": "I, III, and IV has been suggested to improve electron channeling and control ROS production, maintain the structural",
            "probability": 0.03963304553989928,
            "start_logit": 0.812056303024292,
            "end_logit": 0.6466771364212036
        },
        {
            "text": "armacological inhibition of complexes I",
            "probability": 0.03933842455879569,
            "start_logit": 0.8901320099830627,
            "end_logit": 0.5611399412155151
        },
        {
            "text": "with human diseases",
            "probability": 0.03813933910566978,
            "start_logit": 0.8030744791030884,
            "end_logit": 0.6172419786453247
        },
        {
            "text": "armacological inhibition of complexes I and II affect respirasome assembly",
            "probability": 0.037964969026304515,
            "start_logit": 0.8901320099830627,
            "end_logit": 0.5256020426750183
        }
    ],
    "5890e163621ea6ff7e000004": [
        {
            "text": "cut points throughout pregnancy.\u00a0Researchers should recognize potential challenges associated",
            "probability": 0.07509483071347398,
            "start_logit": 0.952211856842041,
            "end_logit": 0.560198962688446
        },
        {
            "text": "gus monkeys. Possible changes in breast milk composition over the postpartum period potentially complicated assessment of tanezumab concentration in this matrix",
            "probability": 0.07435875361067908,
            "start_logit": 1.0071808099746704,
            "end_logit": 0.4953796863555908
        },
        {
            "text": "cut points throughout pregnancy.\u00a0Researchers should recognize potential challenges associated with",
            "probability": 0.07203233234478373,
            "start_logit": 0.952211856842041,
            "end_logit": 0.5185623168945312
        },
        {
            "text": "day-specific cut points throughout pregnancy.\u00a0Researchers should recognize potential challenges associated",
            "probability": 0.06957507600575555,
            "start_logit": 0.8758665323257446,
            "end_logit": 0.560198962688446
        },
        {
            "text": "cut points throughout pregnancy.\u00a0Researchers should recognize potential challenges associated with dynamic matrices/physiological",
            "probability": 0.06873926880403804,
            "start_logit": 0.952211856842041,
            "end_logit": 0.4717678725719452
        },
        {
            "text": "cut points throughout",
            "probability": 0.06738918440576404,
            "start_logit": 0.952211856842041,
            "end_logit": 0.45193177461624146
        },
        {
            "text": "day-specific cut points throughout pregnancy.\u00a0Researchers should recognize potential challenges associated with",
            "probability": 0.0667376828756996,
            "start_logit": 0.8758665323257446,
            "end_logit": 0.5185623168945312
        },
        {
            "text": "cut points throughout pregnancy.\u00a0Researchers should recognize potential challenges associated with dynamic matrices/physiological conditions and anticipate that assays",
            "probability": 0.06656771025185153,
            "start_logit": 0.952211856842041,
            "end_logit": 0.43966686725616455
        },
        {
            "text": "gus monkeys. Possible changes in breast milk composition over the",
            "probability": 0.06587280756568188,
            "start_logit": 1.0071808099746704,
            "end_logit": 0.37420400977134705
        },
        {
            "text": "composition over the postpartum period potentially complicated assessment of tanezumab concentration in this matrix",
            "probability": 0.06551692633789061,
            "start_logit": 0.8805879354476929,
            "end_logit": 0.4953796863555908
        },
        {
            "text": "day-specific cut points throughout pregnancy.\u00a0Researchers should recognize potential challenges associated with dynamic matrices/physiological",
            "probability": 0.06368667198770173,
            "start_logit": 0.8758665323257446,
            "end_logit": 0.4717678725719452
        },
        {
            "text": "specific cut points throughout",
            "probability": 0.062435823910255525,
            "start_logit": 0.8758665323257446,
            "end_logit": 0.45193177461624146
        },
        {
            "text": "composition over the postpartum period potentially complicated assessment of tanezumab concentration in this matrix, requiring validation of the quanti",
            "probability": 0.06227817547134748,
            "start_logit": 0.8805879354476929,
            "end_logit": 0.44468221068382263
        },
        {
            "text": "day-specific cut points throughout pregnancy.\u00a0Researchers should recognize potential challenges associated with dynamic matrices/physiological conditions and anticipate that assays",
            "probability": 0.0616747312204897,
            "start_logit": 0.8758665323257446,
            "end_logit": 0.43966686725616455
        },
        {
            "text": "composition over the",
            "probability": 0.05804002449458766,
            "start_logit": 0.8805879354476929,
            "end_logit": 0.37420400977134705
        }
    ],
    "5880b812c872c95565000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58b558d522d3005309000006": [
        {
            "text": "of proteasome assembly as the proteasome has key functions in the",
            "probability": 0.21282280333427406,
            "start_logit": 1.0197737216949463,
            "end_logit": 0.8258146643638611
        },
        {
            "text": "has key functions in the",
            "probability": 0.18339230272832724,
            "start_logit": 0.8709414005279541,
            "end_logit": 0.8258146643638611
        },
        {
            "text": "of proteasome assembly as the proteasome has key functions in the turnover of short-lived proteins regulating diverse biological processes",
            "probability": 0.17788863255393866,
            "start_logit": 1.0197737216949463,
            "end_logit": 0.6465124487876892
        },
        {
            "text": "has key functions in the turnover of short-lived proteins regulating diverse biological processes",
            "probability": 0.15328905287475017,
            "start_logit": 0.8709414005279541,
            "end_logit": 0.6465124487876892
        },
        {
            "text": "of proteasome assembly as the proteasome has key functions",
            "probability": 0.14642811300280908,
            "start_logit": 1.0197737216949463,
            "end_logit": 0.45188936591148376
        },
        {
            "text": "has key functions",
            "probability": 0.12617909550590065,
            "start_logit": 0.8709414005279541,
            "end_logit": 0.45188936591148376
        }
    ],
    "58bbc0fc22d300530900001c": [
        {
            "text": "using HPLC in 15 patients with chronic phase CML. No significant correlation",
            "probability": 0.06509399741483293,
            "start_logit": 0.8401681780815125,
            "end_logit": 1.0738016366958618
        },
        {
            "text": "CO1B3 334TT than",
            "probability": 0.06500795536789,
            "start_logit": 1.0717713832855225,
            "end_logit": 0.8408757448196411
        },
        {
            "text": ") and SLCO",
            "probability": 0.05510457632714646,
            "start_logit": 0.9824216961860657,
            "end_logit": 0.7649485468864441
        },
        {
            "text": "organic anion transporter family members 1B1 (SLCO1B1) and SLCO",
            "probability": 0.05486901846947019,
            "start_logit": 0.9781377911567688,
            "end_logit": 0.7649485468864441
        },
        {
            "text": "is thought to affect the",
            "probability": 0.05185516001294228,
            "start_logit": 0.9365564584732056,
            "end_logit": 0.7500354647636414
        },
        {
            "text": "present study, we",
            "probability": 0.051478025361224936,
            "start_logit": 0.7962442636489868,
            "end_logit": 0.8830482363700867
        },
        {
            "text": "members 1B1 (SLCO1B1) and SLCO",
            "probability": 0.0500962472603457,
            "start_logit": 0.8871350288391113,
            "end_logit": 0.7649485468864441
        },
        {
            "text": "response. The intracellular imatinib concentration was significantly higher in patients with SL",
            "probability": 0.05009300758871385,
            "start_logit": 0.7945362329483032,
            "end_logit": 0.8574826717376709
        },
        {
            "text": ". The intracellular imatinib concentration was significantly higher in patients with SL",
            "probability": 0.04967579068673682,
            "start_logit": 0.7861725091934204,
            "end_logit": 0.8574826717376709
        },
        {
            "text": "CO1B3 334TT than those with 334 TG/GG (p",
            "probability": 0.04893676066421552,
            "start_logit": 1.0717713832855225,
            "end_logit": 0.5568949580192566
        },
        {
            "text": "er family members 1B1 (SLCO1B1) and SLCO",
            "probability": 0.04769926718439432,
            "start_logit": 0.8381049633026123,
            "end_logit": 0.7649485468864441
        },
        {
            "text": "including ATP binding cassette B1 (ABCB), ABCG2, solute carrier 22A1 (SLC22",
            "probability": 0.04673785205394882,
            "start_logit": 0.9001190066337585,
            "end_logit": 0.6825728416442871
        },
        {
            "text": "using HPLC in 15 patients with chronic phase CML. No significant correlation between intracellular and plasma concentrations of imatinib was observed. The",
            "probability": 0.04639526890407401,
            "start_logit": 0.8401681780815125,
            "end_logit": 0.7351667881011963
        },
        {
            "text": ") and SLCO1B3. The imatinib levels in leukocytes were determined",
            "probability": 0.046020061951478786,
            "start_logit": 0.9824216961860657,
            "end_logit": 0.584793210029602
        },
        {
            "text": "mic cells is thought to affect the",
            "probability": 0.04593734686441218,
            "start_logit": 0.8153804540634155,
            "end_logit": 0.7500354647636414
        },
        {
            "text": "thought to affect the",
            "probability": 0.04576528591046177,
            "start_logit": 0.8116278648376465,
            "end_logit": 0.7500354647636414
        },
        {
            "text": "to affect the",
            "probability": 0.04555942319024222,
            "start_logit": 0.8071194887161255,
            "end_logit": 0.7500354647636414
        },
        {
            "text": "CO1B3 genotype",
            "probability": 0.044885567962848386,
            "start_logit": 0.9396601319313049,
            "end_logit": 0.6025936603546143
        },
        {
            "text": ") and SLCO1B3. The im",
            "probability": 0.044489784592077204,
            "start_logit": 0.9824216961860657,
            "end_logit": 0.5509753823280334
        },
        {
            "text": "organic anion transporter family members 1B1 (SLCO1B1) and SLCO1B3. The im",
            "probability": 0.04429960223254375,
            "start_logit": 0.9781377911567688,
            "end_logit": 0.5509753823280334
        }
    ],
    "589185cc621ea6ff7e00000b": [
        {
            "text": "cal dosed antisense drugs. Based in part on the early success of nu",
            "probability": 0.07017544312636873,
            "start_logit": 1.2650392055511475,
            "end_logit": 0.829139232635498
        },
        {
            "text": "cally delivered antisense drugs, and the",
            "probability": 0.06998760778654418,
            "start_logit": 1.288794994354248,
            "end_logit": 0.8027032017707825
        },
        {
            "text": "cally delivered antisense drugs, and the biodistribution of intrathecal dose",
            "probability": 0.061995883182862185,
            "start_logit": 1.288794994354248,
            "end_logit": 0.6814529895782471
        },
        {
            "text": "cal dose",
            "probability": 0.06054047767261922,
            "start_logit": 1.2650392055511475,
            "end_logit": 0.6814529895782471
        },
        {
            "text": "cally delivered antisense drugs, and the biodistribution of intrathecal dosed antisense drugs",
            "probability": 0.05397151286665415,
            "start_logit": 1.288794994354248,
            "end_logit": 0.542841374874115
        },
        {
            "text": "for the treatment of spinal muscular atrophy. Importantly, nusinersen improves disease symptoms when administered",
            "probability": 0.053373165125340974,
            "start_logit": 0.9511510133743286,
            "end_logit": 0.8693370819091797
        },
        {
            "text": "cal dosed antisense drugs",
            "probability": 0.05270448619989006,
            "start_logit": 1.2650392055511475,
            "end_logit": 0.542841374874115
        },
        {
            "text": "cally delivered antisense drugs, and the biodis",
            "probability": 0.05179670207619469,
            "start_logit": 1.288794994354248,
            "end_logit": 0.5017114877700806
        },
        {
            "text": "cally delivered antisense drugs, and the biodistribution of intrathecal dosed antisen",
            "probability": 0.051590642076147476,
            "start_logit": 1.288794994354248,
            "end_logit": 0.49772530794143677
        },
        {
            "text": "cal dosed antisen",
            "probability": 0.050379508354040044,
            "start_logit": 1.2650392055511475,
            "end_logit": 0.49772530794143677
        },
        {
            "text": "neurodegenerative diseases. Antisense drugs are currently in development for the treatment of amyotrophic lateral scler",
            "probability": 0.04964568398474349,
            "start_logit": 1.1663650274276733,
            "end_logit": 0.5817264318466187
        },
        {
            "text": "neurodegen",
            "probability": 0.048352946634205744,
            "start_logit": 1.1663650274276733,
            "end_logit": 0.5553421378135681
        },
        {
            "text": "sense drugs, and the biodistribution of intrathecal dosed antisense drugs. Based in part on the early success of nu",
            "probability": 0.048131831967997335,
            "start_logit": 0.8879845142364502,
            "end_logit": 0.829139232635498
        },
        {
            "text": "sense drugs, and the",
            "probability": 0.046876088935221966,
            "start_logit": 0.8879845142364502,
            "end_logit": 0.8027032017707825
        },
        {
            "text": ". Based in part on the early success of nu",
            "probability": 0.045625790324400374,
            "start_logit": 0.8345139026641846,
            "end_logit": 0.829139232635498
        },
        {
            "text": "sense drugs, and the biodistribution of intrathecal dose",
            "probability": 0.04152341572469364,
            "start_logit": 0.8879845142364502,
            "end_logit": 0.6814529895782471
        },
        {
            "text": "for the treatment of spinal muscular atrophy. Importantly, nusinersen improves disease symptoms when administered to sympt",
            "probability": 0.03793347313453095,
            "start_logit": 0.9511510133743286,
            "end_logit": 0.5278629064559937
        },
        {
            "text": "sense drugs, and the biodistribution of intrathecal dosed antisense drugs",
            "probability": 0.036148877167254304,
            "start_logit": 0.8879845142364502,
            "end_logit": 0.542841374874115
        },
        {
            "text": "sense drugs, and the biodis",
            "probability": 0.03469223895293233,
            "start_logit": 0.8879845142364502,
            "end_logit": 0.5017114877700806
        },
        {
            "text": "sense drugs, and the biodistribution of intrathecal dosed antisen",
            "probability": 0.0345542247073581,
            "start_logit": 0.8879845142364502,
            "end_logit": 0.49772530794143677
        }
    ],
    "58b6978822d300530900000a": [
        {
            "text": "GFP to allow high-",
            "probability": 0.07584576994399564,
            "start_logit": 1.0637781620025635,
            "end_logit": 1.0994455814361572
        },
        {
            "text": "GFP to allow high-resolution imaging, followed by algorithm-based evaluation of mice of both sexes from adolescence to old",
            "probability": 0.06728096824549842,
            "start_logit": 1.0637781620025635,
            "end_logit": 0.9796210527420044
        },
        {
            "text": "cal brain regions after targeted expression of EGFP to allow high-",
            "probability": 0.06355349644957815,
            "start_logit": 0.8869582414627075,
            "end_logit": 1.0994455814361572
        },
        {
            "text": "hippocampal and cortical brain regions after targeted expression of EGFP to allow high-",
            "probability": 0.0619033620076251,
            "start_logit": 0.8606507182121277,
            "end_logit": 1.0994455814361572
        },
        {
            "text": "of both sexes from adolescence to old",
            "probability": 0.05786068150975687,
            "start_logit": 0.9129388332366943,
            "end_logit": 0.9796210527420044
        },
        {
            "text": "loid-",
            "probability": 0.055456819837846394,
            "start_logit": 1.1520497798919678,
            "end_logit": 0.6980767250061035
        },
        {
            "text": ")-linked mutations (Swedish, Dutch, and London), that develop",
            "probability": 0.05508641686938115,
            "start_logit": 0.9378191828727722,
            "end_logit": 0.9056057929992676
        },
        {
            "text": "of both sexes from adolescence to old age. We report that A\u03b2 species gradually accumulated",
            "probability": 0.051570794599018796,
            "start_logit": 0.9129388332366943,
            "end_logit": 0.8645384907722473
        },
        {
            "text": "GFP to allow high-resolution imaging, followed by algorithm-",
            "probability": 0.0491044669718303,
            "start_logit": 1.0637781620025635,
            "end_logit": 0.6646936535835266
        },
        {
            "text": "GFP to allow high-resolution imaging, followed by algorithm-based evaluation of mice of both sexes from adolescence to old age. We",
            "probability": 0.047424975602078465,
            "start_logit": 1.0637781620025635,
            "end_logit": 0.6298926472663879
        },
        {
            "text": ")-",
            "probability": 0.04447199520951523,
            "start_logit": 0.9378191828727722,
            "end_logit": 0.691562294960022
        },
        {
            "text": ")-linked mutations (Swedish, Dutch, and London), that develop plaques only in old age. We",
            "probability": 0.044419684536944296,
            "start_logit": 0.9378191828727722,
            "end_logit": 0.6903853416442871
        },
        {
            "text": "levels of mouse and human APP carrying a combination of three fa",
            "probability": 0.043685047166715466,
            "start_logit": 0.8440841436386108,
            "end_logit": 0.7674435377120972
        },
        {
            "text": ". Soluble, oligomeric amyloid-",
            "probability": 0.04145908220918713,
            "start_logit": 0.8611520528793335,
            "end_logit": 0.6980767250061035
        },
        {
            "text": "cal brain regions after targeted expression of EGFP to allow high-resolution imaging, followed by algorithm-",
            "probability": 0.041146138666098425,
            "start_logit": 0.8869582414627075,
            "end_logit": 0.6646936535835266
        },
        {
            "text": "of both sexes from adolescence to old age. We",
            "probability": 0.040784808549532856,
            "start_logit": 0.9129388332366943,
            "end_logit": 0.6298926472663879
        },
        {
            "text": "GFP to allow high-resolution imaging, followed by algorithm",
            "probability": 0.04054160150346102,
            "start_logit": 1.0637781620025635,
            "end_logit": 0.4730722904205322
        },
        {
            "text": "levels of mouse and human APP carrying a combination of three familial AD (FAD)-",
            "probability": 0.040492818228546903,
            "start_logit": 0.8440841436386108,
            "end_logit": 0.691562294960022
        },
        {
            "text": "hippocampal and cortical brain regions after targeted expression of EGFP to allow high-resolution imaging, followed by algorithm-",
            "probability": 0.04007779995368513,
            "start_logit": 0.8606507182121277,
            "end_logit": 0.6646936535835266
        },
        {
            "text": "levels of mouse and human APP carrying a combination of three familial AD (FA",
            "probability": 0.03783327193970451,
            "start_logit": 0.8440841436386108,
            "end_logit": 0.6236265897750854
        }
    ],
    "58bc347422d300530900001e": [
        {
            "text": "anisms as well as their role in evolution",
            "probability": 0.0871398012390162,
            "start_logit": 1.2025461196899414,
            "end_logit": 0.5961442589759827
        },
        {
            "text": "development of fundamentally new",
            "probability": 0.08637929299397078,
            "start_logit": 0.9437869787216187,
            "end_logit": 0.8461376428604126
        },
        {
            "text": "anisms as well as their",
            "probability": 0.08590933949999416,
            "start_logit": 1.2025461196899414,
            "end_logit": 0.5819230675697327
        },
        {
            "text": "anisms as well as",
            "probability": 0.07618890377936978,
            "start_logit": 1.2025461196899414,
            "end_logit": 0.46184635162353516
        },
        {
            "text": "development of fundamentally new approaches in fight with infectious diseases",
            "probability": 0.07463506130539097,
            "start_logit": 0.9437869787216187,
            "end_logit": 0.7000000476837158
        },
        {
            "text": "anisms as well as their role in evolution of the human as biological species and",
            "probability": 0.07357474407367356,
            "start_logit": 1.2025461196899414,
            "end_logit": 0.42693233489990234
        },
        {
            "text": "aspects of competition between human and pathogenic microorganisms as well as their role in evolution",
            "probability": 0.07324322488276569,
            "start_logit": 1.028818130493164,
            "end_logit": 0.5961442589759827
        },
        {
            "text": "aspects of competition between human and pathogenic microorganisms as well as their",
            "probability": 0.07220899041608804,
            "start_logit": 1.028818130493164,
            "end_logit": 0.5819230675697327
        },
        {
            "text": "their role in evolution",
            "probability": 0.06716497787425017,
            "start_logit": 0.942184329032898,
            "end_logit": 0.5961442589759827
        },
        {
            "text": "their",
            "probability": 0.066216571585718,
            "start_logit": 0.942184329032898,
            "end_logit": 0.5819230675697327
        },
        {
            "text": "aspects of competition between human and pathogenic microorganisms as well as",
            "probability": 0.06403871633557537,
            "start_logit": 1.028818130493164,
            "end_logit": 0.46184635162353516
        },
        {
            "text": "aspects of competition between human and pathogenic microorganisms as well as their role in evolution of the human as biological species and",
            "probability": 0.06184144844557194,
            "start_logit": 1.028818130493164,
            "end_logit": 0.42693233489990234
        },
        {
            "text": "their role in evolution of the human as biological species and",
            "probability": 0.056709402449260114,
            "start_logit": 0.942184329032898,
            "end_logit": 0.42693233489990234
        },
        {
            "text": "their role in evolution of the human as biological species and development of its polymorphism were reviewed. Biological consequences of interaction between human and",
            "probability": 0.05474952511935511,
            "start_logit": 0.942184329032898,
            "end_logit": 0.39176100492477417
        }
    ],
    "588f9f83ed9bbee70d000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58a644e560087bc10a000027": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58c99fcc02b8c60953000029": [
        {
            "text": "lla with human lactoferrin named as GTD8A1-",
            "probability": 0.07236341479607607,
            "start_logit": 1.0714457035064697,
            "end_logit": 0.7545657753944397
        },
        {
            "text": "First, a screening trial using a Plackett-Burman design was done, and variables with statistical",
            "probability": 0.06971360110269506,
            "start_logit": 0.9654794335365295,
            "end_logit": 0.8232266306877136
        },
        {
            "text": "First, a screening trial using a Plackett-",
            "probability": 0.06597274937945821,
            "start_logit": 0.9654794335365295,
            "end_logit": 0.7680729627609253
        },
        {
            "text": "ackett-Burman design was done, and variables with statistical",
            "probability": 0.0636336825959296,
            "start_logit": 0.8742269277572632,
            "end_logit": 0.8232266306877136
        },
        {
            "text": "ett-Burman design was done, and variables with statistical",
            "probability": 0.06351141589719737,
            "start_logit": 0.8723036646842957,
            "end_logit": 0.8232266306877136
        },
        {
            "text": "ackett-",
            "probability": 0.06021908103425978,
            "start_logit": 0.8742269277572632,
            "end_logit": 0.7680729627609253
        },
        {
            "text": "ett-",
            "probability": 0.06010337520146208,
            "start_logit": 0.8723036646842957,
            "end_logit": 0.7680729627609253
        },
        {
            "text": "lla with human lactoferrin named as GTD8A1-HLF, the",
            "probability": 0.05531929625562061,
            "start_logit": 1.0714457035064697,
            "end_logit": 0.48598670959472656
        },
        {
            "text": "lla with human lactofer",
            "probability": 0.05390109804268051,
            "start_logit": 1.0714457035064697,
            "end_logit": 0.46001577377319336
        },
        {
            "text": "First, a screening trial using a Plackett-Burman design was done, and variables with",
            "probability": 0.05330451586749956,
            "start_logit": 0.9654794335365295,
            "end_logit": 0.5548522472381592
        },
        {
            "text": "First, a screening trial using",
            "probability": 0.05174989173834801,
            "start_logit": 0.9654794335365295,
            "end_logit": 0.5252535343170166
        },
        {
            "text": "First, a screening trial using a Plackett-Burman design was done, and variables with statistically significant effects on",
            "probability": 0.05018120700819544,
            "start_logit": 0.9654794335365295,
            "end_logit": 0.49447178840637207
        },
        {
            "text": "ackett-Burman design was done, and variables with",
            "probability": 0.04865567966637474,
            "start_logit": 0.8742269277572632,
            "end_logit": 0.5548522472381592
        },
        {
            "text": "ett-Burman design was done, and variables with",
            "probability": 0.04856219192396078,
            "start_logit": 0.8723036646842957,
            "end_logit": 0.5548522472381592
        },
        {
            "text": "ackett-Burman design was done, and variables with statistically significant effects on",
            "probability": 0.045804763324967586,
            "start_logit": 0.8742269277572632,
            "end_logit": 0.49447178840637207
        },
        {
            "text": "ett-Burman design was done, and variables with statistically significant effects on",
            "probability": 0.04571675337537035,
            "start_logit": 0.8723036646842957,
            "end_logit": 0.49447178840637207
        },
        {
            "text": "ackett-Burman design was done, and variables with statistically significant effects on human lactoferrin bio-",
            "probability": 0.045687533746427915,
            "start_logit": 0.8742269277572632,
            "end_logit": 0.4919091761112213
        },
        {
            "text": "ett-Burman design was done, and variables with statistically significant effects on human lactoferrin bio-",
            "probability": 0.04559974904347643,
            "start_logit": 0.8723036646842957,
            "end_logit": 0.4919091761112213
        }
    ],
    "58ce363b02b8c60953000046": [
        {
            "text": "uncertain whether the association is causal or due to confounding or reverse causality. To clarify this",
            "probability": 0.12131077408968033,
            "start_logit": 1.109459638595581,
            "end_logit": 0.5256197452545166
        },
        {
            "text": "is inconsistent and it remains uncertain whether the association is causal or due to confounding or reverse causality. To clarify this",
            "probability": 0.11431537038762582,
            "start_logit": 1.050065040588379,
            "end_logit": 0.5256197452545166
        },
        {
            "text": "uncertain whether the association is causal or due to confounding or reverse causality. To clarify this relationship, we adopted a Mendel",
            "probability": 0.10451801611025448,
            "start_logit": 1.109459638595581,
            "end_logit": 0.37662357091903687
        },
        {
            "text": "uncertain whether the",
            "probability": 0.10312403019024935,
            "start_logit": 1.109459638595581,
            "end_logit": 0.36319655179977417
        },
        {
            "text": "uncertain whether the association is causal or due to confounding or reverse causality. To clarify this relationship, we",
            "probability": 0.09741370803050471,
            "start_logit": 1.109459638595581,
            "end_logit": 0.3062310516834259
        },
        {
            "text": "uncertain whether the association is causal or due to confounding or reverse causality. To clarify this relationship, we adopted a",
            "probability": 0.09730055656908085,
            "start_logit": 1.109459638595581,
            "end_logit": 0.30506882071495056
        },
        {
            "text": "is inconsistent and it remains uncertain whether the",
            "probability": 0.09717736776082365,
            "start_logit": 1.050065040588379,
            "end_logit": 0.36319655179977417
        },
        {
            "text": "is inconsistent and it remains uncertain whether the association is causal or due to confounding or reverse causality. To clarify this relationship, we",
            "probability": 0.09179633217167389,
            "start_logit": 1.050065040588379,
            "end_logit": 0.3062310516834259
        },
        {
            "text": "is inconsistent and it",
            "probability": 0.08654298526481065,
            "start_logit": 1.050065040588379,
            "end_logit": 0.2472999393939972
        },
        {
            "text": "is inconsistent and",
            "probability": 0.08650085942529628,
            "start_logit": 1.050065040588379,
            "end_logit": 0.24681305885314941
        }
    ],
    "588f8e9794c1512c50000005": [
        {
            "text": "R-package RnBe",
            "probability": 0.06581283294432451,
            "start_logit": 0.9161458015441895,
            "end_logit": 1.0690107345581055
        },
        {
            "text": "associated with ER\u03b2 expression, which could point to mechanisms by which ER\u03b2 could influence risk and prognosis",
            "probability": 0.058393434839324666,
            "start_logit": 0.8846471905708313,
            "end_logit": 0.9808979630470276
        },
        {
            "text": "estrogen receptor \u03b2 (ER\u03b2). Expression of ER\u03b2 is found reduced in tumour tissue and inversely related to mortality",
            "probability": 0.057517391954176884,
            "start_logit": 1.2127474546432495,
            "end_logit": 0.6376816034317017
        },
        {
            "text": "R-package RnBeads. For the comparison of tumours with moderate/high ER\u03b2 versus negative expression,",
            "probability": 0.0574020390834495,
            "start_logit": 0.9161458015441895,
            "end_logit": 0.9322757124900818
        },
        {
            "text": "overall survival (FDR-adjusted p-value<0.05). The regional analysis identified 60 differentially methylated promotor regions.",
            "probability": 0.05687800767826448,
            "start_logit": 0.9618439078330994,
            "end_logit": 0.8774065375328064
        },
        {
            "text": "high. Differentially methylated CpG sites and genomic regions were determined using limma in the R-package RnBe",
            "probability": 0.0561698814655287,
            "start_logit": 0.75771164894104,
            "end_logit": 1.0690107345581055
        },
        {
            "text": "cohort n =\u00a0917,",
            "probability": 0.05431632525262354,
            "start_logit": 0.9244887232780457,
            "end_logit": 0.8686777949333191
        },
        {
            "text": "survival analysis indicates that 30 of the replicated CpGs are also associated with overall survival (FDR-adjusted p-value",
            "probability": 0.051978890072492435,
            "start_logit": 1.045469880104065,
            "end_logit": 0.7037094831466675
        },
        {
            "text": "survival (FDR-adjusted p-value<0.05). The regional analysis identified 60 differentially methylated promotor regions.",
            "probability": 0.05185146024415918,
            "start_logit": 0.8693182468414307,
            "end_logit": 0.8774065375328064
        },
        {
            "text": "overall survival (FDR-adjusted p-value",
            "probability": 0.04780889469835639,
            "start_logit": 0.9618439078330994,
            "end_logit": 0.7037094831466675
        },
        {
            "text": "versus negative expression,",
            "probability": 0.04707551996352099,
            "start_logit": 0.717819094657898,
            "end_logit": 0.9322757124900818
        },
        {
            "text": "of CRC patients recruited in 2003-2010 by the German DACHS study (discovery cohort n =\u00a0917,",
            "probability": 0.04668634310350167,
            "start_logit": 0.7731155753135681,
            "end_logit": 0.8686777949333191
        },
        {
            "text": "HumanMethylation450k BeadChip arrays in two independent tumour sample sets of CRC patients recruited in 2003-2010 by the",
            "probability": 0.04503986787701148,
            "start_logit": 0.8032018542289734,
            "end_logit": 0.8026878833770752
        },
        {
            "text": "sample sets of CRC patients recruited in 2003-2010 by the German DACHS study (discovery cohort n =\u00a0917,",
            "probability": 0.04455024933334906,
            "start_logit": 0.7262816429138184,
            "end_logit": 0.8686777949333191
        },
        {
            "text": "overall survival (FDR-adjusted p-value<0.05). The regional analysis identified 60 differentially methylated promotor",
            "probability": 0.044498902232806475,
            "start_logit": 0.9618439078330994,
            "end_logit": 0.6319622993469238
        },
        {
            "text": "of CRC patients recruited in 2003-2010 by the",
            "probability": 0.04370496763297984,
            "start_logit": 0.7731155753135681,
            "end_logit": 0.8026878833770752
        },
        {
            "text": "survival (FDR-adjusted p-value",
            "probability": 0.043583822710378375,
            "start_logit": 0.8693182468414307,
            "end_logit": 0.7037094831466675
        },
        {
            "text": "linked to oestrogen receptor \u03b2 (ER\u03b2). Expression of ER\u03b2 is found reduced in tumour tissue and inversely related to mortality",
            "probability": 0.043374389055299487,
            "start_logit": 0.9305292367935181,
            "end_logit": 0.6376816034317017
        },
        {
            "text": "sample sets of CRC patients recruited in 2003-2010 by the",
            "probability": 0.04170528415212637,
            "start_logit": 0.7262816429138184,
            "end_logit": 0.8026878833770752
        },
        {
            "text": "=\u00a0907). ER\u03b2 expression was measured using immunohistochemistry and scored as negative,",
            "probability": 0.04165149570632607,
            "start_logit": 0.9261326789855957,
            "end_logit": 0.6015462875366211
        }
    ],
    "58cc5bae02b8c60953000037": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58d0dc878acda34529000004": [
        {
            "text": "ding yeast Saccharomyces cerevisiae has high utility as a metabolic engineering platform because of its",
            "probability": 0.11199942491609406,
            "start_logit": 1.0337930917739868,
            "end_logit": 0.8635228872299194
        },
        {
            "text": "cerevisiae has high utility as a metabolic engineering platform because of its",
            "probability": 0.10422074873853308,
            "start_logit": 0.9618105888366699,
            "end_logit": 0.8635228872299194
        },
        {
            "text": "organic compounds will be helpful for realizing a sustainable society. The",
            "probability": 0.09438646746087874,
            "start_logit": 0.985977292060852,
            "end_logit": 0.7402426600456238
        },
        {
            "text": "ding yeast Saccharomyces",
            "probability": 0.08324850859154823,
            "start_logit": 1.0337930917739868,
            "end_logit": 0.5668593645095825
        },
        {
            "text": "organisms that produce useful organic compounds will be helpful for realizing a sustainable society. The",
            "probability": 0.08283399159830636,
            "start_logit": 0.8554180860519409,
            "end_logit": 0.7402426600456238
        },
        {
            "text": "organic compounds will be helpful for realizing a sustainable society. The budding yeast Saccharomyces",
            "probability": 0.07936158334255783,
            "start_logit": 0.985977292060852,
            "end_logit": 0.5668593645095825
        },
        {
            "text": "ding yeast Saccharomyces cerevisiae has high utility as a metabolic engineering platform because of its high fermentation ability, non-",
            "probability": 0.07866902943966952,
            "start_logit": 1.0337930917739868,
            "end_logit": 0.5102787017822266
        },
        {
            "text": "ding yeast Saccharomyces cerevisiae has high utility as a metabolic engineering platform because of its high ferm",
            "probability": 0.07793293483066975,
            "start_logit": 1.0337930917739868,
            "end_logit": 0.5008777976036072
        },
        {
            "text": "cerevisiae has high utility as a metabolic engineering platform because of its high fermentation ability, non-",
            "probability": 0.07320524330261888,
            "start_logit": 0.9618105888366699,
            "end_logit": 0.5102787017822266
        },
        {
            "text": "cerevisiae has high utility as a metabolic engineering platform because of its high ferm",
            "probability": 0.07252027254183303,
            "start_logit": 0.9618105888366699,
            "end_logit": 0.5008777976036072
        },
        {
            "text": "cerevisiae has high utility as a metabolic engineering platform because of its high fermentation ability, non-pathogenicity,",
            "probability": 0.07197371003322822,
            "start_logit": 0.9618105888366699,
            "end_logit": 0.4933125674724579
        },
        {
            "text": "organisms that produce useful organic compounds will be helpful for realizing a sustainable society. The budding yeast Saccharomyces",
            "probability": 0.06964808520406218,
            "start_logit": 0.8554180860519409,
            "end_logit": 0.5668593645095825
        }
    ],
    "58b6cd3222d300530900000d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58caf0be02b8c6095300002f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "587e1a01fc7e8dd84f000001": [
        {
            "text": "involving RNA",
            "probability": 0.07035961259374456,
            "start_logit": 0.8502776622772217,
            "end_logit": 0.9246746897697449
        },
        {
            "text": "genome browser (JBro",
            "probability": 0.06943309167921002,
            "start_logit": 0.9663657546043396,
            "end_logit": 0.7953307628631592
        },
        {
            "text": "of recognizable homologues of meta",
            "probability": 0.06558092784981964,
            "start_logit": 0.8366584777832031,
            "end_logit": 0.8679593801498413
        },
        {
            "text": "I RNA editing has recently been identified in fungi despite the absence of recognizable homologues of meta",
            "probability": 0.06408630416648727,
            "start_logit": 0.8136042356491089,
            "end_logit": 0.8679593801498413
        },
        {
            "text": "I editing is involved in sexual reproduction of filamentous fungi. Here, we report on the creation of FairBase - a fungal A-",
            "probability": 0.06309658910540229,
            "start_logit": 0.8131546974182129,
            "end_logit": 0.8528449535369873
        },
        {
            "text": "involving RNA editing are built in FairBase to help users understand the functions of RNA editing. Furthermore, each fungal species has a genome browser (JBro",
            "probability": 0.061823001445323426,
            "start_logit": 0.8502776622772217,
            "end_logit": 0.7953307628631592
        },
        {
            "text": "I RNA editing database that provides a platform for deep exploration of fungal RNA editing to relevant academic communities. This database",
            "probability": 0.060598738465125764,
            "start_logit": 0.8619056940078735,
            "end_logit": 0.763701319694519
        },
        {
            "text": "I editing in a gen",
            "probability": 0.05982443529850232,
            "start_logit": 1.0191435813903809,
            "end_logit": 0.5936035513877869
        },
        {
            "text": "I editing in a genomic context",
            "probability": 0.05863409438126438,
            "start_logit": 1.0191435813903809,
            "end_logit": 0.573505699634552
        },
        {
            "text": "genome browser (JBrowse) that allows users to explore A-to-I editing in a gen",
            "probability": 0.05674890538135143,
            "start_logit": 0.9663657546043396,
            "end_logit": 0.5936035513877869
        },
        {
            "text": "genome browser (JBrowse) that allows users to explore A-to-I editing in a genomic context",
            "probability": 0.05561975900919039,
            "start_logit": 0.9663657546043396,
            "end_logit": 0.573505699634552
        },
        {
            "text": "I RNA editing database that provides a platform for deep exploration of fungal RNA editing to relevant academic communities. This database includes a comprehensive collection of A-",
            "probability": 0.05555973995571288,
            "start_logit": 0.8619056940078735,
            "end_logit": 0.6768860816955566
        },
        {
            "text": "I RNA editing has recently been identified in fungi despite the",
            "probability": 0.055194041324653866,
            "start_logit": 0.8136042356491089,
            "end_logit": 0.7185837030410767
        },
        {
            "text": "of recognizable homologues of metazoan ADARs (\"Adenosine Deaminases Acting on RNA",
            "probability": 0.05408600870823664,
            "start_logit": 0.8366584777832031,
            "end_logit": 0.6752499938011169
        },
        {
            "text": "I editing is involved in sexual reproduction of filamentous fungi",
            "probability": 0.05257052918517434,
            "start_logit": 0.8131546974182129,
            "end_logit": 0.6703339219093323
        },
        {
            "text": "I RNA editing database that provides a platform",
            "probability": 0.05026568696360893,
            "start_logit": 0.8619056940078735,
            "end_logit": 0.5767499208450317
        },
        {
            "text": "I editing is involved in sexual reproduction of filamentous fungi. Here, we report on the creation of FairBase -",
            "probability": 0.04651853448719196,
            "start_logit": 0.8131546974182129,
            "end_logit": 0.5480290651321411
        }
    ],
    "58bca2f302b8c6095300000c": [
        {
            "text": "%). Six patients",
            "probability": 0.08249522963798234,
            "start_logit": 1.1593897342681885,
            "end_logit": 1.0177489519119263
        },
        {
            "text": "material increased the risk for development of gonadoblastoma. A total of 124 patients",
            "probability": 0.066188527538959,
            "start_logit": 1.0458128452301025,
            "end_logit": 0.9110925197601318
        },
        {
            "text": "%). Six patients with overt Y chromosome and four patients with cryptic Y chromosome material underwent oophorectomy",
            "probability": 0.060798270934402286,
            "start_logit": 1.1593897342681885,
            "end_logit": 0.7125698328018188
        },
        {
            "text": "among 118 patients without overt Y chromosome (8.5%). Six patients",
            "probability": 0.05848609334617522,
            "start_logit": 0.8154382705688477,
            "end_logit": 1.0177489519119263
        },
        {
            "text": "chromosome material increased the risk for development of gonadoblastoma. A total of 124 patients",
            "probability": 0.05718245183336879,
            "start_logit": 0.8995527625083923,
            "end_logit": 0.9110925197601318
        },
        {
            "text": "%). Six patients with overt Y chromosome and four patients with cryptic Y chromosome material underwent oophore",
            "probability": 0.05680120027410929,
            "start_logit": 1.1593897342681885,
            "end_logit": 0.6445659399032593
        },
        {
            "text": "chromosome (8.5%). Six patients",
            "probability": 0.05395305075381083,
            "start_logit": 0.734763503074646,
            "end_logit": 1.0177489519119263
        },
        {
            "text": "%) and 2 of 10 patients",
            "probability": 0.04799983538444359,
            "start_logit": 0.843098521232605,
            "end_logit": 0.7924972772598267
        },
        {
            "text": "toma. A total of 124 patients",
            "probability": 0.046499382576574454,
            "start_logit": 0.6927447319030762,
            "end_logit": 0.9110925197601318
        },
        {
            "text": "be performed only in patients with Turner syndrome harbor",
            "probability": 0.045873325569989305,
            "start_logit": 0.9738270044326782,
            "end_logit": 0.6164550185203552
        },
        {
            "text": "lines had their",
            "probability": 0.04503018811635082,
            "start_logit": 0.8111294507980347,
            "end_logit": 0.7606018781661987
        },
        {
            "text": "material underwent oophorectomy",
            "probability": 0.044131565520794405,
            "start_logit": 0.8390036821365356,
            "end_logit": 0.7125698328018188
        },
        {
            "text": "group was 2.4%,",
            "probability": 0.04408279770761307,
            "start_logit": 0.844424843788147,
            "end_logit": 0.706043004989624
        },
        {
            "text": "a occurred in one of six patients with an overt Y chromosome (16.7%) and 2 of 10 patients",
            "probability": 0.04337459570159396,
            "start_logit": 0.74177485704422,
            "end_logit": 0.7924972772598267
        },
        {
            "text": ") and 2 of 10 patients",
            "probability": 0.04287462240463382,
            "start_logit": 0.7301810383796692,
            "end_logit": 0.7924972772598267
        },
        {
            "text": "lines had their ovaries removed prophylactically. Finally, we",
            "probability": 0.04214579605275183,
            "start_logit": 0.8111294507980347,
            "end_logit": 0.6944037079811096
        },
        {
            "text": "group was 2.4%, and gonadoblastoma occurred in one of six patients",
            "probability": 0.04183311435729058,
            "start_logit": 0.844424843788147,
            "end_logit": 0.6536616086959839
        },
        {
            "text": "material underwent oophore",
            "probability": 0.04123021679779721,
            "start_logit": 0.8390036821365356,
            "end_logit": 0.6445659399032593
        },
        {
            "text": "chromosome (8.5%). Six patients with overt Y chromosome and four patients with cryptic Y chromosome material underwent oophorectomy",
            "probability": 0.03976293189148793,
            "start_logit": 0.734763503074646,
            "end_logit": 0.7125698328018188
        },
        {
            "text": "group was 2.4%, and gonadoblastoma",
            "probability": 0.03925680359987149,
            "start_logit": 0.844424843788147,
            "end_logit": 0.5900981426239014
        }
    ],
    "58bd6c5802b8c60953000012": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "587e3129c32c812009000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58d4d7578acda34529000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58cbf1f402b8c60953000036": [
        {
            "text": "vital group of enzymes in catalyzing triacylglycerol biosynthesis. DGAT genes like D",
            "probability": 0.08687384459928454,
            "start_logit": 0.8889796137809753,
            "end_logit": 0.6160438060760498
        },
        {
            "text": "of enzymes in catalyzing triacylglycerol biosynthesis. DGAT genes like DGAT1 and DGAT2,",
            "probability": 0.08615142063534523,
            "start_logit": 0.8769945502281189,
            "end_logit": 0.6196783185005188
        },
        {
            "text": "of enzymes in catalyzing triacylglycerol biosynthesis. DGAT genes like D",
            "probability": 0.085838870554294,
            "start_logit": 0.8769945502281189,
            "end_logit": 0.6160438060760498
        },
        {
            "text": "vital group of enzymes in catalyzing",
            "probability": 0.08248687335582239,
            "start_logit": 0.8889796137809753,
            "end_logit": 0.564225971698761
        },
        {
            "text": "of enzymes in catalyzing",
            "probability": 0.0815041636188528,
            "start_logit": 0.8769945502281189,
            "end_logit": 0.564225971698761
        },
        {
            "text": "vital group of enzymes in catalyzing triacylglycerol biosy",
            "probability": 0.08100471616990858,
            "start_logit": 0.8889796137809753,
            "end_logit": 0.5460941791534424
        },
        {
            "text": "of enzymes in catalyzing triacylglycerol biosy",
            "probability": 0.08003966415518086,
            "start_logit": 0.8769945502281189,
            "end_logit": 0.5460941791534424
        },
        {
            "text": "aimed to characterize DGAT family genes in buffalo and to find candidate markers or D",
            "probability": 0.07694319608040795,
            "start_logit": 0.9464905261993408,
            "end_logit": 0.43714332580566406
        },
        {
            "text": "aimed to characterize DGAT family genes in buffalo and to find candidate markers or DGAT genes influencing lactation performance.",
            "probability": 0.07490112223035612,
            "start_logit": 0.9464905261993408,
            "end_logit": 0.41024476289749146
        },
        {
            "text": "vital",
            "probability": 0.06937535332301438,
            "start_logit": 0.8889796137809753,
            "end_logit": 0.39111846685409546
        },
        {
            "text": "aimed to characterize DGAT",
            "probability": 0.06828275525161694,
            "start_logit": 0.9464905261993408,
            "end_logit": 0.31773313879966736
        },
        {
            "text": "vital group of enzymes in catalyzing triacylglycerol biosynthesis. DGAT genes like DGAT1 and D",
            "probability": 0.06367832680141088,
            "start_logit": 0.8889796137809753,
            "end_logit": 0.305431067943573
        },
        {
            "text": "of enzymes in catalyzing triacylglycerol biosynthesis. DGAT genes like DGAT1 and D",
            "probability": 0.06291969322450539,
            "start_logit": 0.8769945502281189,
            "end_logit": 0.305431067943573
        }
    ],
    "58bac71222d3005309000013": [
        {
            "text": "question of the possible meaning of the H3K27M-",
            "probability": 0.11165169631778613,
            "start_logit": 0.8984723687171936,
            "end_logit": 0.9390923976898193
        },
        {
            "text": ") represents a defined pathologic entity since the 2016 World Health Organization Central Nervous System classification and includes midline structures, namely the",
            "probability": 0.08931791549165032,
            "start_logit": 0.9536080956459045,
            "end_logit": 0.6607745885848999
        },
        {
            "text": "question of the possible meaning",
            "probability": 0.08723630485467065,
            "start_logit": 0.8984723687171936,
            "end_logit": 0.6923288106918335
        },
        {
            "text": "question of the possible meaning of the H3K27M-mutation in high-grade gliomas arising from the",
            "probability": 0.08133562023321222,
            "start_logit": 0.8984723687171936,
            "end_logit": 0.6222922801971436
        },
        {
            "text": "K27M-mutant\" (a mutation",
            "probability": 0.07315002014574866,
            "start_logit": 0.9395524859428406,
            "end_logit": 0.4751405119895935
        },
        {
            "text": "question of the possible meaning of the H3K27M-mutation in high",
            "probability": 0.0728800072108828,
            "start_logit": 0.8984723687171936,
            "end_logit": 0.5125225782394409
        },
        {
            "text": "question",
            "probability": 0.07237705758978259,
            "start_logit": 0.8984723687171936,
            "end_logit": 0.5055975914001465
        },
        {
            "text": "question of the",
            "probability": 0.07236513465160113,
            "start_logit": 0.8984723687171936,
            "end_logit": 0.5054328441619873
        },
        {
            "text": "question of the possible meaning of the H3K27M-mutation in high-",
            "probability": 0.06985784911243004,
            "start_logit": 0.8984723687171936,
            "end_logit": 0.47017067670822144
        },
        {
            "text": "question of the possible meaning of the H3K27M",
            "probability": 0.06953623046316106,
            "start_logit": 0.8984723687171936,
            "end_logit": 0.46555614471435547
        },
        {
            "text": ") represents a defined pathologic entity since the 2016 World Health Organization Central Nervous System classification and",
            "probability": 0.06742417996624535,
            "start_logit": 0.9536080956459045,
            "end_logit": 0.3795762062072754
        },
        {
            "text": "K27M-",
            "probability": 0.06661393161390017,
            "start_logit": 0.9395524859428406,
            "end_logit": 0.3815418481826782
        },
        {
            "text": "K",
            "probability": 0.06625405234892887,
            "start_logit": 0.9395524859428406,
            "end_logit": 0.3761247396469116
        }
    ],
    "58cdb41302b8c60953000042": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "587f7a69d8d850a152000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "589d965a78275d0c4a000049": [
        {
            "text": "containing transcripts are co-",
            "probability": 0.1411846564620873,
            "start_logit": 1.0889383554458618,
            "end_logit": 0.8088939785957336
        },
        {
            "text": "containing transcripts are co-transcriptionally cleaved during their",
            "probability": 0.11933004426877525,
            "start_logit": 1.0889383554458618,
            "end_logit": 0.6407184600830078
        },
        {
            "text": "containing transcripts are co-transcriptionally cleaved during their synthesis and suggest that exonucleolytic degradation from",
            "probability": 0.113612842609723,
            "start_logit": 1.0889383554458618,
            "end_logit": 0.5916218757629395
        },
        {
            "text": "polymerase II (Pol II)-",
            "probability": 0.11150912010084697,
            "start_logit": 0.9693830013275146,
            "end_logit": 0.6924870610237122
        },
        {
            "text": "polymerase II (Pol II)-derived transcripts",
            "probability": 0.09903412317128603,
            "start_logit": 0.9693830013275146,
            "end_logit": 0.5738451480865479
        },
        {
            "text": "two RNase III processing reactions: Drosha cleavage of nuclear pri-miRNAs and Dicer cleavage of cytoplasmic pre-",
            "probability": 0.09253118764149065,
            "start_logit": 0.8903858661651611,
            "end_logit": 0.5849235653877258
        },
        {
            "text": "splicing. We finally demonstrate that miRNAs can also derive from",
            "probability": 0.08179817838075742,
            "start_logit": 0.8343515992164612,
            "end_logit": 0.5176670551300049
        },
        {
            "text": "splicing. We finally demonstrate that miRNAs can also derive from 3",
            "probability": 0.08081496873826746,
            "start_logit": 0.8343515992164612,
            "end_logit": 0.5055742859840393
        },
        {
            "text": "splicing. We finally demonstrate that miRNAs can",
            "probability": 0.08052799441034156,
            "start_logit": 0.8343515992164612,
            "end_logit": 0.5020169615745544
        },
        {
            "text": "splicing. We",
            "probability": 0.07965688421642453,
            "start_logit": 0.8343515992164612,
            "end_logit": 0.49114054441452026
        }
    ],
    "58cbb98c02b8c60953000034": [
        {
            "text": "% of patients with OCA1B); therefore, the absence of mutations in some of the other patients may indicate the",
            "probability": 0.061266932764682674,
            "start_logit": 0.939903736114502,
            "end_logit": 0.6244456768035889
        },
        {
            "text": "albinism, then screened for mutations in the tyrosinase gene in an effort to establish the molecular basis of the disorder",
            "probability": 0.06090211716451634,
            "start_logit": 0.9998864531517029,
            "end_logit": 0.5584906339645386
        },
        {
            "text": "% of patients with OCA1B); therefore, the absence of mutations in some of the other patients may indicate the involvement",
            "probability": 0.06020736220762285,
            "start_logit": 0.939903736114502,
            "end_logit": 0.6070000529289246
        },
        {
            "text": "1 (OCA1) results from mutations in the tyrosinase gene, which lead to partial or complete loss of activity of the corresponding",
            "probability": 0.059871044811963016,
            "start_logit": 0.8918315768241882,
            "end_logit": 0.6494705677032471
        },
        {
            "text": "some of the other patients may indicate the",
            "probability": 0.05972479368201665,
            "start_logit": 0.9144107103347778,
            "end_logit": 0.6244456768035889
        },
        {
            "text": "some of the other patients may indicate the involvement",
            "probability": 0.058691893387252475,
            "start_logit": 0.9144107103347778,
            "end_logit": 0.6070000529289246
        },
        {
            "text": "mic and dermat",
            "probability": 0.05835426685765842,
            "start_logit": 0.8544653058052063,
            "end_logit": 0.661176323890686
        },
        {
            "text": "albinism, then screened for mutations in the",
            "probability": 0.057986319798609534,
            "start_logit": 0.9998864531517029,
            "end_logit": 0.5094298124313354
        },
        {
            "text": "aneous albinism, then screened for mutations in the tyrosinase gene in an effort to establish the molecular basis of the disorder",
            "probability": 0.05637586385692509,
            "start_logit": 0.9226596355438232,
            "end_logit": 0.5584906339645386
        },
        {
            "text": "% of patients with OCA1B); therefore, the absence of mutations in some",
            "probability": 0.05418371968451255,
            "start_logit": 0.939903736114502,
            "end_logit": 0.5015859007835388
        },
        {
            "text": "mic and dermatological exams on 30 Lebanese subjects",
            "probability": 0.05392102332341052,
            "start_logit": 0.8544653058052063,
            "end_logit": 0.5821642875671387
        },
        {
            "text": "aneous albinism, then screened for mutations in the",
            "probability": 0.053676768932348046,
            "start_logit": 0.9226596355438232,
            "end_logit": 0.5094298124313354
        },
        {
            "text": "some",
            "probability": 0.05281987090019941,
            "start_logit": 0.9144107103347778,
            "end_logit": 0.5015859007835388
        },
        {
            "text": "binism, then screened for mutations in the tyrosinase gene in an effort to establish the molecular basis of the disorder",
            "probability": 0.05275925666926741,
            "start_logit": 0.856357753276825,
            "end_logit": 0.5584906339645386
        },
        {
            "text": "binism, then screened for mutations in the",
            "probability": 0.050233313257351336,
            "start_logit": 0.856357753276825,
            "end_logit": 0.5094298124313354
        },
        {
            "text": "mic and dermatological exams on 30 Lebanese subjects with oculocutaneous albinism, then screened for mutations in the",
            "probability": 0.050138339245695204,
            "start_logit": 0.8544653058052063,
            "end_logit": 0.5094298124313354
        },
        {
            "text": "mic and dermatological exams on",
            "probability": 0.049830978888396986,
            "start_logit": 0.8544653058052063,
            "end_logit": 0.5032806992530823
        },
        {
            "text": "mic and dermatological exams on 30 Lebanese subjects with",
            "probability": 0.04905613456757138,
            "start_logit": 0.8544653058052063,
            "end_logit": 0.4876090884208679
        }
    ],
    "58a6db8660087bc10a00002c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5895f7e978275d0c4a000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "588f9950ed9bbee70d000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58ce9bf1d46b5c2951000002": [
        {
            "text": "markers expression, normal kary",
            "probability": 0.12441544605636355,
            "start_logit": 1.0489505529403687,
            "end_logit": 0.670351505279541
        },
        {
            "text": "markers expression, normal karyotype, ability to differentiate into three embryonic germ layers. Generated iP",
            "probability": 0.1221991850330869,
            "start_logit": 1.0489505529403687,
            "end_logit": 0.6523775458335876
        },
        {
            "text": "markers expression, normal karyotype, ability to differentiate into three embryonic germ layers. Generated iPSC lines would be useful model",
            "probability": 0.1219755200449198,
            "start_logit": 1.0489505529403687,
            "end_logit": 0.6505455374717712
        },
        {
            "text": "markers expression, normal karyotype, ability to differentiate into three embryonic germ",
            "probability": 0.11179190574840425,
            "start_logit": 1.0489505529403687,
            "end_logit": 0.5633643269538879
        },
        {
            "text": "NA mutation associated with Emery-",
            "probability": 0.09142689338724441,
            "start_logit": 0.9301479458808899,
            "end_logit": 0.4810674488544464
        },
        {
            "text": "markers expression, normal karyotype, ability to differentiate into three embryonic germ layers. Generated",
            "probability": 0.09067713245637078,
            "start_logit": 1.0489505529403687,
            "end_logit": 0.3540303707122803
        },
        {
            "text": "markers expression, normal karyotype, ability to differentiate into three embryo",
            "probability": 0.08911417461215415,
            "start_logit": 1.0489505529403687,
            "end_logit": 0.3366435766220093
        },
        {
            "text": "NA mutation associated",
            "probability": 0.08447965778547571,
            "start_logit": 0.9301479458808899,
            "end_logit": 0.4020385444164276
        },
        {
            "text": "NA mutation associated with Emery-Dreifuss muscular dystrophy accompanied by atrioventricular block and parox",
            "probability": 0.08432948281240223,
            "start_logit": 0.9301479458808899,
            "end_logit": 0.4002593159675598
        },
        {
            "text": "NA mutation associated with Emery-Dreifuss",
            "probability": 0.07959060206357835,
            "start_logit": 0.9301479458808899,
            "end_logit": 0.34242379665374756
        }
    ],
    "58bfd8e902b8c60953000018": [
        {
            "text": "managed conservatively and received interferon injections",
            "probability": 0.06990564861439401,
            "start_logit": 1.11846923828125,
            "end_logit": 0.9225854277610779
        },
        {
            "text": "). She also had skin lesions that were proven to be reactive perforating collagenosis and necrobiosis lip",
            "probability": 0.06988643442883022,
            "start_logit": 1.0475431680679321,
            "end_logit": 0.9932366013526917
        },
        {
            "text": "Seip syndrome) is an autosomal recessive condition, presenting during infancy with generalized loss of fat. We report a 30-year-",
            "probability": 0.06434775330389499,
            "start_logit": 1.0481349229812622,
            "end_logit": 0.910075306892395
        },
        {
            "text": "Seip syndrome) is an autosomal recessive condition, presenting",
            "probability": 0.05983294674425338,
            "start_logit": 1.0481349229812622,
            "end_logit": 0.8373297452926636
        },
        {
            "text": ") is an autosomal recessive condition, presenting during infancy with generalized loss of fat. We report a 30-year-",
            "probability": 0.05973262116656264,
            "start_logit": 0.9737111926078796,
            "end_logit": 0.910075306892395
        },
        {
            "text": ") is an autosomal recessive condition, presenting",
            "probability": 0.055541624340399005,
            "start_logit": 0.9737111926078796,
            "end_logit": 0.8373297452926636
        },
        {
            "text": "Congenital generalized lipodystrophy (Berardinelli-Seip syndrome) is an autosomal recessive condition, presenting",
            "probability": 0.05546997095056,
            "start_logit": 0.9724202752113342,
            "end_logit": 0.8373297452926636
        },
        {
            "text": "Seip syndrome) is an autosomal recessive condition, presenting during infancy with generalized loss of fat. We report a 30-",
            "probability": 0.055383305397527754,
            "start_logit": 1.0481349229812622,
            "end_logit": 0.7600514888763428
        },
        {
            "text": ") is an autosomal recessive condition, presenting during infancy with generalized loss of fat. We report a 30-",
            "probability": 0.0514111189653971,
            "start_logit": 0.9737111926078796,
            "end_logit": 0.7600514888763428
        },
        {
            "text": "be a myeloproliferative neoplasm (MPN); essential throm",
            "probability": 0.04656629910831653,
            "start_logit": 1.1520559787750244,
            "end_logit": 0.48272931575775146
        },
        {
            "text": "kidney disease requiring regular treatment with hemodialysis. We believe",
            "probability": 0.04604870880771782,
            "start_logit": 1.005881428718567,
            "end_logit": 0.6177265048027039
        },
        {
            "text": "kidney disease requiring regular treatment with",
            "probability": 0.04305421266456829,
            "start_logit": 1.005881428718567,
            "end_logit": 0.5504868626594543
        },
        {
            "text": "Congenital generalized lipodystrophy (Berardinelli-",
            "probability": 0.04279890895595931,
            "start_logit": 0.9724202752113342,
            "end_logit": 0.578000545501709
        },
        {
            "text": "Congenital",
            "probability": 0.04275189155589126,
            "start_logit": 0.9724202752113342,
            "end_logit": 0.576901376247406
        },
        {
            "text": "Seip syndrome) is an auto",
            "probability": 0.041819944723264155,
            "start_logit": 1.0481349229812622,
            "end_logit": 0.47914665937423706
        },
        {
            "text": "). She also had skin lesions that were proven",
            "probability": 0.041795820214230624,
            "start_logit": 1.0475431680679321,
            "end_logit": 0.4791613817214966
        },
        {
            "text": "kidney function deteriorated furthermore to stage V chronic kidney disease requiring regular treatment with hemodialysis. We believe",
            "probability": 0.039309000154843496,
            "start_logit": 0.8476352095603943,
            "end_logit": 0.6177265048027039
        },
        {
            "text": ") is an auto",
            "probability": 0.03882054597250596,
            "start_logit": 0.9737111926078796,
            "end_logit": 0.47914665937423706
        },
        {
            "text": "Congenital generalized lipodystrophy (Berardinelli-Seip syndrome) is an auto",
            "probability": 0.03877046418704569,
            "start_logit": 0.9724202752113342,
            "end_logit": 0.47914665937423706
        },
        {
            "text": "kidney function deteriorated furthermore to stage V chronic kidney disease requiring regular treatment with",
            "probability": 0.03675277974383787,
            "start_logit": 0.8476352095603943,
            "end_logit": 0.5504868626594543
        }
    ],
    "58adc1ff9ef3c34033000006": [
        {
            "text": "k1 mutants flocculate extensively in a gene-dosage-",
            "probability": 0.075641451451923,
            "start_logit": 1.1413936614990234,
            "end_logit": 1.0579981803894043
        },
        {
            "text": "probably because of the altered expression of one or more hyphal-cell",
            "probability": 0.06310946416432354,
            "start_logit": 1.0676416158676147,
            "end_logit": 0.9506165385246277
        },
        {
            "text": "demonstrates that deltacahk1 mutants flocculate extensively in a gene-dosage-",
            "probability": 0.05553723906754591,
            "start_logit": 0.8324429988861084,
            "end_logit": 1.0579981803894043
        },
        {
            "text": "k1 mutants flocculate extensively in a gene-dosage-dependent manner under conditions which induce germ-tube",
            "probability": 0.05483287767931248,
            "start_logit": 1.1413936614990234,
            "end_logit": 0.7362837195396423
        },
        {
            "text": "-",
            "probability": 0.053976472965877445,
            "start_logit": 0.8941023945808411,
            "end_logit": 0.9678332805633545
        },
        {
            "text": "probably because of the altered expression of one or more hyphal-",
            "probability": 0.05200517770935744,
            "start_logit": 1.0676416158676147,
            "end_logit": 0.7570890784263611
        },
        {
            "text": "induce germ-tube formation, such as growth in medium 199 (pH 7.5). The floccula",
            "probability": 0.0517514795397938,
            "start_logit": 1.079128623008728,
            "end_logit": 0.7407118082046509
        },
        {
            "text": "induce germ-tube",
            "probability": 0.05152282602248945,
            "start_logit": 1.079128623008728,
            "end_logit": 0.7362837195396423
        },
        {
            "text": "kinase gene from C. albicans has been reported. In addition to the",
            "probability": 0.05040116895745461,
            "start_logit": 0.9975194931030273,
            "end_logit": 0.7958822846412659
        },
        {
            "text": "k",
            "probability": 0.0487684960043309,
            "start_logit": 1.1413936614990234,
            "end_logit": 0.6190782785415649
        },
        {
            "text": "of Cahk1p contains a P-",
            "probability": 0.04833081399645441,
            "start_logit": 0.783623456954956,
            "end_logit": 0.9678332805633545
        },
        {
            "text": "is shown here that the N-terminal domain of Cahk1p contains a P-",
            "probability": 0.046354095963149704,
            "start_logit": 0.7418637871742249,
            "end_logit": 0.9678332805633545
        },
        {
            "text": "-loop motif and a sequence which shows significant homology with the seven C-terminal domains of serine/threoni",
            "probability": 0.04513487261855771,
            "start_logit": 0.8941023945808411,
            "end_logit": 0.7889401912689209
        },
        {
            "text": ". Ca",
            "probability": 0.04493703083264278,
            "start_logit": 0.9023868441581726,
            "end_logit": 0.7762627601623535
        },
        {
            "text": "hk1",
            "probability": 0.04395984766111231,
            "start_logit": 0.8624331951141357,
            "end_logit": 0.7942308783531189
        },
        {
            "text": "of Cahk1p",
            "probability": 0.04370304702194376,
            "start_logit": 0.783623456954956,
            "end_logit": 0.8671817779541016
        },
        {
            "text": "hk1p could, in fact, correspond to its sensor sequence. Ca",
            "probability": 0.04317702590091138,
            "start_logit": 0.8624331951141357,
            "end_logit": 0.7762627601623535
        },
        {
            "text": "probably",
            "probability": 0.04275535295048382,
            "start_logit": 1.0676416158676147,
            "end_logit": 0.5612401962280273
        },
        {
            "text": "kinase gene from C. albicans has",
            "probability": 0.042185656008275896,
            "start_logit": 0.9975194931030273,
            "end_logit": 0.6179481744766235
        },
        {
            "text": "is shown here that the N-terminal domain of Cahk1p",
            "probability": 0.04191560348405967,
            "start_logit": 0.7418637871742249,
            "end_logit": 0.8671817779541016
        }
    ],
    "58bfd0db02b8c60953000017": [
        {
            "text": "membrane. A biotinylated DNA probe specific for the BamHI-C region of MCV",
            "probability": 0.13253449683877624,
            "start_logit": 1.1971409320831299,
            "end_logit": 0.7743349075317383
        },
        {
            "text": "ecific hybridization does not occur with herpes simplex virus- or orf virus-infected clinical specimens and that dot",
            "probability": 0.125491820415179,
            "start_logit": 1.2943097352981567,
            "end_logit": 0.6225637197494507
        },
        {
            "text": "using streptavidin alkaline phosphatase conjugate and 5-bromo-",
            "probability": 0.11790110033703104,
            "start_logit": 0.8160107731819153,
            "end_logit": 1.0384682416915894
        },
        {
            "text": "ecific hybridization does not occur with herpes",
            "probability": 0.11047124990004377,
            "start_logit": 1.2943097352981567,
            "end_logit": 0.495078444480896
        },
        {
            "text": "using streptavidin alkaline phosphatase con",
            "probability": 0.10168788054004523,
            "start_logit": 0.8160107731819153,
            "end_logit": 0.8905302286148071
        },
        {
            "text": "contagiosum virus (MCV) DNA in clinical specimens submitted for virus isolation.",
            "probability": 0.10111078306080741,
            "start_logit": 1.102224588394165,
            "end_logit": 0.5986250638961792
        },
        {
            "text": "contagiosum virus (MCV) DNA in clinical specimens submitted for virus isolation. Samples were concentrated by high-",
            "probability": 0.10062836943318207,
            "start_logit": 1.102224588394165,
            "end_logit": 0.5938425064086914
        },
        {
            "text": "using streptavidin alkaline phosphatase conjugate and 5-bromo-4-chloro-3-",
            "probability": 0.07214818766929815,
            "start_logit": 0.8160107731819153,
            "end_logit": 0.5473442673683167
        },
        {
            "text": "using streptavidin alkaline phosphatase conjugate and 5-bromo-4-",
            "probability": 0.06941275084536591,
            "start_logit": 0.8160107731819153,
            "end_logit": 0.5086926817893982
        },
        {
            "text": "using streptavidin al",
            "probability": 0.06861336096027129,
            "start_logit": 0.8160107731819153,
            "end_logit": 0.49710938334465027
        }
    ],
    "58cf5c5a8acda34529000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "587e0116ae05ffb474000002": [
        {
            "text": "interaction of TFs. TICA employs a data-",
            "probability": 0.06428716595725535,
            "start_logit": 1.252519130706787,
            "end_logit": 0.7604631185531616
        },
        {
            "text": "sequencing data. We present our method",
            "probability": 0.06034297305706184,
            "start_logit": 1.2430305480957031,
            "end_logit": 0.7066361904144287
        },
        {
            "text": "sequencing data. We present our method and test it on ENCODE ChIP-seq",
            "probability": 0.05782357395722552,
            "start_logit": 1.2430305480957031,
            "end_logit": 0.6639882326126099
        },
        {
            "text": "TFs. TICA employs a data-",
            "probability": 0.053254518275507985,
            "start_logit": 1.0642417669296265,
            "end_logit": 0.7604631185531616
        },
        {
            "text": "gulation Analyzer (TICA), a novel methodology for predicting hetero",
            "probability": 0.05188919207588465,
            "start_logit": 1.0094693899154663,
            "end_logit": 0.7892633676528931
        },
        {
            "text": "often involve more than one transcription factor (TF) from different families, binding together and attaching to the DNA as a single",
            "probability": 0.05146247165096121,
            "start_logit": 0.918117105960846,
            "end_logit": 0.872357964515686
        },
        {
            "text": "gulation Analyzer (TICA), a novel methodology for predicting heterotypic physical interaction of TFs. TICA employs a data-",
            "probability": 0.0504160851630392,
            "start_logit": 1.0094693899154663,
            "end_logit": 0.7604631185531616
        },
        {
            "text": ". Regulatory mechanisms often involve more than one transcription factor (TF) from different families, binding together and attaching to the DNA as a single",
            "probability": 0.0503907891346704,
            "start_logit": 0.8970726728439331,
            "end_logit": 0.872357964515686
        },
        {
            "text": ") and functional interaction (BioGRID) databases. We",
            "probability": 0.05035938505553925,
            "start_logit": 0.8651934862136841,
            "end_logit": 0.9036137461662292
        },
        {
            "text": "TF) from different families, binding together and attaching to the DNA as a single",
            "probability": 0.0501046777199336,
            "start_logit": 0.89137864112854,
            "end_logit": 0.872357964515686
        },
        {
            "text": "one transcription factor (TF) from different families, binding together and attaching to the DNA as a single",
            "probability": 0.04990322519577297,
            "start_logit": 0.8873499035835266,
            "end_logit": 0.872357964515686
        },
        {
            "text": "Furthermore, predictions by TICA are complementary to other methods for TF-TF interaction prediction (in particular, TACO and CENTDIS",
            "probability": 0.0482298185515339,
            "start_logit": 0.8107893466949463,
            "end_logit": 0.9148103594779968
        },
        {
            "text": "co.dei",
            "probability": 0.04757999257601579,
            "start_logit": 1.1000510454177856,
            "end_logit": 0.6119835376739502
        },
        {
            "text": "of TFs. TICA employs a data-",
            "probability": 0.04709695136530463,
            "start_logit": 0.9413673877716064,
            "end_logit": 0.7604631185531616
        },
        {
            "text": ") data. Its prediction rules are based on the distribution",
            "probability": 0.04661375712581692,
            "start_logit": 0.975488543510437,
            "end_logit": 0.7160294055938721
        },
        {
            "text": ".526 when combining TICA with TACO and 0.585 when combining with CENTDIS",
            "probability": 0.04494639428509096,
            "start_logit": 0.7934342622756958,
            "end_logit": 0.86165851354599
        },
        {
            "text": ") data. Its prediction rules are based on the",
            "probability": 0.04457462245933336,
            "start_logit": 0.975488543510437,
            "end_logit": 0.6712983846664429
        },
        {
            "text": ". We",
            "probability": 0.04408284041985252,
            "start_logit": 0.7320790886878967,
            "end_logit": 0.9036137461662292
        },
        {
            "text": ". We present our method",
            "probability": 0.04336845922934062,
            "start_logit": 0.9127184748649597,
            "end_logit": 0.7066361904144287
        },
        {
            "text": ") and functional interaction (BioGRID) databases. We also compare TICA",
            "probability": 0.043273106744859194,
            "start_logit": 0.8651934862136841,
            "end_logit": 0.7519600987434387
        }
    ],
    "58dfe6b56fddd3e83e000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58e75d483e8b6dc87c000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5880b073c872c95565000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58da111c8acda34529000010": [
        {
            "text": "is a rare congenital malformation syndrome due to the presence of an extra chromosome 13. In this paper, we report the",
            "probability": 0.10502431348662773,
            "start_logit": 1.0911316871643066,
            "end_logit": 0.7581371665000916
        },
        {
            "text": "uri",
            "probability": 0.09473898792538407,
            "start_logit": 1.1185593605041504,
            "end_logit": 0.6276432275772095
        },
        {
            "text": "uripotent stem cell",
            "probability": 0.09311304384119884,
            "start_logit": 1.1185593605041504,
            "end_logit": 0.6103318929672241
        },
        {
            "text": "uripotent stem cell model",
            "probability": 0.08860281340174421,
            "start_logit": 1.1185593605041504,
            "end_logit": 0.5606812238693237
        },
        {
            "text": "uripotent stem cell model of Patau syndrome should serve as a tool to study this congenital",
            "probability": 0.08744241777528972,
            "start_logit": 1.1185593605041504,
            "end_logit": 0.5474981069564819
        },
        {
            "text": "congenital",
            "probability": 0.08254975605289404,
            "start_logit": 1.0609800815582275,
            "end_logit": 0.5474981069564819
        },
        {
            "text": "is a rare congenital malformation syndrome due to the presence of an extra chromosome 13. In this paper, we report the generation",
            "probability": 0.0789908752229906,
            "start_logit": 1.0911316871643066,
            "end_logit": 0.47327762842178345
        },
        {
            "text": "study this congenital",
            "probability": 0.07834648106477113,
            "start_logit": 1.0087199211120605,
            "end_logit": 0.5474981069564819
        },
        {
            "text": "is a rare congenital malformation syndrome due to the presence of an extra chromosome 13. In this paper, we",
            "probability": 0.0783102750243339,
            "start_logit": 1.0911316871643066,
            "end_logit": 0.4646241068840027
        },
        {
            "text": "is a rare congenital malformation syndrome due to the presence of an extra chromosome 13. In this",
            "probability": 0.07689953206598857,
            "start_logit": 1.0911316871643066,
            "end_logit": 0.4464450776576996
        },
        {
            "text": "is a rare congenital malformation syndrome due to the presence of an extra chromosome 13.",
            "probability": 0.07444430051926797,
            "start_logit": 1.0911316871643066,
            "end_logit": 0.41399648785591125
        },
        {
            "text": "uripotent stem cell line from the fibroblasts isolated from chorionic vi",
            "probability": 0.06153720361950931,
            "start_logit": 0.9129390120506287,
            "end_logit": 0.4017798900604248
        }
    ],
    "58af1cb3717cd3f655000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58dd0dde8acda34529000027": [
        {
            "text": "is an evolutionarily ancient protein",
            "probability": 0.10414124017337788,
            "start_logit": 1.0697853565216064,
            "end_logit": 0.6895068287849426
        },
        {
            "text": "is an evolutionarily ancient protein that lends elasticity and resiliency to a variety of tissues. In humans,",
            "probability": 0.08630806374467882,
            "start_logit": 1.0697853565216064,
            "end_logit": 0.5016818046569824
        },
        {
            "text": "is an evolutionarily ancient protein that lends elasticity and resiliency to a variety of tissues. In humans",
            "probability": 0.08094610853325156,
            "start_logit": 1.0697853565216064,
            "end_logit": 0.4375423789024353
        },
        {
            "text": "is an evolutionarily ancient protein that lends elasticity and resili",
            "probability": 0.07635835031550345,
            "start_logit": 1.0697853565216064,
            "end_logit": 0.3791961669921875
        },
        {
            "text": "ency to a variety of tissues. In humans, mutations in fibrillin-1 cause",
            "probability": 0.0747609319401217,
            "start_logit": 0.8878511190414429,
            "end_logit": 0.5399884581565857
        },
        {
            "text": "ency to a variety of tissues. In humans,",
            "probability": 0.07195124916612083,
            "start_logit": 0.8878511190414429,
            "end_logit": 0.5016818046569824
        },
        {
            "text": "is an evolutionarily ancient protein that lends elasticity and resiliency to a variety of tissues. In humans, mutations",
            "probability": 0.07130010322237502,
            "start_logit": 1.0697853565216064,
            "end_logit": 0.3106565475463867
        },
        {
            "text": "is an evolutionarily ancient protein that lends elasticity and resiliency to a",
            "probability": 0.07110656619749793,
            "start_logit": 1.0697853565216064,
            "end_logit": 0.30793845653533936
        },
        {
            "text": "ency to a variety of tissues. In humans",
            "probability": 0.06748122216405211,
            "start_logit": 0.8878511190414429,
            "end_logit": 0.4375423789024353
        },
        {
            "text": "ency to a variety of tissues. In humans, mutations in fibrillin-1 cause Marfan and related syndromes, conditions in which the",
            "probability": 0.06720863703650698,
            "start_logit": 0.8878511190414429,
            "end_logit": 0.43349477648735046
        },
        {
            "text": "ency to a variety of tissues. In humans, mutations",
            "probability": 0.05943977039850498,
            "start_logit": 0.8878511190414429,
            "end_logit": 0.3106565475463867
        },
        {
            "text": "ency to a",
            "probability": 0.05927842706515207,
            "start_logit": 0.8878511190414429,
            "end_logit": 0.30793845653533936
        },
        {
            "text": "ency to a variety of tissues. In humans, mutations in fibrillin-",
            "probability": 0.057103384059562036,
            "start_logit": 0.8878511190414429,
            "end_logit": 0.27055639028549194
        },
        {
            "text": "ency to a variety of tissues. In humans, mutations in fibrillin-1 cause Marfan and related syndromes, conditions",
            "probability": 0.05261594598329452,
            "start_logit": 0.8878511190414429,
            "end_logit": 0.1887122392654419
        }
    ],
    "58853922e56acf5176000016": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5880e417713cbdfd3d000001": [
        {
            "text": "two hemorrhagic symptoms despite no predis",
            "probability": 0.06425755095035829,
            "start_logit": 0.9366292953491211,
            "end_logit": 1.0720518827438354
        },
        {
            "text": "through laboratory findings.",
            "probability": 0.06305380165893376,
            "start_logit": 1.0739234685897827,
            "end_logit": 0.9158468246459961
        },
        {
            "text": "is usually diagnosed based on several clinical symptoms such as the sudden onset of illness, high fevers",
            "probability": 0.05836189136157955,
            "start_logit": 1.147746205329895,
            "end_logit": 0.76469886302948
        },
        {
            "text": "is usually diagnosed based on several clinical symptoms such as the sudden onset of illness, high fevers for less",
            "probability": 0.05371373118489935,
            "start_logit": 1.147746205329895,
            "end_logit": 0.6817044019699097
        },
        {
            "text": ". The main options include: prophylactic strategies, anti-",
            "probability": 0.05332751334647559,
            "start_logit": 1.069309949874878,
            "end_logit": 0.752924382686615
        },
        {
            "text": ".",
            "probability": 0.05300905694506519,
            "start_logit": 1.069309949874878,
            "end_logit": 0.7469347715377808
        },
        {
            "text": "generally provides enough evidence for clinicians to consider EHF and begin supportive treatment until the virus is confirmed through laboratory findings.",
            "probability": 0.052499094645704174,
            "start_logit": 0.8907310366630554,
            "end_logit": 0.9158468246459961
        },
        {
            "text": "of disease in the",
            "probability": 0.05086159845828157,
            "start_logit": 0.9787601828575134,
            "end_logit": 0.7961299419403076
        },
        {
            "text": "is usually diagnosed based on several clinical symptoms such as the sudden onset of illness, high fevers for less than three weeks,",
            "probability": 0.05084637610421404,
            "start_logit": 1.147746205329895,
            "end_logit": 0.626844584941864
        },
        {
            "text": "over 40 years ago in the Democratic Republic of Congo. Endemic to Africa, outbreaks have been recorded in six African countries since its",
            "probability": 0.04998417389566782,
            "start_logit": 0.9319396018981934,
            "end_logit": 0.8255487680435181
        },
        {
            "text": "through laboratory findings. Management of patients",
            "probability": 0.04909169697272177,
            "start_logit": 1.0739234685897827,
            "end_logit": 0.6655483841896057
        },
        {
            "text": "hylactic strategies, anti-",
            "probability": 0.04841372066583817,
            "start_logit": 0.9726408123970032,
            "end_logit": 0.752924382686615
        },
        {
            "text": "balance, blood pressure and oxygen saturation. This also includes",
            "probability": 0.04660983003180923,
            "start_logit": 0.7884688973426819,
            "end_logit": 0.8991245031356812
        },
        {
            "text": "treatment until the virus is confirmed through laboratory findings.",
            "probability": 0.04648035613408918,
            "start_logit": 0.7689648866653442,
            "end_logit": 0.9158468246459961
        },
        {
            "text": "of disease in the most severely affected",
            "probability": 0.04416143054764125,
            "start_logit": 0.9787601828575134,
            "end_logit": 0.6548735499382019
        },
        {
            "text": "over 40 years ago in the Democratic Republic of Congo. Endemic to Africa, outbreaks have been",
            "probability": 0.04398893370194807,
            "start_logit": 0.9319396018981934,
            "end_logit": 0.697780430316925
        },
        {
            "text": "of high fever,",
            "probability": 0.043025922297572496,
            "start_logit": 0.8143427968025208,
            "end_logit": 0.7932419180870056
        },
        {
            "text": "of high fever, chills and myalgia depicting a flu-like",
            "probability": 0.04277502865375445,
            "start_logit": 0.8143427968025208,
            "end_logit": 0.7873936295509338
        },
        {
            "text": "various ways, including human to human transmission through close contact with blood and bodily fluids. The virus has",
            "probability": 0.04277456463082068,
            "start_logit": 0.8934295177459717,
            "end_logit": 0.7082960605621338
        },
        {
            "text": "epidemics is to stop the transmission of disease in the",
            "probability": 0.04276372781262534,
            "start_logit": 0.8053422570228577,
            "end_logit": 0.7961299419403076
        }
    ],
    "5889eb503b87a8a73800000b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58d900428acda3452900000c": [
        {
            "text": "is critically dependent on",
            "probability": 0.0685557908220075,
            "start_logit": 0.8664321303367615,
            "end_logit": 0.8915952444076538
        },
        {
            "text": "associated with defects in cardiolipin, like Sengers syndrome and dilated cardiomyopathy with",
            "probability": 0.05400062653611849,
            "start_logit": 0.9032274484634399,
            "end_logit": 0.6161476969718933
        },
        {
            "text": "ipin, like Sengers syndrome and dilated cardiomyopathy with",
            "probability": 0.0532631063952913,
            "start_logit": 0.8894757032394409,
            "end_logit": 0.6161476969718933
        },
        {
            "text": "cardiolipin, like Sengers syndrome and dilated cardiomyopathy with",
            "probability": 0.05314705698712326,
            "start_logit": 0.8872945308685303,
            "end_logit": 0.6161476969718933
        },
        {
            "text": "ated cardiomyopathy with",
            "probability": 0.05167834180880197,
            "start_logit": 0.8592705726623535,
            "end_logit": 0.6161476969718933
        },
        {
            "text": "associated with defects in cardiolipin, like",
            "probability": 0.05136659851616909,
            "start_logit": 0.9032274484634399,
            "end_logit": 0.5661401748657227
        },
        {
            "text": "is critically dependent on the integrity of mitochondrial membranes. Disorders characterized by mitochondrial",
            "probability": 0.051088599084434166,
            "start_logit": 0.8664321303367615,
            "end_logit": 0.5975087285041809
        },
        {
            "text": "is critically dependent on the integrity of mitochondrial membranes. Disorders characterized by mitochondrial dysfunction are commonly associated with cardiac disease.",
            "probability": 0.05102900437325278,
            "start_logit": 0.8664321303367615,
            "end_logit": 0.5963415503501892
        },
        {
            "text": "ipin, like",
            "probability": 0.05066505293417255,
            "start_logit": 0.8894757032394409,
            "end_logit": 0.5661401748657227
        },
        {
            "text": "cardiolipin, like",
            "probability": 0.050554664152786484,
            "start_logit": 0.8872945308685303,
            "end_logit": 0.5661401748657227
        },
        {
            "text": "membranes. Disorders characterized by mitochondrial",
            "probability": 0.04908793084790692,
            "start_logit": 0.826483964920044,
            "end_logit": 0.5975087285041809
        },
        {
            "text": "membranes. Disorders characterized by mitochondrial dysfunction are commonly associated with cardiac disease.",
            "probability": 0.049030669910754617,
            "start_logit": 0.826483964920044,
            "end_logit": 0.5963415503501892
        },
        {
            "text": "associated with defects in cardiol",
            "probability": 0.04739570165567955,
            "start_logit": 0.9032274484634399,
            "end_logit": 0.4856835901737213
        },
        {
            "text": "associated with defects in cardiolipin, like Sengers syndrome and dilated cardiomyopathy with ataxia (DCMA).",
            "probability": 0.04710077595889095,
            "start_logit": 0.9032274484634399,
            "end_logit": 0.4794415235519409
        },
        {
            "text": "cardiol",
            "probability": 0.046646533909274014,
            "start_logit": 0.8872945308685303,
            "end_logit": 0.4856835901737213
        },
        {
            "text": "ipin, like Sengers syndrome and dilated cardiomyopathy with ataxia (DCMA).",
            "probability": 0.04645749136857167,
            "start_logit": 0.8894757032394409,
            "end_logit": 0.4794415235519409
        },
        {
            "text": "cardiolipin, like Sengers syndrome and dilated cardiomyopathy with ataxia (DCMA).",
            "probability": 0.04635627000273014,
            "start_logit": 0.8872945308685303,
            "end_logit": 0.4794415235519409
        },
        {
            "text": "ated cardiomyopathy with ataxia (DCMA).",
            "probability": 0.04507521774465561,
            "start_logit": 0.8592705726623535,
            "end_logit": 0.4794415235519409
        },
        {
            "text": "is critically dependent on the integrity of mitochondrial membranes",
            "probability": 0.044624039080835,
            "start_logit": 0.8664321303367615,
            "end_logit": 0.46222007274627686
        },
        {
            "text": "membranes",
            "probability": 0.04287652791054381,
            "start_logit": 0.826483964920044,
            "end_logit": 0.46222007274627686
        }
    ],
    "58de18e48acda3452900002a": [
        {
            "text": "miR-30a",
            "probability": 0.07806021020095816,
            "start_logit": 0.9713423252105713,
            "end_logit": 0.829070508480072
        },
        {
            "text": "miR-",
            "probability": 0.07672225093194629,
            "start_logit": 0.9713423252105713,
            "end_logit": 0.8117818236351013
        },
        {
            "text": "of development, growth and meta",
            "probability": 0.07029739681745335,
            "start_logit": 0.8849023580551147,
            "end_logit": 0.8107647895812988
        },
        {
            "text": "roles in the regulation of development, growth and meta",
            "probability": 0.06955718513958134,
            "start_logit": 0.8743168115615845,
            "end_logit": 0.8107647895812988
        },
        {
            "text": "was",
            "probability": 0.06724711987633512,
            "start_logit": 0.8868833780288696,
            "end_logit": 0.7644231915473938
        },
        {
            "text": "roles in the",
            "probability": 0.0648418071171371,
            "start_logit": 0.8743168115615845,
            "end_logit": 0.7405661344528198
        },
        {
            "text": "was validated using a dual-",
            "probability": 0.062242945926756825,
            "start_logit": 0.8868833780288696,
            "end_logit": 0.6870942115783691
        },
        {
            "text": "ase reporter assay. SKOV3/DDP cell line was developed and introduced",
            "probability": 0.059999873768693604,
            "start_logit": 0.9144089221954346,
            "end_logit": 0.6228659152984619
        },
        {
            "text": "reporter assay. SKOV3/DDP cell line was developed and introduced",
            "probability": 0.05900928952446346,
            "start_logit": 0.897761344909668,
            "end_logit": 0.6228659152984619
        },
        {
            "text": "ase reporter assay. SKOV3/DD",
            "probability": 0.05857265233337507,
            "start_logit": 0.9144089221954346,
            "end_logit": 0.5987913608551025
        },
        {
            "text": "was validated using a dual-luciferase reporter assay. SKOV3/DDP cell line was developed and introduced",
            "probability": 0.058370867091769786,
            "start_logit": 0.8868833780288696,
            "end_logit": 0.6228659152984619
        },
        {
            "text": "reporter assay. SKOV3/DD",
            "probability": 0.0576056311898325,
            "start_logit": 0.897761344909668,
            "end_logit": 0.5987913608551025
        },
        {
            "text": "was validated using a dual-luciferase reporter assay. SKOV3/DD",
            "probability": 0.05698239495876722,
            "start_logit": 0.8868833780288696,
            "end_logit": 0.5987913608551025
        },
        {
            "text": "ase reporter assay. SKOV",
            "probability": 0.054286845185276066,
            "start_logit": 0.9144089221954346,
            "end_logit": 0.522805392742157
        },
        {
            "text": "reporter assay. SKOV",
            "probability": 0.053390581741176044,
            "start_logit": 0.897761344909668,
            "end_logit": 0.522805392742157
        },
        {
            "text": "was validated using a dual-luciferase reporter assay. SKOV",
            "probability": 0.05281294819647795,
            "start_logit": 0.8868833780288696,
            "end_logit": 0.522805392742157
        }
    ],
    "58c9a8fe02b8c6095300002a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58d8e6818acda3452900000a": [
        {
            "text": "present a case of a 28-",
            "probability": 0.18518748097232515,
            "start_logit": 1.2716461420059204,
            "end_logit": 1.0528534650802612
        },
        {
            "text": "present a case of a 28-year-old female with Down syndrome and a mutation in the fibrillin",
            "probability": 0.11230130674872807,
            "start_logit": 1.2716461420059204,
            "end_logit": 0.5526702404022217
        },
        {
            "text": "present a case of a 28-year-old female with Down syndrome and a mutation in the fibrillin-1 gene. The",
            "probability": 0.09150121297841586,
            "start_logit": 1.2716461420059204,
            "end_logit": 0.347836971282959
        },
        {
            "text": "present a case of a 28-year-old",
            "probability": 0.09065501833964758,
            "start_logit": 1.2716461420059204,
            "end_logit": 0.3385460376739502
        },
        {
            "text": "year-old female with Down syndrome and a mutation in the fibrillin",
            "probability": 0.07512037218239141,
            "start_logit": 0.8695524334907532,
            "end_logit": 0.5526702404022217
        },
        {
            "text": "of Down syndrome. (Neth Heart J 2009;17:345-",
            "probability": 0.07466630090121607,
            "start_logit": 0.9589637517929077,
            "end_logit": 0.4571959972381592
        },
        {
            "text": "of Down syndrome. (Neth Heart J 2009;17:345-8.",
            "probability": 0.06566905588868348,
            "start_logit": 0.9589637517929077,
            "end_logit": 0.3287949562072754
        },
        {
            "text": "of Down syndrome. (Neth Heart",
            "probability": 0.0632977278203054,
            "start_logit": 0.9589637517929077,
            "end_logit": 0.29201656579971313
        },
        {
            "text": "year-old female with Down syndrome and a mutation in the fibrillin-1 gene. The",
            "probability": 0.061206813821484886,
            "start_logit": 0.8695524334907532,
            "end_logit": 0.347836971282959
        },
        {
            "text": "year-old",
            "probability": 0.06064077894581558,
            "start_logit": 0.8695524334907532,
            "end_logit": 0.3385460376739502
        },
        {
            "text": "year-old female with Down syndrome and a mutation in the fibrillin-1 gene. The patient showed strikingly few manifestations",
            "probability": 0.059940751650717064,
            "start_logit": 0.8695524334907532,
            "end_logit": 0.3269350528717041
        },
        {
            "text": "of Down syndrome. (Net",
            "probability": 0.05981317975026957,
            "start_logit": 0.9589637517929077,
            "end_logit": 0.23539316654205322
        }
    ],
    "58df47f08acda3452900002f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58e23ec66fddd3e83e000010": [
        {
            "text": "bacterium associated with various wild bees and hence poses a latent threat to honey bees visiting the",
            "probability": 0.11046541031816938,
            "start_logit": 0.9519089460372925,
            "end_logit": 0.5254789590835571
        },
        {
            "text": "bacterium associated with various wild bees and hence poses a latent threat to honey bees visiting the same flowers",
            "probability": 0.10753793150601529,
            "start_logit": 0.9519089460372925,
            "end_logit": 0.4986201524734497
        },
        {
            "text": "bacterium associated with various wild bees and hence poses a latent threat to honey bees visiting the same flowers.",
            "probability": 0.10208785092838955,
            "start_logit": 0.9519089460372925,
            "end_logit": 0.4466102421283722
        },
        {
            "text": "associated with various wild bees and hence poses a latent threat to honey bees visiting the",
            "probability": 0.10153706047106038,
            "start_logit": 0.8676303625106812,
            "end_logit": 0.5254789590835571
        },
        {
            "text": "bacterium associated with various wild bees and hence poses a late",
            "probability": 0.10151473075000936,
            "start_logit": 0.9519089460372925,
            "end_logit": 0.4409804344177246
        },
        {
            "text": "bacterium associated with various wild bees",
            "probability": 0.09945125996766349,
            "start_logit": 0.9519089460372925,
            "end_logit": 0.42044419050216675
        },
        {
            "text": "associated with various wild bees and hence poses a latent threat to honey bees visiting the same flowers",
            "probability": 0.09884619468491714,
            "start_logit": 0.8676303625106812,
            "end_logit": 0.4986201524734497
        },
        {
            "text": "associated with various wild bees and hence poses a latent threat to honey bees visiting the same flowers.",
            "probability": 0.09383661603411013,
            "start_logit": 0.8676303625106812,
            "end_logit": 0.4466102421283722
        },
        {
            "text": "associated with various wild bees and hence poses a late",
            "probability": 0.09330981820624923,
            "start_logit": 0.8676303625106812,
            "end_logit": 0.4409804344177246
        },
        {
            "text": "associated with various wild bees",
            "probability": 0.09141312713341612,
            "start_logit": 0.8676303625106812,
            "end_logit": 0.42044419050216675
        }
    ],
    "58d906b28acda3452900000d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5881f9b65bf093691f000001": [
        {
            "text": "compared to non-peripheral artery disease patients. Therefore, the aim of this study was to investigate the coagulation profile in peripheral artery disease patients",
            "probability": 0.12455874967109982,
            "start_logit": 0.8399686813354492,
            "end_logit": 0.8970872163772583
        },
        {
            "text": "compared to non-",
            "probability": 0.10860093440903949,
            "start_logit": 0.8399686813354492,
            "end_logit": 0.7599897384643555
        },
        {
            "text": "rombotic events compared to non-",
            "probability": 0.1082678088185955,
            "start_logit": 0.836896538734436,
            "end_logit": 0.7599897384643555
        },
        {
            "text": "compared",
            "probability": 0.08096553521953254,
            "start_logit": 0.8399686813354492,
            "end_logit": 0.4663332998752594
        },
        {
            "text": "rombotic events compared",
            "probability": 0.08071717923740043,
            "start_logit": 0.836896538734436,
            "end_logit": 0.4663332998752594
        },
        {
            "text": "compared to non-peripheral artery disease patients. Therefore, the aim of this study was to investigate the",
            "probability": 0.07479133526496858,
            "start_logit": 0.8399686813354492,
            "end_logit": 0.3870117664337158
        },
        {
            "text": "rombotic events compared to non-peripheral artery disease patients. Therefore, the aim of this study was to investigate the",
            "probability": 0.07456191819912274,
            "start_logit": 0.836896538734436,
            "end_logit": 0.3870117664337158
        },
        {
            "text": "compared to non-peripheral artery disease patients. Therefore, the aim",
            "probability": 0.07363866748642757,
            "start_logit": 0.8399686813354492,
            "end_logit": 0.37147998809814453
        },
        {
            "text": "rombotic events compared to non-peripheral artery disease patients. Therefore, the aim",
            "probability": 0.0734127861464611,
            "start_logit": 0.836896538734436,
            "end_logit": 0.37147998809814453
        },
        {
            "text": "compared to non-peripheral artery disease patients. Therefore, the aim of this",
            "probability": 0.06733309660686186,
            "start_logit": 0.8399686813354492,
            "end_logit": 0.2819616198539734
        },
        {
            "text": "rombotic events compared to non-peripheral artery disease patients. Therefore, the aim of this",
            "probability": 0.06712655715408791,
            "start_logit": 0.836896538734436,
            "end_logit": 0.2819616198539734
        },
        {
            "text": "rombotic",
            "probability": 0.0660254317864026,
            "start_logit": 0.836896538734436,
            "end_logit": 0.26542186737060547
        }
    ],
    "58e793f53e8b6dc87c000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58dfd70c6fddd3e83e000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58e79e703e8b6dc87c00000a": [
        {
            "text": "IgG specific antibodies against VZV glycoprotein gp1",
            "probability": 0.06908636697136568,
            "start_logit": 1.4685084819793701,
            "end_logit": 0.6272742748260498
        },
        {
            "text": "herpes zoster infection. We will -",
            "probability": 0.06461824112627206,
            "start_logit": 0.9066020250320435,
            "end_logit": 1.1223200559616089
        },
        {
            "text": ". We will -",
            "probability": 0.06087827028652396,
            "start_logit": 0.8469815850257874,
            "end_logit": 1.1223200559616089
        },
        {
            "text": "herpes zoster infection. We will - prospectively -",
            "probability": 0.05867096468560362,
            "start_logit": 0.9066020250320435,
            "end_logit": 1.0257682800292969
        },
        {
            "text": "ZV-specific cell mediated immunity in RA patients after herpes zoster infection. We will -",
            "probability": 0.05835607698358483,
            "start_logit": 0.8046687841415405,
            "end_logit": 1.1223200559616089
        },
        {
            "text": "tuximab, abatace",
            "probability": 0.05577918454954436,
            "start_logit": 0.9384669065475464,
            "end_logit": 0.9433591961860657
        },
        {
            "text": ". We will - prospectively -",
            "probability": 0.0552752099692959,
            "start_logit": 0.8469815850257874,
            "end_logit": 1.0257682800292969
        },
        {
            "text": "ZV-specific cell mediated immunity in RA patients after herpes zoster infection. We will - prospectively -",
            "probability": 0.05298515205952028,
            "start_logit": 0.8046687841415405,
            "end_logit": 1.0257682800292969
        },
        {
            "text": "coprotein gp1",
            "probability": 0.04818122853806651,
            "start_logit": 1.1081205606460571,
            "end_logit": 0.6272742748260498
        },
        {
            "text": "is to evaluate the natural course of herpes",
            "probability": 0.045131201769095616,
            "start_logit": 0.7930620908737183,
            "end_logit": 0.8769370913505554
        },
        {
            "text": "of treatment. The aim of the current research protocol is to evaluate the natural course of herpes",
            "probability": 0.044831103605777634,
            "start_logit": 0.7863904237747192,
            "end_logit": 0.8769370913505554
        },
        {
            "text": "er, while being treated with biologics (anti-TNF,",
            "probability": 0.04437242546604634,
            "start_logit": 0.9117844104766846,
            "end_logit": 0.7412591576576233
        },
        {
            "text": "er, while being treated with biologics (anti-",
            "probability": 0.04423287284500229,
            "start_logit": 0.9117844104766846,
            "end_logit": 0.7381091713905334
        },
        {
            "text": ") inhibitors are at increased risk during the first year of treatment. The aim of the current research protocol is to evaluate the natural course of herpes",
            "probability": 0.04387075509786678,
            "start_logit": 0.7647361755371094,
            "end_logit": 0.8769370913505554
        },
        {
            "text": "ZV",
            "probability": 0.04354124781720719,
            "start_logit": 0.8046687841415405,
            "end_logit": 0.8294652700424194
        },
        {
            "text": "oster, while being treated with biologics (anti-TNF,",
            "probability": 0.04283296769182566,
            "start_logit": 0.8764742612838745,
            "end_logit": 0.7412591576576233
        },
        {
            "text": "oster, while being treated with biologics (anti-",
            "probability": 0.04269825671207397,
            "start_logit": 0.8764742612838745,
            "end_logit": 0.7381091713905334
        },
        {
            "text": "modifying anti-rheumatic drugs (DMARDs) on the VZV",
            "probability": 0.042503998712049545,
            "start_logit": 0.7805582284927368,
            "end_logit": 0.8294652700424194
        },
        {
            "text": ". We will - prospectively - include RA patients who develop herpes zoster, while being treated with biologics (anti-",
            "probability": 0.04145735948509243,
            "start_logit": 0.8469815850257874,
            "end_logit": 0.7381091713905334
        },
        {
            "text": "RA patients receiving tumor necrosis factor (TNF) inhibitors are at increased risk during the first year of treatment. The aim of the",
            "probability": 0.04069711562818553,
            "start_logit": 0.8081885576248169,
            "end_logit": 0.7583940029144287
        }
    ],
    "5880c42fc872c95565000008": [
        {
            "text": "[1.03;1.29] p\u00a0=\u20090.0136; SUSTAIN 6: 1.56",
            "probability": 0.08365798358966377,
            "start_logit": 0.9993429183959961,
            "end_logit": 0.8315039277076721
        },
        {
            "text": "interval] in LEADER: 1.15 [1.03;1.29] p\u00a0=\u20090.0136; SUSTAIN 6: 1.56",
            "probability": 0.08209172208049202,
            "start_logit": 0.9804432392120361,
            "end_logit": 0.8315039277076721
        },
        {
            "text": ".",
            "probability": 0.07956253965122519,
            "start_logit": 1.0658668279647827,
            "end_logit": 0.7147865295410156
        },
        {
            "text": "[1.03;1.29] p\u00a0=\u20090.0136; SUSTAIN 6: 1.56 [1.14;2.17]",
            "probability": 0.07444193794708615,
            "start_logit": 0.9993429183959961,
            "end_logit": 0.7147865295410156
        },
        {
            "text": "(1.8\u2009mg) and once-weekly",
            "probability": 0.07223097655142582,
            "start_logit": 1.048079013824463,
            "end_logit": 0.6358999609947205
        },
        {
            "text": "29",
            "probability": 0.06659073508988003,
            "start_logit": 0.9993429183959961,
            "end_logit": 0.60333251953125
        },
        {
            "text": "glutide consistently reduced",
            "probability": 0.06633162453161139,
            "start_logit": 1.140684723854065,
            "end_logit": 0.4580920338630676
        },
        {
            "text": "interval] in LEADER: 1.15 [1.03;1.29",
            "probability": 0.06534401002236816,
            "start_logit": 0.9804432392120361,
            "end_logit": 0.60333251953125
        },
        {
            "text": "[1.14;2.",
            "probability": 0.06239749342793024,
            "start_logit": 0.8228485584259033,
            "end_logit": 0.7147865295410156
        },
        {
            "text": "[1.14;2.17] p\u00a0=\u20090.0064). Liraglutide and semaglutide consistently reduced",
            "probability": 0.06154994007340077,
            "start_logit": 1.0658668279647827,
            "end_logit": 0.4580920338630676
        },
        {
            "text": ".29",
            "probability": 0.06069077922444732,
            "start_logit": 0.906569242477417,
            "end_logit": 0.60333251953125
        },
        {
            "text": "outcomes in these trials, and the efficacy of liraglutide (1.8\u2009mg) and once-weekly",
            "probability": 0.06002237891542799,
            "start_logit": 0.8629274964332581,
            "end_logit": 0.6358999609947205
        },
        {
            "text": "(1.8\u2009mg) and once-weekly semaglutide (0.5-1.0\u2009mg)",
            "probability": 0.05977848192146415,
            "start_logit": 1.048079013824463,
            "end_logit": 0.44667673110961914
        },
        {
            "text": "outcomes in these trials, and the efficacy of liragluti",
            "probability": 0.05745399801363586,
            "start_logit": 0.8629274964332581,
            "end_logit": 0.5921670794487
        },
        {
            "text": "semaglutide (0.5-1.0\u2009mg)",
            "probability": 0.047855398959941245,
            "start_logit": 0.8256171941757202,
            "end_logit": 0.44667673110961914
        }
    ],
    "58dbb8968acda3452900001b": [
        {
            "text": "analyze the information available about sudden unexpected death in epilepsy (SUDEP) and the",
            "probability": 0.14657807287662908,
            "start_logit": 1.024461030960083,
            "end_logit": 0.5839601755142212
        },
        {
            "text": "analyze the information available about sudden unexpected death in epilepsy (SUDEP) and the general perception of this condition",
            "probability": 0.13567045360881314,
            "start_logit": 1.024461030960083,
            "end_logit": 0.5066307783126831
        },
        {
            "text": "analyze the information available about sudden unexpected death in epilepsy (SUDEP) and the general perception of this",
            "probability": 0.1240333218666893,
            "start_logit": 1.024461030960083,
            "end_logit": 0.4169522225856781
        },
        {
            "text": "analyze the information",
            "probability": 0.11101418194251984,
            "start_logit": 1.024461030960083,
            "end_logit": 0.30605992674827576
        },
        {
            "text": "analyze the information available about sudden unexpected death in epilepsy (SUDEP) and the general perception of this condition by the public on",
            "probability": 0.10360290981682263,
            "start_logit": 1.024461030960083,
            "end_logit": 0.23696738481521606
        },
        {
            "text": "analyze the information available about sudden unexpected death in epilepsy (SUDEP)",
            "probability": 0.10077314549576898,
            "start_logit": 1.024461030960083,
            "end_logit": 0.20927387475967407
        },
        {
            "text": "analyze the information available",
            "probability": 0.09590850718099528,
            "start_logit": 1.024461030960083,
            "end_logit": 0.15979665517807007
        },
        {
            "text": "analyze the information available about sudden unexpected death in epilepsy (SUDEP) and the general perception of this condition by the",
            "probability": 0.0914644964189154,
            "start_logit": 1.024461030960083,
            "end_logit": 0.11235284805297852
        },
        {
            "text": "analyze the information available about sudden unexpected death in epilepsy (SUDEP) and the general perception",
            "probability": 0.09095491079284625,
            "start_logit": 1.024461030960083,
            "end_logit": 0.10676586627960205
        }
    ],
    "5886519c3b87a8a738000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58c6635f02b8c60953000023": [
        {
            "text": "of the important causes of hem",
            "probability": 0.3696683254326147,
            "start_logit": 0.9528031945228577,
            "end_logit": 0.439389169216156
        },
        {
            "text": "of the important causes of hemolytic anemia.",
            "probability": 0.32128558788411726,
            "start_logit": 0.9528031945228577,
            "end_logit": 0.299113392829895
        },
        {
            "text": "of the",
            "probability": 0.30904608668326805,
            "start_logit": 0.9528031945228577,
            "end_logit": 0.26027339696884155
        }
    ],
    "58861d413b87a8a738000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5880dba9c872c95565000009": [
        {
            "text": "gulated CDK activation in BC",
            "probability": 0.05863752858148916,
            "start_logit": 1.1706552505493164,
            "end_logit": 0.7200731039047241
        },
        {
            "text": "of breast cancer. Furthermore, ongoing studies identified more selective CDK inhibitors as promising clinical targets. In this review, we focus",
            "probability": 0.05705891828067852,
            "start_logit": 1.079563856124878,
            "end_logit": 0.783873975276947
        },
        {
            "text": "this review, we focus on the roles of CDKs in driving cell-cycle progression, cell-cycle checkpoints,",
            "probability": 0.056779077210985025,
            "start_logit": 0.9301095008850098,
            "end_logit": 0.9284118413925171
        },
        {
            "text": "), as well as other sub-",
            "probability": 0.05442859227681037,
            "start_logit": 0.972970724105835,
            "end_logit": 0.84327232837677
        },
        {
            "text": "gulated CDK activation in BC. We also discuss the most relevant CDK inhibitors currently in clinical BC trials, with special emphasis on",
            "probability": 0.05418350165601172,
            "start_logit": 1.1706552505493164,
            "end_logit": 0.6410746574401855
        },
        {
            "text": "of breast cancer. Furthermore, ongoing studies identified more selective CDK inhibitors as",
            "probability": 0.05308583210748945,
            "start_logit": 1.079563856124878,
            "end_logit": 0.7116996645927429
        },
        {
            "text": "gulated",
            "probability": 0.05307566030076514,
            "start_logit": 1.1706552505493164,
            "end_logit": 0.6204166412353516
        },
        {
            "text": "gulated CDK activation in BC. We also discuss the most relevant CDK",
            "probability": 0.05260381885688605,
            "start_logit": 1.1706552505493164,
            "end_logit": 0.6114869117736816
        },
        {
            "text": "gulated CDK activation in BC. We also discuss the most relevant CDK inhibitors currently in clinical BC trials,",
            "probability": 0.051683081554933834,
            "start_logit": 1.1706552505493164,
            "end_logit": 0.5938286781311035
        },
        {
            "text": "agents, were approved by the",
            "probability": 0.05099003148165583,
            "start_logit": 0.9767293930053711,
            "end_logit": 0.7742542028427124
        },
        {
            "text": "this review, we focus",
            "probability": 0.0491378705984469,
            "start_logit": 0.9301095008850098,
            "end_logit": 0.783873975276947
        },
        {
            "text": "selective CDK inhibitors as promising clinical targets. In this review, we focus",
            "probability": 0.04865624308045858,
            "start_logit": 0.9202595949172974,
            "end_logit": 0.783873975276947
        },
        {
            "text": "), as well as other sub-types of breast cancer. Furthermore, ongoing studies identified more selective CDK inhibitors as",
            "probability": 0.04771839415816503,
            "start_logit": 0.972970724105835,
            "end_logit": 0.7116996645927429
        },
        {
            "text": "ated CDK activation in BC",
            "probability": 0.04546487398523748,
            "start_logit": 0.9162203669548035,
            "end_logit": 0.7200731039047241
        },
        {
            "text": "selective CDK inhibitors as",
            "probability": 0.04526824603376802,
            "start_logit": 0.9202595949172974,
            "end_logit": 0.7116996645927429
        },
        {
            "text": "), as well as other",
            "probability": 0.04452359237449981,
            "start_logit": 0.972970724105835,
            "end_logit": 0.642401933670044
        },
        {
            "text": "this review, we focus on the roles of CDKs in driving cell-cycle progression, cell",
            "probability": 0.044405225402468995,
            "start_logit": 0.9301095008850098,
            "end_logit": 0.6826010942459106
        },
        {
            "text": "agents,",
            "probability": 0.04430501858187326,
            "start_logit": 0.9767293930053711,
            "end_logit": 0.6337220072746277
        },
        {
            "text": "clins and CDK inhibitors (CKIs). CDKs are key regulatory enzymes involved in cell proliferation through regulating cell-",
            "probability": 0.0440245083129532,
            "start_logit": 0.9219089150428772,
            "end_logit": 0.682191014289856
        },
        {
            "text": "selective CDK inhibitors as promising clinical targets. In this review, we focus on the roles of CDKs in driving cell-cycle progression, cell",
            "probability": 0.04396998516442378,
            "start_logit": 0.9202595949172974,
            "end_logit": 0.6826010942459106
        }
    ],
    "58f4b2f070f9fc6f0f000012": [
        {
            "text": "Secondary endpoints included resting",
            "probability": 0.07571699723377814,
            "start_logit": 1.1483964920043945,
            "end_logit": 1.1087677478790283
        },
        {
            "text": "-deoxy-d-glucose (18F-FDG) PET/CT. Secondary endpoints included resting",
            "probability": 0.057984814988907375,
            "start_logit": 0.8815749883651733,
            "end_logit": 1.1087677478790283
        },
        {
            "text": "-2-fluoro-",
            "probability": 0.0565645910555652,
            "start_logit": 0.852445662021637,
            "end_logit": 1.1130990982055664
        },
        {
            "text": ") PET/CT. Secondary endpoints included resting",
            "probability": 0.05452795241714266,
            "start_logit": 0.8201072812080383,
            "end_logit": 1.1087677478790283
        },
        {
            "text": "flammatory capabilities, increased with acute treatment and was 35% higher upon completion",
            "probability": 0.05328631169819727,
            "start_logit": 1.1763031482696533,
            "end_logit": 0.7295379042625427
        },
        {
            "text": "116, DK071013, and D",
            "probability": 0.053242204243557426,
            "start_logit": 1.0653753280639648,
            "end_logit": 0.8396376371383667
        },
        {
            "text": "-",
            "probability": 0.050831369353194295,
            "start_logit": 0.8815749883651733,
            "end_logit": 0.9771002531051636
        },
        {
            "text": "F-FDG) PET/CT. Secondary endpoints included resting",
            "probability": 0.05067483159060822,
            "start_logit": 0.7468231916427612,
            "end_logit": 1.1087677478790283
        },
        {
            "text": "Secondary endpoints included resting energy expenditure (REE), plasma meta",
            "probability": 0.049640320663880244,
            "start_logit": 1.1483964920043945,
            "end_logit": 0.6865684986114502
        },
        {
            "text": "-2-fluoro-d-2-",
            "probability": 0.04937204358230771,
            "start_logit": 0.852445662021637,
            "end_logit": 0.9771002531051636
        },
        {
            "text": "gron and support the investigation of \u03b23-",
            "probability": 0.049271933939166984,
            "start_logit": 0.9825952053070068,
            "end_logit": 0.8449209928512573
        },
        {
            "text": "weeks in an open-",
            "probability": 0.04804096121545179,
            "start_logit": 0.7629861831665039,
            "end_logit": 1.039229393005371
        },
        {
            "text": "etriq extended-release tablet, Astellas Pharma) for 4 weeks in an open-",
            "probability": 0.04727648776311605,
            "start_logit": 0.7469452619552612,
            "end_logit": 1.039229393005371
        },
        {
            "text": "indicate that human BAT metabolic activity can be increased after chronic pharmacological stimulation with mirabegron and support the investigation of \u03b23-",
            "probability": 0.04556303577823553,
            "start_logit": 0.9043373465538025,
            "end_logit": 0.8449209928512573
        },
        {
            "text": "has",
            "probability": 0.044163819772540774,
            "start_logit": 0.9826259016990662,
            "end_logit": 0.7354415655136108
        },
        {
            "text": "has antidiabetic and antiinflammatory capabilities, increased with acute treatment and was 35% higher upon completion",
            "probability": 0.043903859654325576,
            "start_logit": 0.9826259016990662,
            "end_logit": 0.7295379042625427
        },
        {
            "text": "-2-fluoro-d-",
            "probability": 0.043830439292469034,
            "start_logit": 0.852445662021637,
            "end_logit": 0.858044445514679
        },
        {
            "text": "13, and D",
            "probability": 0.042884026277810225,
            "start_logit": 0.8490233421325684,
            "end_logit": 0.8396376371383667
        },
        {
            "text": "be increased after chronic pharmacological stimulation with mirabegron and support the investigation of \u03b23-",
            "probability": 0.042514762597348994,
            "start_logit": 0.8350919485092163,
            "end_logit": 0.8449209928512573
        },
        {
            "text": "caltrials.gov NCT03049462.FUNDINGThis work was supported by grants from the Intramural Research Program of the",
            "probability": 0.04070923688239659,
            "start_logit": 0.8406292200088501,
            "end_logit": 0.7959873676300049
        }
    ],
    "58efa36d70f9fc6f0f000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58e9f0ba3e8b6dc87c00000e": [
        {
            "text": "Triticum aestivum L) possesses abiotic stress alleviating properties and produces several types of enzymes. However, its gen",
            "probability": 0.14974953407358516,
            "start_logit": 0.88969886302948,
            "end_logit": 0.8150002956390381
        },
        {
            "text": "% and there were 4",
            "probability": 0.13142800608501956,
            "start_logit": 1.0269756317138672,
            "end_logit": 0.5472186207771301
        },
        {
            "text": "53% and there were 4",
            "probability": 0.13004995096666805,
            "start_logit": 1.0164350271224976,
            "end_logit": 0.5472186207771301
        },
        {
            "text": "% and there were 4 170 coding genes, 114 pseudo genes, 30 rRNAs, 86 tR",
            "probability": 0.1197956040145016,
            "start_logit": 1.0269756317138672,
            "end_logit": 0.45454639196395874
        },
        {
            "text": "llus sp. WR11 isolated from the root of wheat (Triticum aestivu",
            "probability": 0.11928061501667533,
            "start_logit": 0.9072946906089783,
            "end_logit": 0.5699191689491272
        },
        {
            "text": "53% and there were 4 170 coding genes, 114 pseudo genes, 30 rRNAs, 86 tR",
            "probability": 0.1185395175061101,
            "start_logit": 1.0164350271224976,
            "end_logit": 0.45454639196395874
        },
        {
            "text": "Triticum aestivu",
            "probability": 0.11720013147458762,
            "start_logit": 0.88969886302948,
            "end_logit": 0.5699191689491272
        },
        {
            "text": "Triticum aestivum L) possesses abiotic stress alleviating properties and produces several",
            "probability": 0.11395664086285262,
            "start_logit": 0.88969886302948,
            "end_logit": 0.541854202747345
        }
    ],
    "58b6d6f322d300530900000f": [
        {
            "text": "recessively-",
            "probability": 0.18969193253254557,
            "start_logit": 0.939262866973877,
            "end_logit": 0.8337627053260803
        },
        {
            "text": "recessively-inherited form of rickets caused by homozygous or compound heterozy",
            "probability": 0.15937422512484656,
            "start_logit": 0.939262866973877,
            "end_logit": 0.6596164107322693
        },
        {
            "text": "recessively",
            "probability": 0.12097168516889369,
            "start_logit": 0.939262866973877,
            "end_logit": 0.3839178681373596
        },
        {
            "text": "recessively-inherited",
            "probability": 0.11631283657766156,
            "start_logit": 0.939262866973877,
            "end_logit": 0.34464478492736816
        },
        {
            "text": "recess",
            "probability": 0.1121046785956118,
            "start_logit": 0.939262866973877,
            "end_logit": 0.3077944219112396
        },
        {
            "text": "recessively-inherited form of rickets caused by homozygous or compound heterozygous mutations in the",
            "probability": 0.11135974404865125,
            "start_logit": 0.939262866973877,
            "end_logit": 0.30112725496292114
        },
        {
            "text": "recessively-inherited form of rickets caused by homozygo",
            "probability": 0.09605067020249641,
            "start_logit": 0.939262866973877,
            "end_logit": 0.1532372236251831
        },
        {
            "text": "recessively-inherited form of rickets",
            "probability": 0.09413422774929314,
            "start_logit": 0.939262866973877,
            "end_logit": 0.13308307528495789
        }
    ],
    "58f4b1a170f9fc6f0f000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "589317e849702f2e01000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58e74bff3e8b6dc87c000004": [
        {
            "text": "disposition for malignancies. Ribosomal proteins are responsible for this syndrome, and the incidence of colorectal cancer in patients",
            "probability": 0.1893836039963419,
            "start_logit": 0.8777479529380798,
            "end_logit": 0.8370823860168457
        },
        {
            "text": "dis",
            "probability": 0.1557376015231767,
            "start_logit": 0.8777479529380798,
            "end_logit": 0.6414803266525269
        },
        {
            "text": "colorectal cancer than usual.",
            "probability": 0.1522665594687772,
            "start_logit": 1.1398221254348755,
            "end_logit": 0.3568662703037262
        },
        {
            "text": "caused by it. In his cancer, ribosomal proteins S19 and TP",
            "probability": 0.13350471194127891,
            "start_logit": 0.9372245073318481,
            "end_logit": 0.42796799540519714
        },
        {
            "text": "colorectal cancer caused by it. In his cancer, ribosomal proteins S19 and TP",
            "probability": 0.12550279978010678,
            "start_logit": 0.8754158020019531,
            "end_logit": 0.42796799540519714
        },
        {
            "text": "disposition for mali",
            "probability": 0.12209163707831461,
            "start_logit": 0.8777479529380798,
            "end_logit": 0.39807966351509094
        },
        {
            "text": "disposition for malignancies. Ribosomal proteins are responsible for this syndrome, and the incidence",
            "probability": 0.12151308621200378,
            "start_logit": 0.8777479529380798,
            "end_logit": 0.3933297395706177
        }
    ],
    "58eb9542eda5a57672000007": [
        {
            "text": "protein in vivo.",
            "probability": 0.07307333237401933,
            "start_logit": 0.9815258979797363,
            "end_logit": 0.9431242942810059
        },
        {
            "text": "mic, and the function of this fraction is not fully",
            "probability": 0.06414281015711272,
            "start_logit": 0.9738306403160095,
            "end_logit": 0.8204680681228638
        },
        {
            "text": "snRNA primary",
            "probability": 0.06325736774821483,
            "start_logit": 0.9468836784362793,
            "end_logit": 0.8335146307945251
        },
        {
            "text": "snRNA primary transcript in vitro, and that coilin knockdown results in accumulation",
            "probability": 0.058438099522075654,
            "start_logit": 0.9468836784362793,
            "end_logit": 0.7542710900306702
        },
        {
            "text": "is not fully",
            "probability": 0.05746595906077286,
            "start_logit": 0.8639113903045654,
            "end_logit": 0.8204680681228638
        },
        {
            "text": "clear domains important for the biogenesis of small nuclear ribonucleoproteins (snRNPs) which function in pre-",
            "probability": 0.05308294529146488,
            "start_logit": 0.9124681353569031,
            "end_logit": 0.6925742626190186
        },
        {
            "text": "snRNA primary transcript in vitro, and that coilin knockdown results in accumulation of the",
            "probability": 0.05279437297148765,
            "start_logit": 0.9468836784362793,
            "end_logit": 0.6527076363563538
        },
        {
            "text": "mic, and the function of this fraction is not fully characterized. Here we",
            "probability": 0.05212140278453311,
            "start_logit": 0.9738306403160095,
            "end_logit": 0.6129317283630371
        },
        {
            "text": "of the",
            "probability": 0.05205252358569441,
            "start_logit": 0.932732343673706,
            "end_logit": 0.6527076363563538
        },
        {
            "text": "clear domains important for the biogenesis of small",
            "probability": 0.051264999961503785,
            "start_logit": 0.9124681353569031,
            "end_logit": 0.6577268242835999
        },
        {
            "text": "mic, and the function of this",
            "probability": 0.049970522181669134,
            "start_logit": 0.9738306403160095,
            "end_logit": 0.5707893371582031
        },
        {
            "text": "activity in vitro. U1 and U2 snRNAs undergo",
            "probability": 0.048496573544389555,
            "start_logit": 0.8713974952697754,
            "end_logit": 0.6432823538780212
        },
        {
            "text": "of the 3' pre-processed U1 and U2 snRNA. These findings",
            "probability": 0.0475895073332234,
            "start_logit": 0.932732343673706,
            "end_logit": 0.5630666613578796
        },
        {
            "text": "snRNA primary transcript in vitro, and that coilin knockdown results in accumulation of the 3' pre-processed",
            "probability": 0.047074054893031896,
            "start_logit": 0.9468836784362793,
            "end_logit": 0.5380250215530396
        },
        {
            "text": "clear domains important for the biogenesis of small nuclear",
            "probability": 0.04679868259884469,
            "start_logit": 0.9124681353569031,
            "end_logit": 0.5665736198425293
        },
        {
            "text": "is not fully characterized. Here we",
            "probability": 0.046695902335265826,
            "start_logit": 0.8639113903045654,
            "end_logit": 0.6129317283630371
        },
        {
            "text": "of the 3' pre-processed",
            "probability": 0.046412585559395654,
            "start_logit": 0.932732343673706,
            "end_logit": 0.5380250215530396
        },
        {
            "text": "activity in vitro. U1 and U2 snRNAs undergo a processing event of the primary transcript prior",
            "probability": 0.04517453930684497,
            "start_logit": 0.8713974952697754,
            "end_logit": 0.5723228454589844
        },
        {
            "text": "activity in vitro. U1 and U2 snRNAs undergo a processing event of the",
            "probability": 0.044093818790455715,
            "start_logit": 0.8713974952697754,
            "end_logit": 0.5481088161468506
        }
    ],
    "58cbd0d502b8c60953000035": [
        {
            "text": "lethal disorder caused by mutations in the LYST",
            "probability": 0.060084424722155805,
            "start_logit": 1.1929090023040771,
            "end_logit": 0.6427984237670898
        },
        {
            "text": "lethal disorder caused by mutations in the LYST gene that involves progressive neurologic dysfunction.",
            "probability": 0.057880656747629766,
            "start_logit": 1.1929090023040771,
            "end_logit": 0.6054310202598572
        },
        {
            "text": "Purkinje cell quantifications likewise distinguished phenotypes of Lyst-mutant mice, as well as background differences",
            "probability": 0.05677623809108221,
            "start_logit": 0.9284958243370056,
            "end_logit": 0.8505788445472717
        },
        {
            "text": "loss of cerebellar",
            "probability": 0.05324945916919689,
            "start_logit": 1.0107684135437012,
            "end_logit": 0.7041760087013245
        },
        {
            "text": "loss of cerebellar Purkinje cells. Here, we tested whether assays for ataxia could measure this observed strain-",
            "probability": 0.05285267878829863,
            "start_logit": 1.0107684135437012,
            "end_logit": 0.6966967582702637
        },
        {
            "text": "Purkinje cell quantifications likewise distinguished phenotypes of Lyst-mutant mice, as well as background differences between wild-",
            "probability": 0.05261872075665244,
            "start_logit": 0.9284958243370056,
            "end_logit": 0.7745329141616821
        },
        {
            "text": ". A composite phenotypic scoring system distinguished phenotypes in Lyst-",
            "probability": 0.05218598847478455,
            "start_logit": 0.8530738353729248,
            "end_logit": 0.8416969776153564
        },
        {
            "text": "Purkinje cell quanti",
            "probability": 0.051015686312866064,
            "start_logit": 0.9284958243370056,
            "end_logit": 0.7435941100120544
        },
        {
            "text": "CHS-associated neurologic deficits. Purkinje cell quanti",
            "probability": 0.049610912911537006,
            "start_logit": 0.9005734920501709,
            "end_logit": 0.7435941100120544
        },
        {
            "text": "of cerebellar",
            "probability": 0.04947907131947923,
            "start_logit": 0.9373305439949036,
            "end_logit": 0.7041760087013245
        },
        {
            "text": "of cerebellar Purkinje cells. Here, we tested whether assays for ataxia could measure this observed strain-",
            "probability": 0.049110385419736,
            "start_logit": 0.9373305439949036,
            "end_logit": 0.6966967582702637
        },
        {
            "text": "types of Lyst-mutant mice, as well as background differences",
            "probability": 0.04856111326465336,
            "start_logit": 0.7722010016441345,
            "end_logit": 0.8505788445472717
        },
        {
            "text": ". A composite phenotypic scoring system distinguished phenotypes in Lyst",
            "probability": 0.048183690171912555,
            "start_logit": 0.8530738353729248,
            "end_logit": 0.7619035243988037
        },
        {
            "text": "enotypes in Lyst-",
            "probability": 0.04799466114154606,
            "start_logit": 0.7693495750427246,
            "end_logit": 0.8416969776153564
        },
        {
            "text": "is a lethal disorder caused by mutations in the LYST",
            "probability": 0.04583582781631164,
            "start_logit": 0.9222244024276733,
            "end_logit": 0.6427984237670898
        },
        {
            "text": "cerebellar",
            "probability": 0.04538381699980994,
            "start_logit": 0.8509363532066345,
            "end_logit": 0.7041760087013245
        },
        {
            "text": "cerebellar Purkinje cells. Here, we tested whether assays for ataxia could measure this observed strain-",
            "probability": 0.04504564627513488,
            "start_logit": 0.8509363532066345,
            "end_logit": 0.6966967582702637
        },
        {
            "text": "types of Lyst-mutant mice, as well as background differences between wild-",
            "probability": 0.045005159630439,
            "start_logit": 0.7722010016441345,
            "end_logit": 0.7745329141616821
        },
        {
            "text": "fications likewise distinguished phenotypes of Lyst-mutant mice, as well as background differences",
            "probability": 0.044660021371147315,
            "start_logit": 0.688456654548645,
            "end_logit": 0.8505788445472717
        },
        {
            "text": "uncovered a previously unrecognized background difference between wild-type C57",
            "probability": 0.04446584061562669,
            "start_logit": 0.8655486702919006,
            "end_logit": 0.6691293716430664
        }
    ],
    "58f3ca5c70f9fc6f0f00000d": [
        {
            "text": "oxynivalenol genotype. F. graminearum isolation",
            "probability": 0.06894249165980025,
            "start_logit": 1.0831336975097656,
            "end_logit": 0.8748754858970642
        },
        {
            "text": ".7% had the 3-acetyldeoxynivalenol genotype. F. graminearum isolation",
            "probability": 0.06487483978907337,
            "start_logit": 1.0223208665847778,
            "end_logit": 0.8748754858970642
        },
        {
            "text": ".",
            "probability": 0.06260860825509154,
            "start_logit": 1.0223208665847778,
            "end_logit": 0.8393183946609497
        },
        {
            "text": "oxynivalenol gen",
            "probability": 0.06210802621188128,
            "start_logit": 0.9694856405258179,
            "end_logit": 0.8841260671615601
        },
        {
            "text": "graminearum isolation",
            "probability": 0.061719481889099786,
            "start_logit": 0.9724606275558472,
            "end_logit": 0.8748754858970642
        },
        {
            "text": "of infection remain unclear. We",
            "probability": 0.060851864318619775,
            "start_logit": 0.9697556495666504,
            "end_logit": 0.8634232878684998
        },
        {
            "text": "< 10%)",
            "probability": 0.060303142682406594,
            "start_logit": 1.060436487197876,
            "end_logit": 0.7636842131614685
        },
        {
            "text": "oxynivalenol genotype and 26.",
            "probability": 0.05938653722610513,
            "start_logit": 0.9694856405258179,
            "end_logit": 0.8393183946609497
        },
        {
            "text": "oxynivalen",
            "probability": 0.05759923729238943,
            "start_logit": 0.9694856405258179,
            "end_logit": 0.8087601661682129
        },
        {
            "text": "graminearum isolation rates from weeds (> 50%) were much higher than from soil (< 10%)",
            "probability": 0.055224591937339515,
            "start_logit": 0.9724606275558472,
            "end_logit": 0.7636842131614685
        },
        {
            "text": ".7% had the 3-",
            "probability": 0.05359614014946442,
            "start_logit": 1.0223208665847778,
            "end_logit": 0.6838926672935486
        },
        {
            "text": "oxynivalenol genotype. F. graminearum isolation rates from weeds (> 50%) were much higher than from soil",
            "probability": 0.051717124303025185,
            "start_logit": 1.0831336975097656,
            "end_logit": 0.58739173412323
        },
        {
            "text": "oxynivalenol genotype and 26.7% had the 3-",
            "probability": 0.050837884132376845,
            "start_logit": 0.9694856405258179,
            "end_logit": 0.6838926672935486
        },
        {
            "text": "much higher than from soil (< 10%)",
            "probability": 0.05027946128569481,
            "start_logit": 0.8786489367485046,
            "end_logit": 0.7636842131614685
        },
        {
            "text": "number of tandem repeat (VNTR) markers were used for population analysis.",
            "probability": 0.04883362841906735,
            "start_logit": 0.8380193710327148,
            "end_logit": 0.7751362919807434
        },
        {
            "text": "graminearum isolation rates from weeds (> 50%) were much higher than from soil",
            "probability": 0.046298792514313555,
            "start_logit": 0.9724606275558472,
            "end_logit": 0.58739173412323
        },
        {
            "text": "Noticeable genetic differentiation was detected between isolates from living plants and soil biome. In contrast, absence",
            "probability": 0.04266521815906748,
            "start_logit": 0.8902970552444458,
            "end_logit": 0.5878234505653381
        },
        {
            "text": "much higher than from soil",
            "probability": 0.042152929775183645,
            "start_logit": 0.8786489367485046,
            "end_logit": 0.58739173412323
        }
    ],
    "587e3e302420191125000002": [
        {
            "text": "simplify analyzing and interpreting ChIP-",
            "probability": 0.07355212041547894,
            "start_logit": 1.0826361179351807,
            "end_logit": 0.7447807788848877
        },
        {
            "text": "ductor packages. Using a standard multicore computer, it can be used with datasets consisting",
            "probability": 0.06865985118189698,
            "start_logit": 1.1479586362838745,
            "end_logit": 0.610628604888916
        },
        {
            "text": "DNA association of transcription factors. To simplify analyzing and interpreting ChIP-",
            "probability": 0.06617123561670794,
            "start_logit": 0.9768877029418945,
            "end_logit": 0.7447807788848877
        },
        {
            "text": "simplify analyzing and interpreting ChIP-Seq data, which typically involves using multiple applications, we describe an integrated, open source, R",
            "probability": 0.06256737769523311,
            "start_logit": 1.0826361179351807,
            "end_logit": 0.5830305218696594
        },
        {
            "text": "ductor packages. Using a",
            "probability": 0.061677351633031195,
            "start_logit": 1.1479586362838745,
            "end_logit": 0.5033807754516602
        },
        {
            "text": "Seq datasets for FOXA1, ER, CTCF",
            "probability": 0.058460742540302375,
            "start_logit": 0.8728035688400269,
            "end_logit": 0.724974513053894
        },
        {
            "text": "where it detected co-",
            "probability": 0.05592153035891631,
            "start_logit": 0.9047737121582031,
            "end_logit": 0.6485983729362488
        },
        {
            "text": "Seq datasets for FOXA1, ER,",
            "probability": 0.05515886346598956,
            "start_logit": 0.8728035688400269,
            "end_logit": 0.6668365001678467
        },
        {
            "text": "simplify analyzing and interpreting ChIP-Seq data, which typically involves using multiple applications, we",
            "probability": 0.05487519244743498,
            "start_logit": 1.0826361179351807,
            "end_logit": 0.4518478810787201
        },
        {
            "text": "visualization, and data export, and can readily be extended via other",
            "probability": 0.054408141583343256,
            "start_logit": 0.9617820978164673,
            "end_logit": 0.564154326915741
        },
        {
            "text": "Seq datasets for FOXA1, ER, CTCF and STAT1, where it detected co-",
            "probability": 0.0541619873056337,
            "start_logit": 0.8728035688400269,
            "end_logit": 0.6485983729362488
        },
        {
            "text": "ctor packages. Using a standard multicore computer, it can be used with datasets consisting",
            "probability": 0.05186329009943174,
            "start_logit": 0.8674052357673645,
            "end_logit": 0.610628604888916
        },
        {
            "text": "visualization, and data export, and can readily be extended via other R and Bioconductor packages. Using a",
            "probability": 0.05120003689538409,
            "start_logit": 0.9617820978164673,
            "end_logit": 0.5033807754516602
        },
        {
            "text": "DNA association of transcription factors. To simplify analyzing and interpreting ChIP-Seq data, which typically involves using multiple applications, we",
            "probability": 0.04936851947217608,
            "start_logit": 0.9768877029418945,
            "end_logit": 0.4518478810787201
        },
        {
            "text": "ctor packages. Using a",
            "probability": 0.04658895009594715,
            "start_logit": 0.8674052357673645,
            "end_logit": 0.5033807754516602
        },
        {
            "text": "Seq datasets for FOX",
            "probability": 0.04552961671765098,
            "start_logit": 0.8728035688400269,
            "end_logit": 0.4749820828437805
        },
        {
            "text": "where it detected co-occurring motifs that were consistent with the literature but not detected",
            "probability": 0.04549498853410774,
            "start_logit": 0.9047737121582031,
            "end_logit": 0.4422510862350464
        },
        {
            "text": "Seq datasets for FOXA1,",
            "probability": 0.044340203941333825,
            "start_logit": 0.8728035688400269,
            "end_logit": 0.4485108554363251
        }
    ],
    "58e9e7aa3e8b6dc87c00000d": [
        {
            "text": "genome evolution remains obscure. We",
            "probability": 0.10334735724609931,
            "start_logit": 0.8960632681846619,
            "end_logit": 0.8647693395614624
        },
        {
            "text": "alternative allele at edited sites and G alleles",
            "probability": 0.09541174734246907,
            "start_logit": 0.8472999334335327,
            "end_logit": 0.8336386680603027
        },
        {
            "text": "dited sites, the nucleotide G is virtually the unique alternative allele at edited sites and G alleles",
            "probability": 0.0920957663804111,
            "start_logit": 0.8119271993637085,
            "end_logit": 0.8336386680603027
        },
        {
            "text": "I RNA edited sites in humans and Drosophila melanogaster. We found that single",
            "probability": 0.08688406236285698,
            "start_logit": 0.9242411851882935,
            "end_logit": 0.6630703210830688
        },
        {
            "text": "I RNA edited sites in humans and Drosophila melanogaster. We found that single nucleotide polymorphisms at edited sites occur 3",
            "probability": 0.0861471081174896,
            "start_logit": 0.9242411851882935,
            "end_logit": 0.6545521020889282
        },
        {
            "text": "genome evolution remains obscure. We looked for population genomics signatures of adaptive evolution associated with A-to-",
            "probability": 0.08532626656978086,
            "start_logit": 0.8960632681846619,
            "end_logit": 0.6731559634208679
        },
        {
            "text": "dited sites, the",
            "probability": 0.08426004454880277,
            "start_logit": 0.8119271993637085,
            "end_logit": 0.7447174787521362
        },
        {
            "text": "edited sites than at unedited sites. Our study reveals that a significant fraction of",
            "probability": 0.07939057614394451,
            "start_logit": 0.9095215797424316,
            "end_logit": 0.5875949859619141
        },
        {
            "text": "genome evolution",
            "probability": 0.07668601769278073,
            "start_logit": 0.8960632681846619,
            "end_logit": 0.5663930177688599
        },
        {
            "text": "human and Drosophila lineage",
            "probability": 0.07357108956190447,
            "start_logit": 0.803142786026001,
            "end_logit": 0.6178462505340576
        },
        {
            "text": "alternative allele",
            "probability": 0.06965031046120265,
            "start_logit": 0.8472999334335327,
            "end_logit": 0.5189241170883179
        },
        {
            "text": "dited sites, the nucleotide G is virtually the unique alternative allele",
            "probability": 0.06722965357225819,
            "start_logit": 0.8119271993637085,
            "end_logit": 0.5189241170883179
        }
    ],
    "58da1aa08acda34529000012": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58e3d9ab3e8b6dc87c000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58ea7248eda5a57672000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58eb4ce7eda5a57672000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58f3c4b970f9fc6f0f00000a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58efa1b870f9fc6f0f000003": [
        {
            "text": "be repurposed",
            "probability": 0.08572587675793118,
            "start_logit": 0.8789290189743042,
            "end_logit": 0.9235520958900452
        },
        {
            "text": "injury, we identify universal cellular mechanisms that may underlie the cognitive deficits in chemobrain.",
            "probability": 0.08499114208495986,
            "start_logit": 0.9600934982299805,
            "end_logit": 0.8337799310684204
        },
        {
            "text": "unmet clinical need. Here",
            "probability": 0.06610679633121576,
            "start_logit": 0.9024427533149719,
            "end_logit": 0.6401551961898804
        },
        {
            "text": "injury, we identify universal cellular mechanisms that may underlie the cognitive deficits in chemobra",
            "probability": 0.06561708991962144,
            "start_logit": 0.9600934982299805,
            "end_logit": 0.5750690698623657
        },
        {
            "text": "be repurposed as treatments for chemobrain, some of which were",
            "probability": 0.06492220949933422,
            "start_logit": 0.8789290189743042,
            "end_logit": 0.645587146282196
        },
        {
            "text": "injury, we identify universal cellular mechanisms that may underlie the cognitive deficits in chemobrain. We further identify existing",
            "probability": 0.0644852150795693,
            "start_logit": 0.9600934982299805,
            "end_logit": 0.5576688647270203
        },
        {
            "text": "unmet clinical need. Here, we",
            "probability": 0.06299743180712503,
            "start_logit": 0.9024427533149719,
            "end_logit": 0.591977596282959
        },
        {
            "text": "injury, we identify universal cellular mechanisms that may underlie the cognitive deficits in chemobrain. We further",
            "probability": 0.061327065212864816,
            "start_logit": 0.9600934982299805,
            "end_logit": 0.5074541568756104
        },
        {
            "text": "be repurposed as treatments",
            "probability": 0.061217443479682894,
            "start_logit": 0.8789290189743042,
            "end_logit": 0.5868295431137085
        },
        {
            "text": "steps to further advance",
            "probability": 0.06094492494635544,
            "start_logit": 0.9549341797828674,
            "end_logit": 0.506362795829773
        },
        {
            "text": "unmet clinical need. Here, we leverage the extensive knowledge in various fields of neuroscience to gain insights",
            "probability": 0.05938775759783864,
            "start_logit": 0.9024427533149719,
            "end_logit": 0.5329717397689819
        },
        {
            "text": "unmet clinical need. Here, we leverage",
            "probability": 0.05560102831667757,
            "start_logit": 0.9024427533149719,
            "end_logit": 0.4670853316783905
        },
        {
            "text": "unmet clinical need. Here, we leverage the extensive knowledge in various",
            "probability": 0.053474388729678336,
            "start_logit": 0.9024427533149719,
            "end_logit": 0.42808645963668823
        },
        {
            "text": "be repurposed as treatments for chemobrain, some of which were already shown to be effective in animal models. Finally, we briefly describe",
            "probability": 0.05250958169018585,
            "start_logit": 0.8789290189743042,
            "end_logit": 0.43339303135871887
        },
        {
            "text": "be effective in animal models. Finally, we briefly describe future steps to further advance",
            "probability": 0.052182078426646086,
            "start_logit": 0.7997027039527893,
            "end_logit": 0.506362795829773
        },
        {
            "text": "be effective in animal models. Finally, we briefly describe",
            "probability": 0.04850997012031358,
            "start_logit": 0.7997027039527893,
            "end_logit": 0.43339303135871887
        }
    ],
    "5890fde5621ea6ff7e000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58c27b7102b8c60953000021": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58f0b0c070f9fc6f0f000006": [
        {
            "text": "trabenazine has been studied less rigorously. There have been no blinded",
            "probability": 0.08120474429153544,
            "start_logit": 1.052306056022644,
            "end_logit": 1.1553010940551758
        },
        {
            "text": "tra",
            "probability": 0.07208765561064902,
            "start_logit": 1.260704755783081,
            "end_logit": 0.8278115391731262
        },
        {
            "text": "trabenazine and valbenazine. Given the favored side effect profile of newer VMAT2 inhibitors, clinicians",
            "probability": 0.06645124595540651,
            "start_logit": 1.260704755783081,
            "end_logit": 0.7463972568511963
        },
        {
            "text": "agents (deutetrabenazine and valbenazine). Tetrabenazine and deutetra",
            "probability": 0.057461523978289956,
            "start_logit": 0.9241204261779785,
            "end_logit": 0.9376286268234253
        },
        {
            "text": "azine have demonstrated safety and efficacy in the treatment of tardive dyskinesia, with multiple double-",
            "probability": 0.05612401264920841,
            "start_logit": 0.9794331789016724,
            "end_logit": 0.8587640523910522
        },
        {
            "text": "trabenazine and valbenazine.",
            "probability": 0.05445747897897241,
            "start_logit": 1.260704755783081,
            "end_logit": 0.5473489165306091
        },
        {
            "text": "profile of the newer agents (deutetrabenazine and valbenazine). Tetrabenazine and deutetra",
            "probability": 0.050892500610514056,
            "start_logit": 0.8027204275131226,
            "end_logit": 0.9376286268234253
        },
        {
            "text": "azine have demonstrated safety and efficacy in the treatment of tardive dyskinesia, with multiple double-blind, placebo-",
            "probability": 0.050379043103140966,
            "start_logit": 0.9794331789016724,
            "end_logit": 0.7507755756378174
        },
        {
            "text": "trabenazine has been studied less rigorously. There have",
            "probability": 0.05009923008142003,
            "start_logit": 1.052306056022644,
            "end_logit": 0.6723330616950989
        },
        {
            "text": "rea associated with Huntington's disease, including in randomized controlled trials, although direct",
            "probability": 0.049856395791170946,
            "start_logit": 1.1911039352416992,
            "end_logit": 0.5286763310432434
        },
        {
            "text": "use, especially as",
            "probability": 0.04808277348647021,
            "start_logit": 0.8263935446739197,
            "end_logit": 0.8571639060974121
        },
        {
            "text": "valbenazine). Tetrabenazine and deutetra",
            "probability": 0.04609053141569381,
            "start_logit": 0.7036123871803284,
            "end_logit": 0.9376286268234253
        },
        {
            "text": "azine have demonstrated",
            "probability": 0.043811345144498054,
            "start_logit": 0.9794331789016724,
            "end_logit": 0.6110931038856506
        },
        {
            "text": "trabenazine has",
            "probability": 0.04332430420014144,
            "start_logit": 1.052306056022644,
            "end_logit": 0.5270411968231201
        },
        {
            "text": "trabenazine has been studied less rigorously.",
            "probability": 0.04216808301155808,
            "start_logit": 1.052306056022644,
            "end_logit": 0.4999910295009613
        },
        {
            "text": "profile of the",
            "probability": 0.03823494302141694,
            "start_logit": 0.8027204275131226,
            "end_logit": 0.6516628861427307
        },
        {
            "text": "metabolism, and dosing vary significantly between the three drugs, and likely underlie",
            "probability": 0.03809489017930792,
            "start_logit": 0.7104029655456543,
            "end_logit": 0.7403106689453125
        },
        {
            "text": "trabenazine in Tourette's syndrome (TS); however, double-blind, placebo-",
            "probability": 0.037420394759287705,
            "start_logit": 0.8722944855690002,
            "end_logit": 0.5605548620223999
        },
        {
            "text": "azine, and valbenazine. Pharmacokinetics, metabolism, and dosing vary significantly between the three drugs,",
            "probability": 0.03707396100222073,
            "start_logit": 0.7484883069992065,
            "end_logit": 0.6750600337982178
        },
        {
            "text": "azine, and valbenazine. Pharmacokinetics, metabolism, and dosing vary significantly between the",
            "probability": 0.03668494272909748,
            "start_logit": 0.7484883069992065,
            "end_logit": 0.6645115613937378
        }
    ],
    "58f4b9d470f9fc6f0f000016": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5895f18ce370baff39000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58f6295a70f9fc6f0f000019": [
        {
            "text": ": parathormone, calcitonin and activated vitamin D (calcitriol), were localized on",
            "probability": 0.06980051552071992,
            "start_logit": 0.9803372025489807,
            "end_logit": 1.2240445613861084
        },
        {
            "text": "of estrogen receptors (ESR1, ES",
            "probability": 0.05591490575303066,
            "start_logit": 0.7391685247421265,
            "end_logit": 1.2434028387069702
        },
        {
            "text": "Additionally, the timing of calciotropic receptor appearance was compared with that of estrogen receptors (ESR1, ES",
            "probability": 0.055548994999701624,
            "start_logit": 0.7326029539108276,
            "end_logit": 1.2434028387069702
        },
        {
            "text": "appearance was compared with that of estrogen receptors (ESR1, ES",
            "probability": 0.05480075311914093,
            "start_logit": 0.7190414667129517,
            "end_logit": 1.2434028387069702
        },
        {
            "text": "short but critical period is characterized by synchronized cellular and molecular events. The m/a bone, as",
            "probability": 0.05380863311914985,
            "start_logit": 1.19768488407135,
            "end_logit": 0.746489405632019
        },
        {
            "text": "express the receptor for activated vitamin D (VDR). At this stage, the vasculature just penetrated the",
            "probability": 0.053770377883442785,
            "start_logit": 0.9484481811523438,
            "end_logit": 0.9950149059295654
        },
        {
            "text": "containing osteo-",
            "probability": 0.05334438146280437,
            "start_logit": 1.0603280067443848,
            "end_logit": 0.8751810193061829
        },
        {
            "text": "containing osteo-blasts, -cytes, -",
            "probability": 0.05171314246021639,
            "start_logit": 1.0603280067443848,
            "end_logit": 0.8441243171691895
        },
        {
            "text": "H1r) appeared",
            "probability": 0.050471027522412976,
            "start_logit": 1.163900375366211,
            "end_logit": 0.7162394523620605
        },
        {
            "text": "structure. Receptors for all",
            "probability": 0.0501692135676976,
            "start_logit": 1.0185221433639526,
            "end_logit": 0.8556197881698608
        },
        {
            "text": "m/a bone structure. Receptors for all",
            "probability": 0.049297688888136716,
            "start_logit": 1.00099778175354,
            "end_logit": 0.8556197881698608
        },
        {
            "text": "short but critical period is characterized",
            "probability": 0.047799186070324136,
            "start_logit": 1.19768488407135,
            "end_logit": 0.6280640959739685
        },
        {
            "text": "short but critical period is characterized by synchronized cellular and molecular events. The",
            "probability": 0.04650910559310385,
            "start_logit": 1.19768488407135,
            "end_logit": 0.6007035970687866
        },
        {
            "text": "express the receptor for activated vitamin D (VDR). At this stage, the vasculature just penetrated the forming bone. On",
            "probability": 0.04611565241674673,
            "start_logit": 0.9484481811523438,
            "end_logit": 0.8414446115493774
        },
        {
            "text": "senchymal condensation into the initial m/a bone structure. Receptors for all",
            "probability": 0.04514478449363322,
            "start_logit": 0.9129953384399414,
            "end_logit": 0.8556197881698608
        },
        {
            "text": "ation into the initial m/a bone structure. Receptors for all",
            "probability": 0.044838333736821334,
            "start_logit": 0.9061840176582336,
            "end_logit": 0.8556197881698608
        },
        {
            "text": "H1r) appeared in the bone already at",
            "probability": 0.043305585570409935,
            "start_logit": 1.163900375366211,
            "end_logit": 0.5631216168403625
        },
        {
            "text": "containing osteo-blasts, -cytes, -clasts) within only two days.",
            "probability": 0.04310496995569714,
            "start_logit": 1.0603280067443848,
            "end_logit": 0.6620506644248962
        },
        {
            "text": "express the receptor for activated vitamin D (VDR). At this stage, the vasculature just",
            "probability": 0.04238100522733716,
            "start_logit": 0.9484481811523438,
            "end_logit": 0.7569924592971802
        },
        {
            "text": ". At this stage, blood vessels were only lining the conde",
            "probability": 0.04216174263947273,
            "start_logit": 0.809868574142456,
            "end_logit": 0.8903850317001343
        }
    ],
    "58ee0dd5eda5a57672000013": [
        {
            "text": "T cells and dendr",
            "probability": 0.13146147261690097,
            "start_logit": 1.2275681495666504,
            "end_logit": 1.1095240116119385
        },
        {
            "text": "T cells and dendritic cells. Here, we discuss the relationship between obesity and leptin expression as well as",
            "probability": 0.10286418014627506,
            "start_logit": 1.2275681495666504,
            "end_logit": 0.8642196655273438
        },
        {
            "text": "T (Th) 17 axis pathway. Furthermore, leptin can have an effect on various types of immune cells such as T cells and dendr",
            "probability": 0.09093934360369539,
            "start_logit": 0.8590470552444458,
            "end_logit": 1.1095240116119385
        },
        {
            "text": "secretes many adipokines which contribute to various metabolic processes, such as blood pressure, glucose homeostasis",
            "probability": 0.07537901173382809,
            "start_logit": 1.0541207790374756,
            "end_logit": 0.7267864346504211
        },
        {
            "text": "T cells and dendritic cells. Here, we discuss",
            "probability": 0.07249747049615328,
            "start_logit": 1.2275681495666504,
            "end_logit": 0.5143618583679199
        },
        {
            "text": "T (Th) 17 axis pathway. Furthermore, leptin can have an effect on",
            "probability": 0.0706251578550767,
            "start_logit": 0.8590470552444458,
            "end_logit": 0.8567177057266235
        },
        {
            "text": "of leptin, a type of adipokine, increases dependently on",
            "probability": 0.06346777039510271,
            "start_logit": 0.9118436574935913,
            "end_logit": 0.6970669031143188
        },
        {
            "text": "development of leptin resistance, suggesting that lept",
            "probability": 0.06058661413978652,
            "start_logit": 0.8608987331390381,
            "end_logit": 0.7015535831451416
        },
        {
            "text": "of leptin,",
            "probability": 0.060151774148338215,
            "start_logit": 0.9118436574935913,
            "end_logit": 0.6434056162834167
        },
        {
            "text": "development of leptin resistance,",
            "probability": 0.05886901655913743,
            "start_logit": 0.8608987331390381,
            "end_logit": 0.67279452085495
        },
        {
            "text": "of leptin, a type of adipokine, increases dependently on adipose",
            "probability": 0.05542965299739402,
            "start_logit": 0.9118436574935913,
            "end_logit": 0.5616493821144104
        },
        {
            "text": "of leptin, a type of adipokine, increases dependently on adipose cell",
            "probability": 0.05445535160486925,
            "start_logit": 0.9118436574935913,
            "end_logit": 0.5439158082008362
        },
        {
            "text": "of leptin, a type of adipokine, increases dependently on adipose cell size and adipose accumulation",
            "probability": 0.0524984966034397,
            "start_logit": 0.9118436574935913,
            "end_logit": 0.5073192119598389
        },
        {
            "text": "T (Th) 17 axis pathway. Furthermore, leptin can have",
            "probability": 0.050774687100002824,
            "start_logit": 0.8590470552444458,
            "end_logit": 0.5267292261123657
        }
    ],
    "589635dd78275d0c4a000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5896271178275d0c4a000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "589630f378275d0c4a000007": [
        {
            "text": ". Low expression of the",
            "probability": 0.07375493209316974,
            "start_logit": 1.0114423036575317,
            "end_logit": 1.1347019672393799
        },
        {
            "text": "be sensitive to MLN7243-induced death. Low expression of the",
            "probability": 0.065692909645525,
            "start_logit": 0.8956854343414307,
            "end_logit": 1.1347019672393799
        },
        {
            "text": "-dependent death.",
            "probability": 0.05679363377466996,
            "start_logit": 0.8662410378456116,
            "end_logit": 1.0185796022415161
        },
        {
            "text": "omib and the ubiquitin E1 enzyme inhibitor MLN7243/TAK-243 on",
            "probability": 0.05480145933846813,
            "start_logit": 1.0385431051254272,
            "end_logit": 0.8105701208114624
        },
        {
            "text": "conferring susceptibility to MLN7243 by increasing sensitivity to MLN7243-",
            "probability": 0.05343568848137773,
            "start_logit": 1.2874250411987305,
            "end_logit": 0.536450207233429
        },
        {
            "text": "omib and the ubiquitin E1 enzyme inhibitor MLN7243/TAK-",
            "probability": 0.053064736580231635,
            "start_logit": 1.0385431051254272,
            "end_logit": 0.7783659100532532
        },
        {
            "text": "further investigation of the potential of proteasome and ubiquitin E1 inhibition for cSCC therapy. Direct delivery of inhibitors could",
            "probability": 0.04898753103907223,
            "start_logit": 1.0436296463012695,
            "end_logit": 0.6933325529098511
        },
        {
            "text": "further investigation of the potential of proteasome and ubiquitin E1 inhibition",
            "probability": 0.048787609750410486,
            "start_logit": 1.0436296463012695,
            "end_logit": 0.6892431378364563
        },
        {
            "text": "of cSCC cell line sensitivity/resistance. Variations in the responses to proteasome inhibitors are associated with differences",
            "probability": 0.048362216132046706,
            "start_logit": 1.0508614778518677,
            "end_logit": 0.6732537746429443
        },
        {
            "text": "lines. The effects of both a pulse of treatment and",
            "probability": 0.048214989280332826,
            "start_logit": 1.201967477798462,
            "end_logit": 0.5190988779067993
        },
        {
            "text": "is relevant to directly-delivered therapy (topical treatment/intratumoral injection) where the",
            "probability": 0.04800846198476656,
            "start_logit": 0.9128010272979736,
            "end_logit": 0.8039726614952087
        },
        {
            "text": "agents can selectively kill cSCC cells but there are variations",
            "probability": 0.04641324958198619,
            "start_logit": 0.9968150854110718,
            "end_logit": 0.6861662864685059
        },
        {
            "text": "of cSCC cell line sensitivity/resistance. Variations in the responses to proteasome inhibitors are associated with differences in the specific",
            "probability": 0.046265883109555345,
            "start_logit": 1.0508614778518677,
            "end_logit": 0.6289397478103638
        },
        {
            "text": "-",
            "probability": 0.04517265190333567,
            "start_logit": 0.8662410378456116,
            "end_logit": 0.7896472215652466
        },
        {
            "text": "be sensitive to MLN7243-",
            "probability": 0.04441217277591227,
            "start_logit": 0.8956854343414307,
            "end_logit": 0.743224561214447
        },
        {
            "text": "gulation confers susceptibility to a short incubation with proteasome inhibitors by priming cSCC cells for rapid BAK-",
            "probability": 0.044190595233706775,
            "start_logit": 0.8442611694335938,
            "end_logit": 0.7896472215652466
        },
        {
            "text": "therapy (topical treatment/intratumoral injection) where the",
            "probability": 0.04375138996595092,
            "start_logit": 0.8199471235275269,
            "end_logit": 0.8039726614952087
        },
        {
            "text": "of cSCC cell",
            "probability": 0.04346665841351344,
            "start_logit": 1.0508614778518677,
            "end_logit": 0.5665290951728821
        },
        {
            "text": "is relevant to directly-delivered therapy (topical treatment/intratumoral injection) where the time of exposure can be controlled and a short exposure may",
            "probability": 0.04329968327100004,
            "start_logit": 0.9128010272979736,
            "end_logit": 0.7007406949996948
        },
        {
            "text": "-dependent death. We observed that bortezomib-resistant cSCC cells can be sensitive to MLN7243-",
            "probability": 0.043123547644968264,
            "start_logit": 0.8662410378456116,
            "end_logit": 0.743224561214447
        }
    ],
    "58f4b25e70f9fc6f0f000011": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "587e2300fc7e8dd84f000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a7d51dafaa1ab7d2e000017": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a43a139966455904c000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6e3299b750ff4455000040": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "58edf567eda5a57672000011": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6a3335b750ff4455000025": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a67b2f7b750ff445500000f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "593ff22b70f9fc6f0f000023": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "590af75d70f9fc6f0f00001c": [
        {
            "text": ") to develop G-OnRamp (http://g-onramp.org), a web-",
            "probability": 0.07027418962078742,
            "start_logit": 1.0275440216064453,
            "end_logit": 1.2021222114562988
        },
        {
            "text": "), a web-",
            "probability": 0.06806602105785073,
            "start_logit": 0.9956175684928894,
            "end_logit": 1.2021222114562988
        },
        {
            "text": ") to develop G-OnRamp (http://g-",
            "probability": 0.062315044307106965,
            "start_logit": 1.0275440216064453,
            "end_logit": 1.0819205045700073
        },
        {
            "text": "https://galaxyproject.org) to develop G-OnRamp (http://g-",
            "probability": 0.05781068524000272,
            "start_logit": 0.9525147676467896,
            "end_logit": 1.0819205045700073
        },
        {
            "text": "), a web-based platform for creating UCSC Genome Browser Assembly Hubs and JBrowse genome browsers. G-",
            "probability": 0.05707491172577927,
            "start_logit": 0.9956175684928894,
            "end_logit": 1.0260087251663208
        },
        {
            "text": "://g-onramp.org), a web-",
            "probability": 0.054699867594305236,
            "start_logit": 0.7770007252693176,
            "end_logit": 1.2021222114562988
        },
        {
            "text": "ramp.org), a web-",
            "probability": 0.054073081481183165,
            "start_logit": 0.7654759287834167,
            "end_logit": 1.2021222114562988
        },
        {
            "text": "), a web-based platform for creating UCSC Genome Browser Assembly Hubs and JBrowse genome browsers",
            "probability": 0.05282816242053635,
            "start_logit": 0.9956175684928894,
            "end_logit": 0.9486885070800781
        },
        {
            "text": "://g-",
            "probability": 0.04850464574725924,
            "start_logit": 0.7770007252693176,
            "end_logit": 1.0819205045700073
        },
        {
            "text": "https://galaxypro",
            "probability": 0.04821897341171302,
            "start_logit": 0.9525147676467896,
            "end_logit": 0.9004994630813599
        },
        {
            "text": "lines",
            "probability": 0.04726653551054573,
            "start_logit": 0.892997145652771,
            "end_logit": 0.9400670528411865
        },
        {
            "text": "typic traits. After a new",
            "probability": 0.044561704014565384,
            "start_logit": 1.099729299545288,
            "end_logit": 0.6744071841239929
        },
        {
            "text": "CUREs) centered",
            "probability": 0.0442440635562234,
            "start_logit": 0.9289148449897766,
            "end_logit": 0.8380680084228516
        },
        {
            "text": "s and about how to utilize large datasets. Development of G-OnRamp was guided by extensive user feedback. Sixty-",
            "probability": 0.04375878702404107,
            "start_logit": 0.7235037684440613,
            "end_logit": 1.0324503183364868
        },
        {
            "text": ". To address the technical barriers to creating genome browsers, the Gen",
            "probability": 0.042266357945394815,
            "start_logit": 0.76882404088974,
            "end_logit": 0.9524290561676025
        },
        {
            "text": "ramp.org), a web-based platform for creating UCSC Genome Browser Assembly Hubs and JBrowse genome browsers",
            "probability": 0.04196780547285072,
            "start_logit": 0.7654759287834167,
            "end_logit": 0.9486885070800781
        },
        {
            "text": "visualize and evaluate multiple lines",
            "probability": 0.04185967362411787,
            "start_logit": 0.7715175151824951,
            "end_logit": 0.9400670528411865
        },
        {
            "text": "typic traits. After a new genome is sequenced and assembled, structural",
            "probability": 0.041362367655214255,
            "start_logit": 1.099729299545288,
            "end_logit": 0.5999038219451904
        },
        {
            "text": "participated through in-person workshops, which produced >20 genome browsers now available",
            "probability": 0.0398347720452016,
            "start_logit": 1.0099339485168457,
            "end_logit": 0.6520678997039795
        },
        {
            "text": "browsers generated for four parasitoid wasp species have been used in a CURE engaging students at 15 colleges and universities.",
            "probability": 0.03901235054532121,
            "start_logit": 0.955956757068634,
            "end_logit": 0.6851831674575806
        }
    ],
    "5a8941c5bc7bade53a000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "590c74d170f9fc6f0f00001e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a89800efcd1d6a10c00000c": [
        {
            "text": "lipid homeostasis",
            "probability": 0.07579994523919646,
            "start_logit": 0.8979077339172363,
            "end_logit": 0.9193629026412964
        },
        {
            "text": "synthesis to provide the cell",
            "probability": 0.07552281569083057,
            "start_logit": 0.9247703552246094,
            "end_logit": 0.8888375163078308
        },
        {
            "text": ")-",
            "probability": 0.07431256868371743,
            "start_logit": 0.9357483386993408,
            "end_logit": 0.8617048263549805
        },
        {
            "text": ")-localized enzymes synthesize the vast majority of cellular lipids. The ER therefore has a major",
            "probability": 0.07137618653815152,
            "start_logit": 0.9357483386993408,
            "end_logit": 0.8213890194892883
        },
        {
            "text": "of cellular lipids. The ER therefore has a major",
            "probability": 0.06849003050083916,
            "start_logit": 0.8944722414016724,
            "end_logit": 0.8213890194892883
        },
        {
            "text": ". The ER therefore has a major",
            "probability": 0.06832843892860344,
            "start_logit": 0.8921101093292236,
            "end_logit": 0.8213890194892883
        },
        {
            "text": "of cellular lipids. The ER therefore has a major influence on cellular lipid biomass and balances the production of different lipid",
            "probability": 0.06731468063264204,
            "start_logit": 0.8944722414016724,
            "end_logit": 0.8040791749954224
        },
        {
            "text": ". The ER therefore has a major influence on cellular lipid biomass and balances the production of different lipid",
            "probability": 0.06715586211557567,
            "start_logit": 0.8921101093292236,
            "end_logit": 0.8040791749954224
        },
        {
            "text": "synthesis to provide the cell with membrane lipids for growth, proliferation, and differentiation-",
            "probability": 0.06699994614896358,
            "start_logit": 0.9247703552246094,
            "end_logit": 0.7690945267677307
        },
        {
            "text": "some key regulatory mechanisms that control ER-localized enzyme activities in animal cells.",
            "probability": 0.0662369237412657,
            "start_logit": 0.8640028238296509,
            "end_logit": 0.8184083104133606
        },
        {
            "text": "lipid homeostasis, as well as how their dysregulation contributes",
            "probability": 0.06548873075201399,
            "start_logit": 0.8979077339172363,
            "end_logit": 0.7731434106826782
        },
        {
            "text": "lipid homeostasis, as",
            "probability": 0.06331800981238653,
            "start_logit": 0.8979077339172363,
            "end_logit": 0.7394351363182068
        },
        {
            "text": "lipid",
            "probability": 0.058262841390115075,
            "start_logit": 0.8979077339172363,
            "end_logit": 0.6562298536300659
        },
        {
            "text": "some key regulatory mechanisms that control ER-localized enzyme activities in animal cells. We also discuss how they act in concert to maintain cellular lipid",
            "probability": 0.056320557529162776,
            "start_logit": 0.8640028238296509,
            "end_logit": 0.6562298536300659
        },
        {
            "text": "synthesis to provide the cell with membrane lip",
            "probability": 0.05507246229653606,
            "start_logit": 0.9247703552246094,
            "end_logit": 0.5730525255203247
        }
    ],
    "5a3e8683966455904c000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a7617b183b0d9ea66000022": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a4df811966455904c00000e": [
        {
            "text": ". CFIm comprises CFIm",
            "probability": 0.10831775608404791,
            "start_logit": 1.0505504608154297,
            "end_logit": 0.6643904447555542
        },
        {
            "text": "is part of the",
            "probability": 0.10302312199219238,
            "start_logit": 0.918487012386322,
            "end_logit": 0.7463382482528687
        },
        {
            "text": ") is a highly regulated process. Most human genes have",
            "probability": 0.10291975908117869,
            "start_logit": 1.0450080633163452,
            "end_logit": 0.6188133955001831
        },
        {
            "text": "is part of the cleavage and polyadenylation (CPA) complex. CFIm comprises CFIm",
            "probability": 0.094917267608876,
            "start_logit": 0.918487012386322,
            "end_logit": 0.6643904447555542
        },
        {
            "text": ". CFIm comprises CFIm25, CFIm59 and CFim68 subunits. It has",
            "probability": 0.0929869156535598,
            "start_logit": 1.0505504608154297,
            "end_logit": 0.5117801427841187
        },
        {
            "text": "regulate which poly(A) site is used. Poly(A) site selection may",
            "probability": 0.0923967737231285,
            "start_logit": 0.9850345849990845,
            "end_logit": 0.5709292888641357
        },
        {
            "text": ". CFIm comprises CFIm25, CFIm59 and CFim68",
            "probability": 0.08904011466425038,
            "start_logit": 1.0505504608154297,
            "end_logit": 0.46840834617614746
        },
        {
            "text": ". CFIm comprises CFIm25, CFIm59 and CFim68 subunits. It",
            "probability": 0.08347771076908438,
            "start_logit": 1.0505504608154297,
            "end_logit": 0.40390101075172424
        },
        {
            "text": "is part of the cleavage and polyadenylation (CPA",
            "probability": 0.08198896209759073,
            "start_logit": 0.918487012386322,
            "end_logit": 0.5179694294929504
        },
        {
            "text": "regulate which poly(A) site is used. Poly(A) site selection may be mediated by cleavage factor I (CFIm",
            "probability": 0.07929918914795454,
            "start_logit": 0.9850345849990845,
            "end_logit": 0.4180651307106018
        },
        {
            "text": "is part of the cleavage and polyadenylation (CPA) complex",
            "probability": 0.07163242917813656,
            "start_logit": 0.918487012386322,
            "end_logit": 0.3829326927661896
        }
    ],
    "5a87e95461bb38fb2400000c": [
        {
            "text": "coding for Pol III associated proteins Brf1 and Brf2, while Polr3gL is up-regulated alongside",
            "probability": 0.06974607489764056,
            "start_logit": 1.0143542289733887,
            "end_logit": 1.0585254430770874
        },
        {
            "text": "coding for Pol III associated",
            "probability": 0.06680043866806291,
            "start_logit": 1.0143542289733887,
            "end_logit": 1.015373945236206
        },
        {
            "text": "while Polr3gL is up-regulated alongside",
            "probability": 0.06215504292484864,
            "start_logit": 0.8991250395774841,
            "end_logit": 1.0585254430770874
        },
        {
            "text": "III dependent transcripts are dramatically down-regulated during the differentiation of skeletal muscle, as are mRNAs coding for Pol III associated",
            "probability": 0.057256301356719295,
            "start_logit": 0.8601822853088379,
            "end_logit": 1.015373945236206
        },
        {
            "text": "coding for Pol III associated proteins Brf1 and Brf2, while Polr3gL is up-",
            "probability": 0.056563161239636166,
            "start_logit": 1.0143542289733887,
            "end_logit": 0.8490222096443176
        },
        {
            "text": "additional regulatory networks exist to control the production of Pol III transcripts during skeletal muscle differentiation. We describe the differential expression of Polr3g and its",
            "probability": 0.054251604841291726,
            "start_logit": 0.9137523770332336,
            "end_logit": 0.9078987240791321
        },
        {
            "text": "is expressed early in the myogenic lineage. This points to the possibility that additional regulatory networks",
            "probability": 0.053417519043295295,
            "start_logit": 0.9320753216743469,
            "end_logit": 0.8740819692611694
        },
        {
            "text": "additional regulatory networks",
            "probability": 0.05244766522189684,
            "start_logit": 0.9137523770332336,
            "end_logit": 0.8740819692611694
        },
        {
            "text": "while Polr3gL is up-",
            "probability": 0.05040693286287932,
            "start_logit": 0.8991250395774841,
            "end_logit": 0.8490222096443176
        },
        {
            "text": "established during development.",
            "probability": 0.04980132924396861,
            "start_logit": 1.033673644065857,
            "end_logit": 0.7023865580558777
        },
        {
            "text": "gL during embryonic development and using a custom tRNA microarray, we demonstrate their",
            "probability": 0.04938327726663689,
            "start_logit": 0.944349467754364,
            "end_logit": 0.7832809090614319
        },
        {
            "text": "coding for Pol III associated proteins Brf1 and Brf2, while Polr3gL is up-regulated alongside contractile protein",
            "probability": 0.04800260584589084,
            "start_logit": 1.0143542289733887,
            "end_logit": 0.6849195957183838
        },
        {
            "text": "established during development. These studies have exclusively focused on the",
            "probability": 0.04433752806459756,
            "start_logit": 1.033673644065857,
            "end_logit": 0.586176335811615
        },
        {
            "text": "established",
            "probability": 0.04361563981833553,
            "start_logit": 1.033673644065857,
            "end_logit": 0.5697606801986694
        },
        {
            "text": "while Polr3gL is up-regulated alongside contractile protein",
            "probability": 0.042778092261602924,
            "start_logit": 0.8991250395774841,
            "end_logit": 0.6849195957183838
        },
        {
            "text": "underpinning skeletal muscle determination and differentiation have been extensively investigated, providing molecular insights into how cell lineages are established during development.",
            "probability": 0.04056602231267605,
            "start_logit": 0.8285627961158752,
            "end_logit": 0.7023865580558777
        },
        {
            "text": "while Polr3gL is up-regulated alongside contractile protein genes. Forcing Polr3g expression in this",
            "probability": 0.04042316963811295,
            "start_logit": 0.8991250395774841,
            "end_logit": 0.6282966136932373
        },
        {
            "text": "III dependent transcripts are dramatically down-",
            "probability": 0.04036943942430882,
            "start_logit": 0.8601822853088379,
            "end_logit": 0.6659092903137207
        },
        {
            "text": "gL during embryonic development and using a custom tRNA microarray, we demonstrate their distinct",
            "probability": 0.03946480322602693,
            "start_logit": 0.944349467754364,
            "end_logit": 0.5590782761573792
        },
        {
            "text": "additional regulatory networks exist to control the production of Pol III transcripts during skeletal muscle differentiation. We describe the",
            "probability": 0.03821335184157205,
            "start_logit": 0.9137523770332336,
            "end_logit": 0.5574511289596558
        }
    ],
    "593fe5c270f9fc6f0f000021": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a7d6287faa1ab7d2e00001c": [
        {
            "text": "GDF15 is an ind",
            "probability": 0.15069054173400423,
            "start_logit": 0.9921442270278931,
            "end_logit": 0.5428591370582581
        },
        {
            "text": ") are promising new anti-",
            "probability": 0.14434007560365347,
            "start_logit": 0.9029049873352051,
            "end_logit": 0.5890421867370605
        },
        {
            "text": ") are promising new anti-obesity therapies as pharmacological treatment with GDF15",
            "probability": 0.1252756746688225,
            "start_logit": 0.9029049873352051,
            "end_logit": 0.4473867416381836
        },
        {
            "text": ") are promising new anti-obesity therapies as pharmacological",
            "probability": 0.12418707847267517,
            "start_logit": 0.9029049873352051,
            "end_logit": 0.4386591613292694
        },
        {
            "text": "GDF15 is an indispensable factor for other interventions that cause weight loss and which are also known to act via these",
            "probability": 0.12262399130189987,
            "start_logit": 0.9921442270278931,
            "end_logit": 0.3367534875869751
        },
        {
            "text": ") are promising new anti-obesity therapies as pharmacological treatment with GDF15 results in dramatic reductions of food intake and",
            "probability": 0.118006026053825,
            "start_logit": 0.9029049873352051,
            "end_logit": 0.3876057267189026
        },
        {
            "text": ") are promising new",
            "probability": 0.10830543840542724,
            "start_logit": 0.9029049873352051,
            "end_logit": 0.3018254041671753
        },
        {
            "text": ") are promising new anti-obesity therapies as pharmacological treatment with GDF15 results",
            "probability": 0.10657117375969256,
            "start_logit": 0.9029049873352051,
            "end_logit": 0.2856830954551697
        }
    ],
    "593fe7f970f9fc6f0f000022": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a7d4721faa1ab7d2e000012": [
        {
            "text": "level enabled characterization of cell-",
            "probability": 0.09377929360429797,
            "start_logit": 0.8917120695114136,
            "end_logit": 1.1354597806930542
        },
        {
            "text": "ule-associated protein Tau",
            "probability": 0.07745192320113216,
            "start_logit": 0.8520089387893677,
            "end_logit": 0.9838762283325195
        },
        {
            "text": "protein Tau",
            "probability": 0.07319064089964876,
            "start_logit": 0.7954190969467163,
            "end_logit": 0.9838762283325195
        },
        {
            "text": "toskeleton related gene signatures (e.g., tubulin transcripts, microtubule-associated protein Tau",
            "probability": 0.07314238136821909,
            "start_logit": 0.7947595119476318,
            "end_logit": 0.9838762283325195
        },
        {
            "text": "protein, EB3, Mapre3) at unprecedented detail. Here, we review these findings with a methodological perspective to highlight how cutting-",
            "probability": 0.06636976535918444,
            "start_logit": 0.8128443360328674,
            "end_logit": 0.8686250448226929
        },
        {
            "text": "level enabled characterization of cell-type specific cytoskeleton related gene signatures (e.g., tubulin",
            "probability": 0.06614531349573503,
            "start_logit": 0.8917120695114136,
            "end_logit": 0.7863697409629822
        },
        {
            "text": "ule-associated protein Tau, Mapt and microtubule end binding protein, EB3, Mapre3)",
            "probability": 0.06476184544368402,
            "start_logit": 0.8520089387893677,
            "end_logit": 0.8049354553222656
        },
        {
            "text": "protein, EB3, Mapre3)",
            "probability": 0.06227449938315134,
            "start_logit": 0.8128443360328674,
            "end_logit": 0.8049354553222656
        },
        {
            "text": "protein Tau, Mapt and microtubule end binding protein, EB3, Mapre3)",
            "probability": 0.061198751147317466,
            "start_logit": 0.7954190969467163,
            "end_logit": 0.8049354553222656
        },
        {
            "text": "toskeleton related gene signatures (e.g., tubulin",
            "probability": 0.06003342460498025,
            "start_logit": 0.7947595119476318,
            "end_logit": 0.7863697409629822
        },
        {
            "text": "level enabled characterization of cell-type specific cytoskeleton related gene signatures (e.g.,",
            "probability": 0.05333532662935189,
            "start_logit": 0.8917120695114136,
            "end_logit": 0.5711145997047424
        },
        {
            "text": "level enabled characterization of cell-type specific cytoskeleton related gene signatures (e.",
            "probability": 0.052208589245890974,
            "start_logit": 0.8917120695114136,
            "end_logit": 0.5497627258300781
        },
        {
            "text": "ule-",
            "probability": 0.05159371937253492,
            "start_logit": 0.8520089387893677,
            "end_logit": 0.5776187777519226
        },
        {
            "text": "toskeleton related gene signatures (e.g., tubulin transcripts, microtubule-",
            "probability": 0.04872296700433205,
            "start_logit": 0.7947595119476318,
            "end_logit": 0.5776187777519226
        },
        {
            "text": "toskeleton related gene signatures (e.g.,",
            "probability": 0.04840709251747135,
            "start_logit": 0.7947595119476318,
            "end_logit": 0.5711145997047424
        },
        {
            "text": "toskeleton related gene signatures (e.",
            "probability": 0.047384466723068314,
            "start_logit": 0.7947595119476318,
            "end_logit": 0.5497627258300781
        }
    ],
    "5a39453d966455904c000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a4e50b242878bf97d000001": [
        {
            "text": "eukaryotic topoisomerases is vital to therapeutic utility, but is poorly understood. We developed a next-",
            "probability": 0.06088298031701439,
            "start_logit": 0.8417831063270569,
            "end_logit": 0.9406946897506714
        },
        {
            "text": "rase II derive from a rich mutational 'landscape' of amino acid substitutions broadly distributed throughout the",
            "probability": 0.060079034462295185,
            "start_logit": 0.9365170001983643,
            "end_logit": 0.8326680660247803
        },
        {
            "text": "amino acid substitutions broadly distributed throughout the",
            "probability": 0.05717655636304524,
            "start_logit": 0.8870000243186951,
            "end_logit": 0.8326680660247803
        },
        {
            "text": "II derive from a rich mutational 'landscape' of amino acid substitutions broadly distributed throughout the",
            "probability": 0.05540791635374884,
            "start_logit": 0.8555785417556763,
            "end_logit": 0.8326680660247803
        },
        {
            "text": "essential DNA transactions and are proven drug targets. Drug discrimination by prokaryotic and eukar",
            "probability": 0.052073927250745985,
            "start_logit": 0.9223289489746094,
            "end_logit": 0.7038595676422119
        },
        {
            "text": "ze essential DNA transactions and are proven drug targets. Drug discrimination by prokaryotic and eukar",
            "probability": 0.05173933805205999,
            "start_logit": 0.91588294506073,
            "end_logit": 0.7038595676422119
        },
        {
            "text": "rase II derive from a rich mutational 'landscape' of amino acid substitutions broadly distributed",
            "probability": 0.05066996821772494,
            "start_logit": 0.9365170001983643,
            "end_logit": 0.662340521812439
        },
        {
            "text": "eukaryotic topoisomerases. We show that alterations conferring resistance to poisons of human and yeast topois",
            "probability": 0.05023827893463828,
            "start_logit": 0.8976971507072449,
            "end_logit": 0.6926042437553406
        },
        {
            "text": "bacterial ciprofloxacin can poison yeast topoisomerase II",
            "probability": 0.049163167375343965,
            "start_logit": 0.9219162464141846,
            "end_logit": 0.6467525959014893
        },
        {
            "text": "proven drug targets. Drug discrimination by prokaryotic and eukar",
            "probability": 0.04908151357082251,
            "start_logit": 0.8631470203399658,
            "end_logit": 0.7038595676422119
        },
        {
            "text": "amino acid substitutions broadly distributed",
            "probability": 0.04822205149672745,
            "start_logit": 0.8870000243186951,
            "end_logit": 0.662340521812439
        },
        {
            "text": "eukar",
            "probability": 0.04804406180928785,
            "start_logit": 0.8417831063270569,
            "end_logit": 0.7038595676422119
        },
        {
            "text": "show that the anti-cancer quinolone vosaroxin acts solely",
            "probability": 0.047496625061423076,
            "start_logit": 0.8613381385803223,
            "end_logit": 0.672844648361206
        },
        {
            "text": "II derive from a rich mutational 'landscape' of amino acid substitutions broadly distributed",
            "probability": 0.04673040080923366,
            "start_logit": 0.8555785417556763,
            "end_logit": 0.662340521812439
        },
        {
            "text": "essential DNA transactions and are proven drug targets. Drug discrimination by prokar",
            "probability": 0.04651704419223696,
            "start_logit": 0.9223289489746094,
            "end_logit": 0.5910139679908752
        },
        {
            "text": "ze essential DNA transactions and are proven drug targets. Drug discrimination by prokar",
            "probability": 0.04621815948422219,
            "start_logit": 0.91588294506073,
            "end_logit": 0.5910139679908752
        },
        {
            "text": "cterial ciprofloxacin can poison yeast topoisomerase II",
            "probability": 0.045301626659131906,
            "start_logit": 0.8401144742965698,
            "end_logit": 0.6467525959014893
        },
        {
            "text": "bacterial ciprofloxacin can poison yeast topoisomerase II. The innate drug-",
            "probability": 0.045289914760552046,
            "start_logit": 0.9219162464141846,
            "end_logit": 0.5646922588348389
        },
        {
            "text": "bacterial cipro",
            "probability": 0.04519481186389727,
            "start_logit": 0.9219162464141846,
            "end_logit": 0.5625901818275452
        },
        {
            "text": "amino acid substitutions broadly distributed throughout the entire enzyme. Both general and discriminatory drug-",
            "probability": 0.04447262296584817,
            "start_logit": 0.8870000243186951,
            "end_logit": 0.5813978910446167
        }
    ],
    "5a87d73861bb38fb2400000b": [
        {
            "text": "associated diarr",
            "probability": 0.13323597980410323,
            "start_logit": 1.0330387353897095,
            "end_logit": 0.6358807682991028
        },
        {
            "text": "associated diarrhoe",
            "probability": 0.12561499863664566,
            "start_logit": 1.0330387353897095,
            "end_logit": 0.5769805908203125
        },
        {
            "text": "associated diarrhoea. Several industrialised countries have reported increased C. difficile infections and outbreaks, which have",
            "probability": 0.11658894569339306,
            "start_logit": 1.0330387353897095,
            "end_logit": 0.5024133920669556
        },
        {
            "text": "associated diarrhoea. Several industrialised countries have",
            "probability": 0.10216362830781646,
            "start_logit": 1.0330387353897095,
            "end_logit": 0.370334655046463
        },
        {
            "text": "associated diarrhoea. Several industrialised countries have reported increased C. difficile infections and outbreaks, which have been attributed to the",
            "probability": 0.09033271395071932,
            "start_logit": 1.0330387353897095,
            "end_logit": 0.24725860357284546
        },
        {
            "text": "associated diarrhoea. Several industrial",
            "probability": 0.0893740138674175,
            "start_logit": 1.0330387353897095,
            "end_logit": 0.23658889532089233
        },
        {
            "text": "associated diarrhoea. Several industrialised countries have reported increased C. difficile",
            "probability": 0.08585812484042828,
            "start_logit": 1.0330387353897095,
            "end_logit": 0.19645515084266663
        },
        {
            "text": "associated diarrhoea. Several industrialised countries have reported increased C. difficile infections and outbreaks, which have been",
            "probability": 0.08563448572018445,
            "start_logit": 1.0330387353897095,
            "end_logit": 0.19384700059890747
        },
        {
            "text": "associated diarrhoea. Several industrialised countries have reported increased C. difficile infections and outbreaks,",
            "probability": 0.08561983277814661,
            "start_logit": 1.0330387353897095,
            "end_logit": 0.19367587566375732
        },
        {
            "text": "associated",
            "probability": 0.08557727640114543,
            "start_logit": 1.0330387353897095,
            "end_logit": 0.1931787133216858
        }
    ],
    "5a6e2b1bb750ff445500003e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a7610af83b0d9ea6600001a": [
        {
            "text": "us kinase (JAK) inhibitors, oral targeted disease-modifying drugs, will be approved for the treatment of rheumato",
            "probability": 0.08137509363803229,
            "start_logit": 1.1445404291152954,
            "end_logit": 0.6673993468284607
        },
        {
            "text": "us kinase (JAK) inhibitors, oral targeted disease-modifying drugs, will be approved for the",
            "probability": 0.07635006011028662,
            "start_logit": 1.1445404291152954,
            "end_logit": 0.60365891456604
        },
        {
            "text": "be approved for the treatment of rheumatoid arthritis (RA) and other diseases. This review compares and contrasts the",
            "probability": 0.07579665267199999,
            "start_logit": 0.9725538492202759,
            "end_logit": 0.7683708071708679
        },
        {
            "text": "us kinase (JAK) inhibitors, oral targeted disease-",
            "probability": 0.07483279611165478,
            "start_logit": 1.1445404291152954,
            "end_logit": 0.5835863351821899
        },
        {
            "text": "us kinase (JAK) inhibitors, oral targeted disease-modifying drugs,",
            "probability": 0.07002368059765561,
            "start_logit": 1.1445404291152954,
            "end_logit": 0.5171635746955872
        },
        {
            "text": "be approved for the treatment of rheumato",
            "probability": 0.06851705355774147,
            "start_logit": 0.9725538492202759,
            "end_logit": 0.6673993468284607
        },
        {
            "text": "rexate-naive patients",
            "probability": 0.06564900328494007,
            "start_logit": 0.9375531077384949,
            "end_logit": 0.659639835357666
        },
        {
            "text": "methotrexate-naive patients, post\u00a0methotrexate failure and post\u00a0biologics.",
            "probability": 0.06524782656596763,
            "start_logit": 0.9375531077384949,
            "end_logit": 0.6535101532936096
        },
        {
            "text": "post\u00a0methotrexate failure and post\u00a0biologics.",
            "probability": 0.06447823829649016,
            "start_logit": 0.9256881475448608,
            "end_logit": 0.6535101532936096
        },
        {
            "text": "be approved for the",
            "probability": 0.06428602320241565,
            "start_logit": 0.9725538492202759,
            "end_logit": 0.60365891456604
        },
        {
            "text": ") inhibitors, oral targeted disease-modifying drugs, will be approved for the treatment of rheumato",
            "probability": 0.06393187991592568,
            "start_logit": 0.9032893180847168,
            "end_logit": 0.6673993468284607
        },
        {
            "text": ") inhibitors, oral targeted disease-modifying drugs, will be approved for the",
            "probability": 0.059983990878791735,
            "start_logit": 0.9032893180847168,
            "end_logit": 0.60365891456604
        },
        {
            "text": ") inhibitors, oral targeted disease-",
            "probability": 0.05879196103987364,
            "start_logit": 0.9032893180847168,
            "end_logit": 0.5835863351821899
        },
        {
            "text": "rexa",
            "probability": 0.0557220333649041,
            "start_logit": 0.9375531077384949,
            "end_logit": 0.49569305777549744
        },
        {
            "text": ") inhibitors, oral targeted disease-modifying drugs,",
            "probability": 0.055013706763320465,
            "start_logit": 0.9032893180847168,
            "end_logit": 0.5171635746955872
        }
    ],
    "5a88370c61bb38fb24000014": [
        {
            "text": "I/MDA5 and competes with the downstream adaptor VISA/MAVS/IP",
            "probability": 0.09503120264238256,
            "start_logit": 1.2008633613586426,
            "end_logit": 0.6764812469482422
        },
        {
            "text": "I (RIG-",
            "probability": 0.09442669081312018,
            "start_logit": 1.2602511644363403,
            "end_logit": 0.610711932182312
        },
        {
            "text": "or VISA/MAVS/IP",
            "probability": 0.09282020226092642,
            "start_logit": 1.1773223876953125,
            "end_logit": 0.6764812469482422
        },
        {
            "text": "IFN-",
            "probability": 0.09260676017869741,
            "start_logit": 0.8126418590545654,
            "end_logit": 1.0388596057891846
        },
        {
            "text": "or VISA/MAVS/IPS-1/Cardif for RIG-I/MDA5 CARD binding.",
            "probability": 0.09106738323777892,
            "start_logit": 1.1773223876953125,
            "end_logit": 0.6574166417121887
        },
        {
            "text": "I and MDA5, a function that does not depend on its E3 ligase activity",
            "probability": 0.08446580327227335,
            "start_logit": 1.0504965782165527,
            "end_logit": 0.7089895009994507
        },
        {
            "text": "CARD binding.",
            "probability": 0.07348682036104343,
            "start_logit": 0.9628287553787231,
            "end_logit": 0.6574166417121887
        },
        {
            "text": "I/MDA5 CARD binding.",
            "probability": 0.06532505780043095,
            "start_logit": 0.8450983762741089,
            "end_logit": 0.6574166417121887
        },
        {
            "text": "I and MDA5.",
            "probability": 0.06523794041059901,
            "start_logit": 0.848708987236023,
            "end_logit": 0.6524715423583984
        },
        {
            "text": "I and MDA5. Overexpression of RNF123 inhibits IFN-",
            "probability": 0.06467841325631336,
            "start_logit": 0.848708987236023,
            "end_logit": 0.6438578367233276
        },
        {
            "text": "terminal CARD domains of RIG-I/MDA5 and competes with the downstream adaptor VISA/MAVS/IP",
            "probability": 0.06260971763465716,
            "start_logit": 0.7835785746574402,
            "end_logit": 0.6764812469482422
        },
        {
            "text": "IFN-\u03b2 production triggered by SeV and EMCV, but not by the sensor of DNA viruses cGAS RNF123 associates with",
            "probability": 0.060962947181914265,
            "start_logit": 0.8126418590545654,
            "end_logit": 0.6207637190818787
        },
        {
            "text": "terminal CARD domains of RIG-",
            "probability": 0.057281060949862884,
            "start_logit": 0.7835785746574402,
            "end_logit": 0.587530791759491
        }
    ],
    "5a885daa61bb38fb24000018": [
        {
            "text": "basal cell carcinoma cells. JAK2 inhibitor decreased STAT3 expression and abolished the inhibitory effects of DEAD (Asp-",
            "probability": 0.06120944000966394,
            "start_logit": 1.0546164512634277,
            "end_logit": 0.9815507531166077
        },
        {
            "text": "terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-",
            "probability": 0.0598273095155331,
            "start_logit": 0.983364999294281,
            "end_logit": 1.0299630165100098
        },
        {
            "text": "basal cell carcinoma cells. DEAD (Asp-Glu-",
            "probability": 0.057695901252482126,
            "start_logit": 0.8713542819023132,
            "end_logit": 1.1056976318359375
        },
        {
            "text": "showed that DEAD (As",
            "probability": 0.05759916585661377,
            "start_logit": 1.078873634338379,
            "end_logit": 0.8965002298355103
        },
        {
            "text": "terminal deoxynucleotidyl transferase-",
            "probability": 0.05500542670812465,
            "start_logit": 0.983364999294281,
            "end_logit": 0.9459326267242432
        },
        {
            "text": "of basal cell carcinoma cells. DEAD (Asp-Glu-",
            "probability": 0.05317613622700093,
            "start_logit": 0.7897778749465942,
            "end_logit": 1.1056976318359375
        },
        {
            "text": "-",
            "probability": 0.05250489321883223,
            "start_logit": 0.9221296310424805,
            "end_logit": 0.9606425166130066
        },
        {
            "text": "carcinoma cells induced by tunicamycin. Results found that DEAD (Asp-Glu-",
            "probability": 0.050541416708375676,
            "start_logit": 0.8840163946151733,
            "end_logit": 0.9606425166130066
        },
        {
            "text": "time polymerase chain reaction, Western blot, and terminal deoxynucleotidyl transferase-",
            "probability": 0.050531319806372675,
            "start_logit": 0.8985264897346497,
            "end_logit": 0.9459326267242432
        },
        {
            "text": "hosphate nick-",
            "probability": 0.04887109837755885,
            "start_logit": 0.7810889482498169,
            "end_logit": 1.0299630165100098
        },
        {
            "text": "basal cell carcinoma cells. DEAD (Asp-",
            "probability": 0.04859274952374265,
            "start_logit": 0.8713542819023132,
            "end_logit": 0.9339858293533325
        },
        {
            "text": "-Ala-Asp) box protein 5 were analyzed in basal cell carcinoma cells. Results showed that DEAD (As",
            "probability": 0.04827511510982068,
            "start_logit": 0.9022817611694336,
            "end_logit": 0.8965002298355103
        },
        {
            "text": "and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-",
            "probability": 0.046752378261581344,
            "start_logit": 0.7367678880691528,
            "end_logit": 1.0299630165100098
        },
        {
            "text": "role of DEAD (Asp-Glu-Ala-Asp) box protein 5 was",
            "probability": 0.04587266856831703,
            "start_logit": 0.7969582080841064,
            "end_logit": 0.9507770538330078
        },
        {
            "text": "carcinoma cells induced by tunicamycin. Results found that DEAD (Asp",
            "probability": 0.044919926614060385,
            "start_logit": 0.8840163946151733,
            "end_logit": 0.8427308797836304
        },
        {
            "text": "of basal cell carcinoma cells. DEAD (Asp-",
            "probability": 0.044786104597125245,
            "start_logit": 0.7897778749465942,
            "end_logit": 0.9339858293533325
        },
        {
            "text": "of DEAD (Asp-Glu-Ala-Asp) box protein 5 was",
            "probability": 0.04436260769973501,
            "start_logit": 0.7634856700897217,
            "end_logit": 0.9507770538330078
        },
        {
            "text": "pathway and DEAD (Asp-Glu-",
            "probability": 0.0440675309671651,
            "start_logit": 0.7345324158668518,
            "end_logit": 0.9730566143989563
        },
        {
            "text": "and terminal deoxynucleotidyl transferase-",
            "probability": 0.04298429156721904,
            "start_logit": 0.7367678880691528,
            "end_logit": 0.9459326267242432
        },
        {
            "text": "box protein",
            "probability": 0.04242451941067544,
            "start_logit": 0.9572709798812866,
            "end_logit": 0.7123212814331055
        }
    ],
    "5a7237672dc08e987e000008": [
        {
            "text": "causing dysarthria and hem",
            "probability": 0.12992928208182256,
            "start_logit": 1.0333713293075562,
            "end_logit": 0.565754771232605
        },
        {
            "text": "causing dysarthria and hemiparesis successfully treated with intravenous thrombolytic therapy",
            "probability": 0.11698148693602338,
            "start_logit": 1.0333713293075562,
            "end_logit": 0.46078014373779297
        },
        {
            "text": "causing dysarthria and hemiparesis successfully treated with intravenous thrombolytic therapy with",
            "probability": 0.11421764153104813,
            "start_logit": 1.0333713293075562,
            "end_logit": 0.4368702173233032
        },
        {
            "text": "causing d",
            "probability": 0.11337116420789646,
            "start_logit": 1.0333713293075562,
            "end_logit": 0.4294315278530121
        },
        {
            "text": "causing dysarthria and hemiparesis",
            "probability": 0.11113299337906618,
            "start_logit": 1.0333713293075562,
            "end_logit": 0.4094920754432678
        },
        {
            "text": "is a specific antidote for the anticoagulant dabigatran. Although its",
            "probability": 0.10832848488025984,
            "start_logit": 0.8535165786743164,
            "end_logit": 0.5637873411178589
        },
        {
            "text": "rucizumab is a specific antidote for the anticoagulant dabigatran. Although its",
            "probability": 0.10626357589493719,
            "start_logit": 0.8342710137367249,
            "end_logit": 0.5637873411178589
        },
        {
            "text": "is a specific antidote for the anticoagulant dabigatran. Although its efficacy has",
            "probability": 0.10084885334657531,
            "start_logit": 0.8535165786743164,
            "end_logit": 0.49224209785461426
        },
        {
            "text": "rucizumab is a specific antidote for the anticoagulant dabigatran. Although its efficacy has",
            "probability": 0.09892651774237103,
            "start_logit": 0.8342710137367249,
            "end_logit": 0.49224209785461426
        }
    ],
    "5a74b1730384be9551000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a774585faa1ab7d2e000005": [
        {
            "text": "is a selective tyrosine kinase inhibitor that modulates mast cells activity. A previous phase",
            "probability": 0.07064550363098145,
            "start_logit": 0.9679455757141113,
            "end_logit": 0.36705172061920166
        },
        {
            "text": "is a selective tyrosine kinase inhibitor that modulates mast cells activity.",
            "probability": 0.06897393747054043,
            "start_logit": 0.9679455757141113,
            "end_logit": 0.3431059718132019
        },
        {
            "text": "is a",
            "probability": 0.06464028313008667,
            "start_logit": 0.9679455757141113,
            "end_logit": 0.27821505069732666
        },
        {
            "text": "study reported a cognitive effect of masitinib in patients with Alzheimer",
            "probability": 0.062341127251670354,
            "start_logit": 0.8787912726402283,
            "end_logit": 0.33115291595458984
        },
        {
            "text": "cognitive effect of masitinib in patients with Alzheimer",
            "probability": 0.06202782996178089,
            "start_logit": 0.8737530708312988,
            "end_logit": 0.33115291595458984
        },
        {
            "text": "is a selective tyrosine kinase inhibitor that modulates mast cells activity. A previous phase II study reported a cognitive effect of mas",
            "probability": 0.05554598505289391,
            "start_logit": 0.9679455757141113,
            "end_logit": 0.12658849358558655
        },
        {
            "text": "is a selective tyrosine kinase inhibitor that modulates mast cells activity. A previous phase II study",
            "probability": 0.055294483526861955,
            "start_logit": 0.9679455757141113,
            "end_logit": 0.12205040454864502
        },
        {
            "text": "is a selective tyrosine kinase inhibitor that modulates mast cells activity",
            "probability": 0.05447954950062552,
            "start_logit": 0.9679455757141113,
            "end_logit": 0.10720264911651611
        },
        {
            "text": "is a selective tyrosine kinase inhibitor that modulates mast cells activity. A previous phase II study reported a cognitive effect of",
            "probability": 0.054080130331273873,
            "start_logit": 0.9679455757141113,
            "end_logit": 0.09984409809112549
        },
        {
            "text": "is a selective tyrosine kinase inhibitor that modulates mast cells activity. A",
            "probability": 0.05326951820092515,
            "start_logit": 0.9679455757141113,
            "end_logit": 0.08474153280258179
        },
        {
            "text": "is a selective tyrosine kinase inhibitor that modulates mast cells activity. A previous phase II study reported a cognitive effect",
            "probability": 0.052419947951761324,
            "start_logit": 0.9679455757141113,
            "end_logit": 0.06866446137428284
        },
        {
            "text": "study reported a cognitive effect of mas",
            "probability": 0.050808158095612205,
            "start_logit": 0.8787912726402283,
            "end_logit": 0.12658849358558655
        },
        {
            "text": "study",
            "probability": 0.05057810853786737,
            "start_logit": 0.8787912726402283,
            "end_logit": 0.12205040454864502
        },
        {
            "text": "cognitive effect of mas",
            "probability": 0.050552820103866095,
            "start_logit": 0.8737530708312988,
            "end_logit": 0.12658849358558655
        },
        {
            "text": "study reported a cognitive effect of",
            "probability": 0.04946733430123087,
            "start_logit": 0.8787912726402283,
            "end_logit": 0.09984409809112549
        },
        {
            "text": "cognitive effect of",
            "probability": 0.04921873466150882,
            "start_logit": 0.8737530708312988,
            "end_logit": 0.09984409809112549
        },
        {
            "text": "study reported a cognitive effect",
            "probability": 0.04794875813905641,
            "start_logit": 0.8787912726402283,
            "end_logit": 0.06866446137428284
        },
        {
            "text": "cognitive effect",
            "probability": 0.047707790151456715,
            "start_logit": 0.8737530708312988,
            "end_logit": 0.06866446137428284
        }
    ],
    "5a735b383b9d13c708000002": [
        {
            "text": "splicing, whereas the latter feature a central PS window that elicits RNase H-mediated cleavage of the",
            "probability": 0.07922692161871342,
            "start_logit": 1.2147014141082764,
            "end_logit": 1.14260995388031
        },
        {
            "text": "nucleic acids can",
            "probability": 0.05994114740649177,
            "start_logit": 1.1088283061981201,
            "end_logit": 0.9695301055908203
        },
        {
            "text": "Ago2 and how these affect the choice of modification and optimization of siRNA efficacy.",
            "probability": 0.058308789349984284,
            "start_logit": 1.1437413692474365,
            "end_logit": 0.9070066809654236
        },
        {
            "text": ". This Account summarizes current siRNA modification strategies with an emphasis on",
            "probability": 0.05554240950774807,
            "start_logit": 0.9685081243515015,
            "end_logit": 1.0336339473724365
        },
        {
            "text": "mediated cleavage of the",
            "probability": 0.053421713468661335,
            "start_logit": 0.820602536201477,
            "end_logit": 1.14260995388031
        },
        {
            "text": "Ago2 and how these affect the",
            "probability": 0.05310562555727051,
            "start_logit": 1.1437413692474365,
            "end_logit": 0.8135367035865784
        },
        {
            "text": ".",
            "probability": 0.050371622443083484,
            "start_logit": 1.0217840671539307,
            "end_logit": 0.8826391100883484
        },
        {
            "text": "), 2'- O-methyl-",
            "probability": 0.05023533085360021,
            "start_logit": 1.1141772270202637,
            "end_logit": 0.7875365614891052
        },
        {
            "text": "properties of native and artificial pairing systems have all stimulated the design of ever more diverse modifications. Modification of nucleic acids can",
            "probability": 0.05020780618496772,
            "start_logit": 0.9316356182098389,
            "end_logit": 0.9695301055908203
        },
        {
            "text": ") and third-generation (e",
            "probability": 0.048553846596801564,
            "start_logit": 1.0342779159545898,
            "end_logit": 0.8333907127380371
        },
        {
            "text": "), 2'- O-methyl-RNA (2'-",
            "probability": 0.04778005820577767,
            "start_logit": 1.1141772270202637,
            "end_logit": 0.7374263405799866
        },
        {
            "text": ". This Account summarizes current siRNA modification strategies with an emphasis on the regio-",
            "probability": 0.04754914812065674,
            "start_logit": 0.9685081243515015,
            "end_logit": 0.8782509565353394
        },
        {
            "text": "terminal nucleotides (guide",
            "probability": 0.044584255626560564,
            "start_logit": 0.9810903668403625,
            "end_logit": 0.8012856245040894
        },
        {
            "text": "these investigations. However, nano",
            "probability": 0.044414530642707374,
            "start_logit": 0.7850848436355591,
            "end_logit": 0.9934770464897156
        },
        {
            "text": "terminal nucleotides (guide/Ago2 PAZ domain) demand",
            "probability": 0.043366102809288466,
            "start_logit": 0.9810903668403625,
            "end_logit": 0.773582935333252
        },
        {
            "text": ". This",
            "probability": 0.04309370753794265,
            "start_logit": 0.9685081243515015,
            "end_logit": 0.7798640727996826
        },
        {
            "text": ") and third-generation (e.g., bicycl",
            "probability": 0.04308188596234889,
            "start_logit": 1.0342779159545898,
            "end_logit": 0.7138199210166931
        },
        {
            "text": "interactions between oligonucleotide and Ago2 and how these affect the choice of modification and optimization of siRNA efficacy.",
            "probability": 0.04265454664296133,
            "start_logit": 0.8311223983764648,
            "end_logit": 0.9070066809654236
        },
        {
            "text": "nucleic acid etiology, and basic research directed at the properties of native and artificial pairing systems have all",
            "probability": 0.04256827091936081,
            "start_logit": 1.0605597496032715,
            "end_logit": 0.6755446195602417
        },
        {
            "text": "third-generation (e",
            "probability": 0.04199228054507306,
            "start_logit": 0.8890902996063232,
            "end_logit": 0.8333907127380371
        }
    ],
    "5a7346662dc08e987e00001a": [
        {
            "text": "night has improved edema of the",
            "probability": 0.07193873099190626,
            "start_logit": 1.1394352912902832,
            "end_logit": 0.8074203729629517
        },
        {
            "text": "improved edema of the",
            "probability": 0.06128480592548237,
            "start_logit": 0.9791524410247803,
            "end_logit": 0.8074203729629517
        },
        {
            "text": "ymphatic toxicity of drugs and their excipients.",
            "probability": 0.06003795398515066,
            "start_logit": 0.938141942024231,
            "end_logit": 0.8278758525848389
        },
        {
            "text": "their excipients.",
            "probability": 0.05629633095486152,
            "start_logit": 0.8737943768501282,
            "end_logit": 0.8278758525848389
        },
        {
            "text": "their excipients. There is no etiological treatment but elastic compression by night has improved edema of the",
            "probability": 0.05515646054790337,
            "start_logit": 0.8737943768501282,
            "end_logit": 0.8074203729629517
        },
        {
            "text": "night has",
            "probability": 0.05341436425191956,
            "start_logit": 1.1394352912902832,
            "end_logit": 0.5096852779388428
        },
        {
            "text": "two patients, additional investigations (biological, radiological, ultrasound) were unremarkable, which helped us, in the",
            "probability": 0.05037391271941039,
            "start_logit": 0.9277951717376709,
            "end_logit": 0.6627191305160522
        },
        {
            "text": "heroin intoxication, and in the",
            "probability": 0.04946613222812143,
            "start_logit": 0.8658936619758606,
            "end_logit": 0.7064354419708252
        },
        {
            "text": "is responsible for many complications, especially cutaneous and infectious. There is a syndrome, rarely observed in rheumatology,",
            "probability": 0.047620931194233905,
            "start_logit": 1.080281376838684,
            "end_logit": 0.45403188467025757
        },
        {
            "text": "two patients",
            "probability": 0.04723854317698225,
            "start_logit": 0.9277951717376709,
            "end_logit": 0.5984558463096619
        },
        {
            "text": "ymphatic toxicity of drugs and their",
            "probability": 0.046949244718372356,
            "start_logit": 0.938141942024231,
            "end_logit": 0.5819660425186157
        },
        {
            "text": "ymphatic toxicity of drugs and their excipients. There is no et",
            "probability": 0.046874631749453756,
            "start_logit": 0.938141942024231,
            "end_logit": 0.5803755521774292
        },
        {
            "text": "heroin intoxication,",
            "probability": 0.04618881967856583,
            "start_logit": 0.8658936619758606,
            "end_logit": 0.6378849744796753
        },
        {
            "text": "other 2 years after stopping injections. In our two patients",
            "probability": 0.04488449864946766,
            "start_logit": 0.8766775131225586,
            "end_logit": 0.5984558463096619
        },
        {
            "text": "ymphatic toxicity of drugs and their excipie",
            "probability": 0.04449623770600225,
            "start_logit": 0.938141942024231,
            "end_logit": 0.5283035635948181
        },
        {
            "text": "heroin intoxication, and in the other 2 years after stopping injections. In our two patients",
            "probability": 0.044403071382709325,
            "start_logit": 0.8658936619758606,
            "end_logit": 0.5984558463096619
        },
        {
            "text": "their",
            "probability": 0.044023322636877193,
            "start_logit": 0.8737943768501282,
            "end_logit": 0.5819660425186157
        },
        {
            "text": "their excipients. There is no et",
            "probability": 0.0439533596199362,
            "start_logit": 0.8737943768501282,
            "end_logit": 0.5803755521774292
        },
        {
            "text": "ymphatic toxicity of drugs and their excipients. There is no etiological treatment but elastic compression by night has",
            "probability": 0.04367545850209182,
            "start_logit": 0.938141942024231,
            "end_logit": 0.5096852779388428
        },
        {
            "text": "their excipie",
            "probability": 0.04172318938055172,
            "start_logit": 0.8737943768501282,
            "end_logit": 0.5283035635948181
        }
    ],
    "5a690487b750ff445500001f": [
        {
            "text": "IgM) by ELISA technique for the diagnosis of acute Cytomegalovirus (CMV) infection. Non-",
            "probability": 0.07626213521655381,
            "start_logit": 1.1810072660446167,
            "end_logit": 1.039777159690857
        },
        {
            "text": ") by ELISA technique for the diagnosis of acute Cytomegalovirus (CMV) infection. Non-",
            "probability": 0.06547631281061665,
            "start_logit": 1.0285191535949707,
            "end_logit": 1.039777159690857
        },
        {
            "text": "%) were diagnosed as HAV infection. E",
            "probability": 0.06477728586525552,
            "start_logit": 0.9990001320838928,
            "end_logit": 1.0585627555847168
        },
        {
            "text": "had evidence of HBV infection, while only 9(4.5%) were diagnosed as HAV infection. E",
            "probability": 0.06377230012000083,
            "start_logit": 0.9833640456199646,
            "end_logit": 1.0585627555847168
        },
        {
            "text": "while only 9(4.5%) were diagnosed as HAV infection. E",
            "probability": 0.0605999720660781,
            "start_logit": 0.9323395490646362,
            "end_logit": 1.0585627555847168
        },
        {
            "text": "BsAg, and IgM anti-HBc) and hepatitis A (IgM-anti-",
            "probability": 0.058099859556775414,
            "start_logit": 1.0225685834884644,
            "end_logit": 0.9262025356292725
        },
        {
            "text": "IgM-anti-",
            "probability": 0.051611280426447,
            "start_logit": 0.9041455984115601,
            "end_logit": 0.9262025356292725
        },
        {
            "text": "BsAg, and IgM anti-HBc) and hepatitis A (IgM-anti-HAV) by the",
            "probability": 0.04992244083148151,
            "start_logit": 1.0225685834884644,
            "end_logit": 0.7745099067687988
        },
        {
            "text": "BsAg, and IgM anti-HBc) and hepatitis A (IgM-",
            "probability": 0.04952000769677463,
            "start_logit": 1.0225685834884644,
            "end_logit": 0.766416072845459
        },
        {
            "text": "%) were diagnosed as HAV infection. EBV and CMV were the possible etiological agents of acute viral hepatitis in (3",
            "probability": 0.04721217018980882,
            "start_logit": 0.9990001320838928,
            "end_logit": 0.7422594428062439
        },
        {
            "text": "hepatitis in (3.5%) and 1%) respectively. Accordingly the Non-A, non-",
            "probability": 0.04694190445857324,
            "start_logit": 0.9303559064865112,
            "end_logit": 0.8051627278327942
        },
        {
            "text": "IgM-anti-HAV) by the",
            "probability": 0.044347113968640044,
            "start_logit": 0.9041455984115601,
            "end_logit": 0.7745099067687988
        },
        {
            "text": "hepatitis in (3",
            "probability": 0.04408005782938773,
            "start_logit": 0.9303559064865112,
            "end_logit": 0.7422594428062439
        },
        {
            "text": "IgM-",
            "probability": 0.0439896244750905,
            "start_logit": 0.9041455984115601,
            "end_logit": 0.766416072845459
        },
        {
            "text": "IgM-anti-HAV) by the ELISA technique. Sera negative for the",
            "probability": 0.04134029344830853,
            "start_logit": 0.9041455984115601,
            "end_logit": 0.7042999267578125
        },
        {
            "text": "BsAg, and IgM anti-",
            "probability": 0.04011322474948867,
            "start_logit": 1.0225685834884644,
            "end_logit": 0.5557453632354736
        },
        {
            "text": "against Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and tested",
            "probability": 0.03991903836258654,
            "start_logit": 0.8652345538139343,
            "end_logit": 0.7082266807556152
        },
        {
            "text": "IGM Heterophil antibodies against Epstein-",
            "probability": 0.03839253056187707,
            "start_logit": 0.9027565717697144,
            "end_logit": 0.6317142248153687
        },
        {
            "text": "against Epstein-",
            "probability": 0.03697865691597975,
            "start_logit": 0.8652345538139343,
            "end_logit": 0.6317142248153687
        },
        {
            "text": "BsAg, and I",
            "probability": 0.0366437904502757,
            "start_logit": 1.0225685834884644,
            "end_logit": 0.46528327465057373
        }
    ],
    "5a7d535ffaa1ab7d2e000018": [
        {
            "text": "37. Moreover, this",
            "probability": 0.07280564911187487,
            "start_logit": 1.2141587734222412,
            "end_logit": 0.9043321013450623
        },
        {
            "text": "bs-A\u03b2) that appear to reduce risks of developing AD. IVIG sequesters A\u03b2 and thus interferes",
            "probability": 0.05606855069505774,
            "start_logit": 1.1486964225769043,
            "end_logit": 0.708575963973999
        },
        {
            "text": "recent Gammaglobulin Alzheimer's Partnership Phase III trial that did not",
            "probability": 0.05517578867384279,
            "start_logit": 0.9423834681510925,
            "end_logit": 0.8988381028175354
        },
        {
            "text": "of a recent Gammaglobulin Alzheimer's Partnership Phase III trial that did not",
            "probability": 0.05442723378500281,
            "start_logit": 0.9287238717079163,
            "end_logit": 0.8988381028175354
        },
        {
            "text": "bs-A\u03b2, preclinical data, and clinical studies of IVIG as potential AD treatments. The",
            "probability": 0.05344021328327677,
            "start_logit": 1.0452919006347656,
            "end_logit": 0.7639689445495605
        },
        {
            "text": "neuronal loss. The peptide amyloid-",
            "probability": 0.052951526187752694,
            "start_logit": 0.8677952289581299,
            "end_logit": 0.9322789907455444
        },
        {
            "text": "37. Moreover, this study critically examines current market and ethical consequences of potential off-",
            "probability": 0.05241823234983133,
            "start_logit": 1.2141587734222412,
            "end_logit": 0.5757930278778076
        },
        {
            "text": "plasma product intravenous immunoglobulin",
            "probability": 0.05222191865816184,
            "start_logit": 0.943378210067749,
            "end_logit": 0.8428214192390442
        },
        {
            "text": "did not",
            "probability": 0.04998482276150397,
            "start_logit": 0.8435786366462708,
            "end_logit": 0.8988381028175354
        },
        {
            "text": "bs-A\u03b2) that appear to reduce risks of developing",
            "probability": 0.04848143952211499,
            "start_logit": 1.1486964225769043,
            "end_logit": 0.5631819367408752
        },
        {
            "text": "plasma product intravenous immunoglobulin (IVIG) contain naturally-",
            "probability": 0.04810529227070017,
            "start_logit": 0.943378210067749,
            "end_logit": 0.7607113122940063
        },
        {
            "text": "recent Gammaglobulin",
            "probability": 0.0478149034637838,
            "start_logit": 0.9423834681510925,
            "end_logit": 0.7556512355804443
        },
        {
            "text": "of a recent Gammaglobulin",
            "probability": 0.04716621169865466,
            "start_logit": 0.9287238717079163,
            "end_logit": 0.7556512355804443
        },
        {
            "text": "cal data, and clinical studies of IVIG as potential AD treatments. The",
            "probability": 0.04639333432410576,
            "start_logit": 0.9038841724395752,
            "end_logit": 0.7639689445495605
        },
        {
            "text": "cal data, and clinical studies of IVIG as potential AD treatments. The focus of this study is the outcomes of a recent Gammaglobulin",
            "probability": 0.04600904847555802,
            "start_logit": 0.9038841724395752,
            "end_logit": 0.7556512355804443
        },
        {
            "text": "did not reach primary endpoints, as well as efforts to compare IVIG with current anti-",
            "probability": 0.04513759191682388,
            "start_logit": 0.8435786366462708,
            "end_logit": 0.7968341112136841
        },
        {
            "text": ") is a devastating neurodegenerative form of dementia with increasing incidence rates in most countries.",
            "probability": 0.044328264244134136,
            "start_logit": 0.9531927704811096,
            "end_logit": 0.6691270470619202
        },
        {
            "text": "plasma product intravenous immunoglobulin (IVIG) contain naturally-occurring anti-",
            "probability": 0.043778004237261345,
            "start_logit": 0.943378210067749,
            "end_logit": 0.6664506196975708
        },
        {
            "text": "plasma product intravenous im",
            "probability": 0.041648768581006385,
            "start_logit": 0.943378210067749,
            "end_logit": 0.6165909171104431
        },
        {
            "text": ") is a devastating neurodegenerative form of dementia with increasing incidence rates in most",
            "probability": 0.04164320575955199,
            "start_logit": 0.9531927704811096,
            "end_logit": 0.6066427826881409
        }
    ],
    "5a68f448b750ff4455000018": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6e4d22b750ff445500004d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a7234352dc08e987e000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6e24a5b750ff445500003c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a888b56d543831129000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a895f51fcd1d6a10c000004": [
        {
            "text": "F to elucidate its",
            "probability": 0.06400367557030344,
            "start_logit": 0.8900030255317688,
            "end_logit": 0.8952707648277283
        },
        {
            "text": "bases to megabases, CTCF and cohesin organize the genome into chromatin loops",
            "probability": 0.06250000667148506,
            "start_logit": 0.9093849658966064,
            "end_logit": 0.8521149754524231
        },
        {
            "text": "is proposed to extrude chromatin loops",
            "probability": 0.061652674075927213,
            "start_logit": 0.8996107578277588,
            "end_logit": 0.8482391238212585
        },
        {
            "text": "we discuss our own recent studies on an internal RNA-Binding Region (RBRi) in CTCF to elucidate its",
            "probability": 0.06065157790709942,
            "start_logit": 0.836208164691925,
            "end_logit": 0.8952707648277283
        },
        {
            "text": ". At the scale of kilobases to megabases, CTCF and cohesin organize the genome into chromatin loops",
            "probability": 0.06053100726918383,
            "start_logit": 0.8773740530014038,
            "end_logit": 0.8521149754524231
        },
        {
            "text": "is proposed to extrude chromatin loops bidirectionally until it encounters occupied CTCF DNA-binding sites. Curiously, loops",
            "probability": 0.05994702370377671,
            "start_logit": 0.8996107578277588,
            "end_logit": 0.8201837539672852
        },
        {
            "text": "nt orientation. How CTCF interacts with and blocks cohesin extrusion in an orientation-",
            "probability": 0.04985799830977739,
            "start_logit": 1.0812389850616455,
            "end_logit": 0.4542732238769531
        },
        {
            "text": "review recent papers that have shed light on these processes and suggest a multi-",
            "probability": 0.04940520802016241,
            "start_logit": 0.8523797988891602,
            "end_logit": 0.6740093231201172
        },
        {
            "text": "review recent papers that have shed light on these processes and suggest a multi-step",
            "probability": 0.04887347712762202,
            "start_logit": 0.8523797988891602,
            "end_logit": 0.6631883382797241
        },
        {
            "text": "review recent papers that have shed light on these processes and suggest",
            "probability": 0.048302520520377236,
            "start_logit": 0.8523797988891602,
            "end_logit": 0.6514372229576111
        },
        {
            "text": "we discuss our own recent",
            "probability": 0.04817152586292054,
            "start_logit": 0.836208164691925,
            "end_logit": 0.6648932099342346
        },
        {
            "text": "we discuss our own recent studies on",
            "probability": 0.046931164599155376,
            "start_logit": 0.836208164691925,
            "end_logit": 0.6388070583343506
        },
        {
            "text": "bases to megabases,",
            "probability": 0.046423827882704126,
            "start_logit": 0.9093849658966064,
            "end_logit": 0.5547611713409424
        },
        {
            "text": ". At the scale of kilobases to megabases,",
            "probability": 0.044961292209163416,
            "start_logit": 0.8773740530014038,
            "end_logit": 0.5547611713409424
        },
        {
            "text": ". At the",
            "probability": 0.04332605055175504,
            "start_logit": 0.8773740530014038,
            "end_logit": 0.5177133083343506
        },
        {
            "text": "F to elucidate its role in regulating CTCF clustering, target",
            "probability": 0.04176076802609257,
            "start_logit": 0.8900030255317688,
            "end_logit": 0.4682875871658325
        },
        {
            "text": "we discuss our own recent studies on an internal RNA-Binding Region (RBRi) in CT",
            "probability": 0.0416891871386414,
            "start_logit": 0.836208164691925,
            "end_logit": 0.520366907119751
        },
        {
            "text": "review recent papers that have shed light on these",
            "probability": 0.04066966332791217,
            "start_logit": 0.8523797988891602,
            "end_logit": 0.47943592071533203
        },
        {
            "text": "we discuss",
            "probability": 0.040366618211245556,
            "start_logit": 0.836208164691925,
            "end_logit": 0.48812827467918396
        },
        {
            "text": "review recent papers that have shed light on these processes and suggest a",
            "probability": 0.039974733014695,
            "start_logit": 0.8523797988891602,
            "end_logit": 0.4622010588645935
        }
    ],
    "5a7d4e9afaa1ab7d2e000013": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6a02a3b750ff4455000021": [
        {
            "text": "months onwards. Because STOP78SER-ApoAII conserved adequate lipid binding capacity as shown by high STOP78",
            "probability": 0.062034079792861095,
            "start_logit": 0.9268949031829834,
            "end_logit": 1.012905478477478
        },
        {
            "text": "loid-laden organs showed they present systemic amyloidosis. The amyloid",
            "probability": 0.058572358040073436,
            "start_logit": 1.013924479484558,
            "end_logit": 0.8684548735618591
        },
        {
            "text": "-ApoAII conserved adequate lipid binding capacity as shown by high STOP78",
            "probability": 0.05840282406917684,
            "start_logit": 0.8665752410888672,
            "end_logit": 1.012905478477478
        },
        {
            "text": "estine in mice of the K line but",
            "probability": 0.05195463210988773,
            "start_logit": 1.076568841934204,
            "end_logit": 0.6859185099601746
        },
        {
            "text": "loid-",
            "probability": 0.05138269902452627,
            "start_logit": 1.013924479484558,
            "end_logit": 0.7374935150146484
        },
        {
            "text": "months onwards. Because STOP78SER-ApoAII conserved adequate lip",
            "probability": 0.05107932413046181,
            "start_logit": 0.9268949031829834,
            "end_logit": 0.8186013698577881
        },
        {
            "text": "loidosis. The amyloid",
            "probability": 0.050940905154737606,
            "start_logit": 0.8743278384208679,
            "end_logit": 0.8684548735618591
        },
        {
            "text": "deposition into preformed fibrils. Thus, our mouse model",
            "probability": 0.05021349805260835,
            "start_logit": 0.875961422920227,
            "end_logit": 0.8524389266967773
        },
        {
            "text": "erular amyloidosis was a major feature with onset of renal insufficiency",
            "probability": 0.04908457171280815,
            "start_logit": 1.0572280883789062,
            "end_logit": 0.6484331488609314
        },
        {
            "text": "deposition into preformed fibrils. Thus, our mouse model faithfully reproduces early-",
            "probability": 0.048670723321059144,
            "start_logit": 0.875961422920227,
            "end_logit": 0.8212327361106873
        },
        {
            "text": "-ApoAII conserved adequate lip",
            "probability": 0.04808932107520558,
            "start_logit": 0.8665752410888672,
            "end_logit": 0.8186013698577881
        },
        {
            "text": "erular amyloidosis was a",
            "probability": 0.0478947811144826,
            "start_logit": 1.0572280883789062,
            "end_logit": 0.6238949298858643
        },
        {
            "text": "approximately 10 nm diameter. Renal glomerular amyloidosis was a major feature with onset of renal insufficiency",
            "probability": 0.04788075206633132,
            "start_logit": 1.032396912574768,
            "end_logit": 0.6484331488609314
        },
        {
            "text": "estine in mice of the K line but not in other amyloid-laden",
            "probability": 0.04732356188313606,
            "start_logit": 1.076568841934204,
            "end_logit": 0.5925559401512146
        },
        {
            "text": "estine in mice of the K line but not in other amyloid-",
            "probability": 0.04716434489264829,
            "start_logit": 1.076568841934204,
            "end_logit": 0.5891858339309692
        },
        {
            "text": "approximately 10 nm diameter. Renal glomerular amyloidosis was a",
            "probability": 0.04672014157995292,
            "start_logit": 1.032396912574768,
            "end_logit": 0.6238949298858643
        },
        {
            "text": "loid-laden organs showed they present systemic amyloidosis. The amyloid burden was a function of STOP78",
            "probability": 0.04643153537288239,
            "start_logit": 1.013924479484558,
            "end_logit": 0.6361708641052246
        },
        {
            "text": "renal insufficiency",
            "probability": 0.04623502841182141,
            "start_logit": 0.9974210262298584,
            "end_logit": 0.6484331488609314
        },
        {
            "text": "erular amyloidosis was a major feature with onset of renal insufficiency occurring in mice older",
            "probability": 0.045362995687929564,
            "start_logit": 1.0572280883789062,
            "end_logit": 0.5695850849151611
        },
        {
            "text": "loidogenic protein. Amyloid deposits stained with Congo red were extracellular, and consisted of fibrils",
            "probability": 0.0445619225074095,
            "start_logit": 0.853462278842926,
            "end_logit": 0.7555339336395264
        }
    ],
    "5a742d620384be9551000002": [
        {
            "text": ") and Alzheimer's disease (AD) has been",
            "probability": 0.09548785410150516,
            "start_logit": 0.9866570234298706,
            "end_logit": 0.7114259004592896
        },
        {
            "text": "s disease (AD) has been",
            "probability": 0.09041569701775247,
            "start_logit": 0.9320758581161499,
            "end_logit": 0.7114259004592896
        },
        {
            "text": "ructive sleep apnoea (OSA) and Alzheimer's disease (AD) has been",
            "probability": 0.08773518620493284,
            "start_logit": 0.901980996131897,
            "end_logit": 0.7114259004592896
        },
        {
            "text": ") and Alzheimer's disease (AD) has",
            "probability": 0.0832699388091351,
            "start_logit": 0.9866570234298706,
            "end_logit": 0.5745144486427307
        },
        {
            "text": "s disease (AD) has",
            "probability": 0.07884677720425251,
            "start_logit": 0.9320758581161499,
            "end_logit": 0.5745144486427307
        },
        {
            "text": "ructive sleep apnoea (OSA) and Alzheimer's disease (AD) has",
            "probability": 0.07650924460954739,
            "start_logit": 0.901980996131897,
            "end_logit": 0.5745144486427307
        },
        {
            "text": ") and Alzheimer",
            "probability": 0.06689850852952903,
            "start_logit": 0.9866570234298706,
            "end_logit": 0.35560351610183716
        },
        {
            "text": "ructive sleep apnoea (OSA",
            "probability": 0.06617277812976818,
            "start_logit": 0.901980996131897,
            "end_logit": 0.42937204241752625
        },
        {
            "text": ") and Alzheimer's disease (AD) has been described in recent years. OSA is a risk factor for AD, but",
            "probability": 0.062241803729657215,
            "start_logit": 0.9866570234298706,
            "end_logit": 0.28345370292663574
        },
        {
            "text": "ructive sleep apnoea (OSA) and Alzheimer",
            "probability": 0.061467012301180186,
            "start_logit": 0.901980996131897,
            "end_logit": 0.35560351610183716
        },
        {
            "text": ") and Alzheimer's disease (AD) has been described in recent years. OSA",
            "probability": 0.06002724787248954,
            "start_logit": 0.9866570234298706,
            "end_logit": 0.24722543358802795
        },
        {
            "text": "s disease (AD) has been described in recent years. OSA is a risk factor for AD, but",
            "probability": 0.05893562192608111,
            "start_logit": 0.9320758581161499,
            "end_logit": 0.28345370292663574
        },
        {
            "text": "s disease (AD) has been described in recent years. OSA",
            "probability": 0.05683869961805948,
            "start_logit": 0.9320758581161499,
            "end_logit": 0.24722543358802795
        },
        {
            "text": "ructive sleep apnoea (OSA) and Alzheimer's disease (AD) has been described in recent years. OSA",
            "probability": 0.0551536299461097,
            "start_logit": 0.901980996131897,
            "end_logit": 0.24722543358802795
        }
    ],
    "5a74a8a70384be9551000005": [
        {
            "text": "i) has emerged as a promising approach to revolutionize cancer treatment. Small interfering RNA (siRNA) can",
            "probability": 0.09383255434471582,
            "start_logit": 0.9009314775466919,
            "end_logit": 0.7017704844474792
        },
        {
            "text": "is important given the high degree of genetic heterogeneit",
            "probability": 0.09125771298868064,
            "start_logit": 0.8613072633743286,
            "end_logit": 0.7135703563690186
        },
        {
            "text": "to inhibit the expression of any gene which is important given the high degree of genetic heterogeneit",
            "probability": 0.0869089793608302,
            "start_logit": 0.8124811053276062,
            "end_logit": 0.7135703563690186
        },
        {
            "text": "be the second leading cause of cancer-related death by 2025. The",
            "probability": 0.08690014242502657,
            "start_logit": 0.8567004203796387,
            "end_logit": 0.6692493557929993
        },
        {
            "text": "revolutionize cancer treatment. Small interfering RNA (siRNA) can",
            "probability": 0.08667289794933176,
            "start_logit": 0.8215608596801758,
            "end_logit": 0.7017704844474792
        },
        {
            "text": "i) has emerged",
            "probability": 0.08637510417583143,
            "start_logit": 0.9009314775466919,
            "end_logit": 0.6189581155776978
        },
        {
            "text": "review pre-clinical studies investigating the",
            "probability": 0.08355346340150681,
            "start_logit": 0.9534314870834351,
            "end_logit": 0.533245325088501
        },
        {
            "text": "NA nanodrugs and review pre-clinical studies investigating the",
            "probability": 0.08148060029929986,
            "start_logit": 0.9283097386360168,
            "end_logit": 0.533245325088501
        },
        {
            "text": "be the second leading cause of cancer-",
            "probability": 0.07946999003394277,
            "start_logit": 0.8567004203796387,
            "end_logit": 0.5798691511154175
        },
        {
            "text": "is important given the high degree of genetic",
            "probability": 0.07572243107255648,
            "start_logit": 0.8613072633743286,
            "end_logit": 0.5269572734832764
        },
        {
            "text": "is important given the high degree of genetic heterogeneity present in pancreatic tumors. Despite the potential of siRNA the",
            "probability": 0.07571211863616807,
            "start_logit": 0.8613072633743286,
            "end_logit": 0.5268210768699646
        },
        {
            "text": "to inhibit the expression of any gene which is important given the high degree of genetic",
            "probability": 0.07211400531210971,
            "start_logit": 0.8124811053276062,
            "end_logit": 0.5269572734832764
        }
    ],
    "5a67b48cb750ff4455000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6e3155b750ff445500003f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6e42f1b750ff4455000046": [
        {
            "text": "is encoded by MEditerranean FeVer (MEFV) gene. Mutations of this gene are the",
            "probability": 0.0907048894993847,
            "start_logit": 1.0921308994293213,
            "end_logit": 0.5396630764007568
        },
        {
            "text": "rheumatoid arthritis",
            "probability": 0.08168902820195695,
            "start_logit": 1.1480064392089844,
            "end_logit": 0.37909597158432007
        },
        {
            "text": "is encoded by MEditerranean FeVer (MEFV) gene. Mutations of this gene are the cause of fa",
            "probability": 0.08060935826729376,
            "start_logit": 1.0921308994293213,
            "end_logit": 0.42166656255722046
        },
        {
            "text": "is encoded by MEditerranean FeVer (MEFV) gene. Mutations of this gene are the cause of familial Mediterranean fever",
            "probability": 0.07683918941414952,
            "start_logit": 1.0921308994293213,
            "end_logit": 0.37376660108566284
        },
        {
            "text": "of inflammation, is encoded by MEditerranean FeVer (MEFV) gene. Mutations of this gene are the",
            "probability": 0.076621980359054,
            "start_logit": 0.9234036207199097,
            "end_logit": 0.5396630764007568
        },
        {
            "text": "is encoded by MEditerranean FeVer (MEFV)",
            "probability": 0.07459945135151325,
            "start_logit": 1.0921308994293213,
            "end_logit": 0.3441849648952484
        },
        {
            "text": "of inflammation,",
            "probability": 0.07070929520823203,
            "start_logit": 0.9234036207199097,
            "end_logit": 0.4593561291694641
        },
        {
            "text": "is encoded by MEditerranean FeVer (MEFV) gene. Mutations of this",
            "probability": 0.06914089092798449,
            "start_logit": 1.0921308994293213,
            "end_logit": 0.2681981325149536
        },
        {
            "text": "of inflammation, is encoded by MEditerranean FeVer (MEFV) gene. Mutations of this gene are the cause of fa",
            "probability": 0.06809388887414307,
            "start_logit": 0.9234036207199097,
            "end_logit": 0.42166656255722046
        },
        {
            "text": "is encoded by MEditerranean FeVer (MEFV",
            "probability": 0.06757585909572414,
            "start_logit": 1.0921308994293213,
            "end_logit": 0.24530261754989624
        },
        {
            "text": "of inflammation, is encoded by MEditerranean FeVer (MEFV) gene. Mutations of this gene are the cause of familial Mediterranean fever",
            "probability": 0.06490907926343412,
            "start_logit": 0.9234036207199097,
            "end_logit": 0.37376660108566284
        },
        {
            "text": "of inflammation, is encoded by MEditerranean FeVer (MEFV)",
            "probability": 0.06301708461141586,
            "start_logit": 0.9234036207199097,
            "end_logit": 0.3441849648952484
        },
        {
            "text": "of inflammation, is encoded by MEditerranean FeVer (MEFV) gene. Mutations of this",
            "probability": 0.058406024371238104,
            "start_logit": 0.9234036207199097,
            "end_logit": 0.2681981325149536
        },
        {
            "text": "of inflammation, is encoded by MEditerranean FeVer (MEFV",
            "probability": 0.057083980554476055,
            "start_logit": 0.9234036207199097,
            "end_logit": 0.24530261754989624
        }
    ],
    "5a6e354fb750ff4455000042": [
        {
            "text": "hyl package is implemented in R and available via Bioconductor. Its",
            "probability": 0.08640830407408788,
            "start_logit": 1.031002402305603,
            "end_logit": 0.8785088658332825
        },
        {
            "text": "package makes it easy to perform quality assessment of large-",
            "probability": 0.08146328051134875,
            "start_logit": 1.236325979232788,
            "end_logit": 0.6142538785934448
        },
        {
            "text": "package makes it easy to perform quality assessment of large-scale methyl",
            "probability": 0.07669119734036443,
            "start_logit": 1.236325979232788,
            "end_logit": 0.5538884401321411
        },
        {
            "text": "hyl",
            "probability": 0.07577122048242914,
            "start_logit": 1.2111177444458008,
            "end_logit": 0.567028284072876
        },
        {
            "text": "package makes it easy to perform quality assessment of large-scale methylation datasets, such as epigenome-",
            "probability": 0.07021931666316251,
            "start_logit": 1.236325979232788,
            "end_logit": 0.4657249450683594
        },
        {
            "text": "package makes it easy",
            "probability": 0.06814514927449668,
            "start_logit": 1.236325979232788,
            "end_logit": 0.43574148416519165
        },
        {
            "text": "package makes it easy to perform quality assessment of large-scale methylation datasets, such as",
            "probability": 0.06231240183803829,
            "start_logit": 1.236325979232788,
            "end_logit": 0.34626197814941406
        },
        {
            "text": "hyl package is implemented in R and",
            "probability": 0.06062752582769573,
            "start_logit": 1.031002402305603,
            "end_logit": 0.5241740942001343
        },
        {
            "text": "hyl package is implemented in R and available via Bioconductor. Its development repository is at https://github.",
            "probability": 0.05821845586069042,
            "start_logit": 1.031002402305603,
            "end_logit": 0.4836274981498718
        },
        {
            "text": "package for interactive quality control of DNA methylation data from Illumina 450k arrays. The package summarizes 450k",
            "probability": 0.055711671118293775,
            "start_logit": 0.9917676448822021,
            "end_logit": 0.47884950041770935
        },
        {
            "text": "package for interactive quality control of DNA methylation data from Illumina 450k arrays",
            "probability": 0.054316236936038986,
            "start_logit": 0.9917676448822021,
            "end_logit": 0.45348304510116577
        },
        {
            "text": "hyl package is implemented in R and available via Bioconductor.",
            "probability": 0.054131647965230484,
            "start_logit": 1.031002402305603,
            "end_logit": 0.410844087600708
        },
        {
            "text": "package for interactive quality control of DNA methyl",
            "probability": 0.051491376335091814,
            "start_logit": 0.9917676448822021,
            "end_logit": 0.40007418394088745
        },
        {
            "text": "Reactive plots allow fast and intuitive quality control assessment of the samples. In addition, exploration of the phenotypic associations is possible through coloring and principal",
            "probability": 0.051262512323211884,
            "start_logit": 0.8876166939735413,
            "end_logit": 0.49977052211761475
        },
        {
            "text": "present shinyMethyl, a Bioconductor package for interactive quality control of DNA methylation data from Illumina 450k arrays",
            "probability": 0.047859378975697024,
            "start_logit": 0.865211546421051,
            "end_logit": 0.45348304510116577
        },
        {
            "text": "present shinyMethyl, a Bioconductor package for interactive quality control of DNA methyl",
            "probability": 0.04537032447412232,
            "start_logit": 0.865211546421051,
            "end_logit": 0.40007418394088745
        }
    ],
    "5a6f960fb750ff445500005c": [
        {
            "text": "diagnose and treat patients with acute sore throat. In diagnosis, Centor clinical scoring system or rapid antigen",
            "probability": 0.06451452856784726,
            "start_logit": 1.1947847604751587,
            "end_logit": 0.6655972003936768
        },
        {
            "text": "diagnose and treat patients",
            "probability": 0.05865146433207967,
            "start_logit": 1.1947847604751587,
            "end_logit": 0.5703192949295044
        },
        {
            "text": "or criteria) physicians can consider the use of rapid antigen",
            "probability": 0.0572779994561602,
            "start_logit": 0.9731583595275879,
            "end_logit": 0.7682497501373291
        },
        {
            "text": "is not a specific indication for antibiotic therapy in sore throat. If antibiotics are indicated, penicillin V, twice",
            "probability": 0.05708692126358417,
            "start_logit": 0.8520419597625732,
            "end_logit": 0.8860245943069458
        },
        {
            "text": "indicated, penicillin V, twice",
            "probability": 0.05416974789619795,
            "start_logit": 0.7995895147323608,
            "end_logit": 0.8860245943069458
        },
        {
            "text": "RAT is performed, throat culture is not necessary after a negative RAT for the diagnosis of group A streptococci.",
            "probability": 0.05312908732154887,
            "start_logit": 0.7813938856124878,
            "end_logit": 0.8848221898078918
        },
        {
            "text": "-2 Centor criteria to relieve symptoms. Modest benefits of antibiotics, which have been",
            "probability": 0.05171098282225141,
            "start_logit": 0.8348178863525391,
            "end_logit": 0.8043438196182251
        },
        {
            "text": "be used in patients with less severe presentation of sore throat, e.g. 0-",
            "probability": 0.05129645254698813,
            "start_logit": 0.9407020807266235,
            "end_logit": 0.6904110312461853
        },
        {
            "text": "established the",
            "probability": 0.050730652147056646,
            "start_logit": 0.9541909694671631,
            "end_logit": 0.6658308506011963
        },
        {
            "text": "Group to write an updated guideline to diagnose and treat patients with acute sore throat. In diagnosis, Centor clinical scoring system or rapid antigen",
            "probability": 0.049617941460213644,
            "start_logit": 0.9322468042373657,
            "end_logit": 0.6655972003936768
        },
        {
            "text": "be used in patients with less severe presentation of sore throat, e.g.",
            "probability": 0.04796371748781854,
            "start_logit": 0.9407020807266235,
            "end_logit": 0.6232342720031738
        },
        {
            "text": "be used in sore throat. There is inconsistent evidence of herbal treatments and acupuncture as",
            "probability": 0.047357274475828735,
            "start_logit": 0.8326353430747986,
            "end_logit": 0.7185766100883484
        },
        {
            "text": "-",
            "probability": 0.04614263704718658,
            "start_logit": 0.8348178863525391,
            "end_logit": 0.6904110312461853
        },
        {
            "text": "established the Sore Throat Guideline Group to write an updated guideline to diagnose and treat patients",
            "probability": 0.04610948840593654,
            "start_logit": 0.9541909694671631,
            "end_logit": 0.5703192949295044
        },
        {
            "text": "or criteria) physicians can consider the",
            "probability": 0.04589058498364606,
            "start_logit": 0.9731583595275879,
            "end_logit": 0.5465931296348572
        },
        {
            "text": "Group to write an updated guideline to diagnose and treat patients",
            "probability": 0.045108675338523745,
            "start_logit": 0.9322468042373657,
            "end_logit": 0.5703192949295044
        },
        {
            "text": "be used in patients",
            "probability": 0.044227655187663216,
            "start_logit": 0.9407020807266235,
            "end_logit": 0.5421397089958191
        },
        {
            "text": "daily for 10 days is recommended. At the present,",
            "probability": 0.043383089553000416,
            "start_logit": 0.9031722545623779,
            "end_logit": 0.56038898229599
        },
        {
            "text": "and treat patients with acute sore throat. In diagnosis, Centor clinical scoring system or rapid antigen",
            "probability": 0.04302058152307971,
            "start_logit": 0.7895729541778564,
            "end_logit": 0.6655972003936768
        },
        {
            "text": "daily for 10 days is recommended.",
            "probability": 0.042610518183388645,
            "start_logit": 0.9031722545623779,
            "end_logit": 0.5424203872680664
        }
    ],
    "5a551a8fb750ff4455000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a87f44061bb38fb2400000f": [
        {
            "text": "dopamine-induced D2R internalization. Since GPCRs can trans",
            "probability": 0.05893026686608508,
            "start_logit": 1.1500179767608643,
            "end_logit": 0.73029625415802
        },
        {
            "text": "dopamine-induced",
            "probability": 0.058728156242392617,
            "start_logit": 1.1500179767608643,
            "end_logit": 0.7268607020378113
        },
        {
            "text": "K inhibitor alectinib completely inhibited dopamine-induced D2R internalization. Since GPCRs can trans",
            "probability": 0.05789545571437898,
            "start_logit": 1.1323020458221436,
            "end_logit": 0.73029625415802
        },
        {
            "text": "K inhibitor alectinib completely inhibited dopamine-induced",
            "probability": 0.057696894138372826,
            "start_logit": 1.1323020458221436,
            "end_logit": 0.7268607020378113
        },
        {
            "text": "present study, using a cell-based system, we investigated whether ALK regulates D2R",
            "probability": 0.055042843803818374,
            "start_logit": 0.9380028247833252,
            "end_logit": 0.8740684390068054
        },
        {
            "text": "present study, using a cell-",
            "probability": 0.054830039727768724,
            "start_logit": 0.9380028247833252,
            "end_logit": 0.8701947927474976
        },
        {
            "text": "K",
            "probability": 0.05268654991945365,
            "start_logit": 1.1323020458221436,
            "end_logit": 0.6360175609588623
        },
        {
            "text": "if D2R stimulation activated AL",
            "probability": 0.05163473991929496,
            "start_logit": 0.8481632471084595,
            "end_logit": 0.8999908566474915
        },
        {
            "text": "we also examined if D2R stimulation activated AL",
            "probability": 0.05096826643129723,
            "start_logit": 0.8351717591285706,
            "end_logit": 0.8999908566474915
        },
        {
            "text": "kinase (ALK) blocked D",
            "probability": 0.04869913509643113,
            "start_logit": 0.8810757398605347,
            "end_logit": 0.808544933795929
        },
        {
            "text": "present study, using a cell",
            "probability": 0.048657067107084874,
            "start_logit": 0.9380028247833252,
            "end_logit": 0.75075364112854
        },
        {
            "text": "kinase (ALK) blocked D2R desens",
            "probability": 0.04736279699779858,
            "start_logit": 0.8810757398605347,
            "end_logit": 0.7807207107543945
        },
        {
            "text": "kinase anaplastic lymphoma kinase (ALK) blocked D",
            "probability": 0.04727320788488833,
            "start_logit": 0.85135817527771,
            "end_logit": 0.808544933795929
        },
        {
            "text": "kinase anaplastic lymphoma kinase (ALK) blocked D2R desens",
            "probability": 0.04597599821954085,
            "start_logit": 0.85135817527771,
            "end_logit": 0.7807207107543945
        },
        {
            "text": "coupled receptor (GPCR) expressed in regions of the",
            "probability": 0.04519770845409648,
            "start_logit": 0.9170805215835571,
            "end_logit": 0.6979252696037292
        },
        {
            "text": "phoma kinase (ALK) blocked D",
            "probability": 0.04473919931371265,
            "start_logit": 0.7962645292282104,
            "end_logit": 0.808544933795929
        },
        {
            "text": "study found that inhibitors of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) blocked D",
            "probability": 0.043997378937536004,
            "start_logit": 0.7795445322990417,
            "end_logit": 0.808544933795929
        },
        {
            "text": "phoma kinase (ALK) blocked D2R desens",
            "probability": 0.04351152460394946,
            "start_logit": 0.7962645292282104,
            "end_logit": 0.7807207107543945
        },
        {
            "text": "present study, using a cell-based system, we investigated whether ALK regulates D2R internalization. The ALK",
            "probability": 0.04338271032785708,
            "start_logit": 0.9380028247833252,
            "end_logit": 0.6360175609588623
        },
        {
            "text": "study found that inhibitors of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) blocked D2R desens",
            "probability": 0.04279006029424224,
            "start_logit": 0.7795445322990417,
            "end_logit": 0.7807207107543945
        }
    ],
    "5a6a3464b750ff4455000026": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6d08d5b750ff445500002c": [
        {
            "text": "i,i+6 stapled peptide with improved, sub",
            "probability": 0.08455151343301162,
            "start_logit": 1.3259191513061523,
            "end_logit": 0.934569776058197
        },
        {
            "text": "i,i+6 stapled peptide with improved,",
            "probability": 0.06462013736360096,
            "start_logit": 1.3259191513061523,
            "end_logit": 0.6657348871231079
        },
        {
            "text": "ox i,i+6 stapled peptide with improved, sub",
            "probability": 0.06266685093914434,
            "start_logit": 1.026390790939331,
            "end_logit": 0.934569776058197
        },
        {
            "text": "i,i+6 stapled peptide with improved, submicromolar",
            "probability": 0.06026353170253928,
            "start_logit": 1.3259191513061523,
            "end_logit": 0.5959359407424927
        },
        {
            "text": "CIP) of the replicative helicase subunit Sld5. By screening stapling",
            "probability": 0.05600204533393416,
            "start_logit": 1.0831934213638306,
            "end_logit": 0.765322744846344
        },
        {
            "text": "i,i+6 stapled peptide with improved, submicromolar binding to Ctf4. The",
            "probability": 0.05398832264094431,
            "start_logit": 1.3259191513061523,
            "end_logit": 0.48597657680511475
        },
        {
            "text": "sub",
            "probability": 0.05349627819960055,
            "start_logit": 0.8681702613830566,
            "end_logit": 0.934569776058197
        },
        {
            "text": "P) of the replicative helicase subunit Sld5. By screening stapling",
            "probability": 0.05072968594091831,
            "start_logit": 0.9843164682388306,
            "end_logit": 0.765322744846344
        },
        {
            "text": "CIP) of the replicative helica",
            "probability": 0.050514374175420866,
            "start_logit": 1.0831934213638306,
            "end_logit": 0.6621924638748169
        },
        {
            "text": "ox i,i+6 stapled peptide with improved,",
            "probability": 0.047894358733627865,
            "start_logit": 1.026390790939331,
            "end_logit": 0.6657348871231079
        },
        {
            "text": "polymerase\u2005\u03b1 from the replisome in yeast extracts. Our study provides proof-of-principle evidence for the development of small-molecule",
            "probability": 0.04733691145651772,
            "start_logit": 0.8737269639968872,
            "end_logit": 0.8066913485527039
        },
        {
            "text": "P) of the replicative helica",
            "probability": 0.04575865617301577,
            "start_logit": 0.9843164682388306,
            "end_logit": 0.6621924638748169
        },
        {
            "text": "ox i,i+6 stapled peptide with improved, submicromolar",
            "probability": 0.04466538332588795,
            "start_logit": 1.026390790939331,
            "end_logit": 0.5959359407424927
        },
        {
            "text": "displace the Ctf4 partner DNA polymerase\u2005\u03b1 from the replisome in yeast extracts. Our study provides proof-of-principle",
            "probability": 0.042951739644328385,
            "start_logit": 0.9160060882568359,
            "end_logit": 0.6671990156173706
        },
        {
            "text": "polymerase\u2005\u03b1 from the replisome in yeast extracts. Our study provides proof-of-principle",
            "probability": 0.041173631004604784,
            "start_logit": 0.8737269639968872,
            "end_logit": 0.6671990156173706
        },
        {
            "text": "lace the",
            "probability": 0.04025063545036984,
            "start_logit": 0.9160060882568359,
            "end_logit": 0.6022476553916931
        },
        {
            "text": "ox i,i+6 stapled peptide with improved, submicromolar binding to Ctf4. The",
            "probability": 0.040014401044104184,
            "start_logit": 1.026390790939331,
            "end_logit": 0.48597657680511475
        },
        {
            "text": "lethality by small-molecule targeting of pathways that maintain gen",
            "probability": 0.03865243953493512,
            "start_logit": 0.8931630253791809,
            "end_logit": 0.584574818611145
        },
        {
            "text": "submicromolar",
            "probability": 0.03812911828957025,
            "start_logit": 0.8681702613830566,
            "end_logit": 0.5959359407424927
        },
        {
            "text": "submicromolar binding to Ctf4. The mode of interaction with Ctf4 was confirmed by a crystal structure",
            "probability": 0.03633998561392377,
            "start_logit": 0.8681702613830566,
            "end_logit": 0.5478763580322266
        }
    ],
    "5a70d42899e2c3af26000002": [
        {
            "text": "pathophysiology of SCAD is not yet fully understood. Loeys-Dietz syndrome is a connective tissue",
            "probability": 0.08640276211944604,
            "start_logit": 0.8990790843963623,
            "end_logit": 0.8496392965316772
        },
        {
            "text": "family with a SMAD3 gene mutation and Loeys-",
            "probability": 0.07679543061156915,
            "start_logit": 0.99199378490448,
            "end_logit": 0.6388500928878784
        },
        {
            "text": "family with a SMAD3 gene mutation and Loeys-Dietz syndrome presenting",
            "probability": 0.07390043704244037,
            "start_logit": 0.99199378490448,
            "end_logit": 0.6004236936569214
        },
        {
            "text": "family with a SMAD3 gene mutation and Loeys-Dietz syndrome presenting with rec",
            "probability": 0.06966442312224967,
            "start_logit": 0.99199378490448,
            "end_logit": 0.5413947105407715
        },
        {
            "text": "pathophysiology of SCAD is not yet fully understood. Loeys-Diet",
            "probability": 0.06748093295608859,
            "start_logit": 0.8990790843963623,
            "end_logit": 0.6024647355079651
        },
        {
            "text": "of acute coronary syndrome. The pathophysiology of SCAD is not yet fully understood. Loeys-Diet",
            "probability": 0.06584105396025866,
            "start_logit": 0.8744775652885437,
            "end_logit": 0.6024647355079651
        },
        {
            "text": "pathophysiology of SCAD is not yet fully understood. Loeys-Dietz syndrome is a connect",
            "probability": 0.06262535938763007,
            "start_logit": 0.8990790843963623,
            "end_logit": 0.5277899503707886
        },
        {
            "text": "artery dissection (SCAD) is a cause of about 4% of acute coronary syndrome. The pathophysio",
            "probability": 0.060908560517484805,
            "start_logit": 0.9097615480422974,
            "end_logit": 0.4893109202384949
        },
        {
            "text": "pathophysiology of SCAD is not yet fully understood. Loeys-Dietz syndrome is a connective tissue disorder",
            "probability": 0.060382990720606246,
            "start_logit": 0.8990790843963623,
            "end_logit": 0.49132710695266724
        },
        {
            "text": "pathophysio",
            "probability": 0.06026136998320993,
            "start_logit": 0.8990790843963623,
            "end_logit": 0.4893109202384949
        },
        {
            "text": "of acute coronary syndrome. The pathophysio",
            "probability": 0.058796936245168595,
            "start_logit": 0.8744775652885437,
            "end_logit": 0.4893109202384949
        },
        {
            "text": "family with a SMAD3 gene mutation and Loeys-Dietz syndrome presenting with recurrent SCAD episodes",
            "probability": 0.057193644955970985,
            "start_logit": 0.99199378490448,
            "end_logit": 0.3441477417945862
        },
        {
            "text": "family with a SMAD3 gene mutation",
            "probability": 0.054561251288375814,
            "start_logit": 0.99199378490448,
            "end_logit": 0.29702889919281006
        },
        {
            "text": "family with a SMAD3 gene mutation and Loeys-Dietz",
            "probability": 0.05339042713847336,
            "start_logit": 0.99199378490448,
            "end_logit": 0.2753364145755768
        },
        {
            "text": "artery dissection (SCAD) is a cause of about 4% of acute coronary",
            "probability": 0.046706844163057114,
            "start_logit": 0.9097615480422974,
            "end_logit": 0.22382789850234985
        },
        {
            "text": "of acute coronary",
            "probability": 0.04508757578797067,
            "start_logit": 0.8744775652885437,
            "end_logit": 0.22382789850234985
        }
    ],
    "5a8b1264fcd1d6a10c00001d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a70e4b399e2c3af26000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a777ab9faa1ab7d2e00000a": [
        {
            "text": "development of therapeutics for central nervous system (CNS) disorders has many challenges that result in low probability of success and longer-",
            "probability": 0.09453193726016028,
            "start_logit": 0.990128755569458,
            "end_logit": 1.052241563796997
        },
        {
            "text": "challenges that result in low probability of success and longer-",
            "probability": 0.08496501997054567,
            "start_logit": 0.8834306597709656,
            "end_logit": 1.052241563796997
        },
        {
            "text": "success and speed? Here we",
            "probability": 0.07897131740597164,
            "start_logit": 0.9876579642295837,
            "end_logit": 0.8748593330383301
        },
        {
            "text": "somra for insomnia, as well as other neurological and psychiatric diseases, continues",
            "probability": 0.07889916766074731,
            "start_logit": 0.9236759543418884,
            "end_logit": 0.9379273056983948
        },
        {
            "text": "success and speed? Here we suggest that this program was unique and set up for success by (1) having a robust and high-",
            "probability": 0.06584266016330888,
            "start_logit": 0.9876579642295837,
            "end_logit": 0.6930425763130188
        },
        {
            "text": "development of therapeutics for central nervous system (CNS) disorders has many challenges that result",
            "probability": 0.05895929291087688,
            "start_logit": 0.990128755569458,
            "end_logit": 0.5801510810852051
        },
        {
            "text": "development of therapeutics for central nervous system (CNS) disorders has many challenges that result in low probability of success",
            "probability": 0.05812150325646832,
            "start_logit": 0.990128755569458,
            "end_logit": 0.5658395290374756
        },
        {
            "text": "readout that was translatable across species, including humans",
            "probability": 0.05557352565227938,
            "start_logit": 0.855789065361023,
            "end_logit": 0.6553504467010498
        },
        {
            "text": "readout that was translatable across species, including humans,",
            "probability": 0.05544515808009447,
            "start_logit": 0.855789065361023,
            "end_logit": 0.6530379056930542
        },
        {
            "text": "readout that was translatable across species, including humans, (2)",
            "probability": 0.05526616941887936,
            "start_logit": 0.855789065361023,
            "end_logit": 0.6498044729232788
        },
        {
            "text": "challenges that result in low probability of success and longer-than-typical development timelines.",
            "probability": 0.05418721806406422,
            "start_logit": 0.8834306597709656,
            "end_logit": 0.602446973323822
        },
        {
            "text": "disease.",
            "probability": 0.05381145315800822,
            "start_logit": 0.9374322891235352,
            "end_logit": 0.5414866209030151
        },
        {
            "text": "challenges that result",
            "probability": 0.05299243456563659,
            "start_logit": 0.8834306597709656,
            "end_logit": 0.5801510810852051
        },
        {
            "text": "challenges that result in low probability of success",
            "probability": 0.05223943175218488,
            "start_logit": 0.8834306597709656,
            "end_logit": 0.5658395290374756
        },
        {
            "text": "somra for insomnia,",
            "probability": 0.051050492604575434,
            "start_logit": 0.9236759543418884,
            "end_logit": 0.5025718212127686
        },
        {
            "text": "readout that was",
            "probability": 0.049143218076198654,
            "start_logit": 0.855789065361023,
            "end_logit": 0.5323823690414429
        }
    ],
    "5a8715a961bb38fb24000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a75f6e083b0d9ea66000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a72329e2dc08e987e000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a735cdc3b9d13c708000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6fa31ab750ff445500005e": [
        {
            "text": "sequencing and analyzed bioinformatically, allowing detection and quantification of all sequences that have contacts with a chosen",
            "probability": 0.08005225479916685,
            "start_logit": 1.0693334341049194,
            "end_logit": 1.211044430732727
        },
        {
            "text": "contacts with a chosen",
            "probability": 0.06562952494285361,
            "start_logit": 0.870679497718811,
            "end_logit": 1.211044430732727
        },
        {
            "text": "model",
            "probability": 0.060278813474472004,
            "start_logit": 1.0456427335739136,
            "end_logit": 0.9510362148284912
        },
        {
            "text": "-ligation-",
            "probability": 0.05819922302150345,
            "start_logit": 0.8424248695373535,
            "end_logit": 1.119145393371582
        },
        {
            "text": "information about the dynamics of enhancer-promoter contacts during differentiation. The technique described for the EB differentiation model",
            "probability": 0.056389473242411926,
            "start_logit": 0.9789445400238037,
            "end_logit": 0.9510362148284912
        },
        {
            "text": "interacting with promoters, assigning them to their",
            "probability": 0.05436373117036164,
            "start_logit": 1.2671031951904297,
            "end_logit": 0.6262922883033752
        },
        {
            "text": "is well-known that tissue-",
            "probability": 0.05243452180343161,
            "start_logit": 0.97559654712677,
            "end_logit": 0.881666898727417
        },
        {
            "text": "information about the dynamics of enhancer-",
            "probability": 0.05230648938210873,
            "start_logit": 0.9789445400238037,
            "end_logit": 0.8758741617202759
        },
        {
            "text": "information about the dynamics of enhancer-promoter contacts during differentiation. The technique",
            "probability": 0.04970264235732493,
            "start_logit": 0.9789445400238037,
            "end_logit": 0.8248118162155151
        },
        {
            "text": "-ligation-mediated PC",
            "probability": 0.04891355753890131,
            "start_logit": 0.8424248695373535,
            "end_logit": 0.9453279972076416
        },
        {
            "text": "sequencing and analyzed bioin",
            "probability": 0.04790782028140548,
            "start_logit": 1.0693334341049194,
            "end_logit": 0.6976435780525208
        },
        {
            "text": "contacts with a chosen promoter. The resulting sequencing data can also be used to gain information about the dynamics of enhancer-",
            "probability": 0.04693930579114637,
            "start_logit": 0.870679497718811,
            "end_logit": 0.8758741617202759
        },
        {
            "text": "-",
            "probability": 0.04331977854918841,
            "start_logit": 0.8424248695373535,
            "end_logit": 0.8238826990127563
        },
        {
            "text": "sequencing and analyzed bioinformatically, allowing detection and quantification of all sequences that have contacts with a chosen promoter. The",
            "probability": 0.0428934030286038,
            "start_logit": 1.0693334341049194,
            "end_logit": 0.5870828628540039
        },
        {
            "text": "is well-known that tissue-specific enhancers play an important role in these",
            "probability": 0.042523288086307405,
            "start_logit": 0.97559654712677,
            "end_logit": 0.6721535921096802
        },
        {
            "text": "-ligation-mediated PCR protocol compatible with commercial DNA library preparation kits. Subsequently, the 4C libraries are subjected to high-",
            "probability": 0.04140024145731844,
            "start_logit": 0.8424248695373535,
            "end_logit": 0.7785601019859314
        },
        {
            "text": "is well-known that tissue-specific enhancers play an important role in these networks by interacting with promoters, assigning them to their",
            "probability": 0.04061715754724794,
            "start_logit": 0.97559654712677,
            "end_logit": 0.6262922883033752
        },
        {
            "text": "is well-known that tissue-specific enhancers play an important role in these networks",
            "probability": 0.039941146835864694,
            "start_logit": 0.97559654712677,
            "end_logit": 0.609508752822876
        },
        {
            "text": "information about the dynamics of enhancer-promoter contacts during differentiation. The technique described for the",
            "probability": 0.039024107192738654,
            "start_logit": 0.9789445400238037,
            "end_logit": 0.5829333066940308
        },
        {
            "text": "-ligation-mediated PCR protocol compatible with commercial DNA library preparation kits. Subsequently, the 4C libraries",
            "probability": 0.03716351949764271,
            "start_logit": 0.8424248695373535,
            "end_logit": 0.6706010103225708
        }
    ],
    "5a871a6861bb38fb24000009": [
        {
            "text": ")-ALK being the",
            "probability": 0.058659443912780225,
            "start_logit": 0.9487802982330322,
            "end_logit": 1.0433710813522339
        },
        {
            "text": "ALK gene alterations have been described across a range of tumour types, including point mutations, deletions and rear",
            "probability": 0.05638875421232044,
            "start_logit": 1.274763584136963,
            "end_logit": 0.6779089570045471
        },
        {
            "text": "ALK kinase domain and are associated with the emergence of different resistance mutation patterns during therapy. This emphasises the need to tailor",
            "probability": 0.05574966990849763,
            "start_logit": 1.0707623958587646,
            "end_logit": 0.8705118894577026
        },
        {
            "text": "patient. Research into",
            "probability": 0.05232911659479773,
            "start_logit": 0.9675890207290649,
            "end_logit": 0.9103667140007019
        },
        {
            "text": "KIs), crizotinib and ceritinib,",
            "probability": 0.05213403469394516,
            "start_logit": 1.060221791267395,
            "end_logit": 0.8139989972114563
        },
        {
            "text": "differently within the ATP-binding pocket of the AL",
            "probability": 0.05112630503158708,
            "start_logit": 1.1451404094696045,
            "end_logit": 0.7095615267753601
        },
        {
            "text": ")-ALK being the most prevalent in non-small-cell lung cancer (NSCL",
            "probability": 0.05111634416504145,
            "start_logit": 0.9487802982330322,
            "end_logit": 0.9057267904281616
        },
        {
            "text": "CLC. Limited",
            "probability": 0.05091335192055105,
            "start_logit": 1.170702576637268,
            "end_logit": 0.6798254251480103
        },
        {
            "text": "K fusion proteins can mediate different signalling outputs,",
            "probability": 0.05085040017894843,
            "start_logit": 0.9916245341300964,
            "end_logit": 0.8576662540435791
        },
        {
            "text": "es the need to tailor the sequence of ALK TKIs according to the ALK signature of each patient. Research into",
            "probability": 0.04947011285790068,
            "start_logit": 0.9114047884941101,
            "end_logit": 0.9103667140007019
        },
        {
            "text": "is a need to better understand the role of ALK in cancer biology in order to optimise treatment strategies. This review sum",
            "probability": 0.04869571890290718,
            "start_logit": 0.9190076589584351,
            "end_logit": 0.886986255645752
        },
        {
            "text": "K fusions found",
            "probability": 0.04772512462788458,
            "start_logit": 1.0541013479232788,
            "end_logit": 0.7317594289779663
        },
        {
            "text": "TKIs), crizotinib and ceritinib,",
            "probability": 0.04755971455560839,
            "start_logit": 0.9683898687362671,
            "end_logit": 0.8139989972114563
        },
        {
            "text": "es the need to tailor",
            "probability": 0.04753726273046461,
            "start_logit": 0.9114047884941101,
            "end_logit": 0.8705118894577026
        },
        {
            "text": "AL",
            "probability": 0.047461607768377816,
            "start_logit": 1.0707623958587646,
            "end_logit": 0.7095615267753601
        },
        {
            "text": "K, and how this information can guide the management of patients with cancer that is ALK-",
            "probability": 0.047253367122733154,
            "start_logit": 0.8450955152511597,
            "end_logit": 0.9308311939239502
        },
        {
            "text": "development of ALK inhibitors, has substantially improved outcomes for patients with ALK-positive NSCLC. Limited",
            "probability": 0.04679817090559307,
            "start_logit": 1.0864214897155762,
            "end_logit": 0.6798254251480103
        },
        {
            "text": "of different resistance mutation patterns during therapy. This emphasises the need to tailor",
            "probability": 0.04678192832719214,
            "start_logit": 0.8953878879547119,
            "end_logit": 0.8705118894577026
        },
        {
            "text": "K fusion proteins can mediate different signalling outputs, depending on properties such as subcellular localisation and protein stability. The",
            "probability": 0.04589151334838231,
            "start_logit": 0.9916245341300964,
            "end_logit": 0.7550584673881531
        },
        {
            "text": "development of ALK inhibitors, has substantially improved outcomes for patients with ALK",
            "probability": 0.04555805823448725,
            "start_logit": 1.0864214897155762,
            "end_logit": 0.6529688239097595
        }
    ],
    "5a67ab79b750ff445500000b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6d196db750ff4455000032": [
        {
            "text": "transmitter identity is acquired at the stem cell level. Our detailed transmitter-",
            "probability": 0.11075250281211499,
            "start_logit": 1.115403175354004,
            "end_logit": 1.2080754041671753
        },
        {
            "text": "nsmitter. Thus, neurotransmitter identity is acquired at the stem cell level. Our detailed transmitter-",
            "probability": 0.10268168084190858,
            "start_logit": 1.0397388935089111,
            "end_logit": 1.2080754041671753
        },
        {
            "text": ". Our detailed transmitter-",
            "probability": 0.09462999784738892,
            "start_logit": 0.9580796957015991,
            "end_logit": 1.2080754041671753
        },
        {
            "text": "is transcribed in many glutamatergic and GABAergic neurons,",
            "probability": 0.07071446934565086,
            "start_logit": 1.0457463264465332,
            "end_logit": 0.8290844559669495
        },
        {
            "text": "transmitter identity is acquired",
            "probability": 0.06360914530168302,
            "start_logit": 1.115403175354004,
            "end_logit": 0.6535346508026123
        },
        {
            "text": "ergic neurons,",
            "probability": 0.059253483274570376,
            "start_logit": 0.8689206838607788,
            "end_logit": 0.8290844559669495
        },
        {
            "text": "nsmitter. Thus, neurotransmitter identity is acquired",
            "probability": 0.058973781997272746,
            "start_logit": 1.0397388935089111,
            "end_logit": 0.6535346508026123
        },
        {
            "text": "behavior and dec",
            "probability": 0.054759102031060804,
            "start_logit": 1.0405075550079346,
            "end_logit": 0.5786166191101074
        },
        {
            "text": "trans",
            "probability": 0.05391963696557313,
            "start_logit": 1.115403175354004,
            "end_logit": 0.48827213048934937
        },
        {
            "text": "nsmitter.",
            "probability": 0.05093183631100809,
            "start_logit": 1.0397388935089111,
            "end_logit": 0.506929874420166
        },
        {
            "text": ". Our detailed transmitter- usage/lineage identity map will be a great resource for studying the developmental basis of behavior and dec",
            "probability": 0.05042644514448682,
            "start_logit": 0.9580796957015991,
            "end_logit": 0.5786166191101074
        },
        {
            "text": "nsmitter. Thus, neurotrans",
            "probability": 0.04999037325055306,
            "start_logit": 1.0397388935089111,
            "end_logit": 0.48827213048934937
        },
        {
            "text": "ns",
            "probability": 0.048638793604727476,
            "start_logit": 1.0397388935089111,
            "end_logit": 0.4608631134033203
        },
        {
            "text": "of 34 hemilineages,",
            "probability": 0.04597217832693937,
            "start_logit": 0.849199652671814,
            "end_logit": 0.5950173139572144
        },
        {
            "text": "of 34 hemilineages, which are clusters of lineally related neurons. Neurons in these hemilineages use one of the three fast-",
            "probability": 0.04282037339425135,
            "start_logit": 0.849199652671814,
            "end_logit": 0.5239949226379395
        },
        {
            "text": "of 34 hemilineages",
            "probability": 0.04192619955081033,
            "start_logit": 0.849199652671814,
            "end_logit": 0.5028918385505676
        }
    ],
    "5a6d1733b750ff4455000030": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a7877c0faa1ab7d2e00000c": [
        {
            "text": "is associated with significant morbidity and rising healthcare utilisation. Patients with sarcoidosis",
            "probability": 0.17316697517462315,
            "start_logit": 1.0660371780395508,
            "end_logit": 0.6224418878555298
        },
        {
            "text": "is associated with significant morbidity and rising healthcare utilisation.",
            "probability": 0.16631314518203796,
            "start_logit": 1.0660371780395508,
            "end_logit": 0.5820580124855042
        },
        {
            "text": "is associated with significant morbidity and rising healthcare utilisation. Patients with sarcoidosis report higher psychological symptoms than the general population.",
            "probability": 0.14128485297444038,
            "start_logit": 1.0660371780395508,
            "end_logit": 0.4189636707305908
        },
        {
            "text": "is associated with significant morbidity and rising healthcare utilisation. Patients with sarcoidosis report higher psychological symptoms than the",
            "probability": 0.13703440383237175,
            "start_logit": 1.0660371780395508,
            "end_logit": 0.3884176015853882
        },
        {
            "text": "is associated with significant morbidity and rising healthcare utilisation. Patients with sarcoidosis report higher psychological symptoms than",
            "probability": 0.13121573700505598,
            "start_logit": 1.0660371780395508,
            "end_logit": 0.3450284004211426
        },
        {
            "text": "is associated with significant morbidity and rising healthcare utilisation. Patients with sarcoidosis report higher",
            "probability": 0.12739490586711907,
            "start_logit": 1.0660371780395508,
            "end_logit": 0.3154773414134979
        },
        {
            "text": "is associated with significant morbidity",
            "probability": 0.12358997996435164,
            "start_logit": 1.0660371780395508,
            "end_logit": 0.2851550579071045
        }
    ],
    "5a68f005b750ff4455000016": [
        {
            "text": "is the central mechanism",
            "probability": 0.07447571492603473,
            "start_logit": 0.912490963935852,
            "end_logit": 1.1280465126037598
        },
        {
            "text": "nervosa,",
            "probability": 0.06437506254629134,
            "start_logit": 1.0916959047317505,
            "end_logit": 0.8030948042869568
        },
        {
            "text": "Behavior Therapy (RO DBT) has been developed to treat disorders characterized by overcontrol. RO DBT targets maladaptive social signaling",
            "probability": 0.05756771113623195,
            "start_logit": 1.0534511804580688,
            "end_logit": 0.7295750379562378
        },
        {
            "text": "nervosa, and personality disorders such as obsessive-",
            "probability": 0.055320259735783577,
            "start_logit": 1.0916959047317505,
            "end_logit": 0.6515076756477356
        },
        {
            "text": "too much self-control, exhibiting as behavioral and cognitive inflexibility, high inhibition",
            "probability": 0.05465261265587116,
            "start_logit": 0.9532673954963684,
            "end_logit": 0.7777940034866333
        },
        {
            "text": "nervosa, and personality",
            "probability": 0.051499815392294084,
            "start_logit": 1.0916959047317505,
            "end_logit": 0.5799466967582703
        },
        {
            "text": "including treatment-resistant depression and anxiety, anorexia nervosa,",
            "probability": 0.05138983770313151,
            "start_logit": 0.8664100170135498,
            "end_logit": 0.8030948042869568
        },
        {
            "text": ". The current article introduces this novel treatment approach and discusses its emphasis on social signaling and its transdiagnostic nature. We",
            "probability": 0.05132072921339951,
            "start_logit": 0.8178868889808655,
            "end_logit": 0.8502722382545471
        },
        {
            "text": "nervosa, and personality disorders such as obsessive-compulsive personality",
            "probability": 0.051192044624764926,
            "start_logit": 1.0916959047317505,
            "end_logit": 0.5739526152610779
        },
        {
            "text": "personality and coping style is a tendency to have too much self-control, exhibiting as behavioral and cognitive inflexibility, high inhibition",
            "probability": 0.049511174319114275,
            "start_logit": 0.8544687628746033,
            "end_logit": 0.7777940034866333
        },
        {
            "text": "Behavior Therapy (RO DB",
            "probability": 0.04735676396845148,
            "start_logit": 1.0534511804580688,
            "end_logit": 0.5343228578567505
        },
        {
            "text": "too much self-control, exhibiting as behavioral and cognitive inflexibility, high inhibition of emotion, high detail-",
            "probability": 0.04499026034119948,
            "start_logit": 0.9532673954963684,
            "end_logit": 0.5832430124282837
        },
        {
            "text": "RO DBT across clinical populations, discuss issues related to assessment of overcontrol, and speculate on future directions for this",
            "probability": 0.04496504401297814,
            "start_logit": 0.9657019972801208,
            "end_logit": 0.5702477693557739
        },
        {
            "text": "too much self-",
            "probability": 0.04460421096083589,
            "start_logit": 0.9532673954963684,
            "end_logit": 0.5746252536773682
        },
        {
            "text": "is the central mechanism of change in treatment. Because RO DBT is used for individuals with an overcontrolled personality",
            "probability": 0.04452879927084803,
            "start_logit": 0.912490963935852,
            "end_logit": 0.613709568977356
        },
        {
            "text": "including treatment-resistant depression and anxiety, anorexia nervosa, and personality disorders such as obsessive-",
            "probability": 0.04416149759035503,
            "start_logit": 0.8664100170135498,
            "end_logit": 0.6515076756477356
        },
        {
            "text": "too much self-control, exhibiting as behavioral and cognitive inflexibility",
            "probability": 0.04407734386933712,
            "start_logit": 0.9532673954963684,
            "end_logit": 0.5627428889274597
        },
        {
            "text": ". Because RO DBT is used for individuals with an overcontrolled personality",
            "probability": 0.04169007653166475,
            "start_logit": 0.8466179370880127,
            "end_logit": 0.613709568977356
        },
        {
            "text": "of an overcontrolled personality and coping style is a tendency to have too much self-",
            "probability": 0.041209358352979016,
            "start_logit": 0.8741044998168945,
            "end_logit": 0.5746252536773682
        },
        {
            "text": "including treatment-resistant depression and anxiety, anorexia nervosa, and personality",
            "probability": 0.04111168284843393,
            "start_logit": 0.8664100170135498,
            "end_logit": 0.5799466967582703
        }
    ],
    "5a79d0b8faa1ab7d2e00000d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6900ebb750ff445500001d": [
        {
            "text": "cal erosion, scler",
            "probability": 0.07090018381306173,
            "start_logit": 1.2898736000061035,
            "end_logit": 0.9694936275482178
        },
        {
            "text": "scia, increased thickness of fa",
            "probability": 0.05812770122570167,
            "start_logit": 0.8474026918411255,
            "end_logit": 1.2133338451385498
        },
        {
            "text": "test was positive in most",
            "probability": 0.057720502778493464,
            "start_logit": 1.0035865306854248,
            "end_logit": 1.0501201152801514
        },
        {
            "text": "injury (RSI), with a mean age of 42.63\u00b18.53 years. Of the 82 patients, 34 (41.",
            "probability": 0.05450476962216444,
            "start_logit": 1.0623645782470703,
            "end_logit": 0.9340178370475769
        },
        {
            "text": ". Of the 82 patients, 34 (41.",
            "probability": 0.052440549613891684,
            "start_logit": 1.023756504058838,
            "end_logit": 0.9340178370475769
        },
        {
            "text": "females) with repetitive stress injury (RSI), with a mean age",
            "probability": 0.05197433570247016,
            "start_logit": 1.0625953674316406,
            "end_logit": 0.8862488865852356
        },
        {
            "text": "injury (RSI), with a mean age",
            "probability": 0.051962341971979686,
            "start_logit": 1.0623645782470703,
            "end_logit": 0.8862488865852356
        },
        {
            "text": ". Cozen's test was positive in most",
            "probability": 0.051536872269678645,
            "start_logit": 0.8902716040611267,
            "end_logit": 1.0501201152801514
        },
        {
            "text": "test was positive in most patients. In DQ, the most affected sites were left and right radial styloid processes.",
            "probability": 0.051116753981860094,
            "start_logit": 1.0035865306854248,
            "end_logit": 0.9286199808120728
        },
        {
            "text": "SPSS Version 21 (IBM Corp., Armonk, NY, USA). Data were represented as frequency and percentage",
            "probability": 0.04796800284502435,
            "start_logit": 0.7796428203582764,
            "end_logit": 1.088985562324524
        },
        {
            "text": "swelling were observed in all patients. In TE, the most affected site was",
            "probability": 0.04749693590881265,
            "start_logit": 0.8154608011245728,
            "end_logit": 1.043298602104187
        },
        {
            "text": "cification in soft tissues. Cozen's test was positive in most",
            "probability": 0.0471461471648584,
            "start_logit": 0.8012263774871826,
            "end_logit": 1.0501201152801514
        },
        {
            "text": "most affected site was",
            "probability": 0.046614123142884885,
            "start_logit": 0.7966991662979126,
            "end_logit": 1.043298602104187
        },
        {
            "text": "or tendon compartment",
            "probability": 0.0460266507389033,
            "start_logit": 1.1149404048919678,
            "end_logit": 0.7123743891716003
        },
        {
            "text": ". Cozen's test was positive in most patients. In DQ, the most affected sites were left and right radial styloid processes.",
            "probability": 0.04564058686240831,
            "start_logit": 0.8902716040611267,
            "end_logit": 0.9286199808120728
        },
        {
            "text": "scia, increased thickness of fascia (>4.5 mm), increased fluid within the first extensor tend",
            "probability": 0.045004622123168324,
            "start_logit": 0.8474026918411255,
            "end_logit": 0.9574567079544067
        },
        {
            "text": "first extensor tendon compartment, cortical erosion, scler",
            "probability": 0.04407809201421974,
            "start_logit": 0.8145634531974792,
            "end_logit": 0.9694936275482178
        },
        {
            "text": "first extensor tend",
            "probability": 0.04355070797204597,
            "start_logit": 0.8145634531974792,
            "end_logit": 0.9574567079544067
        },
        {
            "text": "mean age of 42.63\u00b18.53 years. Of the 82 patients, 34 (41.",
            "probability": 0.04315859088816472,
            "start_logit": 0.8289578557014465,
            "end_logit": 0.9340178370475769
        },
        {
            "text": "or tendon compartment, cortical erosion,",
            "probability": 0.0430315293602079,
            "start_logit": 1.1149404048919678,
            "end_logit": 0.6450868844985962
        }
    ],
    "5a6e1280b750ff4455000037": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a87145861bb38fb24000004": [
        {
            "text": "death rate from lung cancer for Black men",
            "probability": 0.06258750063694969,
            "start_logit": 1.010024905204773,
            "end_logit": 0.4957740604877472
        },
        {
            "text": "death rate from",
            "probability": 0.05935062474847344,
            "start_logit": 1.010024905204773,
            "end_logit": 0.44267112016677856
        },
        {
            "text": "survival between populations of Blacks and Whites. A 45% higher death rate from lung cancer for Black men",
            "probability": 0.05854172692472031,
            "start_logit": 0.943199098110199,
            "end_logit": 0.4957740604877472
        },
        {
            "text": "survival between populations of Blacks and Whites. A 45% higher death rate from",
            "probability": 0.05551408877934088,
            "start_logit": 0.943199098110199,
            "end_logit": 0.44267112016677856
        },
        {
            "text": "survival duration for Black patients with lung cancer that is generally shorter than that for White patients",
            "probability": 0.05528933479535557,
            "start_logit": 1.1365678310394287,
            "end_logit": 0.2452455759048462
        },
        {
            "text": "men",
            "probability": 0.055077197813337406,
            "start_logit": 0.8821951150894165,
            "end_logit": 0.4957740604877472
        },
        {
            "text": "survival duration",
            "probability": 0.05351217687624292,
            "start_logit": 1.1365678310394287,
            "end_logit": 0.2125747799873352
        },
        {
            "text": "survival duration for Black patients with lung cancer that is generally shorter than",
            "probability": 0.050555535720924805,
            "start_logit": 1.1365678310394287,
            "end_logit": 0.1557379961013794
        },
        {
            "text": "survival duration for Black patients with lung cancer that is generally shorter than that for White patients have also",
            "probability": 0.04996952272719814,
            "start_logit": 1.1365678310394287,
            "end_logit": 0.1440788209438324
        },
        {
            "text": "survival duration for Black patients with lung cancer that is generally shorter than that for White patients have also been reported.",
            "probability": 0.049198932654203706,
            "start_logit": 1.1365678310394287,
            "end_logit": 0.12853747606277466
        },
        {
            "text": "death rate from lung cancer for Black men and a survival duration for Black patients with lung cancer that is generally shorter than that for White patients",
            "probability": 0.04871744128540998,
            "start_logit": 1.010024905204773,
            "end_logit": 0.2452455759048462
        },
        {
            "text": "death rate from lung cancer for Black men and a survival duration",
            "probability": 0.04715152288722834,
            "start_logit": 1.010024905204773,
            "end_logit": 0.2125747799873352
        },
        {
            "text": "survival duration for Black patients with lung cancer that is generally shorter",
            "probability": 0.04708262170328375,
            "start_logit": 1.1365678310394287,
            "end_logit": 0.08456951379776001
        },
        {
            "text": "survival duration for Black",
            "probability": 0.04529361637457558,
            "start_logit": 1.1365678310394287,
            "end_logit": 0.045831650495529175
        },
        {
            "text": "survival duration for Black patients with lung cancer that is generally",
            "probability": 0.04511332506560898,
            "start_logit": 1.1365678310394287,
            "end_logit": 0.04184320569038391
        },
        {
            "text": "death rate from lung cancer for Black men and a survival duration for Black patients with lung cancer that is generally shorter than",
            "probability": 0.04454631896463861,
            "start_logit": 1.010024905204773,
            "end_logit": 0.1557379961013794
        },
        {
            "text": "survival between populations of Blacks and Whites. A 45% higher death rate from lung cancer for Black men and a survival duration",
            "probability": 0.04410355979799596,
            "start_logit": 0.943199098110199,
            "end_logit": 0.2125747799873352
        },
        {
            "text": "death rate from lung cancer for Black men and a survival duration for Black patients with lung cancer that is generally shorter than that for White patients have also",
            "probability": 0.04402996162881543,
            "start_logit": 1.010024905204773,
            "end_logit": 0.1440788209438324
        },
        {
            "text": "men and a survival duration for Black patients with lung cancer that is generally shorter than that for White patients",
            "probability": 0.042871501870648074,
            "start_logit": 0.8821951150894165,
            "end_logit": 0.2452455759048462
        },
        {
            "text": "men and a survival duration",
            "probability": 0.04149348874504839,
            "start_logit": 0.8821951150894165,
            "end_logit": 0.2125747799873352
        }
    ],
    "5a6e2578b750ff445500003d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a6f853ab750ff4455000055": [
        {
            "text": "eatinine, significantly decreased from a mean of 3.45 \u03bcg/mm",
            "probability": 0.06637395666349717,
            "start_logit": 1.0744082927703857,
            "end_logit": 0.968316376209259
        },
        {
            "text": "vaso-",
            "probability": 0.06525315531206656,
            "start_logit": 1.1124261617660522,
            "end_logit": 0.9132681488990784
        },
        {
            "text": "People with sickle cell disease often report severe bone pain with repeated bouts of vaso-",
            "probability": 0.06439223536270818,
            "start_logit": 1.0991448163986206,
            "end_logit": 0.9132681488990784
        },
        {
            "text": "I collagen (CTX-1), a well-",
            "probability": 0.06082014178807624,
            "start_logit": 1.346148133277893,
            "end_logit": 0.6091927886009216
        },
        {
            "text": "I collagen (CTX-1), a well-described marker of bone resorption,",
            "probability": 0.06019078263079935,
            "start_logit": 1.346148133277893,
            "end_logit": 0.5987910032272339
        },
        {
            "text": "I collagen (CTX-",
            "probability": 0.056731313934146044,
            "start_logit": 1.346148133277893,
            "end_logit": 0.5395981073379517
        },
        {
            "text": "le cell disease often report severe bone pain with repeated bouts of vaso-",
            "probability": 0.05219672334099729,
            "start_logit": 0.8891714811325073,
            "end_logit": 0.9132681488990784
        },
        {
            "text": "vaso-occlusive crises, but the",
            "probability": 0.0516472913328824,
            "start_logit": 1.1124261617660522,
            "end_logit": 0.6794314980506897
        },
        {
            "text": "often report severe bone pain with repeated bouts of vaso-",
            "probability": 0.05142152860762607,
            "start_logit": 0.8742086887359619,
            "end_logit": 0.9132681488990784
        },
        {
            "text": "People with sickle cell disease often report severe bone pain with repeated bouts of vaso-occlusive crises, but the",
            "probability": 0.050965880859685245,
            "start_logit": 1.0991448163986206,
            "end_logit": 0.6794314980506897
        },
        {
            "text": "cclusive crises, but the",
            "probability": 0.0476758202848011,
            "start_logit": 1.0324127674102783,
            "end_logit": 0.6794314980506897
        },
        {
            "text": "eatinine, significantly decreased from",
            "probability": 0.04499233577055048,
            "start_logit": 1.0744082927703857,
            "end_logit": 0.5795037746429443
        },
        {
            "text": "eatinine, significantly decreased from a mean of 3.45 \u03bcg/mmol during vaso-",
            "probability": 0.04405956102093675,
            "start_logit": 1.0744082927703857,
            "end_logit": 0.5585539937019348
        },
        {
            "text": "crises, but the",
            "probability": 0.04256164538838564,
            "start_logit": 0.9189419150352478,
            "end_logit": 0.6794314980506897
        },
        {
            "text": "prospective cohort of 52 adults with sickle cell disease enrolled in the",
            "probability": 0.041397311820016956,
            "start_logit": 0.976839542388916,
            "end_logit": 0.5937963128089905
        },
        {
            "text": "le cell disease often report severe bone pain with repeated bouts of vaso-occlusive crises, but the",
            "probability": 0.04131324169876336,
            "start_logit": 0.8891714811325073,
            "end_logit": 0.6794314980506897
        },
        {
            "text": "often report severe bone pain with repeated bouts of vaso-occlusive crises, but the",
            "probability": 0.0406996819706143,
            "start_logit": 0.8742086887359619,
            "end_logit": 0.6794314980506897
        },
        {
            "text": "adults enrolled in the study had paired urine samples for CTX-1 analysis. Urinary CTX-",
            "probability": 0.04042212356090105,
            "start_logit": 0.8707624077796936,
            "end_logit": 0.6760347485542297
        },
        {
            "text": "crises to 2.62",
            "probability": 0.03861605469840896,
            "start_logit": 0.9692767858505249,
            "end_logit": 0.5318112373352051
        },
        {
            "text": "collagen (CTX-1), a well-",
            "probability": 0.038269213954136905,
            "start_logit": 0.8828728795051575,
            "end_logit": 0.6091927886009216
        }
    ],
    "5a871b8d61bb38fb2400000a": [
        {
            "text": "I review the adult conditional BACE1 knockout results and consider their",
            "probability": 0.06072899278182004,
            "start_logit": 1.2628223896026611,
            "end_logit": 0.7303710579872131
        },
        {
            "text": "Importantly, the adult",
            "probability": 0.05862536201159123,
            "start_logit": 1.1788475513458252,
            "end_logit": 0.7790920734405518
        },
        {
            "text": "I review the adult conditional BA",
            "probability": 0.05730907144979987,
            "start_logit": 1.2628223896026611,
            "end_logit": 0.6724087595939636
        },
        {
            "text": "Importantly, the adult conditional BACE1 knockout mice largely lack phenotypes, indicating that many BACE",
            "probability": 0.05560036579211966,
            "start_logit": 1.1788475513458252,
            "end_logit": 0.7261144518852234
        },
        {
            "text": "Importantly, the adult conditional BA",
            "probability": 0.055097957608839024,
            "start_logit": 1.1788475513458252,
            "end_logit": 0.7170373201370239
        },
        {
            "text": "development. However, adult",
            "probability": 0.05319241799624296,
            "start_logit": 1.045760989189148,
            "end_logit": 0.8149271011352539
        },
        {
            "text": "indicating that many BACE1 functions are not required in the adult organism. However,",
            "probability": 0.05054382121406217,
            "start_logit": 0.953505277633667,
            "end_logit": 0.8561076521873474
        },
        {
            "text": "their",
            "probability": 0.04904311602319975,
            "start_logit": 1.0491009950637817,
            "end_logit": 0.7303710579872131
        },
        {
            "text": "us granule cells. The infrapy",
            "probability": 0.04874402690742428,
            "start_logit": 1.0643001794815063,
            "end_logit": 0.709054708480835
        },
        {
            "text": "us granule cells. The infrapyramidal bundle abnormality correlated with",
            "probability": 0.04780607022780017,
            "start_logit": 1.0643001794815063,
            "end_logit": 0.6896246671676636
        },
        {
            "text": "forms amyloid plaques in Alzheimer's disease (AD). Small molecule inhibitors of BACE1 are being tested in clinical trials for AD,",
            "probability": 0.047609455177503514,
            "start_logit": 1.1164491176605225,
            "end_logit": 0.6333544850349426
        },
        {
            "text": "many BACE1 functions are not required in the adult organism. However,",
            "probability": 0.04748202116649167,
            "start_logit": 0.8910157084465027,
            "end_logit": 0.8561076521873474
        },
        {
            "text": "BACE1 knockout mice in which the Bace1 gene may be deleted in the",
            "probability": 0.047361400855908634,
            "start_logit": 0.9622123837471008,
            "end_logit": 0.7823674082756042
        },
        {
            "text": "forms amyloid plaques in Alzheimer's disease (AD). Small",
            "probability": 0.04733549035512852,
            "start_logit": 1.1164491176605225,
            "end_logit": 0.6275834441184998
        },
        {
            "text": "BACE1 knockout mice in which the Bace1 gene may be deleted in the whole body of the adult at will. Importantly, the adult",
            "probability": 0.047206530174968515,
            "start_logit": 0.9622123837471008,
            "end_logit": 0.7790920734405518
        },
        {
            "text": "lead to the phenotypes associated with BACE1 deficiency during embryonic and postnatal development. However, adult",
            "probability": 0.04688196202929482,
            "start_logit": 0.9194781184196472,
            "end_logit": 0.8149271011352539
        },
        {
            "text": "us granule cells. The infrapyramidal bundle abnormality correlated with reduced proteolytic processing of the",
            "probability": 0.046735948657197365,
            "start_logit": 1.0643001794815063,
            "end_logit": 0.6669856905937195
        },
        {
            "text": "lead to the phenotypes associated with BACE1 deficiency during embryo",
            "probability": 0.044646589894131644,
            "start_logit": 0.9194781184196472,
            "end_logit": 0.7660720348358154
        },
        {
            "text": "indicating that many BACE",
            "probability": 0.04438260025658039,
            "start_logit": 0.953505277633667,
            "end_logit": 0.7261144518852234
        },
        {
            "text": "CE1 inhibition could be toxic. However, these phenotypes could be the result of BA",
            "probability": 0.04366679941989578,
            "start_logit": 0.9975402355194092,
            "end_logit": 0.6658200621604919
        }
    ],
    "5a6f98e6b750ff445500005d": [
        {
            "text": "be injured and become vulnerable, even with an initial ankle brachial index greater than 0.",
            "probability": 0.06753586444367268,
            "start_logit": 1.1297544240951538,
            "end_logit": 1.0339691638946533
        },
        {
            "text": "is the first case of popliteal artery injury concomitant with a tibial",
            "probability": 0.05866393633894829,
            "start_logit": 0.8862881660461426,
            "end_logit": 1.1366018056869507
        },
        {
            "text": "be injured and become vulnerable, even with an initial ankle brachial index greater than 0.9.",
            "probability": 0.05498748466800445,
            "start_logit": 1.1297544240951538,
            "end_logit": 0.8284159898757935
        },
        {
            "text": "even with an initial ankle brachial index greater than 0.",
            "probability": 0.054810365505948554,
            "start_logit": 0.9209749698638916,
            "end_logit": 1.0339691638946533
        },
        {
            "text": "iatrogenic retraction during surgery. Therefore, a neurovascular examination should be repeated to prevent delayed-",
            "probability": 0.05449700999271678,
            "start_logit": 1.0491617918014526,
            "end_logit": 0.9000488519668579
        },
        {
            "text": "ction during surgery. Therefore, a neurovascular examination should be repeated to prevent delayed-",
            "probability": 0.05405939533778099,
            "start_logit": 1.0410993099212646,
            "end_logit": 0.9000488519668579
        },
        {
            "text": "ulsion owing to initial dashboard injury-",
            "probability": 0.05267693464812425,
            "start_logit": 1.0622326135635376,
            "end_logit": 0.8530098795890808
        },
        {
            "text": "injury-",
            "probability": 0.04994926750861353,
            "start_logit": 1.0090627670288086,
            "end_logit": 0.8530098795890808
        },
        {
            "text": "iatrogenic retraction during surgery. Therefore",
            "probability": 0.04949167757858128,
            "start_logit": 1.0491617918014526,
            "end_logit": 0.8037075400352478
        },
        {
            "text": "concomitant occlusion of the popliteal artery due to iatrogenic retraction during surgery. Therefore",
            "probability": 0.04913299143560341,
            "start_logit": 1.0418879985809326,
            "end_logit": 0.8037075400352478
        },
        {
            "text": "ction during surgery. Therefore",
            "probability": 0.049094256079518506,
            "start_logit": 1.0410993099212646,
            "end_logit": 0.8037075400352478
        },
        {
            "text": "ulsion owing to initial dashboard injury-related arterial intima injury, which can present with a normal ankle brachial index",
            "probability": 0.048870998178480014,
            "start_logit": 1.0622326135635376,
            "end_logit": 0.7780163288116455
        },
        {
            "text": "required with this type of injury. The limb",
            "probability": 0.04752520465570252,
            "start_logit": 0.9740862846374512,
            "end_logit": 0.8382387161254883
        },
        {
            "text": "injury-related arterial intima injury, which can present with a normal ankle brachial index",
            "probability": 0.04634040643662977,
            "start_logit": 1.0090627670288086,
            "end_logit": 0.7780163288116455
        },
        {
            "text": "injury. The limb",
            "probability": 0.04513126658136293,
            "start_logit": 0.9224013686180115,
            "end_logit": 0.8382387161254883
        },
        {
            "text": "be injured and become vulnerable, even with an initial ankle brachia",
            "probability": 0.044959595885721425,
            "start_logit": 1.1297544240951538,
            "end_logit": 0.6270745992660522
        },
        {
            "text": "even with an initial ankle brachial index greater than 0.9.",
            "probability": 0.0446264241634125,
            "start_logit": 0.9209749698638916,
            "end_logit": 0.8284159898757935
        },
        {
            "text": "be injured and become vulnerable, even with an initial ankle brachial index greater",
            "probability": 0.04411349888421792,
            "start_logit": 1.1297544240951538,
            "end_logit": 0.6080762147903442
        },
        {
            "text": "iatrogenic retraction during surgery. Therefore, a neurovascular examination should be repeated to prevent delayed-onset thrombosis",
            "probability": 0.04193508160108723,
            "start_logit": 1.0491617918014526,
            "end_logit": 0.6380257606506348
        },
        {
            "text": "ction during surgery. Therefore, a neurovascular examination should be repeated to prevent delayed-onset thrombosis",
            "probability": 0.041598340075872965,
            "start_logit": 1.0410993099212646,
            "end_logit": 0.6380257606506348
        }
    ],
    "5a897a06fcd1d6a10c00000b": [
        {
            "text": ". Conclusively, mild hypothermia (37.5-37.9\u00b0C) may be anticipated",
            "probability": 0.06479381270106256,
            "start_logit": 1.0482776165008545,
            "end_logit": 1.059867024421692
        },
        {
            "text": "be anticipated",
            "probability": 0.05937482748994959,
            "start_logit": 0.9609378576278687,
            "end_logit": 1.059867024421692
        },
        {
            "text": "P4 <8 ng/mL. Post-",
            "probability": 0.05923853034669269,
            "start_logit": 0.9897738099098206,
            "end_logit": 1.0287328958511353
        },
        {
            "text": "P4 <8 ng/mL. Post-op temperature fluct",
            "probability": 0.0570537245246653,
            "start_logit": 0.9897738099098206,
            "end_logit": 0.9911540746688843
        },
        {
            "text": "two healthy dogs and 15 dogs with pyometra that underwent standardized OHE were included. Rec",
            "probability": 0.05505118314555264,
            "start_logit": 1.2937159538269043,
            "end_logit": 0.6514819264411926
        },
        {
            "text": ".",
            "probability": 0.05317924684080388,
            "start_logit": 1.0482776165008545,
            "end_logit": 0.862325131893158
        },
        {
            "text": "pyometra had significantly lower temperature 6-48 hours post-op",
            "probability": 0.05275224849964999,
            "start_logit": 1.0064693689346313,
            "end_logit": 0.8960715532302856
        },
        {
            "text": "be anticipated 18-42 hours after OHE performed in early diestrus or pregnancy in healthy dogs.",
            "probability": 0.0516778842903817,
            "start_logit": 0.9609378576278687,
            "end_logit": 0.9210265874862671
        },
        {
            "text": "pyometra had significantly lower temperature 6-48 hours post-op compared to all other groups.",
            "probability": 0.051001751521651095,
            "start_logit": 1.0064693689346313,
            "end_logit": 0.862325131893158
        },
        {
            "text": "operatively (post-op). Serum P4 was measured 30 minutes pre-op and 6 and 24 hours post-op.",
            "probability": 0.050927995130341366,
            "start_logit": 0.81967693567276,
            "end_logit": 1.0476703643798828
        },
        {
            "text": "us or pregnancy in healthy dogs.",
            "probability": 0.04868116685026062,
            "start_logit": 0.9012001752853394,
            "end_logit": 0.9210265874862671
        },
        {
            "text": "us. Dogs with pyometra had significantly lower temperature 6-48 hours post-op",
            "probability": 0.04833986991286089,
            "start_logit": 0.919119656085968,
            "end_logit": 0.8960715532302856
        },
        {
            "text": "us. Dogs with pyometra had significantly lower temperature 6-48 hours post-op compared to all other groups.",
            "probability": 0.046735790492438006,
            "start_logit": 0.919119656085968,
            "end_logit": 0.862325131893158
        },
        {
            "text": "showed no significant difference compared to dogs in diestrus. Dogs with pyometra had significantly lower temperature 6-48 hours post-op",
            "probability": 0.04564349260481094,
            "start_logit": 0.8617240190505981,
            "end_logit": 0.8960715532302856
        },
        {
            "text": "pyometra had significantly lower temperature 6-48 hours post-",
            "probability": 0.04511891503814648,
            "start_logit": 1.0064693689346313,
            "end_logit": 0.7397667169570923
        },
        {
            "text": ". Conclusively, mild hypothermia (37.5-",
            "probability": 0.04347353533528321,
            "start_logit": 1.0482776165008545,
            "end_logit": 0.6608092784881592
        },
        {
            "text": ". Conclusively, mild hypothermia (37.5-37.9\u00b0C) may be anticipated 18-",
            "probability": 0.042809462830523275,
            "start_logit": 1.0482776165008545,
            "end_logit": 0.6454160809516907
        },
        {
            "text": "P4) has a thermogenic effect in the bitch and a decrease in P4 has been",
            "probability": 0.04257093880996037,
            "start_logit": 0.9934994578361511,
            "end_logit": 0.6946069002151489
        },
        {
            "text": "us. Dogs with pyometra had significantly lower temperature 6-48 hours post-",
            "probability": 0.0413450145839356,
            "start_logit": 0.919119656085968,
            "end_logit": 0.7397667169570923
        },
        {
            "text": "P4 <8 ng/mL. Post-op",
            "probability": 0.04023060905102984,
            "start_logit": 0.9897738099098206,
            "end_logit": 0.6417888402938843
        }
    ],
    "5a6fa61ab750ff4455000060": [
        {
            "text": "concentrated",
            "probability": 0.07287555162823109,
            "start_logit": 0.8519694805145264,
            "end_logit": 1.0387907028198242
        },
        {
            "text": "%,which was represented by 74 repeat motifs and SSR loci occurred",
            "probability": 0.07186059505641545,
            "start_logit": 1.2773537635803223,
            "end_logit": 0.5993812680244446
        },
        {
            "text": "%,which was represented by 74 repeat motifs and SSR loci occurred per 7 952 bp in length. In the",
            "probability": 0.06977769633277987,
            "start_logit": 1.2773537635803223,
            "end_logit": 0.5699676275253296
        },
        {
            "text": ". 48%),C/G and CCG/CGG were the dominant repeat motifs,respectively. The number of repetitions of the",
            "probability": 0.06487140427434138,
            "start_logit": 0.8416070938110352,
            "end_logit": 0.9328067898750305
        },
        {
            "text": "most abundant repeat motif(42. 5%),followed by tri-nu",
            "probability": 0.057162588216957876,
            "start_logit": 0.7623144388198853,
            "end_logit": 0.8855921626091003
        },
        {
            "text": ". 48%),C/G and CCG/CGG were the dominant",
            "probability": 0.05415875491808683,
            "start_logit": 0.8416070938110352,
            "end_logit": 0.7523195147514343
        },
        {
            "text": "concentrated on 5 to 12 times,and the length was mostly less than 24",
            "probability": 0.052125289746330364,
            "start_logit": 0.8519694805145264,
            "end_logit": 0.7036877274513245
        },
        {
            "text": "containing",
            "probability": 0.05099008845039308,
            "start_logit": 0.918793797492981,
            "end_logit": 0.6148444414138794
        },
        {
            "text": ". 48%),C/G and CCG/CGG were the",
            "probability": 0.05003798581576858,
            "start_logit": 0.8416070938110352,
            "end_logit": 0.6731823086738586
        },
        {
            "text": "most abundant repeat motif(42. 5%),followed by tri-",
            "probability": 0.049719865301629515,
            "start_logit": 0.7623144388198853,
            "end_logit": 0.7460970878601074
        },
        {
            "text": "has",
            "probability": 0.0470843902357982,
            "start_logit": 0.7974873185157776,
            "end_logit": 0.6564611792564392
        },
        {
            "text": "concentrated on",
            "probability": 0.046877237448710016,
            "start_logit": 0.8519694805145264,
            "end_logit": 0.5975697040557861
        },
        {
            "text": "primitive types,high in polymorphism,and highly available,which will provides abundant candidate molecular markers for its genetic diversity analysis,resource identification protection,",
            "probability": 0.04587627331685322,
            "start_logit": 0.8126799464225769,
            "end_logit": 0.6152750849723816
        },
        {
            "text": "primitive",
            "probability": 0.04526016496323963,
            "start_logit": 0.8126799464225769,
            "end_logit": 0.6017543077468872
        },
        {
            "text": "has significant polymorphism. Moreover,it was found that unigene containing",
            "probability": 0.04516510569291317,
            "start_logit": 0.7974873185157776,
            "end_logit": 0.6148444414138794
        },
        {
            "text": "has significant polymorphism. Moreover,it was",
            "probability": 0.04496670790746858,
            "start_logit": 0.7974873185157776,
            "end_logit": 0.610442042350769
        },
        {
            "text": ". 48%),C/G and CCG/CGG were the dominant repeat motifs,respectively. The",
            "probability": 0.04471373355728742,
            "start_logit": 0.8416070938110352,
            "end_logit": 0.5606805682182312
        },
        {
            "text": ". Moreover,it was found that unigene containing",
            "probability": 0.04333345950421595,
            "start_logit": 0.756087601184845,
            "end_logit": 0.6148444414138794
        },
        {
            "text": ". Moreover,it was",
            "probability": 0.04314310763257983,
            "start_logit": 0.756087601184845,
            "end_logit": 0.610442042350769
        }
    ],
    "5a72302b2dc08e987e000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a9d29571d1251d03b000018": [
        {
            "text": "term pharmacologic RAGE inhibition",
            "probability": 0.07990327540720703,
            "start_logit": 1.1046162843704224,
            "end_logit": 0.9673254489898682
        },
        {
            "text": "mechanics, likely due",
            "probability": 0.05945591346486948,
            "start_logit": 1.0823237895965576,
            "end_logit": 0.6940361857414246
        },
        {
            "text": "mechanics, likely due to its differential effects [direct vs. indirect] on bone cell",
            "probability": 0.054199054929543224,
            "start_logit": 1.0823237895965576,
            "end_logit": 0.601464569568634
        },
        {
            "text": "term pharmaco",
            "probability": 0.052523610432540446,
            "start_logit": 1.1046162843704224,
            "end_logit": 0.5477713942527771
        },
        {
            "text": "fibrils have been linked to bone and muscle loss in various pathologies. Further, genetic or pharmacologic RAGE inhibition",
            "probability": 0.05232191827800001,
            "start_logit": 1.0760917663574219,
            "end_logit": 0.5724484920501709
        },
        {
            "text": "induced alterations in bone geometry or mechanics, likely due",
            "probability": 0.05168491506294628,
            "start_logit": 0.9422546625137329,
            "end_logit": 0.6940361857414246
        },
        {
            "text": "-",
            "probability": 0.051492145726492376,
            "start_logit": 0.8542811870574951,
            "end_logit": 0.7782729864120483
        },
        {
            "text": "mechanics, likely due to its differential",
            "probability": 0.0509670848253682,
            "start_logit": 1.0823237895965576,
            "end_logit": 0.5399811267852783
        },
        {
            "text": "two tissues, highlighting a potential explanation for the differential effects of Azeliragon on bone and skeletal muscle",
            "probability": 0.05055864743439836,
            "start_logit": 0.9296070337295532,
            "end_logit": 0.6846518516540527
        },
        {
            "text": "of chronic diseases that primarily affect elderly individuals. Persistent low-",
            "probability": 0.049096302036535235,
            "start_logit": 0.8941622972488403,
            "end_logit": 0.6907463073730469
        },
        {
            "text": "induced alterations in bone geometry or mechanics, likely due to its differential effects [direct vs. indirect] on bone cell",
            "probability": 0.047115137709230225,
            "start_logit": 0.9422546625137329,
            "end_logit": 0.601464569568634
        },
        {
            "text": ". Az",
            "probability": 0.04502289484938431,
            "start_logit": 0.8026061058044434,
            "end_logit": 0.6956899166107178
        },
        {
            "text": ". Azeliragon did not prevent the aging-induced alterations in bone geometry or mechanics, likely due",
            "probability": 0.04494850062931066,
            "start_logit": 0.8026061058044434,
            "end_logit": 0.6940361857414246
        },
        {
            "text": "initially developed to treat Alzheimer's disease. Az",
            "probability": 0.044914541975920416,
            "start_logit": 0.8001965880393982,
            "end_logit": 0.6956899166107178
        },
        {
            "text": "initially developed to treat Alzheimer's disease. Azeliragon did not prevent the aging-induced alterations in bone geometry or mechanics, likely due",
            "probability": 0.04484032679425691,
            "start_logit": 0.8001965880393982,
            "end_logit": 0.6940361857414246
        },
        {
            "text": "and muscle mass are two major clinical complications among the growing list of chronic diseases that primarily affect elderly individuals. Persistent low-",
            "probability": 0.04437474039961769,
            "start_logit": 0.7930489778518677,
            "end_logit": 0.6907463073730469
        },
        {
            "text": "induced alterations in bone geometry or mechanics, likely due to its differential",
            "probability": 0.04430559210500755,
            "start_logit": 0.9422546625137329,
            "end_logit": 0.5399811267852783
        },
        {
            "text": "individuals. Persistent low-",
            "probability": 0.04429065814973467,
            "start_logit": 0.7911523580551147,
            "end_logit": 0.6907463073730469
        },
        {
            "text": "two tissues, highlighting a potential explanation for the",
            "probability": 0.04420759421524388,
            "start_logit": 0.9296070337295532,
            "end_logit": 0.5504144430160522
        },
        {
            "text": "major clinical complications among the growing list of chronic diseases that primarily affect elderly individuals. Persistent low-",
            "probability": 0.04377714557439297,
            "start_logit": 0.7794904708862305,
            "end_logit": 0.6907463073730469
        }
    ],
    "5a9e2386de7cb99d40000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a761ac3aacfb9cd4c000002": [
        {
            "text": "ge Potter's Syndrome,",
            "probability": 0.2993659734449153,
            "start_logit": 1.0424582958221436,
            "end_logit": 0.5812904238700867
        },
        {
            "text": "Potter's Syndrome,",
            "probability": 0.29639285292487033,
            "start_logit": 1.0324772596359253,
            "end_logit": 0.5812904238700867
        },
        {
            "text": "ge Potter's Syndrome, treated with",
            "probability": 0.2031292648868116,
            "start_logit": 1.0424582958221436,
            "end_logit": 0.1934661567211151
        },
        {
            "text": "Potter's Syndrome, treated with",
            "probability": 0.2011119087434029,
            "start_logit": 1.0324772596359253,
            "end_logit": 0.1934661567211151
        }
    ],
    "5a679e8cb750ff4455000006": [
        {
            "text": "afterwards within the period from two months to four years. Different perspectives on prospects of Milwaukee protocol use and other therapeutic techniques",
            "probability": 0.08161346146593561,
            "start_logit": 1.1116148233413696,
            "end_logit": 1.1435019969940186
        },
        {
            "text": "other therapeutic techniques",
            "probability": 0.07806899980120614,
            "start_logit": 1.0672136545181274,
            "end_logit": 1.1435019969940186
        },
        {
            "text": "be more) patients died afterwards within the period from two months to four years. Different perspectives on prospects of Milwaukee protocol use and other therapeutic techniques",
            "probability": 0.054555177002996565,
            "start_logit": 0.7088332176208496,
            "end_logit": 1.1435019969940186
        },
        {
            "text": "of described cases.",
            "probability": 0.05441693230672035,
            "start_logit": 0.7801661491394043,
            "end_logit": 1.069631814956665
        },
        {
            "text": ") were selected as they were complaint with laboratory criteria of active lyssavirus infection. Children",
            "probability": 0.05425211087943564,
            "start_logit": 1.0210081338882446,
            "end_logit": 0.8257563710212708
        },
        {
            "text": "2015) were selected as they were complaint with laboratory criteria of active lyssavirus infection. Children",
            "probability": 0.05387578678727627,
            "start_logit": 1.014047384262085,
            "end_logit": 0.8257563710212708
        },
        {
            "text": ") were selected as they",
            "probability": 0.05218881740557923,
            "start_logit": 1.0210081338882446,
            "end_logit": 0.7869827151298523
        },
        {
            "text": "2015) were selected as they",
            "probability": 0.051826805513089526,
            "start_logit": 1.014047384262085,
            "end_logit": 0.7869827151298523
        },
        {
            "text": "- 2 cases and Europe - 1 case. India and the USA were on the top of the list of countries by the number of described cases.",
            "probability": 0.051414546055681264,
            "start_logit": 0.7234119176864624,
            "end_logit": 1.069631814956665
        },
        {
            "text": "vaccinated and 10% cases were treated with",
            "probability": 0.05018219940374219,
            "start_logit": 1.0518484115600586,
            "end_logit": 0.7169345617294312
        },
        {
            "text": "of described cases. More than",
            "probability": 0.04893632219653766,
            "start_logit": 0.7801661491394043,
            "end_logit": 0.9634763598442078
        },
        {
            "text": "vaccinated and 10% cases were treated with gamma globulin",
            "probability": 0.047879037774405116,
            "start_logit": 1.0518484115600586,
            "end_logit": 0.6699519753456116
        },
        {
            "text": "of convalescence, \"partial\" convalescence or long-term survival of humans (1970",
            "probability": 0.04438651283738833,
            "start_logit": 0.7439526319503784,
            "end_logit": 0.9021056294441223
        },
        {
            "text": "effective vaccines, 40 -",
            "probability": 0.04353290898040339,
            "start_logit": 0.8400006890296936,
            "end_logit": 0.7866390943527222
        },
        {
            "text": "is fatal because therapeutic treatment of lyssavirus encephalitis has not been developed. Since 1970 the number of reports on",
            "probability": 0.04241095030702865,
            "start_logit": 0.7940264940261841,
            "end_logit": 0.8065026998519897
        },
        {
            "text": "fatal because therapeutic treatment of lyssavirus encephalitis has not been developed. Since 1970 the number of reports on",
            "probability": 0.0408286026281832,
            "start_logit": 0.7560027837753296,
            "end_logit": 0.8065026998519897
        },
        {
            "text": "of convalescence, \"partial\" convalescence or long-term survival of humans (1970-2015) were selected as they",
            "probability": 0.039559772028237024,
            "start_logit": 0.7439526319503784,
            "end_logit": 0.7869827151298523
        },
        {
            "text": "of convalescence, \"partial\" convalescence or long-term survival of humans (1970-",
            "probability": 0.03832841040065774,
            "start_logit": 0.7439526319503784,
            "end_logit": 0.7553613781929016
        },
        {
            "text": "% cases were vaccinated and 10% cases were treated with",
            "probability": 0.03671383190994741,
            "start_logit": 0.7393416166305542,
            "end_logit": 0.7169345617294312
        },
        {
            "text": "% cases were vaccinated and 10% cases were treated with gamma globulin",
            "probability": 0.03502881431554886,
            "start_logit": 0.7393416166305542,
            "end_logit": 0.6699519753456116
        }
    ],
    "5aa4f47cd6d6b54f7900000a": [
        {
            "text": "Bacillus cereus. In silico analysis of 1,616 bacterial genomes from long-read sequencing was also done. The",
            "probability": 0.061614215203814125,
            "start_logit": 0.9091476798057556,
            "end_logit": 0.8685585260391235
        },
        {
            "text": "NA gene sequences was investigated using the strain GS2 as a model",
            "probability": 0.06114701808939287,
            "start_logit": 0.9233346581459045,
            "end_logit": 0.8467600345611572
        },
        {
            "text": "NA gene sequences was investigated using the strain GS2 as a model. 16S rRNA copies with the maximum variation had 99",
            "probability": 0.05285305702620074,
            "start_logit": 0.9233346581459045,
            "end_logit": 0.7009944915771484
        },
        {
            "text": "containing variable 16S rRNA gene copies can provide sufficient information for species identification except from species which have",
            "probability": 0.05183149383224909,
            "start_logit": 0.814047634601593,
            "end_logit": 0.7907639145851135
        },
        {
            "text": "NA gene copies can provide sufficient information for species identification except from species which have high similarity of sequences in their 16S rRNA gene copies like",
            "probability": 0.051655438331249706,
            "start_logit": 0.7827571630477905,
            "end_logit": 0.8186519145965576
        },
        {
            "text": "classification of 16S rRNA gene sequences was investigated using the strain GS2 as a model",
            "probability": 0.05129195927106405,
            "start_logit": 0.7475875616073608,
            "end_logit": 0.8467600345611572
        },
        {
            "text": "NA genes. Overall, our results shed light on",
            "probability": 0.05122899742182263,
            "start_logit": 0.9070626497268677,
            "end_logit": 0.6860566735267639
        },
        {
            "text": "NA gene copies can provide sufficient information for species identification except from species which have",
            "probability": 0.05023477329429983,
            "start_logit": 0.7827571630477905,
            "end_logit": 0.7907639145851135
        },
        {
            "text": "is the most common tool in bacterial taxonomic studies. Although used for distinguishing bacterial species, its",
            "probability": 0.04990783932844183,
            "start_logit": 0.9944667816162109,
            "end_logit": 0.572524905204773
        },
        {
            "text": "sequencing of cloned PC",
            "probability": 0.049299912359011676,
            "start_logit": 0.8476971387863159,
            "end_logit": 0.7070387601852417
        },
        {
            "text": "is the most common tool in bacterial taxonomic studies. Although used for distinguishing bacterial species, its use remains",
            "probability": 0.04851343315008412,
            "start_logit": 0.9944667816162109,
            "end_logit": 0.5441875457763672
        },
        {
            "text": "information for species identification except from species which have high similarity of sequences in their 16S rRNA gene copies like",
            "probability": 0.04828429414639729,
            "start_logit": 0.7152680158615112,
            "end_logit": 0.8186519145965576
        },
        {
            "text": "for each phylum was reported with their average genome size and average \"unique copies\" of 16S rRNA genes and",
            "probability": 0.047928178866532625,
            "start_logit": 0.8503946661949158,
            "end_logit": 0.6761225461959839
        },
        {
            "text": "their average genome size and average \"unique copies\" of 16S rRNA genes and",
            "probability": 0.0474294705215437,
            "start_logit": 0.8399348258972168,
            "end_logit": 0.6761225461959839
        },
        {
            "text": "NA gene sequences",
            "probability": 0.04697331703221804,
            "start_logit": 0.7206061482429504,
            "end_logit": 0.7857871651649475
        },
        {
            "text": "information for species identification except from species which have",
            "probability": 0.04695634474274094,
            "start_logit": 0.7152680158615112,
            "end_logit": 0.7907639145851135
        },
        {
            "text": "is sequencing of cloned PC",
            "probability": 0.046271480060237076,
            "start_logit": 0.7843006253242493,
            "end_logit": 0.7070387601852417
        },
        {
            "text": "unique copies\" of 16S rRNA genes and",
            "probability": 0.04626600576375229,
            "start_logit": 0.8150985240936279,
            "end_logit": 0.6761225461959839
        },
        {
            "text": "Bacillus ce",
            "probability": 0.045629955290759486,
            "start_logit": 0.9091476798057556,
            "end_logit": 0.5682303309440613
        },
        {
            "text": "sequencing of cloned PCR products from Serratia fonticola GS2, were compared.",
            "probability": 0.04468281626818805,
            "start_logit": 0.8476971387863159,
            "end_logit": 0.608705461025238
        }
    ],
    "5a9ac7ba1d1251d03b000013": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a8b27e6fcd1d6a10c00001e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a67c497b750ff4455000012": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a9acd921d1251d03b000016": [
        {
            "text": "\u03b1-7 nicotinic acetylcholine receptors by encen",
            "probability": 0.08906653484685281,
            "start_logit": 1.4893202781677246,
            "end_logit": 0.8662410974502563
        },
        {
            "text": "usually a difficult and time-consuming process, and in the case of AD to-",
            "probability": 0.06682404691454552,
            "start_logit": 1.1921494007110596,
            "end_logit": 0.8760913014411926
        },
        {
            "text": "usually a difficult and",
            "probability": 0.05630395569343924,
            "start_logit": 1.1921494007110596,
            "end_logit": 0.7047930955886841
        },
        {
            "text": "protein (AADvac1 and ACI-35) are now in early-",
            "probability": 0.05446045730546788,
            "start_logit": 0.968476414680481,
            "end_logit": 0.8951761722564697
        },
        {
            "text": "transmitter systems (serotoninergic 5-",
            "probability": 0.05100238229650408,
            "start_logit": 0.9990572929382324,
            "end_logit": 0.7989927530288696
        },
        {
            "text": "antibodies and inhibitors or modulators of \u03b3-",
            "probability": 0.05030125358919159,
            "start_logit": 0.9488234519958496,
            "end_logit": 0.8353842496871948
        },
        {
            "text": "antibodies and inhibitors or modulators of \u03b3- and \u03b2-secretase",
            "probability": 0.050167592359664566,
            "start_logit": 0.9488234519958496,
            "end_logit": 0.8327234983444214
        },
        {
            "text": "usually a difficult and time-",
            "probability": 0.049103873457149914,
            "start_logit": 1.1921494007110596,
            "end_logit": 0.5679662227630615
        },
        {
            "text": "e receptors by encen",
            "probability": 0.048201649714698404,
            "start_logit": 0.875329852104187,
            "end_logit": 0.8662410974502563
        },
        {
            "text": "s disease (AD) is considered to be the most common cause of dementia and is an incurable, progressive neurodegenerative disorder",
            "probability": 0.046658837084325486,
            "start_logit": 0.913130521774292,
            "end_logit": 0.7959095239639282
        },
        {
            "text": "upon the central nervous system is usually a difficult and time-consuming process, and in the case of AD to-",
            "probability": 0.0460159598302116,
            "start_logit": 0.8190746903419495,
            "end_logit": 0.8760913014411926
        },
        {
            "text": "antibodies (solanezumab, gantenerumab, crenezumab) seem to be promising, while vaccines against the",
            "probability": 0.045536027787083565,
            "start_logit": 0.9510718584060669,
            "end_logit": 0.733609676361084
        },
        {
            "text": "most common cause of dementia and is an incurable, progressive neurodegenerative disorder",
            "probability": 0.04544922497582512,
            "start_logit": 0.8868639469146729,
            "end_logit": 0.7959095239639282
        },
        {
            "text": "erumab, crenezumab) seem to be promising, while vaccines against the",
            "probability": 0.04542898794735335,
            "start_logit": 0.9487184286117554,
            "end_logit": 0.733609676361084
        },
        {
            "text": "neurodegenerative disorder",
            "probability": 0.04390238159512505,
            "start_logit": 0.8522367477416992,
            "end_logit": 0.7959095239639282
        },
        {
            "text": "-",
            "probability": 0.04341933868668019,
            "start_logit": 0.8380898833274841,
            "end_logit": 0.7989927530288696
        },
        {
            "text": "be the most common cause of dementia and is an incurable, progressive neurodegenerative disorder",
            "probability": 0.04293154768315094,
            "start_logit": 0.829875111579895,
            "end_logit": 0.7959095239639282
        },
        {
            "text": "antibodies (solanezumab, gantenerumab, cr",
            "probability": 0.04204518319520853,
            "start_logit": 0.9510718584060669,
            "end_logit": 0.6538506746292114
        },
        {
            "text": "erumab, cr",
            "probability": 0.041946349153476004,
            "start_logit": 0.9487184286117554,
            "end_logit": 0.6538506746292114
        },
        {
            "text": "Interesting results have also been achieved in trials involving small molecules such as inhibitors of \u03b2-secretase (MK-",
            "probability": 0.04123441588404621,
            "start_logit": 0.8308786749839783,
            "end_logit": 0.7545722723007202
        }
    ],
    "5a76160a83b0d9ea66000020": [
        {
            "text": "logical, and fast results. This method at the",
            "probability": 0.07333759233185291,
            "start_logit": 0.8666142821311951,
            "end_logit": 1.1762789487838745
        },
        {
            "text": "biology, and medical engineering. Entropy is a measure of uncertainty in the",
            "probability": 0.06894310610345246,
            "start_logit": 1.25191330909729,
            "end_logit": 0.7291882038116455
        },
        {
            "text": "biology, and medical engineering. Entropy is a measure of uncertainty",
            "probability": 0.0628959341425082,
            "start_logit": 1.25191330909729,
            "end_logit": 0.6373881101608276
        },
        {
            "text": "is a measure of uncertainty in the",
            "probability": 0.05903508433909768,
            "start_logit": 1.0967636108398438,
            "end_logit": 0.7291882038116455
        },
        {
            "text": "be considered and also did not require high memory for large-length sequences",
            "probability": 0.056854904732957234,
            "start_logit": 0.9075714349746704,
            "end_logit": 0.8807509541511536
        },
        {
            "text": "is a measure of uncertainty",
            "probability": 0.05385696970365201,
            "start_logit": 1.0967636108398438,
            "end_logit": 0.6373881101608276
        },
        {
            "text": "medical engineering. Entropy is a measure of uncertainty in the",
            "probability": 0.049468758154967686,
            "start_logit": 0.9199730157852173,
            "end_logit": 0.7291882038116455
        },
        {
            "text": "theory is a branch of mathematics that overlaps with communications, biology, and medical engineering. Entropy is a measure of uncertainty in the",
            "probability": 0.04930109839288757,
            "start_logit": 0.9165780544281006,
            "end_logit": 0.7291882038116455
        },
        {
            "text": "2015). Following our findings on",
            "probability": 0.04834834436915425,
            "start_logit": 1.0224133729934692,
            "end_logit": 0.6038385033607483
        },
        {
            "text": "2015). Following our findings on investigating the results of genes metabolic pathways based on the gene annotations, it was revealed",
            "probability": 0.04762993156868219,
            "start_logit": 1.0224133729934692,
            "end_logit": 0.5888679027557373
        },
        {
            "text": "logical, and fast results. This method at the same that had not had the disadvantages of aligning allowed the",
            "probability": 0.046469381726314304,
            "start_logit": 0.8666142821311951,
            "end_logit": 0.7199992537498474
        },
        {
            "text": "of uncertainty in the",
            "probability": 0.04537016290871717,
            "start_logit": 0.8334863781929016,
            "end_logit": 0.7291882038116455
        },
        {
            "text": "medical engineering. Entropy is a measure of uncertainty",
            "probability": 0.0451297298725957,
            "start_logit": 0.9199730157852173,
            "end_logit": 0.6373881101608276
        },
        {
            "text": "theory is a branch of mathematics that overlaps with communications, biology, and medical engineering. Entropy is a measure of uncertainty",
            "probability": 0.044976775966830036,
            "start_logit": 0.9165780544281006,
            "end_logit": 0.6373881101608276
        },
        {
            "text": "2015). Following our findings on investigating the results of genes metabolic pathways based on",
            "probability": 0.04428692959172253,
            "start_logit": 1.0224133729934692,
            "end_logit": 0.5160961151123047
        },
        {
            "text": "of genes metabolic pathways based on the gene annotations, it was revealed",
            "probability": 0.04147714700577775,
            "start_logit": 0.8840945959091187,
            "end_logit": 0.5888679027557373
        },
        {
            "text": "of uncertainty",
            "probability": 0.04139063264802111,
            "start_logit": 0.8334863781929016,
            "end_logit": 0.6373881101608276
        },
        {
            "text": "bler divergence was calculated. After obtaining the Kullback-",
            "probability": 0.04115570373603432,
            "start_logit": 0.8633041381835938,
            "end_logit": 0.60187828540802
        },
        {
            "text": "investigating the results of genes metabolic pathways based on the gene annotations, it was revealed",
            "probability": 0.040486535436354436,
            "start_logit": 0.8599214553833008,
            "end_logit": 0.5888679027557373
        },
        {
            "text": "logical, and fast results. This method at the same that had not had the",
            "probability": 0.039585277268420635,
            "start_logit": 0.8666142821311951,
            "end_logit": 0.5596628785133362
        }
    ],
    "5aa55b45d6d6b54f7900000d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a76179d83b0d9ea66000021": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a774fdcfaa1ab7d2e000008": [
        {
            "text": "interaction of 53",
            "probability": 0.06283353986454018,
            "start_logit": 1.1535768508911133,
            "end_logit": 0.7680054903030396
        },
        {
            "text": "interaction of 53BP",
            "probability": 0.060278842108786805,
            "start_logit": 1.1535768508911133,
            "end_logit": 0.7264976501464844
        },
        {
            "text": "regulates 53BP1 stability and 53BP1 recruitment at double-strand breaks, providing yet another mechanism of 53",
            "probability": 0.060213888772516065,
            "start_logit": 1.0150128602981567,
            "end_logit": 0.8639835119247437
        },
        {
            "text": "53BP1",
            "probability": 0.05599242889047824,
            "start_logit": 1.0187056064605713,
            "end_logit": 0.7876042127609253
        },
        {
            "text": "regulates 53BP1 stability and 53BP1 recruitment at double-",
            "probability": 0.055672620707581694,
            "start_logit": 1.0150128602981567,
            "end_logit": 0.7855689525604248
        },
        {
            "text": "survival. In summary, we demonstrate that NUDT16 regulates 53BP1 stability and 53BP1 recruitment at double-",
            "probability": 0.05523565251009638,
            "start_logit": 1.0071330070495605,
            "end_logit": 0.7855689525604248
        },
        {
            "text": "4K20me2. Moreover, NUDT16's catalytic hydrolase activity was required for 53BP1",
            "probability": 0.05325963576483206,
            "start_logit": 0.9686678647994995,
            "end_logit": 0.7876042127609253
        },
        {
            "text": "survival. In summary,",
            "probability": 0.05122456074963687,
            "start_logit": 1.0071330070495605,
            "end_logit": 0.7101794481277466
        },
        {
            "text": ") the mutant binding to TIRR increased after IR; 2) the mutant enhanced 53BP",
            "probability": 0.04830209752082254,
            "start_logit": 0.8727050423622131,
            "end_logit": 0.7858632802963257
        },
        {
            "text": "major role in controlling 53BP1 levels under both normal growth conditions and during DNA damage. Notably, overexpression of a NUDT",
            "probability": 0.048278944159609496,
            "start_logit": 0.7780464291572571,
            "end_logit": 0.8800424337387085
        },
        {
            "text": "hydrolase activity was required for 53BP1",
            "probability": 0.04723606249317381,
            "start_logit": 0.8486467599868774,
            "end_logit": 0.7876042127609253
        },
        {
            "text": "impaired the interaction of 53",
            "probability": 0.04681970128694641,
            "start_logit": 0.8593919277191162,
            "end_logit": 0.7680054903030396
        },
        {
            "text": "impaired the interaction of 53BP",
            "probability": 0.04491609715990427,
            "start_logit": 0.8593919277191162,
            "end_logit": 0.7264976501464844
        },
        {
            "text": "levels under both normal growth conditions and during DNA damage. Notably, overexpression of a NUDT",
            "probability": 0.04482238034224438,
            "start_logit": 0.7037584781646729,
            "end_logit": 0.8800424337387085
        },
        {
            "text": ". We",
            "probability": 0.04480389920033842,
            "start_logit": 0.6733344197273254,
            "end_logit": 0.910054087638855
        },
        {
            "text": "53BP1 de-",
            "probability": 0.044513939076397106,
            "start_logit": 1.0187056064605713,
            "end_logit": 0.558190107345581
        },
        {
            "text": "damage. Notably, overexpression of a NUDT16 catalytically",
            "probability": 0.04432406295838295,
            "start_logit": 0.864838719367981,
            "end_logit": 0.7077823281288147
        },
        {
            "text": "53BP1 de-ADP-ribosylation, 53BP",
            "probability": 0.04417620672281534,
            "start_logit": 1.0187056064605713,
            "end_logit": 0.5505740642547607
        },
        {
            "text": "by blocking 53BP1 Tudor domain binding to H4K20me2 sites. Here, we",
            "probability": 0.04377744540667174,
            "start_logit": 0.7940194010734558,
            "end_logit": 0.7661926746368408
        },
        {
            "text": "53BP1 controls two downstream",
            "probability": 0.0433179943042253,
            "start_logit": 0.925496518611908,
            "end_logit": 0.6241649389266968
        }
    ],
    "5a804f71faa1ab7d2e00001d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a9ac4e81d1251d03b000011": [
        {
            "text": "GBM patients are high.",
            "probability": 0.07218655468936955,
            "start_logit": 1.050386905670166,
            "end_logit": 0.849539577960968
        },
        {
            "text": "phenomenon is not clear.",
            "probability": 0.0637491448174098,
            "start_logit": 1.2016113996505737,
            "end_logit": 0.5740170478820801
        },
        {
            "text": "GBM patients are high. We also show that an increase in NLGN3 concentration promotes the",
            "probability": 0.05715925055475666,
            "start_logit": 1.050386905670166,
            "end_logit": 0.6161270141601562
        },
        {
            "text": "MG cells. Respective use of the cortex neuron culture medium (C-NCM) and basal ganglia neuron culture medium (BG-",
            "probability": 0.057135829119494705,
            "start_logit": 1.0505192279815674,
            "end_logit": 0.6155848503112793
        },
        {
            "text": "levels in the deep brain regions of GBM patients are high.",
            "probability": 0.05665692438355647,
            "start_logit": 0.8081473112106323,
            "end_logit": 0.849539577960968
        },
        {
            "text": "this phenomenon is not clear.",
            "probability": 0.055179468436998245,
            "start_logit": 1.0572465658187866,
            "end_logit": 0.5740170478820801
        },
        {
            "text": "is not clear.",
            "probability": 0.049916532207366915,
            "start_logit": 0.957007884979248,
            "end_logit": 0.5740170478820801
        },
        {
            "text": "deep regions in a",
            "probability": 0.048939698831365064,
            "start_logit": 0.8120288252830505,
            "end_logit": 0.6992327570915222
        },
        {
            "text": "deep brain regions, including the basal ganglia, thalamus, and corpus callosum. But the mechanism",
            "probability": 0.04754364102706291,
            "start_logit": 0.7911326885223389,
            "end_logit": 0.6911880373954773
        },
        {
            "text": "basal ganglia, thalamus, and corpus callosum. But the mechanism",
            "probability": 0.046836917388876353,
            "start_logit": 0.7761563658714294,
            "end_logit": 0.6911880373954773
        },
        {
            "text": "deep brain regions, including the",
            "probability": 0.0466765332020329,
            "start_logit": 0.7911326885223389,
            "end_logit": 0.6727815270423889
        },
        {
            "text": "levels of NLGN3 in the cortex are higher than those in the",
            "probability": 0.04652886048331974,
            "start_logit": 0.7485194206237793,
            "end_logit": 0.7122260332107544
        },
        {
            "text": "levels of NLGN3 in the cortex are higher than those in the deep regions in a",
            "probability": 0.04592820881841906,
            "start_logit": 0.7485194206237793,
            "end_logit": 0.6992327570915222
        },
        {
            "text": "levels in the deep brain regions of GBM patients are high. We also show that an increase in NLGN3 concentration promotes the",
            "probability": 0.04486247266457384,
            "start_logit": 0.8081473112106323,
            "end_logit": 0.6161270141601562
        },
        {
            "text": "deep brain regions, including the basal ganglia, thalamus, and corpus callosum.",
            "probability": 0.04475796584626158,
            "start_logit": 0.7911326885223389,
            "end_logit": 0.6308094263076782
        },
        {
            "text": "basal ganglia, thalamus, and corpus callosum.",
            "probability": 0.04409265053221792,
            "start_logit": 0.7761563658714294,
            "end_logit": 0.6308094263076782
        },
        {
            "text": "deep brain regions, including the basal ganglia, thalamus, and corpus callosum. But the",
            "probability": 0.043741146361827805,
            "start_logit": 0.7911326885223389,
            "end_logit": 0.607829213142395
        },
        {
            "text": "basal ganglia, thalamus, and corpus callosum. But the",
            "probability": 0.04309094580024933,
            "start_logit": 0.7761563658714294,
            "end_logit": 0.607829213142395
        },
        {
            "text": "basal ganglia, thalam",
            "probability": 0.04273036698068155,
            "start_logit": 0.7942237854003906,
            "end_logit": 0.5813587307929993
        },
        {
            "text": "deep brain regions, including the basal ganglia, thalamus, and corpus callosum. But the mechanism underlying this phenomenon is not clear.",
            "probability": 0.04228688785415953,
            "start_logit": 0.7911326885223389,
            "end_logit": 0.5740170478820801
        }
    ],
    "5a8056a2faa1ab7d2e00001f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a9d31711d1251d03b00001c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a9700adfcd1d6a10c00002c": [
        {
            "text": "is a negative regulator of the",
            "probability": 0.10278834784995976,
            "start_logit": 1.1071048974990845,
            "end_logit": 0.7849582433700562
        },
        {
            "text": ".",
            "probability": 0.09745397943707187,
            "start_logit": 0.9954497814178467,
            "end_logit": 0.8433216214179993
        },
        {
            "text": "., diabetes, chronic kidney disease) that are known to precipitate atherosclerosis and enhance cardiovascular risk",
            "probability": 0.08795011091801339,
            "start_logit": 0.9954497814178467,
            "end_logit": 0.7407110929489136
        },
        {
            "text": "., diabetes, chronic kidney disease) that are known to precipitate atherosclerosis and enhance cardiovascular risk. Current knowledge on",
            "probability": 0.08571704514642128,
            "start_logit": 0.9954497814178467,
            "end_logit": 0.7149930596351624
        },
        {
            "text": "is a negative regulator of the canonical Wnt signaling pathway and, accordingly, the consequence of increased sclerostin availability can be disruption of the",
            "probability": 0.08169388745374234,
            "start_logit": 1.1071048974990845,
            "end_logit": 0.5552654266357422
        },
        {
            "text": "is a negative regulator of the canonical Wnt signaling pathway and, accordingly, the",
            "probability": 0.08073079675725514,
            "start_logit": 1.1071048974990845,
            "end_logit": 0.5434063673019409
        },
        {
            "text": "kidney disease) that are known to precipitate atherosclerosis and enhance cardiovascular risk",
            "probability": 0.07732049746621684,
            "start_logit": 0.8666391372680664,
            "end_logit": 0.7407110929489136
        },
        {
            "text": "kidney disease) that are known to precipitate atherosclerosis and enhance cardiovascular risk. Current knowledge on",
            "probability": 0.07535731908551832,
            "start_logit": 0.8666391372680664,
            "end_logit": 0.7149930596351624
        },
        {
            "text": "clerosis and vascular",
            "probability": 0.06452767219198616,
            "start_logit": 0.919641375541687,
            "end_logit": 0.5068439245223999
        },
        {
            "text": "clerosis and vascular aging. Wnt signaling plays a",
            "probability": 0.06324205920703461,
            "start_logit": 0.919641375541687,
            "end_logit": 0.4867193400859833
        },
        {
            "text": "lines of evidence illustrate its",
            "probability": 0.06300801597972634,
            "start_logit": 0.8506677150726318,
            "end_logit": 0.5519853830337524
        },
        {
            "text": "lines of evidence illustrate its role in the pathophysiology of the vascular system.",
            "probability": 0.06069401060394552,
            "start_logit": 0.8506677150726318,
            "end_logit": 0.5145684480667114
        },
        {
            "text": "is cumulating evidence for a contribution of Wnt signaling pathways in multiple processes involved in atherosclerosis and vascular",
            "probability": 0.05951625790310849,
            "start_logit": 0.8387967348098755,
            "end_logit": 0.5068439245223999
        }
    ],
    "5a96c74cfcd1d6a10c000029": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a7639419e632bc066000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a7347a02dc08e987e00001b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a7373f63b9d13c708000008": [
        {
            "text": "ymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis",
            "probability": 0.1024303580258899,
            "start_logit": 0.829521894454956,
            "end_logit": 0.9919590950012207
        },
        {
            "text": "common side effect and the drug must be administered during or after the patient's main meal under direct observation by trained health personnel. Due to late",
            "probability": 0.09198653141645534,
            "start_logit": 0.8480721712112427,
            "end_logit": 0.8658678531646729
        },
        {
            "text": "is the first oral regimen for gHAT that is effective in treating both disease stages. Although fe",
            "probability": 0.09179885962246495,
            "start_logit": 1.1230865716934204,
            "end_logit": 0.5888111591339111
        },
        {
            "text": "is the first oral regimen for gHAT that is effective in treating both disease stages. Although fexin",
            "probability": 0.08417890184859114,
            "start_logit": 1.1230865716934204,
            "end_logit": 0.502155601978302
        },
        {
            "text": ") should only be treated with fexin",
            "probability": 0.08227530776818869,
            "start_logit": 0.9460597038269043,
            "end_logit": 0.656309187412262
        },
        {
            "text": ") should only be treated with",
            "probability": 0.08064075591378049,
            "start_logit": 0.9460597038269043,
            "end_logit": 0.6362423300743103
        },
        {
            "text": ") should only be treated with fexinidazole if no other suitable treatment is available. Nausea and vomiting are a",
            "probability": 0.07707967697033558,
            "start_logit": 0.9460597038269043,
            "end_logit": 0.5910778045654297
        },
        {
            "text": ") should only be treated with fexinidazole if no other suitable treatment is available.",
            "probability": 0.07364766259668847,
            "start_logit": 0.9460597038269043,
            "end_logit": 0.5455305576324463
        },
        {
            "text": "European Medicines Agency",
            "probability": 0.06671908813643844,
            "start_logit": 0.9341695308685303,
            "end_logit": 0.4586194157600403
        },
        {
            "text": "Trypanosoma gambiense (gHAT) in adults and children 6 years and older and weighing 20 or more kg.",
            "probability": 0.06560931535597986,
            "start_logit": 0.8443020582199097,
            "end_logit": 0.5317134857177734
        },
        {
            "text": "ymphatic) and second-stage (meningoe",
            "probability": 0.06206485201324709,
            "start_logit": 0.829521894454956,
            "end_logit": 0.49095579981803894
        },
        {
            "text": "ymphatic) and second-stage (men",
            "probability": 0.060894246017045864,
            "start_logit": 0.829521894454956,
            "end_logit": 0.4719146490097046
        },
        {
            "text": "Trypanosoma gambiense (gHAT) in adults and children 6 years and older and weighing 20 or more kg",
            "probability": 0.0606744443148942,
            "start_logit": 0.8443020582199097,
            "end_logit": 0.4535183906555176
        }
    ],
    "5a95765bfcd1d6a10c000028": [
        {
            "text": "environment. However, to achieve circadian control of\u00a0the entire organism, each cell of the body is equipped",
            "probability": 0.05996849428336114,
            "start_logit": 1.0527946949005127,
            "end_logit": 0.8857007622718811
        },
        {
            "text": "is a master clock in the brain, which responds to light-",
            "probability": 0.0592084937991764,
            "start_logit": 0.999066948890686,
            "end_logit": 0.9266741871833801
        },
        {
            "text": ". However, to achieve circa",
            "probability": 0.05696642842675888,
            "start_logit": 1.0527946949005127,
            "end_logit": 0.8343435525894165
        },
        {
            "text": "clock and confers rhythmicity to individual cells and organs through the",
            "probability": 0.0568920857636823,
            "start_logit": 1.0363852977752686,
            "end_logit": 0.8494470715522766
        },
        {
            "text": "confers rhythmicity to individual cells and organs through the",
            "probability": 0.0551049015287834,
            "start_logit": 1.0044677257537842,
            "end_logit": 0.8494470715522766
        },
        {
            "text": "ox levels signal back to cellular clocks in order to reinforce circadian rhythmicity and to adapt physiology to temporal tissue",
            "probability": 0.0547665889470353,
            "start_logit": 0.9764249324798584,
            "end_logit": 0.871331512928009
        },
        {
            "text": "is a master clock in the brain, which responds to light-darkness cues from the environment. However, to achieve circa",
            "probability": 0.05398651932893178,
            "start_logit": 0.999066948890686,
            "end_logit": 0.8343435525894165
        },
        {
            "text": "equipped",
            "probability": 0.051038703392584345,
            "start_logit": 0.8915596008300781,
            "end_logit": 0.8857007622718811
        },
        {
            "text": "systemic and molecular mechanisms exist",
            "probability": 0.05081690337190909,
            "start_logit": 1.0344146490097046,
            "end_logit": 0.7384905219078064
        },
        {
            "text": "equipped with its own circadian oscillator that is\u00a0controlled by the master clock and confers rhythmicity to individual cells and organs through the",
            "probability": 0.049221501197505034,
            "start_logit": 0.8915596008300781,
            "end_logit": 0.8494470715522766
        },
        {
            "text": "is a master clock in the brain, which responds to light-darkness cues from the",
            "probability": 0.048220220498019675,
            "start_logit": 0.999066948890686,
            "end_logit": 0.7213876247406006
        },
        {
            "text": "environment. However, to achieve circadian control of\u00a0the entire organism, each cell of the body is equipped with its own circadian",
            "probability": 0.04769636734412914,
            "start_logit": 1.0527946949005127,
            "end_logit": 0.6567366719245911
        },
        {
            "text": "ox levels signal back to cellular",
            "probability": 0.04756339895484357,
            "start_logit": 0.9764249324798584,
            "end_logit": 0.7303147315979004
        },
        {
            "text": "clock and confers rhythmicity to individual cells and organs",
            "probability": 0.04636376820210627,
            "start_logit": 1.0363852977752686,
            "end_logit": 0.6448091268539429
        },
        {
            "text": "confers rhythmicity to individual cells and organs",
            "probability": 0.04490731614046985,
            "start_logit": 1.0044677257537842,
            "end_logit": 0.6448091268539429
        },
        {
            "text": "systemic and molecular mechanisms exist that connect the circa",
            "probability": 0.04414708300494685,
            "start_logit": 1.0344146490097046,
            "end_logit": 0.5977883338928223
        },
        {
            "text": "ox levels signal back",
            "probability": 0.04363972438142004,
            "start_logit": 0.9764249324798584,
            "end_logit": 0.6442190408706665
        },
        {
            "text": "is a master clock in the brain, which responds to light-darkness cues from",
            "probability": 0.04344799091725873,
            "start_logit": 0.999066948890686,
            "end_logit": 0.6171737909317017
        },
        {
            "text": "environment. However, to achieve circadian control of\u00a0the entire organism, each",
            "probability": 0.043327493740213,
            "start_logit": 1.0527946949005127,
            "end_logit": 0.5606688261032104
        },
        {
            "text": "systemic and molecular mechanisms exist that connect",
            "probability": 0.04271601677686534,
            "start_logit": 1.0344146490097046,
            "end_logit": 0.5648354291915894
        }
    ],
    "5a992b371d1251d03b00000a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5aa3fb7ad6d6b54f79000009": [
        {
            "text": "problem. Current treatments for chronic hepatitis B are unable",
            "probability": 0.08644697280461258,
            "start_logit": 0.9207671880722046,
            "end_logit": 0.7042552828788757
        },
        {
            "text": ") causes hepatitis, which progresses to fatal liver diseases and remains a global health problem. Current treatments for chronic hepatitis B are unable",
            "probability": 0.08507321239803213,
            "start_logit": 0.9047482013702393,
            "end_logit": 0.7042552828788757
        },
        {
            "text": "cure hepatitis. Thus, new antiviral drugs must be developed. In this study, the viral inhibition",
            "probability": 0.06554925140104306,
            "start_logit": 0.9082006216049194,
            "end_logit": 0.44009244441986084
        },
        {
            "text": "problem. Current treatments for chronic hepatitis B are unable to cure hepatitis. Thus, new antiviral drugs must be developed. In this study, the",
            "probability": 0.0643035293330127,
            "start_logit": 0.9207671880722046,
            "end_logit": 0.40833860635757446
        },
        {
            "text": "cure hepatitis. Thus, new antiviral drugs must be developed. In this study, the",
            "probability": 0.0635005109173164,
            "start_logit": 0.9082006216049194,
            "end_logit": 0.40833860635757446
        },
        {
            "text": "cure hepatitis. Thus, new antiviral drugs must be developed. In this study, the viral inhibition effects of dandelion and taraxa",
            "probability": 0.061426732604044666,
            "start_logit": 0.9082006216049194,
            "end_logit": 0.37513577938079834
        },
        {
            "text": "cure hepatitis. Thus, new antiviral drugs must be developed. In this study, the viral inhibition effects",
            "probability": 0.059345296513531536,
            "start_logit": 0.9082006216049194,
            "end_logit": 0.34066352248191833
        },
        {
            "text": ") causes",
            "probability": 0.055048410576695204,
            "start_logit": 0.9047482013702393,
            "end_logit": 0.2689560651779175
        },
        {
            "text": "problem. Current treatments for chronic hepatitis B are unable to",
            "probability": 0.0535422574269778,
            "start_logit": 0.9207671880722046,
            "end_logit": 0.2251952886581421
        },
        {
            "text": ") causes hepatitis, which progresses to fatal liver diseases and remains a global",
            "probability": 0.05339327186750209,
            "start_logit": 0.9047482013702393,
            "end_logit": 0.23842781782150269
        },
        {
            "text": ") causes hepatitis, which progresses to fatal liver diseases and remains a global health problem. Current treatments for chronic hepatitis B are unable to",
            "probability": 0.052691397865956884,
            "start_logit": 0.9047482013702393,
            "end_logit": 0.2251952886581421
        },
        {
            "text": "problem. Current treatments for chronic hepatitis B are unable to cure hepatitis. Thus, new antiviral drugs must be developed",
            "probability": 0.05059464974130955,
            "start_logit": 0.9207671880722046,
            "end_logit": 0.1685699224472046
        },
        {
            "text": "problem. Current treatments for chronic hepatitis B are unable to cure hepatitis. Thus, new antivira",
            "probability": 0.050303575815764744,
            "start_logit": 0.9207671880722046,
            "end_logit": 0.16280025243759155
        },
        {
            "text": "cure hepatitis. Thus, new antiviral drugs must be developed",
            "probability": 0.049962826948697796,
            "start_logit": 0.9082006216049194,
            "end_logit": 0.1685699224472046
        },
        {
            "text": "cure hepatitis. Thus, new antiviral drugs must be developed. In this study, the viral inhibition effects of dandelion and",
            "probability": 0.04987020130259222,
            "start_logit": 0.9082006216049194,
            "end_logit": 0.16671431064605713
        },
        {
            "text": "cure hepatitis. Thus, new antivira",
            "probability": 0.04967538793596363,
            "start_logit": 0.9082006216049194,
            "end_logit": 0.16280025243759155
        },
        {
            "text": "cure hepatitis. Thus, new antiviral drugs must be developed. In this study, the viral inhibition effects of dandel",
            "probability": 0.04927251454694694,
            "start_logit": 0.9082006216049194,
            "end_logit": 0.15465706586837769
        }
    ],
    "5aa824a8fcf4565872000002": [
        {
            "text": "ophenotyping cells from peripheral blood (particularly T lymphocytes) derived from un",
            "probability": 0.10020652925197326,
            "start_logit": 0.8680867552757263,
            "end_logit": 0.8628940582275391
        },
        {
            "text": "is an oral formulation of the fumaric acid ester that is Food and Drug Administration approved for treatment of relapsing",
            "probability": 0.0872398058147298,
            "start_logit": 1.0802862644195557,
            "end_logit": 0.5121219158172607
        },
        {
            "text": "ophenotyping cells from peripheral blood (particularly T lymphocytes) derived from untreated and 4-6 and 18-",
            "probability": 0.08610817697718695,
            "start_logit": 0.8680867552757263,
            "end_logit": 0.7112650871276855
        },
        {
            "text": "among effector memory",
            "probability": 0.08052144785012406,
            "start_logit": 0.847482442855835,
            "end_logit": 0.6647886037826538
        },
        {
            "text": "memory T cells and central memory T cells were reduced, whereas naive T cells increased in treated patients",
            "probability": 0.07870367237578788,
            "start_logit": 0.9268731474876404,
            "end_logit": 0.5625641345977783
        },
        {
            "text": "of the fumaric acid ester that is Food and Drug Administration approved for treatment of relapsing-remitting multiple scler",
            "probability": 0.07557872825627661,
            "start_logit": 0.8823439478874207,
            "end_logit": 0.5665783882141113
        },
        {
            "text": "treatment. The proportions of both effector memory T cells and central memory T cells were reduced, whereas naive T cells increased in treated patients",
            "probability": 0.07469906871187248,
            "start_logit": 0.8746509552001953,
            "end_logit": 0.5625641345977783
        },
        {
            "text": "memory T cells and central memory T cells were reduced, whereas naive T cells increased in treated patients. T cell activation was",
            "probability": 0.07347418580725769,
            "start_logit": 0.9268731474876404,
            "end_logit": 0.49380844831466675
        },
        {
            "text": "of the fumaric acid ester that is Food and Drug Administration approved for treatment of relapsing",
            "probability": 0.07157303514580247,
            "start_logit": 0.8823439478874207,
            "end_logit": 0.5121219158172607
        },
        {
            "text": "ophenotyping cells from peripheral blood (particularly T lymphocytes) derived from untreated and 4-",
            "probability": 0.06966645917600615,
            "start_logit": 0.8680867552757263,
            "end_logit": 0.4993796944618225
        },
        {
            "text": "T cells and central memory T cells were reduced, whereas naive T cells increased in treated patients",
            "probability": 0.06948306328606203,
            "start_logit": 0.8022663593292236,
            "end_logit": 0.5625641345977783
        },
        {
            "text": "among effector memory T cells and effector memory RA T cells. Th subsets",
            "probability": 0.06787958479140663,
            "start_logit": 0.847482442855835,
            "end_logit": 0.4940003454685211
        },
        {
            "text": "T cells and central memory T cells were reduced, whereas naive T cells increased in treated patients. T cell activation was",
            "probability": 0.06486624255551403,
            "start_logit": 0.8022663593292236,
            "end_logit": 0.49380844831466675
        }
    ],
    "5ad3aa47133db5eb78000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "589a247078275d0c4a000035": [
        {
            "text": "ablative chemotherapy with anti-GD2 antibody dinutuximab has increased the two-year event-free and overall survival of high-",
            "probability": 0.10848136401734584,
            "start_logit": 1.141383409500122,
            "end_logit": 0.5989515781402588
        },
        {
            "text": "ablative chemotherapy with anti-GD2 antibody dinutuximab has increased the",
            "probability": 0.10279810994347215,
            "start_logit": 1.141383409500122,
            "end_logit": 0.5451401472091675
        },
        {
            "text": "ablative chemotherapy with anti-",
            "probability": 0.09241291107227176,
            "start_logit": 1.141383409500122,
            "end_logit": 0.43863987922668457
        },
        {
            "text": "ablative chemotherapy with anti-GD2 antibody dinutuximab has increased the two-year event-free and overall",
            "probability": 0.09218893976615516,
            "start_logit": 1.141383409500122,
            "end_logit": 0.43621334433555603
        },
        {
            "text": "ablative chemotherapy with anti-GD2 antibody dinutuximab has increased the two-",
            "probability": 0.088256876664,
            "start_logit": 1.141383409500122,
            "end_logit": 0.39262479543685913
        },
        {
            "text": "ablative chemotherapy with anti-GD2 antibody din",
            "probability": 0.08588755714740022,
            "start_logit": 1.141383409500122,
            "end_logit": 0.3654121458530426
        },
        {
            "text": "neuroblastoma that remains after myeloablative chemotherapy with anti-GD2 antibody dinutuximab has increased the",
            "probability": 0.08037062744775772,
            "start_logit": 0.8952652215957642,
            "end_logit": 0.5451401472091675
        },
        {
            "text": "ablative chemotherapy with anti-GD2 antibody",
            "probability": 0.07924501686382972,
            "start_logit": 1.141383409500122,
            "end_logit": 0.2849177122116089
        },
        {
            "text": "neuroblastoma that remains after myeloablative chemotherapy with anti-",
            "probability": 0.07225116931854605,
            "start_logit": 0.8952652215957642,
            "end_logit": 0.43863987922668457
        },
        {
            "text": "neuroblastoma that remains after myeloablative chemotherapy with anti-GD2 antibody dinutuximab has increased the two-",
            "probability": 0.06900185769918896,
            "start_logit": 0.8952652215957642,
            "end_logit": 0.39262479543685913
        },
        {
            "text": "neuroblastoma that remains after myeloablative chemotherapy with anti-GD2 antibody din",
            "probability": 0.06714945305597075,
            "start_logit": 0.8952652215957642,
            "end_logit": 0.3654121458530426
        },
        {
            "text": "neuroblastoma that remains after myeloablative chemotherapy with anti-GD2 antibody",
            "probability": 0.06195611700406147,
            "start_logit": 0.8952652215957642,
            "end_logit": 0.2849177122116089
        }
    ],
    "5ac24c9495d0062724000002": [
        {
            "text": "hang from the Forkhead motif, which we term mesas. We show that mesas occur in multiple cellular contexts and exist as single",
            "probability": 0.09189602126246638,
            "start_logit": 1.0544483661651611,
            "end_logit": 0.6826390027999878
        },
        {
            "text": "overhang from the Forkhead motif, which we term mesas. We show that mesas occur in multiple cellular contexts and exist as single",
            "probability": 0.07671035961006337,
            "start_logit": 0.8738273978233337,
            "end_logit": 0.6826390027999878
        },
        {
            "text": "hang from the Forkhead",
            "probability": 0.07460084287228663,
            "start_logit": 1.0544483661651611,
            "end_logit": 0.47413307428359985
        },
        {
            "text": "hang from the Forkhead motif, which we term mesas. We show that mesas occur",
            "probability": 0.07145126198064435,
            "start_logit": 1.0544483661651611,
            "end_logit": 0.430996835231781
        },
        {
            "text": "hang from the Forkhead motif, which we term mesas. We show",
            "probability": 0.06949861522887847,
            "start_logit": 1.0544483661651611,
            "end_logit": 0.4032880961894989
        },
        {
            "text": "hang from the",
            "probability": 0.06938298003910756,
            "start_logit": 1.0544483661651611,
            "end_logit": 0.40162286162376404
        },
        {
            "text": "hang from the Forkhead motif, which we term mesas.",
            "probability": 0.06907740313831368,
            "start_logit": 1.0544483661651611,
            "end_logit": 0.39720892906188965
        },
        {
            "text": "overhang from the Forkhead",
            "probability": 0.062273180115190445,
            "start_logit": 0.8738273978233337,
            "end_logit": 0.47413307428359985
        },
        {
            "text": "seq approach for high resolution mapping of transcription factor DNA sites. We describe an Illumina-based ChIP-exo method",
            "probability": 0.06148973831172407,
            "start_logit": 0.8372100591659546,
            "end_logit": 0.49808987975120544
        },
        {
            "text": "seq approach for high resolution mapping of transcription factor DNA",
            "probability": 0.0612963183418001,
            "start_logit": 0.8372100591659546,
            "end_logit": 0.4949393570423126
        },
        {
            "text": "overhang from the Forkhead motif, which we term mesas. We show that mesas occur",
            "probability": 0.059644062124012034,
            "start_logit": 0.8738273978233337,
            "end_logit": 0.430996835231781
        },
        {
            "text": "seq approach for high resolution mapping of transcription factor DNA sites. We describe an Illumina-",
            "probability": 0.05908509034479397,
            "start_logit": 0.8372100591659546,
            "end_logit": 0.4581981897354126
        },
        {
            "text": "overhang from the Forkhead motif, which we term mesas. We show",
            "probability": 0.058014086936168274,
            "start_logit": 0.8738273978233337,
            "end_logit": 0.4032880961894989
        },
        {
            "text": "overhang from the",
            "probability": 0.05791756026538272,
            "start_logit": 0.8738273978233337,
            "end_logit": 0.40162286162376404
        },
        {
            "text": "overhang from the Forkhead motif, which we term mesas.",
            "probability": 0.0576624794291681,
            "start_logit": 0.8738273978233337,
            "end_logit": 0.39720892906188965
        }
    ],
    "5abc9ecffcf4565872000021": [
        {
            "text": "DNA is replicated by DNA polymerase \u03b3 in concert with accessory proteins such as the mitochondrial DNA helicase, single-",
            "probability": 0.07592591215843997,
            "start_logit": 0.9667831659317017,
            "end_logit": 0.8258630037307739
        },
        {
            "text": "external ophthalmoplegia, ataxia-",
            "probability": 0.0698903007358019,
            "start_logit": 0.8406336307525635,
            "end_logit": 0.8691813945770264
        },
        {
            "text": "polymerase \u03b3 in concert with accessory proteins such as the mitochondrial DNA helicase, single-",
            "probability": 0.06970220659032439,
            "start_logit": 0.8812571167945862,
            "end_logit": 0.8258630037307739
        },
        {
            "text": "external ophthalmoplegia, ataxia-neuropathy, or mitochondrial ne",
            "probability": 0.0667771155885612,
            "start_logit": 0.8406336307525635,
            "end_logit": 0.8236149549484253
        },
        {
            "text": "pletion, which ultimately cause loss of oxidative phosphorylation. These genetic diseases include",
            "probability": 0.058855789509189724,
            "start_logit": 0.8743696808815002,
            "end_logit": 0.6636086702346802
        },
        {
            "text": "external ophthalmoplegia, ataxia-neuropathy,",
            "probability": 0.055730234514101556,
            "start_logit": 0.8406336307525635,
            "end_logit": 0.6427773237228394
        },
        {
            "text": "DNA is replicated by DNA polymerase \u03b3 in concert with accessory proteins such as the mitochondrial DNA helicase, single",
            "probability": 0.055505048762177364,
            "start_logit": 0.9667831659317017,
            "end_logit": 0.5125789642333984
        },
        {
            "text": "pletion, which ultimately cause loss of oxidative phosphorylation. These",
            "probability": 0.05517122100977083,
            "start_logit": 0.8743696808815002,
            "end_logit": 0.5989599227905273
        },
        {
            "text": "pletion, which ultimately cause loss of oxidative phosphorylation. These genetic",
            "probability": 0.053386511089082475,
            "start_logit": 0.8743696808815002,
            "end_logit": 0.5660765767097473
        },
        {
            "text": "pletion syndromes such as Alpers or early infantile he",
            "probability": 0.051883855203222695,
            "start_logit": 0.9198024272918701,
            "end_logit": 0.49209338426589966
        },
        {
            "text": "polymerase \u03b3 in concert with accessory proteins such as the mitochondrial DNA helicase, single",
            "probability": 0.050955257113723784,
            "start_logit": 0.8812571167945862,
            "end_logit": 0.5125789642333984
        },
        {
            "text": "DNA is replicated by DNA polymerase \u03b3 in concert with accessory proteins such as the mitochondrial DNA helica",
            "probability": 0.050034927553784435,
            "start_logit": 0.9667831659317017,
            "end_logit": 0.4088262915611267
        },
        {
            "text": "external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal ence",
            "probability": 0.04909269141785596,
            "start_logit": 0.8406336307525635,
            "end_logit": 0.515964686870575
        },
        {
            "text": "pletion syndromes such as Alpers or early infantile hepatocerebral syndromes, and mitochondrial",
            "probability": 0.04891586429955996,
            "start_logit": 0.9198024272918701,
            "end_logit": 0.43318748474121094
        },
        {
            "text": "external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalom",
            "probability": 0.047896565663555,
            "start_logit": 0.8406336307525635,
            "end_logit": 0.4912983179092407
        },
        {
            "text": "pletion syndromes such as Alpers or early infantile hepatocereb",
            "probability": 0.04749345984950778,
            "start_logit": 0.9198024272918701,
            "end_logit": 0.40367773175239563
        },
        {
            "text": "pletion, which ultimately cause loss of oxidative phosphorylation. These genetic diseases include mitochondrial",
            "probability": 0.046849512982402336,
            "start_logit": 0.8743696808815002,
            "end_logit": 0.43545907735824585
        },
        {
            "text": "polymerase \u03b3 in concert with accessory proteins such as the mitochondrial DNA helica",
            "probability": 0.045933525958938626,
            "start_logit": 0.8812571167945862,
            "end_logit": 0.4088262915611267
        }
    ],
    "5ac138aa95d0062724000001": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5ab147edfcf4565872000013": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a9d99ac4e03427e73000002": [
        {
            "text": "some of which can",
            "probability": 0.18548881353330987,
            "start_logit": 1.1071300506591797,
            "end_logit": 0.6675618886947632
        },
        {
            "text": "of women with endometriosis, women with deep-",
            "probability": 0.15559029837639743,
            "start_logit": 0.9602528810501099,
            "end_logit": 0.6386707425117493
        },
        {
            "text": "some of which can also be found in other healthy tissues. In order to better understand the altered milieu of the",
            "probability": 0.14613767760127694,
            "start_logit": 1.1071300506591797,
            "end_logit": 0.42911648750305176
        },
        {
            "text": "attachment, invasion, proliferation and neovascularization, some of which can",
            "probability": 0.14602178703068713,
            "start_logit": 0.8678913116455078,
            "end_logit": 0.6675618886947632
        },
        {
            "text": "of women with endometriosis, women with deep-infiltrating endometriosis",
            "probability": 0.1332102705636132,
            "start_logit": 0.9602528810501099,
            "end_logit": 0.48337334394454956
        },
        {
            "text": "attachment, invasion,",
            "probability": 0.12228431092222208,
            "start_logit": 0.8678913116455078,
            "end_logit": 0.49015480279922485
        },
        {
            "text": "attachment, invasion, proliferation and neovas",
            "probability": 0.11126684197249338,
            "start_logit": 0.8678913116455078,
            "end_logit": 0.39573734998703003
        }
    ],
    "5ab1483bfcf4565872000014": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5a896c26fcd1d6a10c000007": [
        {
            "text": "failure syndromes, making differential diagnosis challenging and its confirmation often reached with great delay. By whole exome sequencing, we unraveled",
            "probability": 0.26691539550886395,
            "start_logit": 0.9881068468093872,
            "end_logit": 0.8001787066459656
        },
        {
            "text": "typic overlap with other inherited bone marrow failure syndromes, making differential diagnosis challenging and its confirmation often reached with great delay. By whole exome sequencing",
            "probability": 0.2539578469476042,
            "start_logit": 1.0860675573349,
            "end_logit": 0.6524545550346375
        },
        {
            "text": "other inherited bone marrow failure syndromes, making differential diagnosis challenging and its confirmation often reached with great delay. By whole exome sequencing",
            "probability": 0.24886710740585022,
            "start_logit": 1.0658183097839355,
            "end_logit": 0.6524545550346375
        },
        {
            "text": "failure syndromes, making differential diagnosis challenging and its confirmation often reached with great delay. By whole exome sequencing",
            "probability": 0.2302596501376816,
            "start_logit": 0.9881068468093872,
            "end_logit": 0.6524545550346375
        }
    ],
    "5ac37afc0340b9f058000002": [
        {
            "text": "comprehensive quantitative structure-",
            "probability": 0.08056620966082588,
            "start_logit": 1.058634877204895,
            "end_logit": 1.0622557401657104
        },
        {
            "text": "penetration enhancers and the enhancer concentration required for effective skin permeation enhancement are difficult to predict. A comprehensive quantitative structure-",
            "probability": 0.06975147355114478,
            "start_logit": 0.9144940972328186,
            "end_logit": 1.0622557401657104
        },
        {
            "text": "enhancement are difficult to predict. A comprehensive quantitative structure-",
            "probability": 0.06289711076602264,
            "start_logit": 0.8110557794570923,
            "end_logit": 1.0622557401657104
        },
        {
            "text": "\u03b1) was defined. A correlation between the potency parameter \u03b1 and enhancer octanol/water partition coefficient (Koct) was",
            "probability": 0.058893809337828625,
            "start_logit": 0.9596123099327087,
            "end_logit": 0.8479349613189697
        },
        {
            "text": "M is required to induce effective skin permeation enhancement under these conditions. Consistent with the analyses in previous studies,",
            "probability": 0.05499906069414211,
            "start_logit": 1.1481618881225586,
            "end_logit": 0.5909655094146729
        },
        {
            "text": "M is required to induce effective skin permeation enhancement under these conditions. Consistent",
            "probability": 0.053602859987211135,
            "start_logit": 1.1481618881225586,
            "end_logit": 0.5652518272399902
        },
        {
            "text": "comprehensive quantitative structure-enhancement relationship of chemical penetration enhancers",
            "probability": 0.05043451733557517,
            "start_logit": 1.058634877204895,
            "end_logit": 0.5938522219657898
        },
        {
            "text": "comprehensive quantitative structure",
            "probability": 0.050295483353735876,
            "start_logit": 1.058634877204895,
            "end_logit": 0.5910916924476624
        },
        {
            "text": "is required to induce effective skin permeation enhancement under these conditions. Consistent with the analyses in previous studies,",
            "probability": 0.04707205150498773,
            "start_logit": 0.9925252199172974,
            "end_logit": 0.5909655094146729
        },
        {
            "text": "present analysis, data from previous skin permeation studies that used the symmetric/equilibrium configuration and skin parallel pathway model",
            "probability": 0.04608250985170033,
            "start_logit": 0.9609895944595337,
            "end_logit": 0.6012551784515381
        },
        {
            "text": "is required to induce effective skin permeation enhancement under these conditions. Consistent",
            "probability": 0.045877085068134475,
            "start_logit": 0.9925252199172974,
            "end_logit": 0.5652518272399902
        },
        {
            "text": "penetration enhancers and the enhancer concentration required for effective skin permeation enhancement are difficult to predict",
            "probability": 0.045526703748818884,
            "start_logit": 0.9144940972328186,
            "end_logit": 0.6356162428855896
        },
        {
            "text": "\u03b1) was defined. A correlation between the potency parameter \u03b1 and enhancer octanol/water partition coefficient (Koct",
            "probability": 0.04491525255810521,
            "start_logit": 0.9596123099327087,
            "end_logit": 0.5769764184951782
        },
        {
            "text": "present analysis, data from previous skin permeation studies that used the symmetric/equilibrium configuration and skin parallel pathway model were summarized to determine the",
            "probability": 0.044261167891098976,
            "start_logit": 0.9609895944595337,
            "end_logit": 0.5609294176101685
        },
        {
            "text": "penetration enhancers and the enhancer concentration required for effective skin permeation enhancement are difficult to predict. A comprehensive quantitative structure",
            "probability": 0.04354411224828854,
            "start_logit": 0.9144940972328186,
            "end_logit": 0.5910916924476624
        },
        {
            "text": "penetration enhancers and the",
            "probability": 0.04176208876928151,
            "start_logit": 0.9144940972328186,
            "end_logit": 0.5493061542510986
        },
        {
            "text": "enhancement are difficult to predict",
            "probability": 0.04105286931897889,
            "start_logit": 0.8110557794570923,
            "end_logit": 0.6356162428855896
        },
        {
            "text": ": Log",
            "probability": 0.039826884467667495,
            "start_logit": 0.8224601745605469,
            "end_logit": 0.59389328956604
        },
        {
            "text": "enhancement are difficult to predict. A comprehensive quantitative structure-enhancement relationship of chemical penetration enhancers",
            "probability": 0.03937364605634398,
            "start_logit": 0.8110557794570923,
            "end_logit": 0.5938522219657898
        },
        {
            "text": "enhancement are difficult to predict. A comprehensive quantitative structure",
            "probability": 0.03926510383010793,
            "start_logit": 0.8110557794570923,
            "end_logit": 0.5910916924476624
        }
    ],
    "5abcf010fcf4565872000023": [
        {
            "text": "is diagnosed",
            "probability": 0.14027050735197175,
            "start_logit": 1.0860893726348877,
            "end_logit": 0.6725296974182129
        },
        {
            "text": "is diagnosed based on history, physical examination, and nerve conduction testing; however, there are no clear criteria for the",
            "probability": 0.12074094297966076,
            "start_logit": 1.0860893726348877,
            "end_logit": 0.52260422706604
        },
        {
            "text": "is diagnosed based on history, physical examination, and nerve conduction testing; however, there are no clear",
            "probability": 0.10463545685088273,
            "start_logit": 1.0860893726348877,
            "end_logit": 0.37943941354751587
        },
        {
            "text": "no clear criteria for the",
            "probability": 0.10400486993843565,
            "start_logit": 0.9368798136711121,
            "end_logit": 0.52260422706604
        },
        {
            "text": "no clear criteria for the diagnosis of carpal tunnel syndrome. Recently, studies have aimed to diagnose carp",
            "probability": 0.09988038530976452,
            "start_logit": 0.9368798136711121,
            "end_logit": 0.48213982582092285
        },
        {
            "text": "is diagnosed based on history, physical examination, and nerve conduction testing; however, there are no",
            "probability": 0.09559590308464509,
            "start_logit": 1.0860893726348877,
            "end_logit": 0.2890869081020355
        },
        {
            "text": "no clear",
            "probability": 0.09013178804275253,
            "start_logit": 0.9368798136711121,
            "end_logit": 0.37943941354751587
        },
        {
            "text": "no",
            "probability": 0.08234521962148872,
            "start_logit": 0.9368798136711121,
            "end_logit": 0.2890869081020355
        },
        {
            "text": "no clear criteria for the diagnosis of carpal tunnel syndrome. Recently, studies have aimed to diagnose carpal tunnel syndrome through ultrasound",
            "probability": 0.08158977500495958,
            "start_logit": 0.9368798136711121,
            "end_logit": 0.2798704504966736
        },
        {
            "text": "no clear criteria for the diagnosis of carpal tunnel syndrome. Recently,",
            "probability": 0.08080515181543865,
            "start_logit": 0.9368798136711121,
            "end_logit": 0.2702072262763977
        }
    ],
    "5ace17c30340b9f058000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5abd13e1fcf4565872000029": [
        {
            "text": "surface somatometry. While several studies have examined",
            "probability": 0.09097225222741923,
            "start_logit": 1.1384201049804688,
            "end_logit": 0.8161428570747375
        },
        {
            "text": "try and body surface somatometry. While several studies have examined",
            "probability": 0.08185026958909206,
            "start_logit": 1.0327571630477905,
            "end_logit": 0.8161428570747375
        },
        {
            "text": "try. While several studies have examined",
            "probability": 0.0779665181262174,
            "start_logit": 0.9841450452804565,
            "end_logit": 0.8161428570747375
        },
        {
            "text": "several studies have examined",
            "probability": 0.07570149353816596,
            "start_logit": 0.9546634554862976,
            "end_logit": 0.8161428570747375
        },
        {
            "text": "study. Six medial longitudinal and three transverse arch evaluation methods were evaluated for the correlation",
            "probability": 0.07045374615538819,
            "start_logit": 1.0989131927490234,
            "end_logit": 0.6000516414642334
        },
        {
            "text": "using radiographic morphometry and body surface somatometry. While several studies have examined",
            "probability": 0.068880113156677,
            "start_logit": 0.8602330684661865,
            "end_logit": 0.8161428570747375
        },
        {
            "text": "surface somat",
            "probability": 0.06736929362179345,
            "start_logit": 1.1384201049804688,
            "end_logit": 0.5157776474952698
        },
        {
            "text": "angle and transverse arch-length",
            "probability": 0.06331163193110005,
            "start_logit": 0.9671275615692139,
            "end_logit": 0.6249499320983887
        },
        {
            "text": "surface somatometry at medial longitudinal and transverse arches. [Participants and Methods] Fifty healthy adults were included in the",
            "probability": 0.06287321899913036,
            "start_logit": 0.9890896677970886,
            "end_logit": 0.5960390567779541
        },
        {
            "text": "angle and transverse arch-",
            "probability": 0.06078262434784995,
            "start_logit": 0.9671275615692139,
            "end_logit": 0.5841848254203796
        },
        {
            "text": "try and body surface somat",
            "probability": 0.0606140302120442,
            "start_logit": 1.0327571630477905,
            "end_logit": 0.5157776474952698
        },
        {
            "text": "surface somatometry at medial longitudinal and transverse arches. [Participants and Methods] Fifty healthy",
            "probability": 0.059376447298114164,
            "start_logit": 0.9890896677970886,
            "end_logit": 0.5388163924217224
        },
        {
            "text": "angle and transverse arch-length ratio in transverse arch evaluation. Additionally, there was",
            "probability": 0.05715033993019217,
            "start_logit": 0.9671275615692139,
            "end_logit": 0.5225661993026733
        },
        {
            "text": "using radiographic",
            "probability": 0.051689010379155347,
            "start_logit": 0.8602330684661865,
            "end_logit": 0.5290205478668213
        },
        {
            "text": "using radiographic morphometry and body surface somat",
            "probability": 0.05100901048766058,
            "start_logit": 0.8602330684661865,
            "end_logit": 0.5157776474952698
        }
    ],
    "5ac716810340b9f058000003": [
        {
            "text": "development of DCM. The",
            "probability": 0.0649725053208905,
            "start_logit": 0.8881582021713257,
            "end_logit": 1.027297019958496
        },
        {
            "text": "cardiomyopathy pathways may serve crucial roles in the development of DCM. The",
            "probability": 0.06404255910253139,
            "start_logit": 0.873741865158081,
            "end_logit": 1.027297019958496
        },
        {
            "text": "gulated lncRNAs were validated",
            "probability": 0.058637124600437435,
            "start_logit": 1.0442378520965576,
            "end_logit": 0.7686212062835693
        },
        {
            "text": "non\u2011ischemic cardiomyopathy, of which the underlying mechanisms have not yet been fully elucidated. Long noncoding RNAs\u00a0(lncRNAs)",
            "probability": 0.056571493964458895,
            "start_logit": 1.1410313844680786,
            "end_logit": 0.6359648704528809
        },
        {
            "text": "gulated lncRNAs were validated by reverse transcription\u2011polymer",
            "probability": 0.054397179395657136,
            "start_logit": 1.0442378520965576,
            "end_logit": 0.6935654878616333
        },
        {
            "text": "gulated",
            "probability": 0.05304067156475316,
            "start_logit": 1.0442378520965576,
            "end_logit": 0.6683121919631958
        },
        {
            "text": "sequencing",
            "probability": 0.050745648172272353,
            "start_logit": 1.0213629007339478,
            "end_logit": 0.6469539999961853
        },
        {
            "text": "of these dysregulated lncRNAs in DCM.",
            "probability": 0.049224225526641525,
            "start_logit": 1.0180983543395996,
            "end_logit": 0.619778573513031
        },
        {
            "text": "of these dysregulated lncRNA",
            "probability": 0.0488279388655977,
            "start_logit": 1.0180983543395996,
            "end_logit": 0.6116953492164612
        },
        {
            "text": "ated lncRNAs were found to be mainly associated with system development, organ morphogen",
            "probability": 0.04826874779176764,
            "start_logit": 0.8271454572677612,
            "end_logit": 0.7911298871040344
        },
        {
            "text": "of these dysregulated lncRNAs in DCM. Comparison between 8 DCM and 8\u00a0control samples demonstrated",
            "probability": 0.047274076541109065,
            "start_logit": 1.0180983543395996,
            "end_logit": 0.5793547630310059
        },
        {
            "text": "development of DCM",
            "probability": 0.04617456997739525,
            "start_logit": 0.8881582021713257,
            "end_logit": 0.6857620477676392
        },
        {
            "text": "cardiomyopathy pathways may serve crucial roles in the development of DCM",
            "probability": 0.045513677088583865,
            "start_logit": 0.873741865158081,
            "end_logit": 0.6857620477676392
        },
        {
            "text": "present study, a case\u2011control study was performed to identify expression deviations in circulating lncRNA",
            "probability": 0.04536620041943776,
            "start_logit": 0.9636613130569458,
            "end_logit": 0.5925970673561096
        },
        {
            "text": "988\u00a0lncRNAs",
            "probability": 0.04534093012922895,
            "start_logit": 0.9523252248764038,
            "end_logit": 0.6033759713172913
        },
        {
            "text": "analysis. These findings provide a theoretical foundation for future studies of lncRNA",
            "probability": 0.045287219454834944,
            "start_logit": 0.979762077331543,
            "end_logit": 0.5747538208961487
        },
        {
            "text": "present study revealed the genome\u2011wide",
            "probability": 0.045003626181059936,
            "start_logit": 0.8522464036941528,
            "end_logit": 0.6959877014160156
        },
        {
            "text": "988\u00a0lncRNAs and 1,418\u00a0mRNAs in total. The dysregulated lncRNAs",
            "probability": 0.04444313100291662,
            "start_logit": 0.9523252248764038,
            "end_logit": 0.5833762288093567
        },
        {
            "text": "development of DCM. The lncRNA\u2011mRNA co\u2011expression network also suggested that the target genes of the l",
            "probability": 0.043806662340737254,
            "start_logit": 0.8881582021713257,
            "end_logit": 0.633118748664856
        },
        {
            "text": "development of DCM. The lncRNA\u2011mRNA co\u2011expression network also suggested that the",
            "probability": 0.04306181255968867,
            "start_logit": 0.8881582021713257,
            "end_logit": 0.6159694194793701
        }
    ],
    "5ace19420340b9f05800000a": [
        {
            "text": "is a complex genetic trait. Previous work has established that MC1R variants are the principal",
            "probability": 0.09670416752193346,
            "start_logit": 1.0693752765655518,
            "end_logit": 0.6776254177093506
        },
        {
            "text": "associated with over 200 genetic variants and we find",
            "probability": 0.08283407527203758,
            "start_logit": 0.8963519334793091,
            "end_logit": 0.6958317756652832
        },
        {
            "text": "is a complex genetic trait. Previous work has established that MC1R variants are the principal genetic cause of red hair colour,",
            "probability": 0.0822548862723384,
            "start_logit": 1.0693752765655518,
            "end_logit": 0.5157917141914368
        },
        {
            "text": "is a complex genetic trait. Previous work has established that MC1R variants are the principal genetic cause",
            "probability": 0.08199983332503098,
            "start_logit": 1.0693752765655518,
            "end_logit": 0.5126861333847046
        },
        {
            "text": "melanocytes in the",
            "probability": 0.07916482853189463,
            "start_logit": 0.896138072013855,
            "end_logit": 0.6507382392883301
        },
        {
            "text": "is associated with over 200 genetic variants and we find",
            "probability": 0.07898739629267162,
            "start_logit": 0.8488007187843323,
            "end_logit": 0.6958317756652832
        },
        {
            "text": "hair colour, but with variable penetrance. Here",
            "probability": 0.07621398251178199,
            "start_logit": 0.8338149189949036,
            "end_logit": 0.6750742197036743
        },
        {
            "text": "hair colour, but with variable penetrance. Here, we have extensively mapped the genes responsible for hair colour in the white,",
            "probability": 0.07542797784576963,
            "start_logit": 0.8338149189949036,
            "end_logit": 0.6647075414657593
        },
        {
            "text": "other genes contributing to red hair, the",
            "probability": 0.07390723767926795,
            "start_logit": 0.8812299370765686,
            "end_logit": 0.5969250202178955
        },
        {
            "text": "associated with over 200 genetic variants and we find a",
            "probability": 0.07270878968992522,
            "start_logit": 0.8963519334793091,
            "end_logit": 0.5654545426368713
        },
        {
            "text": "is associated with over 200 genetic variants and we find a",
            "probability": 0.06933231241294897,
            "start_logit": 0.8488007187843323,
            "end_logit": 0.5654545426368713
        },
        {
            "text": "hair colour, but with variable penetrance. Here, we have extensively mapped the genes responsible",
            "probability": 0.06547262621920308,
            "start_logit": 0.8338149189949036,
            "end_logit": 0.5231614112854004
        },
        {
            "text": "hair colour,",
            "probability": 0.06499188642519645,
            "start_logit": 0.8338149189949036,
            "end_logit": 0.5157917141914368
        }
    ],
    "5abd5a62fcf4565872000031": [
        {
            "text": "kanamycin",
            "probability": 0.05970783866171737,
            "start_logit": 1.1526788473129272,
            "end_logit": 0.7084805369377136
        },
        {
            "text": "DNA replication were associated with EcoRI fragments R1b (4.2 X 10(6) daltons), R3 (2.",
            "probability": 0.058127463294192806,
            "start_logit": 0.8229650855064392,
            "end_logit": 1.011369228363037
        },
        {
            "text": "kanamycin and tetracycline (KMrTcr)",
            "probability": 0.05744071509681072,
            "start_logit": 1.1526788473129272,
            "end_logit": 0.6697705984115601
        },
        {
            "text": "oxyribonucleic acid from antibiotic-resistant thermophilic bacteria. Of the 10 plasmi",
            "probability": 0.0573136880306264,
            "start_logit": 1.0552006959915161,
            "end_logit": 0.7650348544120789
        },
        {
            "text": "cline (Tcr",
            "probability": 0.05689955049980588,
            "start_logit": 1.110357642173767,
            "end_logit": 0.7026258707046509
        },
        {
            "text": "53 (KmrTcr). Determinants of Kmr,",
            "probability": 0.056553378192354266,
            "start_logit": 1.028404712677002,
            "end_logit": 0.7784762978553772
        },
        {
            "text": "kanamycin and tetracycline (KMrTcr). Three plasmids were not",
            "probability": 0.05443095416874365,
            "start_logit": 1.1526788473129272,
            "end_logit": 0.6159502267837524
        },
        {
            "text": "cleavage maps of the two plasmids, pTB19 and pT",
            "probability": 0.05183133592097749,
            "start_logit": 0.757797360420227,
            "end_logit": 0.961893618106842
        },
        {
            "text": "ds pTB512 (Kmr), pTB52 (Tcr",
            "probability": 0.051363098188426264,
            "start_logit": 0.9193055629730225,
            "end_logit": 0.7913104891777039
        },
        {
            "text": "kanamycin and tetracycline (KMrTcr). Three plasmids were not self-",
            "probability": 0.04904816303260383,
            "start_logit": 1.1526788473129272,
            "end_logit": 0.5118199586868286
        },
        {
            "text": "kanamy",
            "probability": 0.04865453788755493,
            "start_logit": 1.1526788473129272,
            "end_logit": 0.5037623047828674
        },
        {
            "text": "of Kmr,",
            "probability": 0.045903413199081415,
            "start_logit": 0.8197592496871948,
            "end_logit": 0.7784762978553772
        },
        {
            "text": "53 (KmrTcr).",
            "probability": 0.04513855447658056,
            "start_logit": 1.028404712677002,
            "end_logit": 0.5530281066894531
        },
        {
            "text": "ucleic acid from antibiotic-resistant thermophilic bacteria. Of the 10 plasmi",
            "probability": 0.04465420527021208,
            "start_logit": 0.8056097030639648,
            "end_logit": 0.7650348544120789
        },
        {
            "text": "oxyribonucleic acid from antibiotic-resistant thermophilic bacteria. Of the",
            "probability": 0.044511845548083746,
            "start_logit": 1.0552006959915161,
            "end_logit": 0.5122507214546204
        },
        {
            "text": ") daltons), and R1a (4.2 X 10(6) daltons), respectively. Restriction",
            "probability": 0.04438850638894215,
            "start_logit": 1.0451198816299438,
            "end_logit": 0.5195567607879639
        },
        {
            "text": "circular deoxyribonucleic acid from antibiotic-resistant thermophilic bacteria. Of the 10 plasmi",
            "probability": 0.04437675282850643,
            "start_logit": 0.7993769645690918,
            "end_logit": 0.7650348544120789
        },
        {
            "text": "closed circular deoxyribonucleic acid from antibiotic-resistant thermophilic bacteria. Of the 10 plasmi",
            "probability": 0.04403557806421411,
            "start_logit": 0.7916591167449951,
            "end_logit": 0.7650348544120789
        },
        {
            "text": "cycline (Tcr",
            "probability": 0.043218844571583724,
            "start_logit": 0.8353468179702759,
            "end_logit": 0.7026258707046509
        },
        {
            "text": "), respectively. Restriction",
            "probability": 0.042401576678982346,
            "start_logit": 0.9993248581886292,
            "end_logit": 0.5195567607879639
        }
    ],
    "5a8980d2fcd1d6a10c00000d": [
        {
            "text": "coupled respiration through the induction of the uncoupling protein (Ucp1) to generate heat. TH",
            "probability": 0.06543203257239097,
            "start_logit": 0.9567375183105469,
            "end_logit": 0.9503674507141113
        },
        {
            "text": "of the uncoupling protein (Ucp1) to generate heat. TH",
            "probability": 0.060245677700688685,
            "start_logit": 0.8741564154624939,
            "end_logit": 0.9503674507141113
        },
        {
            "text": "warm-blooded animals. During cold exposure, there is obligatory therm",
            "probability": 0.05560142109389278,
            "start_logit": 0.9788346290588379,
            "end_logit": 0.7654671669006348
        },
        {
            "text": "co",
            "probability": 0.055466323688579774,
            "start_logit": 0.9567375183105469,
            "end_logit": 0.785131573677063
        },
        {
            "text": "coupled respiration through the induction of the uncoupling protein",
            "probability": 0.0551113827512415,
            "start_logit": 0.9567375183105469,
            "end_logit": 0.7787117958068848
        },
        {
            "text": ". TH",
            "probability": 0.05314491773069022,
            "start_logit": 0.7487480640411377,
            "end_logit": 0.9503674507141113
        },
        {
            "text": "warm-blooded animals. During cold exposure, there is obligatory thermogenesis derived from body metabolism as well as adaptive thermogen",
            "probability": 0.05299448233639363,
            "start_logit": 0.9788346290588379,
            "end_logit": 0.7174462080001831
        },
        {
            "text": "warm-blooded animals. During cold exposure, there is obligatory thermogen",
            "probability": 0.051906972886795764,
            "start_logit": 0.9788346290588379,
            "end_logit": 0.696711540222168
        },
        {
            "text": "to generate heat. TH",
            "probability": 0.05157449544387444,
            "start_logit": 0.7187528610229492,
            "end_logit": 0.9503674507141113
        },
        {
            "text": "acquire thermogenic potential. Thyroid hormone (TH) also exerts profound effects on therm",
            "probability": 0.051069587920006536,
            "start_logit": 0.7388358116149902,
            "end_logit": 0.9204463958740234
        },
        {
            "text": "of the uncoupling protein",
            "probability": 0.05074307601857314,
            "start_logit": 0.8741564154624939,
            "end_logit": 0.7787117958068848
        },
        {
            "text": ". We have termed the TH-mediated thermogenesis under thermoneutral conditions \"activated\" thermogen",
            "probability": 0.05025213941610828,
            "start_logit": 0.6832531690597534,
            "end_logit": 0.959892988204956
        },
        {
            "text": "coupled respiration through the induction of the uncoup",
            "probability": 0.049417589405917554,
            "start_logit": 0.9567375183105469,
            "end_logit": 0.6696619391441345
        },
        {
            "text": "of the uncoup",
            "probability": 0.04550059117909939,
            "start_logit": 0.8741564154624939,
            "end_logit": 0.6696619391441345
        },
        {
            "text": ". We have termed the TH-mediated thermogen",
            "probability": 0.04441999677278845,
            "start_logit": 0.6832531690597534,
            "end_logit": 0.8365296125411987
        },
        {
            "text": ") and muscle; however, white adipose tissue",
            "probability": 0.042939201362232234,
            "start_logit": 0.7446417808532715,
            "end_logit": 0.7412364482879639
        },
        {
            "text": "acquire thermogenic potential. Thyroid hormone (TH) also exerts profound effects on",
            "probability": 0.04254789560284836,
            "start_logit": 0.7388358116149902,
            "end_logit": 0.7378876209259033
        },
        {
            "text": ". We have termed the TH-mediated thermogenesis under thermoneutral conditions \"activated\" therm",
            "probability": 0.04253252229633229,
            "start_logit": 0.6832531690597534,
            "end_logit": 0.7931088805198669
        },
        {
            "text": ". TH acts centrally to activate the BAT and browning through the sympathetic nervous system.",
            "probability": 0.04014295528624955,
            "start_logit": 0.7487480640411377,
            "end_logit": 0.6697919368743896
        },
        {
            "text": "to generate heat. TH acts centrally to activate the BAT and browning through the sympathetic nervous system.",
            "probability": 0.03895673853529632,
            "start_logit": 0.7187528610229492,
            "end_logit": 0.6697919368743896
        }
    ],
    "5a9e202bde7cb99d40000002": [
        {
            "text": "specificity of antibody-based detection methods, allowing multiplex biomarker detection and high-",
            "probability": 0.18617644015486695,
            "start_logit": 0.8638958930969238,
            "end_logit": 1.0403395891189575
        },
        {
            "text": "specificity of antibody-",
            "probability": 0.17636424986325397,
            "start_logit": 0.8638958930969238,
            "end_logit": 0.9861962199211121
        },
        {
            "text": "levels exhibited a strong correlation with clinical values for CA125. We identified 52 proteins",
            "probability": 0.17442612388218465,
            "start_logit": 1.0683835744857788,
            "end_logit": 0.7706583738327026
        },
        {
            "text": ". We identified 52 proteins",
            "probability": 0.16066973030266976,
            "start_logit": 0.9862331748008728,
            "end_logit": 0.7706583738327026
        },
        {
            "text": "levels exhibited a strong correlation",
            "probability": 0.15181167455158712,
            "start_logit": 1.0683835744857788,
            "end_logit": 0.6317978501319885
        },
        {
            "text": "levels exhibited a strong correlation with clinical values for CA",
            "probability": 0.1505517812454375,
            "start_logit": 1.0683835744857788,
            "end_logit": 0.6234641671180725
        }
    ],
    "5a885add61bb38fb24000017": [
        {
            "text": "distances observed between closely-spaced H4 cleavages, as predicted from structural",
            "probability": 0.0843537245836431,
            "start_logit": 0.9763262271881104,
            "end_logit": 1.2105354070663452
        },
        {
            "text": "spaced H4 cleavages, as predicted from structural",
            "probability": 0.08205005660124504,
            "start_logit": 0.9486367702484131,
            "end_logit": 1.2105354070663452
        },
        {
            "text": "red from distances observed between closely-spaced H4 cleavages, as predicted from structural",
            "probability": 0.07910001015710146,
            "start_logit": 0.9120202660560608,
            "end_logit": 1.2105354070663452
        },
        {
            "text": "specific hemisomes are also inferred from distances observed between closely-spaced H4 cleavages, as predicted from structural",
            "probability": 0.0758978387394054,
            "start_logit": 0.8706954717636108,
            "end_logit": 1.2105354070663452
        },
        {
            "text": "spaced H4 cleavages, as predicted from structural modeling. Our results indicate that the orientation and rotational position of the stable hemisome at each",
            "probability": 0.07467389489940063,
            "start_logit": 0.9486367702484131,
            "end_logit": 1.116336464881897
        },
        {
            "text": "distances observed between closely-",
            "probability": 0.07394544766908095,
            "start_logit": 0.9763262271881104,
            "end_logit": 1.0788440704345703
        },
        {
            "text": "red from distances observed between closely-",
            "probability": 0.06933998102118072,
            "start_logit": 0.9120202660560608,
            "end_logit": 1.0788440704345703
        },
        {
            "text": "specific hemisomes are also inferred from distances observed between closely-",
            "probability": 0.06653292063157241,
            "start_logit": 0.8706954717636108,
            "end_logit": 1.0788440704345703
        },
        {
            "text": "is occupied by oppositely oriented Cse4/H4/H2A/H2B hemisomes in two rotational phases within the",
            "probability": 0.06325977031631964,
            "start_logit": 0.9830189347267151,
            "end_logit": 0.9160733222961426
        },
        {
            "text": ".",
            "probability": 0.05842722325548066,
            "start_logit": 1.0625529289245605,
            "end_logit": 0.7570716738700867
        },
        {
            "text": "genome and are incompatible with symmetrical structures, including octameric nucleosomes and (Cse",
            "probability": 0.04946921837136547,
            "start_logit": 0.923554539680481,
            "end_logit": 0.7296387553215027
        },
        {
            "text": "genome and are incompatible with symmetrical",
            "probability": 0.04863733445682174,
            "start_logit": 0.923554539680481,
            "end_logit": 0.7126795649528503
        },
        {
            "text": "including octameric nucleosomes and (Cse",
            "probability": 0.047621801695255324,
            "start_logit": 0.885494589805603,
            "end_logit": 0.7296387553215027
        },
        {
            "text": "budding yeast, a single cenH3 (Cse4) nucleosome occupies the \u223c120-bp",
            "probability": 0.04518932201470915,
            "start_logit": 0.8452504873275757,
            "end_logit": 0.7174530029296875
        },
        {
            "text": "ding yeast, a single",
            "probability": 0.04288403832152016,
            "start_logit": 0.8452504873275757,
            "end_logit": 0.665091872215271
        },
        {
            "text": "budding yeast, a single cenH3 (Cse4) nucleosome occupies the \u223c120-bp functional",
            "probability": 0.038617417265898304,
            "start_logit": 0.8452504873275757,
            "end_logit": 0.560295581817627
        }
    ],
    "5aacd487fcf4565872000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5ac0a82d19833b0d7b000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5ac725250340b9f058000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5ad6e431133db5eb7800000e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5ac08fe7d0c506ce46000003": [
        {
            "text": "-7 cells share a similar genetic display. A significant number of unique chromosomal translocations were observed between the",
            "probability": 0.06850985864636373,
            "start_logit": 0.8710365295410156,
            "end_logit": 1.158098578453064
        },
        {
            "text": ". A significant number of unique chromosomal translocations were observed between the",
            "probability": 0.06569092531781667,
            "start_logit": 0.8290196657180786,
            "end_logit": 1.158098578453064
        },
        {
            "text": "romosomal translocations were observed between the",
            "probability": 0.0642819814042815,
            "start_logit": 0.8073382377624512,
            "end_logit": 1.158098578453064
        },
        {
            "text": "-",
            "probability": 0.05827208783214985,
            "start_logit": 0.8710365295410156,
            "end_logit": 0.9962441325187683
        },
        {
            "text": "ays, a microarray analysis revealed distinct estrogen-responsive gene expression patterns with surprisingly moderate to low overlap. We conclude that BG-",
            "probability": 0.05585410353793813,
            "start_logit": 0.8994643092155457,
            "end_logit": 0.9254361391067505
        },
        {
            "text": "1 NIEHS was identical with that of MCF-",
            "probability": 0.05528297256815257,
            "start_logit": 0.7957082986831665,
            "end_logit": 1.0189141035079956
        },
        {
            "text": "has enabled several laboratories to study the estrogenic responses of ovarian cancers. We",
            "probability": 0.0529095426760489,
            "start_logit": 1.109771966934204,
            "end_logit": 0.6609691977500916
        },
        {
            "text": "profile as previously reported, whereas the BG-1 NIEHS and MCF-",
            "probability": 0.05249384855678582,
            "start_logit": 0.7666093111038208,
            "end_logit": 0.9962441325187683
        },
        {
            "text": "is the original ovarian cancer cell line, whereas the BG-1 NIEHS is a variant from the MCF-",
            "probability": 0.04827809177575867,
            "start_logit": 0.8144274950027466,
            "end_logit": 0.8647078275680542
        },
        {
            "text": "a variant from the MCF-",
            "probability": 0.04664564433907184,
            "start_logit": 0.7800291776657104,
            "end_logit": 0.8647078275680542
        },
        {
            "text": "F-7 cells, suggesting that acquired genotypic differences",
            "probability": 0.04589751971268444,
            "start_logit": 0.7752977609634399,
            "end_logit": 0.8532707691192627
        },
        {
            "text": "lines from a common origin. Although all cell",
            "probability": 0.0456768319050778,
            "start_logit": 1.000718116760254,
            "end_logit": 0.6230305433273315
        },
        {
            "text": "is the original ovarian cancer cell line, whereas the BG-1 NIEHS is a variant from the",
            "probability": 0.0448456743588286,
            "start_logit": 0.8144274950027466,
            "end_logit": 0.7909570932388306
        },
        {
            "text": "a variant from the MCF-7 cells. These findings provide much needed clarification",
            "probability": 0.04402898749047184,
            "start_logit": 0.7800291776657104,
            "end_logit": 0.8069764971733093
        },
        {
            "text": "a variant from the",
            "probability": 0.043329288696909773,
            "start_logit": 0.7800291776657104,
            "end_logit": 0.7909570932388306
        },
        {
            "text": "1 NIEHS was identical with that of MCF-7 cells. From",
            "probability": 0.043302737100822324,
            "start_logit": 0.7957082986831665,
            "end_logit": 0.7746649980545044
        },
        {
            "text": "These findings provide much needed clarification",
            "probability": 0.04296278960048164,
            "start_logit": 0.7555153369903564,
            "end_logit": 0.8069764971733093
        },
        {
            "text": "used to study estrogen action",
            "probability": 0.04118431434322468,
            "start_logit": 0.883134126663208,
            "end_logit": 0.6370807886123657
        },
        {
            "text": "1 cells are a valuable in vitro model that has enabled several laboratories to study the estrogenic responses of ovarian cancers. We",
            "probability": 0.04117337976608444,
            "start_logit": 0.8589801788330078,
            "end_logit": 0.6609691977500916
        },
        {
            "text": "a variant from the MCF-7 cells. These findings provide much needed clarification of the",
            "probability": 0.03937942037104678,
            "start_logit": 0.7800291776657104,
            "end_logit": 0.6953716278076172
        }
    ],
    "5ab2cc66fcf4565872000015": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5ace238e0340b9f05800000d": [
        {
            "text": ") that may result",
            "probability": 0.06768019397785933,
            "start_logit": 1.0558849573135376,
            "end_logit": 1.1079332828521729
        },
        {
            "text": "is the sole mechanism",
            "probability": 0.06374919762700428,
            "start_logit": 0.9293649196624756,
            "end_logit": 1.1746163368225098
        },
        {
            "text": "ploids (XXYY) that may result",
            "probability": 0.06217870948574803,
            "start_logit": 0.9711040258407593,
            "end_logit": 1.1079332828521729
        },
        {
            "text": "ploids (XXXY) and their nuclear truncation products",
            "probability": 0.059043316229333065,
            "start_logit": 1.0625344514846802,
            "end_logit": 0.9647615551948547
        },
        {
            "text": "poietic cell transplant recipients with male donors, using a highly specific conjoint immunoh",
            "probability": 0.053208115752823144,
            "start_logit": 0.9655044078826904,
            "end_logit": 0.9577311873435974
        },
        {
            "text": ") that may result from transdifferentiation with subsequent tetraploidization, nor their unique truncation products",
            "probability": 0.052492021749574694,
            "start_logit": 1.0558849573135376,
            "end_logit": 0.853800892829895
        },
        {
            "text": "is the sole mechanism, we modeled the chromosome distribution based on",
            "probability": 0.05133856932271985,
            "start_logit": 0.9293649196624756,
            "end_logit": 0.9581020474433899
        },
        {
            "text": "phenomenon which occurs in rodents under highly selective conditions-",
            "probability": 0.050200928618411245,
            "start_logit": 1.0034681558609009,
            "end_logit": 0.8615900278091431
        },
        {
            "text": "rodents under highly selective conditions-",
            "probability": 0.049011025253958916,
            "start_logit": 0.9794799089431763,
            "end_logit": 0.8615900278091431
        },
        {
            "text": "traploidization, nor their unique truncation products",
            "probability": 0.048927556431052135,
            "start_logit": 0.9855645298957825,
            "end_logit": 0.853800892829895
        },
        {
            "text": "selective conditions-",
            "probability": 0.048886544069427364,
            "start_logit": 0.9769368171691895,
            "end_logit": 0.8615900278091431
        },
        {
            "text": "othesized that the distribution of Y chromosome-",
            "probability": 0.045553827249551156,
            "start_logit": 0.9290637969970703,
            "end_logit": 0.838855504989624
        },
        {
            "text": "conjoint immunoh",
            "probability": 0.0453366078998479,
            "start_logit": 0.8054082989692688,
            "end_logit": 0.9577311873435974
        },
        {
            "text": "containing cells could",
            "probability": 0.04462885007754018,
            "start_logit": 1.0474528074264526,
            "end_logit": 0.6999523639678955
        },
        {
            "text": "assessed for rare instances of donor origin, revealing a Y chromosome in 67.",
            "probability": 0.04450088421005051,
            "start_logit": 0.897083044052124,
            "end_logit": 0.8474506735801697
        },
        {
            "text": "oidization, nor their unique truncation products",
            "probability": 0.04446286419306934,
            "start_logit": 0.8898780941963196,
            "end_logit": 0.853800892829895
        },
        {
            "text": "of hepatocytes by hematopoietic stem cells-a phenomenon which occurs in rodents under highly selective conditions-",
            "probability": 0.04403402685329203,
            "start_logit": 0.8723973035812378,
            "end_logit": 0.8615900278091431
        },
        {
            "text": "containing cells could be predicted by a similar model. After modification to account for",
            "probability": 0.042152806128361996,
            "start_logit": 1.0474528074264526,
            "end_logit": 0.6428731083869934
        },
        {
            "text": "phenomenon which occurs in rodents under highly selective conditions-results from infrequent fusion between incoming myelomonocytes and host he",
            "probability": 0.041802394665743335,
            "start_logit": 1.0034681558609009,
            "end_logit": 0.6785101294517517
        },
        {
            "text": "rodents under highly selective conditions-results from infrequent fusion between incoming myelomonocytes and host he",
            "probability": 0.04081156020463161,
            "start_logit": 0.9794799089431763,
            "end_logit": 0.6785101294517517
        }
    ],
    "5ac09a7b19833b0d7b000001": [
        {
            "text": "conjugated with epithelial cell adhesion molecule (EpCAM) aptamer in EpCAM-",
            "probability": 0.22376256883519127,
            "start_logit": 1.0791854858398438,
            "end_logit": 0.5458966493606567
        },
        {
            "text": "conjugated with epithelial cell adhesion molecule (EpCAM) aptamer",
            "probability": 0.2034677908574083,
            "start_logit": 1.0791854858398438,
            "end_logit": 0.45081883668899536
        },
        {
            "text": "conjugated with epithelial cell",
            "probability": 0.1987815420113188,
            "start_logit": 1.0791854858398438,
            "end_logit": 0.4275175631046295
        },
        {
            "text": "conjugated with epithelial cell adhesion molecule (EpCAM) aptamer in EpCAM-positive cancer cells.",
            "probability": 0.19442283765467885,
            "start_logit": 1.0791854858398438,
            "end_logit": 0.40534648299217224
        },
        {
            "text": "conjugated with epithelial cell adhesion",
            "probability": 0.17956526064140269,
            "start_logit": 1.0791854858398438,
            "end_logit": 0.32584983110427856
        }
    ],
    "5abbe429fcf456587200001c": [
        {
            "text": "ban (Lixiana\u00ae), which are direct anti-",
            "probability": 0.07299740357660964,
            "start_logit": 1.0862412452697754,
            "end_logit": 0.9855239391326904
        },
        {
            "text": "is long-",
            "probability": 0.06911232193519,
            "start_logit": 1.1001818180084229,
            "end_logit": 0.9168925285339355
        },
        {
            "text": "i.e. range 2.0-3.0) as",
            "probability": 0.05767469489630122,
            "start_logit": 0.9981200695037842,
            "end_logit": 0.838039755821228
        },
        {
            "text": "is not routinely required due to their predictable anticoagulant effects. In this chapter, we discuss clinical and laboratory aspects of NOAC. These",
            "probability": 0.055994033087412215,
            "start_logit": 0.8433486819267273,
            "end_logit": 0.9632377624511719
        },
        {
            "text": ". These",
            "probability": 0.05525438119060119,
            "start_logit": 0.8300511837005615,
            "end_logit": 0.9632377624511719
        },
        {
            "text": "agents do not interact with dietary constituents and alcohol, have few reported drug interactions, and monitoring of their anticoagulant intensity is not",
            "probability": 0.052911160132896484,
            "start_logit": 0.9476325511932373,
            "end_logit": 0.802323043346405
        },
        {
            "text": "is not routinely required due to their predictable anticoagulant effects. In this chapter, we",
            "probability": 0.05165831292453393,
            "start_logit": 0.8433486819267273,
            "end_logit": 0.8826437592506409
        },
        {
            "text": "agents have been approved for several therapeutic indications based on phase III prospective randomised controlled clinical trials using",
            "probability": 0.050251988897225416,
            "start_logit": 0.8710967302322388,
            "end_logit": 0.8272947072982788
        },
        {
            "text": ". These agents have been approved for several therapeutic indications based on phase III prospective randomised controlled clinical trials using",
            "probability": 0.048231125970835294,
            "start_logit": 0.8300511837005615,
            "end_logit": 0.8272947072982788
        },
        {
            "text": "is not",
            "probability": 0.04767134167797287,
            "start_logit": 0.8433486819267273,
            "end_logit": 0.802323043346405
        },
        {
            "text": "i.e. range",
            "probability": 0.04692236434499841,
            "start_logit": 0.9981200695037842,
            "end_logit": 0.6317156553268433
        },
        {
            "text": "is long-term anticoagulation with oral vitamin K antagonists (VKA) such as warfarin. However,",
            "probability": 0.04648765486590661,
            "start_logit": 1.1001818180084229,
            "end_logit": 0.5203462839126587
        },
        {
            "text": "is long-term anticoagulation with oral vitamin",
            "probability": 0.04619468574643023,
            "start_logit": 1.1001818180084229,
            "end_logit": 0.5140242576599121
        },
        {
            "text": "i.e. range 2.0-",
            "probability": 0.045740613705658094,
            "start_logit": 0.9981200695037842,
            "end_logit": 0.6062078475952148
        },
        {
            "text": "agents do not interact with dietary constituents and alcohol, have few reported drug interactions, and monitoring of their",
            "probability": 0.04540655266924763,
            "start_logit": 0.9476325511932373,
            "end_logit": 0.6493651866912842
        },
        {
            "text": "\u00ae), a direct thrombin inhibitor, and rivaroxaban (Xarelto",
            "probability": 0.04366055894933479,
            "start_logit": 1.0136784315109253,
            "end_logit": 0.5441080331802368
        },
        {
            "text": "i.e. range 2.0-3.0) as the comparator. However these",
            "probability": 0.0428245506889981,
            "start_logit": 0.9981200695037842,
            "end_logit": 0.5403327941894531
        },
        {
            "text": "these",
            "probability": 0.04255856293526529,
            "start_logit": 0.9918895959854126,
            "end_logit": 0.5403327941894531
        },
        {
            "text": "agents do not interact with dietary constituents and alcohol, have few reported drug interactions, and monitoring of their anticoagulant intensity",
            "probability": 0.04028469223640912,
            "start_logit": 0.9476325511932373,
            "end_logit": 0.5296803116798401
        },
        {
            "text": "bin inhibitor, and rivaroxaban (Xarelto",
            "probability": 0.03816299956817342,
            "start_logit": 0.8790997266769409,
            "end_logit": 0.5441080331802368
        }
    ],
    "5abbfd97fcf456587200001d": [
        {
            "text": "formalin test. We previously showed that swimming stress modulates the pain-related behaviors during the",
            "probability": 0.13317354361810152,
            "start_logit": 0.9366378784179688,
            "end_logit": 0.7786762714385986
        },
        {
            "text": ") of the formalin test. We previously showed that swimming stress modulates the pain-related behaviors during the",
            "probability": 0.13227450506054925,
            "start_logit": 0.9298641085624695,
            "end_logit": 0.7786762714385986
        },
        {
            "text": "formalin test.",
            "probability": 0.12468928374893634,
            "start_logit": 0.9366378784179688,
            "end_logit": 0.7128480672836304
        },
        {
            "text": ") of the formalin test.",
            "probability": 0.12384752140817189,
            "start_logit": 0.9298641085624695,
            "end_logit": 0.7128480672836304
        },
        {
            "text": "formalin test. We previously showed that swimming stress modulates the pain-",
            "probability": 0.11138296138177808,
            "start_logit": 0.9366378784179688,
            "end_logit": 0.5999975204467773
        },
        {
            "text": ") of the formalin test. We previously showed that swimming stress modulates the pain-",
            "probability": 0.11063102842110133,
            "start_logit": 0.9298641085624695,
            "end_logit": 0.5999975204467773
        },
        {
            "text": "formalin test. We previously showed that swimming stress modulates the pain-related behaviors during the interphase of the",
            "probability": 0.08833068027040371,
            "start_logit": 0.9366378784179688,
            "end_logit": 0.36811065673828125
        },
        {
            "text": "formalin test. We previously showed that swimming stress modulates the pain-related behaviors during the interphase of the formalin test. In this",
            "probability": 0.08793610560717098,
            "start_logit": 0.9366378784179688,
            "end_logit": 0.3636336326599121
        },
        {
            "text": ") of the formalin test. We previously showed that swimming stress modulates the pain-related behaviors during the interphase of the",
            "probability": 0.08773437048378689,
            "start_logit": 0.9298641085624695,
            "end_logit": 0.36811065673828125
        }
    ],
    "5ab90a79fcf456587200001b": [
        {
            "text": "oidal anti-",
            "probability": 0.058875552762264284,
            "start_logit": 0.8130927085876465,
            "end_logit": 1.1211700439453125
        },
        {
            "text": "H after anterior cervical spine surgery, and to investigate the risk factors and treatment experience of this serious complication.Neurological deterioration after anterior cervical spine surgery was",
            "probability": 0.05414558988403214,
            "start_logit": 1.078326940536499,
            "end_logit": 0.7721863985061646
        },
        {
            "text": ") preoperatively, but without anticoagulant drugs or pre-spinal surgery. The coagulation function",
            "probability": 0.05372009166219795,
            "start_logit": 1.0299354791641235,
            "end_logit": 0.812688410282135
        },
        {
            "text": "1.8-16.7\u200ahours) from the initial deterioration to evacuation. Five patients underwent emergency evacuation, and one patient underwent conservative treatment. Four patients who underwent",
            "probability": 0.053490914422050506,
            "start_logit": 1.0403796434402466,
            "end_logit": 0.7979689836502075
        },
        {
            "text": "deterioration to evacuation. Five patients underwent emergency evacuation, and one patient underwent conservative treatment. Four patients who underwent",
            "probability": 0.05342515459770938,
            "start_logit": 1.039149522781372,
            "end_logit": 0.7979689836502075
        },
        {
            "text": ". Four patients who underwent",
            "probability": 0.05204479992391868,
            "start_logit": 1.0129727125167847,
            "end_logit": 0.7979689836502075
        },
        {
            "text": "H after anterior cervical spine surgery, and to investigate the risk factors and treatment experience of this serious complication.",
            "probability": 0.050529662050474974,
            "start_logit": 1.078326940536499,
            "end_logit": 0.7030704021453857
        },
        {
            "text": "score) score at the last follow-",
            "probability": 0.04967805632926276,
            "start_logit": 0.9993090629577637,
            "end_logit": 0.765091061592102
        },
        {
            "text": "Five patients underwent emergency evacuation, and one patient underwent conservative treatment. Four patients who underwent",
            "probability": 0.04963743559292797,
            "start_logit": 0.9656131267547607,
            "end_logit": 0.7979689836502075
        },
        {
            "text": "1.8-16.7\u200ahours) from the initial deterioration to evacuation. Five patients",
            "probability": 0.04896570786182448,
            "start_logit": 1.0403796434402466,
            "end_logit": 0.7095773816108704
        },
        {
            "text": "deterioration to evacuation. Five patients",
            "probability": 0.048905511165198076,
            "start_logit": 1.039149522781372,
            "end_logit": 0.7095773816108704
        },
        {
            "text": "H) after anterior cervical spine surgery is very rare, but it has disastrous consequences for the patients. Timely diagnosis and evaluation can effectively reduce the sequel",
            "probability": 0.04837378644376725,
            "start_logit": 1.0975648164749146,
            "end_logit": 0.6402300596237183
        },
        {
            "text": "is very rare, but it has disastrous consequences for the patients. Timely diagnosis and evaluation can effectively reduce the sequel",
            "probability": 0.04804663375306138,
            "start_logit": 1.0907788276672363,
            "end_logit": 0.6402300596237183
        },
        {
            "text": "score at the last follow-",
            "probability": 0.04801805005434674,
            "start_logit": 0.965322732925415,
            "end_logit": 0.765091061592102
        },
        {
            "text": "score) score at the last follow-up. One",
            "probability": 0.047532918749684065,
            "start_logit": 0.9993090629577637,
            "end_logit": 0.7209502458572388
        },
        {
            "text": "1.8-16.7\u200ahours) from the initial deterioration to evacuation. Five patients underwent emergency evacuation,",
            "probability": 0.04752973435895874,
            "start_logit": 1.0403796434402466,
            "end_logit": 0.6798126697540283
        },
        {
            "text": "deterioration to evacuation. Five patients underwent emergency evacuation",
            "probability": 0.0474713029969939,
            "start_logit": 1.039149522781372,
            "end_logit": 0.6798126697540283
        },
        {
            "text": ") preoperatively, but without anticoagulant drugs or pre-spinal surgery. The coagulation function was normal in all",
            "probability": 0.047257278921002406,
            "start_logit": 1.0299354791641235,
            "end_logit": 0.6845080256462097
        },
        {
            "text": "score) score at the",
            "probability": 0.04640722561782453,
            "start_logit": 0.9993090629577637,
            "end_logit": 0.6969829201698303
        },
        {
            "text": "score at the last follow-up. One",
            "probability": 0.04594459285249976,
            "start_logit": 0.965322732925415,
            "end_logit": 0.7209502458572388
        }
    ],
    "5ace1a590340b9f05800000b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5ace2d600340b9f05800000e": [
        {
            "text": "H were classified as damaging by the majority of the",
            "probability": 0.08162198602800051,
            "start_logit": 1.2091386318206787,
            "end_logit": 1.1990892887115479
        },
        {
            "text": "160W and D294H were classified as damaging by the majority of the",
            "probability": 0.07228421649515843,
            "start_logit": 1.0876457691192627,
            "end_logit": 1.1990892887115479
        },
        {
            "text": "I155T, R160W and D294H were classified as damaging by the majority of the",
            "probability": 0.06595600817253956,
            "start_logit": 0.996027946472168,
            "end_logit": 1.1990892887115479
        },
        {
            "text": "H, R151C, I155T, R160W and D294H were classified as damaging by the majority of the",
            "probability": 0.06340785546684724,
            "start_logit": 0.9566277265548706,
            "end_logit": 1.1990892887115479
        },
        {
            "text": "C, I155T, R160W and D294H were classified as damaging by the majority of the",
            "probability": 0.05620099634803793,
            "start_logit": 0.8359744548797607,
            "end_logit": 1.1990892887115479
        },
        {
            "text": "H were classified as damaging by the majority of the tools while the r variants V60L, V92M and R163Q have",
            "probability": 0.05576971955868055,
            "start_logit": 1.2091386318206787,
            "end_logit": 0.8182216882705688
        },
        {
            "text": "significantly correlated with the scores of two consensus programs. All",
            "probability": 0.05140797086838449,
            "start_logit": 1.0109548568725586,
            "end_logit": 0.9349676370620728
        },
        {
            "text": "163Q have",
            "probability": 0.048740683634387764,
            "start_logit": 1.0744216442108154,
            "end_logit": 0.8182216882705688
        },
        {
            "text": "indicated as the most damaging",
            "probability": 0.04775433840773284,
            "start_logit": 0.95415198802948,
            "end_logit": 0.9180471897125244
        },
        {
            "text": "H,",
            "probability": 0.0457566585454588,
            "start_logit": 0.9566277265548706,
            "end_logit": 0.8728388547897339
        },
        {
            "text": "163Q have been predicted as neutral in most of the programs The combination of the",
            "probability": 0.04392503970492055,
            "start_logit": 1.0744216442108154,
            "end_logit": 0.7141921520233154
        },
        {
            "text": "H); C273Y showed to be highly damaging",
            "probability": 0.043510802788234694,
            "start_logit": 1.2015701532363892,
            "end_logit": 0.5775683522224426
        },
        {
            "text": "classification was significantly correlated with the scores of two consensus programs. All",
            "probability": 0.0421067314196421,
            "start_logit": 0.8113692402839661,
            "end_logit": 0.9349676370620728
        },
        {
            "text": "significantly correlated with the scores of two consensus programs. Alleles associated with",
            "probability": 0.0413155588309991,
            "start_logit": 1.0109548568725586,
            "end_logit": 0.7164135575294495
        },
        {
            "text": "160W and D",
            "probability": 0.041192631808586504,
            "start_logit": 1.0876457691192627,
            "end_logit": 0.636742889881134
        },
        {
            "text": "62% were classified as damaging in more than five tools. The classification was significantly correlated with the scores of two consensus programs. All",
            "probability": 0.04110096814918027,
            "start_logit": 0.7871932983398438,
            "end_logit": 0.9349676370620728
        },
        {
            "text": "development of melanoma. Here we used 11",
            "probability": 0.041038550372591645,
            "start_logit": 0.852363646030426,
            "end_logit": 0.8682774901390076
        },
        {
            "text": "I, L206P, T242I, G255R,",
            "probability": 0.040143179742247674,
            "start_logit": 0.8340691328048706,
            "end_logit": 0.8645126819610596
        },
        {
            "text": "damage-",
            "probability": 0.0388099975631328,
            "start_logit": 0.9103635549545288,
            "end_logit": 0.7544435858726501
        },
        {
            "text": "significantly correlated with the scores of two consensus programs.",
            "probability": 0.037956106095236544,
            "start_logit": 1.0109548568725586,
            "end_logit": 0.631604790687561
        }
    ],
    "5aac543bfcf4565872000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5abcf0b0fcf4565872000024": [
        {
            "text": "Human leishmaniasis",
            "probability": 0.08307995216544133,
            "start_logit": 1.1175605058670044,
            "end_logit": 1.0105044841766357
        },
        {
            "text": "i.e., cutaneous leishmaniasis",
            "probability": 0.06386204884192298,
            "start_logit": 1.158813714981079,
            "end_logit": 0.7061731219291687
        },
        {
            "text": "i.e., cutaneous leishmaniasis (CL), mucocutaneous lei",
            "probability": 0.05714541077666625,
            "start_logit": 1.158813714981079,
            "end_logit": 0.5950469374656677
        },
        {
            "text": "aneous leishmaniasis",
            "probability": 0.056378192229927335,
            "start_logit": 1.0341708660125732,
            "end_logit": 0.7061731219291687
        },
        {
            "text": "aneous leishmaniasis (CL), mucocutaneous lei",
            "probability": 0.050448662582057546,
            "start_logit": 1.0341708660125732,
            "end_logit": 0.5950469374656677
        },
        {
            "text": "i.e., cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL),",
            "probability": 0.050133479915901,
            "start_logit": 1.158813714981079,
            "end_logit": 0.46413689851760864
        },
        {
            "text": "i.e., cutaneous lei",
            "probability": 0.04998789501786154,
            "start_logit": 1.158813714981079,
            "end_logit": 0.46122872829437256
        },
        {
            "text": "i.e., cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis",
            "probability": 0.04990978268874146,
            "start_logit": 1.158813714981079,
            "end_logit": 0.45966488122940063
        },
        {
            "text": "Human leishmaniasis which is considered a neglected tropical parasitic disease presents in three main clinical forms (i.e., cutaneous lei",
            "probability": 0.04796769038867787,
            "start_logit": 1.1175605058670044,
            "end_logit": 0.46122872829437256
        },
        {
            "text": "i.e., cutaneous leishmaniasis (CL",
            "probability": 0.04689313484799262,
            "start_logit": 1.158813714981079,
            "end_logit": 0.39731913805007935
        },
        {
            "text": "Human lei",
            "probability": 0.04608286639326045,
            "start_logit": 1.1175605058670044,
            "end_logit": 0.4211422801017761
        },
        {
            "text": "aneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral lei",
            "probability": 0.045918965907286426,
            "start_logit": 1.0341708660125732,
            "end_logit": 0.5009689331054688
        },
        {
            "text": "Human leishmania",
            "probability": 0.04546470436934498,
            "start_logit": 1.1175605058670044,
            "end_logit": 0.407637357711792
        },
        {
            "text": "aneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis",
            "probability": 0.044305325994309794,
            "start_logit": 1.0341708660125732,
            "end_logit": 0.46519559621810913
        },
        {
            "text": "aneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL),",
            "probability": 0.044258444868408645,
            "start_logit": 1.0341708660125732,
            "end_logit": 0.46413689851760864
        },
        {
            "text": "aneous lei",
            "probability": 0.044129920752501245,
            "start_logit": 1.0341708660125732,
            "end_logit": 0.46122872829437256
        },
        {
            "text": "aneous leishmaniasis (CL), mucocutaneous leishmaniasis",
            "probability": 0.0440609622397927,
            "start_logit": 1.0341708660125732,
            "end_logit": 0.45966488122940063
        },
        {
            "text": "i.",
            "probability": 0.04375551112045049,
            "start_logit": 1.158813714981079,
            "end_logit": 0.328065425157547
        },
        {
            "text": "aneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmania",
            "probability": 0.04322848105180396,
            "start_logit": 1.0341708660125732,
            "end_logit": 0.4405902624130249
        },
        {
            "text": "i.e.,",
            "probability": 0.042988567847651246,
            "start_logit": 1.158813714981079,
            "end_logit": 0.31038206815719604
        }
    ],
    "5a74eaa50384be955100000b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5ace12be0340b9f058000007": [
        {
            "text": ". The value of this approach is illustrated by FOXP2, a transcription factor gene that was implicated in speech apraxia, and subsequently investigated",
            "probability": 0.11599726393344678,
            "start_logit": 0.8684394955635071,
            "end_logit": 0.5943553447723389
        },
        {
            "text": "enable",
            "probability": 0.10997848550946104,
            "start_logit": 1.031581163406372,
            "end_logit": 0.3779318332672119
        },
        {
            "text": "for other neurodevelopmental syndromes, gene-driven studies show",
            "probability": 0.10185163206667082,
            "start_logit": 0.9640989303588867,
            "end_logit": 0.3686464726924896
        },
        {
            "text": "other neurodevelopmental syndromes, gene-driven studies show",
            "probability": 0.1018316306448474,
            "start_logit": 0.9639025330543518,
            "end_logit": 0.3686464726924896
        },
        {
            "text": "for other neurodevelopmental syndromes, gene-",
            "probability": 0.09781107721211543,
            "start_logit": 0.9640989303588867,
            "end_logit": 0.3281671404838562
        },
        {
            "text": "other neurodevelopmental syndromes, gene-",
            "probability": 0.09779186926645343,
            "start_logit": 0.9639025330543518,
            "end_logit": 0.3281671404838562
        },
        {
            "text": "of key human capacities. The value of this",
            "probability": 0.09738944226244058,
            "start_logit": 0.8754793405532837,
            "end_logit": 0.41246670484542847
        },
        {
            "text": ". The value of this",
            "probability": 0.09670624331419478,
            "start_logit": 0.8684394955635071,
            "end_logit": 0.41246670484542847
        },
        {
            "text": "of key human capacities. The value of this approach is illustrated by FOXP2, a transcription factor gene that was implicated",
            "probability": 0.09063910012802064,
            "start_logit": 0.8754793405532837,
            "end_logit": 0.3406345844268799
        },
        {
            "text": ". The value of this approach is illustrated by FOXP2, a transcription factor gene that was implicated",
            "probability": 0.09000325566234911,
            "start_logit": 0.8684394955635071,
            "end_logit": 0.3406345844268799
        }
    ],
    "5be48c39133db5eb7800001d": [
        {
            "text": "state-of-",
            "probability": 0.12421827828329256,
            "start_logit": 0.8217598795890808,
            "end_logit": 1.1163947582244873
        },
        {
            "text": "izumab in mismatch repair (MMR) deficient tumors. Despite the significant recent achievements in the",
            "probability": 0.09488650122924909,
            "start_logit": 0.8518558144569397,
            "end_logit": 0.8169399499893188
        },
        {
            "text": "ry, microsatellite instability, and tumor mutation",
            "probability": 0.09033915541687737,
            "start_logit": 0.8671014904975891,
            "end_logit": 0.7525838017463684
        },
        {
            "text": "izumab in mismatch repair (MMR) deficient tumors. Despite the",
            "probability": 0.0872640046565818,
            "start_logit": 0.8518558144569397,
            "end_logit": 0.7331965565681458
        },
        {
            "text": "state-of-knowledge of MMR alterations in syndromic and sporadic tumors and discuss the available armamentarium for MMR patholo",
            "probability": 0.08023751043923656,
            "start_logit": 0.8217598795890808,
            "end_logit": 0.6793455481529236
        },
        {
            "text": "izumab in mismatch repair (MMR",
            "probability": 0.07933718579036941,
            "start_logit": 0.8518558144569397,
            "end_logit": 0.6379654407501221
        },
        {
            "text": "state-of-knowledge of MMR alterations in syndromic and sporadic tumors and discuss the available armamentarium for MM",
            "probability": 0.07780348189556739,
            "start_logit": 0.8217598795890808,
            "end_logit": 0.6485406160354614
        },
        {
            "text": "state-of-knowledge of MMR alterations in syndromic and sporadic tumors and discuss the",
            "probability": 0.07690819156350324,
            "start_logit": 0.8217598795890808,
            "end_logit": 0.6369668245315552
        },
        {
            "text": "subclasses of cancers based on the MMR status remains a major challenge. Many investigations have",
            "probability": 0.07640238102387921,
            "start_logit": 0.8173288106918335,
            "end_logit": 0.6347993612289429
        },
        {
            "text": "state-of-knowledge of MMR alterations in syndromic and sporadic tumors and discuss",
            "probability": 0.07252082803426362,
            "start_logit": 0.8217598795890808,
            "end_logit": 0.578228235244751
        },
        {
            "text": "subclasses of cancers based on the MMR status remains a major challenge. Many investigations have assessed the role of different diagnostic tools, including immun",
            "probability": 0.0704427712653884,
            "start_logit": 0.8173288106918335,
            "end_logit": 0.5535861253738403
        },
        {
            "text": "state-",
            "probability": 0.06963971040179134,
            "start_logit": 0.8217598795890808,
            "end_logit": 0.5376893877983093
        }
    ],
    "5c5f56501a4c55d80b00002a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c65b7657c78d6947100000c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5acf74460340b9f058000013": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5be44ed3133db5eb78000016": [
        {
            "text": "accepted that breast milk is home to its own unique microbiome. The origins of bacteria in breast milk have",
            "probability": 0.06981250730913222,
            "start_logit": 1.0183606147766113,
            "end_logit": 0.8371926546096802
        },
        {
            "text": ".",
            "probability": 0.06875177376434882,
            "start_logit": 1.0035576820373535,
            "end_logit": 0.8366849422454834
        },
        {
            "text": "bioactive health factors. Breast feeding",
            "probability": 0.06842422256963421,
            "start_logit": 1.0137426853179932,
            "end_logit": 0.8217242956161499
        },
        {
            "text": ". Human milk derived strains can be regarded as potential probiotics; therefore, many studies have focused on isolating strains from",
            "probability": 0.06820992888233343,
            "start_logit": 1.0035576820373535,
            "end_logit": 0.8287725448608398
        },
        {
            "text": "is home to its own unique microbiome. The origins of bacteria in breast milk have",
            "probability": 0.060690111126927945,
            "start_logit": 0.8783282041549683,
            "end_logit": 0.8371926546096802
        },
        {
            "text": "accepted that breast milk is home to its own unique microbiome. The origins of bacteria",
            "probability": 0.05833079394138171,
            "start_logit": 1.0183606147766113,
            "end_logit": 0.6575096249580383
        },
        {
            "text": "bioactive health factors. Breast feeding is associated with improved infant health and immune development, less incidences of gastrointestinal disease and lower mortality",
            "probability": 0.05746055742104666,
            "start_logit": 1.0137426853179932,
            "end_logit": 0.6470961570739746
        },
        {
            "text": "accepted that breast milk is home to its own unique microbiome. The",
            "probability": 0.057409336669002116,
            "start_logit": 1.0183606147766113,
            "end_logit": 0.641586422920227
        },
        {
            "text": "is a source of commensal bacteria which further enhance infant health by preventing pathogen adhesion and promoting gut",
            "probability": 0.05373807223385151,
            "start_logit": 0.862091600894928,
            "end_logit": 0.7317702174186707
        },
        {
            "text": "is a source of commensal bacteria which further enhance infant health by preventing pathogen adhesion and promoting gut colon",
            "probability": 0.05102442767755117,
            "start_logit": 0.862091600894928,
            "end_logit": 0.6799529790878296
        },
        {
            "text": "accepted that breast milk is home",
            "probability": 0.0507305365032672,
            "start_logit": 1.0183606147766113,
            "end_logit": 0.5179075002670288
        },
        {
            "text": "is home to its own unique microbiome. The origins of bacteria",
            "probability": 0.05070871256276034,
            "start_logit": 0.8783282041549683,
            "end_logit": 0.6575096249580383
        },
        {
            "text": "milk is a source of commensal bacteria which further enhance infant health by preventing pathogen adhesion and promoting gut",
            "probability": 0.05067793195780184,
            "start_logit": 0.803460419178009,
            "end_logit": 0.7317702174186707
        },
        {
            "text": "is home to its own unique microbiome. The",
            "probability": 0.04990766205741461,
            "start_logit": 0.8783282041549683,
            "end_logit": 0.641586422920227
        },
        {
            "text": "of beneficial microbes. While breast milk was",
            "probability": 0.04896485137402395,
            "start_logit": 0.9638965129852295,
            "end_logit": 0.5369462966918945
        },
        {
            "text": "milk is a source of commensal bacteria which further enhance infant health by preventing pathogen adhesion and promoting gut colon",
            "probability": 0.04811881719120964,
            "start_logit": 0.803460419178009,
            "end_logit": 0.6799529790878296
        },
        {
            "text": "is home",
            "probability": 0.044101580312518235,
            "start_logit": 0.8783282041549683,
            "end_logit": 0.5179075002670288
        },
        {
            "text": "formula fed infants. As well as providing fundamental nutrients",
            "probability": 0.042938176445794514,
            "start_logit": 0.8173561096191406,
            "end_logit": 0.5521453022956848
        }
    ],
    "5ad83cd6133db5eb78000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c58474786df2b9174000001": [
        {
            "text": "< 0.02) as well as between angular standard deviation and RNASeq cluster",
            "probability": 0.061577890378762726,
            "start_logit": 0.9855042099952698,
            "end_logit": 0.9202659726142883
        },
        {
            "text": "p < 0.005). In addition, we identified associations between bounding ellipsoid",
            "probability": 0.06011126582018887,
            "start_logit": 0.9934816360473633,
            "end_logit": 0.8881829380989075
        },
        {
            "text": "Recent analysis identified distinct genomic subtypes of lower-",
            "probability": 0.05855560260795457,
            "start_logit": 0.9733681678771973,
            "end_logit": 0.8820759057998657
        },
        {
            "text": ".005 were considered statistically significant. We found the strongest association between RNA",
            "probability": 0.05725762599768326,
            "start_logit": 0.89777672290802,
            "end_logit": 0.9352514147758484
        },
        {
            "text": "subtypes of lower-",
            "probability": 0.05685451643450642,
            "start_logit": 0.9438870549201965,
            "end_logit": 0.8820759057998657
        },
        {
            "text": "operative imaging and genomic data of 110 patients from 5 institutions with lower-",
            "probability": 0.056538740999202614,
            "start_logit": 0.8639910221099854,
            "end_logit": 0.9564023613929749
        },
        {
            "text": "p < 0.005). In addition, we identified associations between bounding ellipsoid volume ratio and all",
            "probability": 0.05565453560111415,
            "start_logit": 0.9934816360473633,
            "end_logit": 0.8111492395401001
        },
        {
            "text": ".02) as well as between angular standard deviation and RNASeq cluster",
            "probability": 0.05559715985953523,
            "start_logit": 0.8833334445953369,
            "end_logit": 0.9202659726142883
        },
        {
            "text": "of lower-",
            "probability": 0.0547198906239825,
            "start_logit": 0.9056186676025391,
            "end_logit": 0.8820759057998657
        },
        {
            "text": ".005 were considered statistically significant. We",
            "probability": 0.05260393538495881,
            "start_logit": 0.89777672290802,
            "end_logit": 0.8504815101623535
        },
        {
            "text": "tumor genomic subtypes. We used preoperative imaging and genomic data of 110 patients from 5 institutions with lower-",
            "probability": 0.051574708055522174,
            "start_logit": 0.7720963358879089,
            "end_logit": 0.9564023613929749
        },
        {
            "text": "we applied a Bonferroni correction. P-values lower than 0.005 were considered statistically significant. We",
            "probability": 0.051457098478943177,
            "start_logit": 0.8757342100143433,
            "end_logit": 0.8504815101623535
        },
        {
            "text": "liomas from The Cancer Genome Atlas. Based on automatic deep learning segmentations, we extracted three features which quantify two-dimensional and three-",
            "probability": 0.04493887012078351,
            "start_logit": 0.9048506021499634,
            "end_logit": 0.6859198212623596
        },
        {
            "text": "p < 0.005). In addition, we identified associations between bounding ellipsoid volume ratio and all tested",
            "probability": 0.04452721541407428,
            "start_logit": 0.9934816360473633,
            "end_logit": 0.5880862474441528
        },
        {
            "text": ".005 were considered statistical",
            "probability": 0.0405654181777896,
            "start_logit": 0.89777672290802,
            "end_logit": 0.5906065106391907
        },
        {
            "text": "p < 0.005). In addition, we identified associations between bounding ellipsoid volume ratio and all tested molecular sub",
            "probability": 0.039823107968738995,
            "start_logit": 0.9934816360473633,
            "end_logit": 0.47643300890922546
        },
        {
            "text": "we applied a Bonferroni correction. P-values lower than 0.005 were considered statistical",
            "probability": 0.03968103722161595,
            "start_logit": 0.8757342100143433,
            "end_logit": 0.5906065106391907
        },
        {
            "text": "between the imaging features and genomic clusters, we",
            "probability": 0.03945858225322609,
            "start_logit": 0.862635612487793,
            "end_logit": 0.5980832576751709
        },
        {
            "text": "we applied a Bonferroni correction. P-",
            "probability": 0.0393445430857914,
            "start_logit": 0.8757342100143433,
            "end_logit": 0.5820903778076172
        },
        {
            "text": "< 0.02) as well as between angular standard deviation and RNA",
            "probability": 0.0391582555156256,
            "start_logit": 0.9855042099952698,
            "end_logit": 0.4675743579864502
        }
    ],
    "5be47fcb133db5eb7800001a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c5f094c1a4c55d80b00000c": [
        {
            "text": "-",
            "probability": 0.12932882993424052,
            "start_logit": 0.8888479471206665,
            "end_logit": 0.9845438003540039
        },
        {
            "text": "of cellular organisation, the formation of membrane-",
            "probability": 0.11283298476339318,
            "start_logit": 0.9764834046363831,
            "end_logit": 0.7604588270187378
        },
        {
            "text": ". In addition, a new level of compartmentalisation has recently emerged",
            "probability": 0.10780217875374351,
            "start_logit": 0.8646083474159241,
            "end_logit": 0.826723039150238
        },
        {
            "text": "of cellular organisation, the formation of membrane-less organelles. Many of these structures are dynamic,",
            "probability": 0.10358294692655934,
            "start_logit": 0.9764834046363831,
            "end_logit": 0.6749228239059448
        },
        {
            "text": "components is facilitated by a complex network of membrane bound organelles. Both the membrane composition and the",
            "probability": 0.10328278792031145,
            "start_logit": 0.8893564939498901,
            "end_logit": 0.7591477632522583
        },
        {
            "text": ". In addition, a new level of compartmentalisation has recently emerged as a fundamental principle of cellular organisation, the formation of membrane-",
            "probability": 0.10089028680974857,
            "start_logit": 0.8646083474159241,
            "end_logit": 0.7604588270187378
        },
        {
            "text": "of cellular organisation, the formation of membrane-less organelles. Many of these",
            "probability": 0.09250895419997578,
            "start_logit": 0.9764834046363831,
            "end_logit": 0.5618555545806885
        },
        {
            "text": "-less organelles focusing particularly on",
            "probability": 0.08686076996581873,
            "start_logit": 0.8888479471206665,
            "end_logit": 0.5864920616149902
        },
        {
            "text": "-less organelles focusing particularly on their",
            "probability": 0.08433789414911744,
            "start_logit": 0.8888479471206665,
            "end_logit": 0.5570168495178223
        },
        {
            "text": ". In addition, a new level of compartmentalisation has",
            "probability": 0.07857236657709148,
            "start_logit": 0.8646083474159241,
            "end_logit": 0.510445237159729
        }
    ],
    "5c2f669e133db5eb78000031": [
        {
            "text": "evolutionary rates (Ka) and show relaxed selection (Ka/Ks) compared to single copy genes. Both features are time-",
            "probability": 0.06759364061875335,
            "start_logit": 1.0625920295715332,
            "end_logit": 0.9875954389572144
        },
        {
            "text": "ecific strains, we",
            "probability": 0.06601885527014431,
            "start_logit": 1.1456916332244873,
            "end_logit": 0.8809223175048828
        },
        {
            "text": "ecific strains, we find greater",
            "probability": 0.06006911847647065,
            "start_logit": 1.1456916332244873,
            "end_logit": 0.78647780418396
        },
        {
            "text": "-",
            "probability": 0.05817011367437686,
            "start_logit": 0.912449836730957,
            "end_logit": 0.9875954389572144
        },
        {
            "text": "show relaxed selection (Ka/Ks) compared to single copy genes. Both features are time-",
            "probability": 0.05700840758738866,
            "start_logit": 0.8922768831253052,
            "end_logit": 0.9875954389572144
        },
        {
            "text": "hytic symbioses with their host grasses. Retained duplicates within this genus have two independent origins, but both long pre-",
            "probability": 0.05452788574263882,
            "start_logit": 1.1314606666564941,
            "end_logit": 0.7039251327514648
        },
        {
            "text": "ecific",
            "probability": 0.052844162835864295,
            "start_logit": 1.1456916332244873,
            "end_logit": 0.6583291888237
        },
        {
            "text": "-dependent. Through comparison of conspecific strains, we",
            "probability": 0.052284428402233435,
            "start_logit": 0.912449836730957,
            "end_logit": 0.8809223175048828
        },
        {
            "text": "suggest that cis-regulatory changes make important contributions to the expression patterns of retained duplicates. Coupled with supporting observations from the",
            "probability": 0.050090710878018085,
            "start_logit": 0.874712347984314,
            "end_logit": 0.8757967948913574
        },
        {
            "text": "-dependent. Through comparison of conspecific strains, we find greater",
            "probability": 0.047572462614155875,
            "start_logit": 0.912449836730957,
            "end_logit": 0.78647780418396
        },
        {
            "text": "common drivers behind the",
            "probability": 0.047327988892120955,
            "start_logit": 0.9058095812797546,
            "end_logit": 0.7879658341407776
        },
        {
            "text": "of genetic material from which new functions arise. Most duplicated genes revert to single copy genes and only a small proportion are retained",
            "probability": 0.04539457513899078,
            "start_logit": 0.9427986741065979,
            "end_logit": 0.7092674970626831
        },
        {
            "text": "arise. Most duplicated genes revert to single copy genes and only a small proportion are retained. However, it remains unclear why",
            "probability": 0.045026282785433115,
            "start_logit": 0.933777928352356,
            "end_logit": 0.7101420164108276
        },
        {
            "text": "arise. Most duplicated genes revert to single copy genes and only a small proportion are retained",
            "probability": 0.044986923642636616,
            "start_logit": 0.933777928352356,
            "end_logit": 0.7092674970626831
        },
        {
            "text": "of genetic material from which new functions arise. Most duplicate",
            "probability": 0.04426596961806939,
            "start_logit": 0.9427986741065979,
            "end_logit": 0.6840910911560059
        },
        {
            "text": "arise. Most duplicate",
            "probability": 0.043868453203451056,
            "start_logit": 0.933777928352356,
            "end_logit": 0.6840910911560059
        },
        {
            "text": "-dependent. Through comparison of conspecific",
            "probability": 0.041850571885289706,
            "start_logit": 0.912449836730957,
            "end_logit": 0.6583291888237
        },
        {
            "text": "show relaxed selection (Ka/Ks) compared to single copy genes. Both features are time-dependent. Through comparison of conspecific",
            "probability": 0.04101478077139862,
            "start_logit": 0.8922768831253052,
            "end_logit": 0.6583291888237
        },
        {
            "text": "suggest that cis-regulatory changes make important contributions to the expression patterns of retained duplicates. Coupled with supporting observations from the model",
            "probability": 0.04010757222990613,
            "start_logit": 0.874712347984314,
            "end_logit": 0.6535263657569885
        },
        {
            "text": "of genetic material from which new functions arise. Most",
            "probability": 0.039977095732659375,
            "start_logit": 0.9427986741065979,
            "end_logit": 0.5821815729141235
        }
    ],
    "5c58962286df2b9174000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c59872b86df2b9174000017": [
        {
            "text": "repetitive scores based on k-mer counting for repeat detection. However, we noticed that these tools can still be improved in terms of repetitive score calculation",
            "probability": 0.12677235039699555,
            "start_logit": 0.8556264638900757,
            "end_logit": 0.831317663192749
        },
        {
            "text": "named Repeat Locat",
            "probability": 0.10116410718018073,
            "start_logit": 0.8830879330635071,
            "end_logit": 0.57820725440979
        },
        {
            "text": "regulation. A large number of approaches have been proposed to identify various repeats in the genome. Some de novo repeat identification tools can efficiently",
            "probability": 0.1009676105616692,
            "start_logit": 1.0027422904968262,
            "end_logit": 0.4566086530685425
        },
        {
            "text": "genome evolution",
            "probability": 0.10091358213802722,
            "start_logit": 0.97200608253479,
            "end_logit": 0.4868096113204956
        },
        {
            "text": ":/",
            "probability": 0.09916876901526926,
            "start_logit": 0.8602501153945923,
            "end_logit": 0.5811241865158081
        },
        {
            "text": "named Repeat Locator (RepLo",
            "probability": 0.09914693057356896,
            "start_logit": 0.8830879330635071,
            "end_logit": 0.5580661296844482
        },
        {
            "text": "genome evolution and regulation. A large number of approaches have been proposed to identify various repeats in the genome. Some de novo repeat identification tools can efficiently",
            "probability": 0.09791145696781929,
            "start_logit": 0.97200608253479,
            "end_logit": 0.4566086530685425
        },
        {
            "text": "named Repeat Locator (RepLoc), which is based on",
            "probability": 0.09520047151461658,
            "start_logit": 0.8830879330635071,
            "end_logit": 0.5174481272697449
        },
        {
            "text": "repetitive scores based on k-mer counting for repeat detection. However, we noticed",
            "probability": 0.09058077709442933,
            "start_logit": 0.8556264638900757,
            "end_logit": 0.49516671895980835
        },
        {
            "text": "vital role in genome evolution",
            "probability": 0.08817394455742393,
            "start_logit": 0.8370530605316162,
            "end_logit": 0.4868096113204956
        }
    ],
    "5be48987133db5eb7800001c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c307474133db5eb78000033": [
        {
            "text": "mRNA within the insulated neighborhoods without significantly affecting the",
            "probability": 0.09401973399331745,
            "start_logit": 0.9363065361976624,
            "end_logit": 1.1360859870910645
        },
        {
            "text": "without significantly affecting the",
            "probability": 0.09122027755854424,
            "start_logit": 0.9060790538787842,
            "end_logit": 1.1360859870910645
        },
        {
            "text": "these loops. Here, we",
            "probability": 0.08253093887238169,
            "start_logit": 1.0504825115203857,
            "end_logit": 0.8915785551071167
        },
        {
            "text": "these loops",
            "probability": 0.06860975071009345,
            "start_logit": 1.0504825115203857,
            "end_logit": 0.7068399786949158
        },
        {
            "text": "), which binds the Mediator co-activator complex, to impair enhancers",
            "probability": 0.06685448453879231,
            "start_logit": 0.8757452964782715,
            "end_logit": 0.8556609153747559
        },
        {
            "text": "ulated neighborhoods without causing mESC differentiation. Esrrb depletion reduces Mediator binding, promoter-enhancer looping",
            "probability": 0.06659395871417868,
            "start_logit": 0.9585503935813904,
            "end_logit": 0.7689512968063354
        },
        {
            "text": ") and then into",
            "probability": 0.0592471837582996,
            "start_logit": 0.9356411695480347,
            "end_logit": 0.6749649047851562
        },
        {
            "text": "ulated neighborhoods without causing mESC differentiation. Esrr",
            "probability": 0.05604604432482662,
            "start_logit": 0.9585503935813904,
            "end_logit": 0.5965110063552856
        },
        {
            "text": "ulated",
            "probability": 0.05412425622590322,
            "start_logit": 0.9585503935813904,
            "end_logit": 0.5616198778152466
        },
        {
            "text": ") and then into smaller sub-domains. One class of sub-",
            "probability": 0.05349683027864451,
            "start_logit": 0.9356411695480347,
            "end_logit": 0.572869062423706
        },
        {
            "text": "mRNA within the insulated neighborhoods without significantly",
            "probability": 0.053402398663146895,
            "start_logit": 0.9363065361976624,
            "end_logit": 0.570436954498291
        },
        {
            "text": "), which binds the Mediator co-activator complex, to impair",
            "probability": 0.05276699280578791,
            "start_logit": 0.8757452964782715,
            "end_logit": 0.6190283894538879
        },
        {
            "text": "ulated neighborhoods without causing mESC differentiation. Esrrb depletion reduces Mediator binding, promoter-",
            "probability": 0.0525356936611922,
            "start_logit": 0.9585503935813904,
            "end_logit": 0.5318302512168884
        },
        {
            "text": "without significantly",
            "probability": 0.05181233153340478,
            "start_logit": 0.9060790538787842,
            "end_logit": 0.570436954498291
        },
        {
            "text": "), which binds the Mediator co-activator complex, to impair enhancers of genes within 222 insulated",
            "probability": 0.04982303101676684,
            "start_logit": 0.8757452964782715,
            "end_logit": 0.5616198778152466
        },
        {
            "text": "sub-domains. One class of sub-",
            "probability": 0.04691609334471973,
            "start_logit": 0.8043795228004456,
            "end_logit": 0.572869062423706
        }
    ],
    "5c632542e842deac6700000d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c58b99586df2b9174000012": [
        {
            "text": "is always room for novel therapeutic approaches. We review new and potential treatments for NMSC",
            "probability": 0.07404116006625218,
            "start_logit": 1.1409245729446411,
            "end_logit": 0.9607406258583069
        },
        {
            "text": ") inhibitors such as vismodegib offered a promising alternative to patients with advanced disease.",
            "probability": 0.06347560650134891,
            "start_logit": 0.9101454615592957,
            "end_logit": 1.0375542640686035
        },
        {
            "text": "is always room for novel therapeutic approaches. We review new and potential treatments for NMSCs since",
            "probability": 0.06267339309277302,
            "start_logit": 1.1409245729446411,
            "end_logit": 0.7940564751625061
        },
        {
            "text": ". The development of oral hedgehog (Hh) inhibitors such as vismodegib offered a promising alternative to patients with advanced disease.",
            "probability": 0.06075505338847658,
            "start_logit": 0.8663400411605835,
            "end_logit": 1.0375542640686035
        },
        {
            "text": ". We review new and potential treatments for NMSC",
            "probability": 0.05843985855340252,
            "start_logit": 0.9043015837669373,
            "end_logit": 0.9607406258583069
        },
        {
            "text": "specific indications and side effects, thus there is always room for novel therapeutic approaches. We review new and potential treatments for NMSC",
            "probability": 0.05802667909584624,
            "start_logit": 0.8972063064575195,
            "end_logit": 0.9607406258583069
        },
        {
            "text": "), combination RT with vismodegib, PD",
            "probability": 0.05632958890551666,
            "start_logit": 0.9022300243377686,
            "end_logit": 0.9260339736938477
        },
        {
            "text": ". We review new and potential treatments for NMSCs since",
            "probability": 0.04946740737349505,
            "start_logit": 0.9043015837669373,
            "end_logit": 0.7940564751625061
        },
        {
            "text": "specific indications and side effects, thus there is always room for novel therapeutic approaches. We review new and potential treatments for NMSCs since",
            "probability": 0.04911766462853923,
            "start_logit": 0.8972063064575195,
            "end_logit": 0.7940564751625061
        },
        {
            "text": "time,",
            "probability": 0.04818687976789346,
            "start_logit": 1.0460686683654785,
            "end_logit": 0.6260621547698975
        },
        {
            "text": ") inhibitors such as vismodegib offered a promising alternative to patients with advanced disease. Each treatment has its",
            "probability": 0.045362218125569315,
            "start_logit": 0.9101454615592957,
            "end_logit": 0.7015781402587891
        },
        {
            "text": "electrodesiccation and curettage, or more definitive surgical options. Over time,",
            "probability": 0.04483928832991708,
            "start_logit": 0.9740666151046753,
            "end_logit": 0.6260621547698975
        },
        {
            "text": ". We review new and potential treatments for NMSCs since 2018 including topical sonidegib, cemiplimab, taladegi",
            "probability": 0.04262945353941981,
            "start_logit": 0.9043015837669373,
            "end_logit": 0.6452878713607788
        },
        {
            "text": "such as 5-fluorouracil, imiquimod, ingenol me",
            "probability": 0.04223744328609839,
            "start_logit": 1.0710279941558838,
            "end_logit": 0.46932315826416016
        },
        {
            "text": "electrodesiccation and curettage, or more definitive surgical options. Over",
            "probability": 0.042111401875277746,
            "start_logit": 0.9740666151046753,
            "end_logit": 0.5632959604263306
        },
        {
            "text": "such as 5-",
            "probability": 0.041990812054427576,
            "start_logit": 1.0710279941558838,
            "end_logit": 0.4634668827056885
        },
        {
            "text": "time, topical agents such as 5-fluorouracil, imiquimod, ingenol me",
            "probability": 0.041196272687419204,
            "start_logit": 1.0460686683654785,
            "end_logit": 0.46932315826416016
        },
        {
            "text": "time, topical agents such as 5-",
            "probability": 0.040955721018504886,
            "start_logit": 1.0460686683654785,
            "end_logit": 0.4634668827056885
        },
        {
            "text": "), combination RT with vis",
            "probability": 0.040053612192725574,
            "start_logit": 0.9022300243377686,
            "end_logit": 0.5850328803062439
        },
        {
            "text": "electrodesiccation and curettage, or more definitive surgical options. Over time, topical agents such as 5-",
            "probability": 0.03811048551709674,
            "start_logit": 0.9740666151046753,
            "end_logit": 0.4634668827056885
        }
    ],
    "5be494a0133db5eb7800001f": [
        {
            "text": "P or antQ (IQ- or IP-form, respectively). We",
            "probability": 0.054839485448759384,
            "start_logit": 0.8321631550788879,
            "end_logit": 0.9648485779762268
        },
        {
            "text": "I-form BGCs. Finally, our findings suggest that the ancestral antimycin producer harboured an L",
            "probability": 0.05425132065453696,
            "start_logit": 0.907994270324707,
            "end_logit": 0.878234326839447
        },
        {
            "text": "ia are ubiquitous in diverse environments",
            "probability": 0.053889592502408455,
            "start_logit": 1.0114901065826416,
            "end_logit": 0.7680485248565674
        },
        {
            "text": "e and a phosphopantetheinyl transferase (PPTase), respectively. The majority of BGC",
            "probability": 0.05287653504863897,
            "start_logit": 0.8117523789405823,
            "end_logit": 0.9488085508346558
        },
        {
            "text": "P or antQ (IQ- or IP-",
            "probability": 0.05261207866934822,
            "start_logit": 0.8321631550788879,
            "end_logit": 0.9233838319778442
        },
        {
            "text": "geographical distribution and phylogenetic relationships of antimycin producers and BGC",
            "probability": 0.05258681232461562,
            "start_logit": 0.8536014556884766,
            "end_logit": 0.9014651775360107
        },
        {
            "text": "cteria and classify them based on the presence or absence of cluster-situated genes antP and antQ, which encode",
            "probability": 0.052418197636731,
            "start_logit": 0.7919899821281433,
            "end_logit": 0.9598650932312012
        },
        {
            "text": "IQ- or IP-form, respectively). We",
            "probability": 0.05196195310628774,
            "start_logit": 0.7782644629478455,
            "end_logit": 0.9648485779762268
        },
        {
            "text": "I-form BGCs. Finally, our findings suggest that the ancestral antimycin",
            "probability": 0.05106575001614069,
            "start_logit": 0.907994270324707,
            "end_logit": 0.8177210092544556
        },
        {
            "text": "or antQ (IQ- or IP-form, respectively). We",
            "probability": 0.050297862305423234,
            "start_logit": 0.7457152605056763,
            "end_logit": 0.9648485779762268
        },
        {
            "text": "IQ- or IP-",
            "probability": 0.04985142260671668,
            "start_logit": 0.7782644629478455,
            "end_logit": 0.9233838319778442
        },
        {
            "text": "or antQ (IQ- or IP-",
            "probability": 0.04825492192091379,
            "start_logit": 0.7457152605056763,
            "end_logit": 0.9233838319778442
        },
        {
            "text": "shown to inhibit Bcl-",
            "probability": 0.047880520709403296,
            "start_logit": 0.7285344004631042,
            "end_logit": 0.932775616645813
        },
        {
            "text": "P or antQ (IQ-",
            "probability": 0.04728287361588431,
            "start_logit": 0.8321631550788879,
            "end_logit": 0.8165862560272217
        },
        {
            "text": "clusters. Antimycin is an inhibitor of mitochondrial cytochrome c reductase and more recently was shown to inhibit Bcl-",
            "probability": 0.04728030059727278,
            "start_logit": 0.7159193754196167,
            "end_logit": 0.932775616645813
        },
        {
            "text": "Streptomyces species and other Actinobacteria are ubiquitous in diverse environments",
            "probability": 0.047256735669844965,
            "start_logit": 0.8801479339599609,
            "end_logit": 0.7680485248565674
        },
        {
            "text": "IQ- and IP-",
            "probability": 0.04698620642204785,
            "start_logit": 0.9169797897338867,
            "end_logit": 0.725475549697876
        },
        {
            "text": "geographical distribution and phylogenetic relationships of antimycin",
            "probability": 0.04640289173542346,
            "start_logit": 0.8536014556884766,
            "end_logit": 0.7763615846633911
        },
        {
            "text": "geographical distribution and phylogenetic relationships of antimycin producers and BGCs. We show that antimycin",
            "probability": 0.04619251717588912,
            "start_logit": 0.8536014556884766,
            "end_logit": 0.7718176245689392
        },
        {
            "text": "IP-",
            "probability": 0.045812021833713495,
            "start_logit": 0.8916722536087036,
            "end_logit": 0.725475549697876
        }
    ],
    "5c34ac49da8336e21a000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c532ad97e3cb0e23100001a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c011057133db5eb78000025": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c0112dd133db5eb78000026": [
        {
            "text": "time profiles could be described by one-",
            "probability": 0.0692284650332853,
            "start_logit": 0.9683537483215332,
            "end_logit": 1.05280339717865
        },
        {
            "text": "additional meta",
            "probability": 0.06633101538822099,
            "start_logit": 1.163281798362732,
            "end_logit": 0.8151208162307739
        },
        {
            "text": "M1. Once allometrically scaled to humans with a fixed exponent of 0.",
            "probability": 0.05987171802971837,
            "start_logit": 0.9654241800308228,
            "end_logit": 0.9105250835418701
        },
        {
            "text": "additional metabolite compartment with first-order elimination was found appropriate to capture the pharmacokinetics of sutezolid-",
            "probability": 0.05609793379548498,
            "start_logit": 1.163281798362732,
            "end_logit": 0.6475622057914734
        },
        {
            "text": "etics of sutezolid-M1. Once allometrically scaled to humans with a fixed exponent of 0.",
            "probability": 0.05567517613841614,
            "start_logit": 0.892754316329956,
            "end_logit": 0.9105250835418701
        },
        {
            "text": "time profiles could be described by one-compartment body models with first-order elimination. One additional meta",
            "probability": 0.05458338549653287,
            "start_logit": 0.9683537483215332,
            "end_logit": 0.8151208162307739
        },
        {
            "text": "izolid phosphate and sutezolid were administered orally to NHPs either once or twice",
            "probability": 0.05257498128978023,
            "start_logit": 0.8968011140823364,
            "end_logit": 0.8491842746734619
        },
        {
            "text": "Once allometrically scaled to humans with a fixed exponent of 0.",
            "probability": 0.0523408860431101,
            "start_logit": 0.8309977650642395,
            "end_logit": 0.9105250835418701
        },
        {
            "text": "additional metabolite compartment with first-order elimination was found appropriate to capture the pharmacokinetic",
            "probability": 0.05154845889930237,
            "start_logit": 1.163281798362732,
            "end_logit": 0.5629855394363403
        },
        {
            "text": "additional metabolite compartment with first-order elimination was found appropriate to capture the pharmacokinetics of sutezolid-M1.",
            "probability": 0.05129672580496229,
            "start_logit": 1.163281798362732,
            "end_logit": 0.5580901503562927
        },
        {
            "text": "thought to be a good precl",
            "probability": 0.050090900637661834,
            "start_logit": 1.1956841945648193,
            "end_logit": 0.5019001960754395
        },
        {
            "text": "and sutezolid were administered orally to NHPs either once or twice",
            "probability": 0.04989835386192006,
            "start_logit": 0.844548761844635,
            "end_logit": 0.8491842746734619
        },
        {
            "text": "etics of sutezolid-",
            "probability": 0.04280142939363325,
            "start_logit": 0.892754316329956,
            "end_logit": 0.6475622057914734
        },
        {
            "text": "izolid phosphate and sutezolid were administered orally to NHPs either once or twice daily for up to eight",
            "probability": 0.0426034108647901,
            "start_logit": 0.8968011140823364,
            "end_logit": 0.6388782262802124
        },
        {
            "text": "M1.",
            "probability": 0.042088279587925395,
            "start_logit": 0.9654241800308228,
            "end_logit": 0.5580901503562927
        },
        {
            "text": "Once allometrically scaled to humans with a fixed exponent of 0.75 for apparent clearance and 1 for apparent volume of distribution, the AU",
            "probability": 0.04087828662074778,
            "start_logit": 0.8309977650642395,
            "end_logit": 0.6633462905883789
        },
        {
            "text": "M1. Once allometrically scaled to humans with a fixed exponent of 0.75 for apparent clearance",
            "probability": 0.040645887790935996,
            "start_logit": 0.9654241800308228,
            "end_logit": 0.5232185125350952
        },
        {
            "text": "cl",
            "probability": 0.040556045098072264,
            "start_logit": 0.9845296740531921,
            "end_logit": 0.5019001960754395
        },
        {
            "text": "izolid phosphate and sutezolid were administered",
            "probability": 0.04045421747526879,
            "start_logit": 0.8968011140823364,
            "end_logit": 0.5871148109436035
        },
        {
            "text": "and sutezolid were administered orally to NHPs either once or twice daily for up to eight",
            "probability": 0.04043444275023064,
            "start_logit": 0.844548761844635,
            "end_logit": 0.6388782262802124
        }
    ],
    "5c588d0986df2b9174000003": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c580aff07647bbc4b00001a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c581e1507647bbc4b00001c": [
        {
            "text": "comprehensive functional annotation, and causal variant prior",
            "probability": 0.08122871313214597,
            "start_logit": 0.9585638642311096,
            "end_logit": 1.380676507949829
        },
        {
            "text": "-child trios. eDiVA combines next-generation sequencing data analysis, comprehensive functional annotation, and causal variant prior",
            "probability": 0.07712845195466465,
            "start_logit": 0.9067673087120056,
            "end_logit": 1.380676507949829
        },
        {
            "text": "WES disease studies point to the need for improved variant pathogenicity classification and causal variant prior",
            "probability": 0.05528700661531342,
            "start_logit": 1.1055768728256226,
            "end_logit": 0.8489326238632202
        },
        {
            "text": "connecting genotype",
            "probability": 0.05286271651378465,
            "start_logit": 1.2445409297943115,
            "end_logit": 0.6651289463043213
        },
        {
            "text": "-",
            "probability": 0.052256956736204535,
            "start_logit": 0.9067673087120056,
            "end_logit": 0.9913772940635681
        },
        {
            "text": "WES disease studies point to the",
            "probability": 0.052189422637248926,
            "start_logit": 1.1055768728256226,
            "end_logit": 0.7912745475769043
        },
        {
            "text": "lial disease cases to demonstrate its clinical applicability",
            "probability": 0.05132730072325015,
            "start_logit": 0.7934678196907043,
            "end_logit": 1.0867265462875366
        },
        {
            "text": "mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state-of-the-art competitors demonstrates",
            "probability": 0.04866159725599353,
            "start_logit": 0.9185645580291748,
            "end_logit": 0.9082971811294556
        },
        {
            "text": "variants and small insertions and deletions) for rare diseases using WES of families or parent-",
            "probability": 0.04711775201146155,
            "start_logit": 0.8032441139221191,
            "end_logit": 0.9913772940635681
        },
        {
            "text": "to improve the precision of the prioritization algorithm. Benchmarking against state-of-the-art competitors demonstrates",
            "probability": 0.047002760689350324,
            "start_logit": 0.8838807344436646,
            "end_logit": 0.9082971811294556
        },
        {
            "text": "mode of inheritance, is incorporated to improve the precision of the prior",
            "probability": 0.046304173692135936,
            "start_logit": 0.9185645580291748,
            "end_logit": 0.858639121055603
        },
        {
            "text": "disease studies point to the need for improved variant pathogenicity classification and causal variant prior",
            "probability": 0.04502720729124424,
            "start_logit": 0.9003058671951294,
            "end_logit": 0.8489326238632202
        },
        {
            "text": "demonstrates",
            "probability": 0.04496529098500521,
            "start_logit": 0.8395652770996094,
            "end_logit": 0.9082971811294556
        },
        {
            "text": "to improve the precision of the prior",
            "probability": 0.04472569988856072,
            "start_logit": 0.8838807344436646,
            "end_logit": 0.858639121055603
        },
        {
            "text": "-child trios. eDiVA combines next-",
            "probability": 0.0437178834196338,
            "start_logit": 0.9067673087120056,
            "end_logit": 0.8129615187644958
        },
        {
            "text": "mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state-",
            "probability": 0.04291821212733127,
            "start_logit": 0.9185645580291748,
            "end_logit": 0.7827032804489136
        },
        {
            "text": "disease studies point to the",
            "probability": 0.04250445258953255,
            "start_logit": 0.9003058671951294,
            "end_logit": 0.7912745475769043
        },
        {
            "text": "improved variant pathogenicity classification and causal variant prior",
            "probability": 0.04212714135844402,
            "start_logit": 0.8337311744689941,
            "end_logit": 0.8489326238632202
        },
        {
            "text": "to improve the precision of the prioritization algorithm. Benchmarking against state-",
            "probability": 0.04145516315922535,
            "start_logit": 0.8838807344436646,
            "end_logit": 0.7827032804489136
        },
        {
            "text": "% reported for multiple WES disease studies point to the need for improved variant pathogenicity classification and causal variant prior",
            "probability": 0.041192097219469384,
            "start_logit": 0.8112853765487671,
            "end_logit": 0.8489326238632202
        }
    ],
    "5c55d9b707647bbc4b000009": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5ad4d758133db5eb78000007": [
        {
            "text": "s disease (PD",
            "probability": 0.09326623501012365,
            "start_logit": 1.0372567176818848,
            "end_logit": 1.2897863388061523
        },
        {
            "text": "tia nigra of 12 patients with typical Parkinson's disease (PD",
            "probability": 0.08196141821138023,
            "start_logit": 0.9080471992492676,
            "end_logit": 1.2897863388061523
        },
        {
            "text": "of 12 patients with typical Parkinson's disease (PD",
            "probability": 0.07914889263391899,
            "start_logit": 0.8731293678283691,
            "end_logit": 1.2897863388061523
        },
        {
            "text": "controls, probably representing \"incidental PD\". We conclude that there is a close relationship between pale bodies and typical Lewy",
            "probability": 0.07198116144852566,
            "start_logit": 1.200471043586731,
            "end_logit": 0.8675183057785034
        },
        {
            "text": "controls, probably representing \"incidental PD",
            "probability": 0.07193232739521542,
            "start_logit": 1.200471043586731,
            "end_logit": 0.8668396472930908
        },
        {
            "text": "controls, probably representing \"incidental PD\". We conclude that there is a close relationship between pale bodies and typical Lewy bodies in the sub",
            "probability": 0.06003137883537462,
            "start_logit": 1.200471043586731,
            "end_logit": 0.685981273651123
        },
        {
            "text": "s disease (PD), in 5 patients with diffuse Lew",
            "probability": 0.056063823423574924,
            "start_logit": 1.0372567176818848,
            "end_logit": 0.7808189392089844
        },
        {
            "text": ". Alternatively, these observations may suggest that pale bodies represent a stage in the formation of Lew",
            "probability": 0.05419392991314183,
            "start_logit": 1.0328123569488525,
            "end_logit": 0.7513414621353149
        },
        {
            "text": "these observations may suggest that pale bodies represent a stage in the formation of Lew",
            "probability": 0.04982054330369525,
            "start_logit": 0.9486708641052246,
            "end_logit": 0.7513414621353149
        },
        {
            "text": "tia nigra of 12 patients with typical Parkinson's disease (PD), in 5 patients with diffuse Lew",
            "probability": 0.04926831749614235,
            "start_logit": 0.9080471992492676,
            "end_logit": 0.7808189392089844
        },
        {
            "text": "We conclude that there is a close relationship between pale bodies and typical Lewy",
            "probability": 0.04825611132118992,
            "start_logit": 0.8005890846252441,
            "end_logit": 0.8675183057785034
        },
        {
            "text": "of 12 patients with typical Parkinson's disease (PD), in 5 patients with diffuse Lew",
            "probability": 0.047577663452565276,
            "start_logit": 0.8731293678283691,
            "end_logit": 0.7808189392089844
        },
        {
            "text": "munoreactive pale bodies and Lew",
            "probability": 0.041115502622834164,
            "start_logit": 0.8234771490097046,
            "end_logit": 0.6844930052757263
        },
        {
            "text": "We conclude that there is a close relationship between pale bodies and typical Lewy bodies in the sub",
            "probability": 0.04024498690419085,
            "start_logit": 0.8005890846252441,
            "end_logit": 0.685981273651123
        },
        {
            "text": "munoreactive pale bodies and Lewy bodies. BF10, a monocl",
            "probability": 0.03989651158204282,
            "start_logit": 0.8234771490097046,
            "end_logit": 0.654396653175354
        },
        {
            "text": "If pale bodies and Lewy bodies reflect separate aspects of the cellular pathology in PD, their formation probably occurs in parallel",
            "probability": 0.039577574161585596,
            "start_logit": 0.7692269086837769,
            "end_logit": 0.7006206512451172
        },
        {
            "text": "If pale bodies and Lewy bodies reflect separate aspects of the cellular pathology in PD, their formation probably",
            "probability": 0.03869003941262937,
            "start_logit": 0.7692269086837769,
            "end_logit": 0.6779401898384094
        },
        {
            "text": "If pale bodies and Lewy bodies reflect separate aspects of the cellular pathology in PD",
            "probability": 0.036973582871869255,
            "start_logit": 0.7692269086837769,
            "end_logit": 0.6325616836547852
        }
    ],
    "5c2cf051133db5eb78000030": [
        {
            "text": "kinase and Wnt signalling pathways. We have found that invertebrate (Caenorhabditis elegans,",
            "probability": 0.19256951941326397,
            "start_logit": 1.172045350074768,
            "end_logit": 0.4950503408908844
        },
        {
            "text": "kinase and Wnt signalling pathways. We",
            "probability": 0.18261831717548366,
            "start_logit": 1.172045350074768,
            "end_logit": 0.44199138879776
        },
        {
            "text": "kinase and Wnt signalling pathways. We have found",
            "probability": 0.17920262235463155,
            "start_logit": 1.172045350074768,
            "end_logit": 0.4231102466583252
        },
        {
            "text": "residing on chromosome 2. Thus, while genes encoding upstream (such as Wnts and frizzelds) and downstream",
            "probability": 0.1665946691152577,
            "start_logit": 0.8545575737953186,
            "end_logit": 0.6676446199417114
        },
        {
            "text": "residing on",
            "probability": 0.14884526211111326,
            "start_logit": 0.8545575737953186,
            "end_logit": 0.5549881458282471
        },
        {
            "text": "residing on chromosome 2. Thus, while genes encoding upstream (such as",
            "probability": 0.1301696098302499,
            "start_logit": 0.8545575737953186,
            "end_logit": 0.42091917991638184
        }
    ],
    "5c5f0d071a4c55d80b000010": [
        {
            "text": "either to find the",
            "probability": 0.11425428101249999,
            "start_logit": 0.9857931137084961,
            "end_logit": 0.6445985436439514
        },
        {
            "text": "either to find the consistent/common clusters across different views, or to identify the differential clusters among different views. In reality",
            "probability": 0.10532635952989908,
            "start_logit": 0.9857931137084961,
            "end_logit": 0.5632357597351074
        },
        {
            "text": "either to find",
            "probability": 0.0997662714434416,
            "start_logit": 0.9857931137084961,
            "end_logit": 0.5090022087097168
        },
        {
            "text": "either to find the consistent/common clusters across different views, or to identify the differential clusters among",
            "probability": 0.09823734928847698,
            "start_logit": 0.9857931137084961,
            "end_logit": 0.49355852603912354
        },
        {
            "text": "view clustering has",
            "probability": 0.09386278296454786,
            "start_logit": 0.9436691403388977,
            "end_logit": 0.4901299774646759
        },
        {
            "text": "either to find the consistent/common clusters across different views",
            "probability": 0.08615651166012775,
            "start_logit": 0.9857931137084961,
            "end_logit": 0.362337589263916
        },
        {
            "text": "view clustering has attracted much attention in recent years. Several models and algorithms have been proposed for finding the clusters.",
            "probability": 0.0838007631018567,
            "start_logit": 0.9436691403388977,
            "end_logit": 0.37673813104629517
        },
        {
            "text": "view clustering has attracted much attention in recent years. Several models and algorithms have been",
            "probability": 0.08224375196333314,
            "start_logit": 0.9436691403388977,
            "end_logit": 0.35798344016075134
        },
        {
            "text": "view clustering has attracted much attention in recent years. Several models and algorithms have been proposed for finding the",
            "probability": 0.08194618204976482,
            "start_logit": 0.9436691403388977,
            "end_logit": 0.3543587327003479
        },
        {
            "text": "view clustering has attracted much attention in recent years. Several models and algorithms have been proposed for finding the clusters. However,",
            "probability": 0.08037820056845761,
            "start_logit": 0.9436691403388977,
            "end_logit": 0.33503901958465576
        },
        {
            "text": "view clustering has attracted much attention in recent years. Several",
            "probability": 0.07402754641759438,
            "start_logit": 0.9436691403388977,
            "end_logit": 0.2527332901954651
        }
    ],
    "5c56b96e07647bbc4b000010": [
        {
            "text": "30 million PubMed abstracts",
            "probability": 0.07362138996316595,
            "start_logit": 1.093109130859375,
            "end_logit": 1.2427550554275513
        },
        {
            "text": "importantly, the extrinsic evaluation results demonstrate that using BioConceptVec with advanced deep learning models can",
            "probability": 0.06020025517063065,
            "start_logit": 1.3293383121490479,
            "end_logit": 0.8052668571472168
        },
        {
            "text": "ptVec, via four different machine learning models on ~30 million PubMed abstracts",
            "probability": 0.0592616734048075,
            "start_logit": 0.876136302947998,
            "end_logit": 1.2427550554275513
        },
        {
            "text": "beddings, BioConceptVec, via four different machine learning models on ~30 million PubMed abstracts",
            "probability": 0.058192274620453115,
            "start_logit": 0.8579261302947998,
            "end_logit": 1.2427550554275513
        },
        {
            "text": ". Despite multiple attempts, existing biomedical concept embeddings generally suffer from sub",
            "probability": 0.05682797753722251,
            "start_logit": 0.8073896169662476,
            "end_logit": 1.2695677280426025
        },
        {
            "text": "dings. Despite multiple attempts, existing biomedical concept embeddings generally suffer from sub",
            "probability": 0.05361597174667586,
            "start_logit": 0.7492078542709351,
            "end_logit": 1.2695677280426025
        },
        {
            "text": "embeddings, BioConceptVec, via four different machine learning models on ~30 million PubMed abstracts",
            "probability": 0.053312094776931176,
            "start_logit": 0.7703367471694946,
            "end_logit": 1.2427550554275513
        },
        {
            "text": "train the embeddings. Despite multiple attempts, existing biomedical concept embeddings generally suffer from sub",
            "probability": 0.05254069024684604,
            "start_logit": 0.7289487719535828,
            "end_logit": 1.2695677280426025
        },
        {
            "text": "nsic evaluation tasks), which is, by far, the most comprehensive to our best knowledge. The intrinsic evaluation results",
            "probability": 0.0505097397754983,
            "start_logit": 1.2254492044448853,
            "end_logit": 0.7336455583572388
        },
        {
            "text": "importantly, the extrinsic evaluation results demonstrate that using BioConceptVec with advanced deep learning models can significantly improve performance in downstream",
            "probability": 0.048983187345662454,
            "start_logit": 1.3293383121490479,
            "end_logit": 0.5990673899650574
        },
        {
            "text": "nsic evaluation tasks)",
            "probability": 0.04751997842201279,
            "start_logit": 1.2254492044448853,
            "end_logit": 0.6726295948028564
        },
        {
            "text": "beddings to date. To evaluate the validity and utility of BioConce",
            "probability": 0.04605293529285502,
            "start_logit": 1.0528185367584229,
            "end_logit": 0.8139015436172485
        },
        {
            "text": "30 million PubMed abstracts. BioConceptVec covers over 400,000 biomedical concepts mentioned in the literature and",
            "probability": 0.045944450343159894,
            "start_logit": 1.093109130859375,
            "end_logit": 0.7712525129318237
        },
        {
            "text": "comprehensive to our best knowledge. The intrinsic evaluation results",
            "probability": 0.0454321173733114,
            "start_logit": 1.119502305984497,
            "end_logit": 0.7336455583572388
        },
        {
            "text": ". The capturing of the semantic relatedness of biological entities is vital to many biological applications, such as protein-",
            "probability": 0.04532803427917428,
            "start_logit": 0.875935435295105,
            "end_logit": 0.9749188423156738
        },
        {
            "text": "of the semantic relatedness of biological entities is vital to many biological applications, such as protein-",
            "probability": 0.042306821734895514,
            "start_logit": 0.8069580793380737,
            "end_logit": 0.9749188423156738
        },
        {
            "text": "400,000 biomedical concepts mentioned in the literature and",
            "probability": 0.041948683595668404,
            "start_logit": 1.0021231174468994,
            "end_logit": 0.7712525129318237
        },
        {
            "text": "is vital to many biological applications, such as protein-",
            "probability": 0.040450033689572146,
            "start_logit": 0.7620772123336792,
            "end_logit": 0.9749188423156738
        },
        {
            "text": "entity recognition (NER) tools are first used to identify and normalize concepts from the literature,",
            "probability": 0.03916691986833921,
            "start_logit": 0.9896315336227417,
            "end_logit": 0.715129554271698
        },
        {
            "text": "dings to date. To evaluate the validity and utility of BioConce",
            "probability": 0.038784770813117854,
            "start_logit": 0.881054699420929,
            "end_logit": 0.8139015436172485
        }
    ],
    "5c5f30c91a4c55d80b000025": [
        {
            "text": "is (EAE) are resistant to disease and have defective priming of IL-17-secret",
            "probability": 0.19639351703882119,
            "start_logit": 1.2706584930419922,
            "end_logit": 0.7982203364372253
        },
        {
            "text": "is (EAE) are resistant to disease and have defective priming of IL-",
            "probability": 0.18551619089663549,
            "start_logit": 1.2706584930419922,
            "end_logit": 0.7412421107292175
        },
        {
            "text": "is (EAE) are resistant to disease and have defective priming of IL-17-secreting \u03b3\u03b4 T (\u03b3\u03b4T17",
            "probability": 0.143201418146375,
            "start_logit": 1.2706584930419922,
            "end_logit": 0.4823521077632904
        },
        {
            "text": "secret",
            "probability": 0.1399441012538135,
            "start_logit": 0.9317811727523804,
            "end_logit": 0.7982203364372253
        },
        {
            "text": "is (EAE) are resistant to disease and have",
            "probability": 0.13206596203284646,
            "start_logit": 1.2706584930419922,
            "end_logit": 0.40140146017074585
        },
        {
            "text": "secreting \u03b3\u03b4 T (\u03b3\u03b4T17",
            "probability": 0.1020410147082637,
            "start_logit": 0.9317811727523804,
            "end_logit": 0.4823521077632904
        },
        {
            "text": "IL-17-secreting \u03b3\u03b4 T (\u03b3\u03b4T17) cells and Th17 cells. However, T\u00a0cells from Il17a",
            "probability": 0.10083779592324477,
            "start_logit": 0.9317811727523804,
            "end_logit": 0.4704905152320862
        }
    ],
    "5ad35d01133db5eb78000003": [
        {
            "text": "Brazilian patient with",
            "probability": 1.0,
            "start_logit": 1.0994261503219604,
            "end_logit": 0.29997682571411133
        }
    ],
    "5c6be8f07c78d69471000032": [
        {
            "text": "trometry analysis and database search (redox proteomics). We demonstrated that exposure of bronchial cells to cigarette smoke extract induces",
            "probability": 0.06476894262518573,
            "start_logit": 1.0389035940170288,
            "end_logit": 0.8013631701469421
        },
        {
            "text": "). We demonstrated that exposure of bronchial cells to cigarette smoke extract induces",
            "probability": 0.06359098232103978,
            "start_logit": 1.0205490589141846,
            "end_logit": 0.8013631701469421
        },
        {
            "text": "induces",
            "probability": 0.05765964030509226,
            "start_logit": 0.9226348400115967,
            "end_logit": 0.8013631701469421
        },
        {
            "text": "trometry analysis and database",
            "probability": 0.057096456623575396,
            "start_logit": 1.0389035940170288,
            "end_logit": 0.6752790212631226
        },
        {
            "text": ".5-5-10-",
            "probability": 0.056757221872601446,
            "start_logit": 0.8639707565307617,
            "end_logit": 0.8442527055740356
        },
        {
            "text": "cigarette smoke extract induces",
            "probability": 0.05365412967910425,
            "start_logit": 0.850635826587677,
            "end_logit": 0.8013631701469421
        },
        {
            "text": "We demonstrated that exposure of bronchial cells to cigarette smoke extract induces",
            "probability": 0.0525703552881345,
            "start_logit": 0.8302297592163086,
            "end_logit": 0.8013631701469421
        },
        {
            "text": "reactive molecules able to induce oxidative stress, which in turn contributes to smoking-",
            "probability": 0.04910766559446036,
            "start_logit": 0.8251283168792725,
            "end_logit": 0.7383273839950562
        },
        {
            "text": "induces carbonylation of a large number of proteins distributed throughout the cell.",
            "probability": 0.04792749826852079,
            "start_logit": 0.9226348400115967,
            "end_logit": 0.6164951324462891
        },
        {
            "text": "manner. The main",
            "probability": 0.04786658927794739,
            "start_logit": 0.8294697999954224,
            "end_logit": 0.7083885073661804
        },
        {
            "text": "and chromosome segregation, thus confirming that reactive carbonyl species contained in cigarette smoke markedly alter cell homeostasis and functions.",
            "probability": 0.047782247005830975,
            "start_logit": 0.8690717220306396,
            "end_logit": 0.6670230031013489
        },
        {
            "text": "manner. The main carbonylated proteins were identified by means of two-dimensional electrophoresis coupled to MALDI-",
            "probability": 0.04765787558335932,
            "start_logit": 0.8294697999954224,
            "end_logit": 0.7040186524391174
        },
        {
            "text": "reactive carbonyl species contained in cigarette smoke markedly alter cell homeostasis and functions.",
            "probability": 0.047388495797222464,
            "start_logit": 0.8607970476150513,
            "end_logit": 0.6670230031013489
        },
        {
            "text": "induces carbonylation of a large number of proteins distributed throughout the cell. Proteins undergoing carbonylation",
            "probability": 0.04618832342102869,
            "start_logit": 0.9226348400115967,
            "end_logit": 0.5795327425003052
        },
        {
            "text": "cigarette smoke extract induces carbonylation of a large number of proteins distributed throughout the cell.",
            "probability": 0.04459806189715605,
            "start_logit": 0.850635826587677,
            "end_logit": 0.6164951324462891
        },
        {
            "text": "(2.5-5-10-20%) of cigarette smoke extract for 1, 3, and 24\u00a0h. Carbonylation",
            "probability": 0.0441221658012436,
            "start_logit": 0.8639707565307617,
            "end_logit": 0.5924320816993713
        },
        {
            "text": "We demonstrated that exposure of bronchial cells to cigarette smoke extract induces carbonylation of a large number of proteins distributed throughout the cell.",
            "probability": 0.04369721348790779,
            "start_logit": 0.8302297592163086,
            "end_logit": 0.6164951324462891
        },
        {
            "text": "cigarette smoke extract induces carbonylation of a large number of proteins distributed throughout the cell. Proteins undergoing carbonylation",
            "probability": 0.042979704371714875,
            "start_logit": 0.850635826587677,
            "end_logit": 0.5795327425003052
        },
        {
            "text": "(2.5-5-10-20%) of cigarette smoke extract for 1, 3, and 24\u00a0h. Carbonylation was",
            "probability": 0.04251441485572911,
            "start_logit": 0.8639707565307617,
            "end_logit": 0.555312991142273
        },
        {
            "text": "reactive molecules able to induce oxidative stress,",
            "probability": 0.04207201592314516,
            "start_logit": 0.8251283168792725,
            "end_logit": 0.5836950540542603
        }
    ],
    "5c6ffde47c78d69471000059": [
        {
            "text": "challenge among gynecological malignancies. Immune checkpoint blockade therapy is promising in many cancers",
            "probability": 0.16950626553369927,
            "start_logit": 0.8994579315185547,
            "end_logit": 0.7344698309898376
        },
        {
            "text": "publicly available datasets. CIBERSORT was applied to infer the infiltration fraction of 22",
            "probability": 0.15682505166977218,
            "start_logit": 0.9259301424026489,
            "end_logit": 0.6302385926246643
        },
        {
            "text": "publicly available datasets.",
            "probability": 0.1495777877971621,
            "start_logit": 0.9259301424026489,
            "end_logit": 0.5829243063926697
        },
        {
            "text": "challenge among gynecological malignancies. Immune checkpoint blockade therapy is promising in many cancers but shows low response rates in OC because of its",
            "probability": 0.14395515356491914,
            "start_logit": 0.8994579315185547,
            "end_logit": 0.5710817575454712
        },
        {
            "text": "publicly available datasets. CIBERSORT was applied to infer the infiltration fraction",
            "probability": 0.13632292367929472,
            "start_logit": 0.9259301424026489,
            "end_logit": 0.49013423919677734
        },
        {
            "text": "publicly available datasets. CIBERSORT was applied to infer",
            "probability": 0.12567831987025743,
            "start_logit": 0.9259301424026489,
            "end_logit": 0.4088333547115326
        },
        {
            "text": "challenge among gynecological malignancies. Immune checkpoint blockade therapy is promising in many",
            "probability": 0.11813449788489515,
            "start_logit": 0.8994579315185547,
            "end_logit": 0.37340372800827026
        }
    ],
    "5c73ad367c78d69471000099": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c7b1a5fd774d0424000000c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c5219f67e3cb0e231000006": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c630666e842deac6700000c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c74111f7c78d694710000a1": [
        {
            "text": "Alu element (SINE Alu) repeat sequence. Validation of methylation inhibition",
            "probability": 0.07364478425131685,
            "start_logit": 1.0178368091583252,
            "end_logit": 0.7868154048919678
        },
        {
            "text": "prostate cancer progression by enhancing",
            "probability": 0.07286878695841796,
            "start_logit": 1.1628303527832031,
            "end_logit": 0.6312289237976074
        },
        {
            "text": "Alu element (SINE Alu) repeat sequence. Validation of methylation inhibition on MI",
            "probability": 0.07137052772297636,
            "start_logit": 1.0178368091583252,
            "end_logit": 0.7554470896720886
        },
        {
            "text": "is hypermethylated in normal cells leading to repression of the gene. In cancer, the hypomethylation of a part of this",
            "probability": 0.06489020497643827,
            "start_logit": 1.053114891052246,
            "end_logit": 0.6249806880950928
        },
        {
            "text": "regulation, is one of the most widely altered mechanisms in prostate cancer. This phenomenon frames",
            "probability": 0.06380144777427606,
            "start_logit": 0.811686635017395,
            "end_logit": 0.8494881391525269
        },
        {
            "text": ") repeat sequence. Validation of methylation inhibition",
            "probability": 0.061150262616330525,
            "start_logit": 0.8319176435470581,
            "end_logit": 0.7868154048919678
        },
        {
            "text": "USF transcription factors. These results suggest the MI",
            "probability": 0.06053052495827037,
            "start_logit": 0.811870813369751,
            "end_logit": 0.7966758608818054
        },
        {
            "text": "is hypermethylated in normal cells leading to repression of the gene. In cancer, the",
            "probability": 0.059876768458963885,
            "start_logit": 1.053114891052246,
            "end_logit": 0.5445725917816162
        },
        {
            "text": ") repeat sequence. Validation of methylation inhibition on MI",
            "probability": 0.05926185483051455,
            "start_logit": 0.8319176435470581,
            "end_logit": 0.7554470896720886
        },
        {
            "text": "Alu element (SINE Alu) repeat sequence. Validation of methyl",
            "probability": 0.05903546992727338,
            "start_logit": 1.0178368091583252,
            "end_logit": 0.5657005310058594
        },
        {
            "text": "transfera",
            "probability": 0.05643284849027577,
            "start_logit": 0.9934350848197937,
            "end_logit": 0.5450152158737183
        },
        {
            "text": "regulation, is one of the most widely altered mechanisms in prostate cancer. This phenomenon frames the basis to study the DNA methyl",
            "probability": 0.0526999553116183,
            "start_logit": 0.811686635017395,
            "end_logit": 0.6583268642425537
        },
        {
            "text": "USF transcription factors.",
            "probability": 0.05137044108221618,
            "start_logit": 0.811870813369751,
            "end_logit": 0.6325910091400146
        },
        {
            "text": ". MIEN1 mRNA and protein increases upon inhibition",
            "probability": 0.05006795570330948,
            "start_logit": 0.8403346538543701,
            "end_logit": 0.5784454345703125
        },
        {
            "text": ") repeat sequence. Validation of methyl",
            "probability": 0.049019554153513584,
            "start_logit": 0.8319176435470581,
            "end_logit": 0.5657005310058594
        },
        {
            "text": ". MIEN1 mRNA and protein increases upon inhibition of individual DNA methyltransfera",
            "probability": 0.048421841279508895,
            "start_logit": 0.8403346538543701,
            "end_logit": 0.5450152158737183
        },
        {
            "text": "USF transcription factors. These results suggest the MIEN1 promoter",
            "probability": 0.045556771504779714,
            "start_logit": 0.811870813369751,
            "end_logit": 0.5124873518943787
        }
    ],
    "5c536b857e3cb0e23100001c": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c73ad027c78d6947100008d": [
        {
            "text": "deliver mental health treatments on",
            "probability": 0.17608323510503307,
            "start_logit": 0.9520185589790344,
            "end_logit": 0.9400777816772461
        },
        {
            "text": "deliver mental health treatments on a large scale. This randomized controlled trial evaluated the",
            "probability": 0.14291064228760528,
            "start_logit": 0.9520185589790344,
            "end_logit": 0.7313405275344849
        },
        {
            "text": "deliver mental health treatments on a large scale. This",
            "probability": 0.11258525928278801,
            "start_logit": 0.9520185589790344,
            "end_logit": 0.4928317666053772
        },
        {
            "text": "deliver mental health treatments on a large scale. This randomized controlled trial evaluated the efficacy of an unguided IM",
            "probability": 0.10829873878956606,
            "start_logit": 0.9520185589790344,
            "end_logit": 0.45401448011398315
        },
        {
            "text": "deliver mental health treatments on a large scale. This randomized controlled",
            "probability": 0.10051472718740827,
            "start_logit": 0.9520185589790344,
            "end_logit": 0.3794252276420593
        },
        {
            "text": "deliver mental health treatments on a large scale. This randomized controlled trial evaluated the efficacy of an un",
            "probability": 0.09389444255807691,
            "start_logit": 0.9520185589790344,
            "end_logit": 0.3112921714782715
        },
        {
            "text": "deliver mental health treatments on a large scale.",
            "probability": 0.08953786860774214,
            "start_logit": 0.9520185589790344,
            "end_logit": 0.2637826204299927
        },
        {
            "text": "deliver mental",
            "probability": 0.08898334395242935,
            "start_logit": 0.9520185589790344,
            "end_logit": 0.25757017731666565
        },
        {
            "text": "deliver mental health treatments on a large scale. This randomized controlled trial evaluated",
            "probability": 0.08719174222935097,
            "start_logit": 0.9520185589790344,
            "end_logit": 0.2372305989265442
        }
    ],
    "5c783d32d774d04240000004": [
        {
            "text": "absorbed trans-",
            "probability": 0.09351329914604616,
            "start_logit": 0.9249699115753174,
            "end_logit": 0.8734499216079712
        },
        {
            "text": "absorbed trans-mucosal and trans-cutaneous in individuals colonized with superantigen producing Staphylococcus au",
            "probability": 0.07863917891807977,
            "start_logit": 0.9249699115753174,
            "end_logit": 0.7002162933349609
        },
        {
            "text": "absorbed trans-mucosal and trans-",
            "probability": 0.07588836752130508,
            "start_logit": 0.9249699115753174,
            "end_logit": 0.6646096706390381
        },
        {
            "text": "is (EAE). In this study we",
            "probability": 0.07431700519172905,
            "start_logit": 1.0039827823638916,
            "end_logit": 0.5646731853485107
        },
        {
            "text": "absorbed trans-mucos",
            "probability": 0.0687937966569115,
            "start_logit": 0.9249699115753174,
            "end_logit": 0.5664598345756531
        },
        {
            "text": "is (EAE). In this study we investigated the role of staphylococcal enterotoxin",
            "probability": 0.06575715664270092,
            "start_logit": 1.0039827823638916,
            "end_logit": 0.4423018991947174
        },
        {
            "text": "hylococcal enterotoxin B in immunologic and pathologic changes in experimental animal model",
            "probability": 0.06545126298161245,
            "start_logit": 0.8999045491218567,
            "end_logit": 0.5417174100875854
        },
        {
            "text": "is (EAE). In this study we investigated the role of staphyl",
            "probability": 0.06487202812280157,
            "start_logit": 1.0039827823638916,
            "end_logit": 0.4287499189376831
        },
        {
            "text": "is (EAE). In this study we investigated the role of st",
            "probability": 0.06393625604258606,
            "start_logit": 1.0039827823638916,
            "end_logit": 0.4142199754714966
        },
        {
            "text": "is (EAE). In this",
            "probability": 0.06346160915460491,
            "start_logit": 1.0039827823638916,
            "end_logit": 0.4067685306072235
        },
        {
            "text": "hylococcal enterotoxin",
            "probability": 0.05925737697483032,
            "start_logit": 0.8999045491218567,
            "end_logit": 0.4423018991947174
        },
        {
            "text": "hyl",
            "probability": 0.05845973916546084,
            "start_logit": 0.8999045491218567,
            "end_logit": 0.4287499189376831
        },
        {
            "text": "is (EAE)",
            "probability": 0.057963380255760234,
            "start_logit": 1.0039827823638916,
            "end_logit": 0.31614482402801514
        },
        {
            "text": "is (EAE). In this study we investigated the role of staphylococcal enterotoxin B in immunolo",
            "probability": 0.0576962715232551,
            "start_logit": 1.0039827823638916,
            "end_logit": 0.31152594089508057
        },
        {
            "text": "hylococcal enterotoxin B in immunolo",
            "probability": 0.05199327170231589,
            "start_logit": 0.8999045491218567,
            "end_logit": 0.31152594089508057
        }
    ],
    "5c76d0417c78d694710000a8": [
        {
            "text": "kidneys. There are few published reports of pregnancy in women with cystinosis, and little evidence is available regarding optimal management.",
            "probability": 0.5127829838405197,
            "start_logit": 1.2026407718658447,
            "end_logit": 0.462542861700058
        },
        {
            "text": "kidneys.",
            "probability": 0.4872170161594803,
            "start_logit": 1.2026407718658447,
            "end_logit": 0.411399781703949
        }
    ],
    "5c6545bae842deac6700001d": [
        {
            "text": "has emerged as the standard of care for the treatment of AL amyloidosis. Novel anti-",
            "probability": 0.06503910933793725,
            "start_logit": 1.0064655542373657,
            "end_logit": 0.9058644771575928
        },
        {
            "text": "loidosis (AL amyloidosis) is a rare, life-threatening disease characterized by the deposition",
            "probability": 0.057522443228066364,
            "start_logit": 0.9881196618080139,
            "end_logit": 0.8013967871665955
        },
        {
            "text": "osis. Novel anti-",
            "probability": 0.0555044128998388,
            "start_logit": 0.8479393124580383,
            "end_logit": 0.9058644771575928
        },
        {
            "text": "is a rare, life-threatening disease characterized by the deposition",
            "probability": 0.05222922728096458,
            "start_logit": 0.8915867209434509,
            "end_logit": 0.8013967871665955
        },
        {
            "text": "of the existing organ damage. Autologous stem cell transplantation has",
            "probability": 0.0512004918270447,
            "start_logit": 0.793342113494873,
            "end_logit": 0.8797482848167419
        },
        {
            "text": "bulin",
            "probability": 0.049938006273874944,
            "start_logit": 0.8211832046508789,
            "end_logit": 0.8269404172897339
        },
        {
            "text": "omodulators, monoclonal antibodies targeting a surface protein on the",
            "probability": 0.0497548276384893,
            "start_logit": 0.848866879940033,
            "end_logit": 0.7955818772315979
        },
        {
            "text": "clonal antibodies targeting a surface protein on the",
            "probability": 0.0497046005964052,
            "start_logit": 0.847856879234314,
            "end_logit": 0.7955818772315979
        },
        {
            "text": "bulin light chain amyloidosis (AL amyloidosis) is a rare, life-threatening disease characterized by the deposition",
            "probability": 0.048678562178710194,
            "start_logit": 0.8211832046508789,
            "end_logit": 0.8013967871665955
        },
        {
            "text": "has emerged",
            "probability": 0.04862048334276699,
            "start_logit": 1.0064655542373657,
            "end_logit": 0.6149206161499023
        },
        {
            "text": "loidosis) is a rare, life-threatening disease characterized by the deposition",
            "probability": 0.048588363757235756,
            "start_logit": 0.8193285465240479,
            "end_logit": 0.8013967871665955
        },
        {
            "text": ") is a rare, life-threatening disease characterized by the deposition",
            "probability": 0.0482864382101877,
            "start_logit": 0.813095211982727,
            "end_logit": 0.8013967871665955
        },
        {
            "text": "surface protein on the",
            "probability": 0.04793354405882097,
            "start_logit": 0.8115749359130859,
            "end_logit": 0.7955818772315979
        },
        {
            "text": "be widely applied as patients are often frail at presentation, making them ineligible",
            "probability": 0.04732750229979925,
            "start_logit": 0.8160783052444458,
            "end_logit": 0.7783545255661011
        },
        {
            "text": "loidosis (AL amyloidosis) is a rare, life-",
            "probability": 0.04706723015095949,
            "start_logit": 0.9881196618080139,
            "end_logit": 0.6007986068725586
        },
        {
            "text": "of AL amyloidosis, including antifibril directed therapies under current investigation",
            "probability": 0.04695297222208604,
            "start_logit": 0.932227373123169,
            "end_logit": 0.6542603969573975
        },
        {
            "text": "plasma cell disorder, most often a small plasma cell clone of <10%. Current therapy is directed",
            "probability": 0.04694314731208663,
            "start_logit": 0.9125276803970337,
            "end_logit": 0.6737508177757263
        },
        {
            "text": "plasma cell disorder, most often",
            "probability": 0.046702116400262464,
            "start_logit": 0.9125276803970337,
            "end_logit": 0.6686030626296997
        },
        {
            "text": "loidosis, including antifibril directed therapies under current investigation",
            "probability": 0.046541386548872084,
            "start_logit": 0.9234228134155273,
            "end_logit": 0.6542603969573975
        },
        {
            "text": ". However, there is still a need for therapies that directly target the",
            "probability": 0.04546513443559153,
            "start_logit": 0.767521321773529,
            "end_logit": 0.7867656946182251
        }
    ],
    "5c7161f47c78d69471000066": [
        {
            "text": "of folate receptor (FR) on",
            "probability": 0.2421129795811997,
            "start_logit": 0.8692466616630554,
            "end_logit": 0.6781095862388611
        },
        {
            "text": "of folate receptor (FR) on tumors of women",
            "probability": 0.23918587160288796,
            "start_logit": 0.8692466616630554,
            "end_logit": 0.6659460663795471
        },
        {
            "text": "of folate receptor (FR) on tumors of women with recurrent/refractory",
            "probability": 0.20381189336626843,
            "start_logit": 0.8692466616630554,
            "end_logit": 0.5059025883674622
        },
        {
            "text": "of folate receptor (FR) on tumors of women with recurrent/refractory ovarian or endometrial cancer and corre",
            "probability": 0.16842130935281052,
            "start_logit": 0.8692466616630554,
            "end_logit": 0.3151737451553345
        },
        {
            "text": "of folate receptor (FR) on tumors of women with recurrent/refractory ovarian or end",
            "probability": 0.14646794609683333,
            "start_logit": 0.8692466616630554,
            "end_logit": 0.17551171779632568
        }
    ],
    "5c6aef167c78d69471000023": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c646fd3e842deac6700001a": [
        {
            "text": "of myelosuppression, several grade\u00a0\u2265\u00a03 hepatic adverse events, and veno-occlusive",
            "probability": 0.08328252108570648,
            "start_logit": 1.024243950843811,
            "end_logit": 1.0058109760284424
        },
        {
            "text": "several grade\u00a0\u2265\u00a03 hepatic adverse events, and veno-occlusive",
            "probability": 0.08256592751792505,
            "start_logit": 1.0156023502349854,
            "end_logit": 1.0058109760284424
        },
        {
            "text": "armacodynamic modeling was able to support the safety and efficacy of these regimens. Significant exposure-",
            "probability": 0.07487221300172772,
            "start_logit": 0.8939691185951233,
            "end_logit": 1.0296299457550049
        },
        {
            "text": ". Significant exposure-",
            "probability": 0.06881746195087071,
            "start_logit": 0.8096438050270081,
            "end_logit": 1.0296299457550049
        },
        {
            "text": "armacodynamic modeling was able to support the",
            "probability": 0.06041419976427379,
            "start_logit": 0.8939691185951233,
            "end_logit": 0.8150712847709656
        },
        {
            "text": "showed efficacy, but pharmacokinetic (PK) data were not collected in these trials.",
            "probability": 0.05964575806082478,
            "start_logit": 1.2198615074157715,
            "end_logit": 0.4763777554035187
        },
        {
            "text": "ozogamicin (Mylotarg; Pfizer, New York, NY) was",
            "probability": 0.05676370954257118,
            "start_logit": 0.9064186215400696,
            "end_logit": 0.7402948141098022
        },
        {
            "text": "tuzumab ozogamicin (Mylotarg; Pfizer, New York, NY) was",
            "probability": 0.055645305553551176,
            "start_logit": 0.8865191340446472,
            "end_logit": 0.7402948141098022
        },
        {
            "text": "armacodynamic modeling was",
            "probability": 0.05286425867101885,
            "start_logit": 0.8939691185951233,
            "end_logit": 0.6815745830535889
        },
        {
            "text": ". Significant exposure-response relationships were found for the attainment of complete remission with and without platelet recovery, attainment of blast-",
            "probability": 0.05032103719310059,
            "start_logit": 0.8096438050270081,
            "end_logit": 0.7165956497192383
        },
        {
            "text": "of myelosuppression, several grade\u00a0\u2265\u00a03 hepatic adverse events,",
            "probability": 0.04935254075274054,
            "start_logit": 1.024243950843811,
            "end_logit": 0.48256152868270874
        },
        {
            "text": "several grade\u00a0\u2265\u00a03 hepatic adverse events,",
            "probability": 0.04892789326613659,
            "start_logit": 1.0156023502349854,
            "end_logit": 0.48256152868270874
        },
        {
            "text": "of myelosuppression, several grade\u00a0\u2265\u00a03 hepatic",
            "probability": 0.04853310706585143,
            "start_logit": 1.024243950843811,
            "end_logit": 0.46581846475601196
        },
        {
            "text": "several grade\u00a0\u2265\u00a03 hepatic",
            "probability": 0.048115510289307564,
            "start_logit": 1.0156023502349854,
            "end_logit": 0.46581846475601196
        },
        {
            "text": ". Significant exposure-response relationships were found for the attainment of complete remission with and without platelet recovery, attainment of blast-free",
            "probability": 0.0420353885940294,
            "start_logit": 0.8096438050270081,
            "end_logit": 0.5366842746734619
        },
        {
            "text": "micin received full approval by the",
            "probability": 0.04040724293908191,
            "start_logit": 0.7908996343612671,
            "end_logit": 0.5159256458282471
        },
        {
            "text": "2-17\u00a0years.",
            "probability": 0.03950259898825843,
            "start_logit": 0.8065187931060791,
            "end_logit": 0.47766390442848206
        },
        {
            "text": "micin received full approval by the US Food and Drug Administration (FDA) in September 2017 for newly diagnosed and relapsed AML in adult",
            "probability": 0.03793332576302381,
            "start_logit": 0.7908996343612671,
            "end_logit": 0.4527466297149658
        }
    ],
    "5c61d278e842deac67000005": [
        {
            "text": "(58.2%), and 23 were female (41.8%); their mean ages were 62.65\u2009\u00b1\u200913\u00a0years.",
            "probability": 0.05745056966213491,
            "start_logit": 0.8977130651473999,
            "end_logit": 1.0541727542877197
        },
        {
            "text": "11",
            "probability": 0.05722594985840442,
            "start_logit": 1.2259998321533203,
            "end_logit": 0.7219685316085815
        },
        {
            "text": "study cohort restricted to one province of Turkey,",
            "probability": 0.056367663977543954,
            "start_logit": 0.9777902960777283,
            "end_logit": 0.9550662636756897
        },
        {
            "text": "49.9\u00a0years. Two cases had juvenile-onset. Fourteen (25.5%) bulbar-onset versus 40 (72.7%)",
            "probability": 0.05576841077115937,
            "start_logit": 1.0073504447937012,
            "end_logit": 0.9148180484771729
        },
        {
            "text": "40 (72.",
            "probability": 0.05506421242181907,
            "start_logit": 0.9946428537368774,
            "end_logit": 0.9148180484771729
        },
        {
            "text": "%) patients showed marked frontotemporal dementia. Twenty-nine (52.7%) patients died during the follow-",
            "probability": 0.05330502217406509,
            "start_logit": 0.9136102795600891,
            "end_logit": 0.9633811712265015
        },
        {
            "text": "variants in six different ALS genes (C9orf72, SOD1, VCP",
            "probability": 0.051894673260770734,
            "start_logit": 0.9646481275558472,
            "end_logit": 0.8855289220809937
        },
        {
            "text": ") bulbar-onset versus 40 (72.",
            "probability": 0.05132117017650144,
            "start_logit": 0.9242461919784546,
            "end_logit": 0.9148180484771729
        },
        {
            "text": "two rare (SH3TC2-p.Met523Thr and TBK1-",
            "probability": 0.0510698347290463,
            "start_logit": 0.9769771695137024,
            "end_logit": 0.857177734375
        },
        {
            "text": "Thirty-two patients were male (58.2%), and 23 were female (41.8%); their mean ages were 62.65\u2009\u00b1\u200913\u00a0years.",
            "probability": 0.05037371436182588,
            "start_logit": 0.766257643699646,
            "end_logit": 1.0541727542877197
        },
        {
            "text": "49.9\u00a0years. Two cases had juvenile-onset.",
            "probability": 0.050244280707769214,
            "start_logit": 1.0073504447937012,
            "end_logit": 0.8105071783065796
        },
        {
            "text": "%) patients showed marked frontotemporal dementia. Twenty-",
            "probability": 0.048605821562747994,
            "start_logit": 0.9136102795600891,
            "end_logit": 0.8710939288139343
        },
        {
            "text": "%) patients showed marked frontote",
            "probability": 0.04815023761501375,
            "start_logit": 0.9136102795600891,
            "end_logit": 0.8616766929626465
        },
        {
            "text": "patient had both. Six (10.9%) patients showed marked frontotemporal dementia. Twenty-",
            "probability": 0.04552631700555126,
            "start_logit": 0.848157525062561,
            "end_logit": 0.8710939288139343
        },
        {
            "text": "two rare (SH3TC2-p.Met523Thr and TBK1-p.Glu643del",
            "probability": 0.045191192024255616,
            "start_logit": 0.9769771695137024,
            "end_logit": 0.7348859310150146
        },
        {
            "text": "patient had both. Six (10.9%) patients showed marked frontote",
            "probability": 0.04509959735427627,
            "start_logit": 0.848157525062561,
            "end_logit": 0.8616766929626465
        },
        {
            "text": "two rare (SH3TC2-p.Met523Th",
            "probability": 0.04468139395065982,
            "start_logit": 0.9769771695137024,
            "end_logit": 0.7235409021377563
        },
        {
            "text": "Two cases had juvenile-onset. Fourteen (25.5%) bulbar-onset versus 40 (72.",
            "probability": 0.04442821071930967,
            "start_logit": 0.7800174951553345,
            "end_logit": 0.9148180484771729
        },
        {
            "text": "lial, 45 sporadic) in whom ALS was suspected due to their",
            "probability": 0.04416717081722389,
            "start_logit": 0.8700281381607056,
            "end_logit": 0.818914532661438
        },
        {
            "text": "variants in six different ALS genes (C9orf72, SOD1, VCP, SPG11",
            "probability": 0.044064556849921464,
            "start_logit": 0.9646481275558472,
            "end_logit": 0.7219685316085815
        }
    ],
    "5c6473b2e842deac6700001b": [
        {
            "text": "be armed with cellular toxins or radionucl",
            "probability": 0.07314054995496858,
            "start_logit": 1.0125844478607178,
            "end_logit": 1.0464088916778564
        },
        {
            "text": "city and complement-mediated cell lysis. The antibodies can also be armed with cellular toxins or radionucl",
            "probability": 0.07095997116914114,
            "start_logit": 0.9823174476623535,
            "end_logit": 1.0464088916778564
        },
        {
            "text": "two monoclonal antibodies -",
            "probability": 0.05722074576265083,
            "start_logit": 0.9700228571891785,
            "end_logit": 0.8435040712356567
        },
        {
            "text": "activity against B cell chronic lymphocytic and hairy cell leukaemia. Monocl",
            "probability": 0.054120920314071994,
            "start_logit": 1.0228060483932495,
            "end_logit": 0.73502516746521
        },
        {
            "text": "ymphocytic leukaemia, respectively. Although",
            "probability": 0.0525451165389,
            "start_logit": 1.1181025505065918,
            "end_logit": 0.6101800203323364
        },
        {
            "text": "clonal antibodies have dramatically impacted the treatment of haematological malignancies, as evidenced by the",
            "probability": 0.05006253049751164,
            "start_logit": 1.033128261566162,
            "end_logit": 0.6467549800872803
        },
        {
            "text": "ymphocytic leukaemia, respectively.",
            "probability": 0.049685673599331924,
            "start_logit": 1.1181025505065918,
            "end_logit": 0.5542244911193848
        },
        {
            "text": "ymphoma and S\u00e9zar",
            "probability": 0.049670892005894675,
            "start_logit": 1.060619592666626,
            "end_logit": 0.6114099025726318
        },
        {
            "text": "cl",
            "probability": 0.04777518555602088,
            "start_logit": 0.8980916142463684,
            "end_logit": 0.73502516746521
        },
        {
            "text": "ymphoma and S\u00e9zary syndrome, and adult T cell",
            "probability": 0.04762763931692086,
            "start_logit": 1.060619592666626,
            "end_logit": 0.5694040656089783
        },
        {
            "text": "Monocl",
            "probability": 0.04723238059021948,
            "start_logit": 0.8866649270057678,
            "end_logit": 0.73502516746521
        },
        {
            "text": "two monoclonal antibodies - the anti-CD33 immunotoxin gemtuzumab ozoga",
            "probability": 0.04702870272887101,
            "start_logit": 0.9700228571891785,
            "end_logit": 0.6473456621170044
        },
        {
            "text": "activity against B cell chronic lymphocytic and hairy cell leukaemia. Monoclonal antibodies",
            "probability": 0.045128141639251024,
            "start_logit": 1.0228060483932495,
            "end_logit": 0.5533103942871094
        },
        {
            "text": "city and complement-mediated cell l",
            "probability": 0.04506180502290698,
            "start_logit": 0.9823174476623535,
            "end_logit": 0.5923279523849487
        },
        {
            "text": "ukaemia. Monocl",
            "probability": 0.04503028098642007,
            "start_logit": 0.8389204144477844,
            "end_logit": 0.73502516746521
        },
        {
            "text": "ozoga",
            "probability": 0.04489400282634066,
            "start_logit": 0.9235689640045166,
            "end_logit": 0.6473456621170044
        },
        {
            "text": "ozogamicin and the CD52-directed antibody alemtuzumab - are approved for treatment of rela",
            "probability": 0.044331577790930325,
            "start_logit": 0.9235689640045166,
            "end_logit": 0.6347386837005615
        },
        {
            "text": "and the CD52-directed antibody alemtuzumab - are approved for treatment of rela",
            "probability": 0.04320295145653979,
            "start_logit": 0.8977805376052856,
            "end_logit": 0.6347386837005615
        },
        {
            "text": "ematological malignancies, as evidenced by the",
            "probability": 0.042904797435557175,
            "start_logit": 0.8788390755653381,
            "end_logit": 0.6467549800872803
        },
        {
            "text": "two monoclonal antibodies - the anti-CD33 immunotoxin gemtuzumab ozogamic",
            "probability": 0.04237613480755101,
            "start_logit": 0.9700228571891785,
            "end_logit": 0.5431728959083557
        }
    ],
    "5c5312097e3cb0e231000011": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c65abd17c78d69471000009": [
        {
            "text": "TMEM132 proteins contain five conserved domains including three tandem immunoglobulin",
            "probability": 0.09731374283326555,
            "start_logit": 0.8620831370353699,
            "end_logit": 0.8685056567192078
        },
        {
            "text": "associated with non-",
            "probability": 0.094274148048368,
            "start_logit": 0.994928777217865,
            "end_logit": 0.7039268016815186
        },
        {
            "text": "associated with non-syndromic",
            "probability": 0.09275736931582482,
            "start_logit": 0.994928777217865,
            "end_logit": 0.6877069473266602
        },
        {
            "text": "of choanoflagellates and metazoa. The extra-",
            "probability": 0.09117810716912148,
            "start_logit": 0.9152127504348755,
            "end_logit": 0.7502506375312805
        },
        {
            "text": "emergence of choanoflagellates and metazoa. The extra-",
            "probability": 0.0898181163637521,
            "start_logit": 0.9001846313476562,
            "end_logit": 0.7502506375312805
        },
        {
            "text": "of choanoflagellates and metazoa. The",
            "probability": 0.07846180492577585,
            "start_logit": 0.9152127504348755,
            "end_logit": 0.600047767162323
        },
        {
            "text": "of choanoflagellates and metazoa. The extra-cellular portions of T",
            "probability": 0.07823177380946578,
            "start_logit": 0.9152127504348755,
            "end_logit": 0.597111701965332
        },
        {
            "text": "TMEM132 proteins contain five conserved domains including three tandem immunoglobulin domains, and a cohesin domain homologue",
            "probability": 0.07746770043410282,
            "start_logit": 0.8620831370353699,
            "end_logit": 0.640426516532898
        },
        {
            "text": "emergence of choanoflagellates and metazoa. The",
            "probability": 0.07729148743855477,
            "start_logit": 0.9001846313476562,
            "end_logit": 0.600047767162323
        },
        {
            "text": "emergence of choanoflagellates and metazoa. The extra-cellular portions of T",
            "probability": 0.077064887411273,
            "start_logit": 0.9001846313476562,
            "end_logit": 0.597111701965332
        },
        {
            "text": "T",
            "probability": 0.07418383477976177,
            "start_logit": 0.8620831370353699,
            "end_logit": 0.597111701965332
        },
        {
            "text": "associated with non-syndro",
            "probability": 0.07195702747073401,
            "start_logit": 0.994928777217865,
            "end_logit": 0.43378889560699463
        }
    ],
    "5c0115e0133db5eb78000029": [
        {
            "text": "hylene bacterial type II topois",
            "probability": 0.28761649813478074,
            "start_logit": 1.085340142250061,
            "end_logit": 0.3948535621166229
        },
        {
            "text": "hylene bacterial",
            "probability": 0.25172484985801885,
            "start_logit": 1.085340142250061,
            "end_logit": 0.26156219840049744
        },
        {
            "text": "hylene bacterial type II topoisomerase inhibitor, is in development for treatment of un",
            "probability": 0.23191596424856595,
            "start_logit": 1.085340142250061,
            "end_logit": 0.17960065603256226
        },
        {
            "text": "hylene bacterial type II topoisome",
            "probability": 0.22874268775863454,
            "start_logit": 1.085340142250061,
            "end_logit": 0.1658233106136322
        }
    ],
    "5c5f1f371a4c55d80b00001a": [
        {
            "text": "accordance with the reduced exoribonuclease activity. Apparently, p53, via control of its",
            "probability": 0.07738131733876487,
            "start_logit": 1.2502739429473877,
            "end_logit": 1.0688931941986084
        },
        {
            "text": "53, via control of its",
            "probability": 0.059509360923303466,
            "start_logit": 0.9876621961593628,
            "end_logit": 1.0688931941986084
        },
        {
            "text": "importance of this function",
            "probability": 0.05622324485682927,
            "start_logit": 1.1647615432739258,
            "end_logit": 0.8349905014038086
        },
        {
            "text": "polysome-associated pathways. Antagonistic interplay\u00a0was detected between p53\u00a0levels and execution of its",
            "probability": 0.052742550436926286,
            "start_logit": 1.0766544342041016,
            "end_logit": 0.8591898679733276
        },
        {
            "text": "mRNA levels. The observed connection between exoribonuclease activity and p53 abundance highlights the importance of this function",
            "probability": 0.05077360613334491,
            "start_logit": 1.0628079175949097,
            "end_logit": 0.8349905014038086
        },
        {
            "text": "53 expresses an exoribonuclease activity through the binding to ARE sequences of p53-mRNA via translation-",
            "probability": 0.0502936743509003,
            "start_logit": 1.2143383026123047,
            "end_logit": 0.6739627718925476
        },
        {
            "text": "p53 levels are low in normal cells and elevated under stress conditions. While low levels of p53 promote tumor",
            "probability": 0.049665589397864446,
            "start_logit": 1.2173244953155518,
            "end_logit": 0.658409595489502
        },
        {
            "text": "oribonuclease activity, mediating degradation of adenylate/uridylate-",
            "probability": 0.04965802344788971,
            "start_logit": 0.8705824613571167,
            "end_logit": 1.0049992799758911
        },
        {
            "text": "-independent \"RNA",
            "probability": 0.04857323996307453,
            "start_logit": 0.8376724720001221,
            "end_logit": 1.0158220529556274
        },
        {
            "text": "p53 levels are low in normal cells and elevated under stress conditions.",
            "probability": 0.04828075156747102,
            "start_logit": 1.2173244953155518,
            "end_logit": 0.6301302313804626
        },
        {
            "text": "through the binding to ARE sequences of p53-mRNA. Antagonistic interplay exists between stress-induced p53 and execution of its",
            "probability": 0.047948246035395665,
            "start_logit": 0.8965796828269958,
            "end_logit": 0.9439643025398254
        },
        {
            "text": "p53, via control of its",
            "probability": 0.047521658618229226,
            "start_logit": 0.762714147567749,
            "end_logit": 1.0688931941986084
        },
        {
            "text": "minute 2 (mdm2)-independent \"RNA",
            "probability": 0.04743751413488676,
            "start_logit": 0.8140130639076233,
            "end_logit": 1.0158220529556274
        },
        {
            "text": "translation-dependent polysome-associated pathways. Antagonistic interplay\u00a0was detected between p53\u00a0levels and execution of its",
            "probability": 0.046749783238205105,
            "start_logit": 0.9560415148735046,
            "end_logit": 0.8591898679733276
        },
        {
            "text": "accordance with the reduced exoribonuclease activity. Apparently, p53, via control",
            "probability": 0.046686458272880864,
            "start_logit": 1.2502739429473877,
            "end_logit": 0.5636019706726074
        },
        {
            "text": "53 expresses an exoribonuclease activity through the binding to ARE sequences of",
            "probability": 0.04658207251118448,
            "start_logit": 1.2143383026123047,
            "end_logit": 0.5972992181777954
        },
        {
            "text": "p53 stress response",
            "probability": 0.04481111038106112,
            "start_logit": 0.8510199785232544,
            "end_logit": 0.9218578934669495
        },
        {
            "text": "importance of this function affecting p53 expression, imperative for multiple functions, with implications for the steady-",
            "probability": 0.04324008705237104,
            "start_logit": 1.1647615432739258,
            "end_logit": 0.5724282264709473
        },
        {
            "text": "p53-mRNA, which is a target of p53 itself,",
            "probability": 0.04297121612633424,
            "start_logit": 0.9341366291046143,
            "end_logit": 0.7968156337738037
        },
        {
            "text": "53, via control of its own mRNA stability and/or translation in cytoplasm, might act as a negative",
            "probability": 0.04295049521308262,
            "start_logit": 0.9876621961593628,
            "end_logit": 0.7428077459335327
        }
    ],
    "5c5249077e3cb0e23100000b": [
        {
            "text": "placed longitudinal fractures [vertical root fractures (VRFs)] is challenging in clinical practice. Radiographic techniques",
            "probability": 0.10528153941425993,
            "start_logit": 1.077775478363037,
            "end_logit": 0.9706534743309021
        },
        {
            "text": ")] is challenging in clinical practice. Radiographic techniques",
            "probability": 0.09926380531284888,
            "start_logit": 1.0189183950424194,
            "end_logit": 0.9706534743309021
        },
        {
            "text": "placed longitudinal fractures [vertical root fractures (VRFs)] is challenging in clinical practice. Radiographic",
            "probability": 0.07396024921837212,
            "start_logit": 1.077775478363037,
            "end_logit": 0.6175431609153748
        },
        {
            "text": ")] is challenging in clinical practice. Radiographic",
            "probability": 0.06973279285378581,
            "start_logit": 1.0189183950424194,
            "end_logit": 0.6175431609153748
        },
        {
            "text": ")] is challenging in clinical practice. Radiographic techniques showed a difficulty in detection of VRFs. Cone-",
            "probability": 0.06396394698042882,
            "start_logit": 1.0189183950424194,
            "end_logit": 0.5311920642852783
        },
        {
            "text": "placed longitudinal fractures [vertical root fractures (VRFs",
            "probability": 0.06148158330575939,
            "start_logit": 1.077775478363037,
            "end_logit": 0.4327530562877655
        },
        {
            "text": ")] is challenging in clinical practice. Radiographic techniques showed a difficulty in detection of VRFs. Cone-beam computed tomography",
            "probability": 0.05548143360362206,
            "start_logit": 1.0189183950424194,
            "end_logit": 0.3889209032058716
        },
        {
            "text": ") images for dental",
            "probability": 0.054783154448879844,
            "start_logit": 0.9516432285308838,
            "end_logit": 0.4435303807258606
        },
        {
            "text": "placed longitudinal fractures [vertical root fractures (VRFs)] is challenging in clinical practice.",
            "probability": 0.05144306112452332,
            "start_logit": 1.077775478363037,
            "end_logit": 0.2544909715652466
        },
        {
            "text": ")] is challenging in clinical practice.",
            "probability": 0.04850265329108612,
            "start_logit": 1.0189183950424194,
            "end_logit": 0.2544909715652466
        },
        {
            "text": ") images",
            "probability": 0.04801894949940486,
            "start_logit": 0.9516432285308838,
            "end_logit": 0.3117433488368988
        },
        {
            "text": "placed longitudinal fractures [vertical root fractures (VRFs)] is",
            "probability": 0.046181719002749824,
            "start_logit": 1.077775478363037,
            "end_logit": 0.1465994119644165
        },
        {
            "text": "placed longitudinal fractures [vertical root fractures (VRFs)] is challenging in clinical practice. Radiographic techniques showed a difficulty in detection of VRFs",
            "probability": 0.04595165261304847,
            "start_logit": 1.077775478363037,
            "end_logit": 0.1416051983833313
        },
        {
            "text": "placed longitudinal fractures [vertical root fractures (VRFs)] is challenging in clinical practice. Radiographic techniques showed a difficulty in detection of VR",
            "probability": 0.045853607733201796,
            "start_logit": 1.077775478363037,
            "end_logit": 0.13946926593780518
        },
        {
            "text": ")] is",
            "probability": 0.043542041554540056,
            "start_logit": 1.0189183950424194,
            "end_logit": 0.1465994119644165
        },
        {
            "text": ")] is challenging in clinical practice. Radiographic techniques showed a difficulty in detection of VRFs",
            "probability": 0.04332512541289355,
            "start_logit": 1.0189183950424194,
            "end_logit": 0.1416051983833313
        },
        {
            "text": ")] is challenging in clinical practice. Radiographic techniques showed a difficulty in detection of VR",
            "probability": 0.043232684630595264,
            "start_logit": 1.0189183950424194,
            "end_logit": 0.13946926593780518
        }
    ],
    "5c65897a7c78d69471000006": [
        {
            "text": "denib in humans, a minority of patients with advanced myeloid neoplasms experienced",
            "probability": 0.08869124300184085,
            "start_logit": 1.2956526279449463,
            "end_logit": 0.7011184692382812
        },
        {
            "text": "denib in humans,",
            "probability": 0.07900411146344238,
            "start_logit": 1.2956526279449463,
            "end_logit": 0.5854572057723999
        },
        {
            "text": "asidenib in humans, a minority of patients with advanced myeloid neoplasms experienced",
            "probability": 0.061930875696573566,
            "start_logit": 0.9365103244781494,
            "end_logit": 0.7011184692382812
        },
        {
            "text": "H2 acute myeloid leukemia (AML). During the first study of enasidenib in humans,",
            "probability": 0.05932262327483058,
            "start_logit": 1.0091434717178345,
            "end_logit": 0.5854572057723999
        },
        {
            "text": "H2 acute myeloid leukemia (AML). During the",
            "probability": 0.05756320024981684,
            "start_logit": 1.0091434717178345,
            "end_logit": 0.5553499460220337
        },
        {
            "text": "denib in humans, a minority of patients with advanced myeloid neo",
            "probability": 0.057012169760929474,
            "start_logit": 1.2956526279449463,
            "end_logit": 0.2592220604419708
        },
        {
            "text": "asidenib in humans,",
            "probability": 0.05516659414119542,
            "start_logit": 0.9365103244781494,
            "end_logit": 0.5854572057723999
        },
        {
            "text": "denib in humans, a minority of patients with advanced myeloid",
            "probability": 0.052861886808082396,
            "start_logit": 1.2956526279449463,
            "end_logit": 0.18363991379737854
        },
        {
            "text": "denib in humans, a minority of patients with",
            "probability": 0.052829393001953655,
            "start_logit": 1.2956526279449463,
            "end_logit": 0.1830250322818756
        },
        {
            "text": "H2 acute myeloid leukemia (AML). During the first study",
            "probability": 0.051130036860737804,
            "start_logit": 1.0091434717178345,
            "end_logit": 0.4368385970592499
        },
        {
            "text": "H2 acute myeloid",
            "probability": 0.04986690323683212,
            "start_logit": 1.0091434717178345,
            "end_logit": 0.41182398796081543
        },
        {
            "text": "H2 acute myeloid leukemia (AML). During the first study of en",
            "probability": 0.04974766659852218,
            "start_logit": 1.0091434717178345,
            "end_logit": 0.40943002700805664
        },
        {
            "text": "H2) protein inhibitor that promotes differentiation of leukemic myeloblasts, was",
            "probability": 0.04836869694720562,
            "start_logit": 1.06321120262146,
            "end_logit": 0.3272515833377838
        },
        {
            "text": "H2) protein inhibitor that promotes differentiation of leukemic myeloblasts, was recently approved by the",
            "probability": 0.043731587251922145,
            "start_logit": 1.06321120262146,
            "end_logit": 0.22646939754486084
        },
        {
            "text": "asidenib in humans, a minority of patients with advanced myeloid neo",
            "probability": 0.03981017154740733,
            "start_logit": 0.9365103244781494,
            "end_logit": 0.2592220604419708
        },
        {
            "text": "H2 acute myeloid leukemia (AML). During the first study of enasidenib in humans, a minority of patients with",
            "probability": 0.03966854535593448,
            "start_logit": 1.0091434717178345,
            "end_logit": 0.1830250322818756
        },
        {
            "text": "H2 acute myeloid leukemia (AML).",
            "probability": 0.039492718789329986,
            "start_logit": 1.0091434717178345,
            "end_logit": 0.1785827875137329
        },
        {
            "text": "asidenib in humans, a minority of patients with advanced myeloid",
            "probability": 0.03691213281259058,
            "start_logit": 0.9365103244781494,
            "end_logit": 0.18363991379737854
        },
        {
            "text": "asidenib in humans, a minority of patients with",
            "probability": 0.03688944320085262,
            "start_logit": 0.9365103244781494,
            "end_logit": 0.1830250322818756
        }
    ],
    "5c5310c37e3cb0e231000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c65901c7c78d69471000008": [
        {
            "text": "clearance) and efficacy (protection) have also been assessed. The results indicate that ADA induction in na\u00efve macaques may result",
            "probability": 0.07055571232457691,
            "start_logit": 1.0153956413269043,
            "end_logit": 1.039818525314331
        },
        {
            "text": "macaques may result",
            "probability": 0.05775009630171669,
            "start_logit": 0.8151180148124695,
            "end_logit": 1.039818525314331
        },
        {
            "text": "assessed. The results indicate that ADA induction in na\u00efve macaques may result",
            "probability": 0.05743823709397411,
            "start_logit": 0.8097032308578491,
            "end_logit": 1.039818525314331
        },
        {
            "text": "clearance",
            "probability": 0.05282335846984416,
            "start_logit": 1.0153956413269043,
            "end_logit": 0.7503693699836731
        },
        {
            "text": "ays. Timing of the anti-Id responses and their impact on pharmacokinetic profiles (clearance",
            "probability": 0.0527435032193568,
            "start_logit": 1.0138827562332153,
            "end_logit": 0.7503693699836731
        },
        {
            "text": "idiotypic antibodies (ADA, anti-",
            "probability": 0.05137641493737658,
            "start_logit": 0.9176918268203735,
            "end_logit": 0.8202989101409912
        },
        {
            "text": "antibodies play increasingly important roles as immunotherapeutic treatments for human cancers as well as inflammatory and infectious diseases",
            "probability": 0.05098450106616278,
            "start_logit": 1.097230315208435,
            "end_logit": 0.6331028938293457
        },
        {
            "text": "antibodies play increasingly important roles as immunotherapeutic treatments for human cancers as well as inflammatory and infectious diseases and have",
            "probability": 0.04976395701431184,
            "start_logit": 1.097230315208435,
            "end_logit": 0.6088721752166748
        },
        {
            "text": "kg subcutaneous (SC) injections in na\u00efve macaques of the HIV bnAb PGT121 and",
            "probability": 0.04843949890439554,
            "start_logit": 0.9610306024551392,
            "end_logit": 0.7180964946746826
        },
        {
            "text": "challenge in macaque models and reduce HIV viremia in HIV-infected individuals",
            "probability": 0.048310839468177116,
            "start_logit": 1.002123236656189,
            "end_logit": 0.6743442416191101
        },
        {
            "text": "human cancers as well as inflammatory and infectious diseases",
            "probability": 0.04801840274585482,
            "start_logit": 1.0372929573059082,
            "end_logit": 0.6331028938293457
        },
        {
            "text": "human cancers as well as inflammatory and infectious diseases and have",
            "probability": 0.04686886563898426,
            "start_logit": 1.0372929573059082,
            "end_logit": 0.6088721752166748
        },
        {
            "text": "challenge in macaque models and reduce HIV viremia in HIV-infected individuals. In the present study,",
            "probability": 0.04607938865000784,
            "start_logit": 1.002123236656189,
            "end_logit": 0.6270540356636047
        },
        {
            "text": "bnAb and the",
            "probability": 0.045855347295019035,
            "start_logit": 0.8369701504707336,
            "end_logit": 0.7873331904411316
        },
        {
            "text": "kg sub",
            "probability": 0.045750913616018594,
            "start_logit": 0.9610306024551392,
            "end_logit": 0.6609926819801331
        },
        {
            "text": "clearance) and efficacy (protection) have also been",
            "probability": 0.045570879907935985,
            "start_logit": 1.0153956413269043,
            "end_logit": 0.6026847958564758
        },
        {
            "text": "two weeks of a first or second PGT121-",
            "probability": 0.045503881634551886,
            "start_logit": 1.0254220962524414,
            "end_logit": 0.591187059879303
        },
        {
            "text": "ays. Timing of the anti-Id responses and their impact on pharmacokinetic profiles (clearance) and efficacy (protection) have also been",
            "probability": 0.04550198852852747,
            "start_logit": 1.0138827562332153,
            "end_logit": 0.6026847958564758
        },
        {
            "text": "ays. Timing of the anti-",
            "probability": 0.045386203390217,
            "start_logit": 1.0138827562332153,
            "end_logit": 0.600136935710907
        },
        {
            "text": "be compromised by unanticipated immunogenicity in humans, rendering them ineffective. Several potent broadly neutralizing HIV mono",
            "probability": 0.04527800979299032,
            "start_logit": 0.8272906541824341,
            "end_logit": 0.784342348575592
        }
    ],
    "5c78080e7c78d694710000ae": [
        {
            "text": "neuron disorder in adulthood. We report the case of siblings presenting in their",
            "probability": 0.09483252808855595,
            "start_logit": 0.8499081134796143,
            "end_logit": 0.7813718914985657
        },
        {
            "text": "present as a lower motor neuron disorder in adulthood. We report the case of siblings presenting in their",
            "probability": 0.09085493062146086,
            "start_logit": 0.8070597052574158,
            "end_logit": 0.7813718914985657
        },
        {
            "text": "neuron disorder in adulthood. We",
            "probability": 0.08058015777943195,
            "start_logit": 0.8499081134796143,
            "end_logit": 0.6185118556022644
        },
        {
            "text": "neuron disorder in adulthood. We report the case of siblings presenting",
            "probability": 0.08033858632654575,
            "start_logit": 0.8499081134796143,
            "end_logit": 0.6155094504356384
        },
        {
            "text": "neuron disorder",
            "probability": 0.07741785420086351,
            "start_logit": 0.8499081134796143,
            "end_logit": 0.5784768462181091
        },
        {
            "text": "present as a lower motor neuron disorder in adulthood. We",
            "probability": 0.07720035300208497,
            "start_logit": 0.8070597052574158,
            "end_logit": 0.6185118556022644
        },
        {
            "text": "present as a lower motor neuron disorder in adulthood. We report the case of siblings presenting",
            "probability": 0.07696891387424051,
            "start_logit": 0.8070597052574158,
            "end_logit": 0.6155094504356384
        },
        {
            "text": "neuron disorder in adulthood. We report the",
            "probability": 0.07560241020440989,
            "start_logit": 0.8499081134796143,
            "end_logit": 0.5547475814819336
        },
        {
            "text": "present as a lower motor neuron disorder",
            "probability": 0.07417068714770073,
            "start_logit": 0.8070597052574158,
            "end_logit": 0.5784768462181091
        },
        {
            "text": "present as a lower motor neuron disorder in adulthood. We report the",
            "probability": 0.07243138902215761,
            "start_logit": 0.8070597052574158,
            "end_logit": 0.5547475814819336
        },
        {
            "text": "blood test can confirm the diagnosis",
            "probability": 0.07093077270374959,
            "start_logit": 1.0739896297454834,
            "end_logit": 0.2668822705745697
        },
        {
            "text": "neuron disorder in adulthood. We report the case of siblings presenting in their late 40s with a motor ne",
            "probability": 0.0657138390193264,
            "start_logit": 0.8499081134796143,
            "end_logit": 0.4145689606666565
        },
        {
            "text": "present as a lower motor neuron disorder in adulthood. We report the case of siblings presenting in their late 40s with a motor ne",
            "probability": 0.06295757800947242,
            "start_logit": 0.8070597052574158,
            "end_logit": 0.4145689606666565
        }
    ],
    "5c65468ce842deac6700001e": [
        {
            "text": "human CCR4 immunotoxin. The single-chain fold-back diabody isoform was",
            "probability": 0.06103105495253652,
            "start_logit": 1.0130598545074463,
            "end_logit": 0.9706555604934692
        },
        {
            "text": "was the strongest among the three versions. In\u00a0vitro efficacy analysis demonstrated that the bivalent",
            "probability": 0.05744055594253022,
            "start_logit": 0.8711206912994385,
            "end_logit": 1.0519624948501587
        },
        {
            "text": "body). Binding analysis by flow cytometry showed that all three versions of the anti-human",
            "probability": 0.05651204152621664,
            "start_logit": 1.200052261352539,
            "end_logit": 0.7067340612411499
        },
        {
            "text": "NOD/SCID IL-",
            "probability": 0.0555074117245347,
            "start_logit": 0.9845401048660278,
            "end_logit": 0.9043090343475342
        },
        {
            "text": "In\u00a0vitro efficacy analysis demonstrated that the bivalent",
            "probability": 0.0541607492512969,
            "start_logit": 0.8123265504837036,
            "end_logit": 1.0519624948501587
        },
        {
            "text": "NOD/SCID IL-2 receptor \u03b3(-/-",
            "probability": 0.05312713584658868,
            "start_logit": 0.9845401048660278,
            "end_logit": 0.8604803085327148
        },
        {
            "text": "4(+) human PBMC. The bivalent isoform bound stronger than its monovalent counterpart and the single",
            "probability": 0.05181406452848983,
            "start_logit": 0.9390267133712769,
            "end_logit": 0.8809674978256226
        },
        {
            "text": "NOD/SCID IL-2 receptor \u03b3(-",
            "probability": 0.05159451629626215,
            "start_logit": 0.9845401048660278,
            "end_logit": 0.8312078714370728
        },
        {
            "text": "human CCR4 immunotoxin. The single-chain fold-back diabody iso",
            "probability": 0.05024969394141809,
            "start_logit": 1.0130598545074463,
            "end_logit": 0.7762771844863892
        },
        {
            "text": "bivalent and single",
            "probability": 0.04953171999622639,
            "start_logit": 0.8293778896331787,
            "end_logit": 0.9455679655075073
        },
        {
            "text": "using a human CCR4(+) tumor-bearing mouse model. The immunotoxin significantly",
            "probability": 0.04887157353673285,
            "start_logit": 0.828203022480011,
            "end_logit": 0.933325469493866
        },
        {
            "text": "human CCR4(+) tumor cell line as well as CCR4(+) human PBMC. The bi",
            "probability": 0.04837704909665166,
            "start_logit": 1.1047890186309814,
            "end_logit": 0.6465690732002258
        },
        {
            "text": "tumor cell line as well as CCR4(+) human PBMC. The bivalent isoform bound stronger than its monovalent counterpart",
            "probability": 0.04793150823032628,
            "start_logit": 0.9595519304275513,
            "end_logit": 0.7825537323951721
        },
        {
            "text": "human CCR4 immunotoxin. The single-chain fold-",
            "probability": 0.04786872240905663,
            "start_logit": 1.0130598545074463,
            "end_logit": 0.7277350425720215
        },
        {
            "text": "4(+) human PBMC. The bivalent isoform bound stronger than its monovalent counterpart",
            "probability": 0.0469577312977076,
            "start_logit": 0.9390267133712769,
            "end_logit": 0.7825537323951721
        },
        {
            "text": "or Tregs. In this study we have successfully developed three versions of diphtheria-",
            "probability": 0.04496615522202699,
            "start_logit": 0.9816398620605469,
            "end_logit": 0.6966028213500977
        },
        {
            "text": "using a",
            "probability": 0.04457922590226133,
            "start_logit": 0.828203022480011,
            "end_logit": 0.8413975238800049
        },
        {
            "text": "CL) and cutaneous T cell",
            "probability": 0.04447772504835004,
            "start_logit": 0.9061305522918701,
            "end_logit": 0.7611905336380005
        },
        {
            "text": "T cell lymphoma (PTCL) and cutaneous T cell",
            "probability": 0.042817587370391305,
            "start_logit": 0.8680909872055054,
            "end_logit": 0.7611905336380005
        },
        {
            "text": "is also expressed on majority of Tregs, mainly effector Tregs. In this study we have successfully developed three versions of diphtheria-",
            "probability": 0.04218377788039524,
            "start_logit": 0.9177654981613159,
            "end_logit": 0.6966028213500977
        }
    ],
    "5c51f01e07ef653866000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c531d8f7e3cb0e231000017": [
        {
            "text": "recessive congenital",
            "probability": 0.06115424143963106,
            "start_logit": 0.9947726726531982,
            "end_logit": 0.6569324731826782
        },
        {
            "text": ") is a subtype of autosomal recessive congenital",
            "probability": 0.05817991394960506,
            "start_logit": 0.9449136257171631,
            "end_logit": 0.6569324731826782
        },
        {
            "text": "recessive congenital ich",
            "probability": 0.057252727988321706,
            "start_logit": 0.9947726726531982,
            "end_logit": 0.5910085439682007
        },
        {
            "text": "I) is a subtype of autosomal recessive congenital",
            "probability": 0.05534596519345025,
            "start_logit": 0.8949772119522095,
            "end_logit": 0.6569324731826782
        },
        {
            "text": ") is a subtype of autosomal recessive congenital ich",
            "probability": 0.05446815640790651,
            "start_logit": 0.9449136257171631,
            "end_logit": 0.5910085439682007
        },
        {
            "text": "family and even in the same individual across",
            "probability": 0.0533738212198507,
            "start_logit": 0.8878656625747681,
            "end_logit": 0.627760648727417
        },
        {
            "text": "glutaminase 1, encoded by the gene TGM1. We describe a rare case of intrafami",
            "probability": 0.052232841142491944,
            "start_logit": 0.9580463171005249,
            "end_logit": 0.5359710454940796
        },
        {
            "text": "I) is a subtype of autosomal recessive congenital ich",
            "probability": 0.051815007690018455,
            "start_logit": 0.8949772119522095,
            "end_logit": 0.5910085439682007
        },
        {
            "text": "recessive congenital ichthyosis (ARCI) characterized",
            "probability": 0.05072387067185073,
            "start_logit": 0.9947726726531982,
            "end_logit": 0.46992987394332886
        },
        {
            "text": ") is a sub",
            "probability": 0.04862678637778965,
            "start_logit": 0.9449136257171631,
            "end_logit": 0.47756683826446533
        },
        {
            "text": ") is a subtype of autosomal recessive congenital ichthyosis (ARCI) characterized",
            "probability": 0.04825683977770187,
            "start_logit": 0.9449136257171631,
            "end_logit": 0.46992987394332886
        },
        {
            "text": "family and even in the",
            "probability": 0.04767398762105124,
            "start_logit": 0.8878656625747681,
            "end_logit": 0.5148261785507202
        },
        {
            "text": "recessive congenital ichthyosis (ARCI) characterized by the development of large platelike",
            "probability": 0.04757402310029865,
            "start_logit": 0.9947726726531982,
            "end_logit": 0.4058201313018799
        },
        {
            "text": "recessive congenital ichthyosis (ARCI)",
            "probability": 0.04638530242706611,
            "start_logit": 0.9947726726531982,
            "end_logit": 0.3805159032344818
        },
        {
            "text": "I) is a sub",
            "probability": 0.04625817131090405,
            "start_logit": 0.8949772119522095,
            "end_logit": 0.47756683826446533
        },
        {
            "text": "I) is a subtype of autosomal recessive congenital ichthyosis (ARCI) characterized",
            "probability": 0.04590624484243885,
            "start_logit": 0.8949772119522095,
            "end_logit": 0.46992987394332886
        },
        {
            "text": ") is a subtype of autosomal recessive congenital ichthyosis (ARCI) characterized by the development of large platelike",
            "probability": 0.0452601897277102,
            "start_logit": 0.9449136257171631,
            "end_logit": 0.4058201313018799
        },
        {
            "text": ") is a subtype of autosomal recessive congenital ichthyosis (ARCI)",
            "probability": 0.04412928425246108,
            "start_logit": 0.9449136257171631,
            "end_logit": 0.3805159032344818
        },
        {
            "text": "I) is a subtype of autosomal recessive congenital ichthyosis (ARCI) characterized by the development of large platelike",
            "probability": 0.04305556188152127,
            "start_logit": 0.8949772119522095,
            "end_logit": 0.4058201313018799
        },
        {
            "text": "family and even in the same individual across time. We also present a concise review of the genotypic spectrum of BSI from",
            "probability": 0.042327062977930784,
            "start_logit": 0.8878656625747681,
            "end_logit": 0.39586693048477173
        }
    ],
    "5c5205137e3cb0e231000001": [
        {
            "text": "83, p\u2264.005). The measure of general cognitive ability",
            "probability": 0.06115091338703234,
            "start_logit": 1.190345048904419,
            "end_logit": 0.772121012210846
        },
        {
            "text": ". Two measures of general cognitive ability were created by entering scores on",
            "probability": 0.0586134031437332,
            "start_logit": 1.0419836044311523,
            "end_logit": 0.8781010508537292
        },
        {
            "text": ".",
            "probability": 0.05842334747838973,
            "start_logit": 1.0419836044311523,
            "end_logit": 0.874853253364563
        },
        {
            "text": "83, p\u2264.005). The",
            "probability": 0.05465914099203566,
            "start_logit": 1.190345048904419,
            "end_logit": 0.6598926782608032
        },
        {
            "text": "83, p\u2264.005). The measure of general cognitive ability based on",
            "probability": 0.051497371853736595,
            "start_logit": 1.190345048904419,
            "end_logit": 0.6003069877624512
        },
        {
            "text": "measure of general cognitive ability created using the reference tests. Four-week test-retest reliability of the UK Biobank",
            "probability": 0.04984822768743992,
            "start_logit": 0.9649736285209656,
            "end_logit": 0.7931305766105652
        },
        {
            "text": "term test-retest reliability of the",
            "probability": 0.04977233012948704,
            "start_logit": 1.03922438621521,
            "end_logit": 0.7173560857772827
        },
        {
            "text": "83, p\u2264.005). The measure of general cognitive ability based on the UK",
            "probability": 0.0494768412080495,
            "start_logit": 1.190345048904419,
            "end_logit": 0.5602809190750122
        },
        {
            "text": "created by entering scores on",
            "probability": 0.04923620195331111,
            "start_logit": 0.8676493763923645,
            "end_logit": 0.8781010508537292
        },
        {
            "text": "83 (p < .001) with a measure of general cognitive ability",
            "probability": 0.04915499523831418,
            "start_logit": 0.9668247103691101,
            "end_logit": 0.777275025844574
        },
        {
            "text": "measure of general cognitive ability",
            "probability": 0.04906408948183817,
            "start_logit": 0.9649736285209656,
            "end_logit": 0.777275025844574
        },
        {
            "text": "cognitive ability created using the reference tests. Four-week test-retest reliability of the UK Biobank",
            "probability": 0.04860248936465449,
            "start_logit": 0.9396654367446899,
            "end_logit": 0.7931305766105652
        },
        {
            "text": "cognitive ability",
            "probability": 0.047837947262232255,
            "start_logit": 0.9396654367446899,
            "end_logit": 0.777275025844574
        },
        {
            "text": "Two measures of general cognitive ability were created by entering scores on",
            "probability": 0.04711849848483259,
            "start_logit": 0.823685884475708,
            "end_logit": 0.8781010508537292
        },
        {
            "text": "= 0.83 (p < .001) with a measure of general cognitive ability",
            "probability": 0.04664648677165129,
            "start_logit": 0.914443850517273,
            "end_logit": 0.777275025844574
        },
        {
            "text": ".001) with a measure of general cognitive ability created using the reference tests. Four-week test-retest reliability of the UK Biobank",
            "probability": 0.046392373746915745,
            "start_logit": 0.8931257724761963,
            "end_logit": 0.7931305766105652
        },
        {
            "text": ".83 (p < .001) with a measure of general cognitive ability",
            "probability": 0.045696667269657536,
            "start_logit": 0.8938716053962708,
            "end_logit": 0.777275025844574
        },
        {
            "text": ".001) with a measure of general cognitive ability",
            "probability": 0.045662597897479104,
            "start_logit": 0.8931257724761963,
            "end_logit": 0.777275025844574
        },
        {
            "text": "weeks later to repeat the UK Biobank tests. Correlations were calculated between UK Biobank tests and reference tests.",
            "probability": 0.045622736914564664,
            "start_logit": 0.7946742177009583,
            "end_logit": 0.874853253364563
        },
        {
            "text": "-term test-retest reliability of the",
            "probability": 0.045523339734644744,
            "start_logit": 0.9499903321266174,
            "end_logit": 0.7173560857772827
        }
    ],
    "5c7039207c78d69471000065": [
        {
            "text": "agents targeting IL-4 and IL-13 (e. g., dupilumab, tralokinumab,",
            "probability": 0.0700576839019202,
            "start_logit": 0.9314134120941162,
            "end_logit": 0.824587345123291
        },
        {
            "text": "ini",
            "probability": 0.069288217730193,
            "start_logit": 0.8592531681060791,
            "end_logit": 0.8857035040855408
        },
        {
            "text": "uritus, and JAK/STAT signaling. Advances",
            "probability": 0.06519607572157621,
            "start_logit": 1.0405241250991821,
            "end_logit": 0.6435569524765015
        },
        {
            "text": "agents targeting IL-",
            "probability": 0.06501140742616686,
            "start_logit": 0.9314134120941162,
            "end_logit": 0.7498311400413513
        },
        {
            "text": "agents targeting IL-4 and IL-13 (e. g., dupilumab, tralo",
            "probability": 0.06323085619364359,
            "start_logit": 0.9314134120941162,
            "end_logit": 0.7220607995986938
        },
        {
            "text": "uritus, and JAK/STAT signaling. Advances in our",
            "probability": 0.058733055661471884,
            "start_logit": 1.0405241250991821,
            "end_logit": 0.5391603708267212
        },
        {
            "text": "phodiesterase 4 and JAK/STAT inhibitors. In this article, we",
            "probability": 0.05338527457385509,
            "start_logit": 0.8628549575805664,
            "end_logit": 0.6213617920875549
        },
        {
            "text": "inib). Novel topical treatments include phosphodiesterase 4 and JAK/STAT inhibitors. In this article, we",
            "probability": 0.05319333791901163,
            "start_logit": 0.8592531681060791,
            "end_logit": 0.6213617920875549
        },
        {
            "text": "phodiestera",
            "probability": 0.05152064638601206,
            "start_logit": 0.8628549575805664,
            "end_logit": 0.5858094692230225
        },
        {
            "text": "inib). Novel topical treatments include phosphodiestera",
            "probability": 0.051335413649051545,
            "start_logit": 0.8592531681060791,
            "end_logit": 0.5858094692230225
        },
        {
            "text": "phodiesterase 4",
            "probability": 0.05111352455573526,
            "start_logit": 0.8628549575805664,
            "end_logit": 0.5778759717941284
        },
        {
            "text": "inib). Novel topical treatments include phosphodiesterase 4",
            "probability": 0.05092975554829267,
            "start_logit": 0.8592531681060791,
            "end_logit": 0.5778759717941284
        },
        {
            "text": "phodiesterase 4 and JAK/STAT inhibitors. In this article, we review the",
            "probability": 0.05034168369926014,
            "start_logit": 0.8628549575805664,
            "end_logit": 0.562660276889801
        },
        {
            "text": "inib). Novel topical treatments include phosphodiesterase 4 and JAK/STAT inhibitors. In this article, we review the",
            "probability": 0.0501606896995935,
            "start_logit": 0.8592531681060791,
            "end_logit": 0.562660276889801
        },
        {
            "text": "phodiesterase 4 and JAK/STAT inhibitors. In this article",
            "probability": 0.05006287190977173,
            "start_logit": 0.8628549575805664,
            "end_logit": 0.5571064949035645
        },
        {
            "text": "inib). Novel topical treatments include phosphodiesterase 4 and JAK/STAT inhibitors. In this article",
            "probability": 0.049882880325146185,
            "start_logit": 0.8592531681060791,
            "end_logit": 0.5571064949035645
        },
        {
            "text": "inib).",
            "probability": 0.048605536588521084,
            "start_logit": 0.8592531681060791,
            "end_logit": 0.5311660766601562
        },
        {
            "text": "% of cases",
            "probability": 0.04795108851077738,
            "start_logit": 0.849075198173523,
            "end_logit": 0.5277881026268005
        }
    ],
    "5c51f9dd07ef653866000005": [
        {
            "text": "1, 2 and 22 the",
            "probability": 0.06697474181513152,
            "start_logit": 1.0482091903686523,
            "end_logit": 0.8243330717086792
        },
        {
            "text": "V events. Out of 24 miRNA genes over-",
            "probability": 0.05635876432518477,
            "start_logit": 0.8521634936332703,
            "end_logit": 0.8478009700775146
        },
        {
            "text": "1, 2 and 22 the actual number of miRNA loci affected by de novo CNVs in patients",
            "probability": 0.05482246754401193,
            "start_logit": 1.0482091903686523,
            "end_logit": 0.6241176128387451
        },
        {
            "text": "random CNV events. Out of 24 miRNA genes over-",
            "probability": 0.054273720922070584,
            "start_logit": 0.8144658803939819,
            "end_logit": 0.8478009700775146
        },
        {
            "text": "V events. Out of 24 miRNA genes over-represented in CNVs from",
            "probability": 0.052889905725780645,
            "start_logit": 0.8521634936332703,
            "end_logit": 0.7842757105827332
        },
        {
            "text": "subjects",
            "probability": 0.05103096519788794,
            "start_logit": 0.9319563508033752,
            "end_logit": 0.6687029600143433
        },
        {
            "text": "random CNV events. Out of 24 miRNA genes over-represented in CNVs from",
            "probability": 0.05093319588046576,
            "start_logit": 0.8144658803939819,
            "end_logit": 0.7842757105827332
        },
        {
            "text": "V events. Out of 24 miRNA genes over-represented in CNVs from these three chromosomes only hsa-",
            "probability": 0.050290238557517006,
            "start_logit": 0.8521634936332703,
            "end_logit": 0.7338742017745972
        },
        {
            "text": "origins. Previous studies have investigated the role of de novo Copy Number Variants (CNVs) and microRNAs as important but distinct",
            "probability": 0.0496122551925389,
            "start_logit": 0.8535808324813843,
            "end_logit": 0.718883752822876
        },
        {
            "text": "random CNV events. Out of 24 miRNA genes over-represented in CNVs from these three chromosomes only hsa-",
            "probability": 0.0484297057477419,
            "start_logit": 0.8144658803939819,
            "end_logit": 0.7338742017745972
        },
        {
            "text": "first step towards a full understanding of how a dysregulated",
            "probability": 0.04841489668611883,
            "start_logit": 0.9476305246353149,
            "end_logit": 0.6004037261009216
        },
        {
            "text": "subjects as reported in the Database of Genomic Variants. Altogether the",
            "probability": 0.04813347098793581,
            "start_logit": 0.9319563508033752,
            "end_logit": 0.6102481484413147
        },
        {
            "text": "first step towards a full",
            "probability": 0.046998656303653845,
            "start_logit": 0.9476305246353149,
            "end_logit": 0.5707151889801025
        },
        {
            "text": "V events. Out of 24 miRNA genes over-represented in CNVs from these three chromosomes only hsa-mir-",
            "probability": 0.04676641000934068,
            "start_logit": 0.8521634936332703,
            "end_logit": 0.6612284183502197
        },
        {
            "text": "subjects as reported in the Database of Gen",
            "probability": 0.046408915687326094,
            "start_logit": 0.9319563508033752,
            "end_logit": 0.5737619400024414
        },
        {
            "text": "subjects as reported in the Database of Genomic Variants. Altogether the results reported in this study represent a first step towards a full",
            "probability": 0.04626773445725044,
            "start_logit": 0.9319563508033752,
            "end_logit": 0.5707151889801025
        },
        {
            "text": ". Altogether the",
            "probability": 0.04620036705822226,
            "start_logit": 0.8909662961959839,
            "end_logit": 0.6102481484413147
        },
        {
            "text": ". Altogether the results reported in this study represent a first step towards a full understanding of how a dysregulated",
            "probability": 0.04574778250445744,
            "start_logit": 0.8909662961959839,
            "end_logit": 0.6004037261009216
        },
        {
            "text": "random CNV events. Out of 24 miRNA genes over-represented in CNVs from these three chromosomes only hsa-mir-",
            "probability": 0.045036244420281896,
            "start_logit": 0.8144658803939819,
            "end_logit": 0.6612284183502197
        },
        {
            "text": ". Altogether the results reported in this study represent a first step towards a full",
            "probability": 0.04440956097708168,
            "start_logit": 0.8909662961959839,
            "end_logit": 0.5707151889801025
        }
    ],
    "5c5f29a81a4c55d80b00001f": [
        {
            "text": "% in HIV-",
            "probability": 0.07372058021110166,
            "start_logit": 1.141783356666565,
            "end_logit": 1.0830330848693848
        },
        {
            "text": "Tg-rats, but not in controls; Tg rats displayed a 2.5-",
            "probability": 0.06629359121743367,
            "start_logit": 1.07025945186615,
            "end_logit": 1.048368215560913
        },
        {
            "text": "plasma triglyceride and cholesterol levels were elevated in Tg+cART rats, but were lowered by Mg-",
            "probability": 0.06324397320138084,
            "start_logit": 0.9301245212554932,
            "end_logit": 1.1414097547531128
        },
        {
            "text": "-1 expression on",
            "probability": 0.06181832669684979,
            "start_logit": 0.8560389280319214,
            "end_logit": 1.1926953792572021
        },
        {
            "text": "Mg-supplementation. Thus, the synergistic effects of cART and HIV-1 expression on",
            "probability": 0.05712842460572365,
            "start_logit": 0.7771408557891846,
            "end_logit": 1.1926953792572021
        },
        {
            "text": "Mg-",
            "probability": 0.0542724196369749,
            "start_logit": 0.7771408557891846,
            "end_logit": 1.1414097547531128
        },
        {
            "text": "factor 2), a master transcription factor controlling redox homeostasis, was down-regulated 50% in HIV-",
            "probability": 0.05314549972226564,
            "start_logit": 0.8145347833633423,
            "end_logit": 1.0830330848693848
        },
        {
            "text": "Tg rats displayed a 2.5-",
            "probability": 0.051930862419613186,
            "start_logit": 0.8260794878005981,
            "end_logit": 1.048368215560913
        },
        {
            "text": "controls; Tg rats displayed a 2.5-",
            "probability": 0.04917152497087033,
            "start_logit": 0.771480917930603,
            "end_logit": 1.048368215560913
        },
        {
            "text": ". Concomitantly, iNOS (inducible nitric oxide synthase) was upregulated 2-",
            "probability": 0.04629109796205805,
            "start_logit": 0.8934499621391296,
            "end_logit": 0.8660341501235962
        },
        {
            "text": "Two downstream antioxidant genes, heme oxygenase-1(HmOX1) and Glutathione-",
            "probability": 0.045267511399011987,
            "start_logit": 0.9421629309654236,
            "end_logit": 0.7949610948562622
        },
        {
            "text": "gulated 2-",
            "probability": 0.04524324800926439,
            "start_logit": 0.870553731918335,
            "end_logit": 0.8660341501235962
        },
        {
            "text": "with normal or 6-fold dietary-Mg. Oxidative/nitrosative and lip",
            "probability": 0.04522069297645667,
            "start_logit": 0.8901864290237427,
            "end_logit": 0.8459028005599976
        },
        {
            "text": "with normal or 6-fold",
            "probability": 0.041443973009902275,
            "start_logit": 0.8901864290237427,
            "end_logit": 0.7586904764175415
        },
        {
            "text": "oxidant genes, heme oxygenase-1(HmOX1) and Glutathione-",
            "probability": 0.0413984811086788,
            "start_logit": 0.8528175354003906,
            "end_logit": 0.7949610948562622
        },
        {
            "text": ". Nrf2 (Nuclear erythroid-derived factor 2), a",
            "probability": 0.0413662034469027,
            "start_logit": 0.8671261668205261,
            "end_logit": 0.779872477054596
        },
        {
            "text": ". In parallel, cART-treatment led to substantial increases in plasma 8-",
            "probability": 0.041359019260373685,
            "start_logit": 0.9029750823974609,
            "end_logit": 0.7438498735427856
        },
        {
            "text": "Two downstream antioxidant genes, heme oxygenase-1(HmOX1) and Glutathione-S-",
            "probability": 0.04115445754942914,
            "start_logit": 0.9421629309654236,
            "end_logit": 0.6997037529945374
        },
        {
            "text": "HmOX1 and GST expression. Concomitantly, iNOS (ind",
            "probability": 0.04057725440912621,
            "start_logit": 0.9143338799476624,
            "end_logit": 0.7134082317352295
        },
        {
            "text": ". Oxidative/nitrosative and lip",
            "probability": 0.039952858186582674,
            "start_logit": 0.7663318514823914,
            "end_logit": 0.8459028005599976
        }
    ],
    "5c5b4a941a4c55d80b000002": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c6b7fb27c78d6947100002d": [
        {
            "text": "H) determine their",
            "probability": 0.08802025970335217,
            "start_logit": 1.195345401763916,
            "end_logit": 0.8101611137390137
        },
        {
            "text": "H) determine their long term outcomes and future quality of life. Biochemical screening of potentially affected",
            "probability": 0.07702401212510979,
            "start_logit": 1.195345401763916,
            "end_logit": 0.6767113208770752
        },
        {
            "text": "H) determine their long term outcomes and future quality of life. Biochemical screening of potentially affected newborns in fa",
            "probability": 0.07300034430401454,
            "start_logit": 1.195345401763916,
            "end_logit": 0.6230582594871521
        },
        {
            "text": "H) determine their long term outcomes and future quality of life. Biochemical screening of potentially affected newborns in fami",
            "probability": 0.067311788284505,
            "start_logit": 1.195345401763916,
            "end_logit": 0.5419294834136963
        },
        {
            "text": "H",
            "probability": 0.06701867875233564,
            "start_logit": 1.195345401763916,
            "end_logit": 0.5375654697418213
        },
        {
            "text": "H-related dental, neurosurgical, rheumatological, cardiovascular, renal and ENT complications. In 2018, the",
            "probability": 0.06415571472995624,
            "start_logit": 0.9958130121231079,
            "end_logit": 0.6934396624565125
        },
        {
            "text": "H-",
            "probability": 0.06264989289187484,
            "start_logit": 0.9958130121231079,
            "end_logit": 0.6696884632110596
        },
        {
            "text": "H for de novo cases should lead to earlier diagnosis and treatment initiation. The follow-up of children",
            "probability": 0.061801699636286164,
            "start_logit": 1.082338571548462,
            "end_logit": 0.5695317983627319
        },
        {
            "text": "H for de novo cases should lead to earlier diagnosis and treatment initiation. The follow-up of children with XLH",
            "probability": 0.06134412587320528,
            "start_logit": 1.082338571548462,
            "end_logit": 0.562100350856781
        },
        {
            "text": "H for de novo cases should",
            "probability": 0.0568384675037913,
            "start_logit": 1.082338571548462,
            "end_logit": 0.48581427335739136
        },
        {
            "text": "H for de novo cases should lead to earlier diagnosis and treatment initiation. The follow-up of children with XL",
            "probability": 0.05657900103602159,
            "start_logit": 1.082338571548462,
            "end_logit": 0.48123884201049805
        },
        {
            "text": "term outcomes and future quality of life. Biochemical screening of potentially affected",
            "probability": 0.05651063045579728,
            "start_logit": 0.8856569528579712,
            "end_logit": 0.6767113208770752
        },
        {
            "text": "term outcomes and future quality of life. Biochemical screening of potentially affected newborns in fa",
            "probability": 0.05355856396326682,
            "start_logit": 0.8856569528579712,
            "end_logit": 0.6230582594871521
        },
        {
            "text": "H-related dental, neurosurgical, rheumatological, cardiovascular, renal and EN",
            "probability": 0.052687254877456895,
            "start_logit": 0.9958130121231079,
            "end_logit": 0.49650007486343384
        },
        {
            "text": ". Diagnostic criteria of XL",
            "probability": 0.05211455607041821,
            "start_logit": 0.8920252323150635,
            "end_logit": 0.5893585681915283
        },
        {
            "text": "term outcomes and future quality of life. Biochemical screening of potentially affected newborns in fami",
            "probability": 0.049385009792608285,
            "start_logit": 0.8856569528579712,
            "end_logit": 0.5419294834136963
        }
    ],
    "5c629937e842deac67000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c7839edd774d04240000003": [
        {
            "text": "rotein (AFP) is a widely used tumor marker in hepatocellular carcinoma (HCC), 40% of newly diagnosed",
            "probability": 0.08439962437839929,
            "start_logit": 1.0361883640289307,
            "end_logit": 0.6048370599746704
        },
        {
            "text": "is a widely used tumor marker in hepatocellular carcinoma (HCC), 40% of newly diagnosed",
            "probability": 0.08340222962476439,
            "start_logit": 1.024300456047058,
            "end_logit": 0.6048370599746704
        },
        {
            "text": ") is a widely used tumor marker in hepatocellular carcinoma (HCC), 40% of newly diagnosed",
            "probability": 0.07596152337020666,
            "start_logit": 0.9308523535728455,
            "end_logit": 0.6048370599746704
        },
        {
            "text": "rotein (AFP) is a widely used tumor marker in hepatocellular carcinoma (HCC), 40",
            "probability": 0.07571717457822244,
            "start_logit": 1.0361883640289307,
            "end_logit": 0.49627912044525146
        },
        {
            "text": "is a widely used tumor marker in hepatocellular carcinoma (HCC), 40",
            "probability": 0.07482238490065482,
            "start_logit": 1.024300456047058,
            "end_logit": 0.49627912044525146
        },
        {
            "text": "is a widely used tumor marker in hepatocellular carcinoma (HCC), 40% of newly diagnosed patients do not",
            "probability": 0.07197608713713059,
            "start_logit": 1.024300456047058,
            "end_logit": 0.45749595761299133
        },
        {
            "text": "rotein (AFP) is a widely used tumor marker in hepatocellular carcinoma (HCC),",
            "probability": 0.07121682610226868,
            "start_logit": 1.0361883640289307,
            "end_logit": 0.43500322103500366
        },
        {
            "text": "is a widely used tumor marker in hepatocellular carcinoma (HCC),",
            "probability": 0.0703752194097262,
            "start_logit": 1.024300456047058,
            "end_logit": 0.43500322103500366
        },
        {
            "text": ") is a widely used tumor marker in hepatocellular carcinoma (HCC), 40",
            "probability": 0.06814712705903568,
            "start_logit": 0.9308523535728455,
            "end_logit": 0.49627912044525146
        },
        {
            "text": "rotein (AFP) is a widely used tumor marker in hepa",
            "probability": 0.06728412976692993,
            "start_logit": 1.0361883640289307,
            "end_logit": 0.378198504447937
        },
        {
            "text": "is a widely used tumor marker in hepa",
            "probability": 0.06648899781549437,
            "start_logit": 1.024300456047058,
            "end_logit": 0.378198504447937
        },
        {
            "text": ") is a widely used tumor marker in hepatocellular carcinoma (HCC), 40% of newly diagnosed patients do not",
            "probability": 0.06555476094298267,
            "start_logit": 0.9308523535728455,
            "end_logit": 0.45749595761299133
        },
        {
            "text": ") is a widely used tumor marker in hepatocellular carcinoma (HCC),",
            "probability": 0.06409671417570857,
            "start_logit": 0.9308523535728455,
            "end_logit": 0.43500322103500366
        },
        {
            "text": ") is a widely used tumor marker in hepa",
            "probability": 0.06055720073847562,
            "start_logit": 0.9308523535728455,
            "end_logit": 0.378198504447937
        }
    ],
    "5c6e05f37c78d69471000049": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c6bec987c78d69471000033": [
        {
            "text": "uncovered new",
            "probability": 0.1220849985558721,
            "start_logit": 0.9111778736114502,
            "end_logit": 0.6487338542938232
        },
        {
            "text": "uncovered new genetic alterations, the prognostic implications of these",
            "probability": 0.11187395162034028,
            "start_logit": 0.9111778736114502,
            "end_logit": 0.561389148235321
        },
        {
            "text": "uncovered new genetic alterations, the prognostic implications of these discoveries are still unclear. This article provides an update on the",
            "probability": 0.10601656434149317,
            "start_logit": 0.9111778736114502,
            "end_logit": 0.5076116919517517
        },
        {
            "text": "uncovered new genetic alterations, the prognostic implications of these discoveries are still unclear. This article provides an update on the histologic and",
            "probability": 0.0992157118800558,
            "start_logit": 0.9111778736114502,
            "end_logit": 0.4413127303123474
        },
        {
            "text": "uncovered new genetic",
            "probability": 0.09597994348604347,
            "start_logit": 0.9111778736114502,
            "end_logit": 0.4081555902957916
        },
        {
            "text": "uncovered new genetic alterations, the prognostic implications of these discoveries are still unclear. This article provides an update on",
            "probability": 0.09568798718466101,
            "start_logit": 0.9111778736114502,
            "end_logit": 0.40510910749435425
        },
        {
            "text": "uncovered new genetic alterations,",
            "probability": 0.09561656675245604,
            "start_logit": 0.9111778736114502,
            "end_logit": 0.40436244010925293
        },
        {
            "text": "uncovered new genetic alterations, the",
            "probability": 0.09353970122074637,
            "start_logit": 0.9111778736114502,
            "end_logit": 0.38240230083465576
        },
        {
            "text": "uncovered new genetic alterations, the pro",
            "probability": 0.09038223676304899,
            "start_logit": 0.9111778736114502,
            "end_logit": 0.3480640947818756
        },
        {
            "text": "uncovered new genetic alterations, the prognostic implications of these discoveries",
            "probability": 0.08960233819528274,
            "start_logit": 0.9111778736114502,
            "end_logit": 0.33939775824546814
        }
    ],
    "5c7aae9dd774d0424000000a": [
        {
            "text": "TMEM173) encoding stimulator of interfer",
            "probability": 0.12764972829306334,
            "start_logit": 1.0411185026168823,
            "end_logit": 0.4234679937362671
        },
        {
            "text": "TMEM173) encoding stimulator of inter",
            "probability": 0.12094884165814763,
            "start_logit": 1.0411185026168823,
            "end_logit": 0.3695456385612488
        },
        {
            "text": "TMEM173) encoding stimulator of interferon genes (STING) underlie",
            "probability": 0.11775970532812313,
            "start_logit": 1.0411185026168823,
            "end_logit": 0.34282413125038147
        },
        {
            "text": "TMEM173) encoding st",
            "probability": 0.1106435321898871,
            "start_logit": 1.0411185026168823,
            "end_logit": 0.28049159049987793
        },
        {
            "text": "TMEM173",
            "probability": 0.10848336814709068,
            "start_logit": 1.0411185026168823,
            "end_logit": 0.2607748508453369
        },
        {
            "text": "TME",
            "probability": 0.10736462272525428,
            "start_logit": 1.0411185026168823,
            "end_logit": 0.25040870904922485
        },
        {
            "text": "TMEM173) encoding",
            "probability": 0.1063875733930454,
            "start_logit": 1.0411185026168823,
            "end_logit": 0.24126675724983215
        },
        {
            "text": "TMEM173) encoding stimulator of interferon genes (STING) underlie a recently described type I interferono",
            "probability": 0.10155077193881368,
            "start_logit": 1.0411185026168823,
            "end_logit": 0.19473686814308167
        },
        {
            "text": "TMEM173) encoding stimulator of interferon genes (STING",
            "probability": 0.09921185632657464,
            "start_logit": 1.0411185026168823,
            "end_logit": 0.17143550515174866
        }
    ],
    "5c6e0f537c78d6947100004a": [
        {
            "text": "solid tumors in pediatrics and adult patients. It acts by inhibiting tropomyosin receptor kinase. In this paper, we report the",
            "probability": 0.10501844667860266,
            "start_logit": 0.9993610978126526,
            "end_logit": 0.6637996435165405
        },
        {
            "text": "solid",
            "probability": 0.08877373721982673,
            "start_logit": 0.9993610978126526,
            "end_logit": 0.4957544803619385
        },
        {
            "text": "rotrectinib, is an orally active novel small molecule approved for the treatment of solid",
            "probability": 0.08864054341985617,
            "start_logit": 0.9978595972061157,
            "end_logit": 0.4957544803619385
        },
        {
            "text": "solid tumors in pediatrics and adult",
            "probability": 0.08695185521300465,
            "start_logit": 0.9993610978126526,
            "end_logit": 0.4750182032585144
        },
        {
            "text": "rotrectinib, is an orally active novel small molecule approved for the treatment of solid tumors in pediatrics and adult",
            "probability": 0.08682139491727967,
            "start_logit": 0.9978595972061157,
            "end_logit": 0.4750182032585144
        },
        {
            "text": "is an orally active novel small molecule approved for the treatment of solid",
            "probability": 0.08658080868388365,
            "start_logit": 0.9743484258651733,
            "end_logit": 0.4957544803619385
        },
        {
            "text": "is an orally active novel small molecule approved for the treatment of solid tumors in pediatrics and adult",
            "probability": 0.08480393162071949,
            "start_logit": 0.9743484258651733,
            "end_logit": 0.4750182032585144
        },
        {
            "text": "solid tumors in pediatrics and adult patients. It acts by inhibiting tropomyosin receptor kinase.",
            "probability": 0.08218432003622539,
            "start_logit": 0.9993610978126526,
            "end_logit": 0.41862815618515015
        },
        {
            "text": "solid tumors in pediatrics and adult patients. It acts by inhibiting tropomyosin receptor kinase. In this paper, we",
            "probability": 0.07996286009705642,
            "start_logit": 0.9993610978126526,
            "end_logit": 0.3912259042263031
        },
        {
            "text": "ton",
            "probability": 0.07603424314262544,
            "start_logit": 0.8443194627761841,
            "end_logit": 0.4958890676498413
        },
        {
            "text": "tonitrile enriched with internal standard (IS, enasidenib",
            "probability": 0.06759552356855661,
            "start_logit": 0.8443194627761841,
            "end_logit": 0.3782470226287842
        },
        {
            "text": "tonitrile enriched with internal standard (IS",
            "probability": 0.06663233540236294,
            "start_logit": 0.8443194627761841,
            "end_logit": 0.3638952374458313
        }
    ],
    "5c6e16eb7c78d6947100004e": [
        {
            "text": "ivity and automation to improve performance and reduce labor costs.",
            "probability": 0.07838349115246876,
            "start_logit": 1.1670777797698975,
            "end_logit": 0.8778073787689209
        },
        {
            "text": "ivity and automation to improve performance and reduce labor costs. We also demonstrate the clinical utility of citrate-",
            "probability": 0.06044641967948247,
            "start_logit": 1.1670777797698975,
            "end_logit": 0.6179513931274414
        },
        {
            "text": "sensors derived from a facile citrate -based synthesis platform that utilize dynamic quenching mechanisms. Based on",
            "probability": 0.05968919553707121,
            "start_logit": 0.9272234439849854,
            "end_logit": 0.8451994061470032
        },
        {
            "text": "sitivities.",
            "probability": 0.05831603739506677,
            "start_logit": 0.8482566475868225,
            "end_logit": 0.9008923172950745
        },
        {
            "text": "be achieved with such a fa",
            "probability": 0.05826731164724989,
            "start_logit": 0.9305539131164551,
            "end_logit": 0.8177591562271118
        },
        {
            "text": "Fibrosis",
            "probability": 0.05782658198441807,
            "start_logit": 0.8145530223846436,
            "end_logit": 0.926167368888855
        },
        {
            "text": "sensors with improved chloride sensitivities.",
            "probability": 0.05440791022967534,
            "start_logit": 0.7788890600204468,
            "end_logit": 0.9008923172950745
        },
        {
            "text": "time a selective",
            "probability": 0.05388090634979976,
            "start_logit": 0.9833815097808838,
            "end_logit": 0.6866664886474609
        },
        {
            "text": "simultaneously, promising both selectivity and automation to improve performance and reduce labor costs.",
            "probability": 0.053860012831103865,
            "start_logit": 0.7918527722358704,
            "end_logit": 0.8778073787689209
        },
        {
            "text": "sensors derived from a facile citrate -based synthesis platform that utilize dynamic quenching mechanisms. Based on this low-",
            "probability": 0.05365063692666885,
            "start_logit": 0.9272234439849854,
            "end_logit": 0.7385417222976685
        },
        {
            "text": "time a selective sensing strategy that uses a single fluorophore to detect multiple halides simultaneously",
            "probability": 0.05012933035899667,
            "start_logit": 0.9833815097808838,
            "end_logit": 0.6144965887069702
        },
        {
            "text": "be achieved with such a facile synthesis platform, demonstrated in our citrate-based biodegradable polymers with intrinsic fluorescence sensing",
            "probability": 0.04959364865866214,
            "start_logit": 0.9305539131164551,
            "end_logit": 0.6565806865692139
        },
        {
            "text": "sitivities. Thus citra",
            "probability": 0.04862453083463378,
            "start_logit": 0.8482566475868225,
            "end_logit": 0.7191433310508728
        },
        {
            "text": "sensors derived from a facile citrate -based synthesis platform",
            "probability": 0.04703011663575035,
            "start_logit": 0.9272234439849854,
            "end_logit": 0.6068365573883057
        },
        {
            "text": "sensors with improved chloride sensitivities. Thus citra",
            "probability": 0.04536589293076069,
            "start_logit": 0.7788890600204468,
            "end_logit": 0.7191433310508728
        },
        {
            "text": "sitivities. Thus citrate-based fluorescent materials may enable low-cost, automated multi-",
            "probability": 0.04531935092857793,
            "start_logit": 0.8482566475868225,
            "end_logit": 0.6487492918968201
        },
        {
            "text": "sensors with improved chloride sensitivities. Thus citrate-based fluorescent materials may enable low-cost, automated multi-",
            "probability": 0.04228221407234728,
            "start_logit": 0.7788890600204468,
            "end_logit": 0.6487492918968201
        },
        {
            "text": "simultaneously, promising both selectivity and automation to improve performance and reduce labor costs. We also demonstrate the clinical utility of citrate-",
            "probability": 0.04153482948594943,
            "start_logit": 0.7918527722358704,
            "end_logit": 0.6179513931274414
        },
        {
            "text": "simultaneously",
            "probability": 0.041391582361316764,
            "start_logit": 0.7918527722358704,
            "end_logit": 0.6144965887069702
        }
    ],
    "5c51fb7a07ef653866000006": [
        {
            "text": "is followed by an unsupervised transfer learning algorithm",
            "probability": 0.061296570992698876,
            "start_logit": 1.0344202518463135,
            "end_logit": 0.9010849595069885
        },
        {
            "text": "further investigate these data sets to identify which mutations build better predictors of variant functions.",
            "probability": 0.059738903530185926,
            "start_logit": 0.9852524995803833,
            "end_logit": 0.9245122671127319
        },
        {
            "text": "perform the unsupervised transfer learning algorithm to predict",
            "probability": 0.05441740620586765,
            "start_logit": 0.8709803819656372,
            "end_logit": 0.94548499584198
        },
        {
            "text": "is followed by an unsupervised transfer learning algorithm that extends the knowledge",
            "probability": 0.05311463575947001,
            "start_logit": 1.0344202518463135,
            "end_logit": 0.757813572883606
        },
        {
            "text": "is followed by an unsupervised transfer learning algorithm that extends the knowledge to a homologous protein. We",
            "probability": 0.053049853925091206,
            "start_logit": 1.0344202518463135,
            "end_logit": 0.7565931677818298
        },
        {
            "text": ".",
            "probability": 0.05255280699288926,
            "start_logit": 1.0247536897659302,
            "end_logit": 0.7568461298942566
        },
        {
            "text": "of transfer learning algorithms we call TLmutation, which implements a supervised transfer learning algorithm that transfers knowledge",
            "probability": 0.05218645677240871,
            "start_logit": 0.9454513788223267,
            "end_logit": 0.8291529417037964
        },
        {
            "text": "further investigate these data sets to identify which mutations build better predictors of variant functions. In the second case, we apply the algorithm",
            "probability": 0.051816371851088776,
            "start_logit": 0.9852524995803833,
            "end_logit": 0.7822349667549133
        },
        {
            "text": "these data sets to identify which mutations build better predictors of variant functions.",
            "probability": 0.051700537740644044,
            "start_logit": 0.8407372236251831,
            "end_logit": 0.9245122671127319
        },
        {
            "text": "solely from single point mutagenesis data. Finally, we perform the unsupervised transfer learning algorithm to predict",
            "probability": 0.05157827552788285,
            "start_logit": 0.817396879196167,
            "end_logit": 0.94548499584198
        },
        {
            "text": "perform the unsupervised transfer learning algorithm to predict mutational effects of homolog",
            "probability": 0.05043440916645811,
            "start_logit": 0.8709803819656372,
            "end_logit": 0.8694745898246765
        },
        {
            "text": "amino acid variation in proteins. With the recent advancements in sequencing techniques, sufficient genomic data has become available to train models that predict the evolutionary statistical",
            "probability": 0.048717923478629695,
            "start_logit": 0.9991483688354492,
            "end_logit": 0.7066799402236938
        },
        {
            "text": "into protein variant functions. As these algorithms are generalized to transfer knowledge between Markov random field models, we expect these algorithms to be applicable to other disciplines",
            "probability": 0.04718360962025541,
            "start_logit": 0.8590123653411865,
            "end_logit": 0.8148155212402344
        },
        {
            "text": "further investigate these data sets to identify which mutations build better predictors of variant functions. In the second case, we apply the algorithm to predict",
            "probability": 0.046074317126657764,
            "start_logit": 0.9852524995803833,
            "end_logit": 0.6647844910621643
        },
        {
            "text": "is followed by an un",
            "probability": 0.04573506011021797,
            "start_logit": 1.0344202518463135,
            "end_logit": 0.6082262396812439
        },
        {
            "text": "perform the unsupervised transfer learning algorithm to predict mutational effects of homologous proteins from experimental data sets.",
            "probability": 0.04506226516686084,
            "start_logit": 0.8709803819656372,
            "end_logit": 0.7568461298942566
        },
        {
            "text": "these data sets to identify which mutations build better predictors of variant functions. In the second case, we apply the algorithm",
            "probability": 0.04484404852052234,
            "start_logit": 0.8407372236251831,
            "end_logit": 0.7822349667549133
        },
        {
            "text": ". These algorithms are generalized to transfer knowledge between Markov random field models. We show the benefit of our transfer learning algorithms to utilize inform",
            "probability": 0.04468278560511706,
            "start_logit": 1.0247536897659302,
            "end_logit": 0.5946159362792969
        },
        {
            "text": "amino acid variation in proteins. With the recent advancements",
            "probability": 0.043423113007372616,
            "start_logit": 0.9991483688354492,
            "end_logit": 0.5916247963905334
        },
        {
            "text": "proteins. With the recent advancements in sequencing techniques, sufficient genomic data has become available to train models that predict the evolutionary statistical",
            "probability": 0.042390648899680854,
            "start_logit": 0.8600291609764099,
            "end_logit": 0.7066799402236938
        }
    ],
    "5c51fe8907ef653866000007": [
        {
            "text": "comprehensive detection of multiple pesticides in groundwater. Based on",
            "probability": 0.06691827206180989,
            "start_logit": 1.0762159824371338,
            "end_logit": 0.7553375363349915
        },
        {
            "text": "study on the comprehensive detection of multiple pesticides in groundwater. Based on",
            "probability": 0.06222394937884423,
            "start_logit": 1.0034838914871216,
            "end_logit": 0.7553375363349915
        },
        {
            "text": "is an important commodity grain base of China, and this is the",
            "probability": 0.05617315101104901,
            "start_logit": 0.8892731666564941,
            "end_logit": 0.767247200012207
        },
        {
            "text": "is an important commodity grain base of China, and this is the first study on the comprehensive detection of multiple pesticides in groundwater. Based on",
            "probability": 0.05550811570891255,
            "start_logit": 0.8892731666564941,
            "end_logit": 0.7553375363349915
        },
        {
            "text": "is the",
            "probability": 0.054606643168823354,
            "start_logit": 0.8609898090362549,
            "end_logit": 0.767247200012207
        },
        {
            "text": "this is the",
            "probability": 0.054455108084133605,
            "start_logit": 0.8582109212875366,
            "end_logit": 0.767247200012207
        },
        {
            "text": "hyl-p-nitrophenyl phenylphosphonothioate and methyl",
            "probability": 0.05402727414972113,
            "start_logit": 0.8821157813072205,
            "end_logit": 0.7354546785354614
        },
        {
            "text": "is the first study on the comprehensive detection of multiple pesticides in groundwater. Based on",
            "probability": 0.053960153791161536,
            "start_logit": 0.8609898090362549,
            "end_logit": 0.7553375363349915
        },
        {
            "text": "this is the first study on the comprehensive detection of multiple pesticides in groundwater. Based on",
            "probability": 0.05381041273402796,
            "start_logit": 0.8582109212875366,
            "end_logit": 0.7553375363349915
        },
        {
            "text": "p-nitrophenyl phenylphosphonothioate and methyl",
            "probability": 0.04767180643585982,
            "start_logit": 0.7569669485092163,
            "end_logit": 0.7354546785354614
        },
        {
            "text": ". Based on",
            "probability": 0.04589068489572045,
            "start_logit": 0.8121712803840637,
            "end_logit": 0.6421723365783691
        },
        {
            "text": ". A new insight",
            "probability": 0.04588052985810902,
            "start_logit": 0.8087136149406433,
            "end_logit": 0.6454086899757385
        },
        {
            "text": ". Based on the spatial distribution, the characteristic of nonpoint",
            "probability": 0.04539795935035635,
            "start_logit": 0.8121712803840637,
            "end_logit": 0.6313773393630981
        },
        {
            "text": ". According to health risk assessment,",
            "probability": 0.044527337894522075,
            "start_logit": 0.7984199523925781,
            "end_logit": 0.6257648468017578
        },
        {
            "text": "hyl-",
            "probability": 0.044438174703756196,
            "start_logit": 0.8821157813072205,
            "end_logit": 0.5400645732879639
        },
        {
            "text": "Nine core pesticides and three distinct clusters of the",
            "probability": 0.04390400671572749,
            "start_logit": 0.7377831339836121,
            "end_logit": 0.6723039150238037
        },
        {
            "text": ". A new insight for prediction of pesticide occurrence was provided by the Pearson correlation between some individual pesticide concentrations and the",
            "probability": 0.04301296010423539,
            "start_logit": 0.8087136149406433,
            "end_logit": 0.5808693170547485
        },
        {
            "text": ". Based on the spatial distribution, the characteristic",
            "probability": 0.04259568214261659,
            "start_logit": 0.8121712803840637,
            "end_logit": 0.5676630735397339
        },
        {
            "text": "a significant relationship between the",
            "probability": 0.04256207274969097,
            "start_logit": 0.7714098691940308,
            "end_logit": 0.6076351404190063
        },
        {
            "text": "Nine core pesticides and three distinct clusters of the core pesticides",
            "probability": 0.042435705060922466,
            "start_logit": 0.7377831339836121,
            "end_logit": 0.6382884383201599
        }
    ],
    "5c6f14297c78d69471000052": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a": [
        {
            "text": "cal virome transplantation (FVT), decreases the risk of invasive",
            "probability": 0.08419490906569425,
            "start_logit": 0.9790287613868713,
            "end_logit": 0.7033088207244873
        },
        {
            "text": "cal virome transplantation (FVT), decreases the risk of invasive infections caused by bacteria. However, eukar",
            "probability": 0.08150707294825733,
            "start_logit": 0.9790287613868713,
            "end_logit": 0.6708641648292542
        },
        {
            "text": "cal virome transplantation (FVT), decreases the",
            "probability": 0.07970684952871686,
            "start_logit": 0.9790287613868713,
            "end_logit": 0.6485298871994019
        },
        {
            "text": "cal virome transplantation (FVT), decreases the risk of invasive infections caused by bacteria",
            "probability": 0.07764668202910573,
            "start_logit": 0.9790287613868713,
            "end_logit": 0.6223431825637817
        },
        {
            "text": "accepted as a promising experimental treatment for patients suffering from GM imbalances (dysbiosis), e.g.",
            "probability": 0.07749927820108402,
            "start_logit": 1.0861434936523438,
            "end_logit": 0.5133282542228699
        },
        {
            "text": "human health and disease, and routes for manipulating the GM have become an area of intense research. Due to its",
            "probability": 0.07099454654884921,
            "start_logit": 0.9621013402938843,
            "end_logit": 0.5497048497200012
        },
        {
            "text": "cal virome",
            "probability": 0.07018063562482585,
            "start_logit": 0.9790287613868713,
            "end_logit": 0.5212467908859253
        },
        {
            "text": "obesity and type-2-",
            "probability": 0.06982936408208715,
            "start_logit": 0.8986773490905762,
            "end_logit": 0.5965803861618042
        },
        {
            "text": "disease, and routes for manipulating the GM have become an area of intense research. Due to its",
            "probability": 0.068188821373747,
            "start_logit": 0.9217789173126221,
            "end_logit": 0.5497048497200012
        },
        {
            "text": ") composition and function are linked to human health and disease, and routes for manipulating the GM have become an area of intense research. Due to its",
            "probability": 0.06751684696442578,
            "start_logit": 0.9118754267692566,
            "end_logit": 0.5497048497200012
        },
        {
            "text": "ge-encoded virulence factors remain a safety issue. Recent in vivo",
            "probability": 0.06451488717044984,
            "start_logit": 0.8124889731407166,
            "end_logit": 0.6036101579666138
        },
        {
            "text": "composition and function are linked to human health and disease, and routes for manipulating the GM have become an area of intense research. Due to its",
            "probability": 0.06387987184682803,
            "start_logit": 0.8565025925636292,
            "end_logit": 0.5497048497200012
        },
        {
            "text": "obesity and type-2-diabetes (T2D). In this review, we discuss the promises and limitations of FV",
            "probability": 0.06271807930734719,
            "start_logit": 0.8986773490905762,
            "end_logit": 0.4891755282878876
        },
        {
            "text": "obesity and type-",
            "probability": 0.06162215530858193,
            "start_logit": 0.8986773490905762,
            "end_logit": 0.4715472459793091
        }
    ],
    "5c0117fd133db5eb7800002a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c71d7ca7c78d6947100006b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c53143b7e3cb0e231000013": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c5b268986df2b9174000019": [
        {
            "text": "user-friendly capability of browsing and searching the",
            "probability": 0.08550474506214063,
            "start_logit": 0.8540186285972595,
            "end_logit": 1.1447111368179321
        },
        {
            "text": "capability of browsing and searching the",
            "probability": 0.07935905066546782,
            "start_logit": 0.7794292569160461,
            "end_logit": 1.1447111368179321
        },
        {
            "text": "DNA replication per cell",
            "probability": 0.0682413119760573,
            "start_logit": 0.8231644034385681,
            "end_logit": 0.9500436186790466
        },
        {
            "text": "), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues.",
            "probability": 0.06707701077631686,
            "start_logit": 0.905816376209259,
            "end_logit": 0.8501828908920288
        },
        {
            "text": "-line origin, occur in somatic cells during DNA replication per cell",
            "probability": 0.06451797450971572,
            "start_logit": 0.7670581340789795,
            "end_logit": 0.9500436186790466
        },
        {
            "text": "DNA replication per cell-division. The somatic mutations, recording the unique genetic cell-lineage",
            "probability": 0.054187758069684455,
            "start_logit": 0.8231644034385681,
            "end_logit": 0.7194485068321228
        },
        {
            "text": "established DSMNC: a database of somatic mutations in normal cells (http://dsmnc.",
            "probability": 0.053846217317961145,
            "start_logit": 0.9749952554702759,
            "end_logit": 0.5612947940826416
        },
        {
            "text": "), which provides most comprehensive catalogue of somatic SNVs in single",
            "probability": 0.05352359781149046,
            "start_logit": 0.905816376209259,
            "end_logit": 0.6244641542434692
        },
        {
            "text": "-line origin, occur in somatic cells during DNA replication per cell-division. The somatic mutations, recording the unique genetic cell-lineage",
            "probability": 0.05123120134479766,
            "start_logit": 0.7670581340789795,
            "end_logit": 0.7194485068321228
        },
        {
            "text": "DNA replication per",
            "probability": 0.05024363625740499,
            "start_logit": 0.8231644034385681,
            "end_logit": 0.643877387046814
        },
        {
            "text": "erogeneous normal cells.",
            "probability": 0.050069742018057396,
            "start_logit": 0.7724299430847168,
            "end_logit": 0.6911448240280151
        },
        {
            "text": "-line origin, occur in somatic cells during DNA replication per",
            "probability": 0.047502276106121996,
            "start_logit": 0.7670581340789795,
            "end_logit": 0.643877387046814
        },
        {
            "text": "we established DSMNC: a database of somatic mutations in normal cells (http://dsmnc.",
            "probability": 0.046641916156776764,
            "start_logit": 0.8313627243041992,
            "end_logit": 0.5612947940826416
        },
        {
            "text": "NC, which serves as a timely and valuable collection of somatic mutations in individual normal cells, has made it possible to analyze the",
            "probability": 0.046186867090940414,
            "start_logit": 0.7871097326278687,
            "end_logit": 0.5957436561584473
        },
        {
            "text": "we",
            "probability": 0.0461425658267766,
            "start_logit": 0.8313627243041992,
            "end_logit": 0.5505310297012329
        },
        {
            "text": "SNVs accumulated in \u223c600 single",
            "probability": 0.04585897071813832,
            "start_logit": 0.8237676620483398,
            "end_logit": 0.5519610643386841
        },
        {
            "text": "SNVs accumulated in \u223c600",
            "probability": 0.0450542142232065,
            "start_logit": 0.8237676620483398,
            "end_logit": 0.5342567563056946
        },
        {
            "text": "NVs accumulated",
            "probability": 0.044810944068944744,
            "start_logit": 0.8237676620483398,
            "end_logit": 0.5288426280021667
        }
    ],
    "5c72ade07c78d69471000070": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c53191a7e3cb0e231000016": [
        {
            "text": "28-day dose-",
            "probability": 0.07632215433304314,
            "start_logit": 0.9064100980758667,
            "end_logit": 1.17359459400177
        },
        {
            "text": "showed evidence of P.\u00a0gulae DNA and neuronal lysine-gingipain,",
            "probability": 0.07038585861260009,
            "start_logit": 0.9027127027511597,
            "end_logit": 1.0963211059570312
        },
        {
            "text": "ysine-gingipain target engagement and reduction of bacterial load and downstream pathology. In a 28-day dose-",
            "probability": 0.0635548355458826,
            "start_logit": 0.723349928855896,
            "end_logit": 1.17359459400177
        },
        {
            "text": "uronal lysine-",
            "probability": 0.06268753381913744,
            "start_logit": 0.7868829369544983,
            "end_logit": 1.0963211059570312
        },
        {
            "text": "28-day dose-response study, COR388 inhibited the lysine-",
            "probability": 0.05722028283220451,
            "start_logit": 0.9064100980758667,
            "end_logit": 0.8855397701263428
        },
        {
            "text": "etics and pharmacodynamics of COR388 lysine-gingipain inhibition",
            "probability": 0.05110940526301174,
            "start_logit": 0.9621374011039734,
            "end_logit": 0.7168725728988647
        },
        {
            "text": "is systemic and spreads beyond its",
            "probability": 0.049856659728665716,
            "start_logit": 0.9767428636550903,
            "end_logit": 0.6774506568908691
        },
        {
            "text": "28-day dose-response study, COR388 inhibited the lysine-gingipain target",
            "probability": 0.04881770461687002,
            "start_logit": 0.9064100980758667,
            "end_logit": 0.72672438621521
        },
        {
            "text": "gipain target",
            "probability": 0.04771093592771475,
            "start_logit": 0.8834776878356934,
            "end_logit": 0.72672438621521
        },
        {
            "text": "etics and ph",
            "probability": 0.047679343316208815,
            "start_logit": 0.9621374011039734,
            "end_logit": 0.647402286529541
        },
        {
            "text": "is associated with periodontal disease, which provides a physiologically relevant model to investigate the pharmacology of COR388",
            "probability": 0.046532572626537184,
            "start_logit": 0.9064688086509705,
            "end_logit": 0.6787251830101013
        },
        {
            "text": "is systemic and spreads beyond its oral reservoir, similar to recent observations of P.\u00a0gingivalis",
            "probability": 0.04391941829766851,
            "start_logit": 0.9767428636550903,
            "end_logit": 0.5506551265716553
        },
        {
            "text": "disease in naturally occurring P.\u00a0gulae infection in the dog, support the use of COR388 in targeting lysine-gingipain",
            "probability": 0.04330429529530998,
            "start_logit": 0.9412118196487427,
            "end_logit": 0.572081446647644
        },
        {
            "text": "is associated with periodontal disease, which provides a physiologically relevant model",
            "probability": 0.04280449450052238,
            "start_logit": 0.9064688086509705,
            "end_logit": 0.5952157378196716
        },
        {
            "text": "is associated with periodontal disease, which provides a physiologically relevant model to investigate the pharmacology of COR38",
            "probability": 0.04275973413121643,
            "start_logit": 0.9064688086509705,
            "end_logit": 0.5941694974899292
        },
        {
            "text": "P.\u00a0gulae infection is systemic and spreads beyond its",
            "probability": 0.041899819512325936,
            "start_logit": 0.8028723001480103,
            "end_logit": 0.6774506568908691
        },
        {
            "text": "neuronal lysine-gingipain, demonstrating that P.\u00a0gulae infection is systemic and spreads beyond its",
            "probability": 0.04123519569592988,
            "start_logit": 0.7868829369544983,
            "end_logit": 0.6774506568908691
        },
        {
            "text": "occurring P.\u00a0gulae infection in the dog, support the use of COR388 in targeting lysine-gingipain",
            "probability": 0.04114814608365385,
            "start_logit": 0.8901388645172119,
            "end_logit": 0.572081446647644
        },
        {
            "text": "28-",
            "probability": 0.04071697912654178,
            "start_logit": 0.9064100980758667,
            "end_logit": 0.5452765226364136
        },
        {
            "text": "disease in naturally occurring P.\u00a0gulae infection in the dog, support the use of COR388",
            "probability": 0.04033463073495513,
            "start_logit": 0.9412118196487427,
            "end_logit": 0.5010400414466858
        }
    ],
    "5c7813f57c78d694710000b0": [
        {
            "text": "lines",
            "probability": 0.17775611374265374,
            "start_logit": 1.289475440979004,
            "end_logit": 0.8380984663963318
        },
        {
            "text": "Fifteen hybridoma cell lines",
            "probability": 0.13974440786843018,
            "start_logit": 1.0488780736923218,
            "end_logit": 0.8380984663963318
        },
        {
            "text": "lines producing monocl",
            "probability": 0.12974010852531861,
            "start_logit": 1.289475440979004,
            "end_logit": 0.5232192873954773
        },
        {
            "text": "lines producing monoclonal antibodies specific for the determinants of cholera toxin were derived from the fusion of mouse myeloma cells and spleen",
            "probability": 0.1267693067479856,
            "start_logit": 1.289475440979004,
            "end_logit": 0.5000549554824829
        },
        {
            "text": "remaining two appear to react with both subunits.",
            "probability": 0.12356518332442713,
            "start_logit": 0.8629924058914185,
            "end_logit": 0.9009378552436829
        },
        {
            "text": "Fifteen hybridoma cell lines producing monocl",
            "probability": 0.10199623664649232,
            "start_logit": 1.0488780736923218,
            "end_logit": 0.5232192873954773
        },
        {
            "text": "cl",
            "probability": 0.10137496857754154,
            "start_logit": 1.0427683591842651,
            "end_logit": 0.5232192873954773
        },
        {
            "text": "clonal antibodies specific for the determinants of cholera toxin were derived from the fusion of mouse myeloma cells and spleen",
            "probability": 0.09905367456715101,
            "start_logit": 1.0427683591842651,
            "end_logit": 0.5000549554824829
        }
    ],
    "5c571dd307647bbc4b000016": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c6b810e7c78d6947100002e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c73ace87c78d69471000084": [
        {
            "text": "has already been tested",
            "probability": 0.08387141817571298,
            "start_logit": 1.006314754486084,
            "end_logit": 1.3263484239578247
        },
        {
            "text": "H)-1 and -2 mutations which are each present in around 10-",
            "probability": 0.07897859168881446,
            "start_logit": 1.1385400295257568,
            "end_logit": 1.1340150833129883
        },
        {
            "text": "already been tested",
            "probability": 0.07074950763824926,
            "start_logit": 0.8361754417419434,
            "end_logit": 1.3263484239578247
        },
        {
            "text": ") fusions and BRAF mutations. The IDH1 inhibitor ivosidenib has already been tested",
            "probability": 0.06890362789977518,
            "start_logit": 0.8097386956214905,
            "end_logit": 1.3263484239578247
        },
        {
            "text": ")-1 and -2 mutations which are each present in around 10-",
            "probability": 0.06469650610054581,
            "start_logit": 0.9390704035758972,
            "end_logit": 1.1340150833129883
        },
        {
            "text": "H)-1 and -2 mutations which are each",
            "probability": 0.051599939798797685,
            "start_logit": 1.1385400295257568,
            "end_logit": 0.7083587646484375
        },
        {
            "text": "H)-",
            "probability": 0.05118976871440361,
            "start_logit": 1.1385400295257568,
            "end_logit": 0.7003779411315918
        },
        {
            "text": "has already been tested in a phase III clinical trial in pretreated cholangiocarcinoma and showed benefit in terms of progression-",
            "probability": 0.046261113619629944,
            "start_logit": 1.006314754486084,
            "end_logit": 0.7313652634620667
        },
        {
            "text": "nt pathway, neurotropic tyrosine kinase receptor (NTRK) fusion",
            "probability": 0.045708035241664655,
            "start_logit": 0.8413332104682922,
            "end_logit": 0.8843191862106323
        },
        {
            "text": ") fusion",
            "probability": 0.04428648685810803,
            "start_logit": 0.8097386956214905,
            "end_logit": 0.8843191862106323
        },
        {
            "text": ")-1 and -2 mutations which are each",
            "probability": 0.04226886993799753,
            "start_logit": 0.9390704035758972,
            "end_logit": 0.7083587646484375
        },
        {
            "text": ") fusions and BRAF mutations. The IDH1 inhibitor ivosideni",
            "probability": 0.04219041249082449,
            "start_logit": 0.8097386956214905,
            "end_logit": 0.8358325958251953
        },
        {
            "text": ")-",
            "probability": 0.04193287209989569,
            "start_logit": 0.9390704035758972,
            "end_logit": 0.7003779411315918
        },
        {
            "text": "has already been tested in a phase III clinical trial in pretreated cholangio",
            "probability": 0.041548376889342147,
            "start_logit": 1.006314754486084,
            "end_logit": 0.6239219903945923
        },
        {
            "text": "already been tested in a phase III clinical trial in pretreated cholangiocarcinoma and showed benefit in terms of progression-free survival.",
            "probability": 0.04133549891263016,
            "start_logit": 0.8361754417419434,
            "end_logit": 0.788924515247345
        },
        {
            "text": "already been tested in a phase III clinical trial in pretreated cholangiocarcinoma and showed benefit in terms of progression-",
            "probability": 0.039023437096640017,
            "start_logit": 0.8361754417419434,
            "end_logit": 0.7313652634620667
        },
        {
            "text": "has already been tested in a phase III clinical trial in pretreated cholangiocarcinoma and showed benefit",
            "probability": 0.038970471011240584,
            "start_logit": 1.006314754486084,
            "end_logit": 0.5598677396774292
        },
        {
            "text": "GFR2 fusions.",
            "probability": 0.03856360976270256,
            "start_logit": 0.8822558522224426,
            "end_logit": 0.6734315156936646
        },
        {
            "text": "already been tested in a phase III clinical trial in pretreated cholangio",
            "probability": 0.03504802079214851,
            "start_logit": 0.8361754417419434,
            "end_logit": 0.6239219903945923
        },
        {
            "text": "already been tested in a phase III clinical trial in pretreated cholangiocarcinoma and showed benefit",
            "probability": 0.032873435270876765,
            "start_logit": 0.8361754417419434,
            "end_logit": 0.5598677396774292
        }
    ],
    "5c61f767e842deac67000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c72f6b17c78d6947100007f": [
        {
            "text": ") causes Wolman disease and cholesterol ester storage disease. With the recent introduction of enzyme replacement therapy to manage LAL deficiency comes the",
            "probability": 0.0888482128920303,
            "start_logit": 0.9580790400505066,
            "end_logit": 0.4286046028137207
        },
        {
            "text": "recent introduction of enzyme replacement therapy to manage LAL deficiency comes the",
            "probability": 0.08677623003392107,
            "start_logit": 0.9344823360443115,
            "end_logit": 0.4286046028137207
        },
        {
            "text": "recent introduction of enzyme replacement therapy to manage LAL deficiency comes the need for a reliable assay of LAL enzymatic activity that can",
            "probability": 0.08333458809496341,
            "start_logit": 0.9344823360443115,
            "end_logit": 0.38813555240631104
        },
        {
            "text": ") causes Wolman disease and cholesterol ester storage",
            "probability": 0.08113959426706262,
            "start_logit": 0.9580790400505066,
            "end_logit": 0.33784621953964233
        },
        {
            "text": ") causes Wolman disease and cholesterol ester storage disease.",
            "probability": 0.07791871397407762,
            "start_logit": 0.9580790400505066,
            "end_logit": 0.29734131693840027
        },
        {
            "text": ") causes Wolman disease and cholesterol ester storage disease. With the recent introduction of enzyme",
            "probability": 0.07700711220538255,
            "start_logit": 0.9580790400505066,
            "end_logit": 0.28557294607162476
        },
        {
            "text": "recent introduction of enzyme",
            "probability": 0.0752112694838644,
            "start_logit": 0.9344823360443115,
            "end_logit": 0.28557294607162476
        },
        {
            "text": ") causes Wolman disease and choles",
            "probability": 0.07517028415965986,
            "start_logit": 0.9580790400505066,
            "end_logit": 0.26143115758895874
        },
        {
            "text": "recent introduction of enzyme replacement therapy to manage LAL deficiency comes the need for a reliable assay of LAL enzymatic activity",
            "probability": 0.07458091221365583,
            "start_logit": 0.9344823360443115,
            "end_logit": 0.2771564722061157
        },
        {
            "text": ")",
            "probability": 0.0726804624247684,
            "start_logit": 0.9580790400505066,
            "end_logit": 0.22774776816368103
        },
        {
            "text": "recent introduction of enzyme replacement therapy to manage LAL deficiency comes the need for a reliable assay of",
            "probability": 0.07092675080107214,
            "start_logit": 0.9344823360443115,
            "end_logit": 0.2269195318222046
        },
        {
            "text": ") causes Wolman disease and cholesterol ester storage disease. With the",
            "probability": 0.0693495548071143,
            "start_logit": 0.9580790400505066,
            "end_logit": 0.18083488941192627
        },
        {
            "text": "recent introduction of enzyme replacement therapy to manage LAL deficiency comes the need for a reliable assay of LAL enzy",
            "probability": 0.06705631464242753,
            "start_logit": 0.9344823360443115,
            "end_logit": 0.17080464959144592
        }
    ],
    "5c89623bf9c2ba6b28000005": [
        {
            "text": ") levels are often found in patients with advanced hepa",
            "probability": 0.14747981255337603,
            "start_logit": 1.002677321434021,
            "end_logit": 0.6439993381500244
        },
        {
            "text": "study aimed to evaluate the expression",
            "probability": 0.14375227773568144,
            "start_logit": 1.1277806758880615,
            "end_logit": 0.49329620599746704
        },
        {
            "text": "study aimed to evaluate the expression of cancer stem cell markers (CD44, CD90) and AFP levels in patients",
            "probability": 0.1369683358005512,
            "start_logit": 1.1277806758880615,
            "end_logit": 0.44495445489883423
        },
        {
            "text": "study aimed to evaluate the expression of cancer stem",
            "probability": 0.13451604111528156,
            "start_logit": 1.1277806758880615,
            "end_logit": 0.4268881380558014
        },
        {
            "text": ") levels are often found in patients with advanced he",
            "probability": 0.12453524308267461,
            "start_logit": 1.002677321434021,
            "end_logit": 0.47489678859710693
        },
        {
            "text": "study aimed to evaluate the expression of cancer stem cell markers (CD44, CD90) and AFP",
            "probability": 0.12011883094893477,
            "start_logit": 1.1277806758880615,
            "end_logit": 0.31368619203567505
        },
        {
            "text": ") levels are often found in patients with advanced hepatocellular carcinoma (HCC). Cluster",
            "probability": 0.09643518719991452,
            "start_logit": 1.002677321434021,
            "end_logit": 0.2191791832447052
        },
        {
            "text": ") levels are often found in patients with advanced hepatocellular carcinoma (HCC). Cluster Differentiation 44 (CD",
            "probability": 0.09619427156358595,
            "start_logit": 1.002677321434021,
            "end_logit": 0.21667784452438354
        }
    ],
    "5c8cdfe50101eac870000004": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c84346b75a4a5d219000001": [
        {
            "text": "is usually with a combination of ampicillin and an aminoglycoside but other regimens have been used. The",
            "probability": 0.22605255777698519,
            "start_logit": 0.9842837452888489,
            "end_logit": 0.7991162538528442
        },
        {
            "text": "reflecting the combination of an",
            "probability": 0.19937087298355208,
            "start_logit": 0.9855715036392212,
            "end_logit": 0.6722277402877808
        },
        {
            "text": "ised hosts. The latter syndrome mimics the",
            "probability": 0.19707288019316482,
            "start_logit": 0.9485297799110413,
            "end_logit": 0.6976763010025024
        },
        {
            "text": "is usually with a",
            "probability": 0.18954426226917093,
            "start_logit": 0.9842837452888489,
            "end_logit": 0.6229712963104248
        },
        {
            "text": "is usually with a combination of ampici",
            "probability": 0.18795942677712693,
            "start_logit": 0.9842837452888489,
            "end_logit": 0.6145748496055603
        }
    ],
    "5c73acef7c78d69471000088": [
        {
            "text": "interface of the calcitonin receptor-like",
            "probability": 0.07995498966860513,
            "start_logit": 0.8443062901496887,
            "end_logit": 1.3446598052978516
        },
        {
            "text": "21-residue-long complementary determining region (CDR)-H3 loop,",
            "probability": 0.05712702284185518,
            "start_logit": 0.992150068283081,
            "end_logit": 0.8606294393539429
        },
        {
            "text": "FDA-approved mAb against a G-protein-coupled receptor (GPCR). Here, we",
            "probability": 0.056272427640796575,
            "start_logit": 0.9076722860336304,
            "end_logit": 0.9300346374511719
        },
        {
            "text": "21-",
            "probability": 0.056119230171389964,
            "start_logit": 0.992150068283081,
            "end_logit": 0.8428307175636292
        },
        {
            "text": ")-H3 loop,",
            "probability": 0.05348150992140125,
            "start_logit": 0.9262087941169739,
            "end_logit": 0.8606294393539429
        },
        {
            "text": "GRPR reveals a direct ligand-blocking mechanism, enabled by a remarkable 21-",
            "probability": 0.0523771436578253,
            "start_logit": 0.9231418371200562,
            "end_logit": 0.8428307175636292
        },
        {
            "text": "ivity. Such structural insights reveal the drug action mechanism of erenumab and shed light on",
            "probability": 0.05181111376565538,
            "start_logit": 0.9464986324310303,
            "end_logit": 0.8086082935333252
        },
        {
            "text": "enumab and shed light on",
            "probability": 0.05008124269482285,
            "start_logit": 0.9125404953956604,
            "end_logit": 0.8086082935333252
        },
        {
            "text": "21-residue-",
            "probability": 0.04965773309333853,
            "start_logit": 0.992150068283081,
            "end_logit": 0.7205063104629517
        },
        {
            "text": "hysiology. Aimovig (erenumab; erenumab-aooe in the",
            "probability": 0.0485109115045665,
            "start_logit": 0.9205113649368286,
            "end_logit": 0.7687796354293823
        },
        {
            "text": "21-residue-long complementary determining region (CDR)-H3 loop, which adopts a tyrosine-rich helix-",
            "probability": 0.04645860935461042,
            "start_logit": 0.992150068283081,
            "end_logit": 0.6539139747619629
        },
        {
            "text": "GRPR reveals a direct ligand-blocking mechanism, enabled by a remarkable 21-residue-",
            "probability": 0.04634650568100118,
            "start_logit": 0.9231418371200562,
            "end_logit": 0.7205063104629517
        },
        {
            "text": "21-residue",
            "probability": 0.04616035873460329,
            "start_logit": 0.992150068283081,
            "end_logit": 0.6474735736846924
        },
        {
            "text": "21-residue-long complementary determining region (CDR)-H3 loop, which adopts a",
            "probability": 0.04421892049227203,
            "start_logit": 0.992150068283081,
            "end_logit": 0.6045049428939819
        },
        {
            "text": "Furthermore, erenumab engages",
            "probability": 0.04407636952939335,
            "start_logit": 0.7939541339874268,
            "end_logit": 0.799471914768219
        },
        {
            "text": "FDA-approved mAb against a G-",
            "probability": 0.043628554509200335,
            "start_logit": 0.9076722860336304,
            "end_logit": 0.6755418181419373
        },
        {
            "text": "GRPR reveals a direct ligand-",
            "probability": 0.04360733987847225,
            "start_logit": 0.9231418371200562,
            "end_logit": 0.6595858931541443
        },
        {
            "text": "FDA-",
            "probability": 0.043533784841412564,
            "start_logit": 0.9076722860336304,
            "end_logit": 0.6733672618865967
        },
        {
            "text": ")-H3 loop, which adopts a tyrosine-rich helix-",
            "probability": 0.04349389226901315,
            "start_logit": 0.9262087941169739,
            "end_logit": 0.6539139747619629
        },
        {
            "text": "GRPR reveals a direct ligand-blocking mechanism, enabled by a remarkable 21-residue",
            "probability": 0.043082339749764685,
            "start_logit": 0.9231418371200562,
            "end_logit": 0.6474735736846924
        }
    ],
    "5c85234775a4a5d219000007": [
        {
            "text": "I) is the",
            "probability": 0.5173125916584269,
            "start_logit": 1.1237497329711914,
            "end_logit": 0.6486641764640808
        },
        {
            "text": "I) is the leading cause of health care-associated infections in the United States. The increasing",
            "probability": 0.48268740834157314,
            "start_logit": 1.1237497329711914,
            "end_logit": 0.5793861150741577
        }
    ],
    "5c8973f3d558e5f232000007": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c8974bcd558e5f232000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c73ad077c78d69471000090": [
        {
            "text": "cal studies have demonstrated that safinamide ameliorates \"wearing",
            "probability": 0.07776066365898515,
            "start_logit": 1.0230106115341187,
            "end_logit": 1.1259307861328125
        },
        {
            "text": "clinical studies have demonstrated that safinamide ameliorates \"wearing",
            "probability": 0.07492600210221609,
            "start_logit": 0.9858759045600891,
            "end_logit": 1.1259307861328125
        },
        {
            "text": "s disease. In addition, safinamide shows non-",
            "probability": 0.05946231385660651,
            "start_logit": 0.8915296196937561,
            "end_logit": 0.9891188144683838
        },
        {
            "text": "dopaminergic effects. In clinical trials of patients with Parkinson's disease with the \"wearing off\" phenomenon",
            "probability": 0.05165741811387064,
            "start_logit": 1.0192276239395142,
            "end_logit": 0.720711886882782
        },
        {
            "text": "is a novel, selective,",
            "probability": 0.05051870971115395,
            "start_logit": 1.081260323524475,
            "end_logit": 0.6363891363143921
        },
        {
            "text": ". In addition, safinamide shows non-",
            "probability": 0.04965568515941331,
            "start_logit": 0.7112997770309448,
            "end_logit": 0.9891188144683838
        },
        {
            "text": "dopaminergic effects. In clinical trials of patients with Parkinson's disease with the \"wearing off\" phenomenon, sa",
            "probability": 0.04944707734033895,
            "start_logit": 1.0192276239395142,
            "end_logit": 0.6769810318946838
        },
        {
            "text": "selectively destroyed dopaminerg",
            "probability": 0.04880005883969041,
            "start_logit": 0.8297854065895081,
            "end_logit": 0.8532518148422241
        },
        {
            "text": "cl",
            "probability": 0.04684440539091779,
            "start_logit": 0.9858759045600891,
            "end_logit": 0.6562613844871521
        },
        {
            "text": "s disease. In addition, safinamide shows non-dopamine",
            "probability": 0.04671207748513426,
            "start_logit": 0.8915296196937561,
            "end_logit": 0.7477788329124451
        },
        {
            "text": "s disease is a neurodegenerative disorder characterized by the degenerative loss of dopaminergic neurons in the",
            "probability": 0.04619589833259054,
            "start_logit": 0.9368596076965332,
            "end_logit": 0.6913371086120605
        },
        {
            "text": "These findings suggest that safinamide not only increases the dopaminergic effect of levodopa, but also reduces levodopa-",
            "probability": 0.046097384521856966,
            "start_logit": 0.8265258073806763,
            "end_logit": 0.7995361089706421
        },
        {
            "text": "cal studies have demonstrated that safinamide ameliorates",
            "probability": 0.04566734007039749,
            "start_logit": 1.0230106115341187,
            "end_logit": 0.5936784744262695
        },
        {
            "text": "phenomenon",
            "probability": 0.04483217304507147,
            "start_logit": 0.8775198459625244,
            "end_logit": 0.720711886882782
        },
        {
            "text": "s disease with",
            "probability": 0.04410951325499085,
            "start_logit": 0.9815380573272705,
            "end_logit": 0.6004431247711182
        },
        {
            "text": "clinical studies have demonstrated that safinamide ameliorates",
            "probability": 0.044002597934641605,
            "start_logit": 0.9858759045600891,
            "end_logit": 0.5936784744262695
        },
        {
            "text": "rgic effect of levodopa, but also reduces levodopa-",
            "probability": 0.04383296309223176,
            "start_logit": 0.7761557102203369,
            "end_logit": 0.7995361089706421
        },
        {
            "text": "after administration in rat and monkey models with selectively destroyed dopaminerg",
            "probability": 0.043821273050677366,
            "start_logit": 0.722173273563385,
            "end_logit": 0.8532518148422241
        },
        {
            "text": "phenomenon, sa",
            "probability": 0.04291387391852373,
            "start_logit": 0.8775198459625244,
            "end_logit": 0.6769810318946838
        },
        {
            "text": "rgic effect of levodopa, but also reduces levodopa-induced",
            "probability": 0.042742571120691124,
            "start_logit": 0.7761557102203369,
            "end_logit": 0.7743453979492188
        }
    ],
    "5c920fc3ecadf2e73f000011": [
        {
            "text": "has a half-",
            "probability": 0.06809606729286097,
            "start_logit": 0.8949280977249146,
            "end_logit": 1.1199681758880615
        },
        {
            "text": "12\u00a0h.",
            "probability": 0.06036205410214619,
            "start_logit": 0.9896600246429443,
            "end_logit": 0.9046774506568909
        },
        {
            "text": "12\u00a0h. Elimination occurs via multiple pathways including metabolism, biliary",
            "probability": 0.05943444892832021,
            "start_logit": 0.9896600246429443,
            "end_logit": 0.8891907930374146
        },
        {
            "text": "prescribed medications, allowing for fixed dosages without the need for therapeutic drug monitoring. The pharmacodynamic effect of apixa",
            "probability": 0.05560545860728614,
            "start_logit": 0.9127587676048279,
            "end_logit": 0.8994994163513184
        },
        {
            "text": "has a half-life of approximately 12\u00a0h.",
            "probability": 0.054906335207201944,
            "start_logit": 0.8949280977249146,
            "end_logit": 0.9046774506568909
        },
        {
            "text": "has a half-life of approximately 12\u00a0h. Elimination occurs via multiple pathways including metabolism, biliary",
            "probability": 0.054062570007829554,
            "start_logit": 0.8949280977249146,
            "end_logit": 0.8891907930374146
        },
        {
            "text": "12\u00a0h. Elimination occurs via multiple pathways including metabolism, biliary excretion, and direct intestinal excretion, with",
            "probability": 0.05235767953794467,
            "start_logit": 0.9896600246429443,
            "end_logit": 0.7624154090881348
        },
        {
            "text": "is\u2009~\u200950%. Food does not have a clinically meaningful impact on the bioavailability. Apixaban exposure increases dose proportionally",
            "probability": 0.052330532837459275,
            "start_logit": 0.7472392916679382,
            "end_logit": 1.0043175220489502
        },
        {
            "text": "allowing for fixed dosages without the need for therapeutic drug monitoring. The pharmacodynamic effect of apixa",
            "probability": 0.052113185067646686,
            "start_logit": 0.8478953838348389,
            "end_logit": 0.8994994163513184
        },
        {
            "text": "liary excretion, and direct intestinal excretion, with",
            "probability": 0.0503953375271976,
            "start_logit": 0.951460063457489,
            "end_logit": 0.7624154090881348
        },
        {
            "text": "namic effect of apixa",
            "probability": 0.04875638114546705,
            "start_logit": 0.7813134789466858,
            "end_logit": 0.8994994163513184
        },
        {
            "text": "Xa, and has been approved for clinical use in several thromboembolic disorders, including reduction of stroke risk in non-",
            "probability": 0.0484388550822477,
            "start_logit": 0.8638592958450317,
            "end_logit": 0.8104197978973389
        },
        {
            "text": "prescribed medications, allowing for fixed dosages without the need for therapeutic drug monitoring. The",
            "probability": 0.0457935723688895,
            "start_logit": 0.9127587676048279,
            "end_logit": 0.7053617835044861
        },
        {
            "text": "Xa, and has been",
            "probability": 0.043834745224458786,
            "start_logit": 0.8638592958450317,
            "end_logit": 0.7105442881584167
        },
        {
            "text": "ban has limited clinically relevant interactions with most commonly prescribed medications, allowing for fixed dosages without the need for therapeutic drug monitoring. The",
            "probability": 0.043654044372414234,
            "start_logit": 0.8649109601974487,
            "end_logit": 0.7053617835044861
        },
        {
            "text": "and has been approved for clinical use in several thromboembolic disorders, including reduction of stroke risk in non-",
            "probability": 0.043534179722533844,
            "start_logit": 0.7571033835411072,
            "end_logit": 0.8104197978973389
        },
        {
            "text": "allowing for fixed dosages without the need for therapeutic drug monitoring. The",
            "probability": 0.04291752952930249,
            "start_logit": 0.8478953838348389,
            "end_logit": 0.7053617835044861
        },
        {
            "text": "Xa, and has been approved for clinical use in several thromboembolic disorders, including reduction of stroke risk in non-valvu",
            "probability": 0.04158480748958976,
            "start_logit": 0.8638592958450317,
            "end_logit": 0.6578524112701416
        },
        {
            "text": "ban are consistent across a broad range of patients, and apixa",
            "probability": 0.041050950072510445,
            "start_logit": 0.8414820432662964,
            "end_logit": 0.6673087477684021
        },
        {
            "text": "Xa, and has been approved",
            "probability": 0.04077126587669279,
            "start_logit": 0.8638592958450317,
            "end_logit": 0.6380950808525085
        }
    ],
    "5c6ab4c17c78d6947100001d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c92871decadf2e73f000016": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c920f13ecadf2e73f000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c72b7277c78d69471000073": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c7d5ae9d774d04240000010": [
        {
            "text": "AMP (PRKAA1), protein kinase A (PKA) and on",
            "probability": 0.07442046456101996,
            "start_logit": 1.0124263763427734,
            "end_logit": 1.0441625118255615
        },
        {
            "text": "ins, vaspin reduced steroidogen",
            "probability": 0.06716078375046261,
            "start_logit": 0.944614052772522,
            "end_logit": 1.0093333721160889
        },
        {
            "text": "and gonadotropins, vaspin reduced steroidogen",
            "probability": 0.06366638274165701,
            "start_logit": 0.891181230545044,
            "end_logit": 1.0093333721160889
        },
        {
            "text": "blot, we",
            "probability": 0.05530005096405353,
            "start_logit": 0.7401835918426514,
            "end_logit": 1.019448161125183
        },
        {
            "text": ") and steroids (PG",
            "probability": 0.05118390163478058,
            "start_logit": 0.9667227864265442,
            "end_logit": 0.7155601978302002
        },
        {
            "text": "ins (FSHR, LHCGR) and steroids (PG",
            "probability": 0.05035898898733948,
            "start_logit": 0.9504748582839966,
            "end_logit": 0.7155601978302002
        },
        {
            "text": "A1 and PKA, while it decreased expression of NFKB2. We observed that vaspin, in a dose-",
            "probability": 0.04990736299387628,
            "start_logit": 1.104256510734558,
            "end_logit": 0.5527699589729309
        },
        {
            "text": "obesity, insulin resistance, inflammation and energy metabolism. Our previous study showed vaspin expression and its regulation in the ovary; however, the",
            "probability": 0.04799938135827972,
            "start_logit": 0.9149906635284424,
            "end_logit": 0.7030553817749023
        },
        {
            "text": ") and steroids (PGR, ESR",
            "probability": 0.0472383344261573,
            "start_logit": 0.9667227864265442,
            "end_logit": 0.6353408694267273
        },
        {
            "text": "GRP78 receptor and PKA, could",
            "probability": 0.047105727619757766,
            "start_logit": 1.0538074970245361,
            "end_logit": 0.5454450249671936
        },
        {
            "text": "basal steroid hormones secretion (progesterone and estradiol), mRNA and protein expression of steroid enzymes using real-",
            "probability": 0.04649076738058745,
            "start_logit": 0.761892557144165,
            "end_logit": 0.8242191076278687
        },
        {
            "text": "ins (FSHR, LHCGR) and steroids (PGR, ESR",
            "probability": 0.046477011075111506,
            "start_logit": 0.9504748582839966,
            "end_logit": 0.6353408694267273
        },
        {
            "text": "of a PKA pharmacological inhibitor (KT5720) and when GRP78 receptor was",
            "probability": 0.046469645575391044,
            "start_logit": 0.8521864414215088,
            "end_logit": 0.7334707975387573
        },
        {
            "text": ") and steroids (PGR, ES",
            "probability": 0.045448923517211776,
            "start_logit": 0.9667227864265442,
            "end_logit": 0.596724271774292
        },
        {
            "text": "ins (FSHR, LHCGR) and steroids (PGR, ES",
            "probability": 0.04471643946217728,
            "start_logit": 0.9504748582839966,
            "end_logit": 0.596724271774292
        },
        {
            "text": "vaspin, by activation",
            "probability": 0.04369384362635318,
            "start_logit": 0.9565169215202332,
            "end_logit": 0.5675482153892517
        },
        {
            "text": "ins (FSHR, L",
            "probability": 0.04341797410690696,
            "start_logit": 0.9504748582839966,
            "end_logit": 0.5672565698623657
        },
        {
            "text": "ins, vaspin reduced steroidogenesis. Thus, vaspin, by activation",
            "probability": 0.04317684453072233,
            "start_logit": 0.944614052772522,
            "end_logit": 0.5675482153892517
        },
        {
            "text": "vaspin, by activation of various signaling",
            "probability": 0.04302850627729573,
            "start_logit": 0.9565169215202332,
            "end_logit": 0.5522038340568542
        },
        {
            "text": "vaspin, by activation of various signaling pathways and stimulation of basal steroid production via GRP78 receptor and PKA, could",
            "probability": 0.0427386654108585,
            "start_logit": 0.9565169215202332,
            "end_logit": 0.5454450249671936
        }
    ],
    "5c83fd8e617e120c34000004": [
        {
            "text": "some of the symptoms at the early stage of the disease. Natural products",
            "probability": 0.07998587701739333,
            "start_logit": 1.3704030513763428,
            "end_logit": 0.9264833927154541
        },
        {
            "text": "some of the symptoms at the",
            "probability": 0.07086909294558236,
            "start_logit": 1.3704030513763428,
            "end_logit": 0.8054677248001099
        },
        {
            "text": "ers involved in the",
            "probability": 0.062925397021757,
            "start_logit": 0.9132575988769531,
            "end_logit": 1.1437286138534546
        },
        {
            "text": "some of the symptoms at the early stage of the disease. Natural products from plants and marine organisms have",
            "probability": 0.061497012202375155,
            "start_logit": 1.3704030513763428,
            "end_logit": 0.6636219024658203
        },
        {
            "text": "agents. Seaweeds contain several",
            "probability": 0.055495639569564485,
            "start_logit": 1.072972059249878,
            "end_logit": 0.8583687543869019
        },
        {
            "text": "of the symptoms at the early stage of the disease. Natural products",
            "probability": 0.05123783151515053,
            "start_logit": 0.9250311255455017,
            "end_logit": 0.9264833927154541
        },
        {
            "text": "is no cure for AD; however, synthetic therapies have been developed to effectively manage some of the symptoms at the",
            "probability": 0.04957123622774488,
            "start_logit": 1.0129793882369995,
            "end_logit": 0.8054677248001099
        },
        {
            "text": "agents. Seaweeds contain several kinds of secondary metabolites such as phlorotannins, carotenoids, sterol",
            "probability": 0.04917489929599199,
            "start_logit": 1.072972059249878,
            "end_logit": 0.7374476194381714
        },
        {
            "text": "is no cure for AD; however, synthetic therapies have been",
            "probability": 0.04782247578170738,
            "start_logit": 1.0129793882369995,
            "end_logit": 0.7695527076721191
        },
        {
            "text": "damage to neurons. Currently there is no cure for AD; however, synthetic therapies have been developed to effectively manage some of the symptoms at the",
            "probability": 0.04716674234575796,
            "start_logit": 0.9632576704025269,
            "end_logit": 0.8054677248001099
        },
        {
            "text": "damage to neurons. Currently there is no cure for AD; however, synthetic therapies have been",
            "probability": 0.04550280697396794,
            "start_logit": 0.9632576704025269,
            "end_logit": 0.7695527076721191
        },
        {
            "text": "of the symptoms at the",
            "probability": 0.045397747444685436,
            "start_logit": 0.9250311255455017,
            "end_logit": 0.8054677248001099
        },
        {
            "text": "agents. Seaweeds contain several kinds of secondary metabolites such as",
            "probability": 0.04492882886457528,
            "start_logit": 1.072972059249878,
            "end_logit": 0.6471439599990845
        },
        {
            "text": "carotenoids, sterols, fucoidans, and poly unsatura",
            "probability": 0.04357822281635807,
            "start_logit": 0.9077613949775696,
            "end_logit": 0.7818325161933899
        },
        {
            "text": "of action have not been",
            "probability": 0.041888091831344676,
            "start_logit": 0.8754064440727234,
            "end_logit": 0.7746315002441406
        },
        {
            "text": "carotenoids, sterol",
            "probability": 0.04168630477209656,
            "start_logit": 0.9077613949775696,
            "end_logit": 0.7374476194381714
        },
        {
            "text": "agents. Seaweeds contain several kinds of secondary meta",
            "probability": 0.04137766096654836,
            "start_logit": 1.072972059249878,
            "end_logit": 0.5648054480552673
        },
        {
            "text": "is no cure for AD; however, synthetic therapies have",
            "probability": 0.04125044782440654,
            "start_logit": 1.0129793882369995,
            "end_logit": 0.6217189431190491
        },
        {
            "text": "of the symptoms at the early stage of the disease. Natural products from plants and marine organisms have",
            "probability": 0.0393941239054647,
            "start_logit": 0.9250311255455017,
            "end_logit": 0.6636219024658203
        },
        {
            "text": "damage to neurons. Currently there is no cure for AD; however, synthetic therapies have",
            "probability": 0.03924956067752737,
            "start_logit": 0.9632576704025269,
            "end_logit": 0.6217189431190491
        }
    ],
    "5c7d5fcfd774d04240000011": [
        {
            "text": "required for fine-tuning in the execution process of thermotaxi",
            "probability": 0.18659262130598234,
            "start_logit": 1.0446470975875854,
            "end_logit": 0.6681800484657288
        },
        {
            "text": "-",
            "probability": 0.17935008017934814,
            "start_logit": 0.8561896085739136,
            "end_logit": 0.8170494437217712
        },
        {
            "text": "required for fine-tuning in the execution process of",
            "probability": 0.1778998662356332,
            "start_logit": 1.0446470975875854,
            "end_logit": 0.6204731464385986
        },
        {
            "text": "required for fine-tuning in the execution process of therm",
            "probability": 0.17317409616915935,
            "start_logit": 1.0446470975875854,
            "end_logit": 0.5935497283935547
        },
        {
            "text": "xins in vertebrates. However, it remains",
            "probability": 0.149497327327736,
            "start_logit": 0.9134299755096436,
            "end_logit": 0.5777479410171509
        },
        {
            "text": "-4 in AFD neurons",
            "probability": 0.133486008782141,
            "start_logit": 0.8561896085739136,
            "end_logit": 0.5217064619064331
        }
    ],
    "5c6acb107c78d6947100001f": [
        {
            "text": "enables detection, searching and visualization of large-",
            "probability": 0.09720879726716421,
            "start_logit": 1.0750012397766113,
            "end_logit": 0.7245808243751526
        },
        {
            "text": "ers for genomic instability, DNA replication and other genetic",
            "probability": 0.0840157062799866,
            "start_logit": 0.9462902545928955,
            "end_logit": 0.707434356212616
        },
        {
            "text": "containing various sequenced chloroplast genomes that enables detection, searching and visualization of large-",
            "probability": 0.08167604042532664,
            "start_logit": 0.9009007215499878,
            "end_logit": 0.7245808243751526
        },
        {
            "text": "21\u2009659 visual",
            "probability": 0.07793327197552923,
            "start_logit": 0.8703742027282715,
            "end_logit": 0.7081996202468872
        },
        {
            "text": "ers for gen",
            "probability": 0.07451913292392481,
            "start_logit": 0.9462902545928955,
            "end_logit": 0.5874865055084229
        },
        {
            "text": "containing various sequenced chlor",
            "probability": 0.0739659720861651,
            "start_logit": 0.9009007215499878,
            "end_logit": 0.6254252791404724
        },
        {
            "text": "enables detection, searching and visualization of large-scale detailed information on IRs. PC",
            "probability": 0.07057152725748575,
            "start_logit": 1.0750012397766113,
            "end_logit": 0.40434637665748596
        },
        {
            "text": "ers for genomic instability, DNA replication and other",
            "probability": 0.06779633663935151,
            "start_logit": 0.9462902545928955,
            "end_logit": 0.492938756942749
        },
        {
            "text": "21\u2009659 visual maps. This database offers an online prediction tool for detecting IRs based on DNA sequences.",
            "probability": 0.0670612321330813,
            "start_logit": 0.8703742027282715,
            "end_logit": 0.5579527616500854
        },
        {
            "text": "21\u2009659 visual maps. This database offers an online prediction tool for detecting IRs based on DNA sequences. PCIR can",
            "probability": 0.0643319368769675,
            "start_logit": 0.8703742027282715,
            "end_logit": 0.5164028406143188
        },
        {
            "text": "ers for genomic instability, DNA replication and other genetic processes. However, little information can",
            "probability": 0.0643015327852251,
            "start_logit": 0.9462902545928955,
            "end_logit": 0.4400140643119812
        },
        {
            "text": "21\u2009659 visual maps. This database offers an online prediction",
            "probability": 0.059413488241022196,
            "start_logit": 0.8703742027282715,
            "end_logit": 0.43686792254447937
        },
        {
            "text": "containing various sequenced chloroplast genomes that enables detection, searching and visualization of large-scale detailed information on IRs. PC",
            "probability": 0.05929507488214185,
            "start_logit": 0.9009007215499878,
            "end_logit": 0.40434637665748596
        },
        {
            "text": "be a valuable resource",
            "probability": 0.057909950226628266,
            "start_logit": 0.8492940664291382,
            "end_logit": 0.43231600522994995
        }
    ],
    "5c8fee200101eac87000000f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c6ad2997c78d69471000020": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c8fef490101eac870000010": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c8d15cf0101eac870000009": [
        {
            "text": "is currently less evidence to support liver fatty acid-binding protein and ileal bile acid",
            "probability": 0.08233735108185435,
            "start_logit": 1.1074259281158447,
            "end_logit": 0.8555603623390198
        },
        {
            "text": "is currently less evidence to support liver fatty acid-",
            "probability": 0.07732255934750402,
            "start_logit": 1.1074259281158447,
            "end_logit": 0.7927212715148926
        },
        {
            "text": "transportation of long-chain fatty acids. Nine fatty acid-",
            "probability": 0.06881787360366712,
            "start_logit": 0.9549020528793335,
            "end_logit": 0.8287228941917419
        },
        {
            "text": "less evidence to support liver fatty acid-binding protein and ileal bile acid",
            "probability": 0.06352063876120932,
            "start_logit": 0.8479659557342529,
            "end_logit": 0.8555603623390198
        },
        {
            "text": ". Nine fatty acid-",
            "probability": 0.06254670147331967,
            "start_logit": 0.8593520522117615,
            "end_logit": 0.8287228941917419
        },
        {
            "text": "less evidence to support liver fatty acid-",
            "probability": 0.059651886973169754,
            "start_logit": 0.8479659557342529,
            "end_logit": 0.7927212715148926
        },
        {
            "text": "exclusive expression in the gastrointestinal tract. The",
            "probability": 0.05960970131696855,
            "start_logit": 0.8983858823776245,
            "end_logit": 0.7415938973426819
        },
        {
            "text": "of intestinal fatty acid-binding protein in blood and urine reflects enterocyte damage, regardless of the underlying cause. The",
            "probability": 0.05758254636215088,
            "start_logit": 0.7977440357208252,
            "end_logit": 0.8076369166374207
        },
        {
            "text": "transportation of long-chain fatty acids. Nine fatty acid-binding proteins have been identified,",
            "probability": 0.056184390486230064,
            "start_logit": 0.9549020528793335,
            "end_logit": 0.6258983612060547
        },
        {
            "text": "transportation of long-",
            "probability": 0.055241232527641286,
            "start_logit": 0.9549020528793335,
            "end_logit": 0.6089690327644348
        },
        {
            "text": "exclusive expression in the gastrointestinal tract. The elevation of intestinal fatty acid-",
            "probability": 0.05497764269844718,
            "start_logit": 0.8983858823776245,
            "end_logit": 0.6607021689414978
        },
        {
            "text": "exclusive expression in the gastrointestinal tract. The elevation",
            "probability": 0.054742950478834276,
            "start_logit": 0.8983858823776245,
            "end_logit": 0.6564241647720337
        },
        {
            "text": "these conditions. More extensive studies with specific endpoints",
            "probability": 0.05253209421332726,
            "start_logit": 0.8202471733093262,
            "end_logit": 0.6933385729789734
        },
        {
            "text": ". Nine fatty acid-binding proteins have been identified,",
            "probability": 0.05106447082979028,
            "start_logit": 0.8593520522117615,
            "end_logit": 0.6258983612060547
        },
        {
            "text": "of intestinal fatty acid-",
            "probability": 0.04971390932003345,
            "start_logit": 0.7977440357208252,
            "end_logit": 0.6607021689414978
        },
        {
            "text": "of intestinal fatty acid-binding protein in blood and urine reflects enterocyte damage, regardless of the underlying cause. The short half-",
            "probability": 0.04789918237929204,
            "start_logit": 0.7977440357208252,
            "end_logit": 0.6235158443450928
        },
        {
            "text": "these conditions. More extensive studies with specific endpoints are required to validate the",
            "probability": 0.0462548681465605,
            "start_logit": 0.8202471733093262,
            "end_logit": 0.5660809874534607
        }
    ],
    "5c72f5247c78d6947100007e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c73acec7c78d69471000086": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c909b6cecadf2e73f000005": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c6d65637c78d69471000038": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c9158a5ecadf2e73f000008": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c915a8becadf2e73f000009": [
        {
            "text": "location in the body where the",
            "probability": 0.06946005729170553,
            "start_logit": 1.276538610458374,
            "end_logit": 0.8314577341079712
        },
        {
            "text": ". We recommend European Union to follow the FDA approach of tissue-agnostic cancer drugs in order to speed up the development of next-generation on",
            "probability": 0.06903654200867342,
            "start_logit": 0.8382254838943481,
            "end_logit": 1.2636549472808838
        },
        {
            "text": "biology. The recent FDA approval could be considered the",
            "probability": 0.05766150297233368,
            "start_logit": 1.1239655017852783,
            "end_logit": 0.7978687286376953
        },
        {
            "text": "no satisfactory alternative treatment options and patients with colorectal cancer that has",
            "probability": 0.05687525182201656,
            "start_logit": 0.9993394613265991,
            "end_logit": 0.9087653160095215
        },
        {
            "text": "huge and fast advances in understanding tumor biology. In fact, the FDA previously approved pembrolizumab taking into",
            "probability": 0.052319690636472925,
            "start_logit": 0.8984981775283813,
            "end_logit": 0.9261190891265869
        },
        {
            "text": "2017, the FDA approved the first cancer treatment (pembrol",
            "probability": 0.0504069233605922,
            "start_logit": 0.954017698764801,
            "end_logit": 0.8333553075790405
        },
        {
            "text": "no satisfactory alternative treatment options and patients",
            "probability": 0.0498719790272878,
            "start_logit": 0.9993394613265991,
            "end_logit": 0.7773643136024475
        },
        {
            "text": "2017, the FDA approved the",
            "probability": 0.04798438599461625,
            "start_logit": 0.954017698764801,
            "end_logit": 0.7841024398803711
        },
        {
            "text": "huge and fast advances in understanding tumor biology. In fact, the FDA previously approved pembrol",
            "probability": 0.046430037206001855,
            "start_logit": 0.8984981775283813,
            "end_logit": 0.806692898273468
        },
        {
            "text": "cancer treatment (pembrol",
            "probability": 0.04628490993365163,
            "start_logit": 0.868705153465271,
            "end_logit": 0.8333553075790405
        },
        {
            "text": "colorectal cancer that has",
            "probability": 0.04616687939748675,
            "start_logit": 0.7907418012619019,
            "end_logit": 0.9087653160095215
        },
        {
            "text": "2017, the FDA approved the first cancer treatment (pembrolizumab) for any solid tumor with a specific genetic biomarker:",
            "probability": 0.045724629467809697,
            "start_logit": 0.954017698764801,
            "end_logit": 0.7358638644218445
        },
        {
            "text": "solid cancer treatment was approved based on the genetic makeup of tumor not on the location in the body where the",
            "probability": 0.04553817357742449,
            "start_logit": 0.8543376922607422,
            "end_logit": 0.8314577341079712
        },
        {
            "text": "2017, the FDA approved the first cancer treatment (pembroliz",
            "probability": 0.04549908021088486,
            "start_logit": 0.954017698764801,
            "end_logit": 0.7309188842773438
        },
        {
            "text": "solid cancer treatment was approved based on the genetic makeup of tumor not on",
            "probability": 0.04540560843159211,
            "start_logit": 0.8543376922607422,
            "end_logit": 0.8285424113273621
        },
        {
            "text": "FDA approved the first cancer treatment (pembrol",
            "probability": 0.04529031419874978,
            "start_logit": 0.8469823598861694,
            "end_logit": 0.8333553075790405
        },
        {
            "text": "be changed under the disruptive wave of molecular biology. The recent FDA approval could be considered the",
            "probability": 0.04519207763079954,
            "start_logit": 0.8802975416183472,
            "end_logit": 0.7978687286376953
        },
        {
            "text": "previously approved pembrolizumab taking into",
            "probability": 0.04514752495822128,
            "start_logit": 0.7510608434677124,
            "end_logit": 0.9261190891265869
        },
        {
            "text": ". We recommend European Union to follow the FDA approach of tissue-agnostic cancer drugs in order to speed up the development of next-",
            "probability": 0.04510530673968594,
            "start_logit": 0.8382254838943481,
            "end_logit": 0.8380188941955566
        },
        {
            "text": "biology. The recent",
            "probability": 0.044599125133993625,
            "start_logit": 1.1239655017852783,
            "end_logit": 0.5409932136535645
        }
    ],
    "5c915ca7ecadf2e73f00000b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c920df7ecadf2e73f00000f": [
        {
            "text": "ran, and direct oral factor Xa inhibitors rivaroxaban, apixaban, and edoxaban-",
            "probability": 0.061879070150433105,
            "start_logit": 1.2174341678619385,
            "end_logit": 0.673302412033081
        },
        {
            "text": "used mostly in adult",
            "probability": 0.05699482934720753,
            "start_logit": 1.0004615783691406,
            "end_logit": 0.8080535531044006
        },
        {
            "text": "agents offer several advantages",
            "probability": 0.05544127322966922,
            "start_logit": 1.0872700214385986,
            "end_logit": 0.6936088800430298
        },
        {
            "text": "agents offer several advantages compared to traditional agents, such as oral route of administration, short on",
            "probability": 0.05440229836444309,
            "start_logit": 1.0872700214385986,
            "end_logit": 0.6746909618377686
        },
        {
            "text": "ran, and direct oral factor Xa inhibitors rivaroxaban, apixaban, and",
            "probability": 0.05415916615181233,
            "start_logit": 1.2174341678619385,
            "end_logit": 0.5400476455688477
        },
        {
            "text": "not reached their",
            "probability": 0.052899288807974267,
            "start_logit": 0.9228357672691345,
            "end_logit": 0.8111087083816528
        },
        {
            "text": "agents offer several advantages compared to traditional",
            "probability": 0.052795236796711276,
            "start_logit": 1.0872700214385986,
            "end_logit": 0.6447055339813232
        },
        {
            "text": "romboembolism (VTE) is a rare, but life-threatening disease in those who have not reached their",
            "probability": 0.05249407778147823,
            "start_logit": 0.9151462316513062,
            "end_logit": 0.8111087083816528
        },
        {
            "text": "agents offer several advantages compared to traditional agents, such as oral route of administration",
            "probability": 0.051246325835862985,
            "start_logit": 1.0872700214385986,
            "end_logit": 0.6149284839630127
        },
        {
            "text": "off-set of action, predictable pharmacologic profile with low risk of food and drug interactions,",
            "probability": 0.0493723526329798,
            "start_logit": 0.8242469429969788,
            "end_logit": 0.8406982421875
        },
        {
            "text": "those who have not reached their",
            "probability": 0.04855301830396528,
            "start_logit": 0.8371022343635559,
            "end_logit": 0.8111087083816528
        },
        {
            "text": "agents, such as oral route of administration, short on",
            "probability": 0.04783298119311625,
            "start_logit": 0.9585790038108826,
            "end_logit": 0.6746909618377686
        },
        {
            "text": "agents offer several advantages compared to traditional agents, such as oral route of administration, short on-set and off-",
            "probability": 0.04779910255282418,
            "start_logit": 1.0872700214385986,
            "end_logit": 0.5452914237976074
        },
        {
            "text": "activity. However, clinical experience with these",
            "probability": 0.047146657041808364,
            "start_logit": 1.0315635204315186,
            "end_logit": 0.5872541666030884
        },
        {
            "text": "used mostly in adult individuals. This",
            "probability": 0.046646893434407095,
            "start_logit": 1.0004615783691406,
            "end_logit": 0.6076993346214294
        },
        {
            "text": "not reached their adulthood. This condition is usually treated with heparin or low molecular weight he",
            "probability": 0.04525220306028594,
            "start_logit": 0.9228357672691345,
            "end_logit": 0.6549701690673828
        },
        {
            "text": "agents, such as oral route of administration",
            "probability": 0.04505810624951957,
            "start_logit": 0.9585790038108826,
            "end_logit": 0.6149284839630127
        },
        {
            "text": "romboembolism (VTE) is a rare, but life",
            "probability": 0.044649398989182854,
            "start_logit": 0.9151462316513062,
            "end_logit": 0.6492491960525513
        },
        {
            "text": "romboembolism (VTE) is a rare, but life-",
            "probability": 0.042722449372949035,
            "start_logit": 0.9151462316513062,
            "end_logit": 0.6051328778266907
        },
        {
            "text": "used mostly in adult individuals. This article reviews the",
            "probability": 0.042655270703369365,
            "start_logit": 1.0004615783691406,
            "end_logit": 0.5182438492774963
        }
    ],
    "5c632cc1e842deac6700000f": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c93ea7cecadf2e73f00001d": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c88b8a275a4a5d21900000b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c890ad575a4a5d21900000d": [
        {
            "text": "is a secoirido",
            "probability": 0.0699154689192403,
            "start_logit": 1.053544282913208,
            "end_logit": 0.8397897481918335
        },
        {
            "text": ".",
            "probability": 0.0638223423519118,
            "start_logit": 1.07582688331604,
            "end_logit": 0.7263235449790955
        },
        {
            "text": "in is a secoirido",
            "probability": 0.061195936875231685,
            "start_logit": 0.9203381538391113,
            "end_logit": 0.8397897481918335
        },
        {
            "text": "is commonly known as Zaytoon in Mediterranean region. Its",
            "probability": 0.06009302332352454,
            "start_logit": 1.182154893875122,
            "end_logit": 0.5597859621047974
        },
        {
            "text": "biological activities including action against dyslipidemia, antiobesity, antidiabetic, antioxidant,",
            "probability": 0.05720520075504563,
            "start_logit": 1.0758016109466553,
            "end_logit": 0.6168903112411499
        },
        {
            "text": "is commonly known as Zaytoon in Mediterranean region. Its fruits and oil are essential components of Mediterranean diets. Olive tree is a prevalent plant",
            "probability": 0.056525174101772005,
            "start_logit": 1.182154893875122,
            "end_logit": 0.4985783100128174
        },
        {
            "text": "biological activities including action against dyslipidemia, antiobe",
            "probability": 0.05321898495523623,
            "start_logit": 1.0758016109466553,
            "end_logit": 0.5446606874465942
        },
        {
            "text": "biological activities including action against dyslipidemia, antiobesity, antidiabetic, antioxidant, antiathero",
            "probability": 0.053097638473318096,
            "start_logit": 1.0758016109466553,
            "end_logit": 0.5423779487609863
        },
        {
            "text": "of metabolic syndrome.",
            "probability": 0.05261291196339597,
            "start_logit": 0.882685124874115,
            "end_logit": 0.7263235449790955
        },
        {
            "text": "biological activities including action against d",
            "probability": 0.051361915987645994,
            "start_logit": 1.0758016109466553,
            "end_logit": 0.5091424584388733
        },
        {
            "text": "is a secoiridoid type of phenolic compound and consists of three structural subunits",
            "probability": 0.049068669350305474,
            "start_logit": 1.053544282913208,
            "end_logit": 0.4857235550880432
        },
        {
            "text": "hepatoprotect",
            "probability": 0.04362613302862151,
            "start_logit": 0.8368062973022461,
            "end_logit": 0.5848971605300903
        },
        {
            "text": "pertensive, antiinflammatory, and hepatoprotect",
            "probability": 0.043405946779488426,
            "start_logit": 0.8317463994026184,
            "end_logit": 0.5848971605300903
        },
        {
            "text": "in is a secoiridoid type of phenolic compound and consists of three structural subunits",
            "probability": 0.042949053171358435,
            "start_logit": 0.9203381538391113,
            "end_logit": 0.4857235550880432
        },
        {
            "text": ") is commonly known as Zaytoon in Mediterranean region. Its",
            "probability": 0.04218569468205362,
            "start_logit": 0.8283423185348511,
            "end_logit": 0.5597859621047974
        },
        {
            "text": "hepatoprotective actions. The",
            "probability": 0.040946338882593046,
            "start_logit": 0.8368062973022461,
            "end_logit": 0.521503210067749
        },
        {
            "text": "pertensive, antiinflammatory, and hepatoprotective actions. The",
            "probability": 0.04073967787121312,
            "start_logit": 0.8317463994026184,
            "end_logit": 0.521503210067749
        },
        {
            "text": ") is commonly known as Zaytoon in Mediterranean region. Its fruits and oil are essential components of Mediterranean diets. Olive tree is a prevalent plant",
            "probability": 0.03968104123617624,
            "start_logit": 0.8283423185348511,
            "end_logit": 0.4985783100128174
        },
        {
            "text": "of oleuropein as a potential agent against metabolic syndrome.",
            "probability": 0.03944154794871555,
            "start_logit": 0.8504441976547241,
            "end_logit": 0.4704226851463318
        },
        {
            "text": "hepatoprotective actions. The scientific evidence supports the role of oleuropein as a potential agent against metabolic syndrome.",
            "probability": 0.03890729934315261,
            "start_logit": 0.8368062973022461,
            "end_logit": 0.4704226851463318
        }
    ],
    "5ca0bf00ecadf2e73f000045": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c890e6d75a4a5d21900000f": [
        {
            "text": ") markers exhibiting higher levels of genetic differentiation among populations. The spatial analysis method Sam\u03b2ada detected 50 individual markers (22",
            "probability": 0.08779067841761992,
            "start_logit": 0.993984580039978,
            "end_logit": 0.9193093776702881
        },
        {
            "text": ") markers exhibiting higher levels",
            "probability": 0.08225510466399447,
            "start_logit": 0.993984580039978,
            "end_logit": 0.8541795015335083
        },
        {
            "text": "eScan identified a total of seven (3.10%) markers exhibiting higher levels",
            "probability": 0.07630714466555359,
            "start_logit": 0.9189257025718689,
            "end_logit": 0.8541795015335083
        },
        {
            "text": "subalpine/alpine plant species endemic to the central part of the",
            "probability": 0.06594241910166612,
            "start_logit": 0.9339062571525574,
            "end_logit": 0.6932142972946167
        },
        {
            "text": "Giseb. is a subalpine/alpine plant species endemic to the central part of the",
            "probability": 0.06555856641283876,
            "start_logit": 0.928068220615387,
            "end_logit": 0.6932142972946167
        },
        {
            "text": "biocl",
            "probability": 0.06428078955228081,
            "start_logit": 1.0093796253204346,
            "end_logit": 0.5922198295593262
        },
        {
            "text": "central part of the",
            "probability": 0.06325561519118597,
            "start_logit": 0.892308235168457,
            "end_logit": 0.6932142972946167
        },
        {
            "text": "bioclimatic variables associated with five out of seven outliers were related to precipitation, suggesting that this variable is",
            "probability": 0.06173713360426103,
            "start_logit": 1.0093796253204346,
            "end_logit": 0.551844596862793
        },
        {
            "text": "is scardica Giseb. is a subalpine/alpine plant species endemic to the central part of the",
            "probability": 0.060102727061976086,
            "start_logit": 0.8411795496940613,
            "end_logit": 0.6932142972946167
        },
        {
            "text": "clusters were revealed by Bayesian clustering methods as well as by Discriminant Analysis of Principal Components and each population formed its respective cluster. The",
            "probability": 0.05628513354250485,
            "start_logit": 0.8018072843551636,
            "end_logit": 0.6669617891311646
        },
        {
            "text": "of Principal Components and each population formed its respective cluster. The",
            "probability": 0.05626114473023656,
            "start_logit": 0.80138099193573,
            "end_logit": 0.6669617891311646
        },
        {
            "text": "inant Analysis of Principal Components and each population formed its respective cluster. The",
            "probability": 0.05564110440747005,
            "start_logit": 0.7902990579605103,
            "end_logit": 0.6669617891311646
        },
        {
            "text": "is",
            "probability": 0.0521725674545076,
            "start_logit": 0.8410508632659912,
            "end_logit": 0.551844596862793
        },
        {
            "text": "clusters were revealed by Bayesian clustering methods as well as by Discriminant Analysis of Principal Components and",
            "probability": 0.05100507432032345,
            "start_logit": 0.8018072843551636,
            "end_logit": 0.5684564709663391
        },
        {
            "text": "of Principal Components and",
            "probability": 0.05098333587758392,
            "start_logit": 0.80138099193573,
            "end_logit": 0.5684564709663391
        },
        {
            "text": "inant Analysis of Principal Components and",
            "probability": 0.05042146099599692,
            "start_logit": 0.7902990579605103,
            "end_logit": 0.5684564709663391
        }
    ],
    "5c9904eaecadf2e73f00002e": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c9a6693ecadf2e73f000031": [
        {
            "text": "ar DNA in E. histolytica and on the distribution of Cpn60-",
            "probability": 0.09115912292268892,
            "start_logit": 1.1213816404342651,
            "end_logit": 0.7915345430374146
        },
        {
            "text": "KOs and mitosomes are distinct and unrelated cellular",
            "probability": 0.07718061113135946,
            "start_logit": 0.9844757914543152,
            "end_logit": 0.7619820833206177
        },
        {
            "text": "ar DNA in E. histolytica and on",
            "probability": 0.07415099076957957,
            "start_logit": 1.1213816404342651,
            "end_logit": 0.5850313901901245
        },
        {
            "text": "DNA in E. histolytica and on the distribution of Cpn60-",
            "probability": 0.07273056502645141,
            "start_logit": 0.8955367803573608,
            "end_logit": 0.7915345430374146
        },
        {
            "text": "distribution of Cpn60-",
            "probability": 0.07222955941577217,
            "start_logit": 0.8886244297027588,
            "end_logit": 0.7915345430374146
        },
        {
            "text": "ofluorescence microscopy failed to detect the presence of DNA in mitosomes,",
            "probability": 0.07208308105424747,
            "start_logit": 0.8668254613876343,
            "end_logit": 0.8113034963607788
        },
        {
            "text": "ar DNA in E. histolytica and on the distribution of Cpn60-containing mitosomes in this",
            "probability": 0.07110231423974937,
            "start_logit": 1.1213816404342651,
            "end_logit": 0.5430478453636169
        },
        {
            "text": "amitochondrial human pathogen Entamoeba histo",
            "probability": 0.06591775708345943,
            "start_logit": 0.9310324192047119,
            "end_logit": 0.6576850414276123
        },
        {
            "text": "chondrial human pathogen Entamoeba histo",
            "probability": 0.06462504001351685,
            "start_logit": 0.9112265110015869,
            "end_logit": 0.6576850414276123
        },
        {
            "text": "ar DNA in E. histolytica and on the distribution of Cpn60-containing mit",
            "probability": 0.0643174064952516,
            "start_logit": 1.1213816404342651,
            "end_logit": 0.4427582621574402
        },
        {
            "text": "DNA in E. histolytica and on",
            "probability": 0.05916076507796688,
            "start_logit": 0.8955367803573608,
            "end_logit": 0.5850313901901245
        },
        {
            "text": "DNA in E. histolytica and on the distribution of Cpn60-containing mitosomes in this",
            "probability": 0.0567284032968484,
            "start_logit": 0.8955367803573608,
            "end_logit": 0.5430478453636169
        },
        {
            "text": "distribution of Cpn60-containing mitosomes in this",
            "probability": 0.05633762882223432,
            "start_logit": 0.8886244297027588,
            "end_logit": 0.5430478453636169
        },
        {
            "text": "DNA in E. histolytica and on the distribution of Cpn60-containing mit",
            "probability": 0.05131511981968971,
            "start_logit": 0.8955367803573608,
            "end_logit": 0.4427582621574402
        },
        {
            "text": "distribution of Cpn60-containing mit",
            "probability": 0.050961634831184634,
            "start_logit": 0.8886244297027588,
            "end_logit": 0.4427582621574402
        }
    ],
    "5c897082d558e5f232000004": [
        {
            "text": "T cell approaches have",
            "probability": 0.07364704140473703,
            "start_logit": 1.148703932762146,
            "end_logit": 0.8589799404144287
        },
        {
            "text": "ecleucel (Kymriah",
            "probability": 0.06526763196158031,
            "start_logit": 1.3827258348464966,
            "end_logit": 0.504170298576355
        },
        {
            "text": "T cell approaches have limitations",
            "probability": 0.06289757535469108,
            "start_logit": 1.148703932762146,
            "end_logit": 0.7012035846710205
        },
        {
            "text": "ractory B-",
            "probability": 0.05696694005780403,
            "start_logit": 0.9671028852462769,
            "end_logit": 0.7837681174278259
        },
        {
            "text": "ractory B-cell malignancies. In 2017, the FDA approved the first CAR T cell",
            "probability": 0.056323159318340914,
            "start_logit": 0.9671028852462769,
            "end_logit": 0.772402822971344
        },
        {
            "text": "difficulties overcoming the suppressive tumor microenvironment, high manufacturing costs and retail prices, and patient access, among others. The CAR T cell",
            "probability": 0.05607894604144767,
            "start_logit": 0.8854537010192871,
            "end_logit": 0.8497066497802734
        },
        {
            "text": "ractory B-cell malignancies. In 2017, the",
            "probability": 0.05464308384885464,
            "start_logit": 0.9671028852462769,
            "end_logit": 0.7421196699142456
        },
        {
            "text": "difficulties overcoming the suppressive tumor microenvironment,",
            "probability": 0.048726008099212806,
            "start_logit": 0.8854537010192871,
            "end_logit": 0.7091591358184814
        },
        {
            "text": "difficulties overcoming the suppressive tumor microenvironment, high manufacturing costs and retail prices",
            "probability": 0.048495711859530374,
            "start_logit": 0.8854537010192871,
            "end_logit": 0.7044215798377991
        },
        {
            "text": "T",
            "probability": 0.04809772686243097,
            "start_logit": 1.148703932762146,
            "end_logit": 0.4329308867454529
        },
        {
            "text": ". The adoptive cell therapy furthest along in clinical development is the engineering of T cells to express chimeric antigen",
            "probability": 0.04756014357985523,
            "start_logit": 0.8947432041168213,
            "end_logit": 0.6756517887115479
        },
        {
            "text": "leucel (Kymriah",
            "probability": 0.04691870566479086,
            "start_logit": 1.0526460409164429,
            "end_logit": 0.504170298576355
        },
        {
            "text": "ractory B-cell malignancies. In 2017, the FDA approved the first CAR T cell products tis",
            "probability": 0.044368943995214224,
            "start_logit": 0.9671028852462769,
            "end_logit": 0.5338367819786072
        },
        {
            "text": "better addresses those challenges will obtain a critical competitive advantage",
            "probability": 0.044121699362735065,
            "start_logit": 1.00209641456604,
            "end_logit": 0.4932551980018616
        },
        {
            "text": "better addresses those",
            "probability": 0.04409756912485809,
            "start_logit": 1.00209641456604,
            "end_logit": 0.49270814657211304
        },
        {
            "text": "difficulties overcoming the suppressive tumor microenvironment, high manufacturing costs and retail prices, and patient access, among others. The",
            "probability": 0.04395408369607936,
            "start_logit": 0.8854537010192871,
            "end_logit": 0.6060917377471924
        },
        {
            "text": "h",
            "probability": 0.04198314378280219,
            "start_logit": 0.941497802734375,
            "end_logit": 0.504170298576355
        },
        {
            "text": ". The adoptive cell",
            "probability": 0.03869621303896602,
            "start_logit": 0.8947432041168213,
            "end_logit": 0.4693984389305115
        },
        {
            "text": ". The adoptive cell therapy furthest",
            "probability": 0.03867129269541621,
            "start_logit": 0.8947432041168213,
            "end_logit": 0.46875423192977905
        },
        {
            "text": ". The adoptive cell therapy fur",
            "probability": 0.03848438025065275,
            "start_logit": 0.8947432041168213,
            "end_logit": 0.4639091491699219
        }
    ],
    "5cb0856decadf2e73f000058": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c896f60d558e5f232000003": [
        {
            "text": "not typical for cancer patients",
            "probability": 0.07089992198961982,
            "start_logit": 1.1171883344650269,
            "end_logit": 1.0637989044189453
        },
        {
            "text": "not typical for cancer patients, with the current antitumor therapy schemes. On the other hand",
            "probability": 0.06325982276399675,
            "start_logit": 1.1171883344650269,
            "end_logit": 0.9497799873352051
        },
        {
            "text": ". On the other hand",
            "probability": 0.05870798861617306,
            "start_logit": 1.0425137281417847,
            "end_logit": 0.9497799873352051
        },
        {
            "text": "-",
            "probability": 0.054161634450905,
            "start_logit": 0.9121754169464111,
            "end_logit": 0.9995152950286865
        },
        {
            "text": "and CAR-mediated cytotoxicity may",
            "probability": 0.0531257938591494,
            "start_logit": 0.8063037395477295,
            "end_logit": 1.0860767364501953
        },
        {
            "text": "phocytes into the tumor stroma; combined viral and CAR-mediated cytotoxicity may",
            "probability": 0.05237828216458691,
            "start_logit": 0.7921332120895386,
            "end_logit": 1.0860767364501953
        },
        {
            "text": ". On the other hand, the most important challenges faced by the current CAR-T cell therapy formats include the lack of targetable tumor-",
            "probability": 0.05191608439410772,
            "start_logit": 1.0425137281417847,
            "end_logit": 0.8268328309059143
        },
        {
            "text": "surface antigens, tumor cell hetero",
            "probability": 0.05114950242502332,
            "start_logit": 0.9154553413391113,
            "end_logit": 0.9390153288841248
        },
        {
            "text": "performance in both immunoco",
            "probability": 0.050998644626359634,
            "start_logit": 1.2772889137268066,
            "end_logit": 0.574228048324585
        },
        {
            "text": "not typical for cancer patients, with the current antitumor therapy schemes. On the other hand, the most",
            "probability": 0.04909786930783584,
            "start_logit": 1.1171883344650269,
            "end_logit": 0.6963452100753784
        },
        {
            "text": "not typical for cancer patients, with the current antitumor therapy schemes. On the other hand, the most important challenges",
            "probability": 0.04802720029279992,
            "start_logit": 1.1171883344650269,
            "end_logit": 0.6742970943450928
        },
        {
            "text": ". On the other hand, the most",
            "probability": 0.04556505261097996,
            "start_logit": 1.0425137281417847,
            "end_logit": 0.6963452100753784
        },
        {
            "text": "er immune cells to attack cancer cells. Thus, testing the combinations of CAR-based and virolytic approaches in the clinical setting appears both logical",
            "probability": 0.045406904475584646,
            "start_logit": 0.9235481023788452,
            "end_logit": 0.8118339776992798
        },
        {
            "text": "not typical for cancer patients, with the current antitumor therapy schemes. On the other hand, the most important challenges faced by the current CAR-",
            "probability": 0.04517365105079484,
            "start_logit": 1.1171883344650269,
            "end_logit": 0.6130435466766357
        },
        {
            "text": ". On the other hand, the most important challenges",
            "probability": 0.04457142313811662,
            "start_logit": 1.0425137281417847,
            "end_logit": 0.6742970943450928
        },
        {
            "text": "to attack cancer cells. Thus, testing the combinations of CAR-based and virolytic approaches in the clinical setting appears both logical",
            "probability": 0.044478091438092414,
            "start_logit": 0.9028806686401367,
            "end_logit": 0.8118339776992798
        },
        {
            "text": "er immune cells to attack cancer cells. Thus, testing the combinations of CAR-",
            "probability": 0.043460412618654735,
            "start_logit": 0.9235481023788452,
            "end_logit": 0.7680202722549438
        },
        {
            "text": "er immune cells to attack cancer cells. Thus, testing the combinations of CAR-based and virolytic approaches in the clinical setting appears",
            "probability": 0.04296457927475581,
            "start_logit": 0.9235481023788452,
            "end_logit": 0.7565458416938782
        },
        {
            "text": "to attack cancer cells. Thus, testing the combinations of CAR-",
            "probability": 0.04257141570681496,
            "start_logit": 0.9028806686401367,
            "end_logit": 0.7680202722549438
        },
        {
            "text": "to attack cancer cells. Thus, testing the combinations of CAR-based and virolytic approaches in the clinical setting appears",
            "probability": 0.04208572479564858,
            "start_logit": 0.9028806686401367,
            "end_logit": 0.7565458416938782
        }
    ],
    "5c9e6407ecadf2e73f000034": [
        {
            "text": "zoa. Since",
            "probability": 0.07489617980589108,
            "start_logit": 0.9538808465003967,
            "end_logit": 1.1410983800888062
        },
        {
            "text": "variety of functions. The present study describes the expression of YB2, a rat Y-box binding protein, and/or RYB-",
            "probability": 0.07277142169581723,
            "start_logit": 1.104691743850708,
            "end_logit": 0.9615079164505005
        },
        {
            "text": ". The present study describes the expression of YB2, a rat Y-box binding protein, and/or RYB-",
            "probability": 0.05907533280064892,
            "start_logit": 0.8961818814277649,
            "end_logit": 0.9615079164505005
        },
        {
            "text": "describes the expression of YB2, a rat Y-box binding protein, and/or RYB-",
            "probability": 0.0584399750964473,
            "start_logit": 0.8853685855865479,
            "end_logit": 0.9615079164505005
        },
        {
            "text": "of YB2, a rat Y-box binding protein, and/or RYB-",
            "probability": 0.0553490733518613,
            "start_logit": 0.8310283422470093,
            "end_logit": 0.9615079164505005
        },
        {
            "text": ". The mRNA and protein were present at high levels in spermatocytes,",
            "probability": 0.054659115619388014,
            "start_logit": 0.9194921255111694,
            "end_logit": 0.8605002164840698
        },
        {
            "text": ". An antibody which recognizes YB2/RYB-",
            "probability": 0.05366856817630875,
            "start_logit": 1.0815507173538208,
            "end_logit": 0.6801531314849854
        },
        {
            "text": ". An antibody which recognizes YB2/RYB-a was developed and applied in an im",
            "probability": 0.05150194623679206,
            "start_logit": 1.0815507173538208,
            "end_logit": 0.6389452219009399
        },
        {
            "text": ". The mRNA and protein",
            "probability": 0.05013593230891871,
            "start_logit": 0.9194921255111694,
            "end_logit": 0.7741221785545349
        },
        {
            "text": ". An antibody which recognizes YB2/RYB-a was",
            "probability": 0.04856225953226738,
            "start_logit": 1.0815507173538208,
            "end_logit": 0.5801723003387451
        },
        {
            "text": "Northern blot analysis of YB2/RYB-a and protamine 2 mRNA expression. Both YB2/RYB-",
            "probability": 0.0476825647704623,
            "start_logit": 0.9147603511810303,
            "end_logit": 0.7286818027496338
        },
        {
            "text": "rat testis is known to express a very low level of protamine 2",
            "probability": 0.047113432852316534,
            "start_logit": 0.9885467290878296,
            "end_logit": 0.6428877711296082
        },
        {
            "text": "rat testis is known to express a very low level of protamine 2, but is also likely to affect the",
            "probability": 0.044581363747012895,
            "start_logit": 0.9885467290878296,
            "end_logit": 0.5876455307006836
        },
        {
            "text": "is known to express a very low level of protamine 2",
            "probability": 0.042467528233133336,
            "start_logit": 0.8847283124923706,
            "end_logit": 0.6428877711296082
        },
        {
            "text": "level and localization of Y",
            "probability": 0.04123542062074751,
            "start_logit": 0.809697687625885,
            "end_logit": 0.6884762644767761
        },
        {
            "text": "out an in-",
            "probability": 0.0409934259736596,
            "start_logit": 0.8138594627380371,
            "end_logit": 0.678428590297699
        },
        {
            "text": "is known to express a very low level of protamine 2, but is also likely to affect the",
            "probability": 0.04018514909606649,
            "start_logit": 0.8847283124923706,
            "end_logit": 0.5876455307006836
        },
        {
            "text": "rat and mouse testes. We also carried out an in-",
            "probability": 0.03988734637959209,
            "start_logit": 0.7865068912506104,
            "end_logit": 0.678428590297699
        },
        {
            "text": "rat testis was comparable to that in mouse testis, although rat testis is known to express a very low level of protamine 2",
            "probability": 0.038834936167678226,
            "start_logit": 0.7953088283538818,
            "end_logit": 0.6428877711296082
        },
        {
            "text": "proposed function of the Y",
            "probability": 0.03795902753499006,
            "start_logit": 0.7720688581466675,
            "end_logit": 0.6433148384094238
        }
    ],
    "5c910ae0ecadf2e73f000007": [
        {
            "text": "recent years, with large pharmaceutical companies relying less on",
            "probability": 0.1492275764109133,
            "start_logit": 1.1058143377304077,
            "end_logit": 0.7241816520690918
        },
        {
            "text": "recent years, with large pharmaceutical companies relying",
            "probability": 0.12383194189335321,
            "start_logit": 1.1058143377304077,
            "end_logit": 0.5376344919204712
        },
        {
            "text": "recent years, with large pharmaceutical companies relying less on research and development and more on cost cutting",
            "probability": 0.12097997655979328,
            "start_logit": 1.1058143377304077,
            "end_logit": 0.5143342018127441
        },
        {
            "text": "recent years, with large pharmaceutical companies relying less on research",
            "probability": 0.11331763055085428,
            "start_logit": 1.1058143377304077,
            "end_logit": 0.4489039182662964
        },
        {
            "text": "recent years, with large pharmaceutical companies relying less on research and development and more on cost cutting and obtaining promising drug candidates through mergers and acquisitions. Concurrently",
            "probability": 0.10971613494165221,
            "start_logit": 1.1058143377304077,
            "end_logit": 0.4166055917739868
        },
        {
            "text": "recent years, with large pharmaceutical companies relying less on research and development and more on cost cutting and obtaining promising drug candidates through mergers and",
            "probability": 0.10971244667418223,
            "start_logit": 1.1058143377304077,
            "end_logit": 0.4165719747543335
        },
        {
            "text": "mergers and acquisitions. Concurrently, drug companies in emerging markets have flourished under a different economic model characterized by public-",
            "probability": 0.09972488274224503,
            "start_logit": 0.8709040880203247,
            "end_logit": 0.5560346245765686
        },
        {
            "text": "mergers and acquisitions. Concurrently",
            "probability": 0.08674616316273134,
            "start_logit": 0.8709040880203247,
            "end_logit": 0.4166055917739868
        },
        {
            "text": "mergers and",
            "probability": 0.086743247064275,
            "start_logit": 0.8709040880203247,
            "end_logit": 0.4165719747543335
        }
    ],
    "5c9efde8ecadf2e73f000039": [
        {
            "text": "mies have been reported in relation to obstructive hydrocephalus and increased intracranial pressure and are most",
            "probability": 0.2193965905878639,
            "start_logit": 1.1276347637176514,
            "end_logit": 0.8061505556106567
        },
        {
            "text": "phalus and increased intracranial pressure and are most",
            "probability": 0.19816277555330442,
            "start_logit": 1.025842547416687,
            "end_logit": 0.8061505556106567
        },
        {
            "text": "mies have been reported in relation to obstructive hydroce",
            "probability": 0.1680916957684311,
            "start_logit": 1.1276347637176514,
            "end_logit": 0.5397791862487793
        },
        {
            "text": "mies have been",
            "probability": 0.16087311421108513,
            "start_logit": 1.1276347637176514,
            "end_logit": 0.4958854913711548
        },
        {
            "text": "phalus and increased intracranial pressure and are most commonly seen as disruption of the floor",
            "probability": 0.13588380589891946,
            "start_logit": 1.025842547416687,
            "end_logit": 0.42886191606521606
        },
        {
            "text": "phalus and increased intracranial pressure and are most commonly seen as disruption of the floor of the third ventricle. Hydrocephalus",
            "probability": 0.11759201798039615,
            "start_logit": 1.025842547416687,
            "end_logit": 0.284282922744751
        }
    ],
    "5c89623bf9c2ba6b28000004": [
        {
            "text": "worsened and died by postnatal day 9. The phenotypic, histopatholo",
            "probability": 0.0688026573267469,
            "start_logit": 1.2345001697540283,
            "end_logit": 0.8687447309494019
        },
        {
            "text": "two alternate transcripts of smaller size",
            "probability": 0.06066182346504592,
            "start_logit": 1.181955337524414,
            "end_logit": 0.7953617572784424
        },
        {
            "text": "associated with the mutation. Evidence of reduced expression of the full-",
            "probability": 0.05996252536780445,
            "start_logit": 1.0276622772216797,
            "end_logit": 0.9380600452423096
        },
        {
            "text": "worsened and died by postnatal day 9. The phenotypic, histopathologic and",
            "probability": 0.058484898191030046,
            "start_logit": 1.2345001697540283,
            "end_logit": 0.7062709331512451
        },
        {
            "text": "associated with the mutation. Evidence of reduced expression of the",
            "probability": 0.05285201027190183,
            "start_logit": 1.0276622772216797,
            "end_logit": 0.8118360042572021
        },
        {
            "text": "two alternate transcripts of smaller size. These alternate transcripts were expressed at very low levels in the wild-type mice and were significantly",
            "probability": 0.052324175218295736,
            "start_logit": 1.181955337524414,
            "end_logit": 0.6475057005882263
        },
        {
            "text": "two alternate transcripts of smaller size. These alternate transcripts were expressed at very low levels in the wild-",
            "probability": 0.05197227923946933,
            "start_logit": 1.181955337524414,
            "end_logit": 0.64075767993927
        },
        {
            "text": "model. The Cfl2A35T/A35T (KI) mouse were indistinguishab",
            "probability": 0.049433176174181206,
            "start_logit": 0.8128573894500732,
            "end_logit": 0.9597669243812561
        },
        {
            "text": "mRNA levels in various tissues including skeletal muscles. Further investigation revealed evidence of alternative splicing with the presence of two alternate transcripts of smaller size",
            "probability": 0.049396639009686764,
            "start_logit": 0.9765231609344482,
            "end_logit": 0.7953617572784424
        },
        {
            "text": "a critical component of the disease mechanism associated with the mutation. Evidence of reduced expression of the full-",
            "probability": 0.04865236823919697,
            "start_logit": 0.8186429738998413,
            "end_logit": 0.9380600452423096
        },
        {
            "text": "levels in various tissues including skeletal muscles. Further investigation revealed evidence of alternative splicing with the presence of two alternate transcripts of smaller size",
            "probability": 0.048427554871448564,
            "start_logit": 0.9567097425460815,
            "end_logit": 0.7953617572784424
        },
        {
            "text": "be a critical component of the disease mechanism associated with the mutation. Evidence of reduced expression of the full-",
            "probability": 0.04748369462498705,
            "start_logit": 0.7943288683891296,
            "end_logit": 0.9380600452423096
        },
        {
            "text": "2 mutation, p.A35T, that first linked cofilin-",
            "probability": 0.04571675918178534,
            "start_logit": 0.9209915995597839,
            "end_logit": 0.7734758853912354
        },
        {
            "text": "mRNA levels",
            "probability": 0.045205755393252146,
            "start_logit": 0.9765231609344482,
            "end_logit": 0.706703782081604
        },
        {
            "text": "Further investigation revealed evidence of alternative splicing with the presence of two alternate transcripts of smaller size",
            "probability": 0.044355618110458864,
            "start_logit": 0.8688801527023315,
            "end_logit": 0.7953617572784424
        },
        {
            "text": "levels",
            "probability": 0.04431888978079447,
            "start_logit": 0.9567097425460815,
            "end_logit": 0.706703782081604
        },
        {
            "text": "tutive Cfl2-knockout (KO) mice described previously, including sarcomeric disruption and actin",
            "probability": 0.0432460608959138,
            "start_logit": 0.9534600377082825,
            "end_logit": 0.6854486465454102
        },
        {
            "text": "2 mutation, p.A35T, that first linked cofilin-2 with the human disease, we created a knock-",
            "probability": 0.04320261039975787,
            "start_logit": 0.9209915995597839,
            "end_logit": 0.7169118523597717
        },
        {
            "text": "a critical component of the disease mechanism associated with the mutation. Evidence of reduced expression of the",
            "probability": 0.042883041535656065,
            "start_logit": 0.8186429738998413,
            "end_logit": 0.8118360042572021
        },
        {
            "text": "including skeletal muscles. Further investigation revealed evidence of alternative splicing with the presence of two alternate transcripts of smaller size",
            "probability": 0.04261746270258662,
            "start_logit": 0.8289048671722412,
            "end_logit": 0.7953617572784424
        }
    ],
    "5c9789a9ecadf2e73f000024": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c9791d2ecadf2e73f000026": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c897167d558e5f232000005": [
        {
            "text": "success",
            "probability": 0.06945466118291489,
            "start_logit": 0.9158862829208374,
            "end_logit": 0.9179776906967163
        },
        {
            "text": ". We provide an overview of the current state of gene-modified HSC therapies, highlighting success",
            "probability": 0.06935048628964015,
            "start_logit": 0.9143852591514587,
            "end_logit": 0.9179776906967163
        },
        {
            "text": "). Newer gene-modifying technologies",
            "probability": 0.0644725341623232,
            "start_logit": 0.9677256941795349,
            "end_logit": 0.7917034029960632
        },
        {
            "text": ". We provide an overview of the current state of gene-",
            "probability": 0.06258438716744598,
            "start_logit": 0.9143852591514587,
            "end_logit": 0.8153203725814819
        },
        {
            "text": "success stories, limitations",
            "probability": 0.061777303223989666,
            "start_logit": 0.9158862829208374,
            "end_logit": 0.8008395433425903
        },
        {
            "text": ". We provide an overview of the current state of gene-modified HSC therapies, highlighting success stories, limitations",
            "probability": 0.06168464358300154,
            "start_logit": 0.9143852591514587,
            "end_logit": 0.8008395433425903
        },
        {
            "text": ") transplantation has been",
            "probability": 0.059582017604995645,
            "start_logit": 0.9955043792724609,
            "end_logit": 0.685039222240448
        },
        {
            "text": ". We",
            "probability": 0.05894423188784511,
            "start_logit": 0.9143852591514587,
            "end_logit": 0.75539630651474
        },
        {
            "text": "ultimately culminating in the approval of two such the",
            "probability": 0.05608556109846871,
            "start_logit": 0.9038165807723999,
            "end_logit": 0.7162516117095947
        },
        {
            "text": ") transplantation has been performed in patients with various",
            "probability": 0.053521162285211546,
            "start_logit": 0.9955043792724609,
            "end_logit": 0.5777625441551208
        },
        {
            "text": "). Newer gene-modifying technologies and treatment regimens",
            "probability": 0.05138229243293229,
            "start_logit": 0.9677256941795349,
            "end_logit": 0.5647577047348022
        },
        {
            "text": "). Newer gene-modifying technologies and treatment regimens have also recently",
            "probability": 0.051198219325566216,
            "start_logit": 0.9677256941795349,
            "end_logit": 0.5611688494682312
        },
        {
            "text": "). Newer gene-modifying technologies and treatment regimens have also recently come to the fore, which hold great promise for the",
            "probability": 0.048908471265388755,
            "start_logit": 0.9677256941795349,
            "end_logit": 0.5154147148132324
        },
        {
            "text": ").",
            "probability": 0.048129243610479426,
            "start_logit": 0.9677256941795349,
            "end_logit": 0.4993540644645691
        },
        {
            "text": "ultimately culminating in the approval of two such therapies in Europe (Strimvelis for a",
            "probability": 0.047452095762026955,
            "start_logit": 0.9038165807723999,
            "end_logit": 0.5490939021110535
        },
        {
            "text": "translation of these therapies to the",
            "probability": 0.04590514906007608,
            "start_logit": 0.9390788078308105,
            "end_logit": 0.48068827390670776
        },
        {
            "text": "success stories, limitations and important considerations for achieving successful translation of these therapies to the",
            "probability": 0.04485274388664796,
            "start_logit": 0.9158862829208374,
            "end_logit": 0.48068827390670776
        },
        {
            "text": ". We provide an overview of the current state of gene-modified HSC",
            "probability": 0.04471479617104597,
            "start_logit": 0.9143852591514587,
            "end_logit": 0.479108989238739
        }
    ],
    "5cb0e4a6ecadf2e73f00005b": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c897555d558e5f232000009": [
        {
            "text": "biology and increased understanding of the associated therapeutic challenges and limitations",
            "probability": 0.11470242416190732,
            "start_logit": 0.9210793972015381,
            "end_logit": 1.0402048826217651
        },
        {
            "text": "cal and clinical successes in AAV-mediated gene replacement, gene silencing and gene editing have helped AAV gain popularity as the",
            "probability": 0.0850352452090559,
            "start_logit": 0.9516007304191589,
            "end_logit": 0.7104082107543945
        },
        {
            "text": "cal and clinical successes in AAV-mediated gene replacement, gene silencing",
            "probability": 0.08065548758250707,
            "start_logit": 0.9516007304191589,
            "end_logit": 0.6575292348861694
        },
        {
            "text": "biology and increased understanding of the associated therapeutic challenges and limitations will",
            "probability": 0.07773261613602386,
            "start_logit": 0.9210793972015381,
            "end_logit": 0.6511386632919312
        },
        {
            "text": "cal and clinical successes in AAV-",
            "probability": 0.07562085086622054,
            "start_logit": 0.9516007304191589,
            "end_logit": 0.5930744409561157
        },
        {
            "text": "cal and clinical successes in AAV",
            "probability": 0.07026269568462729,
            "start_logit": 0.9516007304191589,
            "end_logit": 0.5195834040641785
        },
        {
            "text": "biology and increased understanding of the associated therapeutic challenges and limitations will build the foundation",
            "probability": 0.06960956864499664,
            "start_logit": 0.9210793972015381,
            "end_logit": 0.5407657623291016
        },
        {
            "text": "V) vectors are the leading platform for gene delivery for the treatment of a variety of human diseases. Recent advances in developing clinically desirable AAV",
            "probability": 0.06635648765174443,
            "start_logit": 0.8622493743896484,
            "end_logit": 0.5517352819442749
        },
        {
            "text": "V) vectors are the leading platform for gene delivery for the",
            "probability": 0.06422067895687447,
            "start_logit": 0.8622493743896484,
            "end_logit": 0.5190190076828003
        },
        {
            "text": "biology and increased understanding of the associated therapeutic challenges and limitations will build the",
            "probability": 0.0621790046988045,
            "start_logit": 0.9210793972015381,
            "end_logit": 0.427881121635437
        },
        {
            "text": "biology and increased understanding of the associated therapeutic challenges and",
            "probability": 0.06199220273918046,
            "start_logit": 0.9210793972015381,
            "end_logit": 0.42487233877182007
        },
        {
            "text": "biology and increased understanding of the associated therapeutic challenges and limitations will build the foundation for future clinical success",
            "probability": 0.06082288541199957,
            "start_logit": 0.9210793972015381,
            "end_logit": 0.40582984685897827
        },
        {
            "text": "cal and clinical successes in AAV-mediated gene replacement, gene silencing and",
            "probability": 0.05797752310954985,
            "start_logit": 0.9516007304191589,
            "end_logit": 0.32739779353141785
        },
        {
            "text": "V) vectors are the leading platform for gene delivery for the treatment of a variety of human diseases. Recent advances",
            "probability": 0.0528323291465081,
            "start_logit": 0.8622493743896484,
            "end_logit": 0.32381704449653625
        }
    ],
    "5c89773ed558e5f23200000a": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c9fb428ecadf2e73f000041": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c8fe7cb0101eac87000000c": [
        {
            "text": "ovulatory granulosa cells by stimulation with hCG. The hCG-",
            "probability": 0.07199680984581414,
            "start_logit": 1.0284491777420044,
            "end_logit": 1.2234805822372437
        },
        {
            "text": ". The hCG-",
            "probability": 0.07178698622666424,
            "start_logit": 1.0255305767059326,
            "end_logit": 1.2234805822372437
        },
        {
            "text": "recapitulated in vitro in preovulatory granulosa cells by stimulation with hCG. The hCG-",
            "probability": 0.05825524026787123,
            "start_logit": 0.8166614174842834,
            "end_logit": 1.2234805822372437
        },
        {
            "text": "6) and EGF-receptor tyrosine kinase inhibitor (AG1478), indicating the involvement",
            "probability": 0.05613217167316548,
            "start_logit": 0.9597254991531372,
            "end_logit": 1.0432915687561035
        },
        {
            "text": "vitro in preovulatory granulosa cells by stimulation with hCG. The hCG-",
            "probability": 0.05450857684801077,
            "start_logit": 0.7501854300498962,
            "end_logit": 1.2234805822372437
        },
        {
            "text": "2 has been shown to play an important role in cell",
            "probability": 0.05349857825035388,
            "start_logit": 0.9998775720596313,
            "end_logit": 0.9550854563713074
        },
        {
            "text": ". The hCG-induced Runx2 expression was reduced by antiprogestin (RU486) and E",
            "probability": 0.05298983467670765,
            "start_logit": 1.0255305767059326,
            "end_logit": 0.9198774695396423
        },
        {
            "text": "6) and E",
            "probability": 0.04961508988681985,
            "start_logit": 0.9597254991531372,
            "end_logit": 0.9198774695396423
        },
        {
            "text": ". RUNX2 has been shown to play an important role in cell",
            "probability": 0.04870437309023522,
            "start_logit": 0.9059913158416748,
            "end_logit": 0.9550854563713074
        },
        {
            "text": "78), indicating the involvement",
            "probability": 0.047860400432336914,
            "start_logit": 0.8003048300743103,
            "end_logit": 1.0432915687561035
        },
        {
            "text": "differentiation of follicular cells to become luteal cells. RUNX2 has been shown to play an important role in cell",
            "probability": 0.046477871397482794,
            "start_logit": 0.859198808670044,
            "end_logit": 0.9550854563713074
        },
        {
            "text": "downstream",
            "probability": 0.046459723955231,
            "start_logit": 0.8990482091903687,
            "end_logit": 0.9148455262184143
        },
        {
            "text": "GF-signaling and progester",
            "probability": 0.04605298634009669,
            "start_logit": 0.8861094117164612,
            "end_logit": 0.9189911484718323
        },
        {
            "text": "2 has been shown to play an important role in cell differentiation, but the regulation of Runx2 expression and its function in the",
            "probability": 0.04495276437249708,
            "start_logit": 0.9998775720596313,
            "end_logit": 0.7810426354408264
        },
        {
            "text": "important role in cell",
            "probability": 0.0449468540188995,
            "start_logit": 0.8257032632827759,
            "end_logit": 0.9550854563713074
        },
        {
            "text": ". Runx2 knockdown resulted in reduced levels of mRNA for Rgc32,",
            "probability": 0.04260235298735698,
            "start_logit": 0.8829236030578613,
            "end_logit": 0.8442938327789307
        },
        {
            "text": "78), indicating the involvement of EGF-signaling and progester",
            "probability": 0.0422662133831594,
            "start_logit": 0.8003048300743103,
            "end_logit": 0.9189911484718323
        },
        {
            "text": ". RUNX2 has been shown to play an important role in cell differentiation, but the regulation of Runx2 expression and its function in the",
            "probability": 0.04092438115252247,
            "start_logit": 0.9059913158416748,
            "end_logit": 0.7810426354408264
        },
        {
            "text": "2 expression by small interfering RNA in vitro. Runx2 knockdown resulted in reduced levels of mRNA for Rgc32,",
            "probability": 0.04006757110120922,
            "start_logit": 0.8215814232826233,
            "end_logit": 0.8442938327789307
        },
        {
            "text": ". Runx2 knockdown resulted in reduced levels of mRNA for Rgc32, Ptgds, Fa",
            "probability": 0.03990122009356546,
            "start_logit": 0.8829236030578613,
            "end_logit": 0.7787912487983704
        }
    ],
    "5c9ff25eecadf2e73f000043": [
        {
            "text": "empty",
            "probability": 1.0,
            "start_logit": 0.0,
            "end_logit": 0.0
        }
    ],
    "5c900b9eecadf2e73f000004": [
        {
            "text": "ran (Onpa",
            "probability": 0.07162582340549625,
            "start_logit": 1.0600264072418213,
            "end_logit": 0.8591502904891968
        },
        {
            "text": "These new innovations resulted in the nanoparticle medicines Doxil\u00ae and Abraxa",
            "probability": 0.07019016571019775,
            "start_logit": 0.8145084381103516,
            "end_logit": 1.0844208002090454
        },
        {
            "text": "surface properties (e",
            "probability": 0.06806841144255346,
            "start_logit": 1.0584924221038818,
            "end_logit": 0.8097418546676636
        },
        {
            "text": "i.e., intramuscular, sub",
            "probability": 0.06070874216007499,
            "start_logit": 1.0547435283660889,
            "end_logit": 0.6990652084350586
        },
        {
            "text": "surface",
            "probability": 0.05941966722377012,
            "start_logit": 1.0584924221038818,
            "end_logit": 0.673853874206543
        },
        {
            "text": "surface properties (e.g., PEGylation) to enable long circulation times. These new innovations resulted in the",
            "probability": 0.05692390009672245,
            "start_logit": 1.0584924221038818,
            "end_logit": 0.6309438943862915
        },
        {
            "text": "agents by decreasing systemic exposure and delivering more drug to tumors. Very recently",
            "probability": 0.054376998740780086,
            "start_logit": 0.9247029423713684,
            "end_logit": 0.7189593315124512
        },
        {
            "text": "i.e.",
            "probability": 0.05362728645067421,
            "start_logit": 1.0547435283660889,
            "end_logit": 0.5750355124473572
        },
        {
            "text": "xic cancer agents by decreasing systemic exposure and delivering more drug to tumors. Very recently",
            "probability": 0.05307399669863155,
            "start_logit": 0.9004487991333008,
            "end_logit": 0.7189593315124512
        },
        {
            "text": "agents by decreasing systemic exposure and delivering more drug to tumors. Very recently, the first siRNA lipid nanoparticle medicine, Pat",
            "probability": 0.049903041284147256,
            "start_logit": 0.9247029423713684,
            "end_logit": 0.6331000328063965
        },
        {
            "text": "improve the therapeutic index of cytotoxic cancer agents by decreasing systemic exposure and delivering more drug to tumors. Very recently",
            "probability": 0.04984288950852138,
            "start_logit": 0.8376375436782837,
            "end_logit": 0.7189593315124512
        },
        {
            "text": ".g., Lupron Depot\u00ae, Risperdal",
            "probability": 0.04781205605919558,
            "start_logit": 0.8089693784713745,
            "end_logit": 0.70602947473526
        },
        {
            "text": "These new innovations resulted in the nanoparticle medicines Doxi",
            "probability": 0.04551287603465315,
            "start_logit": 0.8145084381103516,
            "end_logit": 0.6512078642845154
        },
        {
            "text": "These new innovations resulted in the",
            "probability": 0.044599886126141165,
            "start_logit": 0.8145084381103516,
            "end_logit": 0.6309438943862915
        },
        {
            "text": "path starts with innovation from academic collaborations amongst biologists,",
            "probability": 0.04372468518591622,
            "start_logit": 0.832996666431427,
            "end_logit": 0.5926371812820435
        },
        {
            "text": "Often, this path starts with innovation from academic collaborations amongst biologists,",
            "probability": 0.04362104778758482,
            "start_logit": 0.8306236267089844,
            "end_logit": 0.5926371812820435
        },
        {
            "text": "Often, this",
            "probability": 0.04262061080807289,
            "start_logit": 0.8306236267089844,
            "end_logit": 0.5694353580474854
        },
        {
            "text": ".g., Lupron Depot\u00ae, Risperdal Consta\u00ae). With",
            "probability": 0.04239202218782495,
            "start_logit": 0.8089693784713745,
            "end_logit": 0.5857118368148804
        },
        {
            "text": "Over the past 50\u00a0years, drug delivery breakthroughs have enabled the approval of several important medicines. Often, this",
            "probability": 0.04195589308904177,
            "start_logit": 0.8149045705795288,
            "end_logit": 0.5694353580474854
        }
    ],
    "5caa0247ecadf2e73f000055": [
        {
            "text": "interaction experiments are consistent with Crb acting downstream of Src42A in controlling tube size",
            "probability": 0.07888166894689252,
            "start_logit": 0.8641620874404907,
            "end_logit": 1.1534045934677124
        },
        {
            "text": "required for the anisotropic accumulation",
            "probability": 0.06192377423603802,
            "start_logit": 1.051308512687683,
            "end_logit": 0.7242134809494019
        },
        {
            "text": "behaviour downstream of Src42A. Our results indicate that Src42A regulates a mechanism",
            "probability": 0.056210894412661035,
            "start_logit": 0.8426333069801331,
            "end_logit": 0.8360950946807861
        },
        {
            "text": "required for the anisotropic accumulation of Crumbs, thereby identifying the first polarised cell behaviour downstream of Src",
            "probability": 0.05522848646376193,
            "start_logit": 1.051308512687683,
            "end_logit": 0.609788179397583
        },
        {
            "text": ". This work provides new",
            "probability": 0.053198330592104194,
            "start_logit": 0.842135488986969,
            "end_logit": 0.7815093398094177
        },
        {
            "text": "42A regulates a mechanism",
            "probability": 0.05151806881975998,
            "start_logit": 0.7554553151130676,
            "end_logit": 0.8360950946807861
        },
        {
            "text": ". We provide evidence indicating that the accumulation of Crumbs in specific apical domains",
            "probability": 0.050112895311098006,
            "start_logit": 0.8083713054656982,
            "end_logit": 0.7555248737335205
        },
        {
            "text": "interaction experiments are consistent with Crb acting downstream",
            "probability": 0.04896514263068066,
            "start_logit": 0.8641620874404907,
            "end_logit": 0.6765643954277039
        },
        {
            "text": ". This work provides new insights into the key question of how organ growth is",
            "probability": 0.04808020733224802,
            "start_logit": 0.842135488986969,
            "end_logit": 0.6803529262542725
        },
        {
            "text": "behaviour downstream of Src42A. Our results indicate that Src42A regulates a mechanism that increases the fraction of Crb protein",
            "probability": 0.047930644878450425,
            "start_logit": 0.8426333069801331,
            "end_logit": 0.6767395734786987
        },
        {
            "text": "of Crumbs, thereby identifying the first polarised cell behaviour downstream of Src",
            "probability": 0.047880820935184636,
            "start_logit": 0.908544659614563,
            "end_logit": 0.609788179397583
        },
        {
            "text": "prevent disease or malformations. This control incorporates the intrinsic physical anisotropy of tubes to generate proportionate organs that match",
            "probability": 0.04595863351647918,
            "start_logit": 0.8903689384460449,
            "end_logit": 0.5869905948638916
        },
        {
            "text": ". We find that Src42A is required for the anisotropic accumulation",
            "probability": 0.04550477968001098,
            "start_logit": 0.7432217001914978,
            "end_logit": 0.7242134809494019
        },
        {
            "text": "behaviour downstream of Src",
            "probability": 0.044826687876707315,
            "start_logit": 0.8426333069801331,
            "end_logit": 0.609788179397583
        },
        {
            "text": "physiological activity and to prevent disease or malformations. This control incorporates the intrinsic physical anisotropy of tubes to generate proportionate organs that match",
            "probability": 0.04453503001804729,
            "start_logit": 0.8589032888412476,
            "end_logit": 0.5869905948638916
        },
        {
            "text": "organs that match their function. The exact mechanisms underlying tube size control and how tubular anisotropy is translated at the cellular level are still not",
            "probability": 0.04428288730194495,
            "start_logit": 0.8232559561729431,
            "end_logit": 0.6169601678848267
        },
        {
            "text": "organs that match their function. The exact mechanisms underlying",
            "probability": 0.04413509476170902,
            "start_logit": 0.8232559561729431,
            "end_logit": 0.6136171221733093
        },
        {
            "text": "42A regulates a mechanism that increases the fraction of Crb protein",
            "probability": 0.043929104619749616,
            "start_logit": 0.7554553151130676,
            "end_logit": 0.6767395734786987
        },
        {
            "text": "42A regulates a mechanism that increases the fraction of Crb protein at longitudinal junctions, and genetic interaction experiments are consistent with Crb acting downstream",
            "probability": 0.04392140987881491,
            "start_logit": 0.7554553151130676,
            "end_logit": 0.6765643954277039
        },
        {
            "text": "organs that match",
            "probability": 0.04297543778765714,
            "start_logit": 0.8232559561729431,
            "end_logit": 0.5869905948638916
        }
    ],
    "5caa06d0ecadf2e73f000056": [
        {
            "text": "), a master regulator of the antioxidative cellular response to oxidative stress, increased ghrelin",
            "probability": 0.08022767213709746,
            "start_logit": 0.8686040043830872,
            "end_logit": 1.0543068647384644
        },
        {
            "text": "including regulation of food intake, body weight, and blood glucose. Plasma ghrelin levels are robustly regulated by feeding status, with its levels",
            "probability": 0.07691082626478163,
            "start_logit": 1.222795009613037,
            "end_logit": 0.6578940153121948
        },
        {
            "text": "lin",
            "probability": 0.07078165495659279,
            "start_logit": 0.7433353662490845,
            "end_logit": 1.0543068647384644
        },
        {
            "text": "), a master regulator of the antioxidative cellular response to oxida",
            "probability": 0.06582302422331071,
            "start_logit": 0.8686040043830872,
            "end_logit": 0.8564080595970154
        },
        {
            "text": "food intake, body weight, and blood glucose. Plasma ghrelin levels are robustly regulated by feeding status, with its levels",
            "probability": 0.06360798293140175,
            "start_logit": 1.03288733959198,
            "end_logit": 0.6578940153121948
        },
        {
            "text": "blood glucose. Plasma ghrelin levels are robustly regulated by feeding status, with its levels",
            "probability": 0.060761890525625216,
            "start_logit": 0.9871111512184143,
            "end_logit": 0.6578940153121948
        },
        {
            "text": "blood glucose. Plasma ghrelin levels are robustly regulated by feeding status, with its levels increasing upon caloric restriction and decreasing",
            "probability": 0.0599936659029341,
            "start_logit": 0.9871111512184143,
            "end_logit": 0.6451702117919922
        },
        {
            "text": "lower plasma ghrelin. Also dissociated mouse gastric mucosal cell preparations,",
            "probability": 0.05615838496252283,
            "start_logit": 0.8651385307312012,
            "end_logit": 0.7010798454284668
        },
        {
            "text": "weight, and blood glucose. Plasma ghrelin levels are robustly regulated by feeding status, with its levels",
            "probability": 0.055340903757524165,
            "start_logit": 0.8936606645584106,
            "end_logit": 0.6578940153121948
        },
        {
            "text": "weight, and blood glucose. Plasma ghrelin levels are robustly regulated by feeding status, with its levels increasing upon caloric restriction and decreasing",
            "probability": 0.05464121774478267,
            "start_logit": 0.8936606645584106,
            "end_logit": 0.6451702117919922
        },
        {
            "text": "),",
            "probability": 0.05387097992169557,
            "start_logit": 0.8686040043830872,
            "end_logit": 0.6560302972793579
        },
        {
            "text": "lower plasma ghrelin. Also dissociated mouse gastric mucos",
            "probability": 0.053292707013851325,
            "start_logit": 0.8651385307312012,
            "end_logit": 0.6487033367156982
        },
        {
            "text": "plasma ghrelin. Also dissociated mouse gastric mucosal cell preparations,",
            "probability": 0.05123037281925558,
            "start_logit": 0.7732951045036316,
            "end_logit": 0.7010798454284668
        },
        {
            "text": "regulation of food intake, body weight, and blood glucose. Plasma ghrelin levels are robustly regulated by feeding status, with its levels",
            "probability": 0.049799814021105296,
            "start_logit": 0.7881596088409424,
            "end_logit": 0.6578940153121948
        },
        {
            "text": "lin secretion. These antioxidant compounds blocked the inhibitory effects of glucose on ghrelin secretion.",
            "probability": 0.04975935768938868,
            "start_logit": 0.7433353662490845,
            "end_logit": 0.7019055485725403
        },
        {
            "text": "hrelin cells to inhibit ghrelin secretion.",
            "probability": 0.049183381207302417,
            "start_logit": 0.766877293586731,
            "end_logit": 0.6667208671569824
        },
        {
            "text": "plasma ghrelin. Also dissociated mouse gastric mucos",
            "probability": 0.04861616392082779,
            "start_logit": 0.7732951045036316,
            "end_logit": 0.6487033367156982
        }
    ],
    "5c93e8bdecadf2e73f00001c": [
        {
            "text": "gulated genes involved in G1/S transition and DNA replication. The",
            "probability": 0.09769882045275463,
            "start_logit": 1.1343961954116821,
            "end_logit": 1.169616460800171
        },
        {
            "text": ". The",
            "probability": 0.07115818586952302,
            "start_logit": 0.8174120783805847,
            "end_logit": 1.169616460800171
        },
        {
            "text": "is not known if the SAMHD1-induced dNTP imbalance favors accumulation",
            "probability": 0.05795569090183661,
            "start_logit": 0.8939474821090698,
            "end_logit": 0.8878544569015503
        },
        {
            "text": "if the SAMHD1-induced dNTP imbalance favors accumulation",
            "probability": 0.055981700836982076,
            "start_logit": 0.8592935800552368,
            "end_logit": 0.8878544569015503
        },
        {
            "text": "balance and concentration of the four dNTPs. Deficiency of SAMHD1 leads to unequally increased pools and marked dNTP imbalance.",
            "probability": 0.04945926333344929,
            "start_logit": 0.9752640724182129,
            "end_logit": 0.6480084657669067
        },
        {
            "text": "balance and concentration of the four dNTPs.",
            "probability": 0.04919919284402449,
            "start_logit": 0.9752640724182129,
            "end_logit": 0.6427363157272339
        },
        {
            "text": "hosphoh",
            "probability": 0.04658602401902805,
            "start_logit": 0.8598663806915283,
            "end_logit": 0.7035573720932007
        },
        {
            "text": "and WT cells by exome next-generation sequencing. Somatic variant analysis indicated a mutator phenotype",
            "probability": 0.046129496549379506,
            "start_logit": 0.8890410661697388,
            "end_logit": 0.6645346879959106
        },
        {
            "text": "activity of the dNTP triphosphoh",
            "probability": 0.045860297534032174,
            "start_logit": 0.844165563583374,
            "end_logit": 0.7035573720932007
        },
        {
            "text": "i-",
            "probability": 0.045630904924027445,
            "start_logit": 0.8257602453231812,
            "end_logit": 0.7169481515884399
        },
        {
            "text": "is not known if the SAMHD1-induced dNTP imbalance favors accumulation of somatic mutations in non-transformed cells. Here, we",
            "probability": 0.04538307641379639,
            "start_logit": 0.8939474821090698,
            "end_logit": 0.6433149576187134
        },
        {
            "text": "is not known if the SAMHD1-induced dNTP imbalance favors accumulation of somatic mutations in non-",
            "probability": 0.04515568866458507,
            "start_logit": 0.8939474821090698,
            "end_logit": 0.6382919549942017
        },
        {
            "text": "cent, faster rate of excision repair of UV-",
            "probability": 0.04495637293540678,
            "start_logit": 0.8854796886444092,
            "end_logit": 0.6423360109329224
        },
        {
            "text": "if the SAMHD1-induced dNTP imbalance favors accumulation of somatic mutations in non-transformed cells. Here, we",
            "probability": 0.043837313770657416,
            "start_logit": 0.8592935800552368,
            "end_logit": 0.6433149576187134
        },
        {
            "text": "hosphohydrolase SAMHD1 sets the balance and concentration of the four dNTPs.",
            "probability": 0.0438370577064688,
            "start_logit": 0.8598663806915283,
            "end_logit": 0.6427363157272339
        },
        {
            "text": "if the SAMHD1-induced dNTP imbalance favors accumulation of somatic mutations in non-",
            "probability": 0.043617670923643416,
            "start_logit": 0.8592935800552368,
            "end_logit": 0.6382919549942017
        },
        {
            "text": "activity of the dNTP triphosphohydrolase SAMHD1 sets the balance and concentration of the four dNTPs.",
            "probability": 0.043154155173535685,
            "start_logit": 0.844165563583374,
            "end_logit": 0.6427363157272339
        },
        {
            "text": "abolic activity of the dNTP triphosphoh",
            "probability": 0.0424530245719765,
            "start_logit": 0.7669639587402344,
            "end_logit": 0.7035573720932007
        },
        {
            "text": ". The normally growing AGS cells exhibited unchanged DNA replication dynamics and, when quiescent, faster rate of excision repair of UV-",
            "probability": 0.041998122668801215,
            "start_logit": 0.8174120783805847,
            "end_logit": 0.6423360109329224
        },
        {
            "text": "abolic activity of the dNTP triphosphohydrolase SAMHD1 sets the balance and concentration of the four dNTPs.",
            "probability": 0.039947939906091585,
            "start_logit": 0.7669639587402344,
            "end_logit": 0.6427363157272339
        }
    ],
    "5cb39707ecadf2e73f000060": [
        {
            "text": "splicing regulation. We conclude that germ",
            "probability": 0.0705469863457794,
            "start_logit": 1.0486812591552734,
            "end_logit": 1.1508911848068237
        },
        {
            "text": "T-cell receptor variable-region \u03b2-chain (TCRVB) was",
            "probability": 0.06437383567133559,
            "start_logit": 1.1116812229156494,
            "end_logit": 0.9963195323944092
        },
        {
            "text": "istically, we show that nuclear PTEN most likely regulates Aire expression via its emerging role in splicing regulation. We conclude that germ",
            "probability": 0.06141084954381777,
            "start_logit": 0.9099888205528259,
            "end_logit": 1.1508911848068237
        },
        {
            "text": "T-cell receptor variable-region \u03b2-",
            "probability": 0.05723405514409763,
            "start_logit": 1.1116812229156494,
            "end_logit": 0.878761351108551
        },
        {
            "text": "We conclude that germ",
            "probability": 0.05601137221051831,
            "start_logit": 0.8179570436477661,
            "end_logit": 1.1508911848068237
        },
        {
            "text": "associated with a reduction in expression of the Autoimmune Regulator (Aire), a critical mediator of central immune tolerance. Mechan",
            "probability": 0.053508785243315926,
            "start_logit": 1.1403157711029053,
            "end_logit": 0.7828235626220703
        },
        {
            "text": "pmental issues including autism spectrum disorders (ASD). Although well recognized as a tumor suppressor, involvement",
            "probability": 0.05113184847710161,
            "start_logit": 0.938024640083313,
            "end_logit": 0.9396764039993286
        },
        {
            "text": "T-cell receptor variable-region \u03b2-chain (TC",
            "probability": 0.050079138623226736,
            "start_logit": 1.1116812229156494,
            "end_logit": 0.7452167868614197
        },
        {
            "text": "-",
            "probability": 0.04921005570225609,
            "start_logit": 0.8660120964050293,
            "end_logit": 0.973379373550415
        },
        {
            "text": "T-cell receptor variable-region \u03b2-chain (TCR",
            "probability": 0.048511770630948456,
            "start_logit": 1.1116812229156494,
            "end_logit": 0.71341872215271
        },
        {
            "text": "repertoire, characterized by increased prevalence of high frequency clones",
            "probability": 0.048118076192486814,
            "start_logit": 1.0533366203308105,
            "end_logit": 0.7636147737503052
        },
        {
            "text": "en. We found that PTEN mutations in humans and mice are associated with a skewed T-",
            "probability": 0.0463502106322065,
            "start_logit": 0.9747687578201294,
            "end_logit": 0.8047505617141724
        },
        {
            "text": "T-cell receptor variable-region \u03b2-chain (TCRVB) was performed on peripheral blood from PHTS patients. Based on",
            "probability": 0.04582154730503488,
            "start_logit": 1.1116812229156494,
            "end_logit": 0.6563667058944702
        },
        {
            "text": "ivity towards increased T-",
            "probability": 0.04462510262835296,
            "start_logit": 1.023789405822754,
            "end_logit": 0.7178006172180176
        },
        {
            "text": "repertoire, characterized by increased prevalence of high frequency clones. Immunological characterization showed that Pten mutants have increased B-cell proliferation and a procl",
            "probability": 0.044328974814104,
            "start_logit": 1.0533366203308105,
            "end_logit": 0.6815953850746155
        },
        {
            "text": "neurodevelopmental issues including autism spectrum disorders (ASD). Although well recognized as a tumor suppressor, involvement",
            "probability": 0.044019260971954056,
            "start_logit": 0.788244366645813,
            "end_logit": 0.9396764039993286
        },
        {
            "text": "istically, we",
            "probability": 0.042268772072816485,
            "start_logit": 0.9099888205528259,
            "end_logit": 0.7773532271385193
        },
        {
            "text": "-specific predominance of Pten. We found that PTEN mutations in humans and mice are associated with a skewed T-",
            "probability": 0.041573759000266254,
            "start_logit": 0.8660120964050293,
            "end_logit": 0.8047505617141724
        },
        {
            "text": "en. We found that PTEN mutations in humans and mice are associated with a sk",
            "probability": 0.041054644803915886,
            "start_logit": 0.9747687578201294,
            "end_logit": 0.6834287047386169
        },
        {
            "text": "en. We found that PTEN mutations in humans and mice are associated with a skewed T- and B-",
            "probability": 0.039820953986464645,
            "start_logit": 0.9747687578201294,
            "end_logit": 0.6529179811477661
        }
    ]
}
